<?xml version='1.0' encoding='UTF-8'?>
<!--EXPORT_PROGRAM:=1.0.7-ECLASS XML 5.0.0 export-->
<!--File saved on: 2025-10-28 20:44:43.096 GMT-->
<!--XML Schema used: ECLASS XML 5.0.0-->
<dic:eclass_dictionary xmlns:dic="urn:eclass:xml-schema:dictionary:5.0" xmlns:ontoml="urn:iso:std:iso:is:13584:-32:ed-1:tech:xml-schema:ontoml" xmlns:cmn="urn:eclass:xml-schema:common:5.0" xmlns:hea="urn:eclass:xml-schema:header:5.0" xmlns:idt="urn:iso:std:iso:ts:29002:-5:ed-1:tech:xml-schema:identifier" xmlns:cat="urn:iso:std:iso:ts:29002:-10:ed-1:tech:xml-schema:catalogue" xmlns:basic="urn:iso:std:iso:ts:29002:-4:ed-1:tech:xml-schema:basic" xmlns:val="urn:iso:std:iso:ts:29002:-10:ed-1:tech:xml-schema:value" xmlns:dt="urn:eclass:template:xml-schema:data-type:5.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:eclass:xml-schema:dictionary:5.0 https://www.eclass.eu/eclassxml/5.0/ECLASSXML/dictionary/dictionary.xsd">
  <hea:header>
    <schema_version>ECLASS XML 5.0</schema_version>
    <generator_version>1.0.7-ECLASS XML 5.0.0 export</generator_version>
    <generation_date>2025-10-28T20:44:43.096Z</generation_date>
    <creator>
      <cmn:organisation>ECLASS e.V.</cmn:organisation>
      <cmn:contact>
        <cmn:email>ECLASS e.V.</cmn:email>
        <cmn:url>http://eclass-cdp.com</cmn:url>
      </cmn:contact>
    </creator>
    <authorisation>
      <cmn:name>ECLASS e.V.</cmn:name>
      <cmn:contact>
        <cmn:email>ECLASS e.V.</cmn:email>
      </cmn:contact>
    </authorisation>
    <content_date>2025-10-25T00:35:26.228Z</content_date>
    <content_identification>
      <cmn:irdi>0173-1#11-ECLASS16.0#001</cmn:irdi>
    </content_identification>
    <content_description language_code="ENG">ECLASS16.0 ASSET</content_description>
    <content_language language_ref="0112-1#LG-EN#001"/>
    <originating_system>ECLASS ContentDevelopmentPlatform</originating_system>
  </hea:header>
  <ontoml:ontoml>
    <header id="0173-1#11-ECLASS16.0#001">
      <global_language language_code="en" country_code="US"/>
      <description>ECLASS16.0 ASSET</description>
      <version>ECLASS XML 5.0.0</version>
      <name>ECLASS16_0_ASSET_EN_SG_42.xml</name>
      <date_time_stamp>2025-10-28T20:44:43.104Z</date_time_stamp>
      <author>ECLASS e.V. ECLASS e.V.</author>
      <organisation>ECLASS</organisation>
      <pre_processor_version>1.0.7-ECLASS XML 5.0.0 export</pre_processor_version>
      <originating_system>ECLASS ContentDevelopmentPlatform</originating_system>
      <authorisation>ECLASS e.V.</authorisation>
      <ontoml_information>
        <revision>16.0</revision>
        <preferred_name>
          <label>ECLASS16.0</label>
        </preferred_name>
      </ontoml_information>
      <ontoml_structure>
        <source_document_identifier>869</source_document_identifier>
        <status>IS</status>
        <name>ONTOML</name>
        <date>2019</date>
      </ontoml_structure>
    </header>
    <dictionary>
      <is_complete>true</is_complete>
      <contained_classes>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW752#015" guid="9a6f99effcf24e939bc47da077250f51">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HSV antigen</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological substance that is utilized for the identification or detection of the Herpes Simplex Virus (HSV) in various clinical and laboratory settings. This antigen is instrumental in diagnosing infections caused by HSV, which can manifest in various forms, including oral and genital lesions. The detection of this antigen aids in differentiating between HSV types and understanding the immune response of an individual to the infection. It is commonly used in immunological assays and diagnostic tests to provide insights into active or past infections, thereby facilitating appropriate clinical management and treatment decisions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050411</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW753#015" guid="5955f95e88a14520b72f409766b949db">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HSV antibody (total)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a total antibody test for HSV is a diagnostic tool used to detect the presence of antibodies against the herpes simplex virus in an individual’s blood. This test identifies both types of HSV, Type 1 and Type 2, which are responsible for oral and genital herpes infections, respectively. The presence of these antibodies indicates past or present infection, aiding in the diagnosis of herpes-related diseases. This test is essential in clinical settings for assessing immune response and guiding treatment decisions. It is distinct from specific antibody tests that target only one type of HSV or other viral infections, providing a broader view of an individual’s exposure to herpes simplex viruses.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050412</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW754#015" guid="297db7f0afc54898bba9f0eef1dc2a9c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HSV (IgG)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses assays designed to detect the presence of specific immunoglobulin G antibodies against the herpes simplex virus. These tests are utilized in the diagnosis and management of infections caused by this virus, which can lead to conditions affecting the skin, mucous membranes, and central nervous system. The detection of these antibodies is crucial for understanding an individual's immune response to past or current infections. This category includes various methodologies for identifying and quantifying IgG antibodies, contributing to clinical decision-making and patient care in infectious disease management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050413</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW755#015" guid="86d9d111d96a477694cb90b687eb2b85">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HSV (IgM)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses diagnostic reagents and tests specifically designed to detect the presence of Immunoglobulin M (IgM) antibodies related to herpes simplex virus infections. IgM antibodies are typically produced in response to an acute infection and serve as a key indicator for recent exposure to the virus. The offerings in this category may include various formats of diagnostic assays, including but not limited to enzyme-linked immunosorbent assays (ELISA), rapid tests, and other immunoassays that facilitate the identification of IgM antibodies against herpes simplex virus serotypes. The focus is on enhancing clinical diagnosis and monitoring of infection status, thereby aiding in effective patient management and treatment decisions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050414</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW756#015" guid="636c2cf343414f46b6f5fdcd8031de46">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HSV 1 antibody (total)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of antibody that is produced in response to the presence of Herpes Simplex Virus type 1 (HSV-1) in the human body. The total antibody test detects both IgG and IgM antibodies, which are indicative of an immune response to HSV-1 infection, whether recent or past. This classification is distinct from other viral antibodies and reflects the unique immunological response associated with HSV-1, differentiating it from antibodies related to other viruses and their respective infections. It serves as a critical tool in diagnosing and monitoring infections caused by HSV-1, allowing for proper medical intervention and understanding of the patient's immune status regarding this virus.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050415</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW757#015" guid="aec2e158f9a24730a2bce724d08328bc">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HSV 1 (IgG)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a type of laboratory test used to detect the presence of specific antibodies in the blood that indicate a previous or current infection with a particular virus. This test measures the immunoglobulin G (IgG) response, which is typically associated with long-term immunity and can help determine whether an individual has been exposed to the virus in the past. The results can aid in diagnosing infections, guiding treatment decisions, and assessing immune status. This classification encompasses various assays and methodologies employed in immunological testing, providing essential information for clinical evaluation and patient management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050416</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW758#015" guid="9df0caac93c942f6bcfdce8a0d5b9012">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HSV 1 (IgM)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific type of diagnostic reagent used to detect the presence of immunoglobulin M (IgM) antibodies against the herpes simplex virus type 1 (HSV 1) in biological samples. This reagent is utilized in laboratory settings for the purpose of identifying recent infections, as IgM antibodies typically indicate a primary immune response. The detection of these antibodies assists healthcare professionals in diagnosing and managing infections caused by HSV 1, contributing to clinical decision-making and patient care. The classification of this diagnostic tool is distinct from other related antibody tests and viral diagnostics, focusing specifically on the IgM response to HSV 1.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050417</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW759#015" guid="a5d53bbf4266456e9a3467422111f51c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HSV 2 antibody (total)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological substance used for the detection of antibodies specific to the Herpes Simplex Virus Type 2 (HSV-2) in a sample. This item is utilized in immunological assays to determine the presence of total antibodies, which may indicate past or present infection. The product plays a critical role in diagnosing infections and monitoring immune responses. It is distinct from tests related to other herpes simplex virus types or different viral pathogens, focusing specifically on the immunological response to HSV-2. Such products are essential in clinical laboratories for the effective diagnosis and management of viral infections.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050418</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW760#015" guid="c4fc36eabc3749d4b245642bcd118227">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HSV 2 (IgG)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of immunoglobulin G (IgG) antibody associated with the herpes simplex virus type 2 (HSV-2). It is utilized in the context of diagnostic testing to identify the presence of antibodies in the serum or plasma of individuals, indicating previous exposure or infection by HSV-2. The classification distinguishes this antibody from other types of antibodies related to different viruses or other types of herpes simplex viruses. It serves as a vital tool in clinical diagnostics, allowing healthcare professionals to assess immune responses and inform treatment decisions for infections caused by HSV-2.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050419</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW761#015" guid="6b5f721fd29f4aba849ff88fc9292880">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HSV 2 (IgM)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a specific type of laboratory diagnostic test used to detect the presence of antibodies related to a particular virus known to cause infections in humans. It is part of a broader category focused on viral immunology, particularly dealing with various viral pathogens and their associated immunological responses. This type of test is primarily utilized in clinical settings to aid in the diagnosis of infections, assess immune status, and guide treatment decisions. The test specifically targets immunoglobulin M (IgM) antibodies, which indicate recent infection. This classification distinguishes it from other similar tests that may target different viruses or immunoglobulin types, or that may be designed for different diagnostic purposes within the field of infectious diseases.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050420</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW762#015" guid="2f6d7b5594a34388ab6ecb81088c94df">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HSV 1+2 (IgM)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic products specifically designed to detect the presence of immunoglobulin M (IgM) antibodies for herpes simplex virus types 1 and 2. These products are essential for identifying active infections and understanding the immune response to the herpes simplex virus. They are utilized in clinical laboratories and healthcare settings to aid in the diagnosis of viral infections, contributing to patient management and treatment decisions. The products may include various testing methodologies such as enzyme-linked immunosorbent assays (ELISA), chemiluminescent immunoassays, or other immunological techniques, ensuring accurate and reliable results for healthcare professionals.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050421</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW763#015" guid="6a2ddc37417e43b29aaade8375848334">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HSV 1+2 (IgG)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic reagents utilized in the detection of antibodies specific to herpes simplex viruses 1 and 2, indicative of past or present infections. These reagents facilitate the assessment of the immune response to these viruses, aiding in the diagnosis of herpes simplex virus infections. The category distinguishes itself by focusing specifically on immunoglobulin G (IgG) antibodies, which are typically indicative of a more established immune response compared to other antibody types. This classification does not encompass reagents targeting other viral infections or those associated with different immune response markers, thus ensuring a focused approach to herpes simplex virus diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050422</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW764#015" guid="8aff32f0e43a4b15bc4663aa724f945d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HSV (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific type of diagnostic reagent used for the detection and analysis of herpes simplex virus (HSV) infections in laboratory settings. This category encompasses various assays and methodologies that facilitate the identification of HSV presence through nucleic acid amplification techniques. It is designed for use in immunological tests, aiding healthcare professionals in diagnosing viral infections accurately. The reagents are integral to clinical diagnostics, providing essential data for patient management and treatment decisions related to HSV. The classification excludes other viral reagents and focuses solely on those pertinent to HSV analysis, ensuring clarity in its application within infectious immunology practices.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050423</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW765#015" guid="45f2b70509804b9fa0120bc710634407">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">EBV antibody</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance derived from the immune response to the Epstein-Barr virus, characterized by the presence of specific antibodies. This component is crucial for the diagnosis and monitoring of infections related to this virus, which is known to cause various health issues, including infectious mononucleosis and certain types of cancers. The detection and quantification of these antibodies provide valuable information regarding the immune status of an individual and the potential presence of an active or past infection. This category encompasses various formats and assays used to assess the presence of these antibodies in clinical and laboratory settings, serving as an essential tool in virology and infectious disease management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050424</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW766#015" guid="252a934c637b480ea4ef3f5147b9d52b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">EBV (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a specific category of reagents used for the detection and analysis of the Epstein-Barr virus (EBV). These reagents are crucial in laboratory diagnostics for identifying the presence of EBV-related infections. They facilitate various testing methodologies that assess viral load, immune response, or the presence of specific viral components. This classification is distinct from other categories related to similar viral infections and is specifically focused on the unique characteristics of EBV testing. The reagents may be employed in both research and clinical settings, contributing significantly to the understanding and management of infectious diseases associated with EBV.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050425</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW767#015" guid="cc4c7889f70446cf8bf6a3dc05da3900">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Adenovirus (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">adenovirus (NA reagent) refers to a specific type of nucleic acid reagent used in laboratory diagnostics to detect the presence of adenoviral genetic material. This reagent facilitates the identification of adenovirus infections, which are associated with a range of illnesses, from respiratory infections to conjunctivitis. The application of this reagent is crucial in virology, particularly in the context of infectious immunology, where accurate detection of viral pathogens is essential for diagnosis, treatment, and public health monitoring. The classification of this reagent distinguishes it from other related viral detection methods and highlights its unique role in the assessment of adenoviral infections.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050426</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW768#015" guid="942b5baf2cf5407fad5b30f1c7d29d2c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Enterovirus (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a reagent used for the detection or analysis of enteroviruses within a laboratory setting. This type of reagent is essential for conducting tests that identify the presence of enteroviruses in various samples, often aiding in diagnosing infections caused by these viruses. It serves as a critical tool in virology, particularly in the context of infectious immunology, facilitating research and clinical diagnostics. This category distinguishes itself from other reagents used for viral detection and encompasses a variety of testing methodologies designed to provide reliable results in the identification of enteroviral infections, contributing to patient management and public health surveillance.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050427</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW769#015" guid="e13e013dd9ab48eb9420137ec7f8a8d5">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Human papilloma virus (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance used in laboratory procedures that detects or quantifies the presence of the human papilloma virus (HPV) in biological samples. This reagent is pivotal for diagnosing HPV infections and is utilized in various immunological assays. It plays a crucial role in virology studies, contributing to the understanding and management of viral infections. The reagent is specific to human papilloma virus and is distinct from other viral detection and quantification agents within the category of infectious immunology. This substance aids healthcare professionals in the identification of HPV strains, facilitating appropriate medical interventions and patient management strategies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050428</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW770#015" guid="5fe38f33082d4fd087e3a00dc62575f5">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Influenza and para influenza (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic reagents specifically designed for the detection of influenza and para-influenza viruses. These reagents are utilized in various immunological assays to identify viral presence or immune response. The products in this category facilitate the diagnosis of respiratory illnesses caused by these viruses, aiding in the differentiation between influenza strains and other respiratory pathogens. They play a crucial role in clinical settings, contributing to efficient patient management and outbreak control. The reagents may be used in various testing methodologies, including nucleic acid testing and serological assays, ensuring accurate identification and monitoring of viral infections.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050429</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW771#015" guid="b289b8c7d9d3409095b1f9000d00244c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Respiratory syncytial virus (RSV, NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a category of substances or preparations specifically designed for the detection or analysis of respiratory syncytial virus (RSV). These items are utilized primarily in laboratory settings for diagnostic purposes. They may include various reagents that facilitate the identification of RSV through methods such as immunoassays or molecular techniques. The classification distinguishes these products from others that are associated with different viruses within the field of virology, particularly those related to infectious immunology. The focus is on reagents that are not only specific to RSV but also play a critical role in understanding and diagnosing respiratory infections caused by this pathogen.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050430</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW772#015" guid="2ce941eccb80433397dbb51666e6ca91">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Rotavirus (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a specific type of reagent used in the detection and analysis of a particular virus associated with gastrointestinal infections. Such reagents are designed to identify viral RNA or other components in biological samples, facilitating the diagnosis of infections caused by this virus. They are crucial in clinical laboratories for both diagnostic testing and research purposes. This category is distinct from other viral detection reagents, serving a unique role in virology by focusing on a virus that primarily affects the gastrointestinal system, thus aiding in public health monitoring and response to outbreaks.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050431</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW773#015" guid="9f77ea994b384f0a9c4ee558d7ce33a1">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Measles (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses reagents specifically designed for the detection and analysis of the measles virus within the field of virology, particularly in the context of infectious immunology. These reagents are utilized in various diagnostic applications to identify the presence of measles virus components or antibodies in biological samples. The focus is on tools that support the understanding of measles infection, immune response, and potential epidemiological studies. This category is distinct from other viral detection reagents, as it addresses the unique characteristics and requirements associated with measles diagnostics, ensuring a targeted approach to studying this specific infectious agent while excluding other related viruses within the broader virology domain.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050432</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW774#015" guid="2f277e05de1c47548db1984d815ae791">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Mumps, parotitis (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological reagent specifically designed for the detection or diagnosis of mumps and parotitis infections. This reagent may be utilized in various laboratory techniques to identify the presence of specific viral nucleic acids or antibodies related to the mumps virus, aiding in the understanding of immune responses or the confirmation of active infection. It is essential in clinical virology for assessing patient samples and contributes to the overall management of infectious diseases associated with mumps. The reagent is distinct from other related viral detection products, focusing exclusively on the mumps virus and its associated immunological markers.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050433</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW775#015" guid="bb70e66597fa47d2b85b71aad9ae0872">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Parvovirus B 19 (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a reagent specifically designed for the detection and analysis of Parvovirus B19, a virus known to cause fifth disease and other medical conditions. This reagent is utilized in laboratory settings for various diagnostic applications, particularly in virology and infectious immunology. It aids in identifying the presence of the virus or antibodies against it in biological samples, facilitating the diagnosis of infections. The reagent may be employed in conjunction with other diagnostic tests to provide a comprehensive assessment of viral presence, immune response, and potential health implications. Its specificity and sensitivity are crucial for accurate results in clinical diagnostics and research applications.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050434</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW776#015" guid="419378ee0e814e4abdebc047969b3a8c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Varicella zoster virus (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance used in laboratory settings that specifically targets the Varicella zoster virus, essential for the detection and analysis of this pathogen in various biological specimens. This reagent is instrumental in virological testing, allowing for the identification and quantification of the virus, which is crucial for diagnosing infections and monitoring immune responses. It plays a significant role in research and clinical diagnostics, enabling healthcare professionals to better understand the prevalence and impact of this virus on public health. The reagent is distinct from other viral detection agents, focusing solely on the Varicella zoster virus, thereby facilitating targeted studies and assessments within the field of infectious immunology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050435</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW777#015" guid="c373a7488dad402fa65b1423c651f462">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Dengue virus (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological agent utilized for the detection and analysis of the Dengue virus, specifically designed for use in immunological assays. This product serves as a crucial tool in the field of infectious disease research and diagnostics, enabling the identification of Dengue virus presence in various samples. It is characterized by its ability to interact with specific antibodies or viral components, facilitating the assessment of immune responses or active infections. This agent is distinct from other viral reagents in its specific application to Dengue, allowing for targeted studies and diagnostic procedures related to this particular virus and its associated diseases. Its use is essential in both clinical and laboratory settings for effective disease management and epidemiological studies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050436</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW778#015" guid="0059d77900764817a0e4d767be3431f4">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">FSME virus (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a reagent specifically designed for the detection and analysis of the FSME virus, which is associated with tick-borne illnesses. This reagent is utilized in laboratory settings for diagnostic purposes, enabling the identification of the FSME virus in biological samples. It is integral in virology research and clinical diagnostics, aiding in the understanding of viral infections and their impact on human health. This reagent is distinct from other viral detection agents, primarily focusing on the FSME virus, and plays a critical role in infectious disease monitoring and epidemiology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050437</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW779#015" guid="e63f86c3679443788d3a1f9c40b608e2">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">LCM virus (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses biochemical substances utilized in laboratory procedures for the detection or analysis of specific viruses associated with infectious diseases, particularly those affecting the immune system. These substances are designed for use in in vitro diagnostics and assist in identifying viral infections by targeting specific viral components or markers. The classification differentiates these substances based on their intended use, such as antibody detection or nucleic acid testing, and the specific viruses they are associated with. This ensures a systematic approach to categorizing products that aid in the diagnosis and understanding of virological conditions, contributing to effective disease management and research.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050438</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW780#015" guid="ee18f86e9dc64ec9878cb5e7d4b91c51">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hantavirus, bunyavirus (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological reagent used in virology for the detection or analysis of Hantavirus, a member of the Bunyaviridae family. This reagent is essential for identifying the presence of antibodies or antigens associated with Hantavirus infections in laboratory settings. It serves as a critical tool for researchers and healthcare professionals in the study of viral infections and immunological responses. The reagent may be utilized in various diagnostic methods, including enzyme-linked immunosorbent assays (ELISAs) and nucleic acid tests (NAT), to facilitate the understanding of Hantavirus pathology and its impact on human health. This classification distinguishes it from other viral reagents that target different viruses or viral components.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050439</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW781#015" guid="2bdf500d4a5840a9990c55c55755f880">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Avian influenza (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance used in laboratory settings for the detection, identification, or quantification of specific agents associated with avian influenza infections. This material is utilized primarily in immunological assays, allowing for the analysis of immune responses or the presence of viral components in biological samples. It is distinct from other reagents used in the detection of various viral pathogens, focusing specifically on those related to avian influenza. This classification encompasses a range of testing methodologies and applications within the field of infectious immunology, facilitating research, diagnosis, and monitoring of avian influenza outbreaks.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050440</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW782#015" guid="3cfdc49f6d7b43f09f855c67d1cbba97">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Human papilloma virus (genotyping NAT)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">human papilloma virus (genotyping NAT) refers to a laboratory procedure designed to detect and identify specific types of human papilloma virus through nucleic acid testing. This method involves the extraction and amplification of viral genetic material, allowing for the determination of the presence and type of the virus. It serves as a critical tool in the diagnosis and risk assessment of HPV-related conditions, contributing to effective patient management and treatment strategies. The classification of this testing method is distinct from other viral tests that focus on different pathogens or employ varying detection techniques, ensuring precise categorization within the broader context of virology and infectious immunology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050441</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW783#015" guid="14626a111db64adfa9ee33205c6dd131">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Adenovirus (antigen-, antibody detection, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">adenovirus detection methods encompass assays designed for the identification of specific viral antigens or antibodies within biological samples, utilized primarily in the context of in vitro diagnostics. These methods facilitate the diagnosis of adenoviral infections by determining the presence of the virus or the host's immune response. This category includes techniques for both qualitative and quantitative analysis, ensuring accurate results for clinical decision-making. The classification of these detection methods is distinct from other viral assays, emphasizing the unique characteristics and requirements of adenoviral testing. The focus is on the specificity and sensitivity of the detection methodologies, which play a crucial role in patient management and therapeutic interventions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050442</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW906#015" guid="b9a20ba4edb842d4ad9c847aa9628ca3">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Infectious immunology (other, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU153#007"/>
          <hierarchical_position>42059090</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADS278#005" guid="69524dda89b84bd6bc720e98e3d46692">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Genetic testing (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses tests and procedures designed to analyze genetic material to identify genetic disorders or predispositions to diseases. It includes methodologies that assess inborn or acquired alterations in genes or chromosomes, enabling the diagnosis, monitoring, and understanding of genetic conditions. The focus is on testing that provides insights into hereditary traits and mutations, as well as changes acquired through environmental influences or disease processes. This classification also covers tests that analyze multiple genetic parameters simultaneously, offering comprehensive insights into an individual's genetic profile. It is distinct from other testing categories that focus on biochemical, immunological, or microbiological analyses.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADJ215#005"/>
          <hierarchical_position>42060000</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU146#005" guid="4c5b8d8146464ae7937e13eaa1be0c6f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Virology (infectious immunology, excluding hepatis-, retrovirus)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a range of diagnostic tools and reagents related to viral infections, particularly those that affect the immune system. It includes various testing methods aimed at detecting antibodies, antigens, and nucleic acids associated with specific viruses. The focus is on viruses that impact human health, excluding those related to hepatitis and retroviruses. Products in this category facilitate the identification and analysis of viral infections, supporting medical diagnostics and research in infectious immunology. These offerings are essential for understanding and managing viral diseases, contributing to effective patient care and epidemiological studies. The classification is distinct from other categories related to bacteria, fungi, and parasites, highlighting its specific relevance to viral pathogens.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS277#005"/>
          <hierarchical_position>42050400</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW742#015" guid="57226e884d274354801f895bf41bfcaa">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Rubella virus antibody (total)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance that detects the presence of antibodies produced in response to an infection by the rubella virus. This measurement encompasses the totality of antibodies, indicating past exposure or immunization against the rubella virus, and is used in various diagnostic and serological tests to assess immunity status or diagnose infection. The total antibodies may include different types that respond to the virus, providing valuable information for clinical assessments. This category is distinct from other specific antibody tests, which focus on individual antibody types or related viral infections.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050401</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW743#015" guid="3d7b6c45f8ee4ce1889a3c8fbfd79868">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Rubella virus (IgG)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific immunological marker indicating the presence of antibodies generated in response to infection by a particular virus known to cause congenital rubella syndrome and other complications. This marker is utilized in diagnostic testing to assess an individual's immune status or previous exposure to the virus. The detection of this antibody is critical for evaluating susceptibility to the infection, determining immunity following vaccination, or assessing the risk of transmission in pregnant individuals. It is distinct from other related immunological markers associated with different viruses or other forms of antibodies against the same virus, reflecting a specific immune response indicative of past infection or vaccination.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050402</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW744#015" guid="e730f3269a5f4af9a3785b5362e3b81d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Rubella virus (IgM)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a specific type of viral detection that identifies the presence of antibodies related to a particular viral infection. It is utilized in medical diagnostics to determine the immune response to the virus in question, indicating recent or past exposure to the pathogen. The focus is on a specific immunoglobulin subtype, which plays a critical role in the body's immune response. This category is differentiated from other related viral assays by its specific focus on the immune markers associated with this virus, thus providing valuable insights into the patient's health status and immune history.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050403</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW745#015" guid="5e1372895618460bba53b88b24cd9340">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Rubella (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic reagent used specifically for the detection and analysis of the rubella virus, which is essential in clinical and laboratory settings for assessing immune response or confirming infection. This type of reagent plays a crucial role in virology, particularly in the field of infectious immunology. It distinguishes itself from other similar products by its specific application and the unique antigenic properties of the rubella virus. The reagent is designed to be utilized in various diagnostic procedures, ensuring accurate results in the identification of rubella virus presence or immunity levels in individuals.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050404</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW746#015" guid="02802e9ca33f4540aa4f2dc9ce1b1d3f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">CMV antigen</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance used in laboratory diagnostics that facilitates the detection or quantification of specific antibodies or immune responses related to cytomegalovirus (CMV). This entity plays a crucial role in the identification of CMV infections, which can impact various populations, particularly immunocompromised individuals. The diagnostic applications may include serological testing, where the presence of CMV-specific antibodies is assessed, or molecular methods aimed at detecting viral nucleic acids. This classification encompasses various formats and methodologies for testing, contributing to the overall understanding and management of CMV-related health conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050405</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW747#015" guid="ef8bb661ddeb46e1ac393a8fb24960d5">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">CMV antibody (total)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic product designed to detect and quantify antibodies against cytomegalovirus (CMV) in human samples, indicating exposure to the virus. This product typically plays a crucial role in assessing immune response, diagnosing infections, and monitoring the effectiveness of treatment. It is utilized in various healthcare settings to evaluate the presence of total antibodies, which may include both IgG and IgM types, reflecting past or recent infections. The classification encompasses a range of similar diagnostic tools used in virology, particularly for infectious immunology, and is distinguished by its specific focus on CMV, differentiating it from other viral immunological assays that target different pathogens.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050406</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW748#015" guid="70842b99a07848f390eba2a599c10630">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">CMV (IgG)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a specific type of immunological test that detects antibodies in the human body, specifically targeting a particular virus known for causing infections. This test is crucial for diagnosing past infections and assessing immune response in individuals. The focus on immunoglobulin G (IgG) indicates that the test is designed to identify long-term immunity to the virus, providing essential information for healthcare providers. The classification distinguishes this test from other similar tests that may target different viruses or different types of antibodies. This specificity enhances the understanding of viral infections and contributes to targeted medical interventions and patient management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050407</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW749#015" guid="38adbd481d8d468b9f639483d32e003c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">CMV (IgM)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a category of diagnostic reagents utilized for the detection of specific immunological responses associated with cytomegalovirus infections. It encompasses products designed to identify the presence of immunoglobulin M antibodies, which indicate recent exposure to the virus. These reagents are critical in clinical settings for diagnosing active infections and monitoring patient immune responses. They serve as essential tools in infectious disease management, contributing to the understanding of viral impact on health. The classification distinctly separates these products from other diagnostic reagents related to various viral infections, ensuring clarity in their specific application and purpose within the field of immunology and virology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050408</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW750#015" guid="964435fc3e3d49d195a8cd248e8ee040">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">CMV (IgG, avidity)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic reagent utilized to assess the presence and levels of Immunoglobulin G (IgG) antibodies against Cytomegalovirus (CMV) with a focus on avidity, which indicates the strength of the binding between the antibody and the antigen. This determination is crucial in evaluating the immune response to CMV infection and can assist in differentiating between recent and past infections. The avidity measurement provides additional insights into the maturity of the immune response, which is important for clinical decision-making in infectious immunology. This reagent is distinct from other related tests that target different viruses or antibody types, emphasizing its specific application in CMV diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050409</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW751#015" guid="f6fe8079db214661ad501cef3fae18d6">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">CMV (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific type of diagnostic reagent utilized in virology to detect or quantify the presence of cytomegalovirus (CMV) in biological samples. This reagent is designed to assist in the identification of viral infections and the assessment of immune responses to CMV. It is employed in various laboratory techniques to facilitate the diagnosis of CMV-related diseases, providing valuable information for patient management and treatment decisions. The reagent supports both qualitative and quantitative analysis, contributing to a comprehensive understanding of the viral load and the immune status of the individual being tested. This classification is distinct from other reagents that target different viruses or immune markers, ensuring precise identification and application within the field of infectious immunology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050410</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW667#015" guid="61ff2bdb8b744d439dfd01a1ac207b64">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hepatitis B core antibody (IgM)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific laboratory test designed to detect the presence of antibodies indicative of an immune response to the core protein of the Hepatitis B virus, specifically the IgM isotype. This test is utilized in diagnosing acute Hepatitis B infections and helps in distinguishing between recent infection and past exposure. It plays a crucial role in clinical assessments and epidemiological studies related to Hepatitis B virus infections. The detection of IgM antibodies can provide essential information for patient management and treatment decisions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050216</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW668#015" guid="7a27cae908e94471a5788e0b6c8747da">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hepatitis Be antigen (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses laboratory test reagents and methodologies used specifically for the detection of the Hepatitis Be antigen, which is a marker of Hepatitis B virus infection. These assays are utilized in the context of in vitro diagnostics to aid in the diagnosis and management of Hepatitis B. The focus is on identifying the presence of the Hepatitis Be antigen, which can indicate active viral replication and infectivity. This category is distinct from other related diagnostic tests that target different viral antigens or antibodies associated with Hepatitis B and other hepatitis viruses. The classification facilitates the systematic organization of diagnostic tools essential for effective clinical decision-making in infectious disease management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050217</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW669#015" guid="e6288384949e4e2d95e33cbeeb222d95">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hepatitis Be antigen (confirmatory)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific diagnostic test utilized to detect the presence of Hepatitis Be antigen, which serves as a confirmatory indicator of Hepatitis B infection. This assay is crucial in the context of infectious disease testing, particularly for identifying active viral replication and assessing the infection status in patients. It is differentiated from other Hepatitis-related tests based on its unique target and role in the diagnosis and management of Hepatitis B virus infections. The test is typically employed in clinical laboratories and is essential for guiding treatment decisions and monitoring disease progression.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050218</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW670#015" guid="9abba7f61490464a8ff416dcff4fab1d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hepatitis Be antibody (total)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance used in the diagnosis of infectious diseases, specifically to detect the presence of antibodies that indicate exposure to a particular virus. This product is employed in laboratory settings to confirm or rule out infections caused by specific viral agents. It plays a crucial role in the assessment of immune response and helps in determining a patient's history of infection, guiding treatment decisions, and monitoring disease progression. The product may vary in terms of specificity and sensitivity, with applications extending to various diagnostic tests aimed at understanding viral infections and their impact on health.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050219</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW671#015" guid="a5928fc63cb340a599dba22e930bf3f2">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hepatitis Be antibody (IgG)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific indicator that detects the presence of antibodies produced in response to the Hepatitis B e antigen. This testing is crucial for assessing immune status and potential past exposure to the Hepatitis B virus. It is utilized in diagnostic procedures to determine whether an individual has been previously infected with the virus or has developed immunity, providing essential information for clinical decision-making. This category encompasses tests that differentiate between various types of antibodies associated with Hepatitis B, allowing healthcare providers to evaluate the patient's history and current health status related to the Hepatitis B virus.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050220</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW672#015" guid="f5d97be89626451eaa41f04c8180e2df">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hepatitis Be antibody (IgM)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a specific type of laboratory test that detects the presence of antibodies indicative of an immune response to a particular hepatitis virus. The presence of these antibodies can provide important insights into the stage of infection or previous exposure to the virus. This test is primarily utilized in clinical diagnostics to aid in the identification and management of viral hepatitis, offering essential information for patient care and treatment decisions. It is distinguished from other related tests that measure different antibodies or viral components associated with various hepatitis viruses. The classification focuses on the unique attributes and diagnostic applications of this specific antibody test within the broader context of viral hepatitis testing.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050221</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW673#015" guid="0571b0692a5f4600adb7438625df54fa">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hepatitis B virus genotyping (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic product utilized for the identification and characterization of specific genetic sequences associated with a viral infection. This reagent is essential for determining the presence of distinct strains or variants of a virus, facilitating accurate diagnosis and treatment decisions. It plays a crucial role in both clinical and research settings by enabling healthcare professionals to assess viral mutations and resistance patterns. This classification encompasses various methodologies employed in molecular biology, particularly nucleic acid amplification and sequencing techniques, aimed at enhancing the understanding and management of viral infections. The product is integral to comprehensive viral testing protocols, ensuring precise and effective patient care.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050222</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW674#015" guid="67bc900e064042089cfbedba1506aa66">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hepatitis B virus (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological material used in laboratory settings for the detection or analysis of the Hepatitis B virus. This substance is specifically designed to facilitate molecular diagnostics, ensuring the identification of the virus's genetic material in samples. It plays a critical role in various diagnostic assays aimed at determining the presence of the Hepatitis B virus, aiding in the diagnosis of infections and monitoring the effectiveness of antiviral treatments. The reagent is an essential tool for healthcare professionals and researchers in the field of infectious diseases, providing valuable data that informs patient management and public health strategies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050223</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW675#015" guid="0bbeb70863574090ad39e19f681dd6a1">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HCV antigen</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic assays that detect the presence of specific antigens associated with a viral infection, particularly focusing on a certain type of hepatitis virus. The identified antigen plays a crucial role in the diagnosis of the infection, aiding in determining the active state of the disease. These assays are essential for clinical decision-making and public health monitoring, enabling healthcare professionals to identify and manage the infection effectively. The classification is distinct from other related diagnostic tests that target different antigens or antibodies associated with various hepatitis viruses, ensuring clarity in the identification and categorization of the specific assay type.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050224</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW676#015" guid="e4d86531f7ca454d9d3c067ed989b9c1">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HCV antigen (confirmatory)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic test designed to detect the presence of antigens associated with the Hepatitis C virus, providing confirmation of infection status. This test is typically used in conjunction with other diagnostic methods to establish a comprehensive understanding of an individual’s exposure to the virus. The assay is crucial for accurately diagnosing Hepatitis C, enabling healthcare professionals to make informed decisions regarding treatment and management. The results contribute to the overall evaluation of liver health and the progression of the disease, ensuring that appropriate therapeutic interventions can be initiated. This classification encompasses tests that specifically identify antigens, distinguishing them from antibody-based assessments and other related methodologies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050225</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW677#015" guid="c474c76b3fbe486d88e384e0c2fffd8e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HCV antibody (total)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic test designed to detect the presence of antibodies against the Hepatitis C virus in a biological sample. This test is utilized in the clinical assessment of individuals suspected of having been exposed to the Hepatitis C virus, aiding in the diagnosis and management of the infection. The test can identify total antibodies, which may indicate prior infection and the immune response to the virus. It serves as an essential tool in the broader context of infectious disease testing, contributing to the understanding of a patient's hepatitis status and informing treatment decisions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050226</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW678#015" guid="f325f530021f46088ac427f43d1fafbb">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HCV antibody (IgG)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a specific type of immunological test used to detect antibodies associated with a particular viral infection. These antibodies indicate the immune response to the virus and are crucial for diagnosing past or current infections. The testing method is typically utilized in clinical laboratories and is essential for monitoring and managing patient health. The defined category focuses on a specific immunoglobulin type, which is an indicator of exposure to the virus, providing valuable information for healthcare professionals in the context of infectious disease management. This classification is distinct from other related tests that assess different antibodies or viral components associated with various hepatitis viruses.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050227</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW679#015" guid="d1ca5826eec741d389ed9c7225f3fbbc">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HCV antibody (IgM)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of test used in diagnostic procedures to detect the presence of antibodies associated with a certain viral infection. These antibodies are produced by the immune system in response to the infection and serve as a crucial indicator of the body's response to the virus. The tests in this category are designed to identify immunoglobulin M (IgM) antibodies, which are typically present during the early stages of an infection. This classification is distinct from other testing categories that focus on different viruses or types of antibodies, ensuring precise identification and differentiation in laboratory settings. The tests are essential for diagnosing active infections and guiding appropriate clinical management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050228</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW680#015" guid="32470b1fa65d44c8aff9d3a7a2ecde01">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HCV antibody (confirmatory)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological test used to detect antibodies specific to the hepatitis C virus in a patient's serum or plasma. This test serves as a confirmatory method to verify the presence of antibodies, indicating past or current infection with the virus. It is crucial for diagnosing hepatitis C and differentiating it from other hepatitis types. The test results can provide essential information for treatment decisions and monitoring of the infection's progression. This category encompasses various testing methods that are designed to ensure high specificity and sensitivity in identifying antibodies associated with hepatitis C, thus aiding healthcare professionals in managing patient care effectively.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050229</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW681#015" guid="3b736736f27749dfaa2a0f799fb572eb">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HCV antigen/antibody combo test</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic test designed to simultaneously detect the presence of specific antigens and antibodies associated with a viral infection. This test aids in the identification and confirmation of exposure to a particular virus, providing crucial information for clinical decision-making and patient management. It is utilized in the context of infectious disease diagnostics, offering insights into both current and past infections. The test is characterized by its ability to deliver results that inform practitioners about the immune response and viral load, contributing to the overall understanding of the patient's health status.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050230</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW682#015" guid="0f38def12f9f41cab7b66e0243f2d149">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hepatitis C virus (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance utilized in laboratory settings for the detection and analysis of the Hepatitis C virus, specifically designed for use in nucleic acid testing. This reagent plays a critical role in diagnosing Hepatitis C infections by identifying the presence of viral genetic material. It is essential for confirming infection status and monitoring viral load in patients. The application of this reagent is primarily found in in vitro diagnostic procedures, contributing to the overall understanding and management of Hepatitis C viral infections. This classification encompasses various reagents that facilitate accurate testing, ensuring reliable results in clinical diagnostics related to this specific virus.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050231</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW683#015" guid="958d0e5723594042b91f5f7b4b167f38">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hepatitis C virus genotyping (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic reagent designed for the detection and characterization of specific genetic sequences associated with the Hepatitis C virus. This testing method is essential for identifying the viral genotype, which can provide critical information for determining the most effective treatment strategies for infected individuals. The assay utilizes nucleic acid amplification techniques to ensure high sensitivity and specificity in the identification of the virus's genetic material. This classification encompasses reagents specifically formulated for in vitro diagnostic use, contributing to the overall understanding and management of Hepatitis C infections.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050232</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW684#015" guid="aa03132f91424c00ae1027bccf518e9f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hepatitis delta antigen</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">hepatitis delta antigen refers to a specific protein associated with the Hepatitis D virus, which is known to require the presence of Hepatitis B virus for its replication. This antigen is utilized in diagnostic testing to identify current infections and to assess the immune status of individuals. The detection of this antigen is critical for the diagnosis of Hepatitis D virus infection, particularly in patients already infected with Hepatitis B. The presence of Hepatitis delta antigen in a sample indicates active viral replication and can guide treatment decisions. This classification is pertinent within the context of infectious disease testing, providing valuable insights into co-infections and the overall management of hepatitis-related diseases.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050233</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW685#015" guid="765ec17d2dcf487dbbb80cd3845538e9">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hepatitis delta antigen (confirmatory)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a specific type of diagnostic reagent used for the detection of a particular antigen associated with a viral infection. It is utilized in confirmatory testing to verify the presence of the antigen, which indicates infection with a specific hepatitis virus subtype. The test is crucial for accurate diagnosis and management of the infection, allowing healthcare professionals to determine the appropriate treatment and monitoring strategies. This classification is distinct from other related diagnostic tests that detect different antigens or antibodies associated with various hepatitis viruses, underscoring its unique role in the broader context of viral hepatitis testing and research.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050234</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW686#015" guid="8f4be62618a64ca2993f19e22e6aa5ad">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hepatitis delta antibody (total)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological marker produced in response to the presence of the hepatitis delta virus, indicating an individual's immune response to the infection. This substance is typically detected through specific immunoassays and is used to support the diagnosis of hepatitis delta virus infection, often in conjunction with other hepatitis evaluations. The presence of this marker can provide critical information regarding the stage of infection, potential for transmission, and the overall immune status against the hepatitis delta virus. It is an important tool in the field of infectious disease diagnostics, particularly in the context of viral hepatitis.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050235</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW687#015" guid="c5a62ca09bd246e58ad1a95169ca224c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hepatitis delta antibody (IgG)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic tests designed to detect the presence of specific antibodies indicating exposure to a particular viral infection. The focus is on the identification of immunoglobulin G (IgG) antibodies related to the hepatitis delta virus. These tests are essential for understanding an individual's immune response and history regarding this virus, which is known to co-infect with hepatitis B and can have significant implications for liver health. The classification provides a structured approach to differentiate between various hepatitis-related diagnostic assays, specifically targeting the unique characteristics of the hepatitis delta antibody. The tests categorized under this classification play a crucial role in clinical diagnostics, epidemiological studies, and patient management strategies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050236</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW688#015" guid="7a31c9d9925744709b538be382d8fe68">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hepatitis delta antibody (IgM)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific type of immunological assay used to detect the presence of antibodies indicating an immune response to a particular viral infection. This test is designed to identify immunoglobulin M (IgM) antibodies associated with the hepatitis delta virus, which is a significant marker for acute infection. The assay plays a crucial role in the diagnosis and management of hepatitis delta infections, contributing to a comprehensive understanding of a patient's immune status and guiding subsequent clinical decisions. It is utilized primarily in laboratory settings and is essential for accurate and timely detection of the hepatitis delta virus in patients suspected of having a hepatitis-related illness.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050237</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW689#015" guid="b175d65943874254ad3d922d70c645ad">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hepatitis delta virus (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological material used for the detection and analysis of the Hepatitis delta virus, which is a significant pathogen associated with liver disease. This type of reagent is essential for diagnostic procedures and helps in the identification of Hepatitis delta infections, often occurring in conjunction with Hepatitis B. The reagent is utilized in laboratory settings, particularly in in vitro diagnostics, to facilitate accurate testing and monitoring of viral presence and activity. It serves as a critical tool for healthcare professionals in the assessment and management of patients with liver-related health issues, contributing to effective treatment decisions and public health interventions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050238</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW690#015" guid="840d82c1eed44882bc9f148822828480">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HEV antigen</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a specific type of biomarker associated with the Hepatitis E virus, which is utilized in diagnostic testing for identifying the presence of the virus in biological samples. The focus is on detecting the antigen, which is a substance that triggers an immune response, indicating an active infection. This classification distinguishes itself from other related testing methods by its unique role in the diagnosis of Hepatitis E, providing essential information for healthcare providers in managing patient care. It plays a critical role in epidemiological studies and public health monitoring, facilitating the understanding of infection dynamics and guiding treatment decisions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050239</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW691#015" guid="cb362f9ee694488a9c73c214a1e9fe85">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HEV antigen (confirmatory)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic tests specifically designed to detect the presence of a particular antigen associated with a viral infection. These tests are utilized in confirmatory scenarios to validate the presence of the virus within a biological sample. The focus is on identifying antigens that are indicative of a specific viral pathogen, providing critical information for the diagnosis and management of infections. This category is distinct from other classifications that assess different viral infections or employ various methodologies for detection. The tests in this classification play a significant role in public health, contributing to the understanding and control of viral diseases.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050240</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW692#015" guid="7c61bbad930747268cee6f5d042a8ae6">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HEV antibody (total)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic tool used to detect the presence of antibodies specific to the Hepatitis E virus in a biological sample. This test is crucial for determining immune response to the virus, indicating either past infection or vaccination status. The presence of total antibodies signifies both IgG and IgM types, providing a comprehensive assessment of the individual's exposure to the virus. This classification is distinct from other related diagnostic tests targeting different hepatitis viruses and their specific antibodies or antigens, thus serving a unique role in the broader context of hepatitis virus testing.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050241</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW693#015" guid="cbc2dacbc8fe407eb4862a7166b0e3a7">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HEV antibody (IgG)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification identifies a specific type of serological test used to detect the presence of antibodies against a particular virus in a biological sample. The focus is on a specific immunoglobulin type, which indicates past infection or immune response to the virus. This category encompasses diagnostic tools that aid in the assessment of immune status or past exposure to the virus, providing essential information for patient management and treatment decisions. The classification distinguishes this item from other related tests that target different viruses or different antibody types, thereby allowing for precise identification and differentiation in laboratory settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050242</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW694#015" guid="3d3a975311ef4b188f74f645b146277e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HEV antibody (IgM)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic test designed to detect the presence of a specific immunoglobulin M (IgM) antibody associated with the Hepatitis E virus. This antibody is an indicator of recent infection and is typically utilized in laboratory settings to help determine the immunological response to the virus. The test assists healthcare practitioners in diagnosing acute Hepatitis E infections, enabling timely medical intervention and management of the disease. It is part of a broader category of diagnostic tools related to viral hepatitis, focusing specifically on the immune response generated during the initial phase of infection. This classification encompasses various serological tests that evaluate different aspects of viral infections, contributing to a comprehensive understanding of patient health and epidemiology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050243</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW695#015" guid="d8e385c1781c4abeb9c5d7eb597f778c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HEV antibody (confirmatory)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a specific type of diagnostic test utilized in the detection of antibodies associated with a particular virus, specifically targeting the hepatitis E virus. The product is designed for confirmatory testing, which means it is used to verify the presence of antibodies following initial screening tests. This type of assay plays a crucial role in the diagnosis and monitoring of infections, ensuring accurate identification of individuals who may have been exposed to the hepatitis E virus. The test is essential for healthcare providers in making informed decisions regarding patient management and treatment strategies. It is distinct from other testing modalities that assess different viral antigens or antibodies, ensuring clarity in the diagnostic process for hepatitis E.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050244</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW696#015" guid="5d91d4c105854dae91503a775cebf205">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hepatitis E virus (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses testing reagents specifically designed for the detection and analysis of the Hepatitis E virus. These reagents are utilized in laboratory settings to facilitate the identification of the presence of Hepatitis E virus in various samples, aiding in the diagnosis and monitoring of infections. They are critical for clinical diagnostics and epidemiological studies, contributing to a comprehensive understanding of Hepatitis E infections. The reagents within this classification are distinct from those used for other hepatitis viruses, ensuring precise and targeted testing methodologies for Hepatitis E, which is essential for effective patient management and public health responses.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050245</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW697#015" guid="f90a2a1952044d5e8941ab34e7fc0dfd">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HGV antigen</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance used in diagnostic procedures to detect the presence of antibodies or antigens associated with Hepatitis G virus infection. This testing is crucial for identifying active infections or immune responses, contributing to the overall understanding of hepatitis-related diseases. The materials involved may include reagents and kits designed for laboratory use, facilitating the accurate measurement of specific viral components in biological samples. These tests are essential for monitoring patient health, guiding treatment decisions, and conducting epidemiological studies related to hepatitis infections. The classification encompasses products that are specifically tailored for in vitro diagnostic applications, ensuring compliance with relevant healthcare standards.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050246</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW698#015" guid="b2b89125c36446cc909a801060f57395">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HGV antigen (confirmatory)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses diagnostic tools designed for the identification and confirmation of antigens associated with a specific viral infection. These tests are utilized in clinical settings to ascertain the presence of a targeted pathogen, thereby aiding in the diagnosis of infectious diseases. The confirmation provided by these tests is critical for ensuring accurate patient assessment and management. The methodologies employed may include various immunological assays that detect specific viral components, and are integral to the overall diagnostic process for hepatitis-related conditions. The results of these tests contribute significantly to determining the appropriate therapeutic strategy and monitoring disease progression.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050247</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW784#015" guid="a08ba5ebed614a85bf36453258f3304d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Enterovirus (antigen-, antibody detection, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses diagnostic methods specifically designed for the identification and analysis of enteroviruses through the detection of antigens and antibodies. These methods are utilized in in vitro diagnostic (IVD) applications and are critical for the assessment of immune responses or the presence of the virus in biological samples. The classification is distinct from other viral detection methods that focus on different pathogens, highlighting its unique role in infectious immunology. It serves as a valuable tool for healthcare professionals in diagnosing and monitoring enterovirus-related infections, contributing to enhanced patient management and public health interventions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050443</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW785#015" guid="b703e6e2f4774c178091801b1b1dc15d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Human papilloma virus (antigen-, antibody detection, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to diagnostic tests designed for the identification and quantification of specific immune responses related to a particular viral infection. It encompasses assays that detect either the presence of viral antigens or antibodies generated in response to the viral infection, aiding in the diagnosis of conditions associated with the virus in question. These tests are crucial in clinical laboratories to provide insights into the immune status of individuals and assist in patient management. The focus is on methodologies that facilitate the detection of human papillomavirus, employing advanced immunological techniques suited for in vitro diagnostics, thereby contributing to the understanding and monitoring of viral infections.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050444</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW786#015" guid="8637f88cca9c470e95697fc9f22e95e2">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Influenza and para influenza (antigen-, antibody detection, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic tests designed to detect antigens or antibodies associated with influenza and para-influenza viruses, utilized in the context of in vitro diagnostics (IVD). These tests are crucial for identifying viral infections, aiding in the diagnosis and management of respiratory illnesses caused by these pathogens. The focus is on the detection of specific immune responses or viral components, which provide valuable information for clinicians in determining the presence of infection and guiding treatment decisions. The category distinguishes itself from other viral detection methods by its specific application to influenza and para-influenza, thereby contributing to a comprehensive understanding of respiratory viral infections and their impact on public health.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050445</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW787#015" guid="a156abe322434bcd8a8006315b05b654">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Respiratory syncytial virus (RSV, antigen-, antibody detection, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses diagnostic tests designed for the detection of respiratory syncytial virus (RSV) through the identification of specific antigens or antibodies. Such tests are utilized within the field of infectious immunology to aid in the diagnosis of RSV infections, which are significant contributors to respiratory illnesses, particularly in pediatric populations. The methods employed may include various immunological techniques and assays that provide rapid and accurate results, assisting healthcare professionals in determining the presence of RSV and guiding appropriate clinical management. This classification differentiates these diagnostic tools from other similar assays that target different viral pathogens or utilize alternative detection methods.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050446</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW788#015" guid="a4eedde316be4dd886c4ba8892393a32">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Rotavirus (antigen-, antibody detection, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses diagnostic tools and reagents specifically designed for the detection of rotavirus antigens and antibodies in vitro. These products are utilized in laboratory settings to identify the presence of rotavirus infections, aiding in the diagnosis of gastroenteritis caused by this virus. The detection methods may include various immunological techniques that leverage the immune response to rotavirus, allowing healthcare professionals to confirm infection status or immunity. This classification is distinct from similar products associated with other viral pathogens and focuses exclusively on rotavirus-related immunological assays. The items categorized here are essential for clinical diagnostics and epidemiological studies related to rotavirus.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050447</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW789#015" guid="7c17fab014a54bb5bb791026e109afe2">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Measles (antigen-, antibody detection, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic methods intended for the detection of specific antigens or antibodies related to the measles virus. These methods are utilized in vitro for identifying the presence of the virus or immune response in a biological sample. The tests can provide crucial information for diagnosing measles infections, assessing immunity, or conducting epidemiological studies. The classification is distinct from other viral assays, focusing solely on the measles virus and its immunological markers, thereby ensuring precise differentiation from related viral tests. Such diagnostics are critical in clinical settings to manage patient care and public health interventions effectively.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050448</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW790#015" guid="e935351c904b48779ad795327e664804">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Mumps, parotitis (antigen-, antibody detection, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic methods aimed at the detection of specific antigens or antibodies associated with mumps and parotitis within the realm of infectious immunology. It is focused on in vitro diagnostic (IVD) tests that facilitate the identification of the immune response to mumps infection. These diagnostic tools are essential for determining the presence of the virus or the body’s immunological response, aiding in accurate diagnosis and management of the disease. The classification differentiates between various testing methodologies and their respective applications in the laboratory setting, ensuring clarity in the identification and usage of these diagnostic resources for healthcare professionals.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050449</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW791#015" guid="1ba4de8cb1b64b44b159ec626712cc09">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Parvovirus (B 19, antigen-, antibody detection, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic reagents and tests specifically designed for the detection of antibodies or antigens associated with Parvovirus B19. These products are utilized in vitro for the identification of the virus, which is known to cause specific infectious diseases. The reagents may include various formats such as enzyme-linked immunosorbent assays (ELISA), lateral flow tests, or other immunological techniques, aimed at determining the presence of viral components or the immune response to infection. The classification distinguishes these products based on their intended use in clinical laboratories, providing essential tools for diagnosing infections, monitoring immune status, or facilitating research in infectious diseases. This category is part of a broader classification that includes related viral diagnostics, each serving a unique purpose in the field of infectious immunology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050450</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW792#015" guid="9ce27b9ec1ea472684a258f2782be094">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Varicella zoster (antigen-, antibody detection, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses diagnostic products designed for the detection of specific antibodies or antigens related to the Varicella zoster virus, which is a pathogenic agent responsible for certain infectious diseases. These products are utilized in in vitro diagnostic testing to identify immune responses or viral presence. The classification focuses on the methodologies and technologies employed in the diagnostics, differentiating them from other similar products targeted at different viruses or infectious agents. The offerings within this classification may include various test formats, reagents, and kits that aid in the diagnosis and monitoring of conditions associated with Varicella zoster, ensuring accurate results for clinical or laboratory use.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050451</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW793#015" guid="f137839cf6f44c64b244dbd7b3e6b3b5">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Dengue virus (antigen-, antibody detection, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific category of diagnostic tools and assays utilized for the detection of antigens and antibodies associated with the Dengue virus. These diagnostic methods are primarily employed in the laboratory setting for in vitro examination, enabling healthcare professionals to identify the presence of the virus or the immune response generated by the body following infection. The focus is on immunological detection techniques, which play a crucial role in the diagnosis and management of dengue fever, distinguishing it from related viral infections by targeting unique markers specific to the Dengue virus. Such tests are essential for clinical decision-making, guiding treatment plans and monitoring patient outcomes in cases of suspected or confirmed dengue infection.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050452</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW794#015" guid="596f646f17d14c218b086e556e7522b1">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">FSME virus (antigen-, antibody detection, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to diagnostic tools utilized for the detection of specific viral antigens or antibodies associated with the FSME virus. Such tools are employed in laboratory settings for in vitro diagnostics, aiding in the identification of infections caused by this tick-borne virus. The classification encompasses a range of assays designed to ascertain the presence of antibodies or antigens, thereby supporting clinical decisions in infectious disease management. These diagnostic methods are essential for monitoring immune responses and diagnosing active or past infections, contributing to public health surveillance and individual patient care. The focus remains on the unique characteristics and applications of the FSME virus diagnostics, distinguishing them from other viral detection methods employed in immunological studies of various pathogens.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050453</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW795#015" guid="7ca457033e234e38b2174d487bffb25e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">LCM virus (antigen-, antibody detection, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic tools specifically designed for the detection of LCM virus-related antigens or antibodies, utilized in laboratory settings for in vitro diagnostic purposes. It includes various methodologies for identifying the presence of the virus, which is relevant for diagnosing infections caused by this specific pathogen. The classification highlights the importance of accurate and reliable testing in the field of infectious immunology, addressing the need for differentiation from other viral pathogens. The focus is on products that facilitate the detection and monitoring of immune responses related to LCM virus, ensuring effective disease management and patient care.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050454</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW796#015" guid="64fb253032a143adace0d1f7f0115b41">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hantavirus, bunyavirus (antigen-, antibody detection, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to biological substances utilized in laboratory diagnostics for the detection of specific antibodies or antigens related to Hantavirus, which is part of the Bunyavirus family. Such substances are critical for identifying past or present infections by analyzing biological samples, typically in the context of immunological tests. They are designed for in vitro diagnostic use, facilitating the evaluation of immune responses to Hantavirus exposure. This category is distinct from other viral diagnostic assays, as it focuses specifically on the immune markers associated with Hantavirus, allowing for the differentiation of infections caused by this particular virus from those caused by other viruses, ensuring accurate diagnosis and aiding in clinical decision-making.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050455</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW797#015" guid="0af087fe3fe94390b44b797ed1f720f0">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Avian influenza (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to the detection and analysis of specific antibodies or antigens associated with avian influenza within the context of infectious disease immunology. It encompasses various diagnostic methods designed to identify the presence of the avian influenza virus or the immune response to it in biological samples. These methods may include immunoassays and molecular techniques tailored for the detection of viral components or the antibodies produced in response to the infection. This category is distinct from others within the same area, focusing specifically on avian influenza, while differentiating itself from related viruses and their corresponding diagnostic reagents. The classification aims to support healthcare and laboratory professionals in the accurate diagnosis and monitoring of avian influenza infections.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050456</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW798#015" guid="b78d0ff9ca4343bfa1a5d2e9d4b86789">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Virology (infectious immunology, excluding hepatis-, retrovirus, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU146#005"/>
          <hierarchical_position>42050490</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU144#005" guid="0d6fc142adee4532a4ee049c1a4e3e8f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hepatitis virus testing (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses products and services specifically designed for the detection and analysis of various hepatitis viruses within the field of infectious immunology. It includes diagnostic tools, reagents, and assays that facilitate the identification of viral antigens, antibodies, and genetic material associated with hepatitis A, B, C, D, E, G, and X viruses. The offerings within this classification are tailored for laboratory use in vitro, ensuring accurate diagnosis, monitoring, and management of hepatitis infections. The classification distinctly separates these items from other infectious immunology domains, emphasizing the unique aspects and methodologies involved in hepatitis virus testing.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS277#005"/>
          <hierarchical_position>42050200</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW652#015" guid="f4303166079b4776b13f9e7d7ed3e96d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HAV antigen confirmatory</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic tool used to confirm the presence of Hepatitis A virus antigens in a biological sample. This type of testing is essential for accurately diagnosing active infections caused by the Hepatitis A virus, differentiating between past infections and current active disease. The method typically involves immunological techniques that specifically detect viral components, providing critical information for patient management and public health responses. Accurate confirmation is vital for effective treatment decisions and controlling the spread of the virus in populations. This class of diagnostic tests serves as an important resource in clinical laboratories and healthcare settings for monitoring and managing Hepatitis A infections.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050201</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW653#015" guid="ebff4745394143a183863e2f9be9e889">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HAV antibody (total)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a specific type of test utilized in the diagnosis and monitoring of viral hepatitis. It is designed to detect the presence of antibodies indicating prior exposure to the Hepatitis A virus, providing insights into the immune response of the individual. The test is essential for distinguishing between current and past infections and plays a vital role in epidemiological studies and public health strategies. It is distinct from other tests that identify antigens or different types of antibodies associated with various hepatitis viruses, allowing for a comprehensive understanding of a patient's hepatitis status and history.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050202</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW654#015" guid="388517c1d67844dca0e42a4b5e57bdea">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HAV antibody (IgG)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic assay designed to detect the presence of immunoglobulin G (IgG) antibodies specific to the Hepatitis A virus. This test is utilized in serological evaluations to assess past infections and the immune response to the Hepatitis A virus. It is distinct in its purpose from other serological tests focusing on different antibodies or antigens related to Hepatitis A or other hepatitis viruses. The assay provides valuable information for medical professionals in diagnosing and monitoring Hepatitis A infections, contributing to effective patient management and public health decisions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050203</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW655#015" guid="15291020acd04d55946e263948198fbe">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HAV antibody (IgM)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific type of diagnostic test used to detect the presence of Immunoglobulin M (IgM) antibodies against Hepatitis A virus in a patient's sample. This test is significant for identifying recent or acute infections, as IgM antibodies are typically produced during the early stages of the immune response. The assay operates through various biochemical techniques to ensure accurate measurement and differentiation from other types of antibodies related to Hepatitis A, as well as from other hepatitis viruses. It serves as a crucial tool in the clinical diagnosis and management of hepatitis A infections, aiding healthcare providers in delivering appropriate treatment and preventive measures.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050204</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW656#015" guid="f5efa543880b4480a6846db705c00dcb">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hepatitis A virus (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic reagents specifically designed for the detection and analysis of the Hepatitis A virus. These reagents are utilized in laboratory settings for in vitro diagnostic purposes, facilitating the identification of the virus in biological samples. The classification is distinct from other related diagnostic tools aimed at various hepatitis viruses, each serving a unique function in the assessment of viral presence or immune response. The reagents are critical for clinical testing, contributing to the overall understanding of hepatitis infections and assisting healthcare professionals in diagnosing and managing viral hepatitis.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050205</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW657#015" guid="be5df08c10124a6c803ad7b2b9617fcf">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hepatitis B Surface antigen</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological marker used in the diagnosis of Hepatitis B infection, this substance is present on the surface of the Hepatitis B virus. It is detected through specific immunological assays and indicates active infection or carrier status. The presence of this marker is crucial for medical professionals to assess the patient's condition, guide treatment options, and determine the need for further monitoring. It plays a significant role in both clinical diagnostics and epidemiological studies related to Hepatitis B infections. Testing for this marker helps in distinguishing between different stages of the disease and in evaluating the efficacy of vaccination against Hepatitis B.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050206</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW658#015" guid="98e7e1baf6344c198e6888c5b7dbde76">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hepatitis B Surface antigen (confirmatory)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological marker used in diagnostics to detect the presence of a specific viral antigen associated with a particular hepatitis virus. This marker is utilized in confirmatory testing to validate the initial results of hepatitis B infection screening. It plays a crucial role in the clinical management of patients by providing insights into the infection status and guiding treatment decisions. The detection and quantification of this antigen are essential for understanding the disease progression and potential transmission risks. This testing method is primarily utilized in laboratory settings, ensuring accurate and reliable outcomes for patient care.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050207</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW659#015" guid="2e42cf3436894ace978bd36af3bde9b5">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hepatitis B Surface antigen (quantitative)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic test designed to quantitatively measure the presence of a specific surface antigen associated with a viral infection. This test is utilized to evaluate an individual's immune response or to diagnose an active infection related to the hepatitis B virus. By determining the concentration of this antigen in a sample, healthcare professionals can assess the status of the infection, monitor disease progression, and make informed decisions regarding treatment options. The quantitative analysis provides critical information that aids in the differentiation of various stages of infection and the effectiveness of therapeutic interventions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050208</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW660#015" guid="63e8bf91ae19462eaa4bb86be73f4a09">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hepatitis B surface antibody (total)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific assay designed to detect the presence of antibodies against the Hepatitis B virus surface antigen, reflecting the immune response to the infection. This test aids in determining immunity to Hepatitis B, typically following vaccination or recovery from infection. The measurement of these antibodies is crucial for assessing a patient's immune status and guiding clinical decisions regarding further vaccination or therapeutic interventions. The assay is an essential component of viral hepatitis diagnostics and is often utilized in conjunction with other tests to provide a comprehensive evaluation of Hepatitis B infection and immunity.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050209</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW661#015" guid="252a696e9c7c40e390999ec59251a15c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hepatitis B surface antibody (IgG)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific type of antibody produced in response to the Hepatitis B virus, indicating past infection or vaccination. This biomarker is crucial in assessing an individual's immune status against Hepatitis B. Testing for this antibody plays a significant role in clinical diagnostics, particularly in determining immunity, guiding vaccination strategies, and monitoring infection status. It is distinct from other Hepatitis B-related tests that assess antigens or other antibody types, allowing healthcare professionals to make informed decisions regarding patient care and treatment options. This test is commonly utilized in laboratories specializing in infectious disease diagnostics and is essential for public health management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050210</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW662#015" guid="bb0d84bcc2204216b1b4e6c094c7afce">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hepatitis B surface antibody (IgM)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific test that detects the presence of antibodies indicative of recent or ongoing infection with Hepatitis B virus. This test is crucial for diagnosing immune responses related to Hepatitis B, particularly in evaluating the patient's immune status following vaccination or infection. The assay identifies the Immunoglobulin M (IgM) form of the surface antibody, which is typically present in the early stages of infection and can help differentiate between acute and chronic conditions. This testing plays a significant role in clinical decision-making, aiding in the management and treatment of Hepatitis B and monitoring patient responses to therapeutic interventions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050211</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW663#015" guid="ab57bfff357d4646bf40d337c4d58659">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hepatitis B Core antigen</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological marker used for the detection of infection with a specific virus that causes inflammation of the liver. This marker is a component of the virus and is utilized in diagnostic testing to confirm the presence of the virus in a patient’s sample. The determination of this marker is critical for diagnosing and monitoring the progression of the disease, as well as for making informed decisions regarding treatment options. The testing for this marker may be performed using various methodologies, which can provide results necessary for both clinical management and epidemiological studies related to liver health. This marker plays a significant role in the overall assessment of liver infections and in differentiating between various strains of the virus.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050212</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW664#015" guid="6e0e5a9d26a2417fac9c5bdfe63c764e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hepatitis B Core antigen (confirmatory)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological marker used for the detection of a specific component associated with Hepatitis B infection. This marker serves as an essential tool in diagnostic testing, aiding in the confirmation of Hepatitis B virus presence. It plays a critical role in differentiating between various stages of infection and assists healthcare professionals in making informed decisions regarding patient management and treatment options. The test results can provide insights into the immune response to the virus and help determine the appropriate course of action in clinical settings. This type of testing is utilized in laboratories specializing in infectious disease diagnostics and is crucial for public health monitoring.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050213</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW665#015" guid="833a9276a8614a099290f4ce09bc648a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hepatitis B Ccre antibody (total)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic tests that detect the presence of antibodies against the Hepatitis B virus in human specimens. These tests are utilized to determine an individual's immune response to the virus, indicating either past infection or vaccination status. The assays measure total antibody levels, providing a comprehensive overview of the immune response to Hepatitis B. The results play a crucial role in diagnosing Hepatitis B infection, evaluating patient immunity, and guiding clinical decisions regarding further testing or treatment. These tests are essential tools in the field of infectious disease diagnostics, aiding healthcare professionals in managing patient care related to Hepatitis B.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050214</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW666#015" guid="461aa35eb4544a69b157deb1b91abad3">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hepatitis B core antibody (IgG)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a laboratory test utilized to detect the presence of specific antibodies in the blood that indicate a previous or ongoing infection with a particular virus. This test is focused on identifying immunoglobulin G (IgG) type antibodies, which are typically produced in response to the virus and can signify past exposure or infection. The assay is significant for diagnostic purposes and assists healthcare professionals in understanding an individual's immune status in relation to the targeted virus. The results can aid in clinical decision-making, including evaluating the need for further testing or treatment options.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050215</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW332#015" guid="ab116efd54fd4a1bb6abf6143afd8520">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Prekallikrein, kallikrein (Fletcher factor)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a category of biochemical substances that play a critical role in the blood coagulation process. These substances are involved in the regulation of various physiological and pathological mechanisms associated with hemostasis, the process that prevents and stops bleeding. They are utilized in laboratory settings for diagnostic and therapeutic applications, aiding in the assessment of coagulation pathways, detecting disorders related to blood clotting, and monitoring anticoagulation therapy. The substances classified here are distinct in their specific functions and interactions within the coagulation cascade, differing from other related entities that also contribute to hemostatic processes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030220</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW333#015" guid="1bd6e563184644bea917c7cc12da431c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Coagulation factor von Willebrand RCO</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological substance that plays a critical role in the regulation of blood clotting by promoting platelet adhesion and aggregation. This factor is essential for maintaining hemostasis, particularly in conditions where blood vessels are damaged. It interacts with platelets and other coagulation factors to form a stable blood clot, thereby preventing excessive bleeding. The presence and functionality of this factor are significant for diagnosing and managing bleeding disorders, as well as guiding therapeutic interventions in patients with coagulation deficiencies. It is often measured in clinical settings to assess the coagulation status of individuals and to monitor treatment effectiveness.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030221</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW334#015" guid="b00f3c189fe1466fb999a5f19b06d424">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Coagulation factor von Willebrand CBA</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specialized type of substance involved in the coagulation process, specifically related to the von Willebrand factor, which is essential for blood clotting and maintaining hemostasis. The element plays a crucial role in the interaction between platelets and blood vessel walls, facilitating adherence and aggregation during the formation of a clot. This particular item may serve diagnostic or therapeutic purposes in medical settings, particularly in evaluating bleeding disorders associated with von Willebrand factor deficiencies or dysfunctions. It is distinct from other coagulation factors and reagents that assess different aspects of the coagulation cascade, ensuring specificity in its application for clinical diagnostics or treatment protocols.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030222</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW335#015" guid="8674650ed4734fb3a5dc9aa72bbc624f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Fibrin sensitivity monomer</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance characterized by its ability to interact with fibrin, influencing the coagulation process, and is utilized for assessing the sensitivity of fibrin to various factors in the context of haemostasis. This material plays a critical role in laboratory analyses aimed at understanding coagulation pathways and disorders. It is essential in the evaluation of clot formation and stability, contributing to the diagnosis and monitoring of conditions related to blood coagulation. Its distinct properties differentiate it from other reagents used in coagulation testing, and it is typically employed in specialized assays designed to measure fibrin responsiveness under various physiological conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030223</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW336#015" guid="7c53bf0af3a045c1869369c0f61a0e87">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Fibrinopeptide A</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">fibrinopeptide A is a specific type of peptide that plays a crucial role in the coagulation process of blood by acting as a marker for fibrin formation. It is produced during the cleavage of fibrinogen into fibrin, which is essential for the formation of blood clots. This substance is significant in various diagnostic and therapeutic applications, particularly in assessing and monitoring haemostasis. The presence and levels of Fibrinopeptide A can provide valuable insights into the coagulation status of an individual, assisting in the identification of coagulation disorders or the effectiveness of anticoagulant therapies. Its measurement is a key component in the comprehensive evaluation of the haemostatic system.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030224</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW337#015" guid="93391af74cae4129bfe0d7f49a9b711d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Heparin test</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic assay designed to measure the activity or concentration of heparin in biological samples, typically blood, to assess anticoagulant therapy or diagnose heparin-related complications. This test evaluates the effectiveness of heparin in preventing blood clot formation and is crucial for monitoring patients undergoing treatments that involve this anticoagulant. The method may involve various techniques such as chromogenic assays or activated partial thromboplastin time-based methods, which provide quantitative results reflecting the level of heparin present. This information aids healthcare providers in making informed decisions regarding treatment adjustments and patient management in various clinical settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030225</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW338#015" guid="b9371f8676a5489ca3fe8b2291ec2f1c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hirudin test</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a Hirudin test is a diagnostic procedure used to assess the anticoagulant effects of hirudin, a naturally occurring peptide derived from the saliva of leeches. This test helps evaluate the efficacy of hirudin therapy in inhibiting thrombin, an essential enzyme in the coagulation cascade. By measuring the time taken for blood to clot in the presence of hirudin, this test can provide critical information regarding a patient's anticoagulation status. It is particularly relevant in clinical settings where alternative anticoagulants are utilized, allowing healthcare professionals to monitor therapeutic levels and make necessary adjustments to treatment protocols. The Hirudin test plays a vital role in managing patients with thromboembolic disorders or those undergoing specific surgical procedures where coagulation monitoring is crucial.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030226</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW339#015" guid="b056af49256f45afbf1d1db292c2893d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Plasmin-a2 (antiplasmin complex)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical agent that serves as a specific inhibitor of plasmin, playing a crucial role in the regulation of fibrinolysis within the coagulation cascade. This substance is involved in maintaining hemostatic balance by preventing excessive breakdown of fibrin, the protein responsible for blood clot formation. Its function is vital in various clinical applications, particularly in the assessment and management of bleeding disorders and thrombotic conditions. By modulating the activity of plasmin, this agent contributes to the overall stability of blood clots, thereby influencing the dynamics of coagulation and the body's response to vascular injuries.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030227</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW340#015" guid="f3073f5871504f3884dceaf647085397">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Prothrombin fragment (1+ 2)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific category of biological assays related to the evaluation of the coagulation process, particularly focusing on a fragment generated during the prothrombin activation pathway. These assays are utilized to assess the functional status of the coagulation cascade and may serve as indicators of thrombotic disorders or conditions affecting hemostasis. The tests in this category differ from other coagulation assays by targeting distinct biomarkers and may provide valuable insights into the patient's coagulation profile. This classification is essential for healthcare professionals in diagnosing and managing various hematological conditions, ensuring accurate testing and interpretation of results in clinical practice.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030228</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW341#015" guid="97a5aa2501a64adca28f4149ff154901">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Thrombin-antithrombin III-complex</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a complex formed by the interaction of thrombin and antithrombin III, which plays a crucial role in the regulation of coagulation processes. This entity is characterized by its ability to inhibit thrombin activity, thereby modulating the coagulation cascade and contributing to the maintenance of hemostasis. The complex is utilized in various diagnostic and therapeutic applications, particularly in assessing coagulation disorders and managing conditions associated with abnormal clotting. It serves as a significant component in laboratory tests aimed at evaluating anticoagulant therapy and understanding the dynamics of thrombus formation and resolution. This classification encompasses products that are integral to the study and management of coagulation processes, highlighting their importance in clinical settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030229</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW342#015" guid="b877964a97c34a03bfe857a63c54c755">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Aggregation reagent</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance utilized in laboratory settings to facilitate the aggregation of specific components during coagulation testing. This reagent plays a crucial role in enhancing the interaction between the elements involved in the clotting process, thereby allowing for more accurate evaluation of hemostatic function. It is typically employed in assays designed to assess the efficiency and effectiveness of the coagulation cascade, contributing to the overall understanding of blood coagulation mechanisms. The aggregation reagent is distinct from other reagents used in coagulation testing, as it specifically targets the aggregation process, which is vital for the assessment of various hemostatic disorders.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030230</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW343#015" guid="e654c3f28e1d4afb8211a4612338ff3d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Platelet factor 4</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biologically active protein involved in the regulation of blood coagulation processes, specifically associated with platelet function and response to vascular injury. This substance plays a crucial role in mediating inflammatory responses and influencing the aggregation of platelets during hemostasis. It is released from platelets upon activation and has various physiological functions, including the modulation of immune responses and the facilitation of clot formation. Its presence and activity can be critical in diagnostic testing related to coagulation disorders, providing insights into platelet dysfunction and thrombotic conditions. This classification encompasses various forms and preparations used in laboratory settings for assays and therapeutic applications.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030231</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW344#015" guid="3d96dbae17b84942befc3b042de64901">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Prostacyclin</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a bioactive compound that serves as a potent vasodilator and inhibitor of platelet aggregation, commonly utilized in medical applications related to vascular health and management of pulmonary arterial hypertension. This substance plays a crucial role in regulating blood flow and preventing blood clots, thereby contributing to the overall balance of hemostasis within the bloodstream. Its therapeutic use is often associated with the treatment of cardiovascular conditions, where modulation of blood vessel tone and prevention of thrombosis are essential. This compound is distinct from other agents used in coagulation studies, reflecting a specific mechanism and application in the domain of anticoagulation and vascular therapy.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030232</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW345#015" guid="82c995fc524d44a1a79a0d97c60c8150">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Thromboxane</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">thromboxane refers to a specific type of biochemical compound that plays a crucial role in the regulation of blood clotting and vascular functions. It is a member of a larger class of substances involved in the hemostatic process, which includes various agents that promote or inhibit coagulation. This compound is primarily recognized for its function in platelet aggregation and vasoconstriction, contributing to the maintenance of hemostasis during vascular injury. As a distinct entity within the realm of coagulation reagents, Thromboxane is differentiated from other agents that may serve differing roles in the coagulation cascade or related diagnostic assays. Its applications may extend to research and clinical settings where understanding platelet activity and thrombotic processes are essential.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030233</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW346#015" guid="1637148fa733475b9a8d921136dba6a9">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">B-thromboglobulin</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance that plays a critical role in the process of blood coagulation by acting as a marker for thrombin generation and platelet activation. This component is utilized in various diagnostic assays to evaluate and monitor the haemostatic function of the blood, particularly in conditions related to clotting disorders. It serves as an important indicator in clinical settings for assessing the risk of thrombosis and the effectiveness of anticoagulant therapies. This entity is distinct from other coagulation factors and assays, highlighting its unique importance in the broader context of haemostasis and coagulation studies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030234</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW347#015" guid="a2f4e4f11c534979879901b9f9133c14">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Screening for primary haemostasis</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">screening for primary haemostasis refers to the evaluation and assessment of the initial phase of blood coagulation, focusing on the ability of platelets to aggregate and form a stable clot in response to vascular injury. This process is crucial for identifying potential bleeding disorders or dysfunctions in the body's hemostatic mechanisms. The screening involves the use of various reagents and methodologies designed to measure the effectiveness of platelet function and interaction with clotting factors. It is essential in clinical diagnostics to ensure proper management of patients with bleeding tendencies or those undergoing surgical procedures, thereby aiding in the prevention of excessive bleeding and ensuring effective hemostatic control.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030235</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW348#015" guid="7ca0d687f9714620bafb9e3f57676497">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">A2-antiplasmin</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a2-antiplasmin refers to a specific protein that functions as an inhibitor of plasmin, playing a critical role in the regulation of fibrinolysis, the process that breaks down fibrin in blood clots. By binding to plasmin, A2-antiplasmin prevents the degradation of fibrin, thus maintaining the integrity of blood clots. This regulatory mechanism is essential in ensuring proper hemostasis and preventing excessive bleeding or thrombosis. A2-antiplasmin is utilized in various diagnostic assays and therapeutic applications related to coagulation disorders, making it important in clinical settings focused on blood coagulation and fibrinolysis management. The classification of this component distinguishes it from other related agents involved in the coagulation pathway, emphasizing its unique role in the coagulation process.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030236</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW349#015" guid="40fb106191ac40028ba9105904288c18">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Fibrinogen degradation product</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance that results from the breakdown of fibrinogen, typically present in the bloodstream following clot formation and subsequent degradation. This product is utilized in the assessment of coagulation disorders and can indicate the presence of thrombotic events or other abnormalities in the hemostatic process. It serves as a marker for various pathological conditions, providing insight into the balance between coagulation and fibrinolysis. Testing for this degradation product is critical in clinical settings to evaluate the effectiveness of anticoagulation therapy and to diagnose conditions related to excessive clotting or bleeding. Its analysis contributes to understanding and managing disorders related to blood coagulation and fibrinolytic activity.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030237</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW350#015" guid="e6cacba11c824336beb28a40d32669b0">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">D-dimer</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance that is a degradation product formed from the breakdown of fibrin in the blood, typically used as a biomarker in the assessment of thrombotic disorders and conditions characterized by increased clot formation and breakdown. The presence and concentration of this compound in the bloodstream are indicative of the body's response to clotting and fibrinolysis processes. It serves as a critical diagnostic tool in various clinical settings, particularly in evaluating suspected venous thromboembolism, pulmonary embolism, and other conditions related to hemostatic imbalance. Measurement of this substance aids healthcare professionals in making informed decisions regarding patient diagnosis and treatment.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030238</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW351#015" guid="d1afe0d994c3461abc2bf7e051acac2a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Plasmin</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance involved in the process of fibrinolysis, functioning to break down fibrin clots within the bloodstream. This component plays a crucial role in regulating hemostasis by promoting the dissolution of clots once they are no longer needed, thereby maintaining proper blood flow and preventing excessive clotting. Its activity is essential for normal physiological processes, particularly in the context of wound healing and cardiovascular health. The presence and concentration of this agent can be critical in various clinical scenarios, particularly in diagnosing and monitoring conditions related to coagulation disorders, where an imbalance in clot formation and breakdown may occur.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030239</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW352#015" guid="385ecfe27b3d43c4920eb55436b2426f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Plasminogen</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological substance crucial for the regulation of fibrinolysis, facilitating the breakdown of fibrin in blood clots. This protein is synthesized in the liver and is converted into its active form, plasmin, through the action of specific activators. In the context of coagulation and haemostasis, this component plays a significant role in maintaining the balance between clot formation and dissolution. Its measurement and analysis are important in various clinical settings, particularly in diagnosing and monitoring conditions related to abnormal clotting and bleeding disorders. This entity is distinct from other reagents used in coagulation assessments, focusing specifically on the fibrinolytic pathway and its implications for hemostatic balance.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030240</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW353#015" guid="1a74eda3671f4cb59e1bb4cfce72820e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Plasminogen activator-Inhibitor</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological substance that plays a crucial role in regulating fibrinolysis by inhibiting the activity of plasminogen activators, thereby controlling the dissolution of fibrin clots in the blood. This element is essential for maintaining a balance between coagulation and fibrinolysis, ensuring proper blood flow and preventing excessive bleeding or thrombosis. It is utilized in various laboratory tests and clinical settings to assess and monitor hemostatic function and is vital in understanding disorders related to coagulation and thrombosis. The presence and activity levels of this inhibitor can provide important insights into an individual's hemostatic status and potential risk for thrombotic events.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030241</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW354#015" guid="f65cda9f09aa4b1680390a3ec51394c9">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Tissue plasminogen activator</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological agent that facilitates the conversion of plasminogen into plasmin, playing a crucial role in the breakdown of fibrin in blood clots. This substance is often utilized in medical settings to enhance thrombolysis, particularly in the treatment of conditions associated with thrombus formation. The agent is characterized by its ability to selectively target and activate the plasminogen system, promoting the dissolution of clots and restoring normal blood flow. It is distinguished from other agents that evaluate or influence coagulation pathways, focusing specifically on the fibrinolytic process. This product is essential in therapeutic interventions where rapid resolution of blood clots is necessary for patient recovery.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030242</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW355#015" guid="9b4928efd2dc4f67a0d7cfa323fe7c60">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Urokinase plasminogen activator</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical agent that functions as a serine protease, involved in the conversion of plasminogen to plasmin, thereby facilitating the breakdown of fibrin in blood clots. This substance is utilized primarily in medical diagnostics and therapeutic applications related to coagulation processes. Its role is critical in managing conditions where the dissolution of blood clots is necessary, such as in certain cardiovascular events. The classification of this agent is distinct from other related diagnostic and therapeutic agents involved in coagulation, which serve various functions in hemostasis, including clotting factor assays and tests for thrombosis.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030243</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW356#015" guid="ef87b2fbfc014d7bafe63c707cdb711b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Thrombin activating fibrinolysis inhibitor</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance that facilitates the inhibition of fibrinolysis by activating thrombin, playing a critical role in regulating blood coagulation processes. This material is utilized in various medical applications to manage hemostatic functions, particularly in scenarios where control of fibrinolytic activity is essential. Its application is distinct from other reagents related to hemostasis, as it specifically targets the thrombin pathway to modulate clot formation and dissolution. This agent is essential in clinical settings for diagnosing and treating coagulation disorders and monitoring therapeutic interventions that involve the coagulation cascade.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030244</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW357#015" guid="48ee6a659d0244fca7eb2c86c36b8e0e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Anti-phospholipid antibody</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific type of biological marker that targets the presence of certain autoantibodies associated with the immune response against phospholipid-binding proteins. This marker plays a significant role in the assessment of thrombotic disorders, particularly in the evaluation of conditions related to increased risk of blood clot formation. The detection of these antibodies is essential for diagnosing various autoimmune conditions and understanding their implications for coagulation pathways. The classification reflects its distinct purpose within the broader context of coagulation testing, differentiating it from other tests that evaluate various aspects of the hemostatic process. This biological marker is utilized in clinical laboratories to support diagnosis and management of patients with suspected thrombotic complications.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030245</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW358#015" guid="3abdcb7f57f64417b3e6f4d7df17eaed">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Antithrombin III</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical substance that plays a crucial role in regulating blood coagulation by inhibiting thrombin and factor Xa, thereby preventing excessive clot formation. This entity is essential in various clinical settings, especially in diagnosing and managing disorders related to coagulation. It is used in laboratory tests to assess the functionality and levels of coagulation pathways, providing insights into thrombotic conditions. The substance can be administered therapeutically to patients with specific deficiencies or to counteract the effects of anticoagulant treatments. Its presence and activity are vital for maintaining hemostatic balance and ensuring proper vascular function.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030246</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW359#015" guid="2429948ccaa2478c81ec0bfa57a54c5d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Coagulation factor VIII inhibitor</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">inhibitors of coagulation factor VIII are specialized proteins that interfere with the activity of factor VIII, a crucial component in the blood coagulation cascade responsible for proper clot formation. These inhibitors can be present in individuals, particularly those with certain bleeding disorders, and may lead to impaired hemostasis, complicating treatment strategies for managing bleeding episodes. The presence of such inhibitors can be detected through specific assays and plays a significant role in the diagnosis and monitoring of coagulation disorders. Understanding the dynamics and characteristics of factor VIII inhibitors is essential for effective clinical management of patients with coagulation abnormalities.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030247</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW360#015" guid="45c2bc8089384666af908712da66b775">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Coagulation factor IX inhibitor</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance that specifically inhibits the activity of coagulation factor IX, an essential component in the blood coagulation cascade. This inhibitor interferes with the normal function of factor IX, which plays a critical role in the activation of the intrinsic pathway of coagulation, leading to a disruption in the formation of blood clots. The presence of this inhibitor can significantly impact coagulation tests and patient management in conditions associated with bleeding disorders. This category encompasses various forms of such inhibitors, which may arise due to autoimmune responses or as a result of therapeutic interventions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030248</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW361#015" guid="cdf9d0f85c6d49388abef8a4c1daf784">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Coagulation factor X inhibitor</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance that specifically inhibits the activity of coagulation factor X, a key component in the blood coagulation cascade, thereby playing a crucial role in regulating blood clot formation. This agent is utilized in clinical settings to manage conditions associated with abnormal coagulation, particularly in the context of anticoagulation therapy. The action of this inhibitor can help prevent excessive clotting, offering therapeutic benefits in various medical situations where maintaining appropriate hemostasis is essential. Its application is vital in the diagnosis and treatment of disorders related to coagulation abnormalities, contributing to improved patient outcomes in the management of thrombotic conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030249</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW362#015" guid="535a7bca6f0a490bb21156ee7d87a0be">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Lupus anticoagulant</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification category encompasses substances that are specifically designed to identify and measure the presence of a particular antibody in the bloodstream, which is associated with an increased risk of thrombosis. These substances are utilized in various diagnostic procedures to evaluate the functionality of the coagulation system and to aid in the diagnosis of autoimmune disorders. This category is distinct from other classifications that focus on different aspects or parameters of coagulation testing. The specificity of this classification lies in its application to the detection of a unique anticoagulant marker, rather than general coagulation factors or tests.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030250</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW363#015" guid="907ae330447c4e9a83c8ebe305530e41">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Protein C</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of biochemical substance essential for the regulation and assessment of coagulation processes within the human body. It is characterized by its role in influencing the formation and dissolution of blood clots, playing a crucial part in hemostasis. The substance is utilized in various diagnostic and therapeutic applications, particularly in the context of coagulation disorders. Its classification distinguishes it from other related biochemical agents that serve different functions within hemostatic assays and treatments. This particular entity is vital for ensuring proper blood clotting mechanisms and is often analyzed in laboratory settings to monitor and manage coagulation-related health conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030251</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW699#015" guid="f3147a0a8146438eaa21798d2022b157">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HGV antibody (total)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a comprehensive diagnostic test designed to detect the presence of antibodies against the Hepatitis G virus in a patient's serum. This test serves as a valuable tool in the evaluation of Hepatitis G virus infections, providing insights into the immune response of the individual. The detection of total antibodies indicates prior exposure to the virus, which can aid in assessing the infection status and guiding further clinical management. This assay is essential for healthcare professionals in diagnosing and monitoring hepatitis-related conditions, contributing to a better understanding of viral hepatitis and its implications on patient health.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050248</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW700#015" guid="7dfa51042146439590d310427ba961b0">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HGV antibody (IgG)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification includes diagnostic tools specifically designed to detect the presence of antibodies against the Hepatitis G virus. These tools are utilized in laboratory settings to assess immune responses in individuals who may have been exposed to this virus. The detection of these antibodies is critical for understanding the status of infection and for guiding clinical decisions related to patient management. The products within this classification are distinguished by their capability to identify various forms of antibodies, contributing to the comprehensive evaluation of Hepatitis G virus exposure and infection.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050249</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW701#015" guid="18d7a2f628f6495b950b2ce831d1fac7">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HGV antibody (IgM)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of immunological assay designed to detect the presence of antibodies produced in response to the Hepatitis G virus. It serves as an important diagnostic tool in clinical laboratories, particularly in the context of infectious disease testing. The product is characterized by its ability to identify immunoglobulin M (IgM) antibodies, which indicate recent or acute infection. The assay contributes to the overall understanding of a patient's immune response and assists healthcare professionals in diagnosing and managing hepatitis infections. This classification is distinct from other related assays that target different viruses or antibody types, ensuring precise identification and differentiation in the realm of viral hepatitis testing.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050250</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW702#015" guid="95ee04cb849e4c2c9a1c468f7234fd3c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hepatitis G virus (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic reagent specifically designed for the detection and analysis of the Hepatitis G virus in clinical laboratories. This reagent facilitates the identification of the virus's presence in biological samples, contributing to the overall assessment of viral infections related to Hepatitis. It is utilized in various diagnostic procedures, ensuring accurate and reliable results for healthcare professionals in their efforts to diagnose and manage Hepatitis-related conditions. The reagent is part of a broader category focused on testing for various Hepatitis viruses, each serving distinct roles in viral identification and monitoring.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050251</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW703#015" guid="ef005e75eded46cdb43d1212052983d4">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HXV antigen</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of biomarker used in the detection of the Hepatitis X virus. It is utilized in diagnostic settings, particularly within the realm of in vitro diagnostics, to identify the presence of viral antigens associated with Hepatitis X. These antigens are crucial for the early diagnosis and monitoring of the infection, providing valuable information for healthcare providers. The focus is on the biochemical properties and immunological responses generated by the presence of the virus, distinct from other hepatitis-related markers. This classification is essential for ensuring accurate and efficient testing procedures in clinical laboratories, contributing to better patient outcomes through timely interventions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050252</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW704#015" guid="0d37e8db0152486fbf7d7c874dad2f3e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HXV antigen (confirmatory)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific type of diagnostic test used to detect the presence of antigens associated with a particular virus, offering confirmation of infection. This test is part of a broader category focused on the detection and analysis of various hepatitis viruses. The confirmatory nature of this test distinguishes it from other diagnostic assays that may target different types of antibodies or antigens related to other hepatitis viruses. Its primary role is to provide reliable confirmation of the presence of the specified antigen, aiding healthcare professionals in diagnosing and managing viral infections. This class is essential for accurate patient assessment and is integral to the overall understanding of hepatitis-related health issues.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050253</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW705#015" guid="4a8c26da507747c18162e25fcf61056f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HXV antibody (total)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses diagnostic products specifically designed to detect and quantify antibodies against the Hepatitis X virus. These tests are utilized in clinical laboratories to aid in the diagnosis and monitoring of infections caused by the Hepatitis X virus. They provide valuable information regarding the immune response of an individual to the virus, which can assist healthcare professionals in making informed decisions about patient management and treatment options. The tests in this category are characterized by their specificity and sensitivity in identifying the presence of total antibodies, thereby contributing to a comprehensive understanding of the patient’s serological status related to Hepatitis X virus infection.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050254</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW706#015" guid="36989b1626dc4c47bdf35df84f6866f3">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HXV antibody (IgG)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of immunoglobulin G (IgG) antibody that is produced in response to the presence of the Hepatitis X virus. The presence of this antibody is indicative of a past or ongoing infection with the virus, playing a crucial role in serological testing and diagnosis. The assay for this antibody is utilized in the context of infectious disease diagnostics, particularly to assess an individual’s immune response to Hepatitis X. The identification of this antibody helps healthcare professionals in determining the infection status and guiding treatment decisions. This category is distinct from other related antibody tests and viral antigens, focusing specifically on the IgG response linked to Hepatitis X infection.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050255</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW707#015" guid="274e104a31284e10b7ebe5043e906975">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HXV antibody (IgM)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a specific type of immunoglobulin M (IgM) antibody associated with the detection of infection by a particular hepatitis virus. The presence of this antibody is indicative of a recent or active infection and is used in diagnostic testing to confirm the body's immune response to the virus. This classification is part of a broader category focused on various tests and reagents used to identify infections caused by hepatitis viruses, providing essential information for clinical decision-making and patient management. The tests within this category are critical for distinguishing between different types of hepatitis infections, facilitating timely and appropriate therapeutic interventions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050256</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW708#015" guid="061518cef7dc4507bb4a9fd0ae75aa77">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hepatitis X virus (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic reagent specifically formulated for the detection or analysis of the Hepatitis X virus, which is utilized in laboratory settings. This reagent is essential for conducting assays aimed at identifying the presence of the virus in biological samples, thereby aiding in the diagnosis and monitoring of infections. Its application is crucial for healthcare professionals and researchers involved in infectious disease management and epidemiological studies. The reagent facilitates precise and sensitive testing methods, contributing to the overall understanding and detection of Hepatitis X virus-related conditions. This classification encompasses various forms of the reagent used in molecular diagnostics, ensuring that it meets the stringent requirements for in vitro diagnostic purposes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050257</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW709#015" guid="4b7d32a4bbdd4ba9b54847fdea7d4482">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hepatitis virus testing (IVD, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU144#005"/>
          <hierarchical_position>42050290</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU127#005" guid="db568f152fa84f38a02b526ef2fcdacb">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Haemostasis reagent (coagulation)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a variety of diagnostic substances and materials utilized in the assessment and monitoring of blood coagulation processes. These reagents are essential for determining various parameters related to haemostasis, including clot formation and breakdown, as well as the activity of specific coagulation factors. The substances included in this category are employed in laboratory settings to facilitate tests that evaluate the body's ability to form clots and prevent excessive bleeding. They play a crucial role in both routine and specialized testing, aiding healthcare professionals in diagnosing conditions related to coagulation disorders. This classification distinctly separates these reagents from those used in other hematological assessments, immunological studies, and histological applications.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS275#005"/>
          <hierarchical_position>42030200</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW313#015" guid="b67d2b811deb4ad085ab4cb3741cdbf2">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Prothrombin time (quick test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic procedure that measures the time it takes for blood to clot, providing essential information on the coagulation status of an individual. This test is commonly used in clinical settings to assess the functionality of the extrinsic pathway of the coagulation cascade, which involves factors that respond to tissue injury. The results are typically expressed in seconds and can aid in the diagnosis of bleeding disorders, monitor anticoagulation therapy, and evaluate liver function. This specific test differs from other coagulation assessments by its unique methodology and the specific factors it evaluates, making it a critical tool in the management of patients with coagulation abnormalities.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030201</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW314#015" guid="a2f8a4e7476245b5afe46bfd5c1178e5">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Activated partial thromboplastin time</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses diagnostic tests used to measure the time it takes for blood to clot in the presence of specific activators, providing essential information regarding the intrinsic pathway of coagulation. It is utilized in clinical settings to assess the efficacy of anticoagulant therapy, diagnose bleeding disorders, and monitor the overall coagulation status of patients. The tests in this classification utilize various reagents and methodologies to determine clotting times, reflecting the functionality of clotting factors and the integrity of the coagulation cascade. The results are pivotal for healthcare professionals in making informed decisions related to patient management in conditions associated with hemostasis.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030202</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW315#015" guid="0401cbcedfb442d1b9dc66d842383a31">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Thrombin time, reptilase, batroxobin time</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a range of analytical procedures that measure the time it takes for blood to clot in the presence of specific reagents that activate the coagulation cascade. These tests are essential for assessing various aspects of the hemostatic process, providing critical information in the diagnosis and management of bleeding disorders. The procedures within this classification are distinct in their methodologies and the specific pathways they evaluate, differentiating them from other coagulation tests. They play a significant role in clinical settings, enabling healthcare professionals to monitor coagulation function and guide therapeutic interventions effectively.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030203</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW316#015" guid="229d157c76ba49ca9a6d77e4eb17842d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Activated clotting time</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a method used to assess the time taken for blood to clot, specifically measuring the intrinsic and common pathways of coagulation. This test is employed in various clinical settings, particularly in monitoring anticoagulant therapy and evaluating coagulation disorders. The activated clotting time is influenced by the presence of specific anticoagulants and can vary based on the reagents and procedures used in the testing process. It serves as a crucial parameter in the management of patients undergoing procedures that may impact hemostasis, helping healthcare professionals make informed decisions regarding treatment and intervention strategies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030204</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW317#015" guid="b61b481adb5f4c0493ce960513109ee0">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Fibrinogen assay (factor I)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a test designed to quantify the concentration of fibrinogen, a key protein in the blood coagulation process, is referred to as a fibrinogen assay. This assay is crucial for evaluating the functionality of the coagulation cascade and can assist in diagnosing various bleeding disorders or conditions related to abnormal clotting. The measurement helps in assessing fibrinogen levels, which can be critical in managing patients undergoing surgery, trauma, or those with liver disease. The results from this assay guide healthcare professionals in making informed decisions regarding treatment options and monitoring anticoagulant therapy. This type of assay stands apart from other coagulation tests that focus on different factors or pathways within the hemostatic process.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030205</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW318#015" guid="6b32db818e9449c895260f9df893a9a4">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Coagulation factor II (prothrombin)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance that plays a crucial role in the blood coagulation process, specifically acting as a precursor to thrombin. This factor is essential for the conversion of fibrinogen to fibrin, which is a key step in the formation of a stable blood clot. It is typically activated in the presence of specific enzymes and is involved in various physiological processes related to hemostasis. The evaluation of this factor is significant for diagnosing and managing bleeding disorders, as well as monitoring anticoagulant therapies. Its activity can be influenced by multiple factors, including genetic variations and the presence of certain medical conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030206</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW319#015" guid="3d8a2ebc6bb84cd2b023749c2c1b27e6">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Coagulation factor IIa (thrombin)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical substance that plays a crucial role in the process of hemostasis by catalyzing the conversion of fibrinogen to fibrin, thereby facilitating the formation of a stable blood clot. This factor is integral to the coagulation cascade and is essential for normal blood clotting functions. Its activity is critical in various diagnostic and therapeutic applications related to coagulation disorders. The substance can be produced in laboratory settings for clinical use and is often evaluated in assays to assess coagulation function and monitor treatment efficacy.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030207</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW320#015" guid="3613dcd8e0a8441c820405ab36b71289">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Coagulation factor V</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a coagulation factor is a specific protein that plays a crucial role in the coagulation cascade, a series of biochemical reactions that lead to blood clot formation. This factor is essential for maintaining hemostasis, the process that prevents excessive bleeding when a blood vessel is injured. Coagulation factors are typically produced in the liver and released into the bloodstream, where they interact with other proteins and cells to facilitate clotting. Each factor has a unique function within the cascade, and deficiencies or abnormalities in these factors can lead to bleeding disorders or thrombotic conditions. This classification encompasses various agents that are used in laboratory settings to assess and monitor coagulation processes, ensuring accurate diagnosis and treatment of related medical conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030208</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW321#015" guid="3a0905b0c1394401b6490bdaa53a5154">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Coagulation factor VII</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological substance involved in the coagulation process, specifically functioning to activate certain proteins that play critical roles in blood clotting. This factor is essential for the formation of stable blood clots and is utilized in various diagnostic and therapeutic applications related to hemostasis. It is distinguished by its specific action within the coagulation cascade and is relevant for assessing coagulation disorders or guiding treatment for patients with bleeding risks. The presence and activity of this factor can be measured through specialized assays, contributing to the overall understanding of an individual's coagulation status.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030209</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW322#015" guid="4b335bb7ca994f998c5bdce9ee7b5c5e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Coagulation factor VIIa</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a bioactive protein involved in the coagulation cascade, specifically functioning as a serine protease that activates factor X to Xa, thereby playing a crucial role in the formation of blood clots. This factor is essential for hemostasis and is utilized in various therapeutic and diagnostic applications related to bleeding disorders. It is primarily indicated for use in patients with specific deficiencies or inhibitors affecting the coagulation pathway. The administration of this factor can aid in the management of bleeding episodes, particularly in individuals undergoing surgical procedures or suffering from hemophilia. Furthermore, it may be employed in laboratory settings for testing and research related to coagulation processes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030210</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW323#015" guid="bae816eec72c403589fa28c2f4506903">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Coagulation factor VIII</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">coagulation factor VIII is a critical protein involved in the blood coagulation process, playing a vital role in the regulation of hemostasis. It functions as a cofactor for factor IXa, enhancing the activation of factor X, which subsequently leads to the formation of thrombin and the conversion of fibrinogen to fibrin. Deficiency or dysfunction of this factor can result in bleeding disorders, most notably hemophilia A. This entity is essential in various diagnostic and therapeutic applications related to blood clotting and is utilized in both laboratory assays and treatment regimens. Its classification distinguishes it from other factors and reagents involved in the coagulation cascade, highlighting its unique properties and clinical significance in managing bleeding diatheses.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030211</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW324#015" guid="4b111ae3c51b4282a75ddaa6b7dd861c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Coagulation factor IX</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific protein involved in the blood coagulation process, functioning primarily as a crucial component in the regulation of hemostasis. This factor is produced in the liver and is essential for the proper formation of blood clots, playing a vital role in preventing excessive bleeding. Its activity can be influenced by various factors, including genetic mutations and the presence of inhibitors. Testing for this protein is important in diagnosing and managing bleeding disorders, and it is utilized in clinical settings to assess coagulation pathways and therapeutic responses. Understanding its functionality contributes to effective treatment strategies for conditions related to coagulation abnormalities.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030212</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW325#015" guid="17b64484ecee4bac81cbb3bfaee45770">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Coagulation factor X</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a coagulation factor is a specific protein in the blood that plays a critical role in the process of blood clotting. It facilitates the formation of blood clots by participating in a series of biochemical reactions known as the coagulation cascade, which ultimately leads to the conversion of fibrinogen into fibrin, the protein that forms the basis of a clot. Coagulation factor X is essential for the proper functioning of this cascade, acting at a point where both intrinsic and extrinsic pathways converge. Abnormal levels or activity of this factor can lead to bleeding disorders or thrombosis, highlighting its importance in maintaining hemostatic balance in the body.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030213</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW326#015" guid="c73ddfd5e62f4d38b7a2f74392b81fd3">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Coagulation factor XI</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance that plays a critical role in the blood coagulation process, specifically involved in the intrinsic pathway of hemostasis. It is essential for the formation of a stable blood clot and is activated in response to vascular injury. This component is produced primarily in the liver and circulates in the bloodstream in an inactive form. Upon activation, it contributes to the catalysis of subsequent reactions leading to the conversion of prothrombin to thrombin, thereby facilitating the transformation of fibrinogen into fibrin. The measurement of this factor is crucial in diagnosing and monitoring coagulation disorders, aiding in the assessment of bleeding risks and the effectiveness of anticoagulant therapies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030214</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW327#015" guid="b3737a79e7254a82b1900f812590b352">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Coagulation factor XII</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a coagulation factor is a specific protein in the blood that plays a crucial role in the process of blood coagulation, contributing to the formation of blood clots. These factors work in a cascade mechanism, where each factor activates the next in the series, ultimately leading to the stabilization of the fibrin clot. Coagulation factor XII, in particular, is essential for initiating the intrinsic pathway of coagulation and is activated upon contact with negatively charged surfaces. Abnormalities or deficiencies in this factor can lead to bleeding disorders and affect the overall hemostatic balance. This category encompasses various reagents used in laboratory testing and diagnostics related to blood coagulation, particularly focusing on the measurement and analysis of this specific factor's activity and function.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030215</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW328#015" guid="af31e12c4bf94a5cb16cbc30d727c678">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Coagulation factor XIIa</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical substance that plays a crucial role in the process of blood coagulation, specifically functioning as an enzyme in the activation of the coagulation cascade. This factor is integral for the transformation of proenzymes into their active forms, thereby facilitating the formation of a stable blood clot. Its presence and activity are vital in regulating hemostasis, contributing to the prevention of excessive bleeding during vascular injury. The assessment of this factor is important in diagnosing and managing various bleeding disorders, as well as for monitoring therapeutic interventions related to coagulation.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030216</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW329#015" guid="fefcc83b795949a9b941a4b78901518b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Coagulation factor XIII</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance that plays a critical role in the blood coagulation process, specifically involved in the stabilization of the fibrin clot. This factor is essential for the formation of cross-links between fibrin molecules, enhancing the structural integrity of the clot. It is produced by the liver and is activated during the coagulation cascade, contributing to hemostasis by preventing excessive bleeding. The absence or dysfunction of this factor can lead to bleeding disorders, highlighting its importance in maintaining normal blood coagulation. This classification includes various forms and preparations of this factor used for diagnostic and therapeutic purposes in clinical settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030217</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW330#015" guid="f4dc42f94603435e9ee53ecc26a0e67b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Coagulation factor HMW-Kininogen (Fitzgerald)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological substance that plays a crucial role in the coagulation process, specifically functioning as a precursor to various bioactive peptides involved in vascular homeostasis and inflammation. This element is integral in the regulation of blood clotting and is essential in maintaining proper hemostatic balance within the circulatory system. Its presence is particularly significant in the assessment and management of coagulation disorders, contributing to diagnostic procedures and therapeutic strategies aimed at restoring hemostatic function. This substance is characterized by its high molecular weight and is utilized in various laboratory tests to evaluate coagulation pathways, making it a vital component in the field of hematology and clinical diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030218</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW331#015" guid="623a8b95a1764dc3b0d4c174480e4d28">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Coagulation factor von Willebrand</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a protein that plays a crucial role in the blood coagulation process, involved in the stabilization of blood clots and the adhesion of platelets to sites of vascular injury. This factor is essential for normal hemostasis and is particularly important in the interaction between platelets and blood vessels. It serves as a carrier for factor VIII and is critical in the prevention of excessive bleeding. Abnormalities or deficiencies in this factor can lead to bleeding disorders, necessitating its measurement in various clinical settings. The classification encompasses various forms and assays related to this factor, emphasizing its significance in both diagnostic and therapeutic applications in the management of coagulation disorders.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030219</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV965#015" guid="cddc705afb264daaa88a63c34e3f158b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Renine direct</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses specific biochemical substances that play significant roles in various physiological processes. It includes a category of proteins that are crucial for hormonal regulation, signaling, and metabolic functions within the body. The focus is on a specialized subset that exhibits unique characteristics and functions, differentiating it from other similar entities in the hormonal landscape. Each entry within this classification may serve specific diagnostic or therapeutic purposes and is essential for understanding complex biological interactions. The classification aims to provide clarity and organization for healthcare professionals, researchers, and manufacturers involved in the study and application of these biochemical agents in clinical and laboratory settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020615</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV966#015" guid="459bf3f6dd904d36a487a5322be1871a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Neutrophil gelatinase associated lipocalin (lipocain 2)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific protein associated with the immune response, particularly linked to the modulation of inflammation and tissue repair processes. It plays a critical role in various physiological and pathological conditions, serving as a biomarker for disease states and responses to injury. The classification within this category is distinct from other related proteins that are involved in hormonal regulation and metabolic processes. This entity is characterized by its unique structure and biological functions, which set it apart from other proteins in the same overarching category. It is primarily utilized in diagnostic applications, providing insights into health conditions and aiding in clinical decision-making.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020616</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV967#015" guid="d10a9a628cf7445aadd10c2c4b381439">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Bone alkaline phosphatase (IC)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">bone alkaline phosphatase is an enzyme primarily associated with bone metabolism and mineralization processes. It plays a crucial role in the regulation of bone formation and is produced by osteoblasts, the cells responsible for bone synthesis. This enzyme is typically found in higher concentrations during periods of active bone growth and remodeling. Its measurement is significant in clinical settings, particularly for assessing bone-related diseases and conditions such as osteoporosis or other metabolic bone disorders. Bone alkaline phosphatase levels can provide valuable insights into the effectiveness of treatments aimed at improving bone health and density.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020617</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV968#015" guid="91f93597af8d4c038da9fec97896c481">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Calcitonin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance that plays a critical role in regulating calcium levels in the body, particularly in bone metabolism and physiological processes related to calcium homeostasis. It is primarily utilized in in vitro diagnostic applications to aid in the identification of specific medical conditions. This substance is derived from the thyroid gland and is involved in various biological functions, including the inhibition of bone resorption and the promotion of calcium excretion in the kidneys. Its measurement is essential for evaluating disorders related to calcium imbalance, bone density, and metabolic functions. The classification of this substance distinguishes it from other hormone-related analytes based on its unique biochemical properties and clinical relevance.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020618</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV969#015" guid="a92d6a48d03a4b66a585ce8c85b249de">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Collagen type I C-terminal propeptide</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">the defined category encompasses a specific biochemical marker involved in the assessment of collagen metabolism and tissue remodeling. This biomarker is crucial for evaluating various physiological and pathological conditions, particularly those related to bone and connective tissue health. It serves as an indicator of collagen synthesis and degradation, providing insights into the body's metabolic processes. This classification distinguishes it from other related substances that may serve different functions or reflect other physiological states. The focus on this particular marker highlights its role in clinical diagnostics and research, contributing to the understanding of various diseases and conditions linked to collagen dynamics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020619</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV970#015" guid="63aef8c193514ad894f53dfe53eda24d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Collagen type III C-terminal propeptide</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical marker that is a specific peptide derived from the C-terminal region of type III collagen, primarily involved in the synthesis and turnover of collagen in connective tissues. This peptide serves as an important indicator of collagen metabolism and is utilized in clinical settings for the assessment of various pathological conditions, particularly those related to connective tissue disorders and fibrosis. Its measurement can provide insights into the body’s healing processes and the state of collagen production, thereby aiding in the diagnosis and monitoring of diseases that affect the extracellular matrix. The classification is distinct from other peptides and hormones that play varying roles in metabolic processes and physiological functions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020620</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV971#015" guid="2992635faed445d5a26eeaae5e4221af">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cross-linked C-telopeptides</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">cross-linked C-telopeptides are biochemical markers associated with bone metabolism and remodeling processes. They are generated during the degradation of collagen, specifically type I collagen, which is a primary component of the bone matrix. The presence of cross-linked C-telopeptides in biological fluids, such as serum or urine, can provide valuable information regarding bone resorption activity and overall bone health. Elevated levels may indicate increased bone turnover, which can be associated with various conditions, including osteoporosis, metabolic bone diseases, and certain malignancies. These biomarkers are utilized in clinical diagnostics to monitor bone-related disorders and assess the effectiveness of therapeutic interventions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020621</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV972#015" guid="d2e81ca879b94e7fa988e8634e61673e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cross-linked N-telopeptides</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">cross-linked N-telopeptides are biomolecules derived from the breakdown of collagen, specifically indicative of bone metabolism. They play a significant role in assessing bone turnover and are often utilized in clinical diagnostics to evaluate conditions related to bone health, including osteoporosis and other metabolic bone diseases. The measurement of these peptides can provide insights into the rate of bone resorption, helping healthcare professionals in the diagnosis and management of various skeletal disorders. Cross-linked N-telopeptides are distinguished from other similar biomarkers by their unique structure and the specific physiological processes they reflect, making them valuable in the context of individualized hormone assessment.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020622</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV973#015" guid="2431392140f149e5a647b92f802778f1">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cyclic adenosin monophosphate</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">cyclic adenosine monophosphate is a nucleotide that plays a crucial role in cellular signaling and regulation. It serves as a second messenger in various biological processes, facilitating the transmission of signals from hormones and neurotransmitters to target cells. This compound is involved in the modulation of numerous physiological functions, including metabolism, cell growth, and differentiation. By activating specific protein kinases, cyclic adenosine monophosphate influences the activity of enzymes and other proteins, thereby impacting a wide range of cellular responses. Its presence and concentration are vital for maintaining homeostasis within the body, making it a significant component in the study of various medical conditions and therapeutic interventions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020623</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV974#015" guid="7291eff2d7e24bd68fdc04e69c90da2c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Deoxypyridinoline (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance that serves as a biochemical marker associated with bone resorption, specifically linked to the degradation of collagen in bone tissue. This compound is often utilized in diagnostic applications to assess bone metabolism and various conditions related to bone health. It plays a significant role in the evaluation of osteoporosis and other metabolic bone diseases. The measurement of this substance is critical in clinical settings to provide insights into bone turnover rates, helping healthcare professionals make informed decisions regarding patient management and treatment strategies. It is a specific product derived from the breakdown of collagen and is indicative of osteoclastic activity, thus serving as an important tool in the study of bone-related disorders.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020624</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV975#015" guid="9d0fb7f105ea41639b2a2b8dce3a0b04">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">1.25-dihydroxyvitamin D</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biologically active metabolite of vitamin D, this substance plays a crucial role in calcium and phosphate homeostasis, influencing bone health and immune function. It is synthesized in the body from its precursor forms and is essential for the regulation of various physiological processes, including the promotion of intestinal absorption of calcium and phosphate. This compound is often measured in clinical settings to assess vitamin D status and its related health implications, particularly in conditions associated with bone metabolism and deficiency disorders. It is distinct from other hormones in this classification, which vary in their specific functions and biological activities.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020625</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV976#015" guid="a66cf047591445a29ce09841f1c3a2bb">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">25-hydroxyvitamin D</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific biochemical substance characterized by its role as a metabolite or precursor in the regulation of various physiological functions. It is a derivative of a well-known vitamin, playing a crucial part in maintaining bone health and calcium metabolism within the human body. The substance is often measured to assess deficiencies or imbalances and is utilized in clinical diagnostics to aid in the evaluation of related health conditions. It is distinct from other similar biochemical entities, highlighting its unique biochemical properties and functions. This classification is essential for the accurate identification and categorization of substances used in medical and health-related applications, facilitating better understanding and treatment of metabolic disorders.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020626</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV977#015" guid="4a64634f8ba6413ba504b84613fca5da">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hydroxyproline (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">hydroxyproline is an amino acid derivative that plays a significant role in the structural integrity of collagen and is often analyzed for its relevance in various medical diagnostics. This substance is classified within the broader category of individual and specified hormones, reflecting its importance in physiological processes and potential implications in health assessments. The classification distinguishes Hydroxyproline from other substances that also fall under the umbrella of hormones and proteins, emphasizing its unique biochemical properties and applications in diagnostics. It serves as a valuable marker in the evaluation of connective tissue disorders, collagen metabolism, and other related health conditions, highlighting its clinical relevance in laboratory testing and research.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020627</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV978#015" guid="f0e64d814df04581ad2b2eeea377b3f8">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Osteocalcine (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance that plays a crucial role in bone metabolism and calcium regulation, osteocalcine is a non-collagenous protein produced primarily by osteoblasts. Its primary function involves the binding of calcium ions, thereby contributing to bone mineralization and maintaining bone density. This protein serves as a marker for bone formation and can provide insights into the metabolic state of bone tissue. The measurement of osteocalcine levels is significant in the diagnosis and monitoring of various bone-related conditions, including osteoporosis and other metabolic bone diseases. It is classified within the category of individual and specified hormones, highlighting its specific biological functions and relevance in clinical diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020628</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV979#015" guid="6701e017f0744a53b74f951ddff7faf5">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Parathyroid hormone intact</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a bioactive peptide involved in calcium homeostasis, parathyroid hormone intact is a protein hormone secreted by the parathyroid glands. It plays a crucial role in regulating serum calcium levels by increasing the release of calcium from bones, reabsorption of calcium in the kidneys, and enhancing the intestinal absorption of calcium through its effects on vitamin D metabolism. This hormone is essential for maintaining the balance of calcium and phosphate in the body, influencing various physiological processes including bone metabolism and neuromuscular function. Its measurement is significant in clinical diagnostics for evaluating parathyroid function and diagnosing disorders related to calcium metabolism.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020629</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV980#015" guid="f89da1cd09cf4b249f86e8240523b99a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Parathyroid hormone (C-/N-terminal, M-regional)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of protein hormone that plays a crucial role in regulating calcium levels in the body. It is characterized by its unique structure, which includes distinct segments at both the C- and N-termini, and is produced by the parathyroid glands. This hormone is essential for maintaining bone health and metabolic functions related to calcium and phosphate homeostasis. The classification distinguishes this hormone from other individual and specified hormones based on its specific biochemical properties and physiological functions. It is utilized in various diagnostic and therapeutic applications, particularly in the context of disorders related to calcium metabolism and bone density.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020630</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV981#015" guid="e3a6e7528f2249cd9c3fced5b23c396d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Parathyroid hormone related peptide</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific peptide that plays a significant role in regulating calcium homeostasis and bone metabolism. It is a product of a precursor protein and is involved in various physiological processes, including the modulation of bone density and cellular functions. This peptide is distinct from other related hormones and proteins that have specific diagnostic or therapeutic implications in the medical field. It is utilized in various applications, including research and clinical diagnostics, to evaluate hormonal levels and their impact on metabolic pathways. The classification emphasizes the uniqueness of this peptide's function and its relevance in the context of health and disease management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020631</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV982#015" guid="b46155e92ad64c6d88ce937cfd516a0a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Pyridinoline (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance that serves as a biomarker in the assessment of various physiological and pathological conditions, specifically related to collagen metabolism and bone turnover. This compound is typically measured in vitro for diagnostic purposes and is associated with the evaluation of bone health, as well as certain disease states affecting connective tissue. It plays a significant role in understanding metabolic bone diseases, osteoporosis, and other disorders that influence collagen synthesis and degradation. The measurement of this substance can provide insights into the underlying biological processes and aid in the monitoring of disease progression or treatment efficacy.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020632</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV983#015" guid="075618e4885e4d1d8e587d4d0175b71b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Tartrate-resistant acid phosphatase 5b</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific biochemical entity that functions as a protein involved in various physiological processes, particularly related to metabolic pathways and cellular signaling. This entity is characterized by its resistance to tartrate, which distinguishes it from similar phosphatases. It plays a significant role in the regulation of bone metabolism and is often measured in clinical settings to assess bone turnover and related disorders. The presence and concentration of this protein can provide valuable insights into health conditions, particularly those affecting bone density and metabolism. Its utility encompasses diagnostic applications and may be relevant in the evaluation of diseases linked to bone health and endocrine function.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020633</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV984#015" guid="da8d99c5d53d4144a2a0c5f6bf540dac">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Procollagen type I N terminal propeptide</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of biomarker associated with the structural protein collagen, primarily found in connective tissues. The focus is on a peptide derived from the N-terminal end of procollagen type I, which plays a crucial role in the formation and metabolism of collagen in the body. This biomarker is significant in various biological processes and is often measured in clinical settings to assess collagen synthesis and degradation. It serves as an important indicator in diagnosing and monitoring conditions related to connective tissue disorders, bone metabolism, and other related health issues. The specificity of this peptide distinguishes it from other hormone-related proteins and markers, making it essential for targeted biochemical analysis and research within the realm of healthcare and diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020634</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV985#015" guid="b12dc269f3e644c7b853daafb24e81e1">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Adrenocortiotropic hormone</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biologically active peptide produced by the anterior pituitary gland, this hormone plays a critical role in regulating the production and release of corticosteroids from the adrenal cortex. It is involved in various physiological functions, including stress response, metabolism, and immune regulation. The measurement of this hormone is essential for diagnosing and monitoring disorders related to adrenal function, particularly conditions affecting cortisol levels. This peptide's presence in the body indicates the functioning of the hypothalamic-pituitary-adrenal axis, making it a significant marker in endocrine studies. Its analysis is utilized in both clinical diagnostics and research to understand hormonal imbalances and their effects on overall health.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020635</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV986#015" guid="0bf6308bbe2641abad172f5e2efa7e57">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Human growth hormone</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">human growth hormone is a peptide hormone that plays a crucial role in growth, metabolism, and overall body composition. It stimulates growth and cell reproduction by promoting protein synthesis and the utilization of fat for energy. This hormone is produced by the pituitary gland and is essential for normal physical development in children, as well as maintaining muscle mass and bone density in adults. In a clinical context, it may be measured to assess growth disorders, pituitary function, or other metabolic conditions. The classification of this hormone distinguishes it from other specific hormones that also influence metabolic processes but serve different physiological roles or functions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020636</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV987#015" guid="def78972acfe4005bde91d8c379bd6e9">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Insulin-like growth factor I (somatomedin C)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">insulin-like growth factor I (somatomedin C) is a protein hormone that plays a crucial role in growth and development by mediating the effects of growth hormone. It is primarily produced in the liver and has various anabolic effects on tissues, including stimulating cell growth, proliferation, and differentiation. This hormone is involved in metabolic processes and influences cellular functions, contributing to the regulation of body composition and overall health. Its measurement is significant in clinical diagnostics and research, particularly in assessing growth disorders and metabolic conditions. The classification of this hormone emphasizes its specific biological functions and its distinction from other similar proteins in the hormonal landscape.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020637</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV988#015" guid="527c7a168553446a9ab7d77990f0690e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Insulin-like growth factor II</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">insulin-like growth factor II is a protein hormone that plays a critical role in growth and development by mediating the effects of growth hormone. It is involved in various cellular processes, including cell proliferation, differentiation, and survival, making it significant in various physiological functions. This hormone is primarily produced in the liver and has been implicated in regulating metabolic processes and influencing tissue growth. Insulin-like growth factor II interacts with specific receptors to exert its effects and is often studied in the context of development, growth disorders, and certain diseases. Its classification is distinct from other related hormones and markers, which serve different functions and applications in medical diagnostics and research.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020638</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV989#015" guid="a88ccb2aa65b4ab6b79b32ac3387d986">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Insulin-like growth factor binding protein 1</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biologically active protein involved in regulating cellular processes, specifically the binding and modulation of insulin-like growth factors. This protein plays a crucial role in the endocrine system, influencing growth, development, and metabolic functions. By interacting with insulin-like growth factors, it can impact cellular signaling pathways, contributing to various physiological responses. The protein is of interest in clinical diagnostics and research, particularly in relation to growth disorders and metabolic diseases. Its measurement may provide insights into hormonal balance and related health conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020639</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV990#015" guid="4978960803bc45f6ad4a43245908a5c0">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Insulin-like growth factor binding protein 3</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific protein molecule that binds to insulin-like growth factors, playing a critical role in regulating their activity within various biological processes. This protein is involved in the transport and modulation of insulin-like growth factors, contributing to their effectiveness and availability in the body. It is distinct from other proteins and hormones in its class, each of which has unique functions and mechanisms of action related to metabolic and physiological regulation. This protein is significant in research and clinical settings, particularly concerning growth, development, and metabolic disorders.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020640</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV991#015" guid="d40e7e96d6b34d4fac95874b64d0310e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Vasointestinal peptide</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">vasointestinal peptide is a biologically active peptide that plays a crucial role in various physiological processes within the human body. It is primarily involved in the regulation of gastrointestinal function, influencing smooth muscle contraction, secretion of digestive enzymes, and promoting the absorption of nutrients. Additionally, this peptide has significant effects on vascular physiology, as it can induce vasodilation and modulate blood flow. Its functions extend to the central nervous system, where it may impact appetite regulation and neuroendocrine signaling. This peptide is classified within a category of individual and specific hormones, which are characterized by their unique structural properties and specific biological activities, distinguishing them from other peptide hormones and related substances.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020641</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV992#015" guid="3432225adfb744668c4f2bb7f0ee2e9d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Vasopressin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a specific substance involved in regulating various physiological processes, primarily through its influence on vascular tone and blood pressure. It is a peptide hormone that plays a critical role in the body’s homeostasis, particularly in response to stress and fluid balance. The substance is utilized in diagnostic and therapeutic contexts, often associated with conditions related to blood circulation and hormonal regulation. This category is distinct from other related peptides and proteins that may serve different functions or mechanisms of action within the endocrine system.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020642</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV993#015" guid="6ade5a7a87fb4a17a34b67c23d393c57">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Bombesin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance classified under this category is a specific type of peptide that plays a role in various physiological processes. Typically involved in signaling pathways, these peptides can influence functions such as metabolism, growth, and hormonal regulation. They are often utilized in diagnostic applications, particularly in the context of in vitro diagnostics, to assess and measure biological functions or pathologies. This classification distinguishes the peptide from other similar substances based on its unique biological activity and clinical relevance, indicating its application in medical diagnostics and research. These peptides are characterized by their specific interactions with receptors and their roles in modulating bodily functions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020643</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV994#015" guid="29a233bd39b54d7fa7e89aca024f95af">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">B-endorphin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological substance that is classified as a hormone, specifically a neuropeptide, known for its role in pain relief and enhancing feelings of well-being. Produced by the body, it functions by interacting with specific receptors to modulate various physiological processes, including mood regulation and stress response. This substance is utilized in in-vitro diagnostics to assess levels in clinical settings, aiding in the understanding of certain health conditions and the body's hormonal balance. Its classification distinguishes it from other related hormones and diagnostic substances that serve different biological functions or are derived from different physiological pathways.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020644</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV995#015" guid="154094a35ad049309e788eaacc045aaa">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">17-hydroxy-ketosterone (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological substance that plays a crucial role in various physiological processes, specifically functioning as a signaling molecule within the endocrine system. This compound is involved in the regulation of metabolism, immune response, and various bodily functions. It is characterized by its specific interaction with receptors, influencing cellular activity and communication. The substance is utilized in diagnostic applications to assess hormonal levels and related disorders, providing insights into health conditions. Its measurement can be indicative of particular physiological states or pathologies, making it essential in clinical diagnostics and research settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020645</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV996#015" guid="25aec89bb0ae4082bca977d7f1ae1922">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">17-ketogenic steroid (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a classification representing a specific type of steroid used in diagnostic applications, characterized by its role in metabolic processes and hormonal regulation. This category includes substances that are synthesized or utilized for their effects on physiological functions, particularly in relation to ketone production and utilization. These compounds may be involved in assessments related to metabolic disorders, hormone levels, and other clinical evaluations. The classification serves to differentiate this type of steroid from others based on specific biochemical properties and clinical applications, ensuring accurate identification and utilization in medical diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020646</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW364#015" guid="fb825955533641789e63f290690c2363">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Protein S</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a specialized category of substances used in the assessment and management of blood coagulation processes. The items in this classification are characterized by their role in providing essential proteins that play a critical part in various hemostatic functions. These proteins are integral to the mechanisms of blood coagulation, influencing the formation and regulation of blood clots. They may be utilized in clinical settings for diagnostic purposes, therapeutic interventions, and research applications. The classification distinguishes itself by focusing on specific proteins involved in coagulation pathways, ensuring a comprehensive understanding of their functionalities and applications in maintaining hemostatic balance within the body.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030252</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW365#015" guid="0aacac5bd0134fb6896e21fb4b511d82">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Heparin cofactor II (tissue factor pathway inhibitor)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological component that acts as a specific inhibitor within the tissue factor pathway, contributing to the regulation of coagulation processes. This factor plays a crucial role in maintaining hemostatic balance by modulating the activity of thrombin and other coagulation factors. It is essential for the prevention of excessive clot formation and is utilized in various diagnostic and therapeutic applications related to blood coagulation disorders. The component is characterized by its ability to interact with specific binding sites, thereby influencing the coagulation cascade and impacting overall hemostatic function. Its measurement and analysis are significant in understanding coagulation pathways and their associated clinical implications.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030253</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW366#015" guid="7f56643601144541861df619b2ccf4c6">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">APC resistance</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a category defined for materials or substances that exhibit resistance to Activated Partial Thromboplastin Time (APTT) assays, which are used to evaluate the intrinsic and common pathways of coagulation. This classification encompasses various agents that influence or interact with the APTT, thereby affecting the test outcomes. The items within this category are crucial for understanding deviations in coagulation profiles and for diagnosing potential abnormalities in the coagulation cascade. These materials may serve as controls, calibrators, or reference standards in laboratory settings, aiding healthcare professionals in the effective monitoring and management of hemostatic disorders.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030254</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW367#015" guid="a7a05694b33e44fd88b0a1505c1d5183">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Pro C global</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a range of substances and tools specifically designed for use in the assessment and monitoring of blood coagulation processes. These items facilitate various diagnostic tests aimed at evaluating the functionality and levels of different components involved in hemostasis. The offerings include reagents that interact with clotting factors, substances that modify the coagulation cascade, and materials used for sample collection and preparation. This category is distinct in its focus on products that aid in the diagnosis and management of coagulation disorders, differing from other related assays and reagents that target specific coagulation tests or factors. The focus is on enhancing the understanding and treatment of disorders related to blood clotting, providing essential resources for medical professionals in clinical settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030255</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW368#015" guid="f427c9d0566243c1ae61d1859bb0a39e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Calibration plasma</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological substance utilized in the calibration of diagnostic devices or assays related to the evaluation of coagulation processes. This material is essential for ensuring the accuracy and reliability of test results in the assessment of hemostatic function. Calibration plasma typically contains specific concentrations of coagulation factors and may be standardized to facilitate consistent performance across various testing platforms. Its role is crucial in maintaining quality control and verifying the precision of laboratory equipment used in coagulation analysis, thereby supporting accurate patient diagnosis and management in clinical settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030256</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW369#015" guid="a3d7119108e948288af0b54b550ae5a1">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Control plasma</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance utilized in laboratory settings to assess and calibrate the performance of tests related to coagulation processes. This material is specifically designed to mimic the characteristics of biological plasma and is used to ensure accuracy and reliability in the measurement of various haemostasis parameters. By providing a controlled environment for testing, it aids in the standardization of coagulation assays, facilitating consistent results across different testing scenarios. The use of this substance is critical in diagnostic procedures to monitor blood clotting mechanisms and evaluate the efficacy of anticoagulant therapies, thereby playing a pivotal role in the management of patients with coagulation disorders.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030257</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW370#015" guid="518eea8b5b4740f1be8b2f4ad841d473">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Prothrombin time (rapid test, home monitoring)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a testing methodology designed for the assessment of prothrombin time, specifically tailored for use in home monitoring settings. It facilitates the rapid evaluation of coagulation status, allowing individuals to conduct tests conveniently outside of clinical environments. The primary focus is on measuring the time it takes for blood to clot in response to specific reagents, which is critical for managing anticoagulation therapy and monitoring the effectiveness of treatment. This classification is distinct from other tests that evaluate different aspects of coagulation, emphasizing its role in providing immediate feedback for patients and healthcare providers regarding blood coagulation levels.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030258</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW371#015" guid="7a39181ca63d4cc9a4b8a9ad0ae7b7c1">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Activated partial thromboplastin time (rapid test, home monitoring)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a rapid testing method designed for home monitoring of blood coagulation, specifically measuring the activated partial thromboplastin time. This procedure assesses the intrinsic pathway of the coagulation cascade, providing critical information regarding the function of various coagulation factors. It is intended for users to evaluate their coagulation status conveniently, allowing for timely adjustments in anticoagulant therapy or other medical interventions. The test is characterized by its ease of use, quick results, and suitability for individuals managing conditions that require regular monitoring of their coagulation parameters. This method plays a significant role in enhancing patient self-management and improving overall healthcare outcomes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030259</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW372#015" guid="d52e098706654879a54063682ae68c61">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">D-dimer (rapid test, home monitoring)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a diagnostic tool utilized for the qualitative assessment of a specific biomarker in the blood, which is indicative of the fibrinolytic process and thrombus formation. It is designed for use in home settings, allowing individuals to monitor their coagulation status conveniently. This product is characterized by its rapid testing capabilities, enabling quick results that facilitate timely decision-making regarding anticoagulation therapy or other related medical interventions. It is distinct from other coagulation assays that measure various factors involved in hemostasis and is particularly useful for patients requiring regular monitoring of their coagulation state.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030260</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW373#015" guid="50857899d6214bce8b79fbe00b092582">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Activated clotting time (rapid test, home monitoring)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a rapid diagnostic tool designed for home use to assess the activated clotting time, which measures the time it takes for blood to clot in response to specific activation agents. This test is crucial for individuals managing conditions that require regular monitoring of their coagulation status. It enables users to obtain real-time results, facilitating timely decision-making regarding anticoagulation therapy. The device typically incorporates user-friendly features, ensuring that non-professionals can perform the test with minimal training. This product plays a significant role in personalized healthcare, allowing patients to keep track of their health metrics conveniently and efficiently, thereby enhancing their ability to manage their treatment and improve health outcomes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030261</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW374#015" guid="8fb56d90c1a44ebe9314c93a633bffa8">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Standard, calibrator, control (rapid test, home monitoring)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses testing materials used for rapid assessment and monitoring of coagulation parameters. These items are designed to provide immediate feedback on the coagulation status of individuals, facilitating timely decision-making in clinical settings. The products are typically utilized in home monitoring or point-of-care environments, enabling patients or healthcare providers to perform tests with minimal complexity. The classification specifically includes those materials that serve as standards, calibrators, or control samples, ensuring the accuracy and reliability of the testing process. These items are crucial for maintaining quality assurance in coagulation testing methodologies, contributing to effective patient management and therapeutic outcomes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030262</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW375#015" guid="a19a244c79e74acd85b18de36dae7f05">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Calcium chloride (haemostasis, auxiliary reagent and supplement, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance employed in medical diagnostics and therapeutic procedures, specifically in the context of hemostasis, that serves as an auxiliary agent and supplement in in vitro diagnostic applications. This compound is utilized primarily to facilitate coagulation processes, enhancing the effectiveness of various tests and treatments related to blood clotting. Its role is crucial in managing and assessing coagulation disorders, contributing to accurate diagnostic outcomes and informed treatment decisions. The product is characterized by its specific biochemical properties that aid in the stabilization and modulation of hemostatic pathways, making it an essential component in laboratory settings focused on coagulation analysis.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030263</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW376#015" guid="0b5e31df85ac4c4bba033b145a718ffe">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Citrate (haemostasis, auxiliary reagent and supplement, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a reagent used in the context of diagnostic procedures related to blood coagulation, specifically designed to facilitate and enhance the measurement and assessment of haemostasis. This substance is employed as an auxiliary component in in vitro diagnostics, contributing to the evaluation of coagulation parameters and supporting the overall analysis of blood samples. It plays a critical role in ensuring accurate and reliable test results by interacting with other components in the coagulation pathway, thereby aiding healthcare professionals in diagnosing and monitoring various conditions related to blood clotting and related disorders. The application of this reagent is essential for effective laboratory practices in the field of coagulation testing.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030264</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW377#015" guid="b00813780fdc473d8373cccb90bf87ff">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Buffer (haemostasis, auxiliary reagent and supplement, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance utilized in medical diagnostics to assist in the evaluation and management of coagulation processes. This category encompasses agents that support the performance and accuracy of tests related to blood coagulation, specifically in the context of in vitro diagnostics. These auxiliary reagents and supplements play a crucial role in enhancing the reliability of haemostasis assessments and may be employed to optimize reagent performance or stabilize test conditions. They are essential for ensuring the integrity of the testing process, contributing to the effective analysis of blood coagulation factors and overall clotting functionality in patients.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030265</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW378#015" guid="860a2888d6fc45c3afbce166ae35bcbc">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Coated tube (citrate, heparin, haemostasis, auxiliary reagent and supplem.)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specialized category of materials utilized in the field of haemostasis, specifically designed to enhance the effectiveness of coagulation processes. These items are characterized by their coating, which facilitates their interaction with biological samples during diagnostic procedures. They often play a crucial role in assays and tests aimed at evaluating blood coagulation and related parameters. The inclusion of components that may feature citrate and heparin underscores their function in modulating coagulation pathways, ensuring accurate results in clinical assessments. These materials are essential for laboratories and healthcare settings focused on monitoring and managing hemostatic conditions, and they serve as auxiliary reagents and supplements that support a variety of haemostasis-related analyses.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030266</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW379#015" guid="f14d80adbae24455819b76003224ab67">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Haemostasis reagent (coagulation, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU127#005"/>
          <hierarchical_position>42030290</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU114#006" guid="7cb64ef412a44d05988fce7d28c49ded">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Individual and specified hormone (protein)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses hormones and proteins that are characterized by their individual and specified roles within immunochemistry. These substances are integral to a variety of biological functions and diagnostic applications, distinguishing them from broader categories such as designated proteins or various testing methodologies. The focus is on specific proteins and hormones that are utilized in clinical settings, particularly in immunological assessments, where precise measurement and identification are crucial. This classification excludes general testing approaches and combines elements of both diagnostic specificity and therapeutic relevance, ensuring a tailored approach to hormone and protein identification for advanced medical and research purposes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS274#006"/>
          <hierarchical_position>42020600</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV951#015" guid="ca85a0c25440451bba9d14a2685e934c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">C-peptide (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific biomarker related to the assessment and monitoring of certain physiological conditions, particularly in the context of diabetic care and research. This entity is a fragment of proinsulin and serves as a valuable indicator in evaluating insulin production and metabolism. Its measurement can assist healthcare professionals in diagnosing and managing various metabolic disorders, including forms of diabetes. The analysis of this biomarker is conducted using in vitro diagnostic methods, which provide critical insights into the endocrine system's function and the body's response to glucose levels. Its specificity allows differentiation from other related hormones and biomarkers, contributing to a more comprehensive understanding of an individual's metabolic status.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020601</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV952#015" guid="88efb4e5257b4490875a20344a7f71cd">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Glucagon (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of hormone that plays a crucial role in glucose metabolism and is utilized primarily in diagnostic applications. It is involved in the regulation of blood sugar levels, particularly in response to hypoglycemia. The substance is recognized for its therapeutic use in emergency scenarios, where it aids in elevating blood sugar levels. The classification highlights the substance's unique biochemical properties and its clinical significance, distinguishing it from other hormones that are similarly related but serve different physiological functions. This categorization is essential for accurate identification and application in medical diagnostics and treatment protocols.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020602</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV953#015" guid="32c7d14cdf2947d68d2b37e3a1be6e1a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Insulin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a bioactive peptide hormone critical for regulating glucose metabolism and energy homeostasis, typically produced by the pancreas. It plays a vital role in facilitating cellular uptake of glucose, thereby lowering blood sugar levels. This hormone is essential for maintaining metabolic balance and is often used in clinical settings for the management of diabetes. Its measurement can be crucial for diagnosing and monitoring various metabolic disorders. The classification of this substance encompasses its various forms and applications in in vitro diagnostics, highlighting its significance in both therapeutic and research contexts.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020603</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV954#015" guid="90046a65be2b429989910e6559b55d67">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Insulin antibody</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological substance that specifically binds to insulin, an important hormone involved in glucose metabolism. This type of antibody is utilized in various diagnostic and therapeutic applications, particularly in the monitoring and management of conditions related to insulin and glucose regulation. Its presence can indicate an immune response to insulin, which may be relevant in certain autoimmune disorders or in the context of diabetes management. The classification of this substance distinguishes it from other related proteins and hormones, each serving unique functions within the endocrine system.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020604</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV955#015" guid="265543fb75eb4daa9be8a298b749f0f9">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">GAD II antibody and other ICA</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses specific antibodies and immunological components utilized in various diagnostic applications related to individual and specified hormones. It includes substances that may interact with or be indicative of certain physiological conditions or diseases. The focus is on antibodies that specifically target GAD II, alongside other related immunological markers. The unique properties and functions of these antibodies are essential for understanding their roles in the immune response and potential implications for health diagnostics. This classification is distinct from other classes that include various hormones and their associated antibodies, emphasizing the unique characteristics and applications of GAD II antibodies in clinical settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020605</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV956#015" guid="12bcbac323a140a3b7e03c6d46b9caa9">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Glycosylated-, glycated haemoglobin (IC)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a specific type of hemoglobin that has undergone glycosylation or glycation, processes that involve the attachment of sugar molecules to the hemoglobin molecule. These modifications can serve as important biomarkers in the assessment of glucose metabolism and are particularly relevant in the management of conditions such as diabetes mellitus. The presence and levels of glycosylated or glycated hemoglobin provide valuable information regarding an individual's average blood glucose levels over an extended period, thus aiding in the evaluation of long-term glycemic control. This entity is distinct from other hormone-related substances and plays a critical role in clinical diagnostics and patient management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020606</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV957#015" guid="83cb5836a2af489a9fda4264227b6648">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Thyrosin phosphatase IA2 antibody</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">an antibody that specifically targets and binds to the enzyme thyrosin phosphatase IA2, which is involved in the regulation of various cellular processes related to hormone signaling. This antibody is utilized in laboratory diagnostics to identify and measure levels of thyrosin phosphatase IA2 in biological samples, aiding in the assessment of autoimmune conditions and metabolic disorders. The specificity of this antibody allows for the differentiation of thyrosin phosphatase IA2 from other hormones and proteins, thereby facilitating precise diagnostics and research applications in the field of endocrinology and immunology. Its use is essential for understanding the role of thyrosin phosphatase IA2 in human health and disease.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020607</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV958#015" guid="0d4ec5a2a456490caae55b5baaa8cf21">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Proinsulin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance that serves as a precursor to insulin, primarily used in the context of in vitro diagnostics (IVD). Proinsulin is a prohormone that is synthesized in the pancreas and subsequently converted into insulin and C-peptide. It plays a crucial role in glucose metabolism and regulation of blood sugar levels. In the context of diagnostic testing, the measurement of proinsulin levels can provide valuable insights into pancreatic function and insulin secretion, making it significant in the assessment and management of diabetes and related metabolic disorders. This classification encompasses various analytical techniques and methodologies used for its detection and quantification in biological samples.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020608</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV959#015" guid="0990c26953f34fadb231402683edf94f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Islet Cell Ab</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of antibody associated with the islet cells of the pancreas, which play a crucial role in insulin production. These antibodies are typically evaluated in the context of autoimmune conditions affecting glucose metabolism and can provide valuable insights into the presence of related disorders. The classification distinguishes this antibody from others involved in various hormonal functions, as well as those linked to different metabolic pathways. This categorization is essential for accurate diagnostics, treatment planning, and understanding the underlying mechanisms of diseases related to endocrine functions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020609</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV960#015" guid="0bf413d65f3c4cd9a703c4c041dbe5bb">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Aldosterone (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">aldosterone is a steroid hormone produced by the adrenal glands, playing a critical role in regulating electrolyte and fluid balance in the body. It primarily influences the reabsorption of sodium and the excretion of potassium in the kidneys, thereby affecting blood pressure and overall homeostasis. This hormone is essential for maintaining blood volume and pressure, and it is involved in various physiological processes, including the body's response to stress and inflammation. Aldosterone testing is used in medical diagnostics to assess adrenal gland function and to help diagnose conditions related to hormone imbalances, such as hyperaldosteronism or adrenal insufficiency. The classification of this hormone distinguishes it from other specific hormones based on its unique biological functions and clinical significance.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020610</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV961#015" guid="107d2cee59924fff90bbfaa475725c0a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Angiotensin (I / II)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a bioactive peptide that plays a crucial role in regulating blood pressure and fluid balance, angiotensin is produced through a complex enzymatic process involving the conversion of angiotensinogen to angiotensin I, followed by its transformation into angiotensin II. Angiotensin II serves as a potent vasoconstrictor and contributes to the stimulation of aldosterone secretion, thereby influencing sodium and water retention in the kidneys. This peptide is significant in the renin-angiotensin system, which is vital for maintaining cardiovascular homeostasis and can have implications in various health conditions, particularly those related to hypertension and heart failure. Its measurement is essential in clinical diagnostics and research to assess cardiovascular health and guide treatment decisions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020611</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV962#015" guid="bf3627e30b7c46f8a21049e7b753d299">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Angiotensin converting enzyme (IC)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical substance that plays a crucial role in the regulation of blood pressure and fluid balance through its enzymatic activity, which facilitates the conversion of angiotensin I to angiotensin II. This compound is essential in the renin-angiotensin system, influencing vascular tone and sodium retention. It is often studied in the context of cardiovascular health and various medical conditions, as it impacts both hormonal mechanisms and physiological responses. This substance is utilized in clinical diagnostics and therapeutic applications, particularly in the management of hypertension and heart failure. Its detection and measurement in biological samples can provide valuable insights into a patient's cardiovascular status and overall endocrine function.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020612</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV963#015" guid="9856140a14094c4bab68e12a55a25327">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cortisol (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses a specific type of steroid hormone produced by the adrenal cortex, primarily involved in regulating various physiological processes, including metabolism, immune response, and stress response. It is utilized in diagnostic applications, particularly in the context of in vitro diagnostics (IVD), where its measurement aids in assessing adrenal function and related disorders. The products classified here are distinct from other hormones in the same broader category due to their unique biochemical properties, physiological roles, and clinical significance. These items are essential for healthcare professionals in diagnosing conditions such as adrenal insufficiency, Cushing's syndrome, and other endocrine-related disorders, thereby providing critical insights into patient health and guiding treatment decisions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020613</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV964#015" guid="5837d722fd8547f5b6886039eb09e47e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Renine (plasma renine activity)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of protein hormone involved in regulating various physiological processes, particularly in relation to blood pressure and fluid balance. The substance is produced by the kidneys and plays a crucial role in the renin-angiotensin system, which influences blood volume and systemic vascular resistance. Its activity level can serve as a significant biomarker for diagnosing and managing conditions related to hypertension and renal function. This category distinguishes itself from other protein hormones used in diagnostics, which may have different physiological roles or mechanisms of action. The focus is on the measurement and analysis of the activity of this specific hormone as a vital component in clinical assessments and research related to cardiovascular and renal health.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020614</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW578#015" guid="2101aca2c73b4bf09440cd4f67695143">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Gonococcal detection (by NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a specific analytical procedure utilized for the identification of a particular bacterial pathogen. It involves the use of nucleic acid reagents to detect the presence of genetic material associated with the pathogen in biological samples. The methodology is crucial in clinical diagnostics, allowing for the timely and accurate identification of infections. This classification distinguishes itself from other related assays that target different pathogens or utilize varying detection mechanisms. It plays a vital role in the field of infectious immunology by providing essential information for patient management and treatment decisions. The focus is on precision and reliability in diagnosing infections caused by specific bacterial strains, contributing to effective healthcare outcomes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050109</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW579#015" guid="ee462bb3f7924cb38e3631998c73799e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Syphilis antigen detection</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic methods specifically designed to identify the presence of antigens associated with a particular infectious disease. These methods employ various techniques to detect specific proteins or substances released by pathogens, aiding in the diagnosis of infections. The focus is on assays that utilize antibodies or other reagents to ascertain the presence of these antigens in biological samples, providing crucial information for clinical decision-making. The classification highlights the uniqueness of each diagnostic method within the broader context of infectious disease detection, ensuring that each assay's specificity and application are clearly delineated. This facilitates effective identification and management of infections, enhancing patient care and treatment outcomes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050110</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW580#015" guid="77bb0e156bb4401bb0c129e8d3214696">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Syphilis antibody assay (total)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic method designed to detect the presence of antibodies specific to a certain infectious agent, aiding in the identification of past or current infections. This assay typically employs techniques that allow for the measurement of various antibody types, which may indicate an immune response to the pathogen. The analysis is crucial in clinical settings for confirming diagnoses and guiding treatment decisions. By focusing on total antibody levels, this approach provides a comprehensive view of the individual's immune status regarding the infectious disease in question, facilitating public health monitoring and epidemiological studies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050111</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW581#015" guid="1479896ced8e4fa9968932597f6e15ec">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Syphilis antibody (IgG)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of immunological assay used to detect the presence of antibodies specific to the bacterium associated with a particular infectious disease. The focus is on identifying immunoglobulin G (IgG) antibodies, which indicate past exposure to the pathogen, thus contributing to the evaluation of an individual’s immune response. This category is distinct from other assays targeting different infections or antibody classes, and it plays a critical role in diagnosing and monitoring the progression of the disease. The assay is integral to clinical diagnostics, aiding healthcare professionals in determining the appropriate course of treatment based on the immune status of the patient.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050112</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW582#015" guid="498aefe4e6274a5880b2474224fdc531">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Syphilis antibody (IgM)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific type of immunological test that identifies the presence of IgM antibodies associated with syphilis infection. This assay is utilized in the diagnosis of syphilis, a sexually transmitted infection caused by the bacterium Treponema pallidum. The detection of IgM antibodies is crucial as they indicate a recent infection, thereby assisting healthcare providers in diagnosing and managing the disease effectively. This type of assay is part of a broader category of tests that assess various infectious agents and their corresponding immune responses, differentiating it from other immunological tests targeting different pathogens or antibody types.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050113</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW583#015" guid="8b3970110f0e4809b7e1d7be67416a74">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Syphilis detection (by NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to the detection methods used to identify the presence of a specific infectious disease caused by a particular bacterium. It encompasses assays that utilize nucleic acid reagents for accurate detection. The focus is on methodologies that enable the identification of antibodies or antigens related to the infection, allowing for diagnosis and monitoring of the disease. This classification differentiates itself by the target pathogen being analyzed and the specific detection techniques employed. It serves as an essential tool in clinical and laboratory settings for understanding and managing infectious diseases, facilitating timely and effective treatment decisions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050114</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW584#015" guid="24e3781c4da041c88e236a9b77de1085">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Helicobacter pylori antigen detection</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific category of diagnostic tests aimed at identifying the presence of antigens associated with Helicobacter pylori, a bacterium linked to gastrointestinal conditions. These tests are crucial for detecting infections and guiding therapeutic interventions. The methods employed may include various immunological techniques that target unique Helicobacter pylori antigens, providing healthcare professionals with essential information for diagnosis and treatment planning. This category is distinct from other related antigen detection tests that focus on different pathogens, highlighting its specialized role in the field of infectious immunology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050115</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW585#015" guid="0ec5df545d514050917c0d911804509a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Helicobacter pylori antibody assay</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic procedure designed to identify the presence of specific antibodies against a bacterium known to cause gastrointestinal infections. This assay is utilized in clinical settings to assist in the diagnosis of infections related to this microorganism, which may lead to conditions such as ulcers and gastritis. The test evaluates the immune response by measuring the levels of antibodies produced by the body in reaction to the pathogen, thereby providing insights into the infection status of the individual. This method is distinct from other assays that detect different bacteria or their antigens, focusing specifically on the immune response to this particular infectious agent.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050116</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW586#015" guid="9bf4b0390eff489583c7570e3fadd252">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Helicobacter pylori detection (by NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses detection methods specifically aimed at identifying the presence of a particular bacterium known to be associated with gastrointestinal conditions. The focus is on the utilization of nucleic acid-based reagents for the purpose of diagnosing infections linked to this bacterium. The detection process involves the extraction and amplification of genetic material, allowing for precise identification of the pathogen. This category is distinct from other similar testing methodologies that target various bacterial infections, each with its own unique detection techniques and pathogen profiles. The objective is to facilitate accurate diagnosis and management of related health issues, contributing to effective treatment strategies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050117</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW587#015" guid="859772da75d8430b82d452302aed4667">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Legionella antigen detection</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a method utilized for the identification and quantification of specific antigens associated with Legionella species, which are pathogenic bacteria known to cause respiratory illness. This detection technique is essential for diagnosing Legionnaires' disease and other related infections. The process typically involves the use of immunological assays that can specifically recognize and bind to Legionella antigens present in clinical specimens, such as respiratory secretions or other biological fluids. The results assist healthcare professionals in confirming the presence of the bacteria, thus guiding appropriate treatment decisions. This classification encompasses various methodologies and technologies aimed at improving the accuracy and speed of Legionella detection in laboratory settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050118</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW588#015" guid="a9edfd7e5e8d41789b2f65c943687ac8">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Legionella antibody assay</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses laboratory tests specifically designed to detect the presence of antibodies against Legionella species, which are bacteria known to cause respiratory infections, including pneumonia. The assays are utilized in clinical settings to assist in diagnosing infections caused by Legionella, providing valuable information about the immune response of the patient to these pathogens. These tests may vary in methodology and may include various immunological techniques to ensure accurate detection and differentiation from other infectious agents. By identifying the presence of specific antibodies, healthcare professionals can better understand the patient's condition and guide appropriate treatment strategies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050119</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW589#015" guid="bca6fb5119314a62a5d4bd31fcf90929">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Legionella detection (by NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to the detection of specific pathogens using nucleic acid-based reagents, focusing on organisms that can cause infectious diseases. It encompasses methods designed to identify the presence of Legionella species, which are known to be responsible for respiratory infections and other health issues. The detection process typically involves the extraction and amplification of genetic material from samples, allowing for accurate identification of the pathogen. This classification is crucial for diagnostic purposes, enabling healthcare providers to initiate appropriate treatment protocols and implement necessary public health measures to prevent outbreaks associated with this infectious agent.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050120</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW590#015" guid="1037ca1ce07d47518011b92977270937">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Lyme antigen detection</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses methods and processes used to identify the presence of specific antigens associated with Lyme disease, a condition caused by Borrelia bacteria. The detection techniques may include various immunological assays that facilitate the diagnosis of Lyme disease by identifying the specific antigens in patient samples. This category is distinct in its focus on Lyme disease, differentiating it from other related infectious immunology tests that target different pathogens or utilize alternative detection methods. The aim is to provide healthcare professionals with the necessary tools to accurately diagnose Lyme disease, supporting timely and effective patient management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050121</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW591#015" guid="7f8292317b484c6b86c040d3e67510ab">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Lyme antibody (total)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a range of immunological assays designed to detect specific antibodies related to Lyme disease. These tests are instrumental in diagnosing infections caused by the Borrelia burgdorferi bacterium, which is transmitted through tick bites. The assay measures the overall presence of Lyme antibodies in the patient's serum, indicating exposure to the pathogen. This testing method is crucial for differentiating Lyme disease from other similar infections and plays a significant role in guiding clinical decisions and treatment strategies. The classification ensures that these assays are distinctly recognized within the broader context of infectious immunology, facilitating better understanding and identification of Lyme-related health issues.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050122</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW592#015" guid="d0639826662a4fb29c0715e16ff8d8bc">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Lyme antibody (IgG)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a specific type of immunological test that detects the presence of antibodies against a particular bacterial infection. It is utilized in the diagnosis and management of infectious diseases, particularly those caused by spirochete bacteria. The testing process typically involves the analysis of a biological sample to identify immunoglobulin G (IgG) antibodies, which indicate a past or ongoing immune response to the infection. This classification differentiates itself from other related immunological tests by focusing on the unique antibody response associated with this specific pathogen. The results can aid healthcare professionals in confirming a diagnosis, guiding treatment decisions, and monitoring patient outcomes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050123</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW593#015" guid="9077375080d84fc19f7032535b55fca8">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Lyme antibody (IgM)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification identifies a specific type of immunological marker used in the detection of Lyme disease, which is caused by the Borrelia burgdorferi bacterium. The marker represents a particular antibody produced by the immune system in response to an infection with Lyme disease. Testing for this antibody is crucial for diagnosing early stages of the disease, as it helps differentiate between active infection and past exposure. This classification is distinct from other immunological tests related to bacterial infections, focusing specifically on the immune response associated with Lyme disease. It is used in laboratory settings for diagnostic purposes, contributing to the understanding and management of infectious diseases within the broader context of immunology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050124</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW594#015" guid="68b9a7d5fcab43f59a31e106794c8ce8">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Lyme detection (by NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses methods used for the detection of Lyme disease through the application of nucleic acid reagents. It is specifically designed to identify the presence of genetic material associated with the causative agent of Lyme disease, enabling diagnosis and monitoring of the infection. This category distinguishes itself from other detection methods within the field of infectious immunology, particularly those targeting various bacterial infections. It serves as a crucial tool in clinical settings, providing healthcare professionals with a reliable means to confirm Lyme disease and inform subsequent treatment strategies. The classification is integral to the broader framework of bacteriological diagnostics, facilitating a systematic approach to infectious disease management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050125</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW595#015" guid="877f74a9c776476c8d54bef9e63241c9">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Mycobacterial antigen detection</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to the detection of specific antigens associated with mycobacterial infections. It encompasses methodologies and techniques designed to identify the presence of antigens produced by mycobacteria, which are a group of bacteria known for their role in various infectious diseases, notably tuberculosis. The classification highlights the analytical processes that differentiate mycobacterial antigens from those associated with other bacterial infections. It is distinct in its focus on mycobacterial pathogens, thereby serving as a critical tool for clinical diagnostics, research, and epidemiological studies in immunology related to infectious diseases. The categorization aids in the accurate diagnosis and management of conditions linked to mycobacterial infections, contributing to improved patient outcomes and public health surveillance.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050126</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW596#015" guid="8230c9b01b3447c5830ad934004baef9">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Mycobacterial antibody assay</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a method used to detect and quantify antibodies generated in response to mycobacterial infections. This assay typically involves the use of specific antigens derived from mycobacteria to stimulate an immune response in a sample, allowing for the identification of antibodies associated with exposure or infection. The resulting data can aid in diagnosing diseases caused by mycobacteria, facilitating appropriate therapeutic measures. This testing process is characterized by its specificity and sensitivity, providing crucial information for clinical decision-making in infectious disease management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050127</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW597#015" guid="8ad799b16a904290ab5e8278093955e7">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Mycobacterial detection (by NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to the detection of specific mycobacterial species through the use of nucleic acid (NA) reagents. It encompasses methodologies that enable the identification of mycobacterial DNA or RNA within clinical samples, facilitating the diagnosis of infections caused by mycobacteria. The processes involved typically utilize techniques such as polymerase chain reaction (PCR) or other molecular assays designed to amplify and detect genetic material unique to mycobacteria. This classification is distinct in its focus on the detection of mycobacteria, setting it apart from other infectious agents and their corresponding detection methods, which may involve different organisms or diagnostic approaches. The objective is to provide accurate and timely identification of mycobacterial pathogens to inform clinical decision-making and treatment strategies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050128</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW598#015" guid="bf9cd952e9ce477e8f091a36bde9c107">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Mycoplasma antigen detection</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses methods and techniques used for the detection of specific antigens associated with mycoplasma organisms. It focuses on identifying the presence of these antigens in various sample types to aid in the diagnosis of infections caused by mycoplasmas. The detection methods may include various laboratory techniques, such as immunoassays, which utilize antibodies that specifically bind to mycoplasma antigens. The aim is to provide reliable results that contribute to the understanding and management of infectious diseases linked to mycoplasmas. This classification serves as a distinct category within the broader context of bacteriology, facilitating targeted applications in clinical and research settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050129</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW599#015" guid="48beff1715e6435fbe3c8d10c65653e2">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Mycoplasma antibody assay</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses assays specifically designed to detect antibodies against Mycoplasma, a type of bacteria lacking a cell wall. These assays are utilized in various clinical and laboratory settings to identify immune responses to Mycoplasma infections. The testing methods may include serological techniques that measure the presence of specific antibodies, providing valuable information for diagnosing infections and guiding therapeutic decisions. The assays can vary in their sensitivity and specificity, and they play a crucial role in infectious disease diagnostics, especially in cases where traditional culture methods may be inadequate. This classification is distinct from other antibody detection methods related to different pathogens, ensuring precise identification of Mycoplasma-related immune responses.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050130</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW600#015" guid="9bd65de8853f406ebddb2c46435aaa20">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Mycoplasma detection (by NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses methods and techniques used for the detection of specific Mycoplasma species through nucleic acid reagents. These methods are essential for identifying Mycoplasma infections, which can impact various biological systems. The detection process often involves the amplification and analysis of nucleic acids to confirm the presence of Mycoplasma in clinical or environmental samples. This classification specifically differentiates itself from other detection methods focused on related pathogens, ensuring a clear identification of Mycoplasma as a distinct entity within the broader field of bacteriology and infectious immunology. The targeted approach in this classification aids in precise diagnostics, contributing to effective treatment and management of infections caused by these microorganisms.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050131</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW601#015" guid="2408163781844bb685c2825f17051642">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Pseudomonas aeruginosa antibody (IgG)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific category of biological products designed for the detection and measurement of antibodies associated with the immune response to Pseudomonas aeruginosa, a pathogenic bacterium. These antibodies, particularly of the immunoglobulin G (IgG) type, play a crucial role in identifying past exposure or ongoing infection. The focus is on diagnostic applications that aid in the clinical evaluation of infections caused by this microorganism. This category is distinguished from other immunological assays related to various bacteria, each targeting different antigens or types of immune responses. The products in this classification are essential for laboratories and healthcare providers in diagnosing and monitoring infections, enabling informed clinical decisions and effective treatment strategies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050132</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW602#015" guid="4751cfbbd968438083885ea139d7fd83">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Pseudomonas detection (by NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to the detection of specific bacteria through the use of nucleic acid reagents. It encompasses methods and procedures employed to identify the presence of microorganisms belonging to the Pseudomonas genus, utilizing advanced techniques that focus on nucleic acid sequences. Such detection methods are crucial for diagnosing infections caused by these pathogens, aiding in the timely and accurate identification of clinical conditions. The classification distinguishes this specific detection from other related assays targeting different bacterial species or antigens, emphasizing its unique application within the broader context of infectious immunology. This classification is essential for laboratories and healthcare providers in the effective monitoring and management of bacterial infections.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050133</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW603#015" guid="761bc50cf24247dd83ec53135f2aa160">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Salmonella antigen detection</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">the detection of specific antigens associated with Salmonella species is a diagnostic process utilized to identify the presence of this pathogen in clinical specimens. This method involves the use of immunological techniques that target unique proteins or polysaccharides produced by Salmonella. The significance of this detection lies in its application for diagnosing infections caused by Salmonella, which can lead to gastrointestinal diseases. By confirming the presence of these antigens, healthcare providers can make informed decisions regarding treatment options and infection control measures. This type of assay is essential in both clinical and environmental microbiology to monitor and respond to Salmonella-related health risks effectively.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050134</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW604#015" guid="5f1dbac001a0493195bf3343a5f2a02d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Salmonella antibody assay</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a specific immunological test designed to detect antibodies related to Salmonella infections. It is utilized in clinical and laboratory settings to identify the presence of antibodies that are produced in response to Salmonella antigens. This assay is essential for diagnosing infections caused by Salmonella species, which can lead to gastrointestinal illnesses. By measuring the levels of these antibodies in a patient’s sample, healthcare providers can assess an individual’s immune response to past or current infections. The test is an important tool in the field of infectious immunology, contributing to the understanding and management of bacterial infections within the human population.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050135</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW605#015" guid="e4537d23eb5c44faa19604142d653e8a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Salmonella detection (by NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to the methods and reagents used for the detection of specific bacterial pathogens, particularly focusing on those causing foodborne illnesses. It encompasses diagnostic techniques that utilize nucleic acid-based reagents to identify the presence of Salmonella species in various samples. Such detection methods are crucial in clinical microbiology and food safety testing, allowing for rapid and accurate identification of these pathogens. The classification highlights the significance of advanced immunological and molecular techniques in the diagnosis and monitoring of infectious diseases. The emphasis is on the specificity and sensitivity of these methods, which are essential for effective disease management and outbreak control. This classification is distinct from other bacterial detection methods, underscoring the unique characteristics and requirements involved in identifying Salmonella.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050136</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW606#015" guid="46c8f8f333f747ebbfbad73646fc5e41">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Streptococcal direct antigen detection</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a method for identifying specific antigens associated with certain bacterial pathogens through direct detection techniques. It involves the use of immunological assays to ascertain the presence of streptococcal antigens in biological samples, aiding in the diagnosis of infections caused by streptococci. The approach focuses on the direct interaction between antibodies and streptococcal antigens, facilitating rapid identification of these bacteria in various clinical settings. This classification is distinct from other antigen detection methods that target different bacteria and utilizes specific reagents tailored for streptococcal detection. The primary objective is to enhance diagnostic accuracy and inform appropriate therapeutic interventions in infectious disease management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050137</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW607#015" guid="2177f6bfa34b45da86f340b57ca4a5d7">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Streptococcal detection (by NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a method or process utilized for the identification and analysis of streptococcal bacteria through the application of nucleic acid reagents. This approach is employed in clinical laboratories to detect the presence of streptococcal infections by targeting specific genetic material. The technique is significant in the diagnosis and management of related infectious diseases, offering quick and reliable results. It distinguishes streptococcal pathogens from other microorganisms, facilitating appropriate treatment decisions. This classification encompasses various methods and technologies used in the detection process, ensuring comprehensive coverage of the streptococcal species involved in human infections.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050138</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW608#015" guid="d6fa1ee531ac4a56b8b3b8c22644bc0c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Staphylococcal direct antigen detection</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">detection methods designed specifically to identify the presence of antigens associated with Staphylococcus species in clinical samples are classified under this category. These techniques are utilized in infectious immunology to aid in the diagnosis of infections caused by Staphylococcus, which may lead to various health complications. The methods employed may include immunological assays that provide rapid results, contributing to timely clinical decision-making. This classification is distinct from other antigen detection methods that target different pathogens or utilize various immunological approaches, emphasizing the unique characteristics and importance of Staphylococcus-related diagnostics in the field of bacteriology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050139</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW609#015" guid="d043356415864f0799f4e213bb15baee">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Staphylotoxin</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biologically active substance produced by certain bacteria, characterized by its capacity to induce toxic effects in biological systems. This substance is often studied in relation to its role in pathogenicity and immune response. Staphylotoxin is a critical component in the field of infectious immunology, where it is analyzed for its impact on human health and disease. The classification of this substance is distinguished from other related immunological reagents and assays that target various bacterial antigens and antibodies, focusing specifically on its unique properties and relevance in diagnosing and understanding infections caused by staphylococcal bacteria. Understanding its mechanisms of action and effects is essential for developing targeted therapeutic strategies and diagnostic tools in clinical settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050140</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV997#015" guid="16a19c6044824e889a1eebc2d960998c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">17-ketosteroid (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific category of biochemical substances that are primarily involved in various physiological processes and regulatory functions within the body. These substances typically include steroid hormones that are characterized by the presence of a ketone group. They play critical roles in metabolism, immune response, and the regulation of various biological activities. The focus of this classification is on substances that are relevant for in-vitro diagnostic applications, often utilized in clinical settings for the assessment or monitoring of hormonal levels and related conditions. Such substances are distinct from other hormonal entities and are defined by their unique chemical properties and biological functions, serving as important biomarkers in medical diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020647</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV998#015" guid="ab9c5878494143d2b535e9099aa06b31">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">A-melanocite stimulating hormone</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a-melanocyte stimulating hormone is a peptide hormone that plays a crucial role in regulating various physiological processes, including pigmentation, energy homeostasis, and appetite control. It is produced by the pituitary gland and is involved in stimulating the production and release of melanin from melanocytes, which are specialized cells responsible for skin and hair pigmentation. This hormone also influences the activity of other hormones and can affect the body's response to stress and inflammation. Due to its significant biological functions, A-melanocyte stimulating hormone is important in both clinical and research settings, particularly in the study of skin disorders, metabolic conditions, and the mechanisms of appetite regulation.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020648</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV999#015" guid="2d27ee20e7da4211a3d20ce5bd0ef34b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Neurotensin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific category of biologically active peptides that play crucial roles in various physiological processes. The focus is on neurotensin, a neuropeptide involved in the regulation of multiple functions, including pain perception, appetite control, and gastrointestinal motility. This category is distinguished by its unique properties and functions relative to other peptides, which may influence metabolic processes, endocrine functions, and nervous system activities. It is important in clinical diagnostics, particularly in the context of neuroendocrine disorders and related health conditions. The classification aids in the identification and categorization of this peptide for research and diagnostic applications within the field of in vitro diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020649</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW000#015" guid="cd50da7f3d8840c0967febd02f795830">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Somatostatin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific peptide that plays a crucial role in the regulation of various physiological processes, including hormone secretion and gastrointestinal function. This substance is particularly relevant in the context of medical diagnostics, where it is utilized to assess specific hormonal levels within the body. It is categorized within a broader classification of individual hormones that are characterized by their protein structure and specific biological functions. This classification helps distinguish it from other similar biomolecules, which may have different roles or mechanisms of action in the endocrine system. The assessment of this peptide is significant for understanding certain health conditions and guiding treatment decisions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020650</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW001#015" guid="f783465e410d4e9c8af346c6977018d5">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Substance P (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">substance P is a neuropeptide that plays a critical role in the transmission of pain and the modulation of inflammatory responses. It is primarily found in the central and peripheral nervous systems and is involved in various physiological processes, including the regulation of mood, anxiety, and stress responses. This substance is known for its involvement in the neurogenic inflammation pathway, acting as a key mediator in the communication between the nervous system and immune response. Additionally, it is associated with the perception of pain and may influence the effects of other hormones and neurotransmitters within the body. Its measurement is significant in the context of various diagnostic assessments and therapeutic applications related to pain management and neurological conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020651</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW002#015" guid="fbee5f2d7029464ba3cb593ebb7a893c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Gastrin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance that is classified within the realm of specific hormones produced by the gastrointestinal tract, playing a crucial role in the regulation of various physiological processes, particularly in the digestive system. This substance is characterized by its involvement in stimulating gastric acid secretion and promoting digestive functions. It is utilized in diagnostic applications related to gastrointestinal disorders and is measured in laboratory settings to assess hormone levels and their implications on health. The classification of this substance differentiates it from other hormones that serve distinct physiological roles, ensuring accurate identification and application in clinical diagnostics and research.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020652</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW003#015" guid="4054665657464de09686bcbadf62fb99">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Gonadotropin-releasing hormone</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a specific type of hormone that plays a crucial role in regulating various physiological processes by influencing the release of other hormones. It is characterized by its unique structure and function, distinguishing it from other hormones that may be present within the broader family of individual and specified hormones. This particular hormone is important in the biological signaling pathways that govern reproductive health and hormonal balance. Its classification is based on its distinct biochemical properties and its specific role in the endocrine system, contributing to the overall hormonal interplay that affects growth, development, and metabolism.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020653</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW004#015" guid="a6886d73799b49ffad2c3bb1fe2989a5">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Melatonine (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance that functions as a hormone involved in the regulation of sleep-wake cycles and other physiological processes. It is primarily produced by the pineal gland in response to darkness and plays a crucial role in circadian rhythm modulation. This hormone is utilized in various diagnostic and therapeutic applications related to sleep disorders and other health conditions. The classification of this substance distinguishes it from other hormones that exhibit different physiological roles and functions, thereby facilitating accurate identification and utilization in medical and laboratory settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020654</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW005#015" guid="9948d64c57184a2894e0ebfe13d3cd13">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Neopterine (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical substance that plays a role in various physiological processes within the human body, specifically categorized under individual and specified hormones that are proteins. This substance is utilized in in vitro diagnostic applications, aiding in the assessment of certain health conditions. It is distinct from other related substances in its specific function, biochemical structure, and its role in diagnostic testing. The substance is measured to provide insights into metabolic, endocrine, and other physiological states, contributing to the understanding of health and disease. Its unique characteristics and applications in diagnostics set it apart from other hormones and related molecules.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020655</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW006#015" guid="3ea08290a7214e85b55df9649c06d942">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Oxytocin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological substance that is a peptide hormone, primarily associated with reproductive and maternal health, and acts by influencing various physiological processes. This substance is utilized in both clinical diagnostics and therapeutic applications. It is involved in the regulation of reproductive functions, lactation, and various aspects of the reproductive cycle, playing a critical role in childbirth and maternal bonding. The classification of this substance distinguishes it based on its specific biochemical characteristics and functional relevance, differentiating it from other related peptide hormones that serve varying roles in metabolic and endocrine functions. Its presence and measurement are significant in understanding certain medical conditions and therapeutic interventions in healthcare settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020656</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW007#015" guid="8953ca12b6964f75937587c770789aa8">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Pepsinogen (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological substance that is a precursor to an enzyme, specifically produced in the gastric mucosa and activated in the presence of acid. This substance plays a crucial role in the digestive process by being converted into an active form that aids in the breakdown of proteins. It is often measured in clinical settings to assess various gastrointestinal functions and disorders. The classification encompasses items that are utilized in in vitro diagnostics to evaluate the presence or levels of this precursor in biological samples, contributing to the understanding of patient health, particularly in relation to digestive enzyme activity and related conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020657</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW008#015" guid="d9abbc27abe043e794af6f1f25a2adfe">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Prostaglandin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical substance that is classified as a specific type of hormone derived from arachidonic acid, playing a crucial role in various physiological processes within the body. This substance is involved in regulating functions such as inflammation, smooth muscle contraction, and modulation of blood flow. It serves as a key signaling molecule, influencing a wide array of biological activities, including the immune response and reproductive functions. The classification distinguishes this substance from related hormones based on its unique structural properties and biological functions, allowing for targeted applications in diagnostics and therapeutics within the field of in vitro diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020658</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW009#015" guid="b86ea1f7d423406184442462841efb3b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Serotonin-uptake (platelet, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a specific biochemical substance involved in the regulation of mood and emotional responses within the human body. It is primarily associated with a particular type of uptake mechanism occurring in platelets, which plays a crucial role in various physiological processes. This substance is measured and analyzed using in vitro diagnostic techniques to assist in the understanding of certain health conditions and to inform clinical decision-making. The focus is on its unique properties and functions, distinguishing it from other similar biomolecules that may also play roles in hormonal and metabolic pathways. This classification is essential for the accurate identification and application of diagnostic tests related to this specific uptake process.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020659</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW010#015" guid="aff08d4669424176afdd63962db2595f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Elastase (Pancreatic polypeptide, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a pancreatic enzyme involved in the digestion of proteins, elastase specifically catalyzes the hydrolysis of peptide bonds in elastin, collagen, and various other proteins. This enzyme is primarily produced in the pancreas and plays a critical role in the digestive process, particularly in breaking down complex proteins into smaller peptides and amino acids for easier absorption. Its presence and activity can be indicative of pancreatic function and health. In medical diagnostics, elastase measurements are utilized to assess conditions related to pancreatic insufficiency and other related disorders.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020660</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW011#015" guid="9a817a2f9da44854803f04e6dd7f2e2d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Adrenalin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a category of biological substances characterized by their role in the regulation of various physiological processes within the body. These substances are typically produced by specific glands or tissues and are involved in signaling pathways that influence metabolism, growth, and homeostasis. They can exist in various forms, including peptides and hormones, and are crucial for maintaining the body's internal balance. The substances in this category are distinguished by their unique biological functions, mechanisms of action, and the specific physiological responses they elicit. This classification facilitates the organization and identification of these substances for medical, research, and therapeutic purposes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020661</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW012#015" guid="ad5ca615230449afb09ce7e357792f7e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Noradrenalin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical compound that serves as a neurotransmitter and hormone, primarily involved in regulating various physiological processes within the body. This substance is associated with the response to stress and plays a crucial role in the regulation of blood pressure, heart rate, and glucose metabolism. It is often measured in clinical settings for diagnostic purposes, particularly in relation to cardiovascular and endocrine functions. The classification of this compound distinguishes it from other hormones and biomarkers that serve specific roles in metabolic, immune, or neurological pathways. This category encompasses a range of similar substances that exhibit distinct biochemical properties and functions, facilitating a comprehensive understanding of their roles in health and disease.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020662</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW013#015" guid="8e2535d347f440628077254b8d9ab835">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Dopamine (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical compound produced by the body that plays a crucial role in transmitting signals within the brain and other areas of the nervous system. This substance is known for its involvement in regulating mood, motivation, and reward mechanisms. It is classified as a hormone and is specifically recognized in the context of in vitro diagnostics. The classification is distinct from other related hormones that influence various physiological processes, including metabolism, stress response, and growth. This category encompasses substances that are essential for understanding neurophysiological functions and their implications in health and disease management, particularly in diagnostic settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020663</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW014#015" guid="69300c8551654bf9aece7d873ecc0818">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Procalcitonin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a specific biomarker found in the body, crucial for assessing inflammatory responses. It is a peptide that serves as a pro-inflammatory marker and is particularly relevant in clinical diagnostics for various infections and conditions characterized by systemic inflammation. The measurement of this biomarker is essential for evaluating the severity of illness, guiding treatment decisions, and monitoring patient responses to therapy. It plays a significant role in the context of in vitro diagnostics, providing valuable insights into a patient's health status through laboratory analysis. This biomarker is distinct from other related substances that may also be involved in hormonal regulation or immune response, emphasizing its unique diagnostic significance in the healthcare field.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020664</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW015#015" guid="39c0c28d69f54dfd9761b8146a26bf5b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Leptin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological substance produced by adipose (fat) tissue, playing a critical role in regulating energy balance, metabolism, and appetite. This protein hormone is involved in signaling pathways that affect food intake and energy expenditure. Its measurement is significant in the context of various health conditions, particularly those related to obesity, metabolic syndrome, and diabetes. By interacting with specific receptors in the body, it influences physiological processes, making it important for both clinical diagnostics and research applications. This substance is distinct from other similar proteins, each with unique functions and regulatory mechanisms within the endocrine system.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020665</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW016#015" guid="c9d4b869315f418781f49075c1b434c0">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Motilin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a bioactive peptide involved in regulating gastrointestinal motility and various physiological functions, this substance is primarily produced in the gastrointestinal tract. It plays a critical role in stimulating gastric motility, enhancing the secretion of digestive enzymes, and promoting the absorption of nutrients. The peptide is also implicated in various metabolic processes and can influence appetite regulation. In laboratory settings, this substance is utilized in diagnostic applications, particularly in assessing hormonal imbalances or gastrointestinal disorders. Its measurement is essential for understanding specific health conditions and guiding therapeutic interventions related to hormonal regulation and digestive health.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020666</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW017#015" guid="ef521e2806f142218692fe5924ac5c48">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cyclic guanosine monophosphate</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">cyclic guanosine monophosphate is a nucleotide that functions as a secondary messenger in various biological processes. It plays a critical role in the signaling pathways of hormones and neurotransmitters, facilitating the transmission of signals within cells. This molecule is involved in numerous physiological functions, including the regulation of vascular smooth muscle relaxation, neurotransmitter release, and cellular responses to hormones. Its presence and concentration can influence various cellular activities, making it an important component in cellular signaling mechanisms. The classification of this substance emphasizes its specific role and distinct characteristics as compared to other similar biomolecules within the same category.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020667</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW018#015" guid="4147538e02614d86aef66cbb47b11835">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Individual and specified hormone (protein, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU114#006"/>
          <hierarchical_position>42020690</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU143#005" guid="cb0b5582b81144a3984c762639991699">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Bacteriology (infectious immunology)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a range of diagnostic methodologies and reagents specifically tailored for the detection and analysis of bacteria related to infectious immunology. It includes various tests and assays designed to identify specific bacterial antigens and antibodies, as well as methods for the direct detection of bacterial pathogens through nucleic acid reagents. The focus is on providing tools for the diagnosis of infections caused by a variety of bacterial agents, facilitating the monitoring and management of infectious diseases. The offerings within this classification support healthcare professionals in their efforts to accurately diagnose and treat bacterial infections, contributing to improved patient outcomes through timely and reliable testing.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS277#005"/>
          <hierarchical_position>42050100</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW570#015" guid="132c84c6440c4140b0c4c267b959637f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Chlamydia antigen detection</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses testing methodologies used to identify the presence of specific antigens related to Chlamydia infections. These diagnostic procedures are crucial in clinical settings for detecting active infections by analyzing samples for Chlamydia-specific proteins. The focus is on immunological assays that provide rapid and accurate results, distinguishing them from assays that measure antibodies or utilize nucleic acid amplification techniques. The classification highlights the importance of antigen detection in infectious disease diagnostics, particularly in the context of sexually transmitted infections, aiding in timely treatment and disease management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050101</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW571#015" guid="04926d81ba4948198ebea83382436033">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Chlamydia antibody assay (total)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a laboratory test that detects the presence of antibodies produced in response to infection by a specific pathogen. It is utilized for diagnostic purposes in infectious immunology, particularly for assessing exposure to a particular microorganism associated with sexually transmitted infections. The assay measures the total level of antibodies, providing a comprehensive indication of the immune response to the pathogen. By identifying these antibodies, healthcare professionals can determine past or current infections, aiding in patient management and treatment decisions. This grouping is distinguished from other tests that focus on different aspects of the immune response or detection of the pathogen itself.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050102</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW572#015" guid="5785a1f9b5a144529d91f60c2f69ea8b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Chlamydia antibody (IgA)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of immunological assay that detects the presence of antibodies, specifically the IgA subtype, against Chlamydia. Such assays are essential for diagnosing infections caused by this bacterium, which can lead to various health issues. The focus is on identifying the immune response through the presence of IgA antibodies, which can indicate an active or recent infection. This classification distinguishes itself by being part of a broader set of immunological tests that assess different aspects of Chlamydia infections, without overlapping with other types of assays that target different antibodies or antigens related to Chlamydia or other infectious agents.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050103</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW573#015" guid="6a1dfdab8e094dd8bbe5983fa4e9ed17">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Chlamydia antibody (IgG)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a specific type of immunological test designed to detect the presence of antibodies against a particular infectious agent in a biological sample. The focus is on the IgG antibody response, which indicates past exposure or infection. This test is essential for diagnosing and monitoring infections, providing valuable information about the immune status of an individual. The classification encompasses various related tests that identify different antibody types or antigens associated with the same or similar pathogens, allowing for a comprehensive understanding of infectious disease dynamics. It serves healthcare professionals in making informed decisions regarding diagnosis and treatment, contributing to effective patient care and public health management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050104</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW574#015" guid="e572e1c0003e4f0193b53c4a9228190b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Chlamydia antibody (IgM)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of laboratory test designed to detect the presence of immunoglobulin M (IgM) antibodies against a particular infectious agent associated with chlamydial infections. The assay is utilized in the diagnostic evaluation of such infections, indicating recent exposure or an active immune response. The results can assist healthcare professionals in determining the appropriate clinical management and intervention for affected individuals. This category is distinct from other tests that focus on different types of antibodies, antigens, or methodologies related to chlamydia and other infectious agents, highlighting its unique role in infectious immunology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050105</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW575#015" guid="60d05236d49c4a5d9e0369bb9f13179b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Chlamydia detection (by NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses diagnostic methods specifically designed for the detection of the Chlamydia bacterium using nucleic acid reagents. These tests are employed to identify the presence of Chlamydia infections in clinical samples, facilitating timely intervention and treatment. The methodology is characterized by its reliance on molecular techniques that target and amplify specific genetic material from the pathogen, ensuring high sensitivity and specificity. This classification is distinct from other related diagnostic assays that focus on different aspects of Chlamydia detection, such as antigen or antibody-based methods. The tests in this category are crucial for public health monitoring and the management of sexually transmitted infections, contributing to improved patient outcomes through accurate and rapid diagnosis.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050106</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW576#015" guid="e4414116e8e1423baca99f6d7cf237b9">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Gonococcal antigen detection</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a specific diagnostic procedure aimed at identifying the presence of antigens associated with a particular infectious microorganism. The detection method is crucial for diagnosing infections caused by this organism and is typically employed in laboratory settings. The procedure relies on various immunological techniques that enable the visualization or measurement of specific antigens, providing essential information for clinical decision-making. This classification is distinct from other similar antigen detection methods, which target different infectious agents or utilize alternative detection mechanisms. The accuracy and reliability of this diagnostic test are vital for appropriate treatment and management of the underlying infection.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050107</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW577#015" guid="24ddd37456e94adcb394da953dd30ce9">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Gonococcal antibody assay (total)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this assay is a laboratory test designed to detect the presence of antibodies specific to a particular bacterial infection. It plays a crucial role in diagnosing infections caused by this bacterium by identifying the immune response in the patient. The test is typically performed on biological samples such as blood or serum and can provide valuable information about the stage of infection and the patient's immune status. It is an important tool in the field of infectious immunology, offering insights that can guide treatment decisions and public health strategies. The assay is distinguished from other immunological tests that target different pathogens or different aspects of the immune response to the same pathogen.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050108</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW651#015" guid="3c85f151135440369ac1c03ebe831810">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Bacteriology (infectious immunology, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050190</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADS279#005" guid="53b66a37ba584339b7a945b06da85158">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">IVD instrument</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses instruments specifically designed for in-vitro diagnostic applications. These instruments facilitate a range of analytical processes essential for detecting, diagnosing, and monitoring various health conditions. The classification includes devices that operate in chemical analysis, immunological testing, blood and tissue examination, as well as microbiological assessments. Additional focus is given to instruments utilized for nucleic acid testing, micro-array analysis, and sample processing systems. Each instrument type is tailored to support specific diagnostic workflows, ensuring accuracy and reliability in laboratory settings. This classification distinguishes itself from other diagnostic modalities, emphasizing the unique functionalities and applications of the instruments within this domain.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADJ215#005"/>
          <hierarchical_position>42070000</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADS276#005" guid="259ef0f6a03449239468f628aa247451">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Microbiology (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a variety of diagnostic methodologies and tools related to the study and analysis of microorganisms for in-vitro diagnostic applications. It includes processes and products designed to identify, isolate, and analyze bacteria, fungi, viruses, and parasites, as well as to assess their characteristics and behaviors. The classification emphasizes the critical role of microbiological testing in diagnosing infections and diseases, ensuring accurate identification and susceptibility profiling of pathogens. It also incorporates rapid testing methods and control materials essential for ensuring the reliability and accuracy of microbiological assays. This category serves as a comprehensive framework for the various techniques and products utilized in microbiological diagnostics, facilitating their organization and standardization.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADJ215#005"/>
          <hierarchical_position>42040000</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADS273#005" guid="94a6ac9e662a475d8568ce6d85c3b97c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Clinical chemistry</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a category focused on analytical methods and reagents used in the evaluation of biological samples to assess various chemical substances, particularly in clinical settings. It includes components that facilitate the quantification and analysis of enzymes, substrates, and electrolytes, excluding electrodes. This area also covers diagnostic tools and materials such as electrodes, biosensors, and multiple parameter testing devices utilized in clinical laboratories. Additionally, it incorporates quality control materials such as standards and calibrators, as well as rapid testing devices intended for point-of-care applications. This classification is distinct from other analytical methods employed in various fields of diagnostics, ensuring a specialized focus on clinical chemistry applications and related technologies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADJ215#005"/>
          <hierarchical_position>42010000</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADS275#005" guid="b84857494c7e40b8a54c2029680ce4d6">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Haematology, histology, cytology</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses products and services related to the analysis and study of blood and tissue samples for diagnostic purposes. It includes reagents and materials specifically designed for examining blood components, assessing coagulation processes, and performing blood grouping. Additionally, it covers items used in tissue typing and the application of monoclonal antibodies and immunomodulators. The classification also addresses reagents utilized in the preparation and examination of histological and cytological specimens. This domain is distinct from other areas focused on chemical analysis, microbiological testing, genetic assessments, and related technological support, emphasizing specialized diagnostics in hematology and histopathology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADJ215#005"/>
          <hierarchical_position>42030000</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADS277#005" guid="b05f32dbb1634f4da421d6f341179779">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Infectious immunology</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses the study and testing of infectious diseases through specific immunological methods. It includes a range of diagnostic practices aimed at identifying and analyzing various infectious agents and their effects on the immune system. This category is distinct from other diagnostic fields, focusing specifically on the immunological response to infections caused by bacteria, viruses, fungi, and parasites. Additionally, it covers the evaluation of multiple parameters related to infectious diseases, the use of controls and standards for accurate testing, and rapid testing methods that facilitate quick diagnosis. The classification also includes reagents, buffers, and supplements that are essential for conducting immunological assays in the context of infectious disease detection and management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADJ215#005"/>
          <hierarchical_position>42050000</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADS274#006" guid="9de14de0714c4007b625624e8c70215b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Immunochemistry (immunology)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specialized area within the broader field of in-vitro diagnostics that focuses on the detection and analysis of specific proteins and markers related to immune responses and diseases. It includes various methodologies and tests designed to assess the presence and concentration of immunological substances in biological samples. The area addresses critical health concerns through targeted evaluations, enabling the diagnosis and monitoring of conditions associated with immune system function, including allergies, autoimmune disorders, and the presence of tumor markers. Additionally, it covers tests related to hormonal functions, therapeutic drug monitoring, and toxicological assessments. This classification serves to enhance diagnostic capabilities and improve patient outcomes through precise immunological testing methods.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADJ215#005"/>
          <hierarchical_position>42020000</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADJ215#005" guid="763e0f7f7cb1443ab9e0737a12cf1a7f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">In-vitro diagnostic</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">In-vitro diagnostic includes each medical device that is used as a reagent, reagent product, calibrator, control material, kit, instrument, apparatus, equipment or system, separately or in combination with the others, intended by the manufacturer to be used for the in-vitro examination of samples derived from the human body, including blood and tissue donations, and that serves solely or principally for the purpose of providing information. The information provides knowledge on physiological or pathological conditions or congenital anomalies or serves for the testing on safety and compatibility with potential recipients, or for monitoring therapeutic measures</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">http://www.ce-zeichen.de/klassifizierung/in-vitro-diagnostika.html</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-AAA002#001"/>
          <hierarchical_position>42000000</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW610#015" guid="304a914717ff4994b254edbf7ac33a4d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Staphylococcal detection (by NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses methods and reagents utilized for the detection of specific bacterial strains associated with various infectious diseases. It is focused on identifying Staphylococcus species through nucleic acid amplification techniques, which enhance the sensitivity and specificity of pathogen detection. The classification is distinct from other methodologies aimed at detecting different bacterial antigens or antibodies, as it specifically addresses Staphylococcal infections. This category plays a crucial role in clinical diagnostics, aiding in the timely identification of infections caused by Staphylococcus and facilitating appropriate therapeutic interventions. The techniques involved are essential for laboratory settings where rapid and accurate results are necessary for patient management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050141</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW611#015" guid="f6c869c77c0b46b298c410ac1f24c2d0">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Listeria antigen detection</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic methods specifically aimed at the detection of Listeria antigens, which are critical for identifying the presence of Listeria monocytogenes, a significant pathogen associated with foodborne illness. The techniques included in this category are designed to facilitate the rapid identification of Listeria in clinical and environmental samples, employing immunological assays that utilize specific reagents to target and capture Listeria antigens. This classification is distinct from other diagnostic assays that focus on various infectious agents, highlighting its unique role in bacteriology and infectious immunology. The methods classified here are essential for clinical diagnostics, epidemiological studies, and ensuring food safety by monitoring and controlling Listeria contamination in food products.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050142</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW612#015" guid="71cb27cb81db4462b85aaf839a6bad8a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Listeria antibody assay</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic procedure that detects the presence of specific antibodies indicative of Listeria infection in biological samples. This assay is designed to assess the immune response to Listeria monocytogenes, a bacterium known to cause foodborne illness. The test is crucial for identifying past or current infections and plays a significant role in clinical diagnostics, particularly in cases involving immunocompromised patients or pregnant women. The assay utilizes specific antigens to elicit an immune response, and the resulting antibodies can be measured quantitatively or qualitatively. This procedure is a vital tool for healthcare professionals in diagnosing listeriosis and guiding appropriate treatment measures.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050143</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW613#015" guid="9505979de7f8477ea6ad1536286996a7">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Listeria monocytogenes direct antigen detection</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a method utilized for the direct detection of specific antigens associated with a particular bacterium known for causing infections in humans. It encompasses techniques that identify the presence of the pathogen's unique protein markers, enabling rapid diagnosis and facilitating timely medical intervention. The focus is on targeting a type of bacteria that can lead to severe health complications, especially in vulnerable populations. This approach is essential for ensuring food safety, controlling outbreaks, and monitoring environmental samples for contamination. The techniques employed in this classification are vital for laboratories and healthcare settings, providing critical information for patient management and public health strategies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050144</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW614#015" guid="d384869601ae4f8dbc14054265263bec">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Listeria monocytogenes antibody assay</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to assays designed to detect specific antibodies against Listeria monocytogenes, a pathogenic bacterium known to cause listeriosis. These assays are utilized in laboratory settings to facilitate the diagnosis of infections caused by this organism. The tests aim to identify the presence of antibodies generated by the immune system in response to exposure to Listeria monocytogenes. The results of such assays are critical for clinicians in determining the appropriate course of treatment and managing patient care. The methodology may vary, encompassing techniques that focus on the specificity and sensitivity of antibody detection, thereby providing valuable data for infectious disease management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050145</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW615#015" guid="2cae9f22bae34351a5237198116c4e66">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Listeria detection (by NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to methods and reagents used for the identification of Listeria species, specifically targeting the detection of nucleic acids associated with the organism. Such techniques are essential in microbiological diagnostics and food safety testing, allowing for the rapid and accurate identification of Listeria infections. The detection process typically involves the use of specific reagents that interact with the nucleic acids of the bacteria, facilitating their identification in various samples. This classification is distinct from other related methodologies that focus on different pathogens or utilize alternate approaches for detection. The emphasis is on the specificity of the reagents employed in identifying Listeria, which is crucial for effective monitoring and control in healthcare and food industries.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050146</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW616#015" guid="c87bb001812641e9b1b310889bf12235">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Campylobacter direct antigen detection</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a specific diagnostic method used to identify the presence of antigens associated with a particular bacterial pathogen, which can cause gastrointestinal infections. The detection process involves the use of immunological techniques that target and bind to specific antigens, providing rapid results that assist in clinical decision-making. This methodology is crucial for timely diagnosis and management of infections caused by the pathogen in question. It is distinct from other diagnostic methods that focus on different bacteria or utilize alternative antigen or antibody detection strategies. The approach is essential for monitoring public health and managing outbreaks related to foodborne illnesses or other related infections.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050147</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW617#015" guid="d92d9822e1674de8a778ca0a4762fda6">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Campylobacter detection (by NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to the methods and reagents utilized for the identification and detection of specific bacteria, particularly focusing on Campylobacter species. The detection process typically involves the application of nucleic acid-based reagents that facilitate the recognition of the genetic material associated with the target bacteria. This approach is essential in microbiological diagnostics, enabling healthcare professionals to accurately identify infections caused by Campylobacter. Such detection methods are crucial for effective disease management, epidemiological studies, and ensuring food safety, as Campylobacter is commonly associated with gastrointestinal diseases. The classification distinguishes this method from other bacterial detection techniques, emphasizing its specific application and relevance in clinical and laboratory settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050148</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW618#015" guid="6cc9ef73031a4a97a621ec90ed56f332">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Escherichia coli direct antigen detection</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">the detection of specific antigens associated with Escherichia coli, a type of bacteria commonly found in the intestines of humans and animals, represents a diagnostic procedure employed to identify the presence of this microorganism in various samples. This method typically utilizes immunological techniques to capture and measure the antigens produced by Escherichia coli, aiding in the diagnosis of infections or other related conditions. The process is crucial for clinical decision-making, particularly in the context of gastrointestinal diseases, where rapid and accurate identification of pathogenic strains is essential for effective treatment and management. This classification encompasses various methodologies and formats used in the detection process, reflecting advancements in immunological testing and pathogen identification.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050149</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW619#015" guid="2bd7dd1fbf164bef8ab94374c0bce2a6">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Escherichia coli toxin</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses biological agents that are produced or secreted by specific strains of bacteria, particularly those with pathogenic properties. These agents can disrupt normal cellular functions, leading to a range of clinical manifestations and immune responses. They are crucial for diagnostic and therapeutic applications in microbiology and infectious disease management. This category specifically identifies toxins associated with Escherichia coli, a commonly studied bacterium in the field of bacteriology and immunology. The classification focuses on distinguishing these toxins based on their unique biochemical characteristics and effects on host organisms, facilitating precise identification and analysis in laboratory settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050150</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW620#015" guid="361fde69adf4479d9f058291ef39e6d8">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Escherichia coli detection (by NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to the methods employed for the detection of specific pathogenic microorganisms through nucleic acid reagents. It encompasses procedures aimed at identifying the presence of Escherichia coli, a bacterium commonly associated with gastrointestinal infections and other health issues. The focus is on utilizing nucleic acid amplification techniques that enhance the sensitivity and specificity of detection, allowing for the timely diagnosis of infections caused by this organism. This method is distinct from other detection techniques targeting various pathogens, emphasizing unique characteristics and methodologies pertinent to the identification of Escherichia coli. The classification provides a framework for understanding the various approaches within the domain of infectious microbiology, specifically tailored to this bacterium's detection and diagnosis.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050151</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW621#015" guid="290dea15e2d0439190ebefbc75914520">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Brucella (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a reagent designed for the detection of specific bacterial pathogens, particularly those belonging to the genus Brucella, which are known to cause infectious diseases in humans and animals. This type of reagent is utilized in laboratory settings to identify the presence of Brucella species in various biological samples. The reagent facilitates the diagnosis of infections by providing a means to detect the associated antigens or genetic material of the bacterium. It plays a critical role in infectious immunology by enabling healthcare professionals to diagnose, monitor, and manage infections caused by Brucella, thereby contributing to improved patient outcomes and public health surveillance.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050152</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW622#015" guid="a0eb779c0424419da1b505bd1cdcdb98">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Clostridium difficile (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a specific type of diagnostic reagent used for the detection of a particular pathogen. It is utilized in microbiological testing to identify the presence of Clostridium difficile, a bacterium associated with gastrointestinal infections. The reagent functions by employing molecular techniques to detect genetic material unique to this organism, facilitating the diagnosis of infections caused by it. This classification is distinct from other diagnostic reagents that target various bacteria or pathogens associated with infectious diseases, highlighting its specialized role in infectious immunology. The focus is on providing accurate and timely results to inform treatment decisions in clinical settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050153</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW623#015" guid="8fe09cfd21cb442d895bd006e352e999">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Coxiella (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a specific category of diagnostic reagents used in the detection and analysis of a particular pathogen associated with infectious diseases. These reagents are designed to identify the presence of specific antigens or antibodies related to the pathogen, facilitating the diagnosis of infections. The classification emphasizes the unique biochemical properties and operational characteristics of these reagents, differentiating them from others that may detect different pathogens or utilize varying methodologies. The classification aims to provide a structured framework for understanding and organizing testing materials in the field of infectious immunology, particularly in bacteriology, ensuring clarity in the identification and utilization of these diagnostic tools in clinical and laboratory settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050154</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW624#015" guid="e7ad79ee57d141ebb09342cc3fcb1472">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Leptospira (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic reagents specifically designed for identifying the presence of Leptospira, a genus of bacteria associated with the disease leptospirosis. These reagents are essential for laboratory testing and are utilized in various immunological assays to detect Leptospira antigens or antibodies in biological samples. The reagents play a crucial role in clinical diagnostics, facilitating early detection and subsequent management of infections caused by this pathogen. They are distinguished from other diagnostic tools aimed at identifying different bacterial pathogens, highlighting their specificity for Leptospira within the broader context of infectious immunology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050155</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW625#015" guid="d711332f08dd4dcd808ea83817d79ad6">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Rickettsia (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a type of analytical reagent specifically designed for the detection and identification of Rickettsia, a genus of bacteria known to be associated with various infectious diseases. These reagents are utilized in laboratory settings to facilitate the diagnosis of infections caused by Rickettsia by employing nucleic acid amplification techniques. The reagents contribute to enhancing the sensitivity and specificity of diagnostic assays, providing critical information for clinical decision-making. The use of such reagents is essential in infectious immunology, allowing healthcare professionals to accurately identify the presence of Rickettsia in clinical samples, thus aiding in the timely management and treatment of related infections.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050156</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW626#015" guid="4e02ad4425a442ecae5921810a233688">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Yersinia (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic reagents specifically designed to detect the presence of Yersinia species, which are significant in the study of infectious diseases. These reagents facilitate the identification of Yersinia at a molecular level, often utilizing nucleic acid amplification techniques to enhance accuracy and sensitivity. They play a critical role in clinical microbiology, aiding in the diagnosis of infections caused by these bacteria. The reagents may be employed in various testing scenarios, including clinical laboratories and research settings, to support epidemiological studies and public health initiatives. This classification distinguishes itself by focusing solely on Yersinia, differentiating it from other infectious agents and their respective detection methods.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050157</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW627#015" guid="c24e91613643464d8f9b426f75ffc7aa">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Bordetella pertussis, parapertussis (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic reagents specifically designed for the detection of Bordetella pertussis and Bordetella parapertussis. These pathogens are known to cause respiratory infections and are significant in the study of infectious diseases. The reagents facilitate the identification of these bacteria in clinical samples, enabling healthcare professionals to diagnose infections accurately and implement appropriate treatment protocols. The focus of this classification is to provide tools that enhance the understanding and management of infectious immunology, distinguishing these reagents from other antigen and antibody detection methods used for different bacterial pathogens.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050158</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW628#015" guid="b5529ea9f8cb46b18a1b10c7cf4211c3">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Diphteria (corynebacterium D., (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a specific substance used in laboratory testing for the detection of a bacterial pathogen associated with a particular infectious disease. The product is typically utilized in diagnostic procedures to identify the presence of the pathogen in clinical samples. It plays a critical role in infectious disease management by allowing healthcare professionals to diagnose the condition accurately and initiate appropriate treatment. This classification encompasses various reagents that are employed in immunological assays targeting specific antigens or genetic material of the microorganism. The focus is on ensuring the reliability and specificity of the diagnostic process, thus aiding in effective disease surveillance and public health interventions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050159</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW629#015" guid="545acb4f3b754bc0a31f962afd8e8062">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Tetanus (clostridium T., NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a category of substances used in laboratory diagnostics that specifically detects the presence of the Tetanus bacterium, which is a pathogenic organism responsible for causing tetanus infection. These substances are designed to identify and measure specific antigens or genetic material associated with the bacterium, aiding in the diagnosis of infections related to this pathogen. The classification encompasses various methodologies and technologies utilized in the detection process, providing essential information for healthcare professionals in their clinical decision-making. This category is distinct from others targeting different infectious agents, focusing solely on Tetanus and its relevant diagnostic applications.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050160</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW630#015" guid="23076507b11840609ed329eb72ec256a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Haemophilus influenzae (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a specific category of biological reagents designed for the detection of a particular bacterial pathogen known for its role in respiratory infections and other diseases. These reagents are utilized in laboratory settings to identify the presence of the pathogen through various analytical techniques, contributing to diagnostics and research in infectious diseases. The focus of this category is on reagents that facilitate the detection of nucleic acids from the specified bacteria, which is essential for accurate diagnosis and treatment decisions. This classification serves healthcare professionals and researchers by providing standardized tools for the identification of this microorganism, thereby enhancing the understanding and management of related health conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050161</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW631#015" guid="b5b3bebb488546afb64174d799a6cf77">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Neisseria meningitidis (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific biochemical reagent designed for the identification and analysis of the bacterium Neisseria meningitidis, which is known to cause meningococcal disease. This reagent is utilized in laboratory settings to facilitate the detection of the pathogen through various immunological techniques, contributing to diagnostics in infectious immunology. The classification of this reagent is distinct from other related diagnostic agents that target different bacterial pathogens or utilize alternative detection methods. The focus is on the unique properties and applications of the reagent in clinical microbiology, underscoring its relevance in diagnosing infections caused by Neisseria meningitidis and aiding in patient management and treatment decisions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050162</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW632#015" guid="a5b2e07e099340a696899e8e4ef96f50">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Proteus (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a category of diagnostic reagents specifically designed for the detection and identification of various microorganisms associated with infectious diseases. These reagents are utilized in laboratory settings to facilitate the rapid and accurate diagnosis of bacterial infections. The products within this category are characterized by their application in immunological assays, employing nucleic acid-based methodologies for the identification of pathogens. They serve a crucial role in clinical diagnostics, aiding healthcare professionals in the detection of infectious agents, thus supporting timely and effective treatment interventions. The reagents may be employed in various analytical procedures, contributing to the overall understanding of infectious disease dynamics and the epidemiology of bacterial infections.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050163</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW633#015" guid="2dcfb61800184302b46b7ec150c76dd1">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Pseudomonas (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a classification for a specific type of biological reagent used in laboratory diagnostics, focusing on the identification and detection of bacterial pathogens. This category encompasses substances that facilitate the recognition of Pseudomonas species through nucleic acid amplification techniques, aiding in the diagnosis of infections caused by these bacteria. The classification distinguishes this reagent from other diagnostic tools that target various bacterial antigens or antibodies, each designed for different organisms and specificities. These reagents play a crucial role in clinical microbiology by providing rapid and accurate results, thus supporting effective patient management and treatment decisions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050164</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW634#015" guid="ac4d408daabc450ba1365b06798bb72c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Shigella (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance used in laboratory diagnostics that facilitates the identification or quantification of specific bacterial pathogens, particularly Shigella species. This reagent is typically employed within immunological assays, where it interacts with target antigens or antibodies to produce measurable results. The application of this reagent plays a crucial role in the detection and diagnosis of infections caused by Shigella, contributing to the overall understanding and management of infectious diseases. Its utilization is essential in clinical microbiology for accurate pathogen identification, aiding healthcare professionals in determining appropriate treatment strategies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050165</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW635#015" guid="40f171d03057439fa7dd8822a6181722">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Legionella (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a specific analytical reagent used for the detection of a particular pathogen associated with severe respiratory infections. The reagent facilitates the identification of the pathogen's presence in various samples, thereby aiding in the diagnosis of related illnesses. It is crucial in clinical settings for monitoring and managing infections, particularly in immunocompromised patients or in outbreak scenarios. The classification encompasses various aspects of the reagent's application, including its specificity, intended use, and the biological context in which it operates. Such reagents play a vital role in public health by enabling timely and accurate detection, which is essential for effective treatment and control measures.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU143#005"/>
          <hierarchical_position>42050166</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV829#015" guid="54b5d3025a0e419e83e832ff9e1b8fdd">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Buffer (unassignable), supplement reagent (Ig's)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a variety of substances that serve as buffers or supplementary reagents, specifically designed for use in immunological assays and related applications. These items may not be directly assignable to a specific category of immunoglobulins but play an essential role in the preparation and stabilization of immunological tests. They may facilitate the detection and quantification of antibodies and other immunological components by maintaining optimal conditions for reactions. These substances are integral to laboratory processes, contributing to the accurate measurement and analysis of proteins and other biomolecules associated with immune responses. Their unique properties and functionalities distinguish them from other related immunological reagents, ensuring precision and reliability in diagnostic and research settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020114</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV830#015" guid="bb20f802b71a49a9a0b7fd586843452e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Complement component (C1q)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses a specific type of biological molecule that plays a role in the immune response by enhancing the ability of antibodies and phagocytic cells to clear pathogens. It is characterized by its function in the complement system, which helps to opsonize pathogens and facilitate their removal from the body. The components within this classification are distinguished by their unique structural and functional properties, contributing to various immune processes. These components are essential in diagnostic applications and may be utilized in clinical laboratories for the assessment of immune function, disease states, and therapeutic monitoring. The classification ensures clarity in identifying these molecules based on their specific roles and characteristics within the broader category of designated proteins.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020115</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV831#015" guid="b51e0973665a4e85893c86e60fc71eb6">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Complement component (C1 inactivator)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a component that plays a role in the immune response by regulating the activity of other proteins within the complement system. This type of protein is crucial for the activation and modulation of various immune pathways, influencing processes such as inflammation and the clearance of pathogens. It serves as an essential factor in maintaining homeostasis in the immune system, with specific functions that differentiate it from other related proteins. This classification encompasses various forms of the component, characterized by their distinct biological roles and interactions within the broader context of immune function.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020116</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV832#015" guid="4e685ea99cd14e9882cc1d7699afa915">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Complement component (C3/C3c)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a diverse range of biological molecules that play crucial roles in the immune response. These components are typically involved in various physiological processes, including inflammation, cell signaling, and pathogen defense. The specific category focuses on proteins that are integral to the complement system, which is a vital part of the innate immune system. These proteins work together to enhance the ability of antibodies and phagocytic cells to clear pathogens from an organism. The classification distinctly identifies those components that are essential for the complement cascade, differentiating them from other immunological substances and reagents. This allows for a clear understanding of their unique functions and applications in diagnostics and research within the field of immunology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020117</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV833#015" guid="7853009fbd494561ace41ffa253e9828">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Complement component (for Bb)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification includes a range of biological substances involved in the immune response, specifically those that play a role in enhancing or regulating the activity of immune cells and proteins. The components categorized here are essential for various immunological processes, contributing to the overall functionality and efficiency of the immune system. These substances can be utilized in diagnostic and therapeutic settings, often serving as tools to measure immune system performance or to aid in the treatment of immune-related conditions. The focus is on components that complement or interact with designated proteins, facilitating their action within biological systems. This classification ensures a clear distinction from other related immunological products and reagents, highlighting their unique roles and applications in clinical and research environments.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020118</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV834#015" guid="e4f8efae1a6f41c6a5f55578ddf52bff">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Complement component (C4)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological substance that plays a crucial role in the immune system, facilitating various physiological functions related to the activation and regulation of immune responses. This component is involved in processes such as inflammation, pathogen clearance, and cell signaling. It is essential for enhancing the effectiveness of antibodies and other immune system components, working synergistically to create a robust defense mechanism against foreign invaders. The classification of this substance is distinct from other specific proteins and antibodies, focusing on its unique functions and interactions within the immune response framework. This component is critical for maintaining homeostasis and supporting the body's defense against infections and diseases.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020119</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV835#015" guid="0e9ce7634f4f4bbeae0b4886a9ec3400">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Complement component (C5a)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a category of biological substances that play a crucial role in the immune response by participating in the complement system. These components are involved in the enhancement of the immune system's ability to eliminate pathogens and facilitate inflammation. Unlike other immunological entities, these substances are specifically characterized by their unique structural and functional properties that distinguish them from various immunoglobulins and other serum proteins. Their primary function includes mediating processes such as opsonization, lysis of pathogens, and activation of inflammatory pathways. This classification is essential for understanding and studying the intricate mechanisms of immune responses and their applications in diagnostics and therapeutics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020120</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV836#015" guid="ed81e6ce0822470881b99c62e3e603e5">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Complement component (C5-9)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a classification for substances that play a role in the immune system's complement pathway, specifically those components that enhance or regulate the activity of the complement system. These entities are not standalone proteins but are integral parts of the complex interactions that facilitate immune responses. They function in various biological processes, including inflammation, cell lysis, and the opsonization of pathogens. This category specifically excludes distinct immunoglobulins and various other protein classes, focusing solely on components that interact within the complement cascade, supporting the immune defense mechanisms.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020121</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV837#015" guid="7b40bc1c78d441f380cd4aeaaf841ae1">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Complement Activity (CH50, total)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a category of biological substances involved in the complement system, which plays a crucial role in immune response by enhancing the ability of antibodies and phagocytic cells to clear pathogens. These components are typically involved in various immunological processes, including inflammation and cell lysis, and are utilized in diagnostic and therapeutic applications. The substances in this category may serve as essential reagents for laboratory testing and analysis, contributing to the understanding of immune function and disease states. This classification specifically excludes immunoglobulins, proteins related to other immune responses, and various diagnostic kits, focusing instead on the specific functions and characteristics of complement-related components.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020122</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV838#015" guid="7cab170e09e14c05937ac42fc7551b63">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Albumin (IC) inclusive uAlbumin</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a class of substances characterized by their specific protein composition, which plays a critical role in various biological processes. This category particularly encompasses a type of protein essential for maintaining osmotic pressure in the blood and is often utilized in clinical settings for diagnostic purposes. The classification includes a notable variant associated with the detection and quantification of this protein in biological fluids, contributing to the assessment of kidney function and other physiological conditions. These proteins are distinct from other related immunological proteins and reagents, emphasizing their unique biochemical properties and applications in healthcare and laboratory diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020123</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV839#015" guid="456c2014a9eb47658aed45a8183496ff">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Ceruloplasmin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical substance that serves as an important protein involved in various physiological processes, particularly in the context of in vitro diagnostics. This substance plays a significant role in the metabolism of copper within the biological system and is often utilized in laboratory settings for diagnostic purposes. It is distinct in its functionality and application compared to other proteins that are typically assessed in similar diagnostic frameworks. This classification encompasses items that may be used in clinical laboratories to evaluate specific health conditions, support diagnostic assessments, and contribute to the understanding of underlying physiological mechanisms related to the presence and levels of this protein in biological samples.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020124</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV840#015" guid="aa0b5131be08452291b0c5a7a0a0b1b4">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Haptoglobin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">haptoglobin is a protein that plays a crucial role in binding free hemoglobin in the bloodstream, thereby aiding in the prevention of hemoglobin-mediated oxidative damage and facilitating the recycling of iron. It is primarily produced in the liver and is involved in the body's response to inflammation and tissue injury. Haptoglobin levels can serve as a biomarker for various medical conditions, including hemolytic anemia and liver disease. In the context of in vitro diagnostics, Haptoglobin is utilized for specific testing and analysis in clinical laboratories to assess health conditions related to hemolysis and overall protein status. This classification focuses on proteins that serve similar diagnostic functions but exhibit distinct biochemical properties and clinical applications.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020125</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV841#015" guid="6e2ef279a5b442e99221e5ea16f025d8">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hemopexin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">hemopexin is a specific type of glycoprotein that plays a crucial role in the binding and transport of heme in the bloodstream, thereby participating in hemoglobin metabolism and protecting tissues from oxidative damage. This protein is particularly significant in clinical diagnostics and laboratory applications, primarily in the context of in vitro diagnostics (IVD). It is used to assess various pathological conditions, including hemolytic disorders and other diseases where heme levels may be altered. The classification of this protein distinguishes it from other related proteins and reagents utilized in immunological and biochemical assays, reflecting its unique biochemical properties and specific applications in healthcare settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020126</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV842#015" guid="571074da7bda453baf6b0c806ef5a362">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Lactoferrin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">lactoferrin is a specific glycoprotein that exhibits a range of biological activities, primarily known for its role in the immune system and its ability to bind iron. It is often utilized in diagnostic applications, particularly within the context of in vitro diagnostics (IVD). This substance is distinguished from other proteins based on its unique properties and functions. Lactoferrin is involved in various physiological processes, including antimicrobial activity, modulation of inflammation, and regulation of immune responses. It is frequently incorporated in clinical testing and research settings to assess various health conditions, especially those related to immune function and inflammation. Its significance in diagnostics makes it an essential component in the assessment of certain medical conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020127</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV843#015" guid="edfcdefabef3471f8971eec47a9a8e52">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Pre-albumin, transthyretin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a type of biomolecule that serves as a specific indicator in diagnostic applications, functioning primarily in the assessment of nutritional status and various clinical conditions. This biomolecule is characterized by its role in transporting vitamin A and other substances within the bloodstream. It plays a crucial role in various physiological processes and is utilized in laboratory testing to aid in the diagnosis of certain health issues. The classification encompasses various related proteins that exhibit distinct immunological properties and functionalities, making them significant in the field of in vitro diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020128</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV844#015" guid="54cca9a5a4d24fde830720c7d4dc92d7">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Retinol binding protein</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">retinol binding protein is a specific type of designated protein that plays a crucial role in the transport of retinol, or vitamin A, within the bloodstream. This protein is essential for the mobilization of retinol from the liver to various tissues, facilitating its uptake and utilization in cellular processes. Retinol binding protein is characterized by its unique structure and function, which distinguishes it from other proteins involved in immune response or other biochemical activities. The classification of this protein emphasizes its significance in nutritional and metabolic contexts, particularly in relation to vision, growth, and cellular differentiation. It is distinct from other proteins that may have similar biological functions or structural characteristics but serve different purposes in the body.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020129</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV845#015" guid="236daa6e825c4f6194339f513ba439e3">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Transferrin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific protein that plays a critical role in the transport of iron in the blood and is utilized in in vitro diagnostic applications. It is commonly assessed in clinical settings to evaluate iron metabolism and diagnose conditions related to iron deficiency or overload. This protein is characterized by its ability to bind to iron ions, facilitating their transport and availability for various physiological processes. The classification of this protein distinguishes it from other proteins involved in immune response and various biochemical functions, emphasizing its unique role within diagnostic procedures.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020130</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV846#015" guid="a90cb06980f445d2a064ac98d4fb446f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Transcobalamin (S)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">transcobalamin (S) refers to a specific protein that functions as a transporter of vitamin B12 within the body. It plays a crucial role in the cellular uptake of this important vitamin, facilitating its delivery to tissues where it is needed for various metabolic processes, including DNA synthesis and the production of red blood cells. This protein is essential for maintaining adequate levels of vitamin B12 in circulation and ensuring its bioavailability for biological functions. The classification of this protein distinguishes it from other related proteins that may serve different roles or have different properties, emphasizing its unique function as a vitamin transporter.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020131</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV847#015" guid="edffddf4f82141aa9a5561395a892ffd">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Apolipoprotein (A I)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of protein that plays a crucial role in lipid metabolism and cardiovascular health. It is characterized by its involvement in the transport and metabolism of lipids, including cholesterol. This protein is a component of lipoproteins and is essential for the proper functioning of the body's lipid transport system. Its presence is vital for maintaining healthy lipid levels and preventing cardiovascular diseases. The classification distinctly separates it from other related proteins that serve different immunological or metabolic functions, ensuring clarity in identifying its unique role within the broader category of designated proteins. This classification aids in the precise identification and study of its functions and applications in health and disease contexts.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020132</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV848#015" guid="97f27ac6029f46cd9212202cd30e12c9">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Apolipoprotein (A II)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">apolipoprotein (A II) refers to a specific type of protein that plays a crucial role in lipid metabolism and the transport of lipids within the bloodstream. It is primarily associated with high-density lipoproteins (HDL) and contributes to the regulation of cholesterol levels in the body. This protein is significant in cardiovascular health and is studied in relation to various lipid disorders. Apolipoprotein (A II) is distinguished from other proteins in the same category by its unique structure, function, and the specific interactions it has within lipid transport mechanisms. Its measurement and analysis can provide insights into metabolic conditions and risk factors for cardiovascular diseases.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020133</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV849#015" guid="9c42c99bbbda458e85fe0c7180a27659">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Apolipoprotein (B)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">apolipoprotein (B) refers to a specific type of protein that plays a crucial role in lipid metabolism and is a primary component of certain lipoproteins. This protein is essential for the transport and metabolism of lipids in the body, particularly in the formation and stabilization of low-density lipoproteins (LDL) and very low-density lipoproteins (VLDL). It is involved in the regulation of cholesterol levels and contributes to the risk assessment of cardiovascular diseases. The classification of this protein is distinct from other proteins that have immunological functions or serve as markers in diagnostic processes. Apolipoprotein (B) is recognized for its significance in both clinical diagnostics and research related to metabolic disorders and cardiovascular health.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020134</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV850#015" guid="66e20f3045c94ca9bf37e1ac81e06012">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Apolipoprotein E-sub-typing</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">apolipoprotein E-sub-typing refers to a specific analytical process used to identify and categorize variations of apolipoprotein E, a protein involved in lipid metabolism and transport. This classification focuses on distinguishing different isoforms of apolipoprotein E, which may have implications in various health conditions and metabolic processes. The process is critical for research and diagnostic purposes, enabling a better understanding of lipid-related disorders and their genetic underpinnings. The differentiation within this classification is based on biochemical properties and functional characteristics, providing insights into the role of apolipoprotein E in health and disease. This classification is distinct from other protein classifications that involve immune response factors or general protein assays.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020135</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV851#015" guid="4aae46874bbd4ef0b5b77b586484d7ba">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Lipoprotein (a)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific type of protein characterized by its association with lipids, playing a crucial role in lipid metabolism and cardiovascular health. This protein is of interest in clinical diagnostics as it may serve as a biomarker for various health conditions, particularly those related to cardiovascular diseases. The classification of this protein emphasizes its distinct biochemical properties and its relevance in laboratory analyses. It is differentiated from other proteins based on its unique structure, function, and the specific clinical implications it holds in relation to systemic lipid levels and cardiovascular risk assessment. This category encompasses various forms and related diagnostic tests, highlighting its importance in medical research and patient care.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020136</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV852#015" guid="0493ca5ccbe14e339edaa2385a2427b8">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">A1-acid glycoprotein (orosomucoid)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a1-acid glycoprotein (orosomucoid) refers to a specific type of glycoprotein that plays a crucial role in various biological processes, including inflammation and immune responses. This substance is characterized by its ability to bind to different ligands and modulate physiological functions, making it significant in clinical diagnostics and therapeutic applications. It is distinct from other proteins commonly classified in similar contexts, as it possesses unique structural and functional properties that differentiate it from other immunoglobulins and complement components. This classification encompasses proteins that are vital for understanding disease mechanisms, guiding treatment strategies, and conducting laboratory analyses in the field of immunology and biochemistry.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020137</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV853#015" guid="471859078dfa4f99a6f02e5682e9d6b1">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">A1-antitrypsin (protease inhibitor)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a1-antitrypsin is a serine protease inhibitor that plays a crucial role in the regulation of proteolytic enzymes, thereby protecting tissues from damage caused by excessive protease activity. It is primarily produced in the liver and circulates in the bloodstream, serving as a key component in the body's defense system against inflammatory processes. This protein is particularly important for maintaining the integrity of lung tissue and preventing conditions associated with protease imbalances. Its measurement can be significant in diagnosing various health conditions, particularly those related to liver function and respiratory issues. A1-antitrypsin is distinct from other proteins involved in immune responses and immune system regulation, highlighting its unique role in the protease inhibition pathway.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020138</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV854#015" guid="482b7dfe867b48cabe39d160e16ceb02">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">A2-macroglobulin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a2-macroglobulin is a type of protease inhibitor that plays a crucial role in regulating various biological processes, including inflammation and immune response. It is a large plasma glycoprotein that binds to and inhibits a wide range of proteases. This protein is significant in clinical diagnostics, particularly in the context of certain diseases where its levels may be altered. Its measurement can aid in the assessment and monitoring of conditions related to inflammation, liver function, and certain malignancies. The classification of this entity is distinct from other proteins and reagents that serve different immunological or diagnostic functions, ensuring clarity in their application in laboratory settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020139</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV855#015" guid="29e218ed43374cddaeb116b08b061fbd">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">A1-microglobulin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a1-microglobulin is a low-molecular-weight protein that plays a crucial role in various physiological processes, including immune response and cellular proliferation. It is primarily found in body fluids and is often used as a biomarker in clinical diagnostics to assess kidney function and detect certain diseases. The measurement of A1-microglobulin levels can provide valuable insights into pathological conditions, particularly those affecting the renal system. This entity is distinct from other related proteins, which may vary in structure, function, and clinical significance. As a diagnostic tool, A1-microglobulin can aid healthcare professionals in monitoring disease progression and evaluating treatment efficacy, making it an essential component in the field of in vitro diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020140</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV856#015" guid="8b88091f46a14ad48d6599b37631a385">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Fibronectin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biologically active glycoprotein that plays a crucial role in cell adhesion, migration, and differentiation. It is primarily involved in the formation of extracellular matrices and is essential in various physiological processes, including wound healing and tissue repair. This substance is used in in vitro diagnostic applications to assess cellular responses and interactions. Its measurement can provide valuable insights into certain pathological conditions, indicating the presence or progression of diseases. The classification distinguishes it from other related proteins by its unique properties and specific applications in diagnostics, reflecting its specialized role in the assessment of health and disease states.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020141</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV857#015" guid="3c138d6b3a1a4038be9b66e54112d6c9">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Trypsin-a1-antitrypsin (elastase)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical substance characterized by its ability to inhibit proteolytic enzymes, specifically elastases, and is involved in regulating inflammatory processes. This substance plays a critical role in maintaining the balance of protease activity in biological systems and is utilized in various diagnostic applications. It is distinct from other related proteins and reagents, which serve different functions in immunological assays and biochemical pathways. Its applications include research in pathophysiological conditions where proteolytic activity is altered, as well as in clinical diagnostics to assess certain diseases. This classification encompasses variants and preparations of the molecule that are relevant in laboratory settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020142</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV858#015" guid="fc606be639fb4953b0e9bc2e059c900d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Immuno reactive trypsin</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of protein that is characterized by its ability to react immunologically with trypsin, a serine protease enzyme. It plays a significant role in clinical diagnostics and is utilized in various immunological assays to assess pancreatic function or diagnose related disorders. The protein serves as a biomarker and is relevant in the context of specific health conditions, helping healthcare professionals in monitoring and diagnosing diseases. The classification distinguishes this protein from other related immunological proteins and reagents that may serve different diagnostic purposes or belong to different biochemical categories, ensuring clarity and precision in the identification of this particular immuno reactive entity.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020143</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV859#015" guid="1c6cdb2600fd4ed8ae428aebb3f05ffc">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cystatin C (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">cystatin C is a low molecular weight protein that functions as a cysteine protease inhibitor, playing a crucial role in regulating various physiological processes, including cellular degradation and immune response. It is primarily produced by all nucleated cells and is released into the bloodstream, making it a valuable biomarker for assessing kidney function and diagnosing renal impairment. The measurement of Cystatin C levels in serum or plasma can provide more accurate information regarding glomerular filtration rate compared to traditional markers, as its concentration is less affected by factors such as age, sex, and muscle mass. This makes it particularly useful in clinical settings for the early detection of kidney dysfunction, monitoring disease progression, and evaluating treatment efficacy in patients with renal conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020144</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV860#015" guid="7244c313aa6446759161e2967242a9b6">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Designated protein (unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020190</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU109#006" guid="53f21c28073f46859e895223bd1fd97d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Designated protein</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific category focused on designated proteins related to immunological functions. It includes various proteins and reagents that play critical roles in immune response and regulation, particularly in diagnostics and laboratory analyses. The items classified under this category are utilized for various applications, including the assessment of immune status, detection of specific antibodies, and measurement of proteins that indicate immune system activity. These products are vital in clinical laboratories for the diagnosis and monitoring of various health conditions, including immune deficiencies and autoimmune disorders. The classification reflects a diverse array of immunological components, emphasizing their importance in both research and clinical settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS274#006"/>
          <hierarchical_position>42020100</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV816#015" guid="37c8784bc8c2439499c9960f00eee780">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Immunoglobulin A (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specialized protein that plays a crucial role in the immune response, specifically in the detection and neutralization of pathogens. This protein is utilized in various diagnostic and therapeutic applications, particularly in the context of in vitro diagnostics. It is characterized by its specific binding properties and is typically measured to assess immune function or disease states. This classification encompasses a range of related proteins that may have similar functions or applications but are differentiated by their unique structural and functional properties. The classification serves to aid in the identification and selection of products relevant to immune system assessments and research.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020101</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV817#015" guid="55786b7f88a54ef38629ce7df3843d14">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Immunoglobulin A (subclass reagent, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance characterized by its role in the immune response, specifically as a type of immunoglobulin that is utilized in laboratory settings for diagnostic purposes. This category encompasses reagents that exhibit specificity for Immunoglobulin A and are typically employed in in vitro diagnostics (IVD). These reagents are essential for various analytical procedures aimed at detecting or quantifying immune components in biological samples. The classification distinguishes this specific subclass from other types of immunoglobulins and related proteins, emphasizing its unique application in clinical diagnostics while ensuring accurate identification and differentiation from similar substances used in immunological assays.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020102</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV818#015" guid="00545a4fafe246169991674e3145650b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Immunoglobulin D (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a specific type of protein that plays a crucial role in the immune response, particularly in the context of in vitro diagnostics (IVD). It is characterized by its unique structure and function, distinguishing it from other immunoglobulins and related proteins. The classification encompasses various forms and applications, including those utilized in laboratory testing and research. This entity is essential for understanding immune system dynamics and is often involved in diagnostic procedures to assess immune function or detect specific conditions. Its differentiation from similar proteins is significant for precise identification and utilization in clinical settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020103</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV819#015" guid="c4b793e3123342849a53c8217e80b873">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Immunoglobulin D (subclass reagent, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a reagent specifically designed for the detection and quantification of the immunoglobulin D subclass in laboratory settings, particularly within in vitro diagnostic applications. This substance is utilized in various assays and tests to analyze the presence and levels of immunoglobulin D, which plays a crucial role in the immune response. The reagent facilitates the understanding of immunological profiles and can aid in diagnosing conditions related to immune function. It is distinct from other immunoglobulin subclasses and related biochemical entities, providing targeted analysis for diagnostic and research purposes in clinical laboratories.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020104</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV820#015" guid="4e0ac10fd7cc47b3888f5c0a19f1656f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Immunoglobulin G (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific type of protein that plays a crucial role in the immune response, primarily functioning as an antibody to identify and neutralize pathogens such as bacteria and viruses. This protein is characterized by its ability to provide long-term immunity and is often used in diagnostic tests and therapeutic applications. It is distinguished from other similar proteins based on its structural and functional properties, specifically in its subclass and application in in vitro diagnostics. Its presence and concentration in biological samples can be indicative of immune system status and response to infections or other medical conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020105</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV821#015" guid="89716099f2f04ba390796d13e93a5566">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Immunoglobulin G (subclass reagent, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific type of immunoglobulin that plays a crucial role in the immune response, particularly in identifying and neutralizing pathogens such as bacteria and viruses. This substance is utilized in various diagnostic and analytical applications within the field of in vitro diagnostics (IVD). It serves as a reagent for detecting and measuring the presence of other immunoglobulins or antibodies in biological samples. The classification of this immunoglobulin distinguishes it from other immunoglobulin types and subclasses, highlighting its unique properties and applications in medical diagnostics and research. Its importance lies in its ability to provide valuable insights into immune function and disease states, making it a vital component in laboratory testing and clinical evaluation.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020106</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV822#015" guid="57610250b34a422aab2c5f11754cb107">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Immunoglobulin M (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological molecule that plays a crucial role in the immune response, specifically involved in identifying and neutralizing pathogens such as bacteria and viruses. This type of molecule is predominantly found in the bloodstream and is characterized by its pentameric structure, which enhances its ability to bind to antigens effectively. It is utilized in various diagnostic applications, particularly in the field of in vitro diagnostics, to assess immune function and diagnose certain conditions. This classification encompasses forms that are intended for laboratory use, distinguishing it from other related molecules that serve different functions or are used in varying contexts within immunological studies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020107</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV823#015" guid="da2e97387fd949d9a1c0c18317f38616">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Immunoglobulin M (subclass reagent, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic reagent specifically designed for the detection and measurement of Immunoglobulin M, a critical antibody involved in the immune response. This reagent is utilized in in vitro diagnostic applications to assess the presence and levels of Immunoglobulin M in biological samples, aiding in the diagnosis of various conditions. It is differentiated from other antibodies and related reagents through its unique properties and applications, specifically focusing on the subclass characteristics of Immunoglobulin M. This reagent is essential for clinical laboratories and healthcare professionals to monitor immune system function and identify potential health issues related to Immunoglobulin M levels.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020108</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV824#015" guid="128ce5531e6344e0a366dbb16c07f1d0">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Kappa and lambda chain</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a specific category of proteins characterized by their structural features and functional roles within biological systems. These proteins are integral components of the immune response, contributing to various physiological processes. They are distinguished by their unique chain structures, which can influence their interactions with other biomolecules and their overall functionality. The classification excludes a wide range of other proteins and immunological substances that serve different roles in diagnostics and therapeutic applications. This category focuses specifically on those proteins that have distinct kappa and lambda chains, which are critical for understanding their biological activities and potential applications in research and clinical settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020109</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV825#015" guid="82d769ff5d41447e8dc0e4fe7b019818">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Immunoelectrophoresis kit</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic kit designed for the immunoelectrophoresis technique, which facilitates the separation and identification of proteins based on their electrophoretic mobility. This kit typically includes specific reagents and materials necessary to perform the immunoelectrophoresis assay, allowing for the qualitative and quantitative analysis of various proteins in a sample. It serves as a vital tool in clinical laboratories for the assessment of protein disorders and the evaluation of immune responses. The components within the kit are formulated to ensure reliability and accuracy in results, aiding healthcare professionals in diagnostics and research applications.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020110</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV826#015" guid="bc177545d1064827b2d7ecf382041fd6">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Immunofixation kit</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic tool designed for the assessment and identification of specific proteins through immunofixation methods. This kit is utilized in laboratory settings to facilitate the separation and quantification of various protein fractions within biological samples. It employs immunological techniques to bind target proteins, allowing for their detection and analysis, thereby assisting in the diagnosis and monitoring of various health conditions. This classification encompasses products that are specifically tailored for the immunofixation process, distinguishing them from other protein-related assays and reagents. The kit serves as an essential component in the broader scope of protein analysis in clinical diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020111</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV827#015" guid="ce218adad7a84079a618c4f99ae24041">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Anti human Ig polyvalent antiserum</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a polyvalent antiserum derived from anti-human immunoglobulins, designed to identify and neutralize a broad spectrum of human antibodies. This product is utilized in various immunological applications, including diagnostic testing and research, providing a tool for detecting the presence of human immunoglobulins in samples. Its formulation allows for enhanced specificity and sensitivity in assays, making it a crucial component in laboratories focused on immunological studies. This antiserum is distinct from other immunoglobulin preparations, emphasizing its role in the detection of multiple human antibody types without being limited to specific subclasses or individual immunoglobulin classes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020112</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV828#015" guid="ec6194d682974023a9049a5c44fc4a5d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Human anti-mouse antibody</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific type of antibody designed to recognize and bind to mouse proteins, primarily utilized in research and diagnostic applications. This antibody plays a crucial role in various immunological assays and experiments, facilitating the detection and quantification of mouse-derived antigens. It is distinct from other antibodies that target human immunoglobulin subclasses and complements, focusing specifically on interactions with mouse proteins. The production and application of this antibody are critical in the development and validation of methodologies in immunology, molecular biology, and biotechnology, contributing to advancements in scientific research and medical diagnostics. Its specificity and affinity for mouse targets make it an essential tool in both experimental and clinical settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU109#006"/>
          <hierarchical_position>42020113</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV901#015" guid="56b76f9cefea482babfe70eca03bc58b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Human placenta like alkaline phosphatase (additional tumor marker)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological substance utilized in clinical diagnostics, specifically to assist in the identification and monitoring of certain types of tumors. This substance is indicative of cellular activity and can provide valuable information regarding the presence or progression of malignancies. Typically analyzed through blood tests or tissue samples, it can be used in conjunction with other diagnostic tools to enhance the accuracy of cancer detection. The presence and levels of this marker may correlate with specific pathological conditions, offering insights into patient prognosis and treatment responses. Its utility in oncology underscores the importance of molecular markers in personalized medicine, enabling targeted therapeutic strategies and improving patient outcomes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020332</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV902#015" guid="3fe82c6f2dcf44bc9689ff4803dc1f6f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Laminin (additional tumor marker)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical compound that serves as an additional indicator in the assessment of tumors, particularly in relation to specific types of cancer. This substance is used in diagnostic procedures to help determine the presence or progression of malignant conditions. Its levels in biological samples may provide valuable information for clinicians in the context of cancer diagnosis, monitoring treatment response, and evaluating prognosis. This marker is distinguished from other established tumor markers by its unique biochemical properties and the specific types of malignancies it is associated with, contributing to a more comprehensive understanding of a patient's condition. It plays a crucial role in enhancing the diagnostic accuracy and therapeutic decision-making in oncology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020333</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV903#015" guid="ee8d99cd1ed74a41b68f5428da7f46a5">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Neuron specific enolase (additional tumor marker)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological substance that serves as a specific marker associated with neuronal tissue, often utilized in clinical diagnostics to aid in the identification of certain tumor types. This marker can indicate the presence of neuroendocrine tumors and is valuable in monitoring disease progression or response to treatment. It is typically analyzed through various laboratory techniques and plays a crucial role in the overall assessment of a patient's health status in relation to tumor activity. The use of this marker enhances the ability to differentiate between various tumor types and aids in the development of tailored treatment strategies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020334</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV904#015" guid="ee26fa1b7a06486c93680811e08296fe">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Thymidine kinase (additional tumor marker)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical substance that serves as an indicator of tumor presence or progression, specifically related to cellular processes and metabolic pathways. This marker is utilized in diagnostic procedures to identify certain types of malignancies by measuring its levels in biological samples. The presence of this substance can provide valuable information about the tumor's characteristics and behavior, assisting healthcare professionals in making informed decisions regarding patient management and treatment strategies. This marker is distinguished from other similar substances based on its unique biochemical properties and the specific tumors it is associated with, contributing to a comprehensive understanding of cancer diagnostics and monitoring.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020335</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV905#015" guid="faaf15077d9d42988b9655e1bad3e1fa">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Tissue associated protein (additional tumor marker)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological substance capable of being present in various tissues and associated with the presence of tumors, functioning as a potential indicator for cancer diagnosis or monitoring. This entity may be utilized in clinical settings to assist in the evaluation of specific cancer types and their progression, serving as a supplemental marker alongside other established tumor indicators. The presence of this substance can provide valuable insights into the underlying biological processes associated with malignancies, thereby aiding healthcare professionals in making informed decisions regarding patient management and treatment strategies. Its detection may be performed through various biochemical assays, contributing to the overall understanding of tumor behavior and patient prognosis.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020336</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV906#015" guid="9b99595c151342969c9f850fe2bfb709">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Matrix-metalloproteinase (additional tumor marker)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biomarker specifically associated with the identification of certain types of tumors, providing essential information for diagnosis, prognosis, and treatment decisions. This substance can be found in various biological samples, such as blood, tissue, or other bodily fluids, and its presence or concentration may indicate the presence of a tumor or the response to therapy. This particular marker is distinct from other tumor-related substances, highlighting its unique role in the context of oncological assessments. It is utilized in clinical settings to aid healthcare professionals in monitoring disease progression and therapeutic responses, contributing to personalized patient care strategies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020337</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV907#015" guid="e1d883bcb08c45f892b480022530f7c4">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Serotonine (additional tumor marker)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses biochemical indicators used in the diagnosis and monitoring of specific tumors. These markers are substances produced by cancer cells or by the body in response to cancer, and they play a crucial role in identifying the presence or progression of certain malignancies. The focus is on the measurement of serotonin levels as an additional marker that can provide valuable information in the context of tumor diagnostics. This category distinguishes itself from other tumor markers by its unique biochemical properties and its relevance in particular oncological assessments. The use of these markers is instrumental in guiding treatment decisions and evaluating patient responses to therapies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020338</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV908#015" guid="f14200f798624cbca23aef85ad2844dc">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Protein S-100 B (additional tumor marker)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses a specialized biochemical marker that plays a role in the diagnosis and monitoring of certain types of tumors. It is utilized in clinical settings to provide additional insights into tumor presence and progression, thereby supporting healthcare professionals in making informed decisions regarding patient management. The marker is distinguished from other similar substances that indicate various cancer types and conditions, each having unique characteristics and clinical significance. Its utilization may involve specific testing methodologies aimed at detecting the presence and levels of this particular protein in biological samples, contributing to the overall understanding of tumor dynamics and patient prognosis.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020339</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV909#015" guid="1386d792d07e4b9a8f3d4520ae847c68">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Colon cancer NAT (additional tumor marker)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific category within the classification system that encompasses diagnostic substances or tests utilized in the identification and monitoring of colon cancer. This classification includes various biomolecules or assays that serve as indicators of the presence or progression of colon malignancies. These items are distinct in their biochemical properties and clinical applications, facilitating the assessment of tumor presence, response to treatment, or prognosis. The classification aims to provide a systematic approach to organizing these diagnostic markers based on their relevance to colon cancer, ensuring clarity and consistency in medical diagnostics and research.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020340</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV910#015" guid="a97c6ab9296b43e5a3643327b63a5329">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Tumor marker (unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020390</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU116#006" guid="17ab3d54dc184845bd9fdd074100220d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Therapeutic drug monitoring</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses the monitoring and assessment of specific therapeutic drugs utilized in clinical settings to optimize patient treatment outcomes. It includes the measurement and analysis of drug concentrations in biological samples, ensuring safe and effective dosing while minimizing adverse effects. This category is distinct from other related testing areas, focusing specifically on the pharmacokinetics and pharmacodynamics of therapeutic agents. The items classified here are critical for managing therapies that require precise dosing adjustments and monitoring to maintain therapeutic efficacy and safety. In addition, the classification supports the evaluation of drug interactions, compliance, and potential toxicity, providing essential information for healthcare professionals in the administration of these medications.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS274#006"/>
          <hierarchical_position>42020800</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW034#015" guid="4cb7741260d64b929f07e1f63533c425">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Digoxin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a medicinal substance that is utilized in the therapeutic monitoring of patients, specifically for its role in managing heart conditions. This compound is vital for ensuring optimal therapeutic outcomes, enabling healthcare providers to assess and adjust dosages based on individual patient responses. It is part of a broader category of therapeutic agents that are monitored to maintain effective and safe levels in the bloodstream, thereby minimizing potential adverse effects while maximizing therapeutic efficacy. This classification is distinct from other similar agents used in the same therapeutic monitoring context, highlighting its unique pharmacological properties and clinical applications.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020801</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW035#015" guid="a7c0c55a90234f838087453a183ebbb6">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Digitoxin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific medicinal compound utilized primarily for therapeutic purposes, particularly in the monitoring of patients' drug levels to ensure efficacy and safety. This substance is crucial in the management of certain medical conditions, where precise dosage and monitoring are essential for patient health. It is differentiated from other similar compounds based on its unique biochemical properties and therapeutic applications. This classification encompasses a range of substances that are monitored in clinical settings to guide treatment decisions and optimize patient outcomes. The focus is on the active ingredient and its specific role within the broader category of therapeutic agents used in clinical diagnostics and patient management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020802</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW036#015" guid="a4a5e807ba044046a3988db12b52fe96">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Disopyramide (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a pharmaceutical substance utilized in the monitoring and treatment of cardiac conditions, specifically acting as an antiarrhythmic agent. This compound is relevant in clinical settings for assessing therapeutic drug levels to ensure efficacy and safety for patients. It is categorized within a broader classification of therapeutic drugs that are used for similar monitoring purposes. The substance plays a significant role in managing certain types of heart rhythm disorders, necessitating regular testing to maintain appropriate dosage and avoid potential toxicity. This classification encompasses various other medications used in therapeutic drug monitoring, each with distinct pharmacological properties and clinical applications.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020803</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW037#015" guid="2d554a677f7b4097b371059f209be285">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Flecainide (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a pharmaceutical compound utilized primarily in the context of therapeutic drug monitoring, this substance is a member of a class of antiarrhythmic agents. It is specifically indicated for managing certain types of cardiac arrhythmias, aiding in the stabilization of heart rhythm. The compound’s therapeutic efficacy is assessed through laboratory testing, ensuring appropriate dosing and minimizing potential toxicity. This monitoring is critical for optimizing patient outcomes and ensuring effective management of the underlying conditions. The classification of this compound is distinct from other similar agents used in therapeutic drug monitoring, reflecting its unique pharmacological properties and clinical applications.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020804</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW038#015" guid="22d0065119d34f84b42e9adbb1576072">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Lidocaine (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance utilized in the medical field primarily for its anesthetic properties, which is specifically indicated for therapeutic drug monitoring. This compound is crucial in assessing therapeutic levels to ensure efficacy and minimize the risk of toxicity. It plays a significant role in patient care by aiding healthcare professionals in the management of various conditions requiring precise dosing and monitoring. The classification of this substance is distinct from other similar compounds that serve similar therapeutic purposes but differ in their specific applications, pharmacological properties, and monitoring requirements. This ensures accurate diagnostic and treatment processes in clinical settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020805</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW039#015" guid="1979d63304f6465ea060b03f3bc6068b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">N-Acetylprocainamide (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific therapeutic agent utilized for monitoring and managing treatment regimens in clinical settings. The substance is characterized by its role in influencing cardiac and neurological functions, necessitating precise measurement and evaluation of its concentration in biological specimens. It is essential for ensuring therapeutic efficacy while minimizing potential toxicity. The classification distinguishes this agent from other similar substances used in therapeutic drug monitoring, highlighting its unique pharmacological properties and clinical applications. This enables healthcare professionals to make informed decisions regarding dosage adjustments and patient management based on therapeutic levels, thereby optimizing treatment outcomes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020806</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW040#015" guid="d61be4d336cd4d4dbbe56ad9b0318575">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Procainamide (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a specific pharmaceutical agent utilized for therapeutic drug monitoring. It is characterized by its role in managing certain medical conditions, where precise measurement of the drug's concentration in biological fluids is crucial for ensuring efficacy and safety. The category encompasses substances that may have varying pharmacokinetic profiles, therapeutic ranges, and clinical implications. This particular agent is distinguished by its unique chemical structure, mechanism of action, and therapeutic applications, setting it apart from other similar substances used in the same context. Its monitoring is essential for optimizing treatment regimens and minimizing potential adverse effects, thereby contributing to improved patient outcomes in clinical settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020807</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW041#015" guid="65fbfc142dfb4bf59bc40667592da2f7">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Propranolol (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a pharmaceutical substance used for therapeutic drug monitoring, characterized by its role in managing specific medical conditions, particularly related to cardiovascular issues. This substance is typically administered to patients for the purpose of controlling heart rate and reducing the risk of arrhythmias. It is often measured in clinical settings to ensure therapeutic efficacy and minimize potential toxicity. The classification distinguishes this substance from other related therapeutic agents that may have different pharmacological effects or target different health concerns. It is crucial for healthcare professionals to monitor and adjust dosages based on individual patient responses and laboratory results to optimize treatment outcomes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020808</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW042#015" guid="cc62c2981dd442ada6c7fe131d0db151">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Quinidine (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">quinidine is a pharmaceutical agent utilized primarily for therapeutic drug monitoring, particularly in the context of arrhythmias and other cardiac conditions. This compound acts as an antiarrhythmic medication, exhibiting properties that help regulate heart rhythm by influencing the electrical activity of the heart muscle. The monitoring of quinidine levels is essential to ensure therapeutic efficacy while minimizing potential toxicity. This substance is distinct from other similarly utilized medications within the therapeutic drug monitoring category, each of which may have varying mechanisms of action, therapeutic windows, and clinical applications. Proper management of quinidine dosage and monitoring is crucial for optimizing patient outcomes and ensuring safe treatment regimens in clinical settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020809</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW043#015" guid="657c3482702f4249ab9f15e197cb28f6">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Carbamazepine (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a pharmaceutical compound utilized in therapeutic drug monitoring, specifically targeting the management of epilepsy and certain mood disorders. It functions by stabilizing electrical activity in the brain and is monitored to ensure effective therapeutic levels while minimizing toxicity. This substance is identified as a key component in the assessment and adjustment of treatment regimens for patients, particularly those requiring careful dosage calibration due to variable individual responses. Its classification distinguishes it from other similar compounds used in therapeutic contexts, ensuring precise identification and application within medical and clinical settings for optimal patient care.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020810</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW044#015" guid="97b018bf8cb64c25ac4f53c53893309c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Ethosuximide (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a pharmaceutical agent indicated for the management and monitoring of specific therapeutic conditions. It is utilized in clinical settings to assess drug levels in biological samples, ensuring optimal dosing and therapeutic efficacy. This agent is characterized by its unique pharmacological properties and is distinct from other therapeutic agents within the same monitoring category, which may target various conditions or mechanisms of action. The classification supports healthcare providers in delivering precise and effective treatment, enhancing patient care through tailored therapeutic approaches. This agent plays a critical role in the therapeutic landscape, contributing to the careful evaluation and management of treatment regimens.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020811</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW045#015" guid="b3c133ddb4524c20baa400165448de58">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Free carbamazepine (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a category that encompasses substances specifically utilized for the purpose of monitoring therapeutic drug levels. This category is distinct in its focus on free forms of certain medications, which are crucial for ensuring effective treatment regimens while minimizing toxicity. The substances within this category are characterized by their ability to provide insights into the pharmacokinetics of the drugs, aiding healthcare professionals in the adjustment of dosages based on individual patient needs. The monitoring of these compounds is essential for optimizing therapeutic outcomes, particularly in the context of serious medical conditions that require precise management of medication levels in the bloodstream.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020812</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW046#015" guid="5ae489cf6ac64f68acf716a4cac355c2">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Free phenytoin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance utilized in therapeutic drug monitoring, specifically designed to assess the concentration of a particular active ingredient in biological samples. This product is essential for ensuring effective dosing and safety in patients undergoing treatment with specific medications that require careful monitoring of their active levels in the bloodstream. The substance serves as a crucial tool in clinical settings, enabling healthcare professionals to make informed decisions regarding the administration and adjustment of therapeutic regimens based on individual patient needs and responses to treatment.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020813</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW047#015" guid="ac9d59698feb437885da635491c5101d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Free primodone (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses substances utilized in therapeutic drug monitoring, specifically focusing on various medications that require careful measurement and management within clinical settings. It includes a range of compounds that play crucial roles in treating various health conditions, necessitating precise monitoring to ensure efficacy and safety. The substances classified here are characterized by their distinct pharmacological properties and applications in patient care, particularly in relation to their therapeutic indices and potential for toxicity. This classification aims to facilitate the organization and identification of these vital agents within healthcare and laboratory environments, ensuring that healthcare professionals can readily access and utilize information pertinent to their therapeutic monitoring practices.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020814</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW048#015" guid="f6cc0a8309744a2ba17a7b2977c4e4ea">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Free valproic acid (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses substances utilized in the assessment and management of therapeutic drug levels within the human body. It specifically refers to a variant of a medication that exists in its unbound form, which is essential for evaluating its pharmacological effects and potential toxicity. The focus is on substances that play a crucial role in monitoring therapeutic efficacy and ensuring optimal dosage for patient safety. This category is distinct in its application and relevance compared to other related compounds used in similar monitoring processes, each of which may have different pharmacodynamics, therapeutic indices, and clinical implications.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020815</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW049#015" guid="afa6a66d7d0542deb849e1700df09ee0">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Phenobarbital (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a pharmaceutical agent utilized in therapeutic drug monitoring, primarily for its sedative and anticonvulsant properties. It is a barbiturate that serves in the management of various medical conditions, particularly those requiring precise monitoring of drug levels for effective treatment. This agent is distinguished by its specific therapeutic applications and the requirement for careful dosage regulation to avoid toxicity. It is used in clinical settings where monitoring of drug concentration is crucial to ensure patient safety and therapeutic efficacy. The classification highlights its role in managing certain health conditions, setting it apart from other similar substances that may have different pharmacological effects or monitoring requirements.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020816</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW050#015" guid="efd4c77631dd4f1e8ecbfb6d28912997">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Phenytoin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a pharmaceutical compound utilized in therapeutic drug monitoring, specifically for managing certain medical conditions, providing crucial data for the assessment of patient treatment efficacy and safety. This substance is primarily used to monitor plasma concentrations to ensure optimal therapeutic effects while minimizing potential toxicity. It plays a vital role in patient care by guiding dosage adjustments and informing clinical decisions regarding treatment regimens. The classification encompasses various related compounds with differing therapeutic applications and monitoring requirements, each tailored to specific medical indications and patient needs. This classification facilitates the organization and retrieval of information pertinent to healthcare professionals involved in pharmacotherapy and patient management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020817</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW051#015" guid="9550a439128e439c8edb4e68fb4f4bcf">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Primidone (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">primidone is a medication used primarily in the management of certain types of seizures and is classified within a category that focuses on monitoring therapeutic drug levels. This classification is essential for ensuring effective treatment outcomes, as it helps healthcare professionals assess the concentration of the drug in a patient's system, thereby optimizing dosing and minimizing potential side effects. The classification encompasses various substances that may share similar therapeutic applications but differ in their pharmacological properties and therapeutic monitoring requirements. Primidone is distinguished from other related compounds and is specifically monitored to ensure patient safety and therapeutic efficacy within the context of drug monitoring protocols.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020818</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW052#015" guid="e5aacb445a214b56b98adff7f7597e78">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Valproic acid (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific chemical compound utilized in the therapeutic monitoring of certain medical conditions, particularly within the realm of neurology and psychiatry. This compound is primarily used to assess levels in the bloodstream to ensure efficacy and safety in treatment regimens. It plays a crucial role in managing conditions that require precise dosing, as variations in concentration can significantly impact patient health outcomes. The analysis of this compound is essential for healthcare providers to optimize therapeutic strategies and minimize adverse effects. It is distinct from other compounds within the same monitoring framework, each serving unique therapeutic purposes and having different clinical implications.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020819</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW053#015" guid="816e23a26b2147ec8e8f87d868074d77">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Amikacin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific category within a classification framework pertaining to therapeutic substances utilized for monitoring drug levels in patients. This category encompasses a particular antimicrobial agent, which is administered intravenously and is effective against a range of bacterial infections. It is primarily used in clinical settings to assess and ensure the appropriate dosage and therapeutic efficacy while minimizing toxicity. The classification distinguishes this substance from other related therapeutic agents by its unique pharmacological properties and its role in patient treatment protocols, emphasizing its importance in personalized medicine and the careful management of antimicrobial therapy.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020820</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU111#006" guid="fe254c761c5b408b8aa43081aa2fbab1">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Tumor marker</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a category of biological substances used primarily for the detection and monitoring of neoplastic conditions. These substances are typically produced by tumor cells or by the body in response to cancer, serving as indicators of the presence or progression of malignancies. The classification includes various specific antigens, proteins, and related markers that are analyzed in clinical settings to aid in diagnosis, prognosis, and therapeutic decision-making for patients with cancer. The assets within this category are essential for understanding tumor behavior and can assist healthcare professionals in tailoring individualized treatment plans based on specific tumor characteristics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS274#006"/>
          <hierarchical_position>42020300</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV870#015" guid="93cfd56bd3fe4de4b5ada3a2ebdc04bf">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Bladder tissue antigen</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological substance found in the bladder that serves as an indicator for specific tumor activity or presence, often utilized in diagnostic tests to assist in the evaluation of certain malignancies. This substance is typically detected in bodily fluids and can provide valuable information regarding the progression or response to treatment of bladder-related cancers. Its measurement is part of a broader panel of tests aimed at identifying various tumor markers, aiding healthcare professionals in the monitoring and management of cancer patients. This particular marker is distinguished from other tumor markers by its unique association with bladder pathology and its specific role in oncological diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020301</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV871#015" guid="84f9ac3cda7f49128127dfdbf9fc25da">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cancer antigen (15-3)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific biological substance found in the bloodstream, associated with certain types of cancer, utilized primarily for diagnostic and monitoring purposes. This marker aids in the detection of disease presence, progression, and response to treatment. Its presence and levels can provide valuable insights into the patient's condition, contributing to clinical decision-making and personalized treatment strategies. This classification encompasses various tumor-related indicators that differ in their specificity and sensitivity to different cancer types, enabling healthcare professionals to tailor their approach based on individual patient profiles and clinical scenarios.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020302</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV872#015" guid="ea92e01e63384c62ab70cfd11e70d398">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cancer antigen (19-9)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification identifies a specific biomarker associated with certain types of cancer, utilized primarily in diagnostic and monitoring contexts. It serves as an indicator for the presence of malignancies, aiding healthcare professionals in assessing disease progression, therapeutic response, and potential recurrence. The unique properties of this biomarker allow it to be distinguished from other related markers, each with its own clinical significance. This classification is crucial for understanding patient health and guiding treatment decisions, supporting the medical community in delivering targeted and effective care. The biomarker's relevance extends beyond mere detection, encompassing comprehensive insights into cancer pathology and patient management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020303</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV873#015" guid="abbfc9b67eea48f4987aa527c32c64ec">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cancer antigen (50)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of biomarker that is utilized in the diagnosis and monitoring of cancer. These substances, typically proteins or glycoproteins, are produced by cancerous cells or by the body in response to cancer. They can be detected and measured in various biological fluids, such as blood or urine, and serve as indicators of the presence, progression, or recurrence of malignancies. The presence and levels of these biomarkers can assist healthcare professionals in making informed decisions regarding diagnosis, treatment options, and patient management. Each type of biomarker has distinct characteristics and clinical applications, contributing to the overall understanding of tumor biology and aiding in personalized medicine strategies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020304</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV874#015" guid="9429c8ccdf384160a409dbbbeb4e4c98">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cancer antigen (72-4)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific type of biomarker utilized in the diagnosis and monitoring of certain cancer types, particularly associated with the presence of malignancies. This substance is produced by cancer cells or by the body in response to cancer. Its detection is significant in clinical settings, as it can aid in assessing the progression of the disease, evaluating treatment efficacy, and potentially guiding therapeutic decisions. The measurement of this biomarker is typically performed using various laboratory techniques, contributing to a comprehensive understanding of the patient's condition. The presence and levels of this biomarker can vary based on individual factors and the specific characteristics of the cancer, making it an important tool in personalized medicine and oncology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020305</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV875#015" guid="c377b7f261dd4c67b3d97a10e3a692ce">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cancer antigen (125)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological molecule used as an indicator in medical diagnostics, specifically related to the presence of cancer. This type of marker is typically measured in blood or tissues and reflects the activity or progression of tumors. The specific category is characterized by its unique biochemical properties and is utilized in clinical settings to aid in the diagnosis, monitoring, and treatment of various malignancies. It serves as a tool for healthcare professionals to assess disease status and make informed decisions about patient management. In this context, it is differentiated from other related markers based on its distinct biological structure and the specific cancer types it is associated with.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020306</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV876#015" guid="fde835c55a0c400caffd07a180556b17">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cancer antigen (195)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance or biological material that is produced by cancer cells or is present in increased levels in the blood or other body fluids of individuals with cancer. These markers are utilized primarily for diagnostic, prognostic, or monitoring purposes in oncology. They can indicate the presence of certain types of tumors or assist in evaluating the effectiveness of treatment. The classification of this substance is distinguished from other similar markers based on its specific biochemical properties, clinical significance, and the types of cancers it is associated with. Such markers play a crucial role in personalized medicine, allowing for tailored therapeutic approaches based on individual patient profiles.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020307</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV877#015" guid="41268fd0290f4f2badce8c33a611dd43">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cancer antigen (242)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific type of biomarker used in oncology, this classification identifies a molecule that is produced by cancer cells or by the body in response to cancer. It is primarily utilized in the diagnosis, monitoring, and treatment of various malignancies. The distinct nature of this marker allows for differentiation from other related substances and serves as an important tool in clinical practice, particularly in guiding therapeutic decisions and assessing disease progression. Its detection may be performed through various laboratory techniques, contributing to a comprehensive understanding of an individual's cancer status.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020308</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV878#015" guid="78cc4437a44a4eebac1c54871f7dba54">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cancer antigen (549)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a specific type of biological marker that is associated with the presence of cancer. These markers are substances produced by cancer cells or by the body in response to cancer, and they can be detected in various bodily fluids or tissues. Their primary function is to assist in the diagnosis, monitoring, and treatment of cancerous conditions. This particular category encompasses a range of antigens that serve as indicators for different types of cancer, offering valuable insights into the disease's progression and response to therapy. The unique characteristics of these antigens differentiate them from other related markers, emphasizing their role in cancer diagnostics and management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020309</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV879#015" guid="6aa28cf06eb441758038ea4897d820f1">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cancer antigen (27.29)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a cancer antigen is a type of biomarker that is associated with the presence of cancerous cells in the body. These antigens can be found in various tissues and fluids and are often used in clinical settings for diagnostic purposes, monitoring treatment responses, and evaluating disease progression. The specific cancer antigen defined here is characterized by its unique properties and potential applications in oncology. It serves as a critical tool in the assessment of certain malignancies, allowing healthcare professionals to identify and quantify tumor presence, which can guide therapeutic decisions and inform patient management. This category encompasses a range of distinct antigens that are relevant in the context of tumor biology and patient care, each with unique clinical implications.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020310</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV880#015" guid="0d8f310c0e8346c38a07bed73f989e4b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">CYFRA 21-1</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific biological marker associated with certain tumors. It serves as a biochemical indicator in the diagnosis, monitoring, and management of cancer. This marker can be detected in various biological fluids and is utilized in clinical settings to provide insights into the presence or progression of malignant conditions. The relevance of this marker lies in its potential to aid healthcare professionals in making informed decisions regarding patient treatment plans and prognoses. It is distinct from other biological markers that are employed in oncology, each serving unique roles and applications in cancer diagnostics and patient care.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020311</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV881#015" guid="5cf5f9e948ad4cdb8b9f5d8d4fbd114c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Human epididymal protein 4</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a protein that is primarily expressed in the epididymis and is associated with various physiological functions in the male reproductive system. This protein may serve as a biomarker for certain types of cancers, particularly in diagnostic applications. Its levels in biological samples can provide valuable information for the detection and monitoring of malignancies, distinguishing it from other tumor markers that indicate different cancer types or stages. This classification encompasses proteins that exhibit specific and measurable changes in concentration in response to the presence of tumors, aiding in the assessment of disease progression or response to therapy. The identification and quantification of this protein in clinical settings can enhance the understanding of tumor dynamics and patient management strategies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020312</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV882#015" guid="e39268d2d6804b43a49bc45690f32a27">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Carcinoembryonic antigen</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific biochemical substance found in the blood that is primarily used as a tumor marker to assist in the diagnosis and monitoring of certain types of cancer. This substance can be elevated in individuals with malignancies and is often used in conjunction with other diagnostic tools to evaluate the presence and progression of cancer. Its levels can help healthcare professionals assess treatment response, track disease recurrence, and make informed decisions regarding patient care. The measurement of this antigen is commonly performed through laboratory testing, providing critical information for oncology assessments.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020313</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV883#015" guid="3495e56d992146a88af9c013b19df9a1">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Prostatic specific antigen (total)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance that is utilized as a biological marker for the detection and monitoring of prostate-related conditions, particularly prostate cancer. This antigen is produced by normal prostate cells and is often elevated in the presence of prostate malignancies. Testing for this marker is commonly performed through blood analysis and serves as a tool for assessing disease progression, response to treatment, and recurrence in individuals diagnosed with prostate cancer. Its measurement is integral to clinical decision-making in urology, aiding healthcare professionals in formulating appropriate management strategies for patients.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020314</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV884#015" guid="82aa7256abf942d296e57b6ae3a3fbf5">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Free prostatic specific antigen</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological substance used as a biomarker for prostate health, specifically associated with the diagnosis and monitoring of prostate-related conditions. This substance is produced by prostatic tissues and is often measured in blood tests to help evaluate the presence of prostate cancer or other prostate abnormalities. Its levels can provide important information regarding the progression of the disease and the effectiveness of treatment modalities. The assessment of this substance is crucial in clinical settings for guiding patient management and therapeutic decisions concerning prostate health.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020315</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV885#015" guid="6ee7c315d81840d8a1d594f9795b2066">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Complexed prostatic specific antigen</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific protein produced by prostate cells, often utilized in medical diagnostics to aid in the detection and monitoring of prostate cancer. This biomarker plays a crucial role in differentiating between benign and malignant conditions affecting the prostate. Elevated levels of this protein in the blood can indicate the presence of prostate cancer or other prostate-related disorders. The measurement of this biomarker is typically conducted through laboratory tests, assisting healthcare professionals in making informed decisions regarding patient management and treatment options. It is important to note that the interpretation of results should always be conducted in conjunction with other clinical assessments and diagnostic procedures.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020316</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV886#015" guid="4612ff4580c444b7ad1680d14e5b5fed">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Squamous cell carcinoma antigen</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological substance that is produced by or interacts with tumor cells, serving as a potential indicator for the presence or progression of certain malignant conditions. This entity is utilized in diagnostic applications to assist in the identification of specific neoplastic processes, providing critical information for patient management and treatment planning. It is characterized by its ability to be detected in bodily fluids, often correlating with tumor burden or response to therapy. This classification encompasses a range of related substances with distinct biochemical properties and clinical relevance, aiding healthcare professionals in monitoring disease states and therapeutic outcomes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020317</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV887#015" guid="dd3d754bd7ff4704aa2feb747781bab5">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Tumor polypeptide antigen (TPA, inclusive TPS)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological substance that is utilized in the diagnosis or monitoring of tumors, specifically indicating the presence or progression of certain types of cancer. This substance can be present in bodily fluids or tissues and is measured to provide valuable information regarding the patient's health status. Its role is often linked to the detection of neoplastic conditions, aiding in the differentiation of various malignancies. The presence of this antigen may correlate with tumor activity and can be used in conjunction with other diagnostic methods to enhance clinical decision-making. This classification includes various markers that serve distinct functions in oncological assessments and monitoring.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020318</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV888#015" guid="014fae331b9c41cdb86945c48b59d654">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Prostatic acid phosphatase (IC)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">prostatic acid phosphatase is a biochemical substance that serves as a specific indicator in the diagnosis and monitoring of prostate-related conditions, particularly malignancies. This marker is utilized in clinical settings to assess the presence and progression of prostate cancer, aiding in the evaluation of treatment effectiveness and disease management. It is distinct from other tumor markers associated with various cancers, providing a focused insight into prostate health. The measurement of prostatic acid phosphatase levels can assist healthcare professionals in making informed decisions regarding patient care and therapeutic strategies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020319</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV889#015" guid="3042e337ceca44a9814c23179f155be4">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Pro-gastrin-releasing peptide</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a specific biochemical substance that plays a role in the diagnosis or monitoring of certain health conditions, particularly those related to neoplastic processes. This entity is utilized in medical testing to provide insights into the presence or progression of malignancies. It serves as a biological marker that can be detected through various analytical methods, aiding healthcare professionals in assessing patient health. The differentiation of this classification is based on its unique biochemical properties and clinical relevance, distinguishing it from other similar markers used in oncology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020320</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV890#015" guid="2f0537bcf2634f3185f07c399667c8ff">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Early prostate cancer antigen-2</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological substance that serves as an indicator of early-stage prostate cancer, aiding in the detection and monitoring of the disease. This marker is utilized in clinical settings to assist healthcare professionals in evaluating the presence or progression of prostate cancer within patients. The substance plays a crucial role in diagnostic processes, contributing to the overall understanding of prostate health and potential malignancies. It is differentiated from other related markers that are associated with various cancers, emphasizing its specific relevance to prostate cancer diagnostics. The utilization of this marker is integral in personalized treatment approaches and tracking therapeutic responses in oncology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020321</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV891#015" guid="a4924ce587904c7d951eb4699d8cfdcd">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cancer associated serum antigen</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a cancer-associated serum antigen is a biomarker found in the blood that is linked to the presence or progression of cancer. These substances, often produced by cancer cells or in response to cancer, serve as indicators that can assist in the diagnosis, monitoring, and management of various malignancies. The presence of these antigens can vary depending on the type of cancer and its stage. Measurement of these serum antigens is commonly employed in clinical settings to provide valuable insights into a patient's health status, aiding healthcare providers in making informed decisions regarding treatment strategies and patient care.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020322</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV892#015" guid="45ad524fdd49492ebb4e4f6442271386">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Estrogen receptor assay</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic test utilized to measure the presence and concentration of estrogen receptors in biological samples, aiding in the assessment of certain cancers. This assay is significant in determining the hormonal responsiveness of tumor cells, which can influence treatment decisions and prognostic evaluations. By identifying estrogen receptor status, healthcare professionals can tailor therapeutic approaches, including the use of hormonal therapies, to improve patient outcomes. The assay is commonly employed in the context of breast cancer, among other malignancies, where receptor expression can be a critical factor in disease management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020323</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV893#015" guid="4dfbd9480713403d86e31a534a1e7701">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Progesterone receptor assay</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a test designed to evaluate the presence or activity of specific receptors that interact with progesterone, often utilized in the context of cancer diagnostics. This assay aids in determining the responsiveness of certain tissues or tumors to hormonal treatments, providing critical information for treatment planning and prognostic assessment. The results can help healthcare professionals decide on appropriate therapeutic strategies, particularly in malignancies where hormone receptor status plays a pivotal role. This assay is distinct from other tumor markers, as it specifically targets the progesterone receptor, contributing to a more tailored approach in patient management and care.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020324</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV894#015" guid="ee2773214a5948e3b58e97a20fe09c7b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HER-2/neu (oncoprotein)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">hER-2/neu is a specific oncoprotein that plays a crucial role in the growth and differentiation of cells. It is a member of the human epidermal growth factor receptor (HER/EGFR) family and is involved in signaling pathways that regulate cell proliferation and survival. The presence or overexpression of HER-2/neu is often associated with certain types of cancers, particularly breast cancer, where it serves as a key biomarker for diagnosis and treatment decisions. Testing for HER-2/neu levels is essential for determining the appropriate therapeutic approach, including the use of targeted therapies that specifically inhibit this pathway. This classification encompasses various biological markers that indicate the presence of tumors and inform clinical management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020325</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV895#015" guid="e98f71dba4fa4d6b81b60ad7cb840df8">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">P53 (oncoprotein)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific type of protein associated with the presence of tumors, typically identified in the biological fluids of patients. This protein serves as a biological marker that can indicate the presence and progression of certain cancers, playing a critical role in diagnosis, monitoring treatment efficacy, and assessing prognosis. The detection and quantification of this protein are often utilized in clinical settings to support healthcare professionals in making informed decisions regarding patient management and therapeutic strategies. This category is distinct from other tumor markers, each of which is utilized for different types of malignancies or clinical conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020326</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV896#015" guid="c3d6d12ed523426381bc1fdf22a923ff">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Alphafetoprotein (additional tumor marker)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific biological substance produced by certain cells, particularly during the development of tumors, which serves as a marker for the presence of neoplastic conditions in the body. This substance can be detected in biological fluids and is utilized in clinical diagnostics to assist in the evaluation and monitoring of cancer progression or treatment response. The identification of this marker can provide valuable insights into the underlying pathology and aid in the differentiation of tumor types, contributing to personalized patient management and therapeutic decisions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020327</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV897#015" guid="7073e9b932a745d7aafb3429a54a4694">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Beta2-microglobulin (additional tumor marker)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance used as a biological indicator in the diagnosis or monitoring of cancerous conditions, specifically associated with certain tumors. This marker is measured to aid in the detection, prognosis, or management of malignancies, providing valuable information about the presence or progression of disease. It is distinct from other similar biological indicators due to its specific associations and roles in oncological assessments. This marker may be utilized in conjunction with other diagnostic tools to enhance the accuracy of cancer detection and treatment efficacy evaluation.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020328</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV898#015" guid="e229d10dfce44a57a6dc531e766f027e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cathepsin-D (additional tumor marker)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological substance that serves as an indicator of tumor presence or progression, specifically associated with various types of cancer. This marker is utilized in clinical diagnostics to aid in the identification and monitoring of malignancies, providing valuable information regarding tumor behavior and response to treatment. The presence and levels of this marker can be evaluated through laboratory tests, assisting healthcare professionals in making informed decisions regarding patient management and therapeutic strategies. Its role is crucial in enhancing the understanding of cancer biology and improving patient outcomes through personalized treatment approaches.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020329</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV899#015" guid="2d2db9c590204ebaa147be656d8c15a5">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Fecal occult blood (IC, additional tumor marker)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological indicator used in medical diagnostics, this category encompasses substances present in biological samples that are utilized for the detection or monitoring of certain health conditions, particularly cancers. These markers assist healthcare professionals in evaluating the presence or progression of tumors through various biological mechanisms. The specific markers included in this classification may vary based on their biochemical properties and the types of cancers they are associated with. This classification is essential for the identification and management of specific health conditions, providing valuable insights into the patient's status and guiding treatment decisions. The use of these indicators can enhance the accuracy of diagnosis and facilitate timely interventions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020330</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV900#015" guid="e03f470caa5445d2bde64297b9eeb367">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">5 HIAA (additional tumor marker)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical substance used as a diagnostic indicator in medical testing, specifically associated with the presence of tumors or cancerous conditions. This marker is utilized to help in the diagnosis, monitoring, and evaluation of treatment responses in patients suspected of having certain malignancies. Its measurement can provide valuable information about the progression of disease, efficacy of therapy, and potential recurrence. The classification encompasses various related markers that serve similar diagnostic purposes, yet each is distinguished by its specific biochemical properties and the types of tumors it is associated with. This marker is particularly relevant in the context of comprehensive cancer diagnostics, facilitating personalized patient management and targeted therapeutic approaches.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU111#006"/>
          <hierarchical_position>42020331</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW084#015" guid="721b66a322aa49419c63cf1ca8d3e63c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Morphine (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a naturally occurring opiate derived from the opium poppy, utilized primarily for its potent analgesic properties. It acts on the central nervous system to relieve pain and is subject to strict regulatory controls due to its potential for abuse and dependence. Morphine is often used in medical settings for severe pain management, particularly in cases where other pain relief methods are inadequate. Its therapeutic applications extend to preoperative sedation and management of chronic pain. The classification emphasizes its distinct role in toxicology, particularly in relation to drug abuse, highlighting the importance of monitoring and testing for this substance in clinical and forensic contexts.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020912</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW085#015" guid="c3f326ceed564b7487424664f5d73922">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Opiate (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a classification referring to a category of substances that are primarily derived from opium or synthesized to mimic its effects. These substances are typically associated with their potential for abuse and dependency. They may be utilized in medical settings for pain management but are closely monitored due to their psychoactive properties and the risks they pose in both therapeutic and non-therapeutic contexts. The classification encompasses various forms and derivatives of these substances, focusing on their chemical composition and effects on the central nervous system. This category is distinguished from others based on specific pharmacological characteristics and regulatory considerations.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020913</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW086#015" guid="46df061ef23f471fab4ea8e5d9de9322">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Phencyclidine (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance that acts as a dissociative anesthetic and is primarily recognized for its potential for abuse. It alters perceptions of sight and sound and can produce feelings of detachment from the environment and self. This compound is often associated with illegal use and has implications in toxicology, particularly in forensic settings. Its presence in biological samples is typically analyzed to assess exposure or intoxication, contributing to assessments in clinical and legal contexts. The classification of this substance aligns with others that are monitored for their potential effects on human health and safety, specifically within the realm of drugs that are frequently abused.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020914</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW087#015" guid="5b8368c7256043a19b0289294f0f3476">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Propoxyphene (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a pharmacological compound characterized by its analgesic properties, propoxyphene is primarily utilized for pain relief but has been associated with a range of side effects and potential for misuse. It belongs to a category of substances recognized for their capacity to induce physical dependence and adverse health effects when abused. This classification encompasses substances that are closely monitored due to their impact on human health, particularly within the context of toxicology. The use of propoxyphene is regulated due to safety concerns, including risks of overdose and serious cardiac effects. This classification serves to assist in the identification and analysis of substances that pose significant risks in toxicological assessments and drug abuse contexts.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020915</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW088#015" guid="6ae48353847b4a6a99f2c6d5da5f14f2">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">6-Acethylmorphium (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a category of substances that are primarily recognized for their potential for abuse and their significant impact on human health. These compounds may induce psychoactive effects, leading to patterns of misuse that can result in physical or psychological dependence. They are commonly analyzed in toxicological screenings and can be critical in clinical and forensic settings. The substances within this classification are often regulated due to their potential for harm and are subject to legal restrictions. Their presence in biological samples can indicate recent use or exposure, making them important markers in drug testing and monitoring.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020916</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW089#015" guid="50679f43f9434088890681fba7357df2">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Buprenorphine (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of pharmaceutical compound that is a synthetic opioid, primarily used for pain management and as part of addiction treatment protocols. It acts on the central nervous system to alleviate pain and may also have effects on mood and perception. This substance is characterized by its potential for misuse and dependency, placing it within a broader context of substances that have significant psychoactive properties. It is essential for medical professionals and toxicologists to identify and differentiate this compound from other similar agents, given its unique pharmacological profile and implications for public health and safety. The classification emphasizes its relevance in both therapeutic applications and toxicological assessments.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020917</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW090#015" guid="08b401fbb92b4045bd0969ce5b835086">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Acetaminophene (paracetamol, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses pharmaceutical substances primarily utilized for pain relief and fever reduction. It includes compounds that are widely recognized for their analgesic and antipyretic properties. The substances within this classification are often administered in various forms, including tablets, capsules, and liquid formulations. They are commonly used in both clinical settings and self-medication practices. The classification specifically addresses substances that may be subject to regulatory scrutiny due to their potential for misuse or specific testing requirements in toxicology. It serves as a reference for healthcare professionals, researchers, and regulatory bodies to ensure the appropriate identification and management of these chemical entities in various applications, including therapeutic use and toxicological analysis.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020919</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW091#015" guid="c341b9eecede4fc2b4a2d1da683deeb4">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">5-Aminolevulinate dehydratase (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance categorized under a classification related to the assessment of potential toxicological effects and the analysis of biological samples for the presence of specific compounds. It plays a significant role in diagnostic procedures and research related to metabolic pathways, particularly in the context of understanding the impact of various chemicals on human health. This particular compound is involved in biochemical reactions and is crucial for evaluating certain physiological processes, making it relevant for clinical and forensic toxicology. Its identification and quantification are essential for ensuring safety and compliance in medical and legal contexts.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020920</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW092#015" guid="e16e261c1f984ec3945e1a86a04d7d92">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Amitriptyline (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">amitriptyline is a pharmaceutical agent classified under the category of substances that may be associated with abuse or toxicity. It is primarily utilized for its therapeutic effects in treating various mental health conditions, such as depression and anxiety disorders. As a tricyclic antidepressant, amitriptyline functions by influencing neurotransmitter levels in the brain, thereby alleviating symptoms of mood disorders. In the context of toxicology, it is important to understand the potential for misuse and the effects of overdose, which may lead to significant health risks. The classification of this substance is crucial for monitoring and regulatory purposes, particularly in environments where substance abuse may be a concern. It serves as a reference for healthcare professionals and toxicologists in assessing and managing potential risks associated with its use.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020921</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW093#015" guid="6ce4e295460c48a6a90fb48066d21f1c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Catecholamine (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical substance that plays a crucial role in the regulation of physiological functions and is typically associated with the body's stress response. This category encompasses compounds that are produced naturally in the body and are involved in the communication between nerve cells and the modulation of various biological processes. These substances can be analyzed for diagnostic purposes in various medical applications, particularly in the realm of toxicology and therapeutic monitoring. Their detection and quantification are essential for understanding certain medical conditions and for ensuring the safe use of therapeutic agents. This classification specifically excludes overlapping categories related to other classes of psychoactive substances.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020922</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW094#015" guid="d28a7e5a8fa24f1e97c4432ab87edc9b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Desipramine (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a therapeutic substance used primarily for the treatment of certain mental health disorders, specifically depression. This compound acts by influencing neurotransmitter levels in the brain, thereby helping to alleviate symptoms associated with mood disorders. It is classified under a category focused on substances that have potential for misuse, particularly in toxicological contexts. Its detection and quantification are crucial for both clinical and forensic applications, as it can be present in various biological samples. This substance is distinct in its chemical structure and pharmacological effects compared to other psychoactive compounds, and its presence in a sample may indicate specific therapeutic interventions or potential substance misuse.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020923</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW095#015" guid="fc3efc8b08df4a6a9d60cec628d88e17">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Doxepin plus metabolite (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">doxepin plus metabolite (IVD) refers to a specific pharmaceutical compound that is utilized in the context of toxicology, particularly for the detection and analysis of substances that can affect the central nervous system. This compound is derived from a tricyclic antidepressant and is assessed in various biological matrices to evaluate its presence and concentration. The classification focuses on substances that are monitored due to their potential for abuse or toxicity, distinguishing this compound from other related substances. Its identification is crucial for clinical and forensic toxicology, aiding in the understanding of substance use and potential health impacts. This classification helps ensure accurate reporting and analysis in toxicological studies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020924</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW096#015" guid="f7f423115a5a4336b948a95c55f4d3ee">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Ethanol (alcohol, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a clear and concise definition for this classification would be: Ethanol is a volatile colorless liquid known for its psychoactive properties commonly referred to as alcohol. It is primarily used as a recreational substance and is also utilized in various industrial applications. In the context of toxicology and drug testing ethanol serves as a significant marker for substance use and abuse with implications for public health and safety. Its presence in biological samples is often analyzed to assess levels of consumption and potential impairment. Recognized for its potential to cause intoxication and dependency ethanol is distinguished from other substances in the context of toxicological investigations emphasizing its unique effects and legal status.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020925</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW097#015" guid="822ac93aeda743678cc2f4e8c824f7ba">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hippuric acid (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a chemical compound that is a derivative of benzoic acid, characterized by the presence of a carboxyl (–COOH) group and an amine group, specifically utilized in various analytical and clinical applications. This substance is often examined in toxicology and forensic science to identify its presence in biological samples, aiding in the assessment of exposure to specific substances. Its detection can provide valuable insights into metabolic processes and potential misuse, contributing to the broader understanding of drug interactions and effects on human health. The compound is relevant in the context of substance abuse investigations and may serve as a marker for certain types of drug consumption.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020926</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW098#015" guid="07d458177e7f4cb595ee317d0b7fcba4">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Imipramine (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a pharmacological substance utilized primarily in the treatment of various mental health conditions, particularly depression, anxiety disorders, and certain types of pain. This compound functions as a tricyclic antidepressant, which means it alters the balance of neurotransmitters in the brain, thereby influencing mood and emotional state. It is recognized for its therapeutic efficacy but also has potential for misuse due to its psychoactive effects. This classification encompasses the substance's application in toxicological analysis and its relevance in distinguishing it from other similar compounds that may be used in both therapeutic and illicit contexts. The focus is on its chemical structure, effects on the central nervous system, and regulatory status within the medical and legal frameworks.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020927</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW099#015" guid="27d9747a3d3742e3bb3b654d65d3f762">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Nortriptyline (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a specific pharmaceutical compound primarily utilized in medical contexts, particularly for its properties related to the treatment of various mental health conditions. It belongs to a broader category of substances that may be regulated due to their potential for misuse and the effects they exert on the central nervous system. This compound is characterized by its chemical structure and mechanism of action, which differentiates it from other substances in the same therapeutic family. It is important for diagnostic purposes, especially in toxicology, as it can be detected in biological samples and may be monitored for compliance with medical treatment protocols. The classification emphasizes its unique role in pharmacology and toxicology while acknowledging its relevance in the context of substance abuse monitoring and treatment.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020928</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW100#015" guid="17bad7f4ed2e46a6bd420d9e56594e3d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Phenols (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses chemical compounds that are primarily characterized by a hydroxyl group attached to an aromatic hydrocarbon structure. These substances are often utilized in various applications, including industrial processes, pharmaceuticals, and research. Their significance is highlighted in toxicological studies, where they are assessed for their potential effects on human health and the environment. The compounds in this classification may exhibit varying degrees of toxicity and are often monitored in clinical and forensic contexts to ensure safety and compliance with regulatory standards. This classification is distinct from other classes associated with psychoactive and controlled substances, focusing specifically on the unique properties and implications of these aromatic compounds.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020929</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW101#015" guid="60451c728f39441ea546ff3896935a5a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Protoporphyrin IX (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">protoporphyrin IX is a biomolecule that plays a crucial role in various biological processes, particularly in the synthesis of heme, which is an essential component of hemoglobin and other hemoproteins. This compound is often analyzed in the context of toxicology and clinical diagnostics to assess certain medical conditions and monitor metabolic pathways. Its relevance extends to understanding disorders related to iron metabolism and porphyria. Protoporphyrin IX's detection and quantification are significant in laboratory settings, especially for evaluating exposure to certain toxic agents and for research on the biochemical mechanisms underlying various diseases.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020930</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW102#015" guid="885036f8c5514587ae3c36497cd0c2b2">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Salicylate (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses substances that are derivatives of salicylic acid, known for their applications in both therapeutic and diagnostic settings, particularly in the field of in vitro diagnostics (IVD). These compounds may exhibit various pharmacological effects and are often utilized in the analysis and detection of specific metabolic pathways or toxicological assessments. The focus is on substances characterized by their potential impact on biological systems, especially in relation to human health monitoring and the assessment of exposure to toxic agents. The classification distinguishes these substances from other related categories based on their unique chemical properties, mechanisms of action, and relevance in clinical diagnostics and toxicology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020931</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW103#015" guid="3b05e618c53244b8bffb5f1b49e08f39">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Trichloroacetic acid (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a chemical compound characterized by its molecular structure and properties, commonly utilized in various industrial and laboratory applications. This specific acid is known for its role in biochemical processes and its significance in toxicological assessments. It is often analyzed in clinical and forensic contexts to determine exposure levels or effects related to health and safety. Its unique characteristics differentiate it from other similar compounds, making it a relevant subject of study in pharmacology and toxicology. The substance may also be subject to regulations due to its potential effects on human health and the environment.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020932</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW104#015" guid="21bfb9151bf84846b6f359c1e5f96ac0">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Tricyclic antidepressants (total, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a category encompassing a specific group of pharmaceutical substances that are primarily utilized for the treatment of various mood disorders. These compounds function by modulating neurotransmitter levels in the brain, thereby influencing mood and emotional stability. The classification includes various chemical entities that share a common mechanism of action, characterized by their tricyclic structure, which differentiates them from other classes of psychoactive substances. This category is important for toxicological analysis and drug screening, as it aids in identifying the presence of these compounds in biological samples. The substances classified here may have implications for both therapeutic use and potential for abuse, necessitating careful monitoring and regulation.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020933</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW105#015" guid="5f8d6d8a3a774be2b3c70cc2ab557d55">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Uro-, coproporphyrin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific category of biochemical compounds characterized by their role in the assessment of metabolic processes related to health and disease. This classification encompasses substances that are pertinent for diagnostic purposes, particularly in the context of toxicological analysis and clinical investigations. These compounds are often utilized in laboratory settings to evaluate bodily functions and potential disturbances caused by various factors, including exposure to toxins or metabolic dysfunctions. The focus is on substances that can be measured in bodily fluids and tissues, providing insights into the biochemical pathways and their alterations in pathological conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020934</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW106#015" guid="24a07c71c7684ba6b9102eab9df75ac4">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Vanillylmandelic acid (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">vanillylmandelic acid is a chemical compound that serves as a significant biomarker in the field of toxicology and drug analysis. It is primarily recognized for its role in the assessment of catecholamine metabolism and is often utilized in clinical diagnostics to monitor certain medical conditions. This compound is particularly relevant in the evaluation of adrenal gland function, as it is a metabolite of epinephrine and norepinephrine. The presence and concentration of vanillylmandelic acid in biological specimens can provide valuable insights into various physiological and pathological states, making it an essential element in toxicological screenings and investigations related to substance abuse or metabolic disorders.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020935</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW107#015" guid="68072d3a344641ceb193f386fc3d784b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Homovanillic acid (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">homovanillic acid is a biochemical compound that serves as a significant metabolite of dopamine. It is primarily utilized in clinical laboratory settings for the assessment of certain neurological conditions and disorders. This substance is noteworthy for its role in the evaluation of catecholamine levels, making it relevant in toxicological investigations. In particular, it can be indicative of neuroblastoma and other neuroendocrine tumors, as well as having implications in various psychiatric and neurological assessments. The detection and quantification of homovanillic acid in biological samples, such as urine and blood, are crucial in understanding its physiological and pathological significance. Its classification is distinct from other substances associated with toxicology and drug analysis, highlighting its unique characteristics and applications in medical diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020936</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW108#015" guid="da971d552d7e427384a85a2ceb50a5df">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Ethyl glucuronide (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance used in various analytical applications to detect and measure specific metabolites associated with certain drug use, particularly in the context of toxicological testing. This compound is often utilized in clinical and forensic settings, aiding in the identification of recent exposure to substances and contributing to the assessment of an individual's drug use history. Its presence in biological samples can indicate prior consumption of specific substances, making it a valuable marker in toxicology. The classification of this substance encompasses its chemical properties, methods of detection, and relevance in drug monitoring and abuse prevention strategies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020918</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW109#015" guid="7d30123ff1544a12a6e84579031d720a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Drugs of abuse, toxicology (unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020990</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU102#005" guid="51a8a45a1ca443f38322de86ea0bce4a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Substrate (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a diverse range of biological substances specifically designed for in vitro diagnostics within the field of clinical chemistry. It includes various analytes used for assessing metabolic processes and can aid in the diagnosis of various medical conditions. The substances classified here are primarily utilized for quantitative and qualitative analysis of bodily fluids, contributing valuable information for patient care. The focus is on metabolites, enzymes, and other biochemical markers that reflect physiological states. This category is distinct from other classifications that pertain to specific reagents, electrode technologies, or multi-parameter tests, ensuring a clear differentiation in application and purpose. The listed items are critical for laboratory assessments and are integral to clinical decision-making processes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS273#005"/>
          <hierarchical_position>42010200</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV676#015" guid="04b8791dd08b4c7684d5a9efe97e8275">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Albumin (IVD, CC)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological compound that plays a crucial role in various physiological processes and is utilized in in vitro diagnostic applications. This substance is essential for maintaining osmotic pressure and transporting hormones, enzymes, and nutrients throughout the body. In a diagnostic context, it serves as a key indicator of health status, often measured to assess liver function, nutritional status, and potential disease states. The applications of this compound in laboratory testing underscore its significance in clinical diagnostics, allowing for the evaluation of various medical conditions. Its identification and quantification are critical for accurate diagnosis and treatment planning in healthcare settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010201</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV677#015" guid="25c4b09394da4052bd31e9e1ab698738">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Bile acid (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">bile acids are a specific group of steroid acids produced in the liver from cholesterol and play a crucial role in the digestion and absorption of fats and fat-soluble vitamins in the intestine. They are synthesized from cholesterol and subsequently conjugated with amino acids to enhance their solubility and functionality. These compounds are involved in various metabolic processes and serve as important biomarkers in the assessment of liver function and bile duct health. The measurement of bile acids is significant in diagnosing and monitoring liver diseases, cholestasis, and certain gastrointestinal disorders. Their analysis can provide valuable insights into the enterohepatic circulation and overall metabolic status of individuals.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010202</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV678#015" guid="0d5bc0f24bbf4a6096b48fb805368072">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Bilirubin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance that is utilized in diagnostic processes, specifically within the context of in vitro diagnostics. This particular substance is crucial for the assessment of liver function, hemolytic disorders, and certain metabolic conditions. It is characterized by its role in the breakdown of hemoglobin and is often measured in serum or plasma samples. The analysis of this substance is essential for medical professionals to evaluate various health conditions and to monitor disease progression or treatment efficacy. It is classified as a biochemical marker and is part of a broader category of substances used in laboratory diagnostics to provide insights into physiological and pathological states.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010203</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV679#015" guid="06361ad350a543788c8f7f34960cd213">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Urea, blood urea nitrogen (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a nitrogen-containing compound primarily found in the blood, which is produced during the metabolism of proteins. This substance is commonly measured in medical laboratories to assess kidney function and overall metabolic health. Its concentration in the bloodstream can provide valuable information regarding renal performance, hydration status, and the presence of certain medical conditions. The analysis of this compound plays a crucial role in diagnostic procedures, enabling healthcare professionals to monitor and evaluate the health status of patients effectively. The classification encompasses various related biochemical substances, each serving a distinct purpose in clinical assessments.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010204</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW054#015" guid="09fcaf186e834402879afef3ffcb088b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Chloramphenicol (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a pharmaceutical substance utilized in the monitoring of therapeutic drug levels in patients. This compound is significant for its role in ensuring safe and effective dosages, particularly in individuals undergoing treatment requiring precise management of medication levels. The substance is categorized within a specialized area focused on the analysis and measurement of drugs that require careful monitoring to optimize therapeutic outcomes and minimize adverse effects. This classification is distinct from other similar substances used in therapeutic drug monitoring, emphasizing the unique characteristics and applications of this compound in clinical settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020821</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW055#015" guid="3b6b30920afc4d68ac1f179b6d5835aa">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Dibekacin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a therapeutic agent utilized primarily for the monitoring and management of specific medical conditions, this substance is essential in assessing the effectiveness and safety of treatment protocols. It plays a critical role in ensuring optimal therapeutic outcomes by measuring drug concentrations within biological samples, thus enabling healthcare professionals to tailor treatment regimens to individual patient needs. This agent is distinct from others in its category due to its unique pharmacological properties and its specific applications in clinical settings. The focus on this agent underscores its importance in the broader context of therapeutic drug monitoring, where precision and accuracy are paramount for patient care.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020822</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW056#015" guid="0aaa87d3b44743d885dc750decd674e9">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Gentamicin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a therapeutic agent utilized primarily in monitoring and managing specific medical conditions, this substance is essential in assessing drug levels for optimal therapeutic efficacy and safety. It plays a crucial role in guiding dosage adjustments and ensuring effective treatment outcomes. The substance is characterized by its unique pharmacological properties and specific indications, differentiating it from similar agents used in therapeutic drug monitoring. It is often employed in clinical settings to evaluate patient response to treatment and to mitigate potential adverse effects associated with improper dosage. This agent is specifically recognized for its application in diagnostics related to certain infections, contributing to informed clinical decisions and personalized patient care.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020823</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW057#015" guid="61cee34e595b404ebc70de559fe41ade">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Kanamycin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance utilized in the medical field for therapeutic purposes, specifically aimed at the treatment of infections caused by certain bacteria. This compound is often employed in diagnostic applications to monitor drug levels in patients, ensuring effective treatment while minimizing potential toxicity. It plays a critical role in managing specific health conditions by providing healthcare professionals with essential information about drug concentration, which can guide dosage adjustments. The monitoring of this substance is crucial for optimizing patient outcomes and ensuring therapeutic efficacy. Its classification is distinct from other similar therapeutic agents used for monitoring, highlighting its unique properties and applications in clinical practice.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020824</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW058#015" guid="dc368163e5ca47c1beca37a143e237f3">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Netilmycin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific pharmaceutical agent used for the therapeutic monitoring of certain medical conditions. It is characterized by its role in assessing and managing the therapeutic levels of the substance in a clinical setting. The focus is on ensuring optimal dosage and minimizing potential toxicity, thereby enhancing patient safety and treatment efficacy. This particular agent is distinct from others within the same therapeutic monitoring category, as it serves unique clinical purposes and has specific pharmacokinetic properties that may require different monitoring protocols compared to its counterparts. The usage of this agent is typically guided by established medical guidelines to ensure its effective application in patient care.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020825</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW059#015" guid="45c00078fd504e1fb451e8f1b637df67">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Sisomycin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a therapeutic agent utilized in the monitoring of specific drug levels within the human body, primarily for the purpose of optimizing treatment regimens and ensuring safety. This substance is classified under a category focused on agents that require careful assessment due to their narrow therapeutic indices. The monitoring of this agent is essential in clinical settings to avoid toxicity and ensure effective dosing. It is distinguished from other agents in the same category by its unique pharmacological properties and specific therapeutic applications. The classification encompasses various substances that are employed in similar monitoring contexts, each serving a distinct role in patient care and treatment management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020826</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW060#015" guid="2e95f5364a5f4f4cb409143efb9c7149">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Streptomycin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance utilized primarily for its antibacterial properties, belonging to a class of compounds known for their ability to inhibit bacterial growth. This particular agent is often employed in the medical field for the treatment and prevention of infections caused by specific types of bacteria. It is characterized by its efficacy in managing certain conditions that require therapeutic drug monitoring to ensure optimal dosing and minimize potential toxicity. The classification of this substance emphasizes its role in clinical diagnostics and treatment protocols, distinguishing it from other similar therapeutic agents that may require different monitoring approaches based on their pharmacological profiles and therapeutic windows.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020827</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW061#015" guid="e5881833f8c4450aac080edd203c509a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Tobramycin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a pharmaceutical agent used for therapeutic drug monitoring, specifically designed to assess and quantify levels of a particular antibiotic in biological samples. This substance plays a critical role in ensuring effective treatment and minimizing toxicity by allowing healthcare professionals to tailor dosages based on individual patient responses. The monitoring of this agent is essential for optimizing therapeutic outcomes, particularly in the context of infectious diseases, where precise dosing is crucial for efficacy. The classification of this agent distinguishes it from other therapeutic monitoring agents, which may have different mechanisms of action, therapeutic uses, or pharmacokinetic profiles.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020828</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW062#015" guid="ec83a78bb4564701be15a40216f80106">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Vancomycin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">an antibiotic used primarily in the treatment of serious infections caused by Gram-positive bacteria, this substance is typically administered intravenously. It is crucial for monitoring levels to ensure therapeutic efficacy and to prevent toxicity, particularly in patients with renal impairment or those receiving other medications that may interact. This classification includes assays and testing methods related to the quantification of the drug in biological samples, facilitating appropriate dosage adjustments and enhancing patient safety. The classification distinguishes this substance from other therapeutic agents used for similar purposes, emphasizing its unique pharmacological properties and clinical applications in managing specific infections.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020829</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW063#015" guid="80206dad9350405c83edb1182fe67a15">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Teicoplanine (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">teicoplanine is a therapeutic agent primarily utilized in the monitoring of drug levels for clinical effectiveness and safety in patients undergoing treatment. This substance is characterized by its role in managing bacterial infections, particularly those caused by gram-positive organisms. The monitoring of this agent is essential to ensure appropriate dosing and to mitigate potential adverse effects. It involves assessing the concentration of the drug in the bloodstream, allowing healthcare professionals to make informed decisions regarding dosage adjustments. This monitoring is particularly crucial in populations with varying pharmacokinetic profiles, such as those with renal impairment or those receiving concurrent therapies that may affect drug metabolism. The classification of this agent highlights its specific therapeutic application within a broader context of similar monitoring practices for various other therapeutic drugs.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020830</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW064#015" guid="f2f1e2c4fdb14a85b1c80ff616cfce40">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Caffeine (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a category for substances used primarily in the monitoring and management of therapeutic drug levels in patients. These substances are often analyzed to ensure that they are within the therapeutic range, thereby optimizing their efficacy and minimizing potential toxicity. The focus is on those compounds that influence physiological functions, particularly in the context of specific medical conditions. This classification encompasses various analytes that require careful measurement and interpretation in clinical settings, facilitating personalized treatment strategies. The category is distinct from other monitoring substances, reflecting unique pharmacological properties and clinical applications aimed at patient safety and treatment effectiveness.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020831</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW065#015" guid="c394c9681b304538a668c9d460b2826a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Theophylline (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a therapeutic agent used in monitoring the levels of drugs that affect respiratory function, particularly in patients with conditions such as asthma or chronic obstructive pulmonary disease. This substance is primarily utilized in vitro for diagnostic purposes, enabling healthcare professionals to assess drug concentration to optimize therapeutic efficacy and minimize toxicity. Its measurement is critical in managing treatment regimens, ensuring that patients receive the appropriate dosage while avoiding adverse effects associated with subtherapeutic or toxic levels. This classification distinguishes it from other monitoring agents that serve different therapeutic areas or mechanisms of action.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020832</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW066#015" guid="3528e6d796bc4c75a5c98ec5f556079a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Methotrexate (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a pharmaceutical agent utilized for its therapeutic properties, specifically in the context of in vitro diagnostics. This substance plays a crucial role in monitoring therapeutic drug levels to ensure efficacy and safety in patient treatment. It is particularly significant in managing conditions that require precise dosage adjustments based on individual patient responses. This classification encompasses a specific agent distinct from other therapeutic compounds used for similar monitoring purposes, emphasizing its unique pharmacological profile and clinical applications. The focus on this agent within the diagnostics framework highlights its importance in optimizing treatment regimens and enhancing patient outcomes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020833</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW067#015" guid="db751c614a684a61881bcd1e7995b4b4">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cyclosporine (total)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance used in therapeutic drug monitoring that specifically refers to a cyclic peptide immunosuppressant. It is primarily utilized in the management of organ transplant recipients to prevent organ rejection and is also indicated in certain autoimmune disorders. This compound works by inhibiting T-lymphocyte activation and proliferation, thereby modulating the immune response. The measurement of this substance is crucial for ensuring effective dosing, minimizing toxicity, and optimizing patient outcomes. This classification encompasses various analytical methods for quantifying the levels of this substance in biological samples, aiding healthcare professionals in adjusting treatment regimens as necessary.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020834</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW068#015" guid="a9adb2719389470283a5d1022bdd0876">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cyclosporine specific</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a specialized category of substances utilized for therapeutic drug monitoring, specifically focusing on a particular immunosuppressive agent. These substances are crucial for managing and optimizing treatment regimens in patients requiring immunosuppression, ensuring effective therapeutic outcomes while minimizing adverse effects. The monitoring of this agent involves assessing its concentration in biological fluids to guide dosage adjustments and improve patient safety. Unlike other therapeutic drugs within the monitoring framework, this category is distinct due to its unique pharmacological properties and the specific clinical contexts in which it is applied, necessitating tailored testing and management strategies to achieve optimal therapeutic efficacy.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020835</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW069#015" guid="37db6693fe0d4ef1b14f79599ee4f038">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Tacrolimus (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses substances utilized for therapeutic drug monitoring, specifically designed to measure and manage the concentration of active pharmaceutical ingredients in biological samples. These compounds are integral to ensuring optimal therapeutic outcomes by enabling healthcare professionals to adjust dosages based on individual patient responses and drug interactions. The focus is on the monitoring of immunosuppressive agents, which play a crucial role in preventing organ rejection in transplant recipients and managing autoimmune disorders. This category is distinct from other therapeutic agents that are similarly monitored due to variations in their pharmacokinetics, therapeutic ranges, and clinical applications.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020836</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW070#015" guid="1e14185435b44680a73474a495a8a451">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Rapamycin (sirolimus, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a pharmaceutical compound used primarily in therapeutic drug monitoring, known for its immunosuppressive properties. This substance is often utilized in clinical settings to manage various medical conditions by inhibiting cellular proliferation and modulating the immune response. It plays a crucial role in transplant medicine, particularly in preventing organ rejection. The monitoring of this compound's levels in the bloodstream is essential to ensure therapeutic efficacy while minimizing the risk of toxicity. It is distinct from other therapeutic agents used in similar contexts, as it targets specific pathways and exhibits a unique pharmacological profile. This classification encompasses various formulations and testing methodologies associated with this compound, emphasizing its importance in personalized medicine and patient care.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020837</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW071#015" guid="302c588b694e4f079e3c96acb49d1fce">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Mycophenolate (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a specific therapeutic agent used for the monitoring of drug levels in patients. It plays a crucial role in ensuring optimal therapeutic outcomes by allowing healthcare professionals to assess the concentration of the drug within the bloodstream. This monitoring is essential for maintaining efficacy while minimizing potential toxicity. The substance is characterized by its immunosuppressive properties, making it significant in various medical contexts, particularly in transplantation and autoimmune conditions. This classification distinguishes it from other therapeutic agents that serve similar monitoring purposes but differ in their pharmacological profiles and clinical applications.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020838</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW072#015" guid="a26ed8979ea04458bc8c37c6d6aacaea">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Therapeutic drug monitoring (unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU116#006"/>
          <hierarchical_position>42020890</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU117#006" guid="79ea71fb55b84c6a939072ce1bf92345">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Drugs of abuse, toxicology</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses substances that are primarily associated with illicit or recreational use and have significant implications in toxicology. It includes a range of analytes that are tested to detect the presence of these substances in biological samples. The focus is on substances that pose a risk to health due to their psychoactive properties and potential for abuse. Analytical methods employed in this category are crucial for forensic investigations, workplace drug testing, and clinical toxicology. The classification facilitates the identification and differentiation of various compounds, ensuring accurate and effective monitoring of drug usage and compliance with safety regulations. It serves as a vital resource for laboratories, healthcare providers, and regulatory authorities engaged in the assessment of drug-related health risks and legal compliance.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS274#006"/>
          <hierarchical_position>42020900</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW073#015" guid="762dbc3d7fd3455f90cbe705027b793d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Amphetamines group</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a classification category that encompasses psychoactive substances known for their stimulant properties and potential for abuse. These compounds primarily affect the central nervous system, leading to increased alertness, energy, and euphoria. They are often associated with significant risks of dependency and adverse health effects. This category is distinct from other classifications of psychoactive substances, such as depressants, hallucinogens, and other drugs with varying mechanisms of action and effects. The substances within this classification are analyzed for their presence in biological samples, especially in toxicological contexts, to assess exposure or abuse patterns.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020901</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW074#015" guid="b52ab444f2844ee8bc3210870cce4f74">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Amphetamine-, methamphetamine specific (and ecstasy)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses substances that are primarily associated with stimulant effects and are often misused for their psychoactive properties. These compounds are known for their potential to induce euphoria, increased energy, and heightened alertness, but also carry significant risks of addiction and adverse health effects. The classification is specifically tailored to differentiate these substances from other categories of drugs, particularly those that are sedative or have different mechanisms of action. The focus is on the unique characteristics of these stimulants, including their chemical structure and physiological impact, as well as their relevance in toxicological analysis and drug abuse contexts.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020902</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW075#015" guid="95e6e2556b024098b9113eff1d0660a2">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Barbiturates (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a category encompassing a specific group of pharmaceutical compounds that act as central nervous system depressants, primarily used in medical settings for their sedative and anesthetic properties. These substances are characterized by their ability to induce sleep and relaxation, but they also carry a potential for abuse and dependency. Their detection is crucial in toxicological analysis due to their implications in both therapeutic and non-therapeutic contexts. The classification reflects their relevance in both clinical and forensic settings, facilitating the identification and differentiation from other psychoactive substances. These compounds are often monitored in various environments to ensure compliance with medical guidelines and regulations surrounding their use.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020903</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW076#015" guid="d510e919d09d4df0b39d06e51736cbe5">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Benzodiazepines (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a classification that encompasses substances typically utilized for their sedative, anxiolytic, muscle relaxant, and anticonvulsant properties, often prescribed for a variety of medical conditions. These compounds work primarily by enhancing the effects of neurotransmitters in the brain, leading to a calming effect on the central nervous system. While they serve legitimate therapeutic purposes, their potential for misuse and dependency categorizes them within a framework focused on monitoring and regulation. This classification is distinct from other categories of psychoactive substances that may have different pharmacological properties or risk profiles, reflecting the unique characteristics and implications of these specific agents.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020904</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW077#015" guid="539bde3aa7f54692b09c132f3313bbb9">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cannabinoid (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses substances derived from the cannabis plant that are used for various medical and therapeutic applications. These compounds may interact with the body's endocannabinoid system, influencing physiological processes such as pain sensation, mood, and appetite. The classification specifically pertains to cannabinoids that are relevant in the context of in vitro diagnostics (IVD). These substances are typically analyzed in clinical settings for their potential use in both therapeutic and toxicological assessments. The focus is on those cannabinoids that are significant for understanding their effects and implications in health, as well as their potential for abuse or toxicity.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020905</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW078#015" guid="90c168f9dcd547e087f13e96399c6ffd">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cocaine and cocaine metabolites (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses substances derived from the coca plant and their metabolites, commonly associated with illicit drug use and toxicological analysis. These compounds are typically identified and quantified in biological samples to assess exposure or potential abuse. The substances within this classification play a significant role in forensic toxicology and clinical diagnostics, often utilized in drug screening processes. They are characterized by their psychoactive effects and potential for dependency, necessitating careful monitoring and evaluation in both medical and legal contexts. The analysis of these substances is crucial for understanding their impact on health and society, as well as for the development of appropriate interventions and treatments.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020906</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW079#015" guid="67f442e6639444e28ddd48b234cdf887">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Codeine (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a naturally occurring or semi-synthetic compound derived from the opium poppy, primarily utilized for its analgesic properties. This substance acts on the central nervous system to relieve pain and can induce feelings of euphoria. It is classified as having a potential for abuse and is regulated under controlled substance laws due to its addictive properties. In toxicological contexts, this compound is often tested for in biological samples to assess exposure or misuse. Its identification and quantification in various matrices are crucial for both clinical and forensic applications, as it can have significant implications for patient management and legal investigations.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020907</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW080#015" guid="95a89c1b623d48338863748d908426b3">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cotinine (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance identified as a metabolite of nicotine, primarily utilized in diagnostic testing for the presence of tobacco use and exposure. It serves as a biochemical marker for assessing smoking habits or exposure to tobacco products, particularly in clinical and toxicological settings. This compound is significant in evaluating health implications associated with nicotine consumption and is often analyzed in biological samples such as urine or blood. The detection and quantification of this metabolite can aid in research, clinical assessments, and forensic investigations related to tobacco use and its effects on health.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020908</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW081#015" guid="a4eb8279cfba45c1a325c3eb752289e7">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Lysergic acid diethylamide (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a classification representing a specific psychoactive substance characterized by its potent hallucinogenic properties, primarily used in research and clinical settings for its effects on perception, mood, and cognition. This substance is categorized under a broader classification of illicit compounds that may pose significant risks to health and safety. The classification distinguishes itself from other psychoactive substances by its unique chemical structure, behavioral effects, and potential applications in controlled environments, particularly in the study of consciousness and mental health disorders. The focus is on its relevance in toxicology and its implications for drug testing and forensic analysis.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020909</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW082#015" guid="2a596f0bab6041058c9b364f8114b3ee">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Methadone (inclusive EDDP, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance that functions as an opioid analgesic, primarily utilized in clinical settings for pain management and opioid dependence treatment. It can be administered through various forms, including oral and injectable routes. This substance exhibits unique pharmacological properties, distinguishing it from other therapeutic agents associated with substance abuse and toxicology. Its interaction with the central nervous system leads to specific effects, including pain relief, sedation, and potential for dependence. The classification encompasses both the active compound and its metabolites, which may be relevant in toxicological evaluations. This classification does not include other categories of drugs typically associated with psychoactive effects or dependence, highlighting its specific medical use and significance in the field of toxicology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020910</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW083#015" guid="fd22b603cb2c498f88074cf4d6c6352e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Methaqualone (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">methaqualone is a psychoactive substance that belongs to a category of drugs characterized by their potential for abuse and toxicity. This substance is primarily known for its sedative and hypnotic properties, often used in various medical and recreational contexts. The classification encompasses substances that are monitored for their effects on the central nervous system and potential for dependence. Methaqualone is distinguished from other similar substances based on its chemical structure, pharmacological effects, and patterns of abuse. It is relevant in toxicology, particularly in the context of drug testing and forensic analysis, where its presence can indicate misuse or exposure. The classification aims to facilitate the systematic organization and identification of such substances for regulatory, clinical, and research purposes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU117#006"/>
          <hierarchical_position>42020911</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV712#015" guid="daef0349c3674e3c885f2cd3657e567b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Substrate (IVD, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010290</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU134#007" guid="7447ab3aa2e44072be2b63e2c47cb0dc">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Haematology, histology, cytology (other)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Group (3rd level) for objects that cannot be classified into other specified groups in the existing structure, but that are classified to their parent-class on the 2nd level. A xx-xx-90-00-class cannot have any other sub-groups besides the generic xx-xx-90-90-class (…(Other, unspecified)) to be generally valid within the parent class on the 2nd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADS275#005"/>
          <hierarchical_position>42039000</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV680#015" guid="215666408b8c42dba2d49f11dd809742">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cholesterol (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="DeepL">Lipophilic substance that occurs in the body as a structural component of cell membranes and is analyzed for various diagnostic tests for cardiovascular health.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">Machine generated by Chat GPT4</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010205</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV681#015" guid="6f088becce034652947868f9031233fa">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Copper (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a chemical element and essential trace mineral, notable for its high electrical and thermal conductivity, utilized extensively in various industrial applications including electronics and construction. In the biomedical field, it plays a crucial role in enzymatic processes and is often analyzed for its physiological importance in health diagnostics. As a specific classification within a broader category of substrates, this substance is characterized by its distinct physical and chemical properties that differentiate it from other biochemical compounds. Its measurement is vital for understanding metabolic functions and potential deficiencies in biological systems.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010206</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV682#015" guid="9c880f7d00b74da586d89435d1fe2274">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Creatinine (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical substance that serves as a waste product of muscle metabolism, creatinine is primarily excreted by the kidneys. It is commonly used in medical diagnostics to assess kidney function and to evaluate muscle mass. The concentration of creatinine in biological fluids can provide critical insights into renal health, and abnormal levels may indicate impaired kidney function or other metabolic disorders. This substance is often analyzed in laboratory settings as part of routine blood and urine tests, helping healthcare professionals monitor and diagnose various health conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010207</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV683#015" guid="b3cf835c2a2e4ed880054fbe99e6aec3">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">D-xylose (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a type of sugar that is classified as a pentose monosaccharide, primarily utilized in biochemical applications and diagnostic processes. It plays a critical role in metabolic pathways and is often measured to assess various physiological states. This substance is especially significant in the context of in vitro diagnostics, providing essential information about carbohydrate metabolism and potential related disorders. Its measurement can aid in the evaluation of specific metabolic conditions and inform clinical decision-making. This classification serves to distinguish it from other biochemical entities used in diagnostics, each with unique metabolic roles and clinical implications.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010208</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV684#015" guid="f9adf43a4b704adb94013c107f98fb26">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Delta-aminolaevulinic acid (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical compound that serves as a precursor in the biosynthesis of heme, this substance is utilized in various in vitro diagnostic applications. It is involved in metabolic processes and is significant in the assessment and monitoring of certain physiological conditions. Its detection and quantification can provide valuable insights into metabolic disorders and biochemical pathways. This compound is characterized by its specific chemical structure and properties, which facilitate its role in laboratory analyses. The application of this substance is critical in diagnostic settings, particularly in relation to conditions affecting hematological functions and metabolic health.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010209</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV685#015" guid="ad298e9960d84545992da0d77cc79567">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Fructosamine (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">fructosamine is a biochemical compound that serves as a marker for assessing glycemic control over a period of time. It is formed from the non-enzymatic reaction between glucose and proteins, primarily albumin, and is utilized in clinical diagnostics to evaluate average blood glucose levels in patients with diabetes mellitus. The measurement of fructosamine levels can provide insights into the efficacy of diabetes management strategies, offering a complementary approach to traditional glucose monitoring. This analyte is particularly valuable in situations where short-term fluctuations in blood glucose may not be adequately represented by other tests, allowing healthcare providers to make informed decisions regarding patient care and treatment adjustments. Fructosamine testing is typically performed using specific immunoassays or chromatographic techniques in laboratory settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010210</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV686#015" guid="242c1b5f9a57487e9576bcfebc007f33">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Fructose (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a class designated for a specific type of carbohydrate, recognized for its sweetening properties and utilized in various applications, particularly in the context of in vitro diagnostics. This classification encompasses the biochemical characteristics and analytical methods relevant to its use in laboratory settings. The focus is on its role in metabolic processes and its significance in diagnostic assessments, allowing for the measurement and analysis of this compound in biological samples. This category is distinct from other classes that include proteins, lipids, and various metabolites, highlighting its unique properties and applications in diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010211</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV687#015" guid="2d093679103047028f16eaffefab301e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Galactose (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">galactose is a monosaccharide that plays a vital role in various biochemical processes within the human body. It is a simple sugar that can be metabolized to produce energy and is integral in the formation of glycoproteins and glycolipids. In the context of in vitro diagnostics (IVD), galactose is often analyzed to assess metabolic disorders, nutritional status, and other health conditions. Its presence and concentration can provide critical insights into an individual's metabolic pathways and overall health. This classification encompasses products or services related to the detection, measurement, and analysis of galactose levels in biological samples, contributing to the diagnostic and monitoring processes in healthcare settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010212</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV688#015" guid="13dc3aa5c98f46939e44bed1be754add">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Glucose (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of simple sugar that plays a crucial role in various metabolic processes within the body. It serves as a primary energy source and is significant in the context of diagnostic procedures related to health assessments. This substance is involved in numerous biochemical pathways and is commonly evaluated in clinical settings to assess carbohydrate metabolism and diagnose conditions such as diabetes. The classification addresses its application in medical diagnostics, specifically in vitro diagnostics, highlighting its importance in laboratory testing and health monitoring. This category is distinct from other similar classifications that pertain to different substances and metabolic markers used in health diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010213</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV689#015" guid="ae432d34c6da4d80a573905e79d9d06e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Glycosylated-, glycated haemoglobin (IVD, CC)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification category encompasses biochemical substances used in in vitro diagnostics that are specifically modifications of hemoglobin influenced by glucose levels in the blood. These substances are critical for monitoring long-term glucose control and are utilized in various clinical settings to assess diabetic patients' management and related health conditions. The analysis of these modified hemoglobins provides valuable insights into the patient's metabolic state, thereby assisting healthcare professionals in making informed decisions regarding treatment and management strategies. The substances included in this category are distinguished by their unique biochemical properties and diagnostic relevance, differentiating them from other substrates commonly analyzed in laboratory settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010214</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV690#015" guid="08c66e1ff7b1418595a87a577061e70c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">High density lipoprotein cholesterol (IVD)</label>
          </preferred_name>
          <definition>
            <text>-no definition</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010215</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV691#015" guid="38cff0a69f9341699857dada5e209d05">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Iron (IVD, CC)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a classification for a specific type of metal, primarily utilized in various analytical and clinical assessments. This category encompasses the forms and characteristics of the metal as it relates to medical diagnostics. Commonly used in laboratory settings, the classification includes its applications in determining physiological and biochemical parameters. This category is distinct from other related substances that are measured or analyzed for health assessments, highlighting its unique biochemical role and significance in diagnostic procedures. The classification is intended for use in contexts where precise identification and differentiation are critical for laboratory testing and medical analysis.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010216</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV692#015" guid="19050fa8812f415c96ede762158d7e76">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Iron binding capacity (Total, CC)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to the total iron binding capacity, a measure of the blood's ability to bind iron with transferrin and other proteins. It is used to assess iron metabolism and diagnose conditions related to iron deficiency or overload. The total iron binding capacity indicates the maximum amount of iron that can be bound in the bloodstream, providing crucial information in the evaluation of anemia and other related disorders. It differs from other assessments of various substrates, each of which focuses on different biochemical parameters or components in the body. This classification helps in the systematic categorization of diagnostic tests and analyses, facilitating accurate interpretation and application in clinical settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010217</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV693#015" guid="46fd7b80c4ca4e6dacffab80262f8bf3">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Lactate (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical substance used primarily in in vitro diagnostics, specifically for assessing various metabolic parameters in biological samples. This substance is characterized by its role in metabolic pathways and can be measured to provide insights into physiological and pathological states. It is distinct from other substances that serve similar diagnostic purposes, as it may participate in different enzymatic reactions or metabolic functions. The classification encompasses a range of substances that are utilized for clinical laboratory testing, each with unique properties and applications in diagnosing medical conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010218</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV694#015" guid="0bbb6d78899b4dbeb3296555b8daa3e9">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Lecithin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">lecithin is a phospholipid that serves as a crucial component in various biological processes, particularly in cellular membranes. It plays a significant role in emulsifying fats, aiding in digestion and absorption of lipids. In the context of in vitro diagnostics, lecithin may be utilized as a substrate in assays to facilitate the detection and analysis of various biomolecules. Its unique properties allow it to interact with a range of substances, making it valuable in laboratory settings for biochemical testing and research. This classification emphasizes its distinct function and application within diagnostic methodologies, differentiating it from other biochemical substances commonly analyzed in clinical laboratories.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010219</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV695#015" guid="ad53c0280ea3420ab2cefd7be3a41bd7">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Lipoprotein, chemical determination/detection</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses substances involved in the biochemical analysis of lipoproteins, which are complexes of lipids and proteins essential for lipid transport and metabolism. This category focuses on the methods and processes used for the determination and detection of various lipoprotein types and their associated characteristics within biological samples. It includes assays and tests that provide insights into lipid profiles, cardiovascular health, and metabolic conditions. The substances classified here serve critical roles in diagnostics, enabling healthcare professionals to assess and monitor lipid-related disorders and systemic health.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010220</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV696#015" guid="6f1e8eb883ed4665b4329676f22ffdb1">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Low density lipoprotein cholesterol (including sd-LDL)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a classification for a biochemical substance that is a component of lipoproteins, primarily associated with the transport of cholesterol in the bloodstream. This substance is characterized by its role in lipid metabolism and its relevance in assessing cardiovascular health. It is utilized in laboratory diagnostics to evaluate lipid profiles and related health conditions. The analysis of this substance may provide insights into various metabolic disorders and the risk of cardiovascular diseases. It is differentiated from other biochemical markers based on its specific function, structure, and clinical significance in the context of in vitro diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010221</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV697#015" guid="9a4e4f3f71eb41889a802312dbd927f6">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Non esterified fatty acid</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">non-esterified fatty acids are organic compounds that consist of long hydrocarbon chains with a carboxylic acid group, and they are not chemically bonded to glycerol. These fatty acids play a crucial role in various metabolic processes, serving as vital energy sources and building blocks for cell membranes. They are typically found in free form in biological fluids and can influence numerous physiological functions, including inflammation, blood sugar regulation, and cardiovascular health. Their measurement is significant in clinical diagnostics and nutritional assessments, as imbalances in non-esterified fatty acids may indicate metabolic disorders or other health issues. This classification emphasizes their unique biochemical properties and clinical relevance in the context of in vitro diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010222</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV698#015" guid="889e8f2d07ae4b749a2c5da77106004d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Oxalate (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a compound characterized by its ability to form salts with various cations, typically utilized in diagnostic settings for its relevance in biochemical assays. This substance plays a critical role in the assessment and monitoring of specific metabolic pathways, contributing to the understanding of certain medical conditions. Often employed in laboratory analyses, it aids in the detection and quantification of particular biomolecules, providing valuable insights into physiological and pathological states. The classification emphasizes its unique properties and applications within the diagnostic landscape, differentiating it from other related substances that serve distinct functions in clinical evaluations.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010223</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV699#015" guid="ebaed08f25a44e9eb2919b4da9051b43">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Phospholipid (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a phospholipid is a type of lipid molecule that is a fundamental component of cellular membranes, playing a crucial role in maintaining structural integrity and fluidity. It consists of a hydrophilic (water-attracting) head and hydrophobic (water-repelling) tails, allowing it to form bilayers that encapsulate cells and organelles. In the context of in vitro diagnostics (IVD), phospholipids may be utilized in various assays and tests to support biochemical analysis or as a reagent in the detection of specific biological markers. Their importance extends to numerous applications, including research and clinical settings, where they contribute to the understanding of lipid metabolism and related disorders.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010224</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV700#015" guid="601daf7543fb43a4b36602e837ba9672">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Porphobilinogen (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a compound that serves as a precursor in the biosynthesis of porphyrins, which are essential components of various biological systems. This substance is primarily utilized in diagnostic processes, particularly in the field of in vitro diagnostics, where it plays a critical role in evaluating metabolic functions and detecting certain disorders. The analysis of this compound can provide valuable insights into the body’s biochemical pathways and contribute to the understanding of various health conditions. Its measurement is often part of a broader panel of tests aimed at assessing health status and diagnosing specific diseases. This substance is distinct from other related metabolites and is characterized by its unique chemical properties and biological significance.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010225</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV701#015" guid="38a5f3025eea4e0b8d45c7e2e6e35229">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Pyruvate (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific biochemical compound commonly utilized in in vitro diagnostics. It is a key metabolite involved in various metabolic processes and is often measured to assess physiological functions or diagnose conditions. The substance is significant in the context of clinical evaluations, particularly for its role in energy metabolism and its association with certain health conditions. Its analysis aids healthcare professionals in monitoring patient health, diagnosing metabolic disorders, and guiding treatment decisions. This classification is distinct from other biochemical substances that may have similar applications but differ in their chemical structure, function, or clinical significance.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010226</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV702#015" guid="f30566bcf57a429d95e0bc99796bb733">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Thymol (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">thymol is a compound primarily used in various diagnostic applications, particularly in the field of in vitro diagnostics (IVD). It serves as a substrate in biochemical assays, where it can facilitate reactions or serve as a reference standard in testing protocols. This substance is recognized for its role in enabling the detection and quantification of specific analytes, contributing to the overall accuracy and reliability of diagnostic results. Thymol's properties are leveraged in laboratory settings to enhance the effectiveness of testing methodologies, providing essential insights into physiological conditions and aiding in disease diagnosis. Its classification is distinct from other biochemical substances utilized in IVD, reflecting its unique characteristics and applications within diagnostic frameworks.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010227</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV703#015" guid="ff85ae8857284ed3b362a30bae7ff6e0">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Lipid (IVD, total)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance that consists of a diverse range of organic compounds that are insoluble in water but soluble in organic solvents. These compounds play crucial roles in biological systems, serving as energy sources, structural components of cell membranes, and signaling molecules. In the context of diagnostic applications, this category encompasses various lipid types that are analyzed to assess metabolic functions, cardiovascular health, and other physiological conditions. The evaluation of these substances is essential for understanding lipid metabolism and its implications in health and disease. The classification focuses on the total content of lipids present in biological samples, providing insights into a patient's lipid profile and overall metabolic state.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010228</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV704#015" guid="22298193b05d475bbcf311cd1ea19181">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Porphyrine (IVD, total)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a specific type of biochemical compound used in in vitro diagnostics. It is characterized by the presence of a porphyrin structure, which is significant in various metabolic processes and can serve as a biomarker for certain medical conditions. The substance is utilized in laboratory tests to assess specific physiological parameters, contributing to the diagnosis and monitoring of diseases. This category distinguishes itself through unique properties and applications in diagnostic procedures, differentiating it from other biochemical substances that may serve different functions or relate to diverse metabolic pathways. The classification encompasses items that are critical for evaluating health conditions and supporting clinical decision-making in healthcare settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010229</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV705#015" guid="a8f290842d214712a0267003848aba9b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Protein (IVD, total)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a category of substances that are essential macromolecules composed of amino acids, which play a vital role in various biological processes. These substances are commonly analyzed in laboratory settings to assess nutritional status, diagnose medical conditions, and monitor treatment efficacy. The focus is on total protein content, which reflects the sum of all protein fractions present in a sample. This category is distinct from other classifications that include specific proteins or metabolic byproducts, highlighting its unique role in understanding overall protein levels within biological specimens.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010230</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV706#015" guid="67c85245226745af8c330bf31a167137">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Triglyceride (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">triglycerides are a type of lipid found in the bloodstream, serving as a key source of energy for the body. They are formed from the glycerol molecule combined with three fatty acids and are important for various metabolic processes. In the context of in vitro diagnostics (IVD), triglycerides are measured to assess overall health, monitor metabolic conditions, and evaluate the risk of cardiovascular diseases. Their concentration can indicate abnormalities in lipid metabolism and provide insights into conditions such as diabetes or pancreatitis. Testing for triglycerides is commonly conducted as part of lipid panels, and results are utilized alongside other biomarker assessments to support clinical decision-making and patient management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010231</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV707#015" guid="69d85ef524cc4c118e382f28d02dc2bb">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Uric acid (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">uric acid refers to a chemical compound formed as a byproduct of purine metabolism in the body. It is primarily excreted through urine and is an important marker in various clinical assessments, particularly in relation to renal function and metabolic disorders. The measurement of uric acid levels can provide valuable insights into conditions such as gout, kidney disease, and other metabolic syndromes. In the context of in vitro diagnostics, this substance is analyzed to assess patient health and diagnose potential abnormalities, distinguishing it from other biochemical substances that may also be measured in clinical laboratories.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010232</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV708#015" guid="d725808b28c94f7d9858b69267efcb26">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Zinc (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a metallic element commonly found in nature, this substance is utilized in various industrial applications, particularly in the field of diagnostics. It is known for its essential role in numerous biochemical processes and is often measured to assess various health conditions. The element is characterized by its specific properties and functions, making it significant in laboratory analyses. Its detection and quantification are vital for understanding metabolic pathways and diagnosing potential deficiencies or excesses in biological systems. This substance is typically examined through specific testing methods that ensure accurate results in clinical settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010233</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV709#015" guid="e854211461fc4e199b26b357e6c61872">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Lipoprotein electrophoresis</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses analytical techniques used to separate and identify various lipoprotein fractions in biological samples, typically for diagnostic purposes. The focus is on distinguishing between different types of lipoproteins based on their size, density, and composition. This process aids in the assessment of metabolic conditions and cardiovascular risk factors. The methods involved may utilize agarose gel electrophoresis or similar technologies to provide a detailed profile of lipoprotein levels, contributing to a comprehensive understanding of lipid metabolism and related health implications. The classification emphasizes the importance of accurate measurement and analysis in the context of in vitro diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010234</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV710#015" guid="8aacc73cc3394f999e4b22d04b2d00c8">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Protein electrophoresis</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a technique used to separate and analyze proteins based on their size and charge through the application of an electric field. This method allows for the identification and quantification of various proteins within a sample, making it essential for diagnostic purposes in clinical laboratories. It is particularly valuable in the evaluation of protein abnormalities, monitoring of diseases, and assessment of therapeutic interventions. The process involves preparing a gel matrix, loading the protein sample, and applying voltage to facilitate migration, resulting in distinct bands that can be visualized and analyzed. This technique is widely utilized in the field of in vitro diagnostics to support clinical decision-making.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010235</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV711#015" guid="d4fdfb63b1cb4a2c9c5815b2f8261561">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Phenylketonuria (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a category encompassing substances utilized for the assessment of phenylketonuria, a metabolic disorder characterized by the inability to properly metabolize the amino acid phenylalanine. This classification includes various forms of diagnostic materials and reagents, specifically designed for in vitro diagnostic applications. It serves to facilitate the detection and monitoring of phenylalanine levels in biological samples, thereby aiding in the diagnosis and management of the condition. The items classified under this category are integral to laboratory testing processes and are essential for clinicians in determining appropriate treatment strategies for affected individuals.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU102#005"/>
          <hierarchical_position>42010236</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW738#015" guid="232cde64e27c4dca9f057a4dfe696abf">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HTLV multiple antibody</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic tests specifically designed to detect antibodies related to multiple human T-lymphotropic virus (HTLV) types. These tests are used in the context of infectious disease diagnostics, particularly in screening for HTLV infections. The focus is on identifying the presence of antibodies that indicate exposure to the virus, providing crucial information for patient management and treatment decisions. This category is distinct from other related tests that target specific HTLV types or use different methodologies. The tests in this classification are essential for public health monitoring and epidemiological studies concerning HTLV infections.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU145#005"/>
          <hierarchical_position>42050329</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW739#015" guid="2f93c351e1a34ea294e0fdd93fca0283">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HTLV multiple antibody (confirmatory)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic tool used to detect the presence of antibodies specific to various strains of HTLV (Human T-cell Lymphotropic Virus) in a biological sample. This test is primarily employed as a follow-up procedure to confirm initial screening results for HTLV infection. It plays a crucial role in identifying individuals who may be carriers of the virus, which is associated with certain health conditions, including adult T-cell leukemia/lymphoma. The specificity and sensitivity of this test are important for accurate diagnosis and management of patients. This classification focuses on confirmatory testing, differentiating it from other testing methodologies that may target different viral antigens or antibodies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU145#005"/>
          <hierarchical_position>42050330</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW740#015" guid="d650af74b4764b1684958fc31f9707b2">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HTLV multiple (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a specific type of diagnostic reagent used for the detection of multiple human T-lymphotropic viruses, which are retroviruses associated with certain hematological disorders. The reagent is designed to identify the presence of nucleic acid from these viruses in biological samples. It serves as an essential tool in clinical laboratories for screening and confirming infections, thereby assisting healthcare professionals in diagnosing and managing conditions related to these retroviruses. The classification differentiates this reagent from others that target single or confirmatory tests for specific viral antigens or antibodies. It is crucial in ensuring accurate and comprehensive testing for patients potentially exposed to these pathogens.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU145#005"/>
          <hierarchical_position>42050331</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW741#015" guid="a26636d2513047bdbf17547ab89e7c6f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Retrovirus testing (IVD, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU145#005"/>
          <hierarchical_position>42050390</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU124#006" guid="8df61a3f35cb4785b8350cf4c93d40ad">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Rapid test (immunochemistry)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic tests that utilize immunochemical methods to rapidly detect specific substances or biomarkers in biological samples. These tests are designed to provide quick results, facilitating timely clinical decision-making. The focus is on assays that identify various proteins, hormones, and metabolites linked to health conditions, including but not limited to reproductive health, cardiac function, drug use, and inflammatory responses. The tests are characterized by their efficiency and accuracy, often employed in point-of-care settings or clinical laboratories to support diagnosis and monitoring of diseases. The classification distinguishes these rapid tests from other immunochemical assays that may involve different methodologies or target analytes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS274#006"/>
          <hierarchical_position>42021600</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW211#015" guid="3eb0ece50b8e4458a829d212b6d421ee">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Albumin inclusive uAlbumin (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological substance that is a key protein found in the blood, playing a crucial role in maintaining osmotic pressure and transporting various substances. This classification encompasses rapid testing methodologies that focus on the detection and quantification of this protein, allowing for quick and efficient assessment of certain health conditions. The tests in this category are typically designed for high sensitivity and specificity, enabling medical professionals to obtain results in a timely manner. This classification is distinct from others in the realm of rapid tests that target different analytes or biomarkers, emphasizing its unique application in clinical diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU124#006"/>
          <hierarchical_position>42021601</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW212#015" guid="79129e815e5548f99a32dae15f73b04e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Glycosylated-, glycated haemoglobin (IC, rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic tool utilized for the quantitative measurement of glycated hemoglobin levels in biological samples, typically blood, to assess glucose control over time. This test is designed to provide rapid results, facilitating timely clinical decision-making in the management of conditions such as diabetes. The methodology employed in this assessment is based on immunochemical techniques, allowing for specific binding and detection of the target analyte. This classification is distinct from other rapid diagnostic assays that focus on different biomarkers or substances, ensuring that it serves a unique role in the evaluation of metabolic and endocrine disorders.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU124#006"/>
          <hierarchical_position>42021602</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW213#015" guid="15d32ffb8f064b4c8d4eba300c63ebfe">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">BTA (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a rapid test is a diagnostic tool designed to provide quick results for various medical conditions through the analysis of biological samples. This specific category encompasses tests that utilize immunochemical methods to detect specific biomarkers or substances in a sample, often enabling timely decision-making in clinical settings. These tests are characterized by their ease of use, speed, and the ability to deliver results within a short timeframe, making them essential for point-of-care testing. The tests in this classification are distinguished by the particular analytes they target, which are indicative of specific health conditions or diseases, thereby facilitating targeted diagnostics and monitoring.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU124#006"/>
          <hierarchical_position>42021603</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW214#015" guid="8a369769a3c641c6a5339e51eabae823">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">PSA (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a rapid test designed for the qualitative or quantitative detection of specific antigens or antibodies in a sample, typically used in clinical diagnostics to provide quick results. This test is characterized by its ability to deliver results in a short timeframe, often within minutes, and is utilized in various medical settings for immediate decision-making. It is distinct from other rapid tests that target different markers or substances, ensuring a focused application in immunochemistry. The technology employed may vary, including lateral flow assays or other methodologies, to achieve reliable and accurate outcomes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU124#006"/>
          <hierarchical_position>42021604</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW215#015" guid="ef38a00f67aa4f0392adbea71d7f5eac">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">FSH (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic tools designed for the rapid detection of specific biomarkers related to fishborne pathogens or related conditions. These tests provide quick results, allowing for timely assessment and decision-making in clinical settings. The tools are utilized primarily in immunochemical assays, which utilize antibodies to detect target substances in biological samples. The rapid nature of these tests enables healthcare providers to deliver immediate patient care and interventions, particularly in acute scenarios or during screenings. It is essential that these tools meet regulatory standards for accuracy and reliability, ensuring they provide valid and actionable results in the diagnosis and monitoring of health conditions associated with fishborne exposure or infections.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU124#006"/>
          <hierarchical_position>42021605</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW216#015" guid="faea0d56b1604a3d8ef91964a820bf9f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HCG (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a rapid test designed for the qualitative or quantitative detection of specific substances or biomarkers in biological samples, typically used for diagnostic purposes. This testing methodology is characterized by its speed and efficiency, allowing for timely decision-making in clinical settings. The tests are often employed to assess various health conditions, providing results in a short timeframe, which aids in the rapid evaluation of a patient's health status. The specific tests in this category are distinguished by their target analytes and applications, serving different diagnostic needs while maintaining a focus on immunochemical principles.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU124#006"/>
          <hierarchical_position>42021606</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW217#015" guid="e689849d914c428e8f95146dfb14876f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HPL (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic tools designed for the rapid detection of specific biomarkers using immunochemical methods. These tools are utilized in various medical settings to provide quick and reliable results, aiding in the diagnosis and monitoring of health conditions. The focus is on assays that allow for immediate interpretation of results, facilitating timely clinical decisions. This category includes tests that assess various physiological parameters, contributing to patient management and treatment strategies. The classification emphasizes the unique features and applications of the tests, distinguishing them from other diagnostic methods that may not employ the same rapid immunochemical techniques.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU124#006"/>
          <hierarchical_position>42021607</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW218#015" guid="e3a7c60d2a3b49b2a59dabbc5a82ea6d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">LH (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to diagnostic tools designed for the rapid detection of specific substances or biomarkers in biological samples, primarily utilized in immunochemical assays. These tools enable swift analysis and interpretation of results, facilitating timely medical decision-making. The focus is on tests that provide immediate feedback regarding the presence or concentration of particular analytes, supporting clinical evaluations and interventions. This category encompasses a variety of tests that are characterized by their quick turnaround times and their role in monitoring, screening, or diagnosing various medical conditions. The classification distinctly differentiates between various types of rapid tests based on the specific analytes they assess, ensuring appropriate categorization within the broader context of immunochemical diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU124#006"/>
          <hierarchical_position>42021608</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW219#015" guid="bb718fd339c94d2da8e8e5368e8c0123">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Neutrophil gelatinase associated lipocalin (lipocalin2)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical marker involved in the immune response, specifically associated with neutrophil activation and inflammation. This substance is utilized in diagnostic procedures to assess various health conditions, particularly those related to kidney function and inflammatory processes. It serves as a valuable indicator in rapid testing methodologies, enabling healthcare professionals to obtain timely results that support clinical decision-making. The detection of this marker can assist in monitoring disease progression or response to treatment, contributing to patient management strategies in a variety of medical contexts.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU124#006"/>
          <hierarchical_position>42021609</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW220#015" guid="034b8fb5b44d4f15a19b0b4641be47e6">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Theophylline (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a rapid diagnostic method designed for the detection and quantification of the compound Theophylline in biological samples. This approach enables timely results, assisting healthcare professionals in making informed decisions regarding patient management. The methodology typically involves immunochemical techniques, which leverage the specificity of antibodies to interact with the target analyte. This type of testing is characterized by its speed and efficiency, making it suitable for point-of-care applications. The tests are primarily utilized in clinical settings to monitor therapeutic drug levels, ensuring patient safety and optimizing therapeutic efficacy. Theophylline testing is crucial for individuals undergoing treatment where this compound is part of their therapeutic regimen.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU124#006"/>
          <hierarchical_position>42021610</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW221#015" guid="75f85181650c499f849155cd3eb84421">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Amphetamine (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a rapid testing method designed for the qualitative detection of amphetamine in various biological samples. This testing approach utilizes immunochemical techniques to provide quick results, often employed in clinical and forensic settings to screen for the presence of this specific substance. The test is characterized by its ability to deliver rapid outcomes, enabling timely decision-making in medical or legal contexts. It is distinct from other rapid tests that target different substances or biomarkers while maintaining a focus on the identification of amphetamine, which is a central nervous system stimulant.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU124#006"/>
          <hierarchical_position>42021611</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW222#015" guid="22bee604df824ffca9f678564932ec69">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Amphetamine, methamphetamine, specific, and ecstasy (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a specific type of diagnostic test designed to detect the presence of certain substances in biological samples, particularly in the context of substance use. Such tests are characterized by their rapid response time, allowing for quick results that can be critical in various situations, including medical emergencies or screening processes. The substances targeted by this classification are related to certain synthetic compounds known for their psychoactive effects. These tests utilize immunochemical methods to identify these substances, providing valuable information for healthcare providers in assessing potential substance abuse or exposure. The classification is distinct from other diagnostic tests that focus on different biomarkers or substances, emphasizing its specialized role in toxicology and substance screening.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU124#006"/>
          <hierarchical_position>42021612</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW223#015" guid="18cfc0008537463b9747c89f8f2974d9">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Barbiturate (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a category that encompasses testing products designed to detect barbiturate substances in biological samples rapidly through immunochemical methods. These tests are characterized by their ability to provide quick and reliable results, facilitating the assessment of barbiturate levels for clinical or forensic purposes. The classification is distinct from other rapid testing products that measure various biomarkers or substances, each serving specific diagnostic or monitoring needs. The methodologies employed often utilize antibodies or antigen interactions to achieve rapid detection, ensuring effectiveness in diverse applications, including drug screening and therapeutic monitoring.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU124#006"/>
          <hierarchical_position>42021613</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW224#015" guid="c378eef1e851403c933df11aad3e4024">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Benzodiazepine (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a rapid testing method designed for the detection and quantification of specific benzodiazepine substances in biological samples. This approach utilizes immunochemical reactions to identify the presence of these compounds, providing timely results that are essential for clinical decision-making, drug screening, or therapeutic monitoring. The test is characterized by its speed and efficiency, allowing for quick analysis while maintaining a level of accuracy suitable for preliminary assessments. It is a valuable tool in both medical and forensic settings, enabling healthcare professionals to make informed choices regarding patient care or legal matters related to substance use.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU124#006"/>
          <hierarchical_position>42021614</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW225#015" guid="667d30b77bd248bca0536c6aeb937eac">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cannabinoid (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a testing method designed to detect the presence of specific compounds derived from cannabis in biological samples. This rapid assessment is utilized in various applications, including medical diagnostics and forensic analysis, to provide timely results regarding cannabinoid levels. The technology involved typically employs immunochemical reactions to yield quick and reliable outcomes, distinguishing it from other rapid testing methodologies that focus on different biomarkers or analytes. This category specifically addresses the unique characteristics and requirements associated with cannabinoid detection, ensuring it meets regulatory standards and provides accurate information for clinical or legal use.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU124#006"/>
          <hierarchical_position>42021615</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW226#015" guid="6954f05ba1a540288f7ee84f67547270">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cocaine and cocaine metabolite (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a rapid testing method designed to detect the presence of specific substances or their metabolites in biological samples. This method employs immunochemical techniques to provide quick results, typically within a short timeframe. The tests are utilized in various settings, including clinical laboratories and point-of-care environments, to facilitate timely decision-making in medical diagnostics. This particular assay focuses on identifying cocaine and its metabolites, allowing for the assessment of substance use or exposure in individuals. It is distinguished from other rapid tests that target different analytes, ensuring specificity and relevance in toxicological evaluations. The results can aid healthcare professionals in diagnosing and managing conditions related to substance use.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU124#006"/>
          <hierarchical_position>42021616</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW227#015" guid="5ecbc9b18b3f474caf532aa446525f11">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Methadone inclusive EDDP (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic tools designed to detect the presence of specific substances in biological samples through rapid immunochemical methods. These tests are engineered for quick and efficient analysis, providing timely results that aid in clinical decision-making. The focus is on substances related to pain management and addiction treatment, specifically targeting compounds utilized in therapeutic and illicit contexts. The tests are characterized by their high sensitivity and specificity, ensuring accurate identification of the target analytes. The products within this classification support healthcare professionals in monitoring patient conditions and guiding treatment choices, thus playing a crucial role in patient care and management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU124#006"/>
          <hierarchical_position>42021617</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW228#015" guid="c7c21ccae7714962a55700d03ad5133f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Opiate (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic testing methods specifically designed to detect the presence of opiates in biological samples. These tests utilize immunochemistry techniques to provide rapid results, enabling timely decision-making in clinical settings. The primary focus is on the identification of opiate substances, which are commonly associated with pain management and substance use. The tests are characterized by their ability to deliver quick and reliable outcomes, facilitating immediate assessment and response in various healthcare environments, including emergency medicine and outpatient services. This category is distinct from other rapid testing methods that target different analytes or substances, ensuring clarity in the specific applications and purposes of the tests.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU124#006"/>
          <hierarchical_position>42021618</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW229#015" guid="6c4c0345045845d9b5eb2c48a4e39544">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Phencyclidine (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a specific type of diagnostic test designed to detect the presence of a particular substance in biological samples, typically used for medical or forensic purposes. The tests are characterized by their rapid turnaround time, allowing for quick decision-making in clinical or emergency settings. They utilize immunochemical methods to identify and quantify the target analyte, offering a streamlined process for health professionals. The category encompasses a range of tests that are employed when there is a need for immediate results, facilitating timely intervention or treatment. The focus is on tests that are specifically tailored to assess a defined substance, ensuring accuracy and reliability in the detection process.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU124#006"/>
          <hierarchical_position>42021619</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW230#015" guid="0095a677dfba4fdb80c779dc1939b9ce">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Tricyclic antidepressant (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a rapid diagnostic tool used for the detection and quantification of specific tricyclic antidepressant substances in biological samples. This method utilizes immunochemical techniques to provide quick results, enabling healthcare professionals to assess therapeutic levels or identify potential overdoses. The tool is designed for point-of-care applications, facilitating immediate decision-making in clinical settings. It is characterized by its high sensitivity and specificity, allowing for reliable outcomes with minimal sample preparation. This diagnostic approach is crucial in monitoring patient adherence to prescribed medication regimens, as well as in toxicological assessments to ensure patient safety and effective treatment management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU124#006"/>
          <hierarchical_position>42021620</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW231#015" guid="80f7067b55134a09be5b43ff06a7fdff">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Multiple drug of abuse-, toxicology (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to diagnostic tests designed to simultaneously detect and identify various substances that may indicate drug abuse or toxicological exposure. These tests are typically performed using rapid immunochemical methods, allowing for quick results in clinical or field settings. They are utilized for screening individuals for the presence of multiple illicit drugs or their metabolites in biological samples, such as urine or blood. The results can aid in clinical decision-making, treatment planning, and monitoring of substance use. This category encompasses a range of tests that can identify different drug classes, providing a comprehensive assessment of potential substance abuse.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU124#006"/>
          <hierarchical_position>42021621</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW232#015" guid="9260fb4c77fd43ee832cc2464fe1ab74">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">C-reactive protein (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic tool designed to detect the presence and quantify levels of a specific protein in biological samples, typically used to assess inflammation or infection. This rapid assessment method provides timely results, facilitating swift clinical decision-making. It operates on principles of immunochemical reactions that can yield results within a short timeframe, making it suitable for point-of-care settings. The test's relevance lies in its ability to aid in the diagnosis and monitoring of various health conditions, reflecting the body's response to inflammation. This category distinguishes itself from other similar diagnostic tools that measure different biomarkers or substances within the same rapid testing framework.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU124#006"/>
          <hierarchical_position>42021622</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW233#015" guid="0ee0e098738046e486a7c71bd7a62a6c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Creatine kinase (MB mass, rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses diagnostic tests that utilize immunochemical methods to detect and quantify the presence of specific biomarkers in biological samples. These tests are characterized by their rapid performance, providing timely results that facilitate clinical decision-making. The focus is on assays that measure the concentration of a particular enzyme variant associated with cardiac tissue, aiding in the evaluation of myocardial injury or other cardiac conditions. These tests are designed for ease of use, often requiring minimal sample preparation and offering quick turnaround times, which are critical in emergency and routine clinical settings. The technologies employed may include lateral flow assays, enzyme-linked immunosorbent assays (ELISA), or other advanced immunoassay methodologies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU124#006"/>
          <hierarchical_position>42021623</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW234#015" guid="0204a224a7f445e599ca288997523062">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Myoglobin (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a rapid test designed to detect and quantify myoglobin levels in biological samples, primarily used in clinical diagnostics. This test serves as a valuable tool for assessing muscle injury or damage, particularly in the context of acute coronary syndromes and other conditions where muscle breakdown is a concern. The methodology typically involves immunochemical techniques to ensure specificity and sensitivity in the measurement of myoglobin, aiding healthcare professionals in making timely and informed decisions regarding patient care. It is distinguished by its rapid turnaround time, allowing for immediate clinical response compared to traditional testing methods.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU124#006"/>
          <hierarchical_position>42021624</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW235#015" guid="6e67421678554f23b365ce6388d9278d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Troponin I/T (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a rapid test designed to detect the presence of Troponin I in biological samples, specifically for the purpose of diagnosing cardiac conditions. This testing method utilizes immunochemical techniques to provide quick results, allowing for timely medical decision-making. The Troponin I rapid test is differentiated from other rapid tests focused on various biomarkers, ensuring specificity in its application for cardiac assessment. It is utilized in clinical settings where rapid diagnostics are critical, especially in emergency situations related to myocardial injury. The product adheres to regulatory standards for accuracy and reliability in results, contributing to effective patient management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU124#006"/>
          <hierarchical_position>42021625</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW236#015" guid="f79ad3e27b624591bf5128f58f8a39cb">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">BNP, proBNP (rapid test, including other natriuric peptides)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification represents a category of diagnostic tests designed to measure specific biomolecules, particularly natriuretic peptides, in biological samples. These tests are characterized by their rapid processing capabilities, allowing for swift results that assist in clinical decision-making. The focus is on identifying and quantifying levels of BNP and proBNP, which are crucial in the diagnosis and management of heart-related conditions. This category is distinct from other rapid tests that assess different biomarkers linked to various physiological and pathological states. The methodologies employed in these tests typically utilize immunochemical techniques, ensuring high specificity and sensitivity in the detection of the targeted peptides.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU124#006"/>
          <hierarchical_position>42021626</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW473#015" guid="ee306f3ccde044cca79ef7d2a3cadc2d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Haematology, histology, cytology (other, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU134#007"/>
          <hierarchical_position>42039090</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU145#005" guid="04a277d33d724c74806df4d6334a35c7">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Retrovirus testing (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic tests and related products specifically designed for the detection and analysis of retroviruses, particularly in the context of infectious diseases. It includes a diverse range of items used for identifying various retroviral infections, including human immunodeficiency virus (HIV) types 1 and 2, as well as human T-lymphotropic virus (HTLV) types I and II. The offerings in this category may consist of antigens, antibodies, and nucleic acid reagents, which serve as essential tools for both initial screening and confirmatory testing. This classification is distinct from other areas of infectious immunology, as it is focused solely on retroviral pathogens and their specific diagnostic requirements. The products are vital for epidemiological studies, clinical diagnostics, and monitoring of retroviral infections, contributing to better patient management and public health outcomes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS277#005"/>
          <hierarchical_position>42050300</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW710#015" guid="d8d551b8cc364048a53996ee5a0ebcdc">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HIV 1 antigen</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic substances utilized for the identification of specific viral proteins associated with the HIV-1 virus. These substances are primarily employed in laboratory settings to facilitate the detection of HIV-1 infections, playing a crucial role in the early diagnosis and monitoring of the disease. The focus is on the antigen component, which is indicative of the virus's presence in biological samples. This classification distinguishes these diagnostic agents from other related tests that may target different viral components or antibodies, ensuring a precise understanding of their specific applications in the context of retroviral testing.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU145#005"/>
          <hierarchical_position>42050301</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW711#015" guid="50dba46f848e45aa80157656f1b76a60">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HIV 1 antigen (confirmatory)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses laboratory diagnostic tests specifically designed to detect the presence of HIV 1 antigen through confirmatory methods. It is utilized in the context of infectious disease testing, particularly for retroviruses. The tests are intended to provide reliable results that assist in the diagnosis and management of HIV infections. They play a crucial role in confirming the presence of the virus in individuals who may have previously tested positive for other HIV-related markers. This classification is distinct from related tests that detect antibodies or other forms of antigens associated with HIV, ensuring precise identification and differentiation of the various components involved in HIV testing and diagnosis.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU145#005"/>
          <hierarchical_position>42050302</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW712#015" guid="4d13b81df8014321ac1aa6b54c509fa9">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HIV 1 antibody (total)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological test that detects the presence of antibodies specific to HIV-1, providing information about an individual's immune response to the virus. This test is crucial for diagnosing HIV infections and monitoring the effectiveness of treatment. It serves as a key component in the broader context of retroviral diagnostics, aiding in the differentiation of various HIV-related conditions. The results can be utilized for both screening and confirmatory purposes, contributing to comprehensive patient management in the field of infectious diseases. The test is typically performed on blood samples and is essential for public health initiatives aimed at controlling HIV transmission.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU145#005"/>
          <hierarchical_position>42050303</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW713#015" guid="3c2e47bfb3c942819df85da186c291a5">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HIV 1 antibody (IgG)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific biological test designed to detect the presence of antibodies, specifically Immunoglobulin G (IgG), produced in response to the Human Immunodeficiency Virus type 1 (HIV-1). This assay is utilized in the diagnosis and monitoring of HIV infections, particularly to confirm past exposure to the virus. The test distinguishes itself by focusing solely on IgG antibodies, providing essential information regarding the immune response to HIV-1. It is an important component of retroviral diagnostics, contributing to the overall understanding of an individual's HIV status and aiding in clinical decision-making. The assay's specificity and sensitivity are crucial for reliable results in the context of infectious disease management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU145#005"/>
          <hierarchical_position>42050304</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW714#015" guid="2a2e2dade92d4cdaaef6414af642dcf3">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HIV 1 antibody (IgM)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a range of in vitro diagnostic assays specifically designed to detect the presence of antibodies related to HIV 1, particularly focusing on the IgM isotype. These assays are essential in the context of HIV testing, as they enable the identification of recent infections and contribute to a comprehensive understanding of an individual's immune response to the virus. The testing methodologies may involve various techniques to ensure specificity and sensitivity in detecting the IgM antibodies, thereby facilitating timely diagnosis and appropriate medical interventions. This classification is distinct from other related tests that focus on different antibodies or antigens associated with HIV, ensuring clarity in the diagnostic options available for healthcare professionals.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU145#005"/>
          <hierarchical_position>42050305</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW715#015" guid="387a9534d9cc495a87e6ea304be0f25e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HIV 1 antibody (confirmatory)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic tool designed to detect the presence of specific antibodies in the human body, serving as a confirmation test for prior HIV infection. This analytical method utilizes various techniques to ensure reliable identification of antibodies associated with HIV-1, thereby facilitating accurate diagnosis and management of the condition. The test is primarily employed in clinical settings to support the diagnosis of HIV infection, particularly in cases where initial screening results are ambiguous or require further validation. It plays a crucial role in the overall strategy for monitoring and treating individuals potentially affected by the virus, ensuring that healthcare providers can make informed decisions based on robust and confirmatory evidence.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU145#005"/>
          <hierarchical_position>42050306</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW716#015" guid="558d0ec398314990809b1b33b7ff3235">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HIV 1 (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a testing reagent designed for the detection of the HIV-1 virus using nucleic acid amplification methods. This reagent is utilized in laboratory settings to facilitate the diagnosis of HIV-1 infections by identifying the genetic material of the virus. It is an essential component in molecular diagnostics, offering increased sensitivity and specificity compared to traditional antigen and antibody tests. The product is specifically formulated for in vitro diagnostic use and is integral to the overall testing process for retroviral infections, helping healthcare professionals to make informed decisions regarding patient care and treatment options.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU145#005"/>
          <hierarchical_position>42050307</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW717#015" guid="52afdb6bb2b544d79aec8caf2716a7ea">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HIV 2 antigen</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific biological component used in diagnostic testing to detect the presence of the HIV type 2 virus. This substance is utilized in various laboratory procedures to identify infections associated with HIV 2, providing critical information for patient management and treatment decisions. Testing for this antigen is vital for ensuring accurate diagnoses, enabling healthcare professionals to differentiate between various types of human immunodeficiency viruses. The presence of this antigen indicates an active infection, thereby guiding further clinical actions. This component is distinct and serves a unique role within the broader context of retroviral diagnostics, ensuring comprehensive testing protocols that address multiple human immunodeficiency virus variants.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU145#005"/>
          <hierarchical_position>42050308</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW718#015" guid="15454bfdb5be4785b2a5e224c298e590">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HIV 2 antibody</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic tests specifically designed to detect antibodies against HIV type 2. These tests are utilized in clinical settings to diagnose infections caused by this particular retrovirus, contributing to the broader spectrum of retroviral diagnostics. The products categorized under this classification are essential for identifying the presence of HIV type 2 antibodies in biological samples, thereby aiding in patient management and monitoring. The distinction is made from other related tests that focus on different HIV types or specific antigen detection, ensuring clarity in the diagnostic purpose and application of each test. This classification plays a crucial role in the comprehensive assessment of HIV infection and is vital for public health initiatives aimed at controlling the spread of retroviral diseases.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU145#005"/>
          <hierarchical_position>42050309</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW719#015" guid="efa465b7fe5241e6a658d7cb1982128c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HIV 2 antibody (confirmatory)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this item pertains to a specific type of diagnostic test designed to detect the presence of antibodies associated with the Human Immunodeficiency Virus type 2 (HIV-2) in biological samples. It serves as a confirmatory test, providing additional verification of previous screening results. The test is crucial for accurate diagnosis and monitoring of HIV-2 infections, distinguishing them from other related viral infections. It is typically utilized in laboratory settings equipped for in vitro diagnostics and is an essential component of comprehensive retrovirus testing. The technology employed in this test may include various methodologies to ensure specificity and sensitivity in detecting the relevant antibodies, thereby aiding healthcare professionals in making informed decisions regarding patient care and treatment options.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU145#005"/>
          <hierarchical_position>42050310</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW720#015" guid="0e1b051af7484127997508d76ee3d52d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HIV 2 (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a specific type of diagnostic reagent used in the detection of HIV type 2. It is designed for use in laboratory settings to facilitate the identification of the virus in biological samples, playing a critical role in the diagnosis and monitoring of infections. The reagent is particularly important for distinguishing HIV type 2 from other types of human immunodeficiency viruses, ensuring accurate results in retrovirus testing. This classification emphasizes the unique characteristics and applications of the reagent, which differ from those related to other HIV types and associated tests. It serves as an essential tool in the field of in vitro diagnostics, contributing to better patient management and treatment outcomes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU145#005"/>
          <hierarchical_position>42050311</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW721#015" guid="657da2c905484829b04640e008b2d032">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HIV P24 antigen</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance used in laboratory testing that is designed to detect the presence of specific proteins associated with HIV infection, particularly the P24 antigen. This antigen is an early marker of HIV infection and is integral for diagnosing the virus in individuals. The testing involves specialized immunoassays that can differentiate this antigen from other components related to various HIV strains and other retroviruses. It plays a crucial role in the early detection of HIV, aiding healthcare professionals in diagnosing and managing the disease effectively. This classification encompasses various testing methodologies and formats designed for accurate and efficient identification of the HIV P24 antigen in biological samples.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU145#005"/>
          <hierarchical_position>42050312</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW722#015" guid="f3921e13743b4afab863bb86c728988d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HIV P24 antibody</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a type of diagnostic test that specifically detects the presence of the P24 antibody associated with HIV. The P24 antibody is an important biomarker in the diagnosis and monitoring of HIV infection, as it is an early indicator of the immune response to the virus. Tests for this antibody are utilized in clinical settings to assess the status of HIV infection, often in conjunction with other tests to provide a comprehensive overview of an individual's health regarding retroviral infections. This classification distinguishes it from other testing methodologies focused on different antibodies or antigens related to HIV and other retroviruses, ensuring clarity in the diagnostic processes and the specific targets of the assay.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU145#005"/>
          <hierarchical_position>42050313</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW723#015" guid="0756a898cda14eea91650b04246f175e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HIV P24 (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance used in laboratory testing that specifically detects the presence of the P24 protein associated with HIV. This reagent plays a crucial role in diagnosing and monitoring HIV infection, particularly in cases where early detection is essential. It is utilized in various immunoassays and molecular testing methods to identify the viral load and immune response in patients. The classification of this reagent is distinct from other HIV-related tests that focus on different antigens or antibodies, reflecting its unique application in the field of retrovirus diagnostics. The designation encompasses a range of methodologies that may include both qualitative and quantitative analyses in clinical settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU145#005"/>
          <hierarchical_position>42050314</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW724#015" guid="82ee5d5abe4f4b0482dcde6976726100">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HIV multiple antigen (multiple, HIV1 and HIV2)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a variety of diagnostic tests designed to detect the presence of multiple antigens associated with specific viral infections, particularly those linked to certain retroviruses. These tests are utilized in clinical settings to provide comprehensive screening for the presence of both HIV-1 and HIV-2, facilitating accurate diagnosis and subsequent management of infections. The focus is on assays that can identify multiple viral components simultaneously, ensuring a more efficient and thorough evaluation of a patient's serological status. This classification distinguishes itself through its emphasis on the detection of multiple viral markers, thereby enhancing the reliability of test results and supporting effective clinical decision-making.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU145#005"/>
          <hierarchical_position>42050315</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW725#015" guid="8437aaaa51bb4d2b858331193708bc0b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HIV multiple antibody (multiple, HIV1 and HIV2)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic products designed for the detection of antibodies specific to multiple strains associated with a particular viral infection. These products are utilized in laboratory settings to determine the presence of immune responses against specific viral proteins, providing crucial information for the diagnosis and management of viral infections. The focus is on the simultaneous detection of antibodies related to both primary strains of the virus, facilitating comprehensive screening. The classification emphasizes the importance of accurate and reliable testing methods in the field of infectious disease diagnostics, ensuring that healthcare providers have access to essential tools for patient care and epidemiological studies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU145#005"/>
          <hierarchical_position>42050316</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW726#015" guid="3b0f1ac8a40249d9bb063397b38e14da">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HIV multiple antibody (confirmatory, multiple, HIV1 and HIV2)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to diagnostic products designed to detect multiple antibodies associated with Human Immunodeficiency Virus (HIV) types 1 and 2. These products are utilized in confirmatory testing scenarios to validate initial screening results, providing a comprehensive analysis of an individual's immune response to the HIV infection. The assays may incorporate various methodologies to ensure high specificity and sensitivity in identifying the presence of these antibodies, which play a crucial role in diagnosing HIV infections. The products can be used in laboratory settings and are essential for clinical decision-making related to HIV management and treatment.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU145#005"/>
          <hierarchical_position>42050317</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW727#015" guid="51acaec687b84fc9882c78fd1258f891">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HIV Multiple antigen/antibody combi test (multiple, HIV1 and HIV2)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic test designed to detect the presence of antibodies and antigens associated with multiple strains of a specific retrovirus. This test simultaneously identifies indicators for both the first and second types of the virus, providing a comprehensive assessment of infection status. The methodology typically employs immunological techniques to ensure sensitivity and specificity, enabling healthcare professionals to make informed decisions based on the results. This type of testing is integral in the screening and diagnosis of infections, supporting public health efforts and individual patient care by facilitating timely interventions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU145#005"/>
          <hierarchical_position>42050318</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW728#015" guid="f0908b463c41416f89684c6b2b8e3c85">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HIV multiple (NA reagent, multiple, HIV1 and HIV2)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses diagnostic reagents designed for the detection and analysis of multiple strains of a specific retrovirus, particularly those associated with particular immune deficiencies. These reagents facilitate the simultaneous identification of various viral components, enabling healthcare professionals to perform comprehensive tests that assess the presence of both viral strains in a sample. Such reagents are utilized in laboratory settings to enhance the accuracy and efficiency of retroviral testing, contributing significantly to public health monitoring and individual patient care. The classification distinguishes these reagents from others that target singular viral components or specific antibodies, thus ensuring precise diagnostics in the field of infectious disease management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU145#005"/>
          <hierarchical_position>42050319</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW729#015" guid="9867c23139524c5bade3f769d215d1a9">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HTLV I antigen</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance used in laboratory testing to detect the presence of antibodies specific to a certain virus associated with human T-cell lymphotropic virus type I. This type of analysis is essential for diagnosing infections and monitoring health status related to this particular retrovirus. The detection is crucial for public health management and patient care, allowing for appropriate treatment and prevention strategies. This category is distinct from others that pertain to different viral infections or variations of antibodies related to similar viruses, thereby providing a focused approach to retroviral diagnostics in the context of infectious disease testing.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU145#005"/>
          <hierarchical_position>42050320</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW730#015" guid="533cd7d23fd94196a85b36c28c1a94a9">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HTLV I antibody</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic tests specifically designed to detect the presence of antibodies against HTLV I, a type of retrovirus. These tests are utilized in the context of infectious disease diagnosis and monitoring, particularly for identifying exposure to HTLV I in individuals. The detection of HTLV I antibodies plays a crucial role in assessing potential infections and guiding clinical decisions. This category is distinct from other retroviral tests, as it focuses solely on HTLV I, differentiating it from tests related to HIV and other retroviruses. The results obtained from these tests can inform further investigation, management, and treatment of associated conditions, contributing to the overall understanding and control of retroviral infections.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU145#005"/>
          <hierarchical_position>42050321</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW731#015" guid="b8f2c0da9e544c3ba0c00d3f80baea43">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HTLV I antibody (confirmatory)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic tests specifically designed to detect the presence of antibodies against the HTLV I virus, confirming prior positive results obtained through initial screening methods. These tests play a crucial role in the diagnosis and management of infections caused by the HTLV I virus, a member of the retrovirus family known for its association with certain hematological disorders and neurological conditions. The confirmatory nature of these tests ensures a high level of specificity and reliability, distinguishing them from other related assays that target different viral antigens or antibodies. This classification is essential for laboratories and healthcare providers involved in infectious disease testing and monitoring.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU145#005"/>
          <hierarchical_position>42050322</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW732#015" guid="eebb30244249444c9c4fd55db4d39853">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HTLV I (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specialized reagent designed for the detection and analysis of human T-lymphotropic virus type I (HTLV I) nucleic acids. This product is utilized in laboratory settings for diagnostic procedures, particularly in the context of infectious disease testing. It plays a crucial role in identifying the presence of HTLV I in biological samples, contributing to the broader field of retroviral diagnostics. The reagent is essential for ensuring accurate and reliable testing outcomes, facilitating the monitoring and management of HTLV I infections. It is distinct from other reagents utilized for different types of retroviruses or various strains of human immunodeficiency viruses, ensuring specificity in testing protocols.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU145#005"/>
          <hierarchical_position>42050323</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW733#015" guid="f2cb89f1bf344c589a6c417996fd77d8">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HTLV II antigen</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological marker used in diagnostic testing to identify the presence of HTLV II, a type of retrovirus associated with certain health conditions. This marker is crucial for screening and confirming infections related to HTLV II, aiding in the diagnosis and management of diseases linked to this virus. The tests utilizing this marker differentiate it from other viral antigens and antibodies, thereby providing specific insights into the patient's retroviral status. The detection of this antigen is significant for guiding treatment decisions and monitoring disease progression or response to therapy in affected individuals.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU145#005"/>
          <hierarchical_position>42050324</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW734#015" guid="d9ab32b85eab496cb22b989bf3c51add">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HTLV II antibody</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a specific type of diagnostic reagent used to detect the presence of antibodies associated with a particular human retrovirus. It is utilized in the context of laboratory testing for viral infections that can lead to various health complications. The product is essential for confirming exposure to the virus and is distinguished by its unique immunological response characteristics. This reagent plays a crucial role in clinical diagnostics, enabling healthcare professionals to assess patient exposure and guide appropriate treatment decisions. Its specificity and sensitivity are vital for reliable results in the diagnosis and monitoring of related conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU145#005"/>
          <hierarchical_position>42050325</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW735#015" guid="acb98e8c6fc943a3845ed91f0cb77ed0">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HTLV II antibody (confirmatory)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a specific diagnostic test used to detect the presence of antibodies associated with a particular retrovirus. Such tests are essential in confirming prior exposure to or infection by the virus, providing critical information for patient management and treatment decisions. The focus is on identifying the immune response generated against this virus, which can assist healthcare professionals in diagnosing related conditions. This classification distinguishes itself from other tests targeting various retroviruses or their components, emphasizing its unique role in the diagnostic landscape. It is designed for laboratory settings, ensuring accurate and reliable results for clinical use.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU145#005"/>
          <hierarchical_position>42050326</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW736#015" guid="b93bb1042df247cb8704b52d3ce89f93">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HTLV II (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification identifies a specific type of diagnostic reagent used in laboratory testing for the detection of HTLV II, a retrovirus associated with certain diseases. It is utilized in in vitro diagnostics to support the diagnosis and monitoring of infections caused by this virus. The reagent is designed to interact with biological samples to provide accurate results, contributing to the overall assessment of a patient's health status regarding HTLV II. This classification is distinct from other related reagents used for different viral infections, ensuring clarity and specificity in the categorization of diagnostic tools.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU145#005"/>
          <hierarchical_position>42050327</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW737#015" guid="6d7c58c312aa4b5a8102cb799f2cccb9">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HTLV multiple antigen</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a type of diagnostic reagent used in immunological testing to identify the presence of multiple antigens associated with human T-lymphotropic virus (HTLV) types. This product facilitates the detection of specific viral proteins that may indicate an infection, aiding in the diagnosis and monitoring of related health conditions. It is designed to provide accurate results through the simultaneous assessment of various antigens, enhancing the efficiency of testing procedures. This classification distinguishes it from other related diagnostic agents that target specific HTLV types or other retroviruses, thereby serving a unique purpose within the domain of in vitro diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU145#005"/>
          <hierarchical_position>42050328</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV672#015" guid="ff44ba98303e42fa8fe5fdec2253cd5d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Pepsin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a digestive enzyme that catalyzes the hydrolysis of proteins into smaller peptides and amino acids. This enzyme is typically derived from the stomach and is utilized in various diagnostic applications within the in vitro diagnostic (IVD) field. Its primary function is to facilitate the breakdown of proteins, making it essential in the analysis of digestive disorders and related medical conditions. This category encompasses products and services that are specifically designed for use in laboratory settings, focusing on the qualitative and quantitative measurement of the enzyme's activity in biological samples. The classification highlights its distinct characteristics and applications, differentiating it from other enzymes used in similar contexts.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU101#005"/>
          <hierarchical_position>42010127</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV673#015" guid="24a94a3e8c164d1c8d3bf97c2bc7f5c1">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Phosphohexose isomerase (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">phosphohexose isomerase is an enzyme that catalyzes the reversible interconversion of glucose-6-phosphate and fructose-6-phosphate, playing a crucial role in carbohydrate metabolism. This enzyme is significant in various biochemical pathways, including glycolysis and gluconeogenesis, contributing to energy production and regulation of blood sugar levels. It is primarily found in tissues that utilize glucose as a major energy source, such as the liver and muscles. The enzyme's activity is vital for maintaining cellular functions and metabolic homeostasis. In the context of in vitro diagnostics, the measurement of phosphohexose isomerase can be important for assessing metabolic disorders and aiding in the diagnosis of certain conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU101#005"/>
          <hierarchical_position>42010128</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV674#015" guid="fd1b28a6c7674490b0e0e5ccc56a0c5d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Sorbitol dehydrogenase (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific type of enzyme that catalyzes the reversible conversion of sorbitol to fructose, often utilized in the diagnostic field. This enzyme plays a crucial role in various metabolic pathways and can be found in different tissues throughout the body. Its measurement is significant in clinical diagnostics for evaluating certain metabolic conditions and enzyme deficiencies. It is characterized by its specificity for the substrate sorbitol and is essential for understanding the biochemical processes related to carbohydrate metabolism. This enzyme is used in laboratory settings for diagnostic purposes, enabling healthcare professionals to assess metabolic health and diagnose related disorders.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU101#005"/>
          <hierarchical_position>42010129</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV675#015" guid="553fb51a2db84c92869399a917fe41fd">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Enzyme (IVD, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU101#005"/>
          <hierarchical_position>42010190</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW237#015" guid="7e0d39919f164affa7eaf1fd901d8337">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Multiple cardiac marker (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic tool designed for the simultaneous detection of various cardiac biomarkers in a rapid testing format. This tool aids in the quick assessment of cardiac events by providing essential information regarding heart function and potential damage. It is utilized in clinical settings to facilitate timely decision-making, particularly in emergency situations. The test leverages immunochemical methods to ensure accurate results within a short timeframe, allowing healthcare providers to effectively monitor and diagnose cardiac conditions. This category encompasses tests that may include multiple markers associated with cardiac health, enabling a comprehensive evaluation in a single procedure.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU124#006"/>
          <hierarchical_position>42021627</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW238#015" guid="68b1c4a3e931480f80ac8cbf9fbd80ba">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Standard, calibrator, control immunochemistry (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic tools designed for rapid testing in the field of immunochemistry. It includes items that serve as standards, calibrators, or controls specifically within immunochemical assays, facilitating the accurate measurement and validation of various biomarkers. These tools are essential for ensuring the reliability and precision of rapid test results, which are commonly used in clinical settings for quick diagnostics and screenings. Their application spans a variety of health assessments, supporting efficient decision-making in patient care. The classification differentiates these items based on their specific use in immunochemical testing, distinct from other rapid testing categories that focus on different analytes or clinical conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU124#006"/>
          <hierarchical_position>42021628</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW239#015" guid="2ffaa2ddfa6445e28f83a94aeb23ced4">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Rapid test (immunochemistry, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU124#006"/>
          <hierarchical_position>42021690</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU101#005" guid="d1d1a84a8d484e4d9a00ded239150186">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Enzyme (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses a range of biological catalysts utilized in diagnostic applications, specifically within the realm of clinical chemistry. These substances facilitate various biochemical reactions and are essential in the assessment of physiological and pathological conditions. The offerings in this category are characterized by their specificity and functionality, which are crucial for accurate and reliable analysis in laboratory settings. Each entry within this classification serves a distinct purpose in enabling the detection, measurement, or monitoring of particular biochemical markers. The products included are designed for in vitro diagnostics, ensuring they meet the rigorous standards required for clinical laboratory use, thus supporting healthcare professionals in their diagnostic processes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS273#005"/>
          <hierarchical_position>42010100</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV646#015" guid="71866e7801384b629fb72cba43737458">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">5'-Nucleotidase</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">an enzymatic substance that catalyzes the hydrolysis of nucleotides, specifically converting 5'-nucleotides into their constituent nucleosides and phosphates. This enzyme plays a significant role in nucleotide metabolism and is often utilized in various diagnostic applications within the in vitro diagnostic (IVD) field. The specific activity and properties of this enzyme can vary, and it may be assessed in clinical settings to provide insights into metabolic processes or conditions affecting nucleic acid turnover. This classification encompasses its distinct characteristics and differentiates it from other enzymatic agents that may function differently in biochemical pathways or diagnostic contexts.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU101#005"/>
          <hierarchical_position>42010101</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV647#015" guid="cc0c177a26d44496a0c689bdc2cf0aa0">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Acid phosphatase (IVD, CC)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical substance that catalyzes the hydrolysis of phosphate esters, resulting in the release of inorganic phosphate. This enzyme is utilized in various diagnostic applications, particularly in the medical field, where it plays a significant role in the assessment of certain physiological and pathological conditions. Its activity can be indicative of specific health issues, making it a valuable component in laboratory testing and analysis. This classification encompasses a range of enzymatic functions related to phosphate metabolism, distinguishing it from other enzymes with different catalytic roles or substrate specificities.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU101#005"/>
          <hierarchical_position>42010102</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV648#015" guid="027be1248221401e83192478f5356273">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Alanine amino-transferase</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">alanine amino-transferase is a specific type of enzyme that plays a crucial role in amino acid metabolism, facilitating the transfer of amino groups between amino acids and keto acids. It is essential for the conversion of alanine and alpha-ketoglutarate to pyruvate and glutamate, thereby participating in various metabolic pathways. This enzyme is particularly important in the context of liver function and is often measured in clinical settings to assess liver health and diagnose liver-related conditions. Its activity can be influenced by various factors including disease states, medications, and physiological changes, making it a significant marker in the field of in vitro diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU101#005"/>
          <hierarchical_position>42010103</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV649#015" guid="505321a9845347b18920d92c74b0d9cd">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Aldolase (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">aldolase is a specific type of enzyme utilized in in vitro diagnostics, playing a critical role in various metabolic processes. This enzyme catalyzes the reversible conversion of fructose 1,6-bisphosphate into glyceraldehyde 3-phosphate and dihydroxyacetone phosphate, which are essential intermediates in glycolysis. The measurement of aldolase activity can be significant in clinical diagnostics, particularly in evaluating liver and muscle disorders, as elevated levels may indicate tissue damage or disease. Aldolase is differentiated from other enzymes based on its unique biochemical properties and functions within metabolic pathways, making it a valuable marker in the assessment of specific health conditions. Its application in diagnostic testing is essential for healthcare professionals in diagnosing and monitoring various diseases.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU101#005"/>
          <hierarchical_position>42010104</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV650#015" guid="41020fa2840547f99eb15d74c5aa487a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Alkaline phosphatase (IVD, total)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of enzyme utilized in in vitro diagnostics, characterized by its ability to catalyze the hydrolysis of phosphate esters, resulting in the release of inorganic phosphate. It plays a significant role in various physiological processes and is employed in clinical settings to assist in the diagnosis and monitoring of certain medical conditions. The classification distinguishes this enzyme from other related enzymes based on its unique biochemical properties and clinical applications. This category is essential for understanding diagnostic methodologies and the interpretation of laboratory results in the context of enzyme activity related to health and disease.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU101#005"/>
          <hierarchical_position>42010105</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV651#015" guid="baad85441df842b3981f84233e9d7112">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Alkaline phosphatase isoenzyme (CC)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical substance characterized by its role in catalyzing the hydrolysis of phosphate esters, resulting in the release of inorganic phosphate. This particular variant of the enzyme is significant in various biological processes and is predominantly utilized in diagnostic applications. It is distinguished from other enzymes that also hydrolyze phosphate groups based on specific structural and functional properties. The enzyme's activity can be measured in clinical settings to assess various physiological conditions, making it a valuable tool in the field of in vitro diagnostics. Its unique characteristics and functions contribute to its classification within a broader category of related enzymatic substances.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU101#005"/>
          <hierarchical_position>42010106</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV652#015" guid="ea38c479b0114a4fb2d3b8d6e1c1a3f5">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Amylase (IVD, total)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical substance that facilitates the hydrolysis of starches and other carbohydrates into simpler sugars, specifically utilized in the context of in vitro diagnostics. This enzyme plays a crucial role in various clinical assessments, contributing to the evaluation of specific medical conditions. Its activity is pivotal in differentiating and diagnosing disorders related to the digestive system and other metabolic processes. The classification emphasizes its distinct characteristics and applications within the broader category of enzymatic substances used in diagnostic procedures, highlighting its relevance in clinical laboratory settings. The definition encompasses the essential functions and significance of the enzyme without overlapping with other enzymatic entities.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU101#005"/>
          <hierarchical_position>42010107</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV653#015" guid="afa1c76a38fd420b836857ca64400456">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Amylase isoenzyme (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of biological catalyst that plays a crucial role in the breakdown of polysaccharides, particularly starch. It is utilized primarily in the medical diagnostics field, where it assists in the analysis of various health conditions by facilitating the measurement of carbohydrate metabolism. This category is distinct from other similar enzymes that may function in different metabolic pathways or have varying substrate specificities. The enzymes classified here are typically characterized by their isoenzymes, which exhibit different kinetic properties and regulatory mechanisms, thereby providing valuable information in clinical assessments and laboratory settings. Their relevance in in vitro diagnostics highlights their importance in understanding disease states and monitoring therapeutic interventions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU101#005"/>
          <hierarchical_position>42010108</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV654#015" guid="3f2c9f4a422c4b5ba4c49a5063737395">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Angiotensin-converting enzyme (CC)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">angiotensin-converting enzyme is a specific type of enzyme that plays a crucial role in the regulation of blood pressure and fluid balance within the body. It catalyzes the conversion of angiotensin I, an inactive precursor, into angiotensin II, a potent vasoconstrictor. This enzymatic activity is significant in various physiological processes, including the renin-angiotensin system, which is fundamental for cardiovascular homeostasis. In a laboratory context, the measurement of angiotensin-converting enzyme activity is often utilized in diagnostics to assess certain medical conditions, such as hypertension or specific diseases that affect the lungs or other organs. This classification encompasses all products or services related to the detection, quantification, and analysis of this enzyme in diagnostic applications.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU101#005"/>
          <hierarchical_position>42010109</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV655#015" guid="0ecb8593442d447e9524b1560a28b5f9">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Aspartate amino-transferase (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">an enzyme that catalyzes the transfer of amino groups from aspartate to α-ketoglutarate, resulting in the formation of oxaloacetate and glutamate. This enzyme plays a crucial role in amino acid metabolism and is particularly significant in the diagnosis and monitoring of certain medical conditions. It is commonly utilized in in vitro diagnostic applications, aiding healthcare professionals in the assessment of metabolic and organ function. The classification of this enzyme distinguishes it from other enzymes with different catalytic activities, ensuring precise identification and utilization in clinical settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU101#005"/>
          <hierarchical_position>42010110</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV656#015" guid="118633fbea644317828510c1ee237123">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cholinesterase (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification includes a specific type of biochemical catalyst that plays a crucial role in various physiological processes. It is involved in the hydrolysis of esters and amides, particularly in the breakdown of neurotransmitters, which can significantly influence neural activity and muscle function. This category encompasses diagnostic agents utilized within in vitro diagnostic applications, which are essential for assessing enzyme activity in clinical laboratories. The classification distinguishes this type based on its unique enzymatic function and relevance to medical diagnostics, facilitating the identification and differentiation from other related enzymatic agents within the broader category of biochemical catalysts.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU101#005"/>
          <hierarchical_position>42010111</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV657#015" guid="cdfee8ab75084e008b90891c32f6b4b1">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Chymotrypsin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">chymotrypsin is a serine protease enzyme that plays a crucial role in the digestive system, facilitating the breakdown of proteins into smaller peptides and amino acids. It is commonly used in in vitro diagnostics (IVD) to assess various physiological conditions, particularly those related to pancreatic function and protein digestion. This enzyme is characterized by its specificity for peptide bonds adjacent to aromatic amino acids, making it essential in clinical evaluations. Its presence in diagnostic assays aids in the identification of certain diseases and conditions, providing valuable information for medical professionals. The classification of this enzyme is distinct within its category, differentiating it from other enzymes based on its biochemical properties and clinical applications.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU101#005"/>
          <hierarchical_position>42010112</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV658#015" guid="d16974b97cad4c01b98bf84a6ff89d38">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Creatine kinase (total)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a type of protein that serves as a biomarker in laboratory diagnostics, particularly in assessing various physiological and pathological conditions. It plays a crucial role in energy metabolism and muscle function, reflecting the state of tissue damage when present in elevated levels. This category includes enzymes that are involved in specific biochemical reactions, primarily linked to muscle and heart health. The items classified here are distinguished by their unique catalytic properties, substrate specificity, and clinical relevance, aiding healthcare professionals in diagnosing and monitoring diseases.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU101#005"/>
          <hierarchical_position>42010113</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV659#015" guid="eb4fa7dca26c49b99fa61863e763466f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Creatine kinase (MB activity, CC)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a specific type of enzyme that is involved in the catalysis of biochemical reactions, particularly related to muscle metabolism and cardiac function. It is utilized in diagnostic applications to measure enzyme activity levels, often serving as a marker for certain medical conditions. The focus here is on the isoenzymes that are indicative of particular physiological states, allowing for differentiation in clinical assessments. This category is characterized by its relevance in in vitro diagnostics, providing insights into metabolic processes and aiding in the evaluation of health conditions. The classification is distinct from other similar enzymes that play roles in various biochemical pathways and diagnostic purposes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU101#005"/>
          <hierarchical_position>42010114</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV660#015" guid="55b77c2649784c4e8767a9374aca91c6">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Creatine kinase isoenzyme (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">creatine kinase isoenzyme refers to a specific form of the enzyme creatine kinase, which is involved in energy metabolism and muscle function. This enzyme catalyzes the conversion of creatine and utilizes adenosine triphosphate (ATP) to form phosphocreatine and adenosine diphosphate (ADP). Creatine kinase isoenzymes are important in clinical diagnostics, particularly for assessing muscle damage or disease states. The isoenzyme designation indicates the enzyme's specific form, which can vary based on tissue origin, with different isoenzymes being present in various bodily tissues. This classification encompasses diagnostic applications in the field of in vitro diagnostics, facilitating the identification and differentiation of enzyme types for medical assessment and monitoring.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU101#005"/>
          <hierarchical_position>42010115</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV661#015" guid="038b08a06e0d4b3b9cb4190ade02ace0">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Gamma-glutamyltransferase (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of enzyme that plays a crucial role in biochemical processes, particularly within the context of in vitro diagnostics. It is characterized by its ability to facilitate the transfer of gamma-glutamyl groups, which are important in various metabolic pathways. The enzyme is utilized in clinical settings to aid in the diagnosis and monitoring of certain health conditions. Its activity can be indicative of various physiological states and is often measured in laboratory tests to provide valuable information regarding organ function and metabolic disorders. This classification distinguishes it from other enzymes based on its unique biochemical function and diagnostic relevance.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU101#005"/>
          <hierarchical_position>42010116</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV662#015" guid="1f73fc607a4347d1801f8a88a896f240">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Glutamate dehydrogenase (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">glutamate dehydrogenase is a type of enzyme that facilitates the reversible oxidative deamination of glutamate to alpha-ketoglutarate and ammonia, playing a crucial role in amino acid metabolism and nitrogen balance in organisms. It is primarily involved in the regulation of the metabolic pathways that generate and utilize glutamate, an important neurotransmitter and metabolic intermediate. This enzyme is of particular significance in clinical diagnostics, as its activity can be indicative of various physiological and pathological conditions, including metabolic disorders and liver function. The classification of this enzyme distinguishes it from others based on its specific biochemical function and the contexts in which it is utilized in diagnostic applications.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU101#005"/>
          <hierarchical_position>42010117</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV663#015" guid="61ad24988d284a388dd2e73ff6b757cf">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hydroxybutyrate dehydrogenase (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical catalyst that facilitates the conversion of hydroxybutyrate to other compounds through oxidation-reduction reactions. This enzyme is utilized in various diagnostic applications, particularly in the field of in vitro diagnostics (IVD). Its activity is essential for metabolic pathways involving hydroxybutyrate, playing a significant role in energy production and metabolic regulation. The enzyme's specificity and function are critical for understanding certain physiological and pathological conditions, making it valuable for clinical assessments and research purposes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU101#005"/>
          <hierarchical_position>42010118</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV664#015" guid="6cd8c0ed70e04ff7bf3a4a5d90656df5">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Lactate dehydrogenase L (LDH-L)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">lactate dehydrogenase L is a specific type of enzyme that catalyzes the conversion of lactate to pyruvate, playing a crucial role in various metabolic processes. It is primarily involved in anaerobic respiration and is important for energy production in tissues, especially during periods of low oxygen availability. This enzyme is part of a broader category of diagnostic enzymes used in in vitro diagnostics (IVD) to assess metabolic and pathological conditions. The classification of this enzyme is distinct from other enzymes in the diagnostic category, which serve various functions and may be involved in different metabolic pathways or physiological processes. Its activity can provide valuable insights into tissue health and function, making it a significant marker in clinical assessments.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU101#005"/>
          <hierarchical_position>42010119</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV665#015" guid="678c5688b0f24dd593ece893463af9a4">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Lactate dehydrogenase P (LDH-P)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">lactate dehydrogenase P is a specific enzyme categorized within the broader classification of enzymes used in in vitro diagnostics (IVD). It plays a crucial role in the metabolic pathway, facilitating the conversion of lactate to pyruvate and vice versa, thereby participating in the process of cellular respiration and energy production. This enzyme is primarily found in various tissues, including the heart and liver, and its activity is often measured to assess metabolic conditions and tissue damage. The classification within this category differentiates it from other enzymes based on its unique biochemical properties and clinical significance, particularly in relation to specific health conditions and diagnostic applications.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU101#005"/>
          <hierarchical_position>42010120</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV666#015" guid="f8aa074448c748298b42636994fa41a2">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Lactate dehydrogenase isoenzyme (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">lactate dehydrogenase isoenzyme (IVD) refers to a specific type of enzyme involved in the conversion of lactate to pyruvate, playing a crucial role in the body’s metabolic processes, particularly in the conversion of carbohydrates into energy. This enzyme is part of a broader category of diagnostic tools used in in vitro diagnostics (IVD) to assess various health conditions. The isoenzyme variant indicates the specific form of lactate dehydrogenase being analyzed, which can provide insights into tissue damage or metabolic disorders. Its measurement is important in clinical settings for diagnosing and monitoring diseases, as different isoenzymes may be associated with particular tissues or pathological states.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU101#005"/>
          <hierarchical_position>42010121</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV667#015" guid="79aef796b7e34d419fbef687d06eb9dc">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Leucine aminopeptidase (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a specific type of enzyme that catalyzes the hydrolysis of peptide bonds, facilitating the breakdown of proteins into smaller peptides or amino acids. It plays a vital role in various biological processes, including digestion and metabolism. The enzyme is utilized in diagnostic applications, particularly in vitro diagnostics, where it aids in the analysis and measurement of certain biomarkers. This category is distinct from other enzymes that serve different functions or have different substrate specificities, providing a clear classification for those involved in specific biochemical pathways.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU101#005"/>
          <hierarchical_position>42010122</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV668#015" guid="8d7b2d7725d1473e821940c4ba873d3b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Lipase (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a specific category of biocatalysts that are utilized in in vitro diagnostics. These enzymes facilitate biochemical reactions, playing critical roles in various metabolic processes. The focus of this category is on lipase, an enzyme that is essential for the hydrolysis of lipids, aiding in the digestion and absorption of dietary fats. Lipase is significant in clinical diagnostics, where its activity can indicate various health conditions. This classification differentiates lipase from other enzymes that may have different functions, substrate specificities, or clinical implications, thereby providing a clear framework for identifying and utilizing this particular enzyme in laboratory and clinical settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU101#005"/>
          <hierarchical_position>42010123</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV669#015" guid="f085d004247340e7aaf384a200a246d0">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Lysozyme (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="DeepL">Naturally occurring enzyme that attacks bacterial cell walls and is often used in medical diagnostics to inhibit or measure bacterial activity.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">Machine generated by Chat GPT4</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU101#005"/>
          <hierarchical_position>42010124</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV670#015" guid="502660dab03f48ed8e549482c5257ede">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Malate dehydrogenase (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biocatalyst that facilitates the conversion of malate to oxaloacetate, playing a crucial role in metabolic processes, particularly within the context of in vitro diagnostic applications. This enzyme is specifically utilized in various diagnostic tests and procedures, aiding in the analysis of metabolic functions and disorders. Its classification distinguishes it from other similar bioactive substances based on functional characteristics, specific substrate interactions, and its application in clinical diagnostics. The enzyme is characterized by its activity in catalyzing the reversible oxidation-reduction reaction, contributing to the regulation of metabolic pathways involving the citric acid cycle and overall cellular respiration.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU101#005"/>
          <hierarchical_position>42010125</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV671#015" guid="332f12a474254e5f88f34d32699bca71">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">N-acetyl-b, D-glucosaminidase (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a specific type of enzyme utilized in in vitro diagnostics, which is characterized by its catalytic properties and role in biochemical reactions. It is distinguished from other enzymes based on its substrate specificity, reaction mechanisms, and applications in diagnostic procedures. This enzyme is crucial in various clinical assessments, providing insights into metabolic processes and aiding in the diagnosis of certain medical conditions. Its classification emphasizes its unique functional attributes and relevance within the broader category of enzymes used for diagnostic purposes, ensuring precise identification and differentiation from similar biochemical substances.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU101#005"/>
          <hierarchical_position>42010126</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU107#005" guid="1186937bacb842be9461300de5ac39a0">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Clinical chemistry (rapid test, point of care)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a variety of diagnostic tools designed for rapid analysis in clinical chemistry settings, particularly at the point of care. It includes devices and reagents that enable the quick assessment of biological samples to provide immediate health insights. The focus is on portable testing solutions that facilitate the measurement of specific analytes, allowing healthcare professionals to make informed decisions swiftly. This classification is distinct from other related categories that cover broader or more specialized laboratory testing. Included within this classification are various test strips and kits that evaluate multiple parameters or single constituents in blood and urine, as well as calibrators and controls that ensure the accuracy and reliability of the tests. These tools play a crucial role in patient management and monitoring in diverse clinical environments.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS273#005"/>
          <hierarchical_position>42010700</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV766#015" guid="6d7d2ab983f447b2b1821514c59bc3c2">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Glucose (blood test strip)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a testing device designed for the quantitative measurement of glucose levels in blood samples, primarily utilized for monitoring glucose concentrations in individuals with diabetes or other metabolic disorders. This device typically comprises a strip that interacts with a blood sample, producing a color change or electronic signal that correlates with the glucose concentration. Such devices are essential in point-of-care settings, allowing for rapid and reliable results that facilitate immediate clinical decision-making. They differ from other similar testing devices by specifically targeting glucose, rather than other substances such as lipids or proteins, and are designed to meet the specific clinical needs associated with glucose monitoring.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU107#005"/>
          <hierarchical_position>42010701</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV767#015" guid="040d3b0faaff46418f8fb28f83f8f054">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cholesterol (blood test strip)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a testing device designed for the quantitative analysis of cholesterol levels in blood samples. This product is utilized in clinical settings for rapid assessment and monitoring of cholesterol, providing healthcare professionals with immediate results to aid in the diagnosis and management of lipid disorders. The test strip is characterized by its ease of use, portability, and the ability to deliver results at the point of care, making it suitable for both professional healthcare environments and home use. It is distinct from other testing strips that measure different blood parameters, ensuring specificity in cholesterol detection and facilitating effective patient management through timely and accurate testing.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU107#005"/>
          <hierarchical_position>42010702</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV768#015" guid="7db5804d15a643c2ae3e5a4ee5b6295b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HDL (blood test strip)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic tool specifically designed for the quantitative measurement of high-density lipoprotein cholesterol levels in blood samples. This product is utilized in clinical settings for rapid testing and point-of-care applications, allowing for swift assessment of lipid profiles to aid in the diagnosis and management of cardiovascular conditions. The device operates through a simple procedure, enabling healthcare professionals to obtain results efficiently and effectively, contributing to timely decision-making in patient care. It is distinct from other similar testing products that measure different parameters related to blood chemistry, ensuring a focused approach to lipid analysis.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU107#005"/>
          <hierarchical_position>42010703</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV769#015" guid="0501c3c05d3d420fb418dd9b49b84f7b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Lactate (blood test strip)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a testing tool designed for the rapid and efficient measurement of lactate levels in biological samples, particularly blood. This device is essential in clinical settings for monitoring metabolic conditions and assessing patient status during various medical evaluations. It is characterized by its ease of use, portability, and quick result generation, making it ideal for point-of-care diagnostics. Unlike other testing tools that assess different substances or parameters, this specific testing tool focuses exclusively on lactate, providing healthcare professionals with critical information for patient management and treatment decisions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU107#005"/>
          <hierarchical_position>42010704</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV770#015" guid="2db6a1010a6d43ef93a290f979072af4">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Triglyceride (blood test strip)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a test device designed for the rapid determination of triglyceride levels in biological samples, specifically blood, utilizing a point-of-care approach. This device is engineered to provide quick and reliable results, facilitating immediate clinical decision-making. It operates through a chemical reaction that generates a measurable signal corresponding to triglyceride concentration. Typically used in various healthcare settings, it aids in monitoring lipid profiles and assessing cardiovascular risk among patients. The device is part of a broader category of diagnostic tools that offer convenience and efficiency in clinical chemistry testing, enabling healthcare professionals to perform tests on-site without the need for extensive laboratory infrastructure.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU107#005"/>
          <hierarchical_position>42010705</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV771#015" guid="667b5394dec842d19a53c66b9c2b02e2">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Urea (blood test strip)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification identifies a specific diagnostic tool designed for the quantitative measurement of urea levels in blood, utilized primarily in laboratory and clinical environments. It is part of a broader category of rapid testing devices intended for point-of-care applications, allowing for swift and reliable results. The device typically consists of a test strip that interacts with blood samples, providing healthcare professionals with critical information regarding a patient's metabolic state. This tool is essential for monitoring renal function and assessing nitrogen balance, contributing to the overall evaluation of a patient's health status. Its distinct functionality differentiates it from other blood test strips that measure various other biochemical parameters.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU107#005"/>
          <hierarchical_position>42010706</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV772#015" guid="9701ecbda7e3402db922488f64d4a715">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Ketone (blood test strip)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a ketone testing strip is a diagnostic tool designed for the quantitative measurement of ketone bodies in blood samples. It is primarily utilized in clinical settings for rapid assessment of metabolic states, particularly in conditions such as diabetes and ketogenic diets. The strip allows healthcare professionals to monitor patients' ketone levels efficiently, facilitating timely medical decisions. The test is performed using a small blood sample, with results typically available within minutes, making it suitable for point-of-care testing environments. This type of testing is crucial for identifying ketoacidosis and managing the treatment of patients with diabetes or other metabolic disorders.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU107#005"/>
          <hierarchical_position>42010707</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV773#015" guid="fc83ab792f954229ab56b55e220e5e95">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HbA1c (blood test strip)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a blood test strip designed for the measurement of glycated hemoglobin (HbA1c) levels in human blood. This diagnostic tool is utilized for monitoring long-term glucose control in individuals with diabetes and is typically employed in point-of-care settings, enabling rapid testing and immediate results. The strip functions by providing a quantitative assessment of HbA1c, which reflects average blood glucose levels over a period of time. This type of test is distinct from other blood test strips that measure different biochemical parameters, offering healthcare professionals critical information for the management and treatment of diabetes. The device is characterized by its ease of use, portability, and the ability to deliver results in a timely manner, facilitating informed clinical decision-making.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU107#005"/>
          <hierarchical_position>42010708</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV774#015" guid="3c06761a72df4751b1d3db359f4ba35d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Multiple parameters blood test</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic procedure designed to assess various biological markers in a single sample, allowing for the simultaneous evaluation of multiple health indicators. This test is typically performed at the point of care, providing rapid results that can guide clinical decision-making. It encompasses a range of parameters, including but not limited to enzymes, electrolytes, and metabolites, facilitating a comprehensive analysis of a patient's health status. The method emphasizes efficiency and accuracy, enabling healthcare professionals to quickly interpret results and initiate appropriate interventions based on the findings. This type of testing is essential in various clinical settings, particularly where timely diagnosis and treatment are critical.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU107#005"/>
          <hierarchical_position>42010709</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV775#015" guid="731ab5c8aa5840a9963bffb5098e71e2">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Calibrator and control (blood test strip)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses tools and materials specifically designed for the calibration and quality control of diagnostic tests in the context of clinical chemistry. These items are essential for ensuring the accuracy and reliability of blood testing procedures, particularly in point-of-care settings. They facilitate the validation of testing equipment and methodologies used for rapid analysis, allowing healthcare professionals to achieve precise measurements and results. The focus is on products that support the maintenance and verification of test performance, thereby enhancing the overall effectiveness of rapid diagnostic testing in various medical applications.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU107#005"/>
          <hierarchical_position>42010710</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV776#015" guid="857db2e3a64849f39def1b4e4674c7fd">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Urine single test strip (inclusive tablet)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic tool designed for the qualitative or quantitative analysis of urine samples, this item facilitates the rapid assessment of specific biochemical parameters. It typically consists of a plastic strip embedded with reactive pads that change color in response to the presence of certain substances in the urine, allowing for immediate interpretation of results. This device is commonly used in point-of-care settings, providing healthcare professionals with convenient access to essential information about a patient's health status. Its functionality may include the detection of various analytes, contributing to the evaluation of metabolic and kidney functions, among other health indicators. The inclusion of a tablet suggests additional functionality, potentially enhancing the accuracy or range of tests performed.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU107#005"/>
          <hierarchical_position>42010711</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV777#015" guid="d377ea174f434478b80f6182e6fcf8b0">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Urine multi-constituent test strip (manual)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a testing device designed for the qualitative or quantitative analysis of various substances present in urine, utilizing a manual procedure for the interpretation of results. This device incorporates multiple test pads that react with specific analytes, enabling healthcare professionals to assess a range of biochemical parameters in a single test. It serves as a diagnostic tool in clinical settings, allowing for rapid evaluation of patient health indicators and facilitating timely decision-making. The test strip is particularly valuable in point-of-care environments, where immediate results are essential for patient management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU107#005"/>
          <hierarchical_position>42010712</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV778#015" guid="e0c9a24b8caf4deca14ae93cca4a157a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Urine multi-constituent test strip (automated)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a testing device designed for the qualitative and quantitative analysis of various constituents found in urine. This instrument typically utilizes an automated process to provide rapid results, enhancing the efficiency of clinical diagnostics. By measuring multiple parameters simultaneously, it aids healthcare professionals in monitoring and diagnosing a range of conditions. Its operation is characterized by the integration of advanced technology that ensures accuracy and reliability, making it suitable for point-of-care testing environments. This type of test strip is distinguished from other testing methodologies that focus on specific analytes or utilize manual procedures.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU107#005"/>
          <hierarchical_position>42010713</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV779#015" guid="168a2bad363d44e6aadd15c6b54ece81">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Urine sediment test kit (manual)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses kits specifically designed for the manual examination of urine sediment. These kits typically include all necessary components for collecting, preparing, and analyzing urine samples to detect and identify various cellular and non-cellular elements within the sediment. The focus is on manual testing procedures, distinguishing them from automated alternatives. Such kits are integral in clinical settings for assessing kidney function, urinary tract conditions, and other health issues through microscopic analysis of urine samples. They serve as valuable tools in diagnostics, providing critical information for patient management and treatment decisions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU107#005"/>
          <hierarchical_position>42010714</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV780#015" guid="076e3f63e03048d78199152db81ecc7f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Urine sediment test kit (automated)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a testing kit designed for the automated analysis of urine sediment, which facilitates the examination of urine samples to identify and quantify various components. This kit is essential for clinical diagnostics, enabling healthcare professionals to quickly assess urinary health by detecting abnormalities in sediment that may indicate underlying medical conditions. The automated nature of the kit enhances efficiency and accuracy in the testing process, providing results that support timely clinical decision-making. It is distinguished from other testing kits that focus on different parameters or methodologies, particularly those that pertain to blood or manual urine testing approaches.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU107#005"/>
          <hierarchical_position>42010715</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV781#015" guid="5b7692032bbc4014b0f130dca2ebab2f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Urine testing calibrator and control</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance or solution specifically designed to ensure the accuracy and reliability of urine testing devices. This type of product is used in conjunction with testing systems to validate the performance of assays and calibrate equipment, ensuring that results are consistent and within acceptable ranges. These items play a crucial role in quality control processes, assisting healthcare professionals in monitoring and maintaining the integrity of diagnostic results derived from urine analysis. They facilitate effective management of patient care by providing trustworthy data for clinical decision-making.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU107#005"/>
          <hierarchical_position>42010716</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV782#015" guid="63e6196caa0b4a2eab96930d060b1314">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Faecal occult blood (CC)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic tool designed for the qualitative or quantitative detection of occult blood in fecal samples, aiding in the screening for gastrointestinal conditions. This testing method is typically utilized at the point of care, providing rapid results to assist healthcare professionals in clinical decision-making. It is distinguished by its specific focus on fecal samples, in contrast to other tests that may analyze blood or urine. The device or kit may utilize various technologies to achieve results, including immunochemical or chemical reactions, and is often employed in routine health screenings or diagnostic evaluations.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU107#005"/>
          <hierarchical_position>42010717</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV783#015" guid="6da0bf1318d4425d87b96141e94f8b46">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Albumin in stool (meconium)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a specific analytical test designed to detect the presence and concentration of albumin in stool samples, particularly in meconium. It is utilized in clinical settings for rapid diagnostic purposes, often at the point of care. This test is essential for assessing various health conditions, particularly those related to gastrointestinal function and potential abnormalities. The method employed is typically non-invasive and offers quick results, aiding healthcare professionals in making timely decisions regarding patient care. The classification distinguishes this test from other blood and urine testing methodologies that measure different biochemical parameters or utilize varying techniques in diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU107#005"/>
          <hierarchical_position>42010718</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV784#015" guid="0f4ac3b9a8b8465d889866e5caf8a214">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Carbon dioxide electrode (blood gas, CC, POC)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a device specifically designed to measure the concentration of carbon dioxide in biological samples, particularly in blood gas analysis settings. This instrument is utilized in point-of-care testing environments, providing rapid and accurate assessments essential for monitoring respiratory and metabolic function. It is integral to clinical chemistry applications, where the timely evaluation of carbon dioxide levels aids in diagnosing and managing various health conditions. This type of electrode is distinct in its function and application within the realm of rapid diagnostic tests, differing from other blood test strips and analytical devices that assess different biochemical parameters or substrates. The technology employed ensures efficient operation and reliable results, contributing to improved patient outcomes in critical care and emergency settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU107#005"/>
          <hierarchical_position>42010719</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV785#015" guid="8dcf93b052d247a491802e325bb62712">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">PH-electrode (blood gas, CC, POC)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses devices specifically designed for measuring pH levels in blood samples, particularly in point-of-care settings. These instruments are essential for rapid assessment of acid-base balance, aiding healthcare professionals in making timely decisions regarding patient treatment. They are utilized in various clinical environments, including emergency departments and laboratories, to facilitate quick and accurate monitoring of a patient's physiological status. The focus on point-of-care applications underscores their importance in delivering immediate diagnostic information, which is critical in acute care situations. These measurement tools are distinguished by their ability to provide precise pH readings, contributing to the broader field of clinical chemistry in rapid testing scenarios.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU107#005"/>
          <hierarchical_position>42010720</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV786#015" guid="124f1f6159f0419d990e55d2f7db62f5">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Oxygen-electrode (blood gas, CC, POC)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a device designed for the measurement of oxygen levels in blood samples, specifically utilized in clinical settings that require rapid and precise assessments. This tool is integral to point-of-care diagnostics, enabling healthcare professionals to evaluate respiratory function and metabolic status swiftly. It operates by utilizing an electrode system that responds to the presence of oxygen in the blood, providing real-time data critical for patient management. This classification encompasses various electrodes focused on blood gas analysis, distinguishing it from other testing methods that assess different biochemical parameters or utilize alternative techniques for sample evaluation.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU107#005"/>
          <hierarchical_position>42010721</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV787#015" guid="9990f383a04e4496b18b56cf568435d6">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">PH, pO2, pCO2-electrode (blood gas, CC, POC)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses devices specifically designed to measure and analyze the levels of pH, partial pressure of oxygen (pO2), and partial pressure of carbon dioxide (pCO2) in biological fluids, particularly in a clinical or point-of-care setting. These instruments are essential for rapid diagnostics in medical environments, providing critical information for the assessment of respiratory function and metabolic status. The technology employed in these devices allows for real-time monitoring and evaluation, supporting healthcare professionals in making timely decisions regarding patient care. This category is distinguished from other blood analysis tools that focus on different parameters, ensuring clarity in the classification of diagnostic equipment used for specific biochemical assessments.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU107#005"/>
          <hierarchical_position>42010722</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV788#015" guid="fae9d12d88fd45cb86442049431f5809">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Blood gas and/or ISE and/or metabolites (electrode, CC, POC)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic tools designed for the rapid assessment of blood gas levels and various metabolites through electrode technology. These instruments enable healthcare professionals to conduct point-of-care testing, facilitating immediate results that support clinical decision-making. The category is distinguished by its focus on measuring specific biochemical parameters in blood samples, utilizing advanced sensors and analytical techniques. It serves as a critical component in the evaluation of respiratory and metabolic conditions, providing insights into a patient's physiological status. The offerings within this classification may include devices capable of analyzing multiple analytes simultaneously, enhancing the efficiency and accuracy of point-of-care diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU107#005"/>
          <hierarchical_position>42010723</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV789#015" guid="995faf35b6bf43708fe84f5b975ce20d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Blood gas buffer and solution (CC, POC)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a solution designed specifically for the analysis and stabilization of blood gas parameters, this category encompasses various buffers and solutions utilized in point-of-care testing environments. These products facilitate the accurate measurement of critical blood gas levels, ensuring reliable diagnostic results. They are essential for the maintenance of pH balance and ionic composition in blood samples, enabling healthcare professionals to monitor patients' respiratory and metabolic functions efficiently. The solutions are often used in conjunction with specific analytical instruments or test systems that assess blood gas concentrations, thereby playing a vital role in rapid clinical diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU107#005"/>
          <hierarchical_position>42010724</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV790#015" guid="d8e0b8f723c14388a9737ec38c27a319">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Blood gas calibrator and control (CC, POC)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses products designed specifically for the calibration and quality control of blood gas analysis systems used in clinical settings, particularly those focused on point-of-care testing. These items ensure the accuracy and reliability of measurements related to various blood gas parameters, facilitating timely diagnostics and patient management. They may include solutions or materials that are utilized to verify the performance of analytical devices, ensuring they produce valid results during testing. Their role is critical in maintaining the integrity of testing processes, enabling healthcare providers to make informed decisions based on precise data. These products are distinct from other types of diagnostic tests, emphasizing their specialized function within clinical chemistry applications.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU107#005"/>
          <hierarchical_position>42010725</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV791#015" guid="fe90bcd2972b460dbd097a06c78c24c4">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Multiple enzymes and/or substrate and/or electrolyte (multiple parameters, POC)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a collection of biological substances that facilitate biochemical reactions, assist in the transformation of substrates, and contribute to the maintenance of electrochemical balance within a clinical testing context. This category encompasses products designed for rapid assessment of multiple parameters in point-of-care environments, providing healthcare professionals with essential information to support diagnostic decision-making. These offerings are distinguished by their ability to evaluate various biochemical constituents simultaneously, thus enabling a comprehensive analysis of physiological conditions. The focus is on versatility and efficiency in testing, ensuring that results are delivered quickly to facilitate timely medical intervention.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU107#005"/>
          <hierarchical_position>42010726</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV792#015" guid="9800bab1fe254a28b894ac5b5d5e6766">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Calibrator and control (multiple parameters, POC)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a device designed to ensure the accuracy and reliability of diagnostic tests by providing reference points for measurement. It is utilized in various clinical settings to validate the performance of testing equipment that analyzes multiple parameters simultaneously. This type of instrument is essential for maintaining quality control in point-of-care testing environments, where rapid and precise results are critical for patient care. It typically includes solutions or materials that mimic biological samples, enabling healthcare professionals to confirm that their devices are functioning correctly and yielding valid test results.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU107#005"/>
          <hierarchical_position>42010727</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV793#015" guid="e737ec1e15494fcaa73ac0319733969b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Clinical chemistry (rapid test, point of care, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU107#005"/>
          <hierarchical_position>42010790</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU113#006" guid="e010877bbddd4dffb5a32990e9f75487">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Fertility, pregnancy hormone and protein</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses substances that play a crucial role in fertility and pregnancy, specifically hormones and proteins that are significant in reproductive health and associated physiological processes. These compounds are involved in the regulation of various reproductive functions, including ovulation, implantation, and fetal development. The items classified within this category are utilized primarily for diagnostic purposes in immunochemistry, aiding in the assessment of reproductive health and monitoring of pregnancy progress. Key hormones and proteins included in this classification are essential for evaluating hormonal balance and pregnancy-related conditions, providing critical information for healthcare professionals in managing fertility and pregnancy-related issues.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS274#006"/>
          <hierarchical_position>42020500</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU154#005" guid="dfe9c80072d44755b4a27b7152770318">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Inborn gene or chromosome alteration</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses inherited genetic variations and chromosomal abnormalities, which are identifiable through diagnostic testing methods. It focuses on conditions resulting from single-gene mutations, polygenic influences, and specific chromosomal anomalies. The aim is to facilitate the identification and understanding of hereditary disorders that can significantly impact health and development. This category distinguishes between various forms of genetic alterations, such as those that are present from birth as opposed to those acquired later in life. It includes tests for both monogenic conditions, which arise from mutations in a single gene, and polygenic conditions, which involve multiple genes. Additionally, it covers chromosomal disorders resulting from structural or numerical changes in chromosomes. Overall, this classification plays a crucial role in advancing personalized medicine and targeted therapeutic strategies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS278#005"/>
          <hierarchical_position>42060100</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW907#015" guid="e8eaf99518ca4a13a6e0293ce5e9a31a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cystic fibrosis (monogenetic, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to the analysis and identification of a specific hereditary condition characterized by a mutation in a single gene, which affects the function of the respiratory, digestive, and reproductive systems. This medical testing method is utilized to detect the presence of genetic variations that lead to this condition, enabling diagnosis and management. The classification differentiates this condition from other hereditary disorders that result from distinct genetic alterations, each with unique clinical manifestations and implications for patient care. This classification assists healthcare professionals in understanding the genetic basis of the condition and guiding appropriate therapeutic and management strategies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU154#005"/>
          <hierarchical_position>42060101</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW908#015" guid="48a94113e44e434c973c39b7e499fa66">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Duchenne muscular dystrophy (monogenetic, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification identifies a specific hereditary condition characterized by progressive muscle degeneration and weakness, primarily affecting skeletal muscles. It results from mutations in a particular gene responsible for producing a protein crucial for muscle function. The condition is inherited in an X-linked recessive manner, meaning it predominantly affects males, while females may be carriers and exhibit milder symptoms. Clinical manifestations typically emerge in early childhood, leading to significant mobility challenges and requiring ongoing medical management. Diagnosis is often confirmed through genetic testing, which can identify the specific mutation responsible for the disorder. This classification distinguishes it from other genetic conditions that may involve different genes, inheritance patterns, and clinical presentations.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU154#005"/>
          <hierarchical_position>42060102</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW909#015" guid="b5edb96a89cf4603b07256dd91d582b1">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Factor V Leiden (monogenetic, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a hereditary condition characterized by a specific genetic mutation in the Factor V gene, which can lead to an increased risk of thrombosis and associated complications. This condition is classified as a monogenic disorder and is typically diagnosed through in vitro diagnostic methods. It is distinct from other hereditary disorders that involve mutations in genes related to various inborn errors of metabolism or structural anomalies. This classification focuses on conditions that arise from single gene alterations, differentiating them from more complex genetic disorders that may involve multiple genes or chromosomal abnormalities.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU154#005"/>
          <hierarchical_position>42060103</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW910#015" guid="1591bc88e732491985d210e99a2709ac">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Fragile X Syndrome (monogenetic, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a condition characterized by a specific genetic mutation that leads to a range of developmental and cognitive challenges. This genetic disorder is inherited in an autosomal manner and can manifest with various symptoms affecting communication, behavior, and learning abilities. It is commonly diagnosed through genetic testing and is categorized within the broader spectrum of inherited genetic conditions. The classification is distinguished from other genetic disorders by its unique genetic etiology and clinical presentation, necessitating specialized diagnostic and therapeutic approaches. Understanding this condition involves a comprehensive evaluation of genetic, clinical, and familial factors, and it plays a critical role in the field of medical diagnostics and genetic counseling.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU154#005"/>
          <hierarchical_position>42060104</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW911#015" guid="239577bdd2254b179869cafb23920613">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Haemochromatosis (monogenetic, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a hereditary condition characterized by excessive iron accumulation in the body due to genetic mutations, leading to potential organ damage and various health complications. This condition is typically identified through diagnostic testing and is classified under genetic disorders that arise from alterations at a single gene level. It is distinct from other genetic conditions that may present with different symptoms or underlying genetic causes. Management of this condition often involves monitoring iron levels and implementing therapeutic strategies to reduce iron overload, thereby preventing associated health risks.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU154#005"/>
          <hierarchical_position>42060105</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW912#015" guid="85413491dcdd45029f7c51a8325c7243">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Haemophilia (monogenetic, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a hereditary condition characterized by a deficiency or dysfunction in a specific clotting factor, which is critical for normal blood coagulation. The condition is identified through genetic testing techniques that assess the presence of mutations or alterations in genes responsible for the synthesis of clotting factors. Diagnosis and monitoring typically involve in vitro diagnostic methods, allowing for the identification of the genetic basis of the disorder. This classification is distinct in its focus on monogenic disorders linked to blood clotting anomalies, setting it apart from other genetic conditions that may involve multiple genes or chromosomal abnormalities. The classification serves to facilitate the understanding and management of this specific hereditary condition within the broader context of genetic disorders.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU154#005"/>
          <hierarchical_position>42060106</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW913#015" guid="3bdaf68e38c54abc9913613ac1a9de44">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Huntington Chorea (monogenetic, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to hereditary disorders caused by specific alterations in genes or chromosomes. It encompasses conditions that arise from single-gene mutations, leading to distinctive clinical features and varying degrees of severity. Such disorders are typically inherited in a Mendelian manner, and their diagnosis often involves genetic testing. The classification distinguishes these conditions based on the underlying genetic mechanisms and their clinical manifestations. This includes various monogenic disorders characterized by specific genetic changes that result in a range of symptoms affecting different bodily systems. Each disorder within this category presents unique challenges for diagnosis and management, reflecting the complexity of genetic influences on health.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU154#005"/>
          <hierarchical_position>42060107</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW914#015" guid="1132bb95fc484801976e156c19166534">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Polycystic kidney disease (monogenetic, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a hereditary condition characterized by the formation of multiple cysts within the kidneys, resulting from specific genetic mutations. It is recognized as a monogenic disorder, meaning it is primarily caused by alterations in a single gene. The condition can lead to various complications, including kidney dysfunction and associated health issues. Diagnosis often involves genetic testing and imaging studies to assess cyst formation. Management of the disease typically requires a multidisciplinary approach, including regular monitoring of kidney function and potential interventions to address complications arising from the condition. This classification distinguishes it from other hereditary disorders with different genetic underpinnings and clinical manifestations.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU154#005"/>
          <hierarchical_position>42060108</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW915#015" guid="04bcee2144e848c0b92647bca1fcc096">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Sickle cell anemia (monogenetic, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a hereditary condition characterized by the presence of abnormal hemoglobin in red blood cells, leading to various clinical manifestations, including pain episodes and increased risk of infections. This disorder results from mutations in the gene responsible for hemoglobin production and is typically inherited in an autosomal recessive manner. Diagnostic methods involve the use of in vitro diagnostic tools to identify specific genetic mutations or the resultant abnormal hemoglobin types. Management often includes supportive care, preventative measures against complications, and in some cases, disease-modifying therapies. This classification encompasses conditions specifically related to single-gene mutations affecting blood composition and function.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU154#005"/>
          <hierarchical_position>42060109</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW916#015" guid="eecf2992de974b3f82c34c1c9ac90d82">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Tay Sachs disease (monogenetic, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses genetic disorders characterized by mutations in a single gene that lead to specific clinical manifestations. These conditions are typically inherited in a Mendelian manner and can result in various physiological abnormalities, often detectable through specific diagnostic testing. The classification includes conditions where early detection and intervention may significantly impact management and outcomes. It serves as a reference for healthcare professionals in identifying, diagnosing, and treating patients affected by these genetic disorders. The focus is on understanding the underlying genetic mechanisms, implications for family members, and available therapeutic options tailored to the unique needs of affected individuals.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU154#005"/>
          <hierarchical_position>42060110</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW917#015" guid="ad04d73301874d1aa0a0dea612500b71">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Thalassaemia (monogenetic, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses hereditary blood disorders characterized by a specific genetic mutation that affects hemoglobin production, leading to various health complications. These conditions are typically inherited in an autosomal recessive manner and are diagnosed through specific laboratory tests designed to detect the underlying genetic alterations. Patients may experience symptoms such as anemia, fatigue, and other organ-related issues due to the impaired function of red blood cells. The classification serves to facilitate the identification, research, and development of diagnostic and therapeutic interventions for individuals affected by these genetic disorders.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU154#005"/>
          <hierarchical_position>42060111</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW918#015" guid="a1355a97e8d64486827a31f0e6d05c2f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Friedreich's ataxia (monogenetic, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a hereditary neurological condition characterized by progressive degeneration of the spinal cord and peripheral nerves, resulting in a decline in movement coordination and balance. This condition arises from mutations in specific genes, leading to a range of motor function impairments. Individuals affected by this disorder may experience symptoms such as gait disturbances, muscle weakness, and sensory abnormalities. Diagnosis typically involves genetic testing, clinical evaluation, and imaging studies to assess the extent of neurological involvement. Management focuses on symptomatic relief and supportive therapies to enhance quality of life. This classification encompasses conditions originating from single genetic alterations impacting motor functions and coordination without involving complex genetic interactions found in other hereditary or chromosomal disorders.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU154#005"/>
          <hierarchical_position>42060112</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW919#015" guid="ad307c0796964406b50e33ccb553bf0c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Spinocerebellar ataxins type 1,2,3,6,7,8 (monogenetic, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a category of genetic disorders characterized by specific mutations in the ataxin genes that lead to progressive degeneration of the cerebellum and spinal cord. These conditions are inherited in an autosomal dominant or recessive manner and primarily affect motor coordination, balance, and gait. The disorders within this classification share a common etiology linked to alterations in gene sequences that encode for proteins involved in neuronal function. Diagnosis typically involves genetic testing and clinical evaluation, with implications for family planning and potential therapeutic interventions. This classification is distinct from other inherited disorders that result from different genetic alterations impacting various physiological systems.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU154#005"/>
          <hierarchical_position>42060113</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW920#015" guid="08a8d1622a534127a7f3c456c9f3189b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Prothrombin mutation (monogenetic, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to genetic variations that are inherited in a monogenic manner, specifically focusing on a mutation affecting prothrombin, a key protein involved in blood clotting. The presence of this mutation can lead to alterations in prothrombin levels, which may predispose individuals to thrombotic events. It is identified through in vitro diagnostic methods that detect specific genetic alterations. This classification is distinct from other inherited genetic conditions that affect various bodily functions or systems, and it serves to categorize the unique characteristics and implications of prothrombin mutation within the broader context of genetic and chromosomal alterations.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU154#005"/>
          <hierarchical_position>42060114</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW921#015" guid="612669ebf4034789903ff9e51c2bbc0c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Alzheimer's disease (polygenetic, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a condition characterized by a progressive decline in cognitive function and memory, influenced by multiple genetic factors rather than a single gene mutation. This disorder is typically diagnosed through a combination of clinical assessments and specialized tests, including those that evaluate genetic predispositions. It manifests with symptoms such as memory loss, difficulty in communication, and changes in behavior. The condition's complexity arises from the interplay of various genetic and environmental influences, making its progression highly individualistic. Diagnostic methods often include in vitro diagnostics, which can assist in identifying specific biomarkers associated with the condition. This classification delineates it from other genetic disorders, particularly those resulting from single-gene alterations, emphasizing its polygenic nature and the broader spectrum of genetic contributions involved.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU154#005"/>
          <hierarchical_position>42060115</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW922#015" guid="361311e8f20643a38948aa44f5e28093">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Asthma (polygenetic, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a hereditary condition characterized by inflammation and narrowing of the airways, resulting in difficulty breathing, wheezing, and coughing. This condition arises from a complex interplay of multiple genetic factors, rather than a single gene mutation. It is often influenced by environmental triggers, such as allergens, irritants, and respiratory infections. The genetic predisposition may involve variations in several genes that contribute to immune response and airway function. Management typically includes medication to control symptoms, lifestyle modifications, and avoidance of known triggers. This classification encompasses various forms and severities of the condition, reflecting its multifactorial nature.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU154#005"/>
          <hierarchical_position>42060116</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW923#015" guid="e542ac2300384288876c522f7c17b26f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Atherosclerosis (polygenetic, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">atherosclerosis refers to a complex condition characterized by the buildup of fats, cholesterol, and other substances in and on the artery walls, leading to narrowed and hardened arteries. This polygenic disorder involves multiple genetic factors that contribute to its development and progression, affecting cardiovascular health. The classification distinguishes this condition from other genetic disorders that are caused by single gene mutations, as well as from various polygenic and chromosomal alterations. It emphasizes the multifactorial nature of the condition, highlighting the interplay between genetic predispositions and environmental influences in the pathogenesis of atherosclerosis. This classification aids in understanding the genetic underpinnings and potential therapeutic approaches for managing the disease.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU154#005"/>
          <hierarchical_position>42060117</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW924#015" guid="61ce7005574f40d2899358b62b611eb7">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Diabetes (polygenetic, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses conditions characterized by alterations in genetic factors that influence the development of diabetes. These conditions arise from complex interactions among multiple genes, which may contribute to the predisposition or manifestation of the disease. This classification distinguishes itself by focusing on polygenic influences, as opposed to single-gene mutations commonly associated with other genetic disorders. The classification serves to facilitate the identification, analysis, and understanding of the genetic underpinnings and hereditary patterns related to diabetes, providing a framework for research and clinical applications in the field of genetic diagnostics and personalized medicine.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU154#005"/>
          <hierarchical_position>42060118</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW925#015" guid="3d695b69240a4fd88a11271aee1542ac">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hypertension (polygenetic, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">hypertension, characterized by increased blood pressure, is a complex condition influenced by multiple genetic factors. This classification encompasses variations in genes that contribute to the regulation of cardiovascular function and blood pressure homeostasis. The condition is distinguished by its polygenic nature, indicating that multiple genes interact with environmental factors to influence its development. This classification is differentiated from other hereditary conditions that arise from single gene mutations. Hypertension can manifest in various forms and may lead to significant health complications if not managed effectively. It is crucial to understand the genetic predisposition and environmental interactions in individuals affected by this condition to facilitate targeted prevention and treatment strategies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU154#005"/>
          <hierarchical_position>42060119</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW926#015" guid="5b0e543f245b49f6aa4063a797d0fd27">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Multiple sclerosis (polygenetic, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a condition characterized by the progressive degeneration of the central nervous system, primarily affecting the myelin sheath of nerve fibers. This disorder is influenced by multiple genetic factors, which contribute to its onset and progression. The condition manifests through a variety of symptoms that can include muscle weakness, coordination difficulties, sensory disturbances, and cognitive changes. The complexity of this condition arises from the interplay of various genes, environmental factors, and immune responses, making it distinct from other hereditary disorders that are caused by single gene mutations. Diagnostic methods often involve a combination of clinical evaluations and specialized tests to assess neurological function and identify specific biomarkers associated with the condition.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU154#005"/>
          <hierarchical_position>42060120</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW927#015" guid="992c4e0286a24e209777acbfdec5efc7">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Osteoporosis (polygenetic, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses conditions resulting from complex interactions among multiple genetic factors, leading to a predisposition for decreased bone density and increased fracture risk. It involves variations in several genes that together influence bone metabolism, density, and overall skeletal health. The conditions categorized here can manifest with varying degrees of severity and may present unique clinical challenges. A thorough understanding of the genetic underpinnings is essential for effective diagnosis, management, and potential therapeutic interventions. This classification is distinct from those related to single-gene disorders or chromosomal abnormalities, which have more straightforward inheritance patterns and clinical presentations. The focus of this classification is on the multifactorial nature of the condition, emphasizing the role of genetics in the development of osteoporosis.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU154#005"/>
          <hierarchical_position>42060121</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW928#015" guid="8ae843d3dd7547aaa5300e3e57a7973b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Down's syndrome (chromosomal, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific condition resulting from chromosomal abnormalities that affect an individual's development and health. It is characterized by a distinct set of physical and intellectual features, which arise from the presence of an extra chromosome. The condition impacts various bodily systems and can lead to a range of developmental challenges. This classification is distinct from other conditions caused by single-gene mutations or other genetic variations. The focus is on the chromosomal nature of the alteration, distinguishing it from disorders linked to monogenic or polygenic influences. Understanding this condition is crucial for diagnosis, treatment planning, and support for affected individuals and their families.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU154#005"/>
          <hierarchical_position>42060122</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW929#015" guid="65bd17078cc94f02a80d893b2ee52c96">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Edwards syndrome (chromosomal, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a classification pertaining to a specific chromosomal anomaly characterized by the presence of an additional chromosome 18, which leads to a spectrum of developmental and physical challenges. This condition is associated with a range of clinical features, including intellectual disability, distinct facial characteristics, and various organ system malformations. The classification encompasses medical and diagnostic aspects relevant to this chromosomal alteration, distinguishing it from other genetic conditions that arise from single gene mutations or other chromosomal abnormalities. It is primarily utilized in the context of genetic testing, diagnosis, and management of affected individuals.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU154#005"/>
          <hierarchical_position>42060123</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW930#015" guid="10368ac960c144339dcc8129e709e63a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Klinefelter syndrome (chromosomal, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a specific chromosomal condition characterized by the presence of an extra X chromosome in males, leading to a range of physical, developmental, and reproductive challenges. The condition may present with features such as reduced testosterone levels, breast development, and infertility, along with potential cognitive and behavioral issues. The classification encompasses various diagnostic and management aspects relevant to healthcare and genetic counseling. It is distinct from other genetic disorders that arise from single-gene mutations or different chromosomal abnormalities, emphasizing the multifaceted nature of chromosomal variations and their implications for affected individuals.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU154#005"/>
          <hierarchical_position>42060124</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW931#015" guid="942b0904c1e2405a8ad1d9031fd32523">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Pätau syndrome (chromosomal, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses genetic conditions resulting from alterations in chromosomes, which can lead to various health issues. It includes disorders that arise due to the presence of atypical chromosomal structures or numbers, impacting an individual's development and physiological functions. These conditions are characterized by their hereditary nature, often manifesting in early life and potentially leading to a spectrum of clinical symptoms. The classification differentiates these chromosomal alterations from monogenetic and polygenetic disorders, focusing specifically on those that are attributed to chromosomal anomalies. This encompasses a range of syndromes that may affect various bodily systems and require specialized diagnostic and therapeutic approaches.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU154#005"/>
          <hierarchical_position>42060125</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW932#015" guid="61ecbf434eb54559a0d17b94c358ab47">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Turner syndrome (chromosomal, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">turner syndrome is a genetic condition resulting from the complete or partial absence of one of the two X chromosomes in females. It is characterized by a variety of physical and developmental features, which may include short stature, ovarian dysfunction, and specific physical anomalies. This condition is classified as a chromosomal alteration, distinguishing it from other genetic disorders that are primarily caused by single-gene mutations. Individuals with Turner syndrome may require multidisciplinary medical management to address the various health challenges associated with the condition, including growth hormone therapy and hormone replacement therapy. The syndrome exemplifies the complexity of chromosomal abnormalities and their impact on human development and health.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU154#005"/>
          <hierarchical_position>42060126</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW933#015" guid="afd462e322294c75bce6aa164c8f2d8a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HLA-Typing (polymorphism)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to genetic testing methods that analyze variations in genes or chromosomes, focusing specifically on the identification of specific polymorphisms associated with inherited conditions. The aim is to provide insights into genetic predispositions, enabling better understanding, diagnosis, and management of genetic disorders. This category encompasses techniques that differentiate between normal and variant genetic sequences, assessing the implications of these variations on health and disease. It is distinct from other classifications that involve single-gene disorders or broader polygenic traits, focusing instead on the nuanced variations within genetic material that may influence an individual's risk for specific conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU154#005"/>
          <hierarchical_position>42060127</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW934#015" guid="f7ed2bfd761d4880a54b767b54add8c8">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Inborn gene or chromosome alteration (unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU154#005"/>
          <hierarchical_position>42060190</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADX042#015" guid="f5a811eb2b744ee3b5327c5f8ac93d3f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Tube with EDTA (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a container specifically designed for the collection, preservation, and transportation of blood, plasma, or serum samples. This type of container is infused with EDTA, a common anticoagulant that prevents blood clotting, making it suitable for in vitro diagnostic applications. It ensures the integrity of the sample by inhibiting coagulation, allowing for accurate testing and analysis. Typically utilized in laboratory settings, this container facilitates various diagnostic procedures and is critical for ensuring reliable results in medical testing and research. The design prioritizes compatibility with standard laboratory practices, ensuring ease of use and effective sample handling.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU169#005"/>
          <hierarchical_position>42090102</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADX043#015" guid="e975309b8c754495bca32503ba611ff4">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Tube with heparin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a transparent or translucent cylindrical vessel designed for the collection, transportation, and storage of blood, plasma, or serum samples, specifically containing heparin as an anticoagulant. This type of container is utilized in in vitro diagnostic applications to prevent clotting during the sample's processing and analysis. The design and material of the container ensure compatibility with various laboratory procedures while maintaining the integrity of the biological sample. The heparinized tube is distinct from other types of tubes that may contain different anticoagulants or no anticoagulant at all, catering to specific testing requirements and enhancing the reliability of diagnostic results.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU169#005"/>
          <hierarchical_position>42090103</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADX044#015" guid="84e10670c6c145f6af41245461c8949f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Tube with citrate (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a tubular container designed specifically for the collection and transportation of biological samples, particularly in the context of in vitro diagnostics. This container is treated or modified with citrate, a substance that acts as an anticoagulant, preventing blood from clotting during the sample preservation period. It is utilized in various medical and laboratory settings to ensure the integrity of samples for subsequent analysis, allowing for accurate diagnostic results. This type of container is distinct from others that may use different anticoagulants or are intended for specific types of samples, ensuring appropriate handling and processing of biological materials.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU169#005"/>
          <hierarchical_position>42090104</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADX045#015" guid="4bc789bc3b68437bb42beeb0968ab51a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Tube with dedicated anticoagulants (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specialized container designed for the collection, storage, and transportation of blood samples, which includes specific anticoagulants to prevent coagulation during analysis. This type of vessel is utilized in in vitro diagnostic procedures, ensuring that the integrity of the sample is maintained for accurate testing. It is distinct from other similar containers that may contain different anticoagulants or none at all, thereby catering to various testing requirements in medical and laboratory settings. The design and formulation of this container support optimal sample processing and analysis, contributing to reliable diagnostic results.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU169#005"/>
          <hierarchical_position>42090105</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADX046#015" guid="7f0be08b59064495868e742efd6660fb">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Container for blood, plasma, and serum sample (IVD, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU169#005"/>
          <hierarchical_position>42090190</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-AFU678#011" guid="6b0c28b4a60c4505a4d284a71ac57c91">
          <date_of_original_definition>2014-11-30Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Container for blood, plasma, and serum sample (IVD, parts)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects with spare part characteristics that maintain or re-store the original condition of the objects classified under the parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU169#005"/>
          <hierarchical_position>42090191</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-AFU860#011" guid="f7e8e306a2b24c90a787c7645f19aae4">
          <date_of_original_definition>2014-11-30Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Container for blood, plasma, and serum sample (IVD, accessories)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects with complemental characteristics, without which the basic function of the objects classified under the parent-class on the 3rd level is still guaranteed</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU169#005"/>
          <hierarchical_position>42090192</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU170#005" guid="29c157c6be8844708556f88f9d515b58">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Container for urine sample (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses receptacles specifically designed for the collection, storage, and transportation of urine samples, primarily used in in vitro diagnostics. These containers are engineered to maintain the integrity of the samples, ensuring that they remain uncontaminated and suitable for analysis. The classification distinguishes between containers that are sterile and non-sterile, catering to various testing requirements. The design and materials used in these containers are tailored to support safe handling and accurate sampling, facilitating reliable testing outcomes in medical and laboratory settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS281#005"/>
          <hierarchical_position>42090200</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADX047#015" guid="eaaa64f7c7f54294b6c71690c045f58f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Non sterile urine containers (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a type of container specifically designed for the collection and transportation of urine samples in in vitro diagnostics, characterized by the absence of sterility. These containers are utilized in various medical and laboratory settings to facilitate urine testing, ensuring that the samples can be safely handled and analyzed without contamination from external sources. They are typically constructed from materials that are resistant to chemical interactions with urine, allowing for accurate test results. Non-sterile urine containers are essential for routine urine analysis and can be used for a range of diagnostic purposes, providing healthcare professionals with a reliable method to obtain and store urine samples prior to laboratory examination.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU170#005"/>
          <hierarchical_position>42090201</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADX048#015" guid="a22b2b45d8c744fab4fdaa1136346e19">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Sterile urine containers (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a type of container specifically designed for the collection, storage, and transportation of urine samples in a sterile manner. These containers are utilized in in vitro diagnostic processes to ensure the integrity and contamination-free status of the specimen. They are engineered to meet stringent hygiene standards, often featuring sealed packaging and materials that prevent microbial growth. Their use is crucial in medical testing and analysis, where the accuracy of results depends on the absence of contaminants. This category is distinct from other containers that do not maintain sterile conditions, ensuring higher reliability in diagnostic outcomes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU170#005"/>
          <hierarchical_position>42090202</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADX049#015" guid="72769d9cf832420ca8281008a6e3acd9">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Container for urine sample (IVD, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU170#005"/>
          <hierarchical_position>42090290</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-AFU679#011" guid="7515f9e9da104e5e81e3523840990871">
          <date_of_original_definition>2014-11-30Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Container for urine sample (IVD, parts)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects with spare part characteristics that maintain or re-store the original condition of the objects classified under the parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU170#005"/>
          <hierarchical_position>42090291</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-AFU861#011" guid="b9b9a7f412ce468596ebd3304103f947">
          <date_of_original_definition>2014-11-30Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Container for urine sample (IVD, accessories)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects with complemental characteristics, without which the basic function of the objects classified under the parent-class on the 3rd level is still guaranteed</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU170#005"/>
          <hierarchical_position>42090292</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU171#005" guid="9286b035dece450494be8089456df480">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Sterile container for sample (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a type of receptacle specifically designed to hold and preserve samples for in vitro diagnostics while ensuring sterility. This container is engineered to minimize contamination risks during the handling, transport, and storage of samples that may be subject to biological hazards. It is distinct from other types of sample containers tailored for specific biological fluids or sample types. This classification encompasses containers that maintain aseptic conditions necessary for accurate testing and analysis, ensuring the integrity and safety of potentially contaminated samples. The design and materials used in these containers are intended to support laboratory protocols and regulatory requirements for handling hazardous biological materials.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS281#005"/>
          <hierarchical_position>42090300</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADX050#015" guid="a4885064bc244acbba4777f0f91b8af8">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Sterile container for potentially contaminated sample (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specialized container designed to securely hold and transport samples that may be contaminated, particularly in the context of in vitro diagnostics (IVD). This type of container ensures the integrity and safety of the samples during handling and analysis, minimizing the risk of contamination or exposure. It typically features sterilization processes and materials that prevent microbial growth while providing an airtight seal and appropriate labeling for biohazard identification. This classification emphasizes the necessity for stringent safety measures in the management of potentially hazardous biological materials, adhering to regulatory standards and best practices in laboratory environments.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU171#005"/>
          <hierarchical_position>42090301</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADX051#015" guid="4d0c94fab86145489ef5abbf69959a31">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Sterile container for sample (IVD, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU171#005"/>
          <hierarchical_position>42090390</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-AFU680#011" guid="b8a55adb63254df99bb900b017d66840">
          <date_of_original_definition>2014-11-30Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Sterile container for sample (IVD, parts)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects with spare part characteristics that maintain or re-store the original condition of the objects classified under the parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU171#005"/>
          <hierarchical_position>42090391</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-AFU862#011" guid="fa5b5b6e655644ffb2a26b6601b5a1e4">
          <date_of_original_definition>2014-11-30Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Sterile container for sample (IVD, accessories)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects with complemental characteristics, without which the basic function of the objects classified under the parent-class on the 3rd level is still guaranteed</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU171#005"/>
          <hierarchical_position>42090392</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU172#005" guid="44aa22624c854f1991b6ac1d15dd4a74">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Container for sample of human origin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific category that encompasses various types of receptacles designed for the secure collection, transport, and storage of biological samples derived from humans for in vitro diagnostic purposes. These containers are essential for maintaining the integrity and viability of human samples during handling and analysis. They are distinct from other categories that focus on specialized containers for specific types of biological fluids. The design and materials used in these receptacles ensure compatibility with laboratory processes and compliance with health and safety standards. This category plays a crucial role in the diagnostic workflow, facilitating accurate testing and analysis while minimizing contamination and sample degradation.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS281#005"/>
          <hierarchical_position>42090400</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADX052#015" guid="915b15505f454345a66fcd26a4b55224">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Container for sample of human origin (IVD, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU172#005"/>
          <hierarchical_position>42090490</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-AFU681#011" guid="d91b694b261943c6a03ad233f679d4f1">
          <date_of_original_definition>2014-11-30Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Container for sample of human origin (IVD, parts)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects with spare part characteristics that maintain or re-store the original condition of the objects classified under the parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU172#005"/>
          <hierarchical_position>42090491</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-AFU863#011" guid="0dbdc1b334d647749a35dedf152c3f55">
          <date_of_original_definition>2014-11-30Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Container for sample of human origin (IVD, accessories)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects with complemental characteristics, without which the basic function of the objects classified under the parent-class on the 3rd level is still guaranteed</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU172#005"/>
          <hierarchical_position>42090492</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU173#007" guid="0b28d18b213544dd8afb689a7fae5353">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Dedicated sample container (IVD, other)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Group (3rd level) for objects that cannot be classified into other specified groups in the existing structure, but that are classified to their parent-class on the 2nd level. A xx-xx-90-00-class cannot have any other sub-groups besides the generic xx-xx-90-90-class (…(Other, unspecified)) to be generally valid within the parent class on the 2nd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADS281#005"/>
          <hierarchical_position>42099000</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADX054#015" guid="b5434f2e92ed41e287ec8cbb89cfd556">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Dedicated sample container (IVD, other, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU173#007"/>
          <hierarchical_position>42099090</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU142#007" guid="2c7efdd87fe34c378662a802b476bf1c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Microbiology (IVD, other)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Group (3rd level) for objects that cannot be classified into other specified groups in the existing structure, but that are classified to their parent-class on the 2nd level. A xx-xx-90-00-class cannot have any other sub-groups besides the generic xx-xx-90-90-class (…(Other, unspecified)) to be generally valid within the parent class on the 2nd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADS276#005"/>
          <hierarchical_position>42049000</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV923#015" guid="3a0fa49a275f4418a3f378913ee36f9a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Androstenedione (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a naturally occurring steroid hormone, androstenedione plays a pivotal role in the biosynthesis of androgens and estrogens. It is primarily produced in the adrenal glands and gonads, and serves as a precursor for testosterone and estrone. This substance is significant in various physiological processes, including the regulation of reproductive functions and overall hormonal balance. In clinical settings, measurements of this hormone can assist in the assessment of disorders related to fertility, hormonal imbalances, and various endocrine conditions. Its specific classification within the broader category of fertility and pregnancy hormones highlights its relevance in reproductive health assessments and diagnostic procedures related to hormonal profiling.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU113#006"/>
          <hierarchical_position>42020501</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV924#015" guid="073e2917a7b3416c98c161237fa6d2ca">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Dehydro-epiandrosterone sulfate (inclusive DHEA)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a naturally occurring steroid hormone that is primarily produced by the adrenal glands and serves as a precursor in the biosynthesis of androgens and estrogens. This substance is involved in various physiological processes including the regulation of hormonal balance and the modulation of reproductive functions. Its measurement is often utilized in clinical settings for assessing adrenal function, fertility issues, and other hormonal disorders. The classification of this substance distinguishes it from other related hormones and proteins that play significant roles in fertility and pregnancy, reflecting its unique biochemical properties and clinical relevance.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU113#006"/>
          <hierarchical_position>42020502</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV925#015" guid="203eb5a82a104777a7e3db6d9d840d16">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Estradiol (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="DeepL">Female sex hormone that is produced in the ovaries and is responsible for the regulation of reproduction and the development of sex-specific characteristics. It is used clinically to assess fertility and menopausal status.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">Machine generated by Chat GPT4</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU113#006"/>
          <hierarchical_position>42020503</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV926#015" guid="1a145d89deea4a73a5cbbd593ab05b44">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Follicle stimulating hormone</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biologically active glycoprotein that plays a crucial role in the regulation of reproductive processes. It is produced by the anterior pituitary gland and is essential for the development of ovarian follicles in females. This hormone stimulates the growth and maturation of ovarian follicles, leading to the production of eggs. In males, it influences spermatogenesis by acting on the Sertoli cells in the testes. The measurement of this hormone is important in assessing fertility issues, hormonal imbalances, and various reproductive health conditions. It is frequently utilized in clinical diagnostics and therapeutic monitoring related to reproductive health.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU113#006"/>
          <hierarchical_position>42020504</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV927#015" guid="39859a5e6297429788e9a9318fe26328">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Luteinizing hormone</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">luteinizing hormone is a glycoprotein hormone produced by the anterior pituitary gland, playing a crucial role in regulating reproductive processes. It is essential for the normal function of the ovaries and testes, stimulating ovulation in females and testosterone production in males. This hormone acts by binding to specific receptors on target cells, triggering a cascade of events that lead to reproductive hormone secretion. Measurement of luteinizing hormone levels is significant in the assessment of fertility issues, menstrual irregularities, and various endocrine disorders. Its role in the reproductive axis makes it a key marker for evaluating gonadal function and diagnosing conditions related to reproductive health.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU113#006"/>
          <hierarchical_position>42020505</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV928#015" guid="c953dcbb5be9405d8aa94dbcfcafb163">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Progesterone (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a specific category of substances that are crucial for reproductive health and hormonal balance, particularly in the context of in vitro diagnostics. The items in this category play significant roles in the regulation of various physiological processes related to fertility and pregnancy. They are utilized in medical testing and diagnostics to assess hormonal levels, monitor reproductive health, and aid in the diagnosis of various conditions. This classification is distinct from other related hormonal substances, emphasizing the unique biochemical properties and clinical applications associated with this particular compound. The focus is on substances that are specifically relevant to fertility and pregnancy, highlighting their importance in both diagnostic and therapeutic contexts.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU113#006"/>
          <hierarchical_position>42020506</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV929#015" guid="260bcf34d7394cf09d1a27d284d733df">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">17 OH Progesterone</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance that plays a crucial role in the reproductive system, particularly in maintaining pregnancy and regulating various physiological processes related to fertility. This item is characterized by its hormonal activity and is involved in preparing the uterine lining for implantation, as well as supporting early stages of pregnancy. It is distinct from other hormones and proteins that are also associated with reproductive health, each having unique functions and indications. This substance may be utilized in various medical diagnostics and treatments related to fertility and pregnancy management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU113#006"/>
          <hierarchical_position>42020507</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV930#015" guid="51007d99a46c4bc995f61ff6a199d33e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Prolactin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical substance that is predominantly produced by the pituitary gland, playing a crucial role in regulating various physiological processes related to reproductive health. This substance is utilized in diagnostic applications to assess and monitor reproductive functions, fertility, and pregnancy status. Its measurement is essential for understanding hormonal balance and potential disorders associated with reproduction. This classification encompasses various assays and testing methodologies specifically designed for evaluating the levels of this hormone in biological samples. The substance is significant in both clinical and research settings, contributing to the advancement of reproductive health diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU113#006"/>
          <hierarchical_position>42020508</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV931#015" guid="5ed1a8d731f241d79e63b6a341f72e2a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Sex hormone binding globulin</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a protein that specifically binds to sex hormones, playing a crucial role in regulating their availability and activity within the body. This biomolecule is involved in various physiological processes related to reproduction and hormonal balance. Its concentration can influence fertility and pregnancy outcomes, making it significant in clinical assessments related to these areas. The measurement of this protein can provide insights into hormonal status and potential reproductive health issues. It is distinct from other related proteins and hormones that play roles in fertility and pregnancy, each exhibiting unique functions and regulatory mechanisms.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU113#006"/>
          <hierarchical_position>42020509</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV932#015" guid="ce4a92ddac4a4b40abcff7d10b90a5ea">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Testosterone (with dehydro and free testosterone)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a naturally occurring steroid hormone primarily produced in the testes, ovaries, and adrenal glands, playing a crucial role in the development and maintenance of male secondary sexual characteristics. It exists in various forms, including free testosterone and its more active metabolite, dehydrotestosterone. This hormone is vital for reproductive health and influences numerous physiological processes, including muscle mass, bone density, and fat distribution. In clinical settings, measurements of this hormone are essential for assessing fertility, hormonal imbalances, and other health-related issues. The classification of this hormone encompasses its various forms and their respective functions, differentiating it from other hormones involved in reproductive health and pregnancy.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU113#006"/>
          <hierarchical_position>42020510</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV933#015" guid="8ca04feaf9414950b8c9eb6ee70dc794">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Androsterone (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biologically active steroid hormone involved in various physiological processes, particularly in the context of reproductive health. This substance plays a crucial role in the regulation of reproductive functions and is often measured in clinical settings to assess hormonal balance and fertility. Its presence can be indicative of specific physiological states or conditions, facilitating the diagnosis of various reproductive disorders. This substance is typically analyzed in laboratory settings, particularly in in vitro diagnostics, to provide insights into hormonal levels and their implications for health.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU113#006"/>
          <hierarchical_position>42020511</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV934#015" guid="5abde8b8046249edb7aa6048d74200b3">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Androstanediol-glucuronide</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">androstanediol-glucuronide is a biochemical compound that serves as a metabolite of androgens, typically involved in various physiological processes related to hormone regulation and metabolism. This substance is primarily linked to the assessment of fertility and reproductive health, reflecting the body's hormonal balance and potential dysfunctions. Its measurement is significant in clinical diagnostics, particularly in evaluating conditions related to hormonal disorders and reproductive health issues. Androstanediol-glucuronide is distinguished from other related hormonal substances by its specific metabolic pathways and clinical implications, providing valuable insights into the endocrine system's functioning.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU113#006"/>
          <hierarchical_position>42020512</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV936#015" guid="be1c8125489c4ebb9c40c2d9cf222a91">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">11-Desoxycortisol</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a naturally occurring steroid hormone involved in various physiological processes, particularly those related to the regulation of adrenal function and the reproductive system. It plays a crucial role in the body's response to stress and the maintenance of homeostasis. This compound is synthesized in the adrenal cortex and exhibits effects on metabolism, immune response, and electrolyte balance. Its measurement is significant in medical diagnostics, particularly in assessing adrenal gland activity and potential hormonal imbalances. This classification encompasses substances that share similar functional characteristics and applications in clinical settings, contributing to the understanding of hormonal regulation within the body.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU113#006"/>
          <hierarchical_position>42020514</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV937#015" guid="856b1e93511d4b1682ce9d2699be8469">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Corticosteron (R/M)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a class of substances characterized by steroid hormones produced by the adrenal cortex, which play a crucial role in various physiological processes. These substances are involved in the regulation of metabolism, immune response, and stress response, and are also associated with reproductive functions. Their measurement is significant in clinical diagnostics, particularly in assessing adrenal function and related disorders. The class includes compounds that may exist in various forms, including those that are biologically active or inactive, and may have implications in both health and disease states. This classification encompasses diverse analytical methods for detection and quantification in laboratory settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU113#006"/>
          <hierarchical_position>42020515</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV938#015" guid="c03b0a8978b841fab656abd76a2259e0">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Alpha2-Pregnancy associated glycoprotein</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific type of protein that is produced during pregnancy, often serving as a biomarker for various physiological states related to gestation. This protein plays a crucial role in the maintenance and progression of pregnancy by facilitating communication between the mother and the developing fetus. Its measurement can provide insights into potential complications or health issues during pregnancy. This category encompasses proteins that are not only essential for normal pregnancy outcomes but also serve as indicators of maternal and fetal well-being. It is distinct from other hormonal and protein classifications associated with fertility and pregnancy, highlighting its unique functions and significance in reproductive health.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU113#006"/>
          <hierarchical_position>42020516</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV939#015" guid="291dbe969a184ceaaa4292cff6473c77">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Estriol (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a bioactive steroid hormone belonging to the category of reproductive and pregnancy-related substances. This specific compound is primarily involved in the regulation of various physiological processes related to female reproductive health, including the menstrual cycle and pregnancy. It is produced in significant amounts during pregnancy, playing a crucial role in maintaining the health of the fetus and supporting the development of placental tissues. This hormone is typically measured in clinical settings to assess and monitor reproductive health, fertility status, and the progression of pregnancy. Its analysis aids in diagnosing potential hormonal imbalances and evaluating the overall wellbeing of both the mother and the developing fetus.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU113#006"/>
          <hierarchical_position>42020517</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV940#015" guid="9e827bead94346959f3c60ef324ea1f8">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Unconjugated (free) estriol</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance that is a naturally occurring estrogen and is primarily produced in the placenta during pregnancy. It plays a crucial role in maintaining pregnancy and supporting fetal development. This hormone exists in its unbound form, which is significant for various physiological processes. The measurement of this hormone can be important in assessing fetal well-being and placental function. It is distinct from other hormones involved in fertility and pregnancy, as it specifically reflects the hormonal status associated with the later stages of gestation. Its clinical applications may include monitoring high-risk pregnancies and evaluating potential complications related to hormone levels.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU113#006"/>
          <hierarchical_position>42020518</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV941#015" guid="3829ed5a128c4c6c9c01d0f3032e63c5">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Estrone (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological substance that is classified under a specific category related to fertility and pregnancy, which is involved in various physiological processes. This substance plays a significant role in reproductive health, influencing hormonal balance and supporting pregnancy. It is distinct from other related substances in this category, each of which has unique functions and characteristics. This classification aids in the identification and understanding of the substance's purpose and application in medical diagnostics and treatment, particularly in assessing reproductive health and pregnancy status.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU113#006"/>
          <hierarchical_position>42020519</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV942#015" guid="dac5af273ef54e43b726cb09ac6d7209">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Human chorionic gonadotropin (total)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses a biological substance produced during pregnancy that plays a crucial role in the maintenance of pregnancy and the development of fetal tissues. It is a glycoprotein hormone that is secreted by the placenta and serves to stimulate the production of progesterone, which is essential for sustaining the uterine lining and promoting fetal growth. The presence and levels of this substance can be indicative of pregnancy status and are often measured in clinical settings for various diagnostic purposes. This classification specifically differentiates it from other hormones and proteins associated with fertility and pregnancy by its unique biological function and production source.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU113#006"/>
          <hierarchical_position>42020520</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV943#015" guid="14a65e5363884725b1b7e8818547a0b3">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">B-Human chorionic gonadotropin (inclusive subunit)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological substance that is classified as a hormone produced during pregnancy, primarily by the placenta. This substance plays a crucial role in maintaining pregnancy and supporting fetal development by promoting hormone production and regulating various physiological processes. It may exist in various forms, including subunits, and is often measured in clinical settings to assess pregnancy health and related conditions. This classification encompasses a range of characteristics that distinguish it from other hormones and proteins associated with reproductive health and pregnancy monitoring. The substance is essential in the context of fertility treatments, pregnancy testing, and monitoring pregnancy progression and potential complications.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU113#006"/>
          <hierarchical_position>42020521</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV944#015" guid="88a44fd1d7464c499e1c2e5fda80b6a9">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Human placental lactogen</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a naturally occurring protein produced by the placenta during pregnancy, known for its role in regulating maternal metabolism and supporting fetal growth. This substance is primarily involved in the modulation of insulin and glucose metabolism, contributing to the nutritional supply for the developing fetus. It also plays a part in the development of the mammary glands in preparation for lactation. The presence and levels of this protein in maternal serum can provide insights into various aspects of pregnancy health and fetal development, making it a significant biomarker in obstetrics and gynecology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU113#006"/>
          <hierarchical_position>42020522</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV945#015" guid="56265fb7fe174befa8bf7a8c02aad68c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Pregnancy specific B1-glycoprotein</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific type of biomolecule associated with pregnancy, primarily produced by the placenta, which plays a role in various physiological processes during gestation. This molecule is utilized in clinical diagnostics to assess pregnancy status and monitor fetal health. It is classified within a broader category of hormones and proteins that are critical to fertility and pregnancy, and it serves as a marker for certain conditions. This entity is distinct from other hormones and proteins in the same category, each possessing unique functions and implications in reproductive health.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU113#006"/>
          <hierarchical_position>42020523</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV946#015" guid="29b0fe1071ff43cfa12880f5229c774f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Glycoprotein a-subunit</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a glycoprotein that consists of a protein component covalently bonded to carbohydrate moieties, typically involved in various biological functions related to fertility and pregnancy. This substance plays a crucial role in reproductive processes, influencing hormone activity and cellular signaling. It is characterized by its specific structure, which differentiates it from other hormones and proteins associated with reproductive health. Glycoproteins of this nature may be used in clinical diagnostics and therapeutic applications, serving as biomarkers or treatment agents in fertility management and pregnancy monitoring. Their detection and quantification can provide valuable insights into hormonal status and reproductive function.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU113#006"/>
          <hierarchical_position>42020524</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV947#015" guid="27784e73efc9454bb58cf5507b83dc50">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Pregnancy associated plasma protein -A (downs)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses specific proteins that are associated with pregnancy and play a significant role in maternal and fetal health. The defined items within this category are characterized by their production during pregnancy and their relevance in various diagnostic and monitoring contexts. These proteins may serve as biomarkers for assessing pregnancy status, potential complications, or the overall health of the mother and fetus. They are utilized in medical testing and research to gain insights into reproductive health and pregnancy outcomes. The classification specifically distinguishes these proteins from other hormones and proteins related to fertility and pregnancy, highlighting their unique functions and clinical significance.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU113#006"/>
          <hierarchical_position>42020525</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV948#015" guid="f35fc9d17eec4b0aba3fa39878bc187b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Placental growth factor (pre-eclampsia)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance that is involved in the physiological processes related to pregnancy, specifically associated with the development and regulation of placental function. This biomarker plays a crucial role in the assessment of maternal and fetal health, particularly in relation to conditions that can arise during pregnancy, such as pre-eclampsia. The presence and levels of this factor can provide insights into the placental development and the overall health of the pregnancy, serving as an important indicator for healthcare professionals in monitoring and managing pregnancy-related complications.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU113#006"/>
          <hierarchical_position>42020526</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV949#015" guid="f9b00a6a4a5d42e9a0c7983cc53be21d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Soluble fms-like tyrosine kinase-1</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical substance involved in various physiological processes, including cell signaling and regulation of cellular activities, primarily associated with reproductive functions. This substance plays a critical role in the modulation of hormonal pathways and can influence fertility outcomes. It is characterized by its solubility and interaction with specific receptors, facilitating a range of biological responses. The classification encompasses elements that are vital for understanding reproductive health and hormonal balance, distinguishing itself from related substances that also impact fertility but operate through different mechanisms or pathways. This category serves as an essential reference for research and clinical applications related to reproductive endocrinology and related fields.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU113#006"/>
          <hierarchical_position>42020527</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV950#015" guid="a61f388aecaa4bc6bfe6983d7451fb03">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Fertility, pregnancy hormone and protein (unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU113#006"/>
          <hierarchical_position>42020590</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-AFU809#011" guid="f3597fc9bd3f48f3883b716647b67141">
          <date_of_original_definition>2014-11-30Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Fertility, pregnancy hormone and protein (accessories)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects with complemental characteristics, without which the basic function of the objects classified under the parent-class on the 3rd level is still guaranteed</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU113#006"/>
          <hierarchical_position>42020592</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADS281#005" guid="7e9a6e2706bf4f8091c6bc96abbdeb05">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Dedicated sample container (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses specialized receptacles designed for the collection, preservation, and transportation of biological samples utilized in laboratory diagnostics. These items are crucial for ensuring the integrity and reliability of samples taken for in-vitro testing purposes. The range includes containers specifically tailored for various types of specimens, such as those derived from blood, plasma, serum, and urine, as well as sterile options for safeguarding samples against contamination. This classification distinctly separates itself from related categories that focus on different diagnostic methodologies and instruments, emphasizing its unique role in the processing and handling of human-origin biological materials for diagnostic analysis.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADJ215#005"/>
          <hierarchical_position>42090000</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU169#005" guid="31bfde65cf404bcd9887f5eda829fc7d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Container for blood, plasma, and serum sample (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a collection of specialized receptacles designed to securely hold and preserve biological fluid samples, specifically blood, plasma, and serum, for in vitro diagnostic purposes. These containers ensure the integrity and stability of the samples during transportation and storage, facilitating accurate analysis in laboratory settings. They are characterized by their compatibility with various anticoagulants, which help to prevent clotting and maintain the samples in a state suitable for testing. This classification encompasses a variety of tubes, each tailored for specific anticoagulant agents, ensuring optimal conditions for different diagnostic applications. The design and materials used in these containers prioritize sterility and reliability to meet the stringent requirements of medical laboratories.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS281#005"/>
          <hierarchical_position>42090100</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADX041#015" guid="6fe438d149ef4130af75dd9d58e8a76d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Tube for serum (without anticoagulant, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a tubular container designed specifically for the collection, storage, and transportation of serum specimens without the presence of anticoagulants. This type of container is commonly utilized in in vitro diagnostic (IVD) procedures, ensuring that the serum remains unaltered for accurate testing and analysis. It is differentiated from other types of tubes that contain specific anticoagulants, which are used to prevent blood clotting during sample processing. This product is essential for laboratories and medical facilities that require reliable and standardized methods for serum sample handling.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU169#005"/>
          <hierarchical_position>42090101</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW507#015" guid="f0e1c8749c6d451eb9f9418507ad92ed">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Single test (disc, strip, dropper)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses products designed for the qualitative and quantitative assessment of microbial organisms through single testing methodologies. These testing solutions facilitate the identification of specific bacteria and assess their susceptibility to various antimicrobial agents. Typically presented in formats such as discs, strips, or droppers, these items are essential for laboratory diagnostics, enabling healthcare professionals to make informed decisions regarding treatment options. The focus is on providing reliable results for clinical specimens, contributing to the effective management of infectious diseases by determining the presence and resistance patterns of targeted microorganisms.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU136#005"/>
          <hierarchical_position>42040212</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW508#015" guid="5ada8f131cd94879b27d47f2ef91be2d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Streptococci grouping slide test</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a testing method used to identify specific types of bacteria by observing their reaction to a particular reagent applied on a slide. This approach is essential for determining the presence of certain bacterial strains within a sample, aiding in diagnosis and treatment decisions. The technique involves the application of a sample onto a specially designed slide, followed by the addition of reagents that react with target bacteria. Interpretation of the results is based on observable changes, enabling healthcare professionals to differentiate between various bacterial species. This method is especially valuable in clinical microbiology for its efficiency and specificity in identifying pathogens.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU136#005"/>
          <hierarchical_position>42040213</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW509#015" guid="181e29396bd64a4ebac8e0f9e1992170">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Staphylococci slide test</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to diagnostic tests designed specifically for the identification and assessment of bacterial pathogens, particularly focusing on the Staphylococci species. The tests aim to detect the presence of these microorganisms in clinical specimens, helping in the diagnosis of infections. These tests are essential in microbiology laboratories and contribute to understanding the susceptibility of Staphylococci to various antimicrobial agents. The procedures involved typically include the use of specific reagents and methodologies that enable the differentiation of Staphylococci from other bacterial types, thereby facilitating targeted treatment strategies. The classification highlights the uniqueness of this test within a broader framework of bacteriological identification and susceptibility assessments.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU136#005"/>
          <hierarchical_position>42040214</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW510#015" guid="ec596414dbec4f3986940f826979e4a0">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Meningitis slide test</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a laboratory diagnostic tool designed for the identification of specific bacterial pathogens associated with meningitis. This testing method utilizes a slide format to facilitate the examination and differentiation of bacteria based on their unique characteristics. It is particularly focused on providing accurate identification to assist in clinical decision-making and treatment options for patients suspected of having meningitis. The test operates within a specialized framework that emphasizes the detection of relevant microorganisms while distinguishing itself from other methodologies aimed at identifying various bacterial species and their susceptibility profiles. This classification encompasses a broad range of applications within bacteriology, enhancing the capabilities of healthcare professionals in managing infectious diseases effectively.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU136#005"/>
          <hierarchical_position>42040215</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW511#015" guid="83a2f64908114e73beae2309e5e39b5d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Serotyping (escherichia coli, salmonella, shigella)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses methods and techniques used for the identification and differentiation of specific bacterial strains, particularly those associated with gastrointestinal diseases. It focuses on the detection and characterization of pathogenic organisms, facilitating the understanding of their characteristics, serotypes, and potential resistance mechanisms. The classification supports laboratory practices aimed at ensuring accurate diagnosis and effective treatment strategies, contributing to public health surveillance and epidemiological studies. It stands distinct from other identification and susceptibility testing methodologies by concentrating specifically on the serological profiling of targeted bacteria, enhancing the capability to monitor and respond to infectious disease outbreaks.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU136#005"/>
          <hierarchical_position>42040216</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW512#015" guid="a2ceeb5fd66840b1826745ed7ee1d426">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">MIC system (dilution method, including E-Test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses systems designed for the evaluation of microbial susceptibility and identification through a dilution methodology. Such systems are integral for determining the effectiveness of various antimicrobial agents against specific pathogens. The method typically involves the preparation of a series of dilutions of antimicrobial substances, which are then used to assess the growth inhibition of microorganisms. This approach aids in identifying resistance patterns and susceptibility profiles, providing critical information for treatment decisions in clinical settings. The classification highlights its unique position within a broader category that includes diverse testing methods for bacterial identification and susceptibility, differentiating it from other automated and manual testing systems that focus on specific bacterial groups or methodologies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU136#005"/>
          <hierarchical_position>42040217</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW513#015" guid="f27951bc99ec42c3b7b6be5c4225e07f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Impregnated disk, multi-disk and tablet</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses specialized items designed for microbiological testing and analysis, particularly focusing on the identification and susceptibility assessment of various microorganisms. These products are characterized by their unique formulation, which enables effective interaction with biological samples to yield precise results. They serve as crucial tools within laboratory settings, facilitating the detection of microbial presence and the evaluation of their resistance to antimicrobial agents. This category distinguishes itself by addressing specific testing methodologies and applications, ensuring that users can select appropriate items tailored for distinct laboratory requirements in the field of bacteriology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU136#005"/>
          <hierarchical_position>42040218</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW514#015" guid="e4102a8952e242fdb96c9a00814f9f81">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Nucleic acid identification (manual)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses methodologies utilized for the identification of nucleic acids in various biological samples, emphasizing manual techniques. These procedures are critical for analyzing genetic material, aiding in the detection of specific organisms or pathogens. The focus is on hands-on processes that require skilled personnel to interpret results, distinguishing them from automated systems. This category includes various approaches that leverage biochemical and molecular principles to ensure accurate identification, facilitating diagnostic processes in clinical and research settings. It supports the understanding of microbial characteristics and resistance mechanisms, ultimately contributing to effective treatment strategies and epidemiological studies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU136#005"/>
          <hierarchical_position>42040219</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW515#015" guid="04005a1f8a794a79a1626444529152d8">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Nucleic acid identification (automated MRSA)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses automated methods specifically designed for the identification of nucleic acids, focusing on the detection of Methicillin-resistant Staphylococcus aureus (MRSA). The technology employed in this category leverages advanced molecular techniques to facilitate rapid and accurate identification of bacterial strains, particularly those exhibiting antibiotic resistance. The processes involved aim to streamline diagnostic workflows in clinical microbiology laboratories, enhancing the efficiency of pathogen detection and ensuring timely intervention in infection control. By utilizing automated systems, this classification also addresses the need for high-throughput testing capabilities, thereby supporting improved patient management and public health outcomes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU136#005"/>
          <hierarchical_position>42040220</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW516#015" guid="8ef7a02b6fa84b359a6dab2b340aa2f6">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Nucleic acid identification (automated additional resistance marker)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a method of identifying nucleic acids through automated processes, specifically targeting additional resistance markers associated with microbial organisms. It is utilized in diagnostic settings to enhance the detection and characterization of pathogens, particularly in the context of antimicrobial resistance. The automated approach streamlines the identification process, providing rapid and accurate results that are critical for effective treatment decisions. This classification serves to differentiate these automated identification systems from other manual and automated methods used for identifying various bacterial groups and their susceptibility patterns. It emphasizes the importance of advanced molecular techniques in contemporary bacteriological analysis, particularly in monitoring resistance traits that impact clinical outcomes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU136#005"/>
          <hierarchical_position>42040221</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW517#015" guid="8569cffbc93d4952bf07de0839b9d0bd">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Bacteriology (Identification and susceptibility testing, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU136#005"/>
          <hierarchical_position>42040290</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU135#005" guid="08d4910c6d87461bb952e98ba4044ff3">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Bacteriology (culture, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a range of products and materials specifically designed for the cultivation and analysis of bacteria within the context of in vitro diagnostics. It includes various forms of culture media, both dehydrated and pre-prepared, that facilitate the growth of bacterial specimens. Additionally, it encompasses raw materials necessary for media preparation, as well as additives that enhance growth or select for specific bacterial strains. The category also features transport media designed for the safe handling of samples, ensuring their viability for subsequent testing. Furthermore, it includes specialized media for susceptibility testing and identification, as well as systems for screening urine samples. Various control materials, stains, and buffers are included to ensure accurate diagnostics and reliable results in bacteriological studies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS276#005"/>
          <hierarchical_position>42040100</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW474#015" guid="eaa0c979ee21433282f5ff3f30443ffc">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Dehydrated culture media (DCM)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">dehydrated culture media are specialized formulations designed for the cultivation of microorganisms in laboratory settings. These media are prepared by removing moisture from nutrient-rich ingredients, allowing for easy transport and storage. Upon rehydration, they provide the necessary nutrients, growth factors, and pH indicators essential for microbial growth and differentiation. Typically used in microbiological research and diagnostics, these formulations support the isolation and identification of various bacterial species, facilitating studies in bacteriology and related fields. Their specific composition can vary to meet the requirements of different microbial types, ensuring optimal growth conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU135#005"/>
          <hierarchical_position>42040101</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW475#015" guid="77db297754c8456eb4fb1b6e673421d0">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Raw material (agar, peptone)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses substances primarily utilized as foundational components in microbiological applications. These materials are essential for cultivating and sustaining microbial life in laboratory settings, providing the necessary nutrients and environment for growth and experimentation. They are often derived from natural sources and may be processed to enhance their effectiveness in supporting specific bacterial strains. The focus is on items that serve as critical inputs in the production of various culture media, playing a vital role in the study and analysis of microorganisms in both clinical and research contexts.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU135#005"/>
          <hierarchical_position>42040102</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW476#015" guid="27d41b33faaa4a3eb8af403f2f1e40f8">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Additive for DCM (growth supplement, selective agent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses substances specifically developed to enhance the growth and selective cultivation of microorganisms in diagnostic applications. These additives are essential for optimizing the conditions necessary for the proliferation and maintenance of specific microbial populations, ensuring accurate and reliable results in laboratory settings. They may serve various functions, including promoting growth, inhibiting unwanted organisms, or enhancing the expression of particular traits in the target microorganisms. The use of these additives is crucial in the preparation of culture media, particularly in the context of in vitro diagnostics, where precise microbial identification and analysis are paramount for effective clinical decision-making.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU135#005"/>
          <hierarchical_position>42040103</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW477#015" guid="0fee24fef5ab4531a9fd7cedb83735c8">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Media in tubes (solid and liquid)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses various media contained within tubes, both in solid and liquid forms, specifically designed for use in bacteriological applications. These media are crucial for the cultivation, isolation, and identification of microorganisms in laboratory settings, particularly in the context of in vitro diagnostics. The offerings within this classification are distinguished by their formulation, intended use, and specificity to different types of bacterial cultures. They serve as the foundation for microbial growth, providing the necessary nutrients and environmental conditions for optimal development, while being differentiated from related products such as dehydrated media, raw materials, and various specialized testing media. This ensures a comprehensive approach to bacteriological analysis and enhances the capabilities of diagnostic laboratories.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU135#005"/>
          <hierarchical_position>42040104</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW478#015" guid="76fbd698382e4e14a7e3f1c3887ad52d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Transport media</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a category dedicated to substances or materials specifically designed for the transportation of biological specimens and samples, ensuring their integrity and viability during transit. This includes products engineered to maintain the necessary conditions for the preservation of microorganisms, cells, or other biological entities, preventing degradation or contamination. These transport solutions are crucial for diagnostic processes, enabling the safe and effective transfer of samples to laboratories for analysis. The focus is on ensuring that the transported materials are suitable for subsequent testing, allowing for accurate and reliable results in microbiological studies and evaluations.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU135#005"/>
          <hierarchical_position>42040105</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW479#015" guid="799aaef282ff43b39ef1c8633be96257">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Sample transport for NA testing</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses products specifically designed for the transportation of samples intended for nucleic acid testing. These items ensure the preservation and integrity of biological specimens during transit, facilitating accurate and reliable testing outcomes. The focus is on items that maintain the viability of the samples while preventing contamination or degradation. Intended for use in laboratory and clinical settings, these transportation solutions are crucial for maintaining the quality of samples from the point of collection to the analysis stage. Their design accommodates various testing requirements, providing essential support in the field of microbiological diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU135#005"/>
          <hierarchical_position>42040106</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW480#015" guid="a398b6cd51f0424da4401b6b0027fd4b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">All media (bottle, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a category encompassing a variety of containers specifically designed for the preservation, transportation, and analysis of biological samples in the context of bacteriological testing and diagnostics. This classification includes items that are utilized for both in vitro and direct applications in clinical settings, emphasizing their role in facilitating microbiological examinations. The offerings within this category are characterized by their compatibility with various testing methodologies and their ability to maintain sample integrity. They serve as essential components in laboratory protocols, supporting the accurate identification and analysis of microbial organisms while ensuring compliance with safety and quality standards.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU135#005"/>
          <hierarchical_position>42040107</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW481#015" guid="ef311fd8d07c4b7eb495d3d559742e50">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Non-chromogenic media</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a category of media utilized in microbiological diagnostics that does not contain chromogenic substances. These media are formulated to support the growth and identification of bacteria through traditional culture methods. They are specifically designed to provide necessary nutrients and optimal conditions for the cultivation of various microbial species without the inclusion of chromogenic indicators, which are often used to reveal specific metabolic activities or characteristics of bacteria. Non-chromogenic media are crucial for accurate microbiological analysis and are widely employed in laboratories for the isolation and enumeration of microorganisms, ensuring that results are based solely on the organisms' natural growth properties.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU135#005"/>
          <hierarchical_position>42040108</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW482#015" guid="f4b0021e525f426ca8204f6dd90d14b7">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Chromogenic ID media (plate)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a type of diagnostic medium specifically designed for the identification of microorganisms through chromogenic reactions. This medium allows for the selective growth of target organisms while inhibiting others, facilitating colorimetric differentiation based on the metabolic activity of the microorganisms present. It is commonly utilized in microbiological laboratories for the cultivation and identification of bacteria, particularly in the context of clinical diagnostics. The formulation is tailored to support specific bacterial growth, enabling the visualization of results through distinct color changes, thereby assisting in the rapid identification of pathogens.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU135#005"/>
          <hierarchical_position>42040109</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW483#015" guid="78ae3c78179846abb99302c65fd030eb">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Susceptibility test media (plate)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses specialized media utilized for the cultivation and assessment of microorganisms, specifically tailored for susceptibility testing in laboratory settings. These media provide an optimal environment for bacterial growth and are designed to facilitate the evaluation of microbial resistance to various antimicrobial agents. The format typically includes plates that support the application of test organisms, allowing for precise observation of growth patterns and inhibition zones. This category is distinct from other forms of culture media and is characterized by its specific use in diagnosing susceptibility to antibiotics, aiding in the determination of effective treatment options in clinical microbiology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU135#005"/>
          <hierarchical_position>42040110</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW484#015" guid="fbcb7c2b05ed419a99e60363f63462bf">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Chromogenic resistance marker media (plate)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a medium designed to facilitate the identification and differentiation of specific microorganisms through chromogenic reactions. This type of media is characterized by its ability to produce distinct color changes in response to the metabolic activities of target bacteria, allowing for easier visual recognition of colonies. It is typically utilized in laboratory settings for diagnostic purposes, particularly in the field of bacteriology, and is ideal for use in clinical diagnostics and microbiological research. This medium plays a crucial role in enhancing the efficiency and accuracy of microbial identification processes, distinguishing it from other types of culture media that do not exhibit chromogenic properties.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU135#005"/>
          <hierarchical_position>42040111</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW485#015" guid="ee35567f41f5401faf2b97f743c60e55">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Urine screening system (automated)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">an automated urine screening system is a sophisticated diagnostic tool designed to analyze urine samples for various parameters, including the presence of pathogens and other biomarkers. This system utilizes advanced technology to perform analyses with minimal human intervention, enhancing efficiency and accuracy in clinical settings. It typically integrates features such as sample processing, result interpretation, and data management, allowing for streamlined workflows and timely reporting of results. This classification encompasses products that facilitate the automation of urine testing, differentiating them from manual testing methods and other media used in microbiological analysis, thus meeting specific laboratory needs in the field of bacteriology and in vitro diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU135#005"/>
          <hierarchical_position>42040112</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW486#015" guid="2910b7acca994f3897adea2f1a1676a2">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Urine screening manual (strip)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic tool designed for the qualitative analysis of urine samples, utilizing a strip format for the detection of various parameters indicative of health conditions. This item enables healthcare professionals to perform tests manually, providing results through a visual readout. It serves as an essential component in the field of microbiology and infectious disease diagnostics, particularly for identifying bacterial infections and other urinary tract issues. The product is characterized by its ease of use, rapid results, and suitability for point-of-care testing, making it a valuable resource in clinical settings for preliminary screening.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU135#005"/>
          <hierarchical_position>42040113</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW487#015" guid="7c06f3e24ebd491dae7347b09c7df6ef">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Urine screening manual (dipslide)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic tool designed for the qualitative assessment of urine samples, utilizing a dipstick method for the detection of various parameters indicative of patient health. This product is employed in clinical settings to screen for potential infections, metabolic disorders, and other health conditions through the analysis of specific chemical reactions on the strip. The manual application allows healthcare professionals to interpret results visually, providing immediate insights into the biochemical composition of the urine. This tool serves as a vital component in laboratory diagnostics, aiding in the initial evaluation and monitoring of patient conditions, and is particularly beneficial for rapid assessment in point-of-care environments.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU135#005"/>
          <hierarchical_position>42040114</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW488#015" guid="b99aa8a8c1ba433bb63f168f84554c88">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Stain (bacteriology, culture, control, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses various types of substances specifically designed for the identification, culture, and control of bacteria within in vitro diagnostics. These materials are utilized in laboratory settings to facilitate the growth and examination of bacterial cultures, allowing for the assessment of microbial presence and characteristics. The substances in this category are distinguished by their specific function in bacteriological procedures, particularly in the context of diagnostic testing. They play a critical role in the accurate detection and analysis of microbial species, contributing essential information for clinical decision-making and public health monitoring. The focus is on products that enhance the understanding of bacterial behavior and resistance patterns in laboratory environments, ensuring reliable results in diagnostic applications.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU135#005"/>
          <hierarchical_position>42040115</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW489#015" guid="fcae2d79063b478e986f2d2c766a6d0c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Buffer (bacteriology, culture, control, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance or formulation specifically designed to provide the necessary environment or nutrients for the growth and maintenance of microorganisms in laboratory settings, particularly for diagnostic purposes. This category encompasses solutions or mixtures used to support the proliferation of bacterial cultures, allowing for the assessment of microbial characteristics and behaviors. These items are integral to in vitro diagnostics, facilitating the evaluation of various microorganisms under controlled conditions. The buffers in this classification are distinct from other media and substances used in microbiological applications, focusing on their role in stabilizing and maintaining the pH and osmotic balance necessary for optimal microbial growth and analysis.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU135#005"/>
          <hierarchical_position>42040116</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW490#015" guid="f12cea53e6254f7e82b975db7dcbddb8">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Gas generating kit</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a gas generating kit is a specialized assembly designed to produce a controlled atmosphere, typically utilized in microbiological applications. This kit facilitates the growth of anaerobic bacteria by creating an environment devoid of oxygen, essential for the cultivation of specific microorganisms. It often includes components such as gas-generating sachets, which release gases like hydrogen and carbon dioxide, along with various materials required for maintaining optimal growth conditions. Such kits are crucial in laboratories and clinical settings, where accurate culturing of bacteria is necessary for diagnostics and research purposes. They enable effective testing and analysis by providing the necessary conditions for the proliferation of anaerobic organisms, thereby supporting the overall goals of bacteriological studies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU135#005"/>
          <hierarchical_position>42040117</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW491#015" guid="c4b06a91f8824da98aa32ab00fdb90ad">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Manual blood culture bottle</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a container specifically designed for the collection and cultivation of blood samples to detect the presence of microorganisms. This vessel is intended for use in laboratory settings to facilitate the growth of bacteria and other pathogens from clinical specimens, allowing for subsequent identification and susceptibility testing. The design of this container ensures optimal conditions for microbial growth, including appropriate nutrient content and environmental factors, while also providing a secure and sterile environment to prevent contamination. This type of product is critical in the diagnosis of infections and plays a vital role in the field of microbiology and clinical diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU135#005"/>
          <hierarchical_position>42040118</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW492#015" guid="6cca1160bfd0471b82d419b221de0c61">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Automated blood culture bottle</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a container designed specifically for the automated cultivation of microorganisms from blood samples, facilitating the detection of bacterial or fungal infections. This item is integral to the process of blood culture testing in clinical diagnostics, allowing for the monitoring of microbial growth in a controlled environment. The automated functionality enhances efficiency and accuracy in identifying pathogens, thereby supporting timely medical intervention. This type of container is distinct in its design and application, differentiating it from various other media types and methodologies used in microbiological testing. Its purpose is to streamline the workflow of laboratory procedures associated with blood sample analysis, contributing to improved patient outcomes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU135#005"/>
          <hierarchical_position>42040119</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW569#015" guid="b4d2295b53c04f19a05de01f543cf234">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Microbiology (IVD, other, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU142#007"/>
          <hierarchical_position>42049090</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU136#005" guid="920fa8e09a144b18997b0faa718bad36">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Bacteriology (identification and susceptibility testing)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic tools and methods focused on the identification of bacterial pathogens and the assessment of their susceptibility to antimicrobial agents. It includes both automated and manual techniques for the detection and characterization of various bacteria, including those that are gram-negative, gram-positive, and anaerobic. The methods range from traditional culture techniques to advanced molecular diagnostics. The classification also covers systems that combine identification and susceptibility testing, providing comprehensive solutions for clinical microbiology laboratories. These tools are essential for guiding effective treatment options and managing infectious diseases, ensuring accurate diagnosis and appropriate therapeutic interventions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS276#005"/>
          <hierarchical_position>42040200</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW496#015" guid="4dd4979435ee49eb9c589bf1fd0f77ad">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Gram negative (automated, ID)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses automated methods for the identification of specific types of bacteria characterized by the absence of a thick peptidoglycan layer in their cell walls. These organisms are typically distinguished by their unique biochemical properties and pathogenicity profiles. The classification focuses on systems designed to accurately identify these bacteria through automated processes, facilitating rapid and reliable diagnosis in clinical microbiology settings. Additionally, it emphasizes the importance of identifying antibiotic resistance patterns associated with these organisms to inform effective treatment strategies. This category is distinct from other classifications that involve different bacterial types or identification methodologies, underscoring its specialized focus on automated identification techniques for this specific group of microorganisms.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU136#005"/>
          <hierarchical_position>42040201</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW497#015" guid="529a45c8f70d4ef19e2226e4e49f81c4">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Gram positive (automated, ID)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses automated systems specifically designed for the identification of Gram-positive bacteria. These systems utilize advanced methodologies to rapidly detect and characterize Gram-positive organisms, facilitating effective diagnosis and treatment decisions. The focus is on the automated processes that streamline the identification procedure, enhancing efficiency and accuracy in clinical microbiology. This classification is distinct from those aimed at Gram-negative bacteria and other types of organisms, as well as various susceptibility testing methods. The primary purpose is to provide a comprehensive framework for the automated identification of Gram-positive species in laboratory settings, ensuring reliable results that support healthcare outcomes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU136#005"/>
          <hierarchical_position>42040202</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW498#015" guid="64377e0abe884062bafb0ac9cf525f44">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Anaerobes and other fastidious organisms (ID)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a variety of organisms that thrive in environments devoid of oxygen and those that have specific growth requirements. It pertains to the identification and testing of susceptibility of these microorganisms, which may not be easily cultured or identified using standard methods. The organisms classified here are of particular interest in clinical microbiology, where accurate identification is crucial for effective treatment. This category supports a range of testing methodologies, reflecting advancements in microbiological practices aimed at improving diagnostic accuracy and therapeutic outcomes. It serves as a vital resource for laboratories focusing on the detection and characterization of challenging pathogens that require specialized handling and testing techniques.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU136#005"/>
          <hierarchical_position>42040203</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW499#015" guid="2116af0a889f430f91aa1092edae9468">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Gram negative automated susceptibility testing</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">automated testing methods designed specifically for evaluating the susceptibility of Gram-negative bacteria to various antimicrobial agents. This classification encompasses systems and techniques that facilitate the rapid and accurate determination of bacterial resistance patterns, aiding in the selection of effective treatment options. Such methods often integrate advanced technologies that streamline the testing process, enhance precision, and reduce turnaround times, ensuring timely patient management. The focus is on Gram-negative organisms, which are known for their diverse resistance mechanisms and clinical relevance in infections. These testing solutions are critical in clinical microbiology laboratories, contributing to improved patient outcomes through targeted antibiotic therapy.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU136#005"/>
          <hierarchical_position>42040204</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW500#015" guid="fc6231da5f3c4488a93c45296afb4f82">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Gram positive automated susceptibility testing</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a method of testing used to determine the susceptibility of bacteria that retain the Gram stain, indicating a specific cell wall structure. This process is typically automated and is utilized in microbiological laboratories to facilitate the identification of effective antibiotics against these organisms. The testing involves exposing bacterial isolates to various antimicrobial agents to assess their growth response, thereby guiding clinical decisions for effective treatment. This approach is essential for managing infections caused by Gram-positive bacteria, ensuring that healthcare providers can select appropriate therapeutic options based on resistance patterns. The methodology is characterized by its standardization, efficiency, and ability to deliver timely results in diagnostic settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU136#005"/>
          <hierarchical_position>42040205</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW501#015" guid="cf90781262b24e4097ff95a9b054d816">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Combined susceptibility and identification system (gram negatives automated)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a system designed to provide simultaneous determination of susceptibility and identification of specific microorganisms within the Gram-negative category. This system employs automated methodologies to enhance precision and efficiency in microbiological diagnostics. It integrates advanced techniques for accurately identifying pathogens while concurrently assessing their resistance profiles against various antimicrobial agents. This classification encompasses products and services that facilitate rapid and reliable results in clinical and laboratory settings, supporting effective treatment decisions and infection control measures. The system is distinct from other identification and susceptibility testing systems that focus solely on either Gram-positive or other bacterial types, highlighting its unique application in the realm of Gram-negative organisms.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU136#005"/>
          <hierarchical_position>42040206</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW502#015" guid="70a0afd2d33c4e8d917c4339df4bfe4f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Combined susceptibility and identification system (gram positives automated)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a system designed to simultaneously assess the susceptibility and identify specific strains of gram-positive bacteria through automated processes. This technology integrates advanced methodologies to provide accurate results in a streamlined manner, enhancing efficiency in microbiological testing. It distinguishes itself from other systems by focusing exclusively on gram-positive organisms and employs sophisticated algorithms and reagents to deliver rapid and reliable outcomes. The system is essential for clinical laboratories aiming to optimize their diagnostic capabilities, specifically in the context of identifying various gram-positive pathogens and determining their resistance patterns to facilitate effective treatment plans.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU136#005"/>
          <hierarchical_position>42040207</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW503#015" guid="ededb2369691465e9ccab8a595be35ff">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Anaerobes and fastidious automated suscept. testing</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses tools and systems specifically designed for the identification and susceptibility testing of anaerobic and fastidious microorganisms. It includes automated methods that facilitate the detection of resistance patterns and sensitivities of these organisms against various antimicrobial agents. The focus is on enhancing the accuracy and efficiency of testing processes, which are critical for effective clinical decision-making and treatment planning. This classification is distinct from other methodologies that apply to broader categories of bacteria, allowing for a specialized approach to the unique challenges posed by anaerobes and other fastidious pathogens.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU136#005"/>
          <hierarchical_position>42040208</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW504#015" guid="6b98ea75c8f1497a84ffcc95fdbb8c47">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Gram negative (manual, ID)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses methods and techniques used for the identification of Gram-negative bacteria through manual processes. It is designed for laboratories and healthcare facilities to facilitate accurate and reliable detection of these microorganisms. This category includes various manual testing protocols that focus on differentiating Gram-negative species and determining their susceptibility to antibiotics. The emphasis is on traditional laboratory methods that require manual intervention, ensuring thorough and precise identification. This classification serves as a crucial resource for microbiologists and clinical laboratories in their efforts to diagnose infections caused by Gram-negative bacteria, which are often associated with significant clinical challenges due to their varied resistance mechanisms.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU136#005"/>
          <hierarchical_position>42040209</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW505#015" guid="a2bd4a2363b44e2a9ac1d9c472369208">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Gram positive (manual, ID)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses methods and techniques specifically used to identify Gram-positive microorganisms through manual procedures. It includes various laboratory practices aimed at determining the presence of specific Gram-positive bacteria, which are characterized by their unique cell wall structure that retains a purple stain during the Gram staining process. The focus is on traditional identification methods that may involve visual inspection, biochemical testing, or other manual techniques to ascertain the type and characteristics of these organisms. This category is distinct from those that pertain to automated identification processes or different types of organisms, emphasizing the hands-on approach in microbiological diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU136#005"/>
          <hierarchical_position>42040210</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW506#015" guid="d9aac51be7e8438ba363198d136bf920">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Mycoplasma (inclusive combined ID-AST)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a category of organisms characterized by their lack of a cell wall and their unique metabolic pathways, which often require specialized techniques for identification and susceptibility testing. These organisms are typically associated with various clinical conditions and can be challenging to detect using standard microbiological methods. The classification includes methodologies for both identifying these organisms and determining their susceptibility to specific antimicrobial agents, facilitating effective treatment options. This category is distinct in its focus on these wall-less microorganisms, which necessitates tailored approaches in laboratory settings to ensure accurate diagnosis and appropriate therapeutic strategies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU136#005"/>
          <hierarchical_position>42040211</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV727#015" guid="797d485feda54dfa93e28f758eb659c0">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Magnesium electrode (clinical laboratory)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specialized device designed for use in clinical laboratories, this item functions as an electrode that selectively measures the concentration of magnesium ions in biological samples. It operates on principles of electrochemistry, providing accurate and reliable readings crucial for various diagnostic applications. This electrode is essential for assessing magnesium levels, which play a vital role in numerous physiological processes. It is specifically engineered to ensure optimal performance and compatibility with laboratory equipment, allowing for seamless integration into automated analytical systems. The device is calibrated to provide precise measurements, aiding healthcare professionals in monitoring and diagnosing conditions related to magnesium imbalances.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU104#005"/>
          <hierarchical_position>42010405</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV728#015" guid="16a577ac1ce44454b175a28f953e1b1a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Potassium electrode (clinical laboratory)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a specialized instrument designed for clinical laboratory environments, utilized to measure the concentration of potassium ions in biological samples. It plays a crucial role in various diagnostic procedures, enabling healthcare professionals to monitor electrolyte levels and assess patient health. The device operates based on electrochemical principles and is essential for evaluating conditions related to kidney function, hydration status, and electrolyte imbalances. The potassium electrode is distinct from other similar instruments that measure different ions or substances, each tailored for specific clinical applications and diagnostic needs.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU104#005"/>
          <hierarchical_position>42010406</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV729#015" guid="0c2ffc26219c42a6b5c4cf4d2859d39c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Sodium electrode (clinical laboratory)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a device designed for clinical laboratory use that measures the concentration of sodium ions in a liquid sample, typically blood or serum. This type of electrode functions through electrochemical principles, providing accurate and reliable readings essential for diagnosing and monitoring various medical conditions related to electrolyte balance. It is distinct from other types of ion-selective electrodes, each tailored for specific ions, thereby allowing for targeted analysis in clinical diagnostics. The sodium electrode plays a critical role in assessing patient health, facilitating timely medical decisions based on electrolyte levels.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU104#005"/>
          <hierarchical_position>42010407</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV730#015" guid="916f682f6c454d62b5427ad0881c8b53">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Carbon dioxide-, bicarbonate electrode (CC)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a device designed to measure the concentration of carbon dioxide in biological fluids, utilizing a bicarbonate-based electrode. This instrument operates on principles of electrochemistry, providing precise and reliable readings essential for clinical laboratory applications. It is specifically tailored for assessing respiratory function and metabolic processes, distinguishing itself from other electrodes that measure different ions or substances. The design facilitates compatibility with various analytical systems, ensuring accurate diagnostics in healthcare settings. Its application is critical for monitoring patients' acid-base balance and overall metabolic status, making it a vital tool in clinical laboratories.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU104#005"/>
          <hierarchical_position>42010408</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV731#015" guid="9ec477a324314ee5a9a6b0097452dd1f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Creatinine electrode (clinical laboratory)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a device designed for the quantitative measurement of creatinine levels in biological samples, primarily used in clinical laboratory settings. This instrument functions by utilizing electrochemical principles to detect creatinine concentration, aiding in the assessment of kidney function and overall metabolic health. It is specifically calibrated for high accuracy and sensitivity in the presence of various biological matrices. This type of electrode plays a critical role in diagnostic procedures, contributing to the monitoring of renal conditions and assisting healthcare professionals in making informed clinical decisions. Its unique operational characteristics set it apart from other types of electrodes used for measuring different analytes in similar environments.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU104#005"/>
          <hierarchical_position>42010409</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV732#015" guid="b3465c54b82e4e0480a1a9a7d9ca9bd1">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Glucose electrode (clinical laboratory)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification identifies a specific type of analytical device used in clinical laboratories for the quantitative measurement of glucose levels in biological samples. It operates based on electrochemical principles, utilizing an electrode to detect glucose concentration, which is crucial for monitoring metabolic conditions, particularly diabetes management. This device plays a vital role in ensuring accurate and timely diagnoses, supporting healthcare professionals in making informed decisions regarding patient care. The glucose electrode is distinguished by its sensitivity, specificity, and response time, setting it apart from other types of electrodes used for different analytes in the clinical laboratory environment.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU104#005"/>
          <hierarchical_position>42010410</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV733#015" guid="6a33711092f848b8811073604e214248">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Glycated haemoglobin electrode (clinical laboratory)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses devices specifically designed to measure glycated haemoglobin levels in clinical laboratory settings. These electrodes are integral in diagnosing and monitoring conditions related to glucose metabolism, such as diabetes. The technology facilitates the accurate assessment of long-term glucose control by quantifying the percentage of glycated haemoglobin in a blood sample. Such measurements are essential for healthcare providers to evaluate a patient's average blood sugar levels over an extended period, enabling informed therapeutic decisions. This classification is distinct from other types of electrodes that measure various electrolytes or metabolites, reflecting its specialized function in clinical diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU104#005"/>
          <hierarchical_position>42010411</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV734#015" guid="03a761be385b42bfbe598b564c55dcb8">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Lactate electrode (clinical laboratory)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a device designed for the measurement of lactate levels in biological samples, typically utilized in clinical laboratory settings. This tool operates on the principle of electrochemical detection, converting biochemical reactions into electrical signals that indicate the concentration of lactate. It is essential for assessing metabolic conditions, monitoring exercise performance, and evaluating patients in critical care environments. The lactate electrode is specifically tailored to provide accurate and rapid results, which aids in diagnosing and managing conditions related to lactic acidosis and other metabolic disorders. It is distinct from other electrodes that measure different ions or metabolites, ensuring its unique application in clinical diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU104#005"/>
          <hierarchical_position>42010412</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV735#015" guid="38616ef9a20e4dfc8bcc0d011b5f2574">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Urea electrode (clinical laboratory)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a urea electrode designed for clinical laboratory applications is a specialized analytical device used to measure the concentration of urea in biological samples. This electrode operates based on electrochemical principles, enabling precise detection and quantification of urea levels, which are critical for assessing kidney function and metabolic states. It is distinct from other types of electrodes used in clinical settings, each tailored to measure different analytes, ensuring accurate diagnostics and monitoring of patient health. The urea electrode's design and functionality are optimized for efficiency, reliability, and ease of use in laboratory environments, contributing to effective patient care and clinical decision-making.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU104#005"/>
          <hierarchical_position>42010413</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV736#015" guid="b9ec1b5540684ba2bf23d1be62653d8c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Bilirubin electrode (clinical laboratory)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a device designed for the quantitative measurement of bilirubin levels in biological samples, typically utilized in clinical laboratory settings. This instrument functions through electrochemical principles to provide accurate and reliable testing outcomes, aiding in the diagnosis and monitoring of various medical conditions related to liver function and hemolysis. The bilirubin electrode is specifically engineered to respond selectively to bilirubin, distinguishing it from other electrodes that measure different analytes. It is an essential tool in clinical diagnostics, contributing to patient care by facilitating timely and precise laboratory analyses.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU104#005"/>
          <hierarchical_position>42010414</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV737#015" guid="0a9dc8387dce47aa8847db2e8c8e987e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Reference electrode (clinical laboratory)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a reference electrode designed for use in clinical laboratory settings is a specialized electrode that serves as a stable reference point for measuring the potential of other electrodes during electrochemical analysis. It is crucial for ensuring accurate and reliable readings in various diagnostic tests, providing a consistent baseline against which the voltages of other electrodes can be measured. This type of electrode is essential for applications that involve potentiometric measurements, where the precise determination of ion concentrations is necessary for clinical assessments. The reference electrode typically utilizes a stable electrochemical system that maintains a constant potential, allowing for precise comparisons in the measurement of various analytes in biological samples.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU104#005"/>
          <hierarchical_position>42010415</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV738#015" guid="cc287bcde796479fa9bb5a9c623f5ea5">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Electrolyte electrode buffer and solution</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a solution or mixture designed to maintain or adjust the ionic environment necessary for the proper functioning of electrodes used in clinical laboratory settings. This type of formulation is specifically tailored to enhance the performance and reliability of electrochemical measurements, ensuring accurate readings by stabilizing the pH and ionic strength of the measurement medium. It serves as a crucial component in various analytical processes, facilitating the interaction between the electrode and the sample being analyzed. These formulations may comprise various salts, acids, or other buffering agents, designed to optimize the operational conditions for a range of electrode types used in clinical diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU104#005"/>
          <hierarchical_position>42010416</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV739#015" guid="9794ff77f9204b3b956f836091e0fa67">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Substrate electrode buffer and solution</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance specifically designed to enhance the performance and stability of electrodes used in clinical laboratory settings. This substance serves as a medium that facilitates the proper functioning of electrodes by providing an optimal environment for electrochemical reactions. It may comprise various chemical components that ensure the electrode maintains its sensitivity and accuracy when measuring specific analytes in biological samples. The formulation is engineered to mitigate interference from other substances present in the sample, thereby ensuring reliable and reproducible results in clinical diagnostics. This category is distinct from others that focus on specific types of electrodes, highlighting its unique role in supporting the overall functionality of electrochemical measurement devices in medical applications.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU104#005"/>
          <hierarchical_position>42010417</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV740#015" guid="f18e49a66f5d42ad96ceee8740593273">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Common buffer and solution (electrolyte)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a solution or mixture utilized to maintain the electrochemical environment necessary for the proper functioning of electrodes in analytical applications. This formulation typically includes electrolytes that facilitate the conduction of electrical currents, enhancing the accuracy and reliability of measurements taken in clinical laboratory settings. These substances are essential for calibrating and stabilizing various types of electrodes, ensuring optimal performance during testing and analysis. Their composition is designed to support a range of laboratory procedures, contributing to the overall efficacy of diagnostic tools and methodologies used in clinical environments.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU104#005"/>
          <hierarchical_position>42010418</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV741#015" guid="c17b014490ae406286fe3b922e7ec9eb">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Electrode and biosensor (clinical laboratory, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU104#005"/>
          <hierarchical_position>42010490</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-AFU664#011" guid="4cd490499b794c469bd4229ad2509aaf">
          <date_of_original_definition>2014-11-30Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Electrode and biosensor (clinical laboratory, parts)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects with spare part characteristics that maintain or re-store the original condition of the objects classified under the parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU104#005"/>
          <hierarchical_position>42010491</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-AFU802#011" guid="d7f3ca2273e74dc4ae0985839444df0b">
          <date_of_original_definition>2014-11-30Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Electrode and biosensor (clinical laboratory, accessories)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects with complemental characteristics, without which the basic function of the objects classified under the parent-class on the 3rd level is still guaranteed</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU104#005"/>
          <hierarchical_position>42010492</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU151#005" guid="521973899a014eb7a5e89540df8921aa">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Rapid test (infectious immunology)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic tests designed for the rapid detection of infectious agents through immunological methods. These tests are typically characterized by their ability to deliver quick results, facilitating timely clinical decision-making. The focus is on identifying specific antigens or antibodies related to various infectious diseases, enabling healthcare professionals to diagnose conditions efficiently. This category specifically excludes other testing areas such as bacteriology, hepatitis virus, retroviruses, virology, parasitology, and mycology, ensuring a clear distinction in the types of immunological tests being classified. The items classified here are essential tools in infectious disease management, particularly in acute settings where rapid diagnosis is critical for effective patient care.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS277#005"/>
          <hierarchical_position>42050900</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW827#015" guid="cad67a007361486198ff939c2e28fd2f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Chlamydia antigen (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a rapid diagnostic test designed to detect the presence of Chlamydia antigens in biological samples, facilitating the identification of Chlamydia infections. This test operates on the principle of immunoassay, providing results in a short timeframe, which is crucial for timely diagnosis and treatment. The test is typically characterized by its ease of use, requiring minimal technical expertise, and is suitable for point-of-care settings. It plays a vital role in public health by enabling rapid screening and monitoring of Chlamydia, contributing to effective disease management and control strategies. The specificity and sensitivity of the test are essential for accurate results, ensuring reliable identification of this common sexually transmitted infection.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU151#005"/>
          <hierarchical_position>42050901</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW828#015" guid="8d75eabab90843ceab411f9f30fa2581">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Helicobacter pylori (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic procedure designed for the rapid detection of a specific bacterium associated with gastrointestinal infections. This test provides a quick assessment of the presence of the bacterium in biological samples, facilitating timely diagnosis and treatment options. The method employed is typically immunological in nature, allowing for the identification of antibodies or antigens related to the bacterium. This rapid testing approach is essential in clinical settings where swift results are crucial for patient management. It is particularly useful in outpatient environments and for initial screening purposes to guide further diagnostic investigations or therapeutic interventions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU151#005"/>
          <hierarchical_position>42050902</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW829#015" guid="b7ad55adb2d042b0b1646cca6612f9c7">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Streptococcus A (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a diagnostic test designed for the rapid identification of a specific bacterial pathogen known to cause infections in humans. The test is characterized by its ability to deliver quick results, facilitating timely medical decisions. It operates on principles of immunological detection, utilizing specific antibodies or antigens related to the targeted organism. This rapid testing method is essential in clinical settings for the swift diagnosis of infections, allowing healthcare professionals to initiate appropriate treatment strategies without significant delays. It is distinct from other similar diagnostic tests that target different infectious agents, emphasizing its unique role in infectious disease management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU151#005"/>
          <hierarchical_position>42050903</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW830#015" guid="2513b8a4ddf949b69a15506657dbd10d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Streptococcus B (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic tool designed for the rapid detection of a specific bacterial pathogen, enabling clinicians to identify the presence of this microorganism in a biological sample. This test utilizes immunological methods to provide results within a short timeframe, facilitating timely diagnosis and treatment decisions. It is essential in the context of infectious diseases, allowing for the differentiation of this pathogen from other similar infections. The product is intended for use in clinical laboratories and point-of-care settings, ensuring quick and efficient patient management. The rapid test contributes to improved healthcare outcomes by allowing for immediate clinical action based on the test results.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU151#005"/>
          <hierarchical_position>42050904</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW831#015" guid="b0dba693157b4c29a6ca3beb656f0f2c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Syphilis (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic tests that provide rapid results for the detection of specific infectious agents. These tests are designed to identify the presence of particular antigens or antibodies associated with various pathogens, facilitating quick decision-making in clinical settings. The focus is on tests that deliver results in a short timeframe, allowing for timely diagnosis and treatment of infections. Each item within this category is distinct in terms of the specific infectious agent it targets, enabling healthcare professionals to accurately assess and manage patient conditions related to infectious diseases.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU151#005"/>
          <hierarchical_position>42050905</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW832#015" guid="77abdd86a2804c79a679ac7b30172c86">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Clostridium difficile (inclusive toxin A and B, rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a diagnostic tool used for the detection of Clostridium difficile, including its associated toxins A and B, through a rapid testing method. It serves to identify the presence of this specific pathogen in clinical samples, facilitating timely diagnosis and treatment. This category is distinct from other rapid testing procedures for various infectious agents, each targeting different pathogens or diseases, thereby highlighting its unique application in infectious immunology. The rapid test is designed to provide quick results, aiding healthcare professionals in making informed decisions regarding patient management and infection control.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU151#005"/>
          <hierarchical_position>42050906</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW833#015" guid="56e2a4f75f364b7b94f229bdd78bc9c8">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Meningitis causitive agent (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic tool designed for the rapid detection of the pathogen responsible for meningitis, utilizing immunological methods to identify specific antigens or antibodies associated with the infectious agent. This test is intended for swift clinical decision-making in situations where timely diagnosis is critical. It aims to provide healthcare professionals with immediate results to facilitate appropriate treatment and management of patients suspected of having meningitis. The methodology employed in this test ensures high sensitivity and specificity, contributing to accurate diagnosis while minimizing the time required for laboratory analysis.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU151#005"/>
          <hierarchical_position>42050907</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW834#015" guid="76f616d58ac14210957472d8ee79af80">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Legionella (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic tool designed to detect the presence of specific antigens associated with the Legionella bacteria in a rapid manner. This method allows for quick identification of potential infections caused by Legionella species, enabling timely clinical decision-making. The test is typically performed on samples such as respiratory secretions, and it is essential in the context of infectious disease management. The rapid nature of this assessment provides results in a short time frame, facilitating prompt treatment and intervention for affected individuals. This classification encompasses various rapid testing methods focusing on infectious immunology, highlighting the importance of swift and accurate detection in managing infectious diseases.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU151#005"/>
          <hierarchical_position>42050908</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW835#015" guid="00836a6fc5874f93bbf5769efb641fa8">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HBsAg (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic tool designed for the rapid detection of Hepatitis B surface antigen (HBsAg) in biological samples. This test is utilized in clinical settings to provide immediate results, facilitating the identification of active Hepatitis B infections. The rapid test format allows healthcare professionals to make timely decisions regarding patient management and treatment. It is characterized by its ease of use, quick turnaround time, and the ability to deliver results without the need for extensive laboratory infrastructure. The technology employed may vary but typically involves immunological methods that yield qualitative results, indicating the presence or absence of the antigen. This classification uniquely addresses the specific needs and applications associated with Hepatitis B diagnosis within the broader category of infectious immunology testing.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU151#005"/>
          <hierarchical_position>42050909</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW836#015" guid="cee336026d61407b9acd719fe56958f6">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HCV antibody (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic tool designed for the rapid detection of antibodies associated with a specific virus, typically used in clinical settings to provide quick results for screening or confirming infections. This type of assay utilizes immunological methods to identify the presence of antibodies in a patient's sample, facilitating timely diagnosis and management of infectious diseases. The rapid test format ensures results are obtained in a short timeframe, supporting immediate clinical decision-making. This category is distinguished from other similar tests based on the specific target antibodies being analyzed, contributing to different diagnostic pathways in infectious immunology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU151#005"/>
          <hierarchical_position>42050910</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW837#015" guid="271ff90190d74da394a36076e025a22a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HIV 1 (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic tool designed for the rapid detection of HIV 1 antibodies, facilitating timely and efficient screening for this specific viral infection. This test employs immunological techniques to determine the presence of antibodies in a patient's sample, providing results in a short timeframe. The method is crucial for early diagnosis, enabling healthcare professionals to initiate appropriate treatment and care. It is important in public health initiatives aimed at controlling the spread of HIV, particularly in high-risk populations. This category is distinct from other rapid tests targeting various infectious agents, each tailored to identify specific pathogens or antibodies relevant to their respective diseases.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU151#005"/>
          <hierarchical_position>42050911</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW838#015" guid="aa8876064edb42b39afb458928439f11">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HIV 1 / 2 (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a rapid diagnostic test designed to detect the presence of antibodies to the Human Immunodeficiency Virus (HIV) types 1 and 2 in human specimens. This test is characterized by its quick turnaround time, enabling healthcare providers to obtain results within a short period, facilitating timely clinical decision-making. It is utilized in various settings, including hospitals, clinics, and community health programs, to screen individuals for HIV infection. The test contributes to public health efforts aimed at early detection and management of HIV, thereby playing a critical role in preventing the transmission of the virus and improving the health outcomes of affected individuals.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU151#005"/>
          <hierarchical_position>42050912</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW839#015" guid="4d12e54e88a5463b95b6416280c5c618">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">CMV (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic tool designed for the rapid detection of specific infectious agents or biomarkers related to immunological responses. This type of test is characterized by its ability to provide quick results, facilitating timely clinical decision-making. It is utilized in various healthcare settings to identify the presence of pathogens or antibodies, aiding in the diagnosis of infectious diseases. The tests are typically designed for ease of use, often requiring minimal preparation and providing results in a short timeframe. They play a critical role in the management of infectious diseases by enabling healthcare professionals to initiate appropriate treatment swiftly, thereby improving patient outcomes and controlling the spread of infections.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU151#005"/>
          <hierarchical_position>42050913</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW840#015" guid="bed8bf519bcb40bdb40493880d8bac58">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">RSV (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic tool designed for the rapid detection of specific infectious diseases through immunological methods. This type of test allows for quick identification of pathogens or their components in various sample types, enabling timely clinical decision-making. The test is characterized by its ease of use, requiring minimal equipment or specialized training for administration. Results are typically available within a short timeframe, facilitating prompt diagnosis and treatment. It is employed in various healthcare settings, including hospitals and clinics, to assist in the management of infectious diseases. This particular category focuses on assays that target a specific infectious agent, differentiating it from other rapid tests aimed at detecting different pathogens or conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU151#005"/>
          <hierarchical_position>42050914</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW493#015" guid="ffb2f436d6504cc7a42d79602006e6f6">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Manual mycobacteria media (tube and bottle)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specialized formulation designed for the cultivation and isolation of mycobacteria in laboratory settings, typically provided in tube or bottle formats. This media is specifically intended for use in microbiological assays, enabling the growth of mycobacterial species by providing essential nutrients, growth factors, and specific environmental conditions. It supports the identification and diagnosis of mycobacterial infections, serving as a critical tool in clinical and research laboratories. The media may include selective agents to inhibit the growth of non-target organisms, ensuring optimal conditions for the proliferation of mycobacteria. This classification distinguishes it from other media types utilized in bacteriological cultures, emphasizing its unique application and formulation tailored for mycobacterial diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU135#005"/>
          <hierarchical_position>42040120</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW494#015" guid="4b9731cf18e4433abd8bf85fee2135eb">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Mycobacteria media, bottle (automated)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a category encompassing specialized liquid media designed for the cultivation and detection of mycobacteria in laboratory settings. This type of media is typically packaged in bottles suitable for automated systems, facilitating efficient processing and analysis of samples. It serves as a vital tool in microbiological diagnostics, particularly in identifying and studying mycobacterial species, which are of significant interest in the context of infectious diseases. The classification distinctly separates it from other media types utilized in bacteriology, focusing on its unique formulation and application in automated laboratory environments.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU135#005"/>
          <hierarchical_position>42040121</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW495#015" guid="8c1b95d8502145d9992bd19c4b1682d2">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Bacteriology (culture, IVD, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU135#005"/>
          <hierarchical_position>42040190</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU108#007" guid="0891e59015b84f5f87bf5e6ad1b31968">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Clinical chemistry (other)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Group (3rd level) for objects that cannot be classified into other specified groups in the existing structure, but that are classified to their parent-class on the 2nd level. A xx-xx-90-00-class cannot have any other sub-groups besides the generic xx-xx-90-90-class (…(Other, unspecified)) to be generally valid within the parent class on the 2nd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADS273#005"/>
          <hierarchical_position>42019000</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV815#015" guid="c58b41c5fb2d4dd1aacca23ce83a1a74">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Clinical chemistry (other, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU108#007"/>
          <hierarchical_position>42019090</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU104#005" guid="acd74af42cde41fd98d7b86935023c68">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Electrode and biosensor (clinical laboratory)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses devices and materials specifically designed for clinical laboratory applications that measure or analyze biochemical substances through electrochemical methods. These items are integral to various diagnostic processes, providing critical information about the concentration of specific ions, metabolites, and other analytes in biological samples. The category includes electrodes tailored for measuring various electrolytes and metabolites, along with associated buffers and solutions that facilitate accurate testing. These components play a vital role in clinical chemistry, ensuring precise and reliable results essential for patient diagnosis and monitoring. This grouping is distinct from other related classifications that involve different types of reagents or methodologies used in clinical settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS273#005"/>
          <hierarchical_position>42010400</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV723#015" guid="b2dc4868a3134849bd609994478d04df">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Ammonia electrode (clinical laboratory)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">an ammonia electrode used in clinical laboratories is a specialized sensor designed to measure the concentration of ammonia in biological samples. This device operates on principles of electrochemistry, providing precise and rapid detection of ammonia levels, which are critical for diagnosing various medical conditions. The ammonia electrode is essential in monitoring metabolic processes and assessing liver function, as elevated ammonia levels can indicate dysfunction. This type of electrode is calibrated for accuracy and sensitivity, ensuring reliable results in laboratory settings. Its application is vital for healthcare professionals who require accurate biochemical data to inform treatment decisions and patient care.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU104#005"/>
          <hierarchical_position>42010401</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV724#015" guid="c17879a754c9442ea5c46f6ee915f46d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Calcium electrode (clinical laboratory)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a device designed to measure the concentration of calcium ions in biological samples, primarily used in clinical laboratory settings. This instrument operates based on electrochemical principles, providing precise and reliable readings essential for diagnosing and monitoring various medical conditions related to calcium metabolism. The device typically features a sensing element that responds to the presence of calcium ions, translating their activity into measurable electrical signals. Its applications are critical in areas such as endocrinology and nephrology, where calcium levels play a significant role in patient health assessment and treatment planning. The functionality of this device is distinct from other ion-selective electrodes, each targeting different ions or compounds relevant to clinical diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU104#005"/>
          <hierarchical_position>42010402</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV725#015" guid="b1951d80e2014f6e9e07f3140fa4f6ac">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Chloride electrode (clinical laboratory)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a device designed for the measurement of chloride ion concentration in biological samples, specifically utilized in clinical laboratory settings. This electrode operates based on the electrochemical response generated by chloride ions, providing precise and reliable analytical data. It is essential for various diagnostic applications, including electrolyte balance assessments and monitoring of metabolic conditions. The functionality of this electrode is tailored to ensure compatibility with standard laboratory equipment, making it a vital tool for healthcare professionals. Its design prioritizes accuracy, stability, and ease of use, contributing to effective patient care through enhanced diagnostic capabilities.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU104#005"/>
          <hierarchical_position>42010403</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV726#015" guid="4bb6fc8f20394f3f80473c1869416070">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Lithium electrode (clinical laboratory)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a device designed for the measurement of voltage or potential differences associated with lithium ions in a clinical laboratory setting. This instrument is utilized in various diagnostic procedures to assess lithium concentration in biological samples, aiding in monitoring therapeutic levels and ensuring patient safety. It plays a critical role in clinical evaluations and research, contributing to the accurate analysis of lithium's pharmacokinetics and its impact on health conditions. The device operates based on electrochemical principles, providing reliable and precise measurements essential for informed clinical decision-making.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU104#005"/>
          <hierarchical_position>42010404</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW297#015" guid="a31fed399eed4a688ea6d9c69784e6cb">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Haemoglobin subtype HbA2,HbC,HbF,HbS (excl. HbA1)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses specific types of haemoglobin fractions that are crucial for diagnostic purposes in the field of haematology. The focus is on distinct subtypes of haemoglobin, each with unique physiological and clinical significance. These subtypes play an essential role in various diagnostic tests aimed at identifying or monitoring specific conditions related to blood disorders. The classification is designed to facilitate the identification and utilization of reagents that detect, quantify, or analyze these haemoglobin variants, thereby supporting healthcare professionals in delivering accurate diagnoses and effective patient management. It is important to note that this classification excludes certain common reagents used for broader haematological assessments or controls, focusing instead on the specialized needs associated with these particular haemoglobin subtypes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU126#005"/>
          <hierarchical_position>42030104</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW298#015" guid="7bc775d6895b4c16b732f3589e9086a6">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Histology, cytology stain</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a category of diagnostic substances specifically designed for the examination and analysis of biological tissue samples and cellular structures. These substances facilitate the identification and differentiation of various cellular components, enhancing the visualization of tissue morphology and cellular characteristics under microscopic evaluation. The category is distinct from other reagents used in hematological assessments, which may involve different methodologies, target different biological markers, or serve specific procedural purposes in blood analysis and related diagnostics. Such substances play a crucial role in supporting medical professionals in diagnosing diseases, conducting research, and advancing clinical knowledge in the field of pathology and cytology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU126#005"/>
          <hierarchical_position>42030105</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW299#015" guid="b51d55273934460282cc0483647a427e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Romanowsky stain</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a staining solution used primarily in the examination of blood and other biological specimens, facilitating the visualization of cellular structures under a microscope. This reagent is integral to the identification and differentiation of various cell types, enhancing the diagnostic capabilities of haematological assessments. It is specifically formulated to produce distinct colorimetric reactions, allowing for the assessment of cellular morphology and the detection of abnormalities. The application of this reagent is critical in clinical and research settings, contributing to the analysis of blood samples and aiding in the diagnosis of hematological disorders.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU126#005"/>
          <hierarchical_position>42030106</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW300#015" guid="27003ea9dddf4a67bd29b522349b2902">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cellular enzyme determination reagent (G-6-PDH, pyruvate kinase)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance used in laboratory testing to identify and quantify specific enzyme activities related to cellular metabolism. This reagent plays a crucial role in diagnostic procedures, particularly in the analysis of blood samples, to assess enzyme functions that can indicate various health conditions. Its application is essential in clinical settings where accurate hematological evaluations are required. This reagent is distinct from other hematology-related substances, focusing specifically on enzymatic reactions rather than general blood component analysis or other diagnostic functions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU126#005"/>
          <hierarchical_position>42030107</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW301#015" guid="483de51ccf134029a75f569180ac45e2">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Erythrocyte sedimentation rate test</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a test used to measure the rate at which red blood cells settle at the bottom of a test tube containing blood. This measurement is utilized to evaluate the presence of inflammation or other medical conditions. The procedure involves the collection of a blood sample, which is then subjected to a standardized process to determine the sedimentation rate. An elevated rate may indicate various health issues, while a normal rate can suggest the absence of significant inflammatory processes. This test is commonly employed in clinical laboratories as part of a comprehensive assessment of a patient's health status.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU126#005"/>
          <hierarchical_position>42030108</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW302#015" guid="23f58ad318cf4a46bd2d0b1790e451b5">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Blood pressure control (normal)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a range of products specifically designed for monitoring and managing normal blood pressure levels. These products are utilized in both clinical and home settings to ensure accurate readings and assessments of blood pressure. They are crucial for preventive healthcare measures, allowing for regular monitoring to maintain cardiovascular health. In this context, the products serve as essential tools for healthcare professionals and patients alike, facilitating ongoing health management and early detection of potential issues. This classification distinctly excludes items related to abnormal blood pressure control, multi-level monitoring devices, and various hematology reagents associated with other specific blood parameters or conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU126#005"/>
          <hierarchical_position>42030109</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW303#015" guid="a2b49bd2bda044e8b65356431c5f480b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Blood pressure control (abnormal)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to the assessment of blood pressure parameters that deviate from established normal ranges. It encompasses products or services designed specifically for monitoring, evaluating, or managing blood pressure levels that are categorized as abnormal. The offerings within this classification support healthcare professionals in diagnosing hypertension or other related cardiovascular conditions. These tools may include diagnostic devices, reagents, and other aids that facilitate the accurate measurement and analysis of blood pressure readings. The focus is on ensuring that such measurements provide reliable data for effective patient management and treatment planning in clinical settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU126#005"/>
          <hierarchical_position>42030110</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW304#015" guid="fda9252fec3149c5ac2c58e4c7727e03">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Blood pressure control (multilevel)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a category for products or services designed specifically for the assessment and management of blood pressure levels, offering various methodologies to ensure accurate monitoring and control. This classification encompasses tools and reagents utilized in clinical settings, focusing on the precise measurement and evaluation of blood pressure variations. These items are essential for healthcare professionals in diagnosing and managing conditions related to hypertension or other cardiovascular issues. The offerings include solutions that may be utilized in both routine checks and specialized testing scenarios, ensuring a comprehensive approach to blood pressure management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU126#005"/>
          <hierarchical_position>42030111</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW305#015" guid="5bf611e99a174498914b1f8e6a94276f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Haemoglobin control</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance or preparation used specifically for the assessment and monitoring of haemoglobin levels in biological samples, enabling healthcare professionals to evaluate and manage conditions related to blood oxygen transport and overall health. This product is designed to provide precise measurements for diagnostic purposes, and is typically utilized in laboratory settings or point-of-care environments. It is distinguished from other reagents that serve different functions in haematological analysis, focusing solely on the control and calibration of haemoglobin detection methods to ensure accuracy in test results.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU126#005"/>
          <hierarchical_position>42030112</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW306#015" guid="5fa9b67e0dff44dda3d695d847e90e2c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Platelet control</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a category of reagents specifically designed for the monitoring and assessment of platelet functionality and concentration in blood samples. These reagents are utilized in various diagnostic procedures to evaluate platelet activity, which is crucial for understanding coagulation processes and diagnosing related disorders. The products in this category are distinguished by their specific application in platelet analysis, differentiating them from other hematological reagents that focus on red blood cells, hemoglobin levels, or general blood composition. They play a vital role in clinical laboratories and healthcare settings, facilitating accurate diagnostic outcomes and effective patient management in conditions involving thrombocytopenia or other platelet function abnormalities.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU126#005"/>
          <hierarchical_position>42030113</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW307#015" guid="3f67094729564c149fab6be7163ce288">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Reticulocyte control</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance or preparation specifically designed for the assessment and monitoring of reticulocyte levels in blood samples. This type of reagent plays a critical role in evaluating bone marrow function and red blood cell production, providing insights into various hematological conditions. It is distinguished from other reagents used in hematology by its unique focus on reticulocyte measurement, which is essential for diagnosing and managing anemia and evaluating responses to treatment. This reagent supports laboratory professionals in accurately determining reticulocyte counts and ensuring reliable results in clinical diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU126#005"/>
          <hierarchical_position>42030114</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW308#015" guid="3198265e29304338b59217105c15b5b1">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Whole blood calibrator</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance or preparation used to establish a reference point in laboratory assays related to the analysis of blood components. This material is specifically designed to ensure accuracy and reliability in testing procedures, providing a standard against which test results can be compared. It plays a crucial role in calibrating instruments and validating methodologies within hematological diagnostics, thereby facilitating the assessment of various blood parameters and contributing to accurate patient assessments. This category encompasses products that are essential for quality control in hematology laboratories, ensuring compliance with testing protocols and enhancing the precision of diagnostic results.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU126#005"/>
          <hierarchical_position>42030115</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW309#015" guid="b95876fbe06d4f00bcc65a10856ed2fc">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Haemoglobin (Hb, Rapid Haematology, Rapid Test, Point-of-Care)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to diagnostic reagents specifically designed for the rapid measurement of haemoglobin levels in blood samples. These reagents facilitate quick and accurate assessment of haemoglobin concentration, enabling immediate clinical decisions at the point of care. Typically used in various healthcare settings, these testing solutions are crucial for monitoring and diagnosing conditions related to blood health, such as anemia or polycythemia. The rapid nature of this testing ensures timely intervention and management of patients, enhancing overall healthcare efficiency and effectiveness. The classification excludes other types of blood reagents or controls that do not focus specifically on the rapid determination of haemoglobin.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU126#005"/>
          <hierarchical_position>42030116</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW310#015" guid="b9ae61184f4e4a438737d30157210cec">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Erythrocytes (Ery, Rapid Haematology, Rapid Test, Point-of-Care)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance specifically designed for the qualitative or quantitative assessment of red blood cells in biological samples, typically utilized in point-of-care testing environments. This category encompasses reagents that facilitate rapid analysis and diagnosis related to erythrocyte characteristics, including their count, morphology, and functionality, thereby aiding healthcare professionals in the swift evaluation of patient conditions. The products in this category are intended for immediate use, often in conjunction with portable testing devices, ensuring timely results in various clinical settings. These reagents may also include components that enhance the accuracy of erythrocyte measurements while differentiating from other hematological assessments.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU126#005"/>
          <hierarchical_position>42030117</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW311#015" guid="0520a868318048ecac5ed66ef0d43ea5">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Haematocrit (HCT, Rapid Haematology, Rapid Test, Point-of-Care)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic materials designed specifically for the rapid assessment of hematocrit levels in blood samples. These substances are utilized in point-of-care settings, enabling healthcare professionals to quickly evaluate the volume percentage of red blood cells in whole blood. The focus is on tests that provide immediate results, facilitating timely clinical decisions. The defined materials are distinct from other hematology reagents that serve different purposes, such as those related to cellular analysis, blood pressure monitoring, or other hematological assessments. The intent is to support effective patient management through efficient and accurate diagnostic processes in various healthcare environments.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU126#005"/>
          <hierarchical_position>42030118</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW312#015" guid="7b747b79a72a44eabda203561a9b5318">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Haematology reagent (unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU126#005"/>
          <hierarchical_position>42030190</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU130#005" guid="eb91358a852b4e229155818b92635476">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Monoclonal antibody</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a category of biologically derived agents specifically designed for therapeutic or diagnostic purposes, primarily in immunological and hematological contexts. These agents are engineered to target specific proteins or cells, facilitating enhanced detection, analysis, or management of various conditions related to the immune system and blood disorders. The focus is on antibodies that have been produced from a single clone of cells, ensuring uniformity and specificity in their interactions with antigens. Applications may include but are not limited to, cellular identification, disease monitoring, and therapeutic interventions, particularly in oncology and immunology. This category serves as a crucial tool in clinical and research settings, aiding in the understanding and treatment of complex biological systems.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS275#005"/>
          <hierarchical_position>42030500</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW401#015" guid="a5a8a163be13433dade5dd0e08046ec5">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Antibody for B and T-cell subtyping</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specialized reagent designed for the identification and classification of B and T-cell populations, facilitating the analysis of immune responses and cellular interactions. This product is utilized in various laboratory applications, including research and clinical diagnostics, to provide insights into immune system functionality and disorders. It is characterized by its specificity in binding to unique markers present on the surface of B and T lymphocytes, enabling precise differentiation and enumeration of these cell types. This reagent is essential in applications such as immunophenotyping, where understanding the composition and characteristics of lymphocyte subsets is critical for diagnosing and monitoring diseases related to the immune system.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU130#005"/>
          <hierarchical_position>42030501</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW402#015" guid="0a78229de9bd46a2ade27214605216fd">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Antibody for HLA class II determinant</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific type of protein that is produced by immune cells, designed to bind to particular molecules known as HLA class II determinants. These proteins play a crucial role in the immune response by identifying and targeting specific antigens presented by cells. This classification includes those antibodies that are generated through hybridoma technology, ensuring high specificity and affinity for their intended target. The primary use of this type of antibody is in research and clinical diagnostics, particularly in the context of immunology and transplantation, where understanding the interaction between immune cells and antigen-presenting cells is essential. It is distinct from other similar products that target different cell types or functionalities in the immune system.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU130#005"/>
          <hierarchical_position>42030502</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW403#015" guid="f60a308358d74dd0a279e5cf8adf511d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Antibody for lymphoma typing (except B- and T-cell typing)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specialized biological reagent designed to bind specifically to unique markers associated with lymphomas, facilitating the identification and classification of these malignancies. This reagent is distinguished from others that target specific cell types or immune responses, focusing solely on lymphoma types not related to B-cell or T-cell lineages. It plays a crucial role in diagnostic procedures, enabling healthcare professionals to ascertain the presence of lymphoma and guide treatment decisions. The application of this reagent is vital for enhancing the accuracy of lymphoma typing, thereby improving patient outcomes through tailored therapeutic approaches.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU130#005"/>
          <hierarchical_position>42030503</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW404#015" guid="ed7269686d5b43ebb84143547133f287">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Antibody for recognizing cell surface receptors</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific type of antibody designed for the recognition and binding to cell surface receptors, facilitating the identification and analysis of various cell types in biological research and clinical applications. This type of antibody is characterized by its ability to selectively interact with specific proteins located on the exterior of cells, playing a critical role in immunological studies, cellular signaling investigations, and diagnostic processes. The usage of this antibody is paramount in assays aimed at understanding cellular interactions, disease mechanisms, and therapeutic targets, making it an essential tool in both research laboratories and clinical settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU130#005"/>
          <hierarchical_position>42030504</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW405#015" guid="95a819a62372477d82ed37fe897d5268">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Antibody for subtyping of leukemia (except B- and T-cell typing)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specialized biological reagent designed for the identification and classification of specific leukemia subtypes, excluding those associated with B- and T-cell lineages. This reagent operates by binding to unique antigens present on the surface of leukemia cells, facilitating their differentiation from other cell types. It is utilized in diagnostic and research settings to enhance understanding of leukemia pathophysiology and to guide therapeutic decisions. The functionality of this reagent is distinct from others that target different cell types or functions, ensuring precise applications in the field of hematology and oncology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU130#005"/>
          <hierarchical_position>42030505</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW406#015" guid="e0c47011d5ab4f008694e31c7d613e09">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Antibody for lymphocyte subtyping</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses specialized biological agents designed to bind to specific proteins on the surface of lymphocytes, facilitating the identification and characterization of different subpopulations within this type of white blood cell. These agents are utilized primarily in immunological research and clinical diagnostics to provide insights into immune responses, disease states, and cellular functions. The focus is on distinguishing between various lymphocyte subtypes, which is crucial for understanding various immunological conditions and for guiding therapeutic decisions. Such products may be employed in laboratory techniques, including flow cytometry and immunohistochemistry, to enhance the accuracy of lymphocyte profiling and to support the development of targeted therapies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU130#005"/>
          <hierarchical_position>42030506</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW407#015" guid="93bef94a4cee4e38be8bb73e8a694a68">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Monoclonal antibody for recognizing enzymes</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to specialized biochemical agents that are engineered to bind specifically to unique enzymes. These agents are utilized extensively in research and clinical settings to facilitate the detection, quantification, and analysis of enzyme activity. They play a crucial role in various applications, including diagnostic assays, therapeutic monitoring, and experimental research. By providing a means to specifically identify and characterize enzymes, these agents contribute to advancements in fields such as immunology, molecular biology, and clinical diagnostics. Their specificity and selectivity make them invaluable tools in understanding enzyme functions and their implications in biological processes and diseases.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU130#005"/>
          <hierarchical_position>42030507</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW408#015" guid="6276ba8cd1ac417dbf6284b7b330227e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">IgA, IgD, IgM, IgG, IgE (monoclonal antibody)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a category of biologically derived proteins designed to specifically bind to a particular antigen. These proteins are produced from a single clone of immune cells, leading to the generation of highly specific binding sites. The focus of this classification is on various types of these proteins, which are distinguished by their unique structures and functional roles in immunological responses. They may be utilized in various applications, including diagnostics, therapeutic interventions, and research purposes, each serving to target specific antigens or markers in biological samples. The classification captures the diverse functionalities of these proteins in relation to immune response, disease identification, and treatment strategies, differentiating them from other similar biologically relevant products.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU130#005"/>
          <hierarchical_position>42030508</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW409#015" guid="950a338449cf42229dbfef63163e3d52">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Monoclonal antibody for detecting cells expressing kappa or lambda light chains</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biopharmaceutical product designed to specifically bind to and identify cells that express either kappa or lambda light chains. This type of agent is utilized in various analytical applications, particularly in immunology and hematology, for the purpose of distinguishing cell populations based on their immunoglobulin light chain expression. The product plays a critical role in research and clinical diagnostics, enabling the assessment of specific cellular characteristics and aiding in the understanding of various biological processes and disease states. It is distinct from other related products that focus on different aspects of cellular identification and characterization.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU130#005"/>
          <hierarchical_position>42030509</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW410#015" guid="156f071ebb6b4da5b2e1810f4a55c55b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Proliferation marker</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a proliferation marker is a specialized reagent or substance used to identify and measure the proliferation of specific cell types, typically in the context of immunological assays. This marker facilitates the assessment of cellular growth and division, often utilized in research and clinical diagnostics to evaluate immune responses, cancer progression, or other biological processes. By binding to particular cellular components or expressing specific characteristics, proliferation markers provide valuable insights into the status and behavior of cells under investigation. They are essential tools in various applications, including flow cytometry and immunohistochemistry, aiding in the understanding of cellular dynamics and immune system function.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU130#005"/>
          <hierarchical_position>42030510</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW411#015" guid="db8ce57989f945f7b6ab89732f70f22c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Stem cell enumeration reagent</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a reagent specifically designed for the quantification and analysis of stem cells within a biological sample, facilitating the identification and enumeration of these cells through various laboratory techniques. This product is essential for research and clinical applications that require precise measurement of stem cell populations, contributing to studies in regenerative medicine, hematology, and developmental biology. The reagent typically interacts with specific markers on stem cells, enabling their differentiation from other cell types in complex mixtures. Its usage is pivotal in understanding stem cell behavior, potential therapeutic applications, and the development of treatments targeting stem cell-related conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU130#005"/>
          <hierarchical_position>42030511</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW412#015" guid="b6e6f83bdf2a48a994b734b4b8d2fb48">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Setup beads (flow cytometry)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to specialized particles utilized in flow cytometry applications, designed to enhance the accuracy and reliability of analytical processes. These particles serve as essential tools for calibrating and optimizing flow cytometers, ensuring precise measurements and interpretations of cellular characteristics. They may be employed to assist in the identification and quantification of specific cell populations, fostering improved experimental outcomes. The defined items are integral in achieving consistent performance across various assays, contributing to the overall quality of laboratory results and advancements in research methodologies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU130#005"/>
          <hierarchical_position>42030512</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW413#015" guid="0dda88fc92c149c4a9257b680eb186cb">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Leucocyte control (flow cytometry)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specialized reagent utilized in flow cytometry for the determination and analysis of leukocyte populations. This product plays a crucial role in immunophenotyping by enabling the identification and quantification of various types of white blood cells based on their specific surface markers. It is designed to facilitate detailed assessments of immune responses, aiding in both diagnostic and research applications. By providing accurate and reliable data regarding leukocyte characteristics, this reagent supports clinical decision-making and enhances the understanding of immune system dynamics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU130#005"/>
          <hierarchical_position>42030513</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW414#015" guid="53aa899f840a408389ff03e6aef18e4c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Lymphocyte subtyping control (flow cytometry)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific reagent utilized in the analysis and classification of lymphocytes through flow cytometry techniques. This product is designed to facilitate the identification and differentiation of various lymphocyte populations based on their unique surface markers. It serves as a control to ensure the accuracy and reliability of flow cytometry results, enabling researchers and clinicians to assess immune responses, diagnose hematological disorders, and monitor therapeutic interventions. The reagent is essential for achieving precise lymphocyte subtyping, contributing to a deeper understanding of immune function and pathology in various health conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU130#005"/>
          <hierarchical_position>42030514</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW841#015" guid="775752dec5854e2e84aa1669ad44ae8b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Mononucleosis (EBV, rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic tests specifically designed for the rapid detection of infectious diseases caused by the Epstein-Barr virus, which is associated with mononucleosis. These tests utilize immunological methods to identify the presence of specific antibodies or antigens related to the virus in biological samples. They are characterized by their quick turnaround times, allowing for prompt diagnosis and management of the condition. Such tests are essential in clinical settings for differentiating mononucleosis from other infectious diseases, aiding healthcare professionals in making informed decisions regarding treatment and patient care.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU151#005"/>
          <hierarchical_position>42050915</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW842#015" guid="c0f266d1522d4eebb7014ae3ca3ef087">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Influenza A and /or B (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic tests specifically designed for the rapid detection of Influenza A and/or B viruses. These tests are utilized in clinical settings to facilitate timely diagnosis and management of influenza infections, enabling healthcare providers to make informed decisions regarding treatment and patient care. The rapid nature of these tests allows for quick results, reducing the time between testing and diagnosis, which is crucial in managing infectious diseases. This category is distinct from other similar diagnostic tests that target different infectious agents, ensuring clarity and precision in the classification of medical diagnostic tools.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU151#005"/>
          <hierarchical_position>42050916</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW843#015" guid="cf6277a3af974f8a8aa002f0cfcb3b3b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">VZV (rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic tests designed for the rapid identification of specific infectious agents through immunological methods. These tests are characterized by their ability to deliver quick results, typically within a short timeframe, facilitating timely clinical decision-making. The focus is on tests that detect antigens, antibodies, or other markers associated with infectious diseases. The offerings within this category vary based on the particular infectious agent being targeted, ensuring versatility in diagnosing a range of health conditions. Each item within this classification is distinguished by its specific application, intended use, and the particular infectious agent it aims to identify, providing essential tools for healthcare providers in managing infectious diseases efficiently.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU151#005"/>
          <hierarchical_position>42050917</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW844#015" guid="855b62904ba0447f9c35985577aad499">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Plasmodium (malaria, rapid test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a rapid diagnostic test designed specifically to detect the presence of the Plasmodium parasite, which is responsible for malaria. This test provides quick results, enabling healthcare professionals to diagnose malaria efficiently and initiate timely treatment. The assay typically utilizes immunological methods to identify specific antigens or antibodies associated with the Plasmodium species. This classification encompasses tests that are distinct from those used for other infectious agents, reflecting the unique characteristics and requirements of malaria diagnosis. The rapid test is crucial for effective disease management, particularly in endemic areas where malaria poses significant public health challenges.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU151#005"/>
          <hierarchical_position>42050918</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW845#015" guid="1e67e13a027146ee89044a81877ac63c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Rapid test (infectious immunology, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU151#005"/>
          <hierarchical_position>42050990</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-AFU670#011" guid="97f83b7e08574796959aa2a3b9b4c85d">
          <date_of_original_definition>2014-11-30Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Rapid test (infectious immunology, parts)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects with spare part characteristics that maintain or re-store the original condition of the objects classified under the parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU151#005"/>
          <hierarchical_position>42050991</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU123#006" guid="5939a501da0e4dc0b7fbb090576101e2">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Control, standard, calibrator (immunochemistry)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a range of items used in laboratory settings to ensure the reliability and accuracy of immunochemical assays. These items are designed to provide established benchmarks for measurement and validation in immunochemistry, facilitating the assessment of various biological substances. They play a critical role in quality control by serving as reference points for calibrating instruments and validating test results. This category includes standards and controls specifically tailored for hormones, proteins, and other analytes, ensuring that diagnostic tests yield consistent and interpretable results. The items included are essential for maintaining the integrity of testing processes in immunological diagnostics and monitoring, supporting clinical decisions in patient care.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS274#006"/>
          <hierarchical_position>42021500</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW193#015" guid="05359f05ac1147efadddafcedce0a924">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">TDM, drug (standard and calibrator)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses substances used for therapeutic drug monitoring and calibration in immunochemistry applications. These substances serve as reference materials that help ensure accuracy and reliability in diagnostic testing processes. They are specifically designed to provide a standardized measure for the quantification and evaluation of drug levels, thereby facilitating precise adjustments in therapeutic regimens. The classification distinguishes these substances from others used in various immunochemical assays, focusing on their unique role in drug monitoring and calibration rather than broader categories of control or standard materials.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU123#006"/>
          <hierarchical_position>42021501</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW194#015" guid="381c6a003d11442091e8ab0128c24143">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">TDM and drug control</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specialized category related to the monitoring and management of therapeutic drugs and their effects within a clinical or laboratory setting. It includes standards and reference materials used to ensure the accuracy and reliability of immunochemical assays for drug measurement. The focus is on calibrating and controlling the parameters necessary for assessing drug levels in biological samples, which is critical for effective patient management and treatment optimization. This category is distinct in its emphasis on specific therapeutic drug monitoring protocols and control mechanisms, differentiating it from other related classifications that might pertain to hormones, proteins, or other biomarkers.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU123#006"/>
          <hierarchical_position>42021502</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW195#015" guid="f11d8d4d6ffa482597311ff98a2a8f25">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hormone (standard and calibrator)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a calibrator designed to establish a reference point for the measurement of hormones in immunochemical assays. This product serves to ensure the accuracy and reliability of hormone quantification by providing known values that can be compared against test results. It is utilized in various laboratory settings to validate and standardize testing procedures, thereby enhancing the consistency of hormonal analysis. The calibrator can be used in conjunction with other controls and standards to ensure comprehensive quality assurance in hormone testing processes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU123#006"/>
          <hierarchical_position>42021503</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW196#015" guid="b554cee7971d447db076c8095d182186">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hormone control</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses substances or materials specifically designed for the control, calibration, or standardization of hormone measurements in immunochemical assays. These items are critical for ensuring accurate and reliable results in assays that measure hormone levels, facilitating the assessment of physiological or pathological conditions related to hormonal imbalances. They may include reference materials or controls that help validate the performance of testing methods used in clinical or laboratory settings. The classification is distinct from other related categories that focus on different analytes or assay types, emphasizing its unique role in hormone-related diagnostics and research applications.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU123#006"/>
          <hierarchical_position>42021504</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW197#015" guid="e62b68c9ae914dcc93a2358142b34542">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Designated protein (standard and calibrator)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a specific category of biological substances used in laboratory settings to assess the accuracy and reliability of immunochemical assays. These designated proteins serve as reference materials that are standardized for calibration purposes, ensuring consistency in testing processes. They are essential for quality control in diagnostic laboratories, enabling the evaluation of performance metrics of various assays. Their role is crucial in the detection, quantification, and validation of specific biomarkers in biological samples. This category is distinct from others that focus on different types of standards and controls related to drugs, hormones, cardiac markers, tumor markers, and other related substances, providing a unique focus on proteins designated for calibration in immunochemical testing.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU123#006"/>
          <hierarchical_position>42021505</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW198#015" guid="45dec93e512840bcbab3108f3af5c6a0">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Designated protein control</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a category of substances specifically utilized for the verification and validation of analytical methods related to designated proteins within the immunochemistry domain. These materials serve as benchmarks to ensure the accuracy and reliability of testing procedures. They are meticulously characterized and formulated to provide consistent performance when used in laboratory settings, aiding in the standardization of assays. This classification is distinct from other related categories that pertain to various biological markers and controls, focusing specifically on the designated proteins required for precise immunochemical assessments.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU123#006"/>
          <hierarchical_position>42021506</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW199#015" guid="49a6dae3e5264537acc4ebff0e5700fb">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cardiac marker (standard and calibrator)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses biological substances specifically designed for the quantitative and qualitative assessment of cardiac markers in laboratory settings. These materials are utilized to establish measurement standards and calibrations in immunochemical assays. They ensure the reliability and accuracy of diagnostic tests related to cardiovascular health. Included in this category are both standard substances that provide a reference point for testing and calibrators that adjust the sensitivity and specificity of the assays. The materials are integral to maintaining the integrity of diagnostic procedures, enabling healthcare professionals to make informed decisions based on precise biomarker evaluations.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU123#006"/>
          <hierarchical_position>42021507</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW200#015" guid="4b364f3e89ed43808d3ea5cc5531dd48">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cardiac marker control</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses substances utilized to assess and ensure the accuracy of testing procedures specifically related to cardiac markers. These substances are essential for maintaining the reliability of immunoassays that measure biochemical markers associated with heart conditions. They are designed to provide a reference point for the calibration and validation of diagnostic tests, thereby facilitating consistent and accurate results in the evaluation of cardiac health. The controls within this category differ from those used for other types of biomarkers, emphasizing their unique role in cardiac diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU123#006"/>
          <hierarchical_position>42021508</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW201#015" guid="7dcfe092a91e4764807387d68d24690c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Tumor marker (standard and calibrator)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological substance used in laboratory settings to detect the presence of tumor-specific markers in biological samples. This type of product serves as a reference point to ensure accurate and reliable test results, providing a standardized method for quantifying tumor markers. These materials are essential in immunochemical assays, enabling healthcare professionals to assess and monitor the progression or regression of certain cancers. They are designed to provide consistency in testing protocols and are critical for ensuring the validity of test outcomes, which can influence patient diagnosis and treatment decisions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU123#006"/>
          <hierarchical_position>42021509</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW202#015" guid="dfa15149968549d29c2a638c69fef698">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Tumor marker control</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses substances utilized in diagnostic procedures to ensure the accuracy and reliability of tumor marker assays. These controls are essential for validating test results, enabling healthcare professionals to make informed decisions regarding patient diagnosis and treatment. They are designed to mimic the behavior of tumor markers in biological samples, providing a benchmark for comparison during testing. The substances in this category are characterized by their ability to demonstrate the performance of immunochemical methods, ensuring consistent quality and precision in the detection of specific tumor-related biomarkers. They play a crucial role in clinical laboratories, contributing to the overall effectiveness of cancer diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU123#006"/>
          <hierarchical_position>42021510</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW203#015" guid="8d5636b21c3b466297f88ab465aed5c9">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Anaemia related, vitamin (standard and calibrator)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses standards and calibrators specifically designed for the measurement and assessment of anemia-related vitamins. These items are essential in immunochemistry to ensure accurate testing and validation of results related to vitamin levels associated with anemia. The focus is on products that facilitate the standardization and calibration processes in laboratory settings, supporting the diagnosis and monitoring of conditions related to vitamin deficiencies impacting anemia. The items classified here differentiate themselves from other standards and controls used for various drugs, hormones, designated proteins, cardiac markers, tumor markers, and autoimmune indicators, thereby highlighting their unique application in the context of anemia and vitamin evaluation.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU123#006"/>
          <hierarchical_position>42021511</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW204#015" guid="b3984925a9f84940ba1019c885c2547d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Anaemia related, vitamin (control)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses products or services specifically designed for the assessment and management of anemia through the use of vitamins. These items play a critical role in immunochemistry applications, particularly in standardization and calibration processes. They are utilized to ensure accuracy and consistency in laboratory testing, aiding healthcare professionals in diagnosing and monitoring conditions related to vitamin deficiency and anemia. The classification distinguishes these items from those related to drug testing, hormone evaluation, and other immunochemical markers, emphasizing their unique application and role in healthcare settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU123#006"/>
          <hierarchical_position>42021512</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW205#015" guid="ea2fb199c9dd4260ab03665629a5ba3a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Rheumatoid, autoimmune (standard and calibrator)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification is designated for products that serve as reference materials specifically for the assessment and calibration of tests used in the detection and measurement of rheumatoid and autoimmune conditions. These items are essential for ensuring the accuracy and reliability of immunochemical testing methods. They are utilized in laboratory settings to provide a standardized benchmark against which test results can be compared, thereby aiding in the diagnosis and monitoring of autoimmune disorders. This category encompasses both standard reference materials and calibrators, which are critical for maintaining quality control in diagnostic processes involving rheumatoid and autoimmune parameters.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU123#006"/>
          <hierarchical_position>42021513</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW206#015" guid="7d0013b5f48b4c8ea70735f641abfc1a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Rheumatoid-, autoimmune (control)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses products designed for the qualitative and quantitative assessment of rheumatoid and autoimmune markers within various biological samples. These items are specifically utilized in immunochemistry applications to ensure accuracy and reliability in testing processes. They serve as reference materials or standards that facilitate the calibration and control of diagnostic tests, enabling healthcare professionals to diagnose and monitor autoimmune conditions. The focus is on the unique characteristics associated with rheumatoid and autoimmune responses, distinguishing them from other types of controls and standards used in different immunological contexts. The products are essential for laboratory settings aimed at delivering precise and consistent analytical results in the field of immunodiagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU123#006"/>
          <hierarchical_position>42021514</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW207#015" guid="ea4352f7d59b4d68ad15fe5537dbe15f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Individual and specified hormone calibrator</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to specialized calibrators designed for the quantitative measurement of specific hormones within immunochemical assays. These calibrators are tailored to ensure accurate and reliable results in diagnostic testing by providing known concentrations of particular hormones. They are utilized in laboratory settings to establish a correlation between the test results and the actual hormone levels, thereby facilitating the performance of quality control and standardization in immunoassays. The focus is on individual hormones, allowing for precise assay calibration and enhancing the accuracy of hormonal assessments in various clinical applications.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU123#006"/>
          <hierarchical_position>42021515</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW208#015" guid="773d5f45ccf24596b7a33c36970f1622">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Individual and specified hormone control</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses specialized products or services that are designed for the regulation and measurement of individual hormones. These offerings may include calibrators that are specifically formulated for distinct hormone testing applications. The focus is on ensuring accurate and reliable hormone quantification in various diagnostic contexts. Products in this classification are utilized in laboratory settings to support the assessment of hormonal levels, contributing to the monitoring and management of health conditions related to hormonal imbalances. The items classified here are distinct from other related offerings, emphasizing their unique role in hormone analysis and control.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU123#006"/>
          <hierarchical_position>42021516</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW209#015" guid="43e4ba909aa043e1be88545945120436">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Multi constituents immunochemistry control</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a range of controls specifically designed for immunochemistry applications that consist of multiple constituents. These controls are utilized to verify the accuracy and reliability of immunochemical assays, ensuring the correct functioning of laboratory procedures. They serve as benchmarks for testing and calibrating various immunoassays, providing a standardized reference to maintain quality control across different analytical processes. This category is distinct in its focus on multi-constituent formulations, differentiating it from other categories that pertain to single analytes or specific types of tests, thereby catering to a broader analytical scope within the field of immunochemistry.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU123#006"/>
          <hierarchical_position>42021517</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW210#015" guid="b948c515a8dc40468a5dd1ab32d1a05f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Control, standard, calibrator (immunochemistry, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU123#006"/>
          <hierarchical_position>42021590</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU126#005" guid="00a45e3ebd8d4b3fba09188d7ad52042">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Haematology reagent</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a range of analytical substances specifically designed for the examination and evaluation of blood parameters, particularly within the context of cellular components and their characteristics. It includes reagents utilized for various diagnostic assays that assess hematological properties, such as the measurement of red blood cell indices, hemoglobin levels, and cell morphology. Additionally, it covers specialized reagents that facilitate the identification and quantification of specific blood components and conditions. These products are essential for laboratory practices aimed at diagnosing, monitoring, and managing hematological disorders, ensuring accuracy and reliability in test results. This classification excludes reagents associated with coagulation studies, blood grouping, and immunological assays.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS275#005"/>
          <hierarchical_position>42030100</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW294#015" guid="445cf5a932b84937abff5f77fcc26928">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">CBC-reagent (cleaning-, diluting-, lysing-, sheath-fluid)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance specifically designed for use in haematological analysis, typically utilized for processes such as cleaning, diluting, lysing, or serving as sheath fluid. This type of reagent plays a crucial role in preparing samples for examination, ensuring the accuracy and reliability of diagnostic results. It is formulated to interact optimally with cellular components and maintains the integrity of blood samples during testing procedures. This category of reagents is distinguished from other haematology-related products that serve different analytical functions, focusing primarily on the preparatory and supportive roles in haematological assessments.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU126#005"/>
          <hierarchical_position>42030101</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW295#015" guid="c14e50f3f8b2485c9bb0b14aee5889f8">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Designated reticulocyte reagent</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specialized reagent designed specifically for the identification and quantification of reticulocytes in a sample, facilitating the assessment of erythropoiesis and anemia diagnosis. This reagent is utilized in hematological analyses to support clinical evaluations of blood conditions, aiding healthcare professionals in monitoring and interpreting reticulocyte counts. It plays a crucial role in differentiating between various hematological disorders and understanding the regenerative capacity of bone marrow in response to anemia or blood loss. This reagent is distinct from other analytical substances used for broader hematology applications, ensuring precise reticulocyte measurement and effective patient management in clinical settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU126#005"/>
          <hierarchical_position>42030102</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW296#015" guid="9308a5f8c16f4944a9d1b4795e843548">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Haemoglobin determination (total, Hb)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a category of diagnostic agents specifically designed for the quantitative assessment of haemoglobin levels in biological samples. These agents are utilized in various analytical techniques to determine the total haemoglobin present, aiding in the evaluation of patients' oxygen-carrying capacity. The focus is on reagents that facilitate accurate and reliable measurements in clinical settings, differentiating them from other related diagnostic agents that may serve distinct purposes, such as those used for cellular analysis, staining, or blood pressure monitoring. The classification emphasizes the importance of precise haemoglobin determination in the context of hematological assessments and patient care.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU126#005"/>
          <hierarchical_position>42030103</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW944#015" guid="fb03fbbc21a64770a5027acc9351368c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">T(14,18), (cancer causing, related alteration)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to genetic alterations associated with an increased risk of cancer, specifically focusing on the T(14,18) alteration. Such alterations involve changes in the structure or number of chromosomes that have been linked to the development of malignancies. These modifications can affect the expression and regulation of genes involved in cell growth and division, leading to uncontrolled proliferation and tumor formation. This classification is distinct from other known alterations, highlighting the unique characteristics and implications of the T(14,18) change in the context of cancer development and diagnosis. It serves as a critical identifier for research, clinical diagnostics, and the understanding of cancer etiology related to genetic factors.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU155#005"/>
          <hierarchical_position>42060210</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW945#015" guid="9b1120a5d94f4ea9bfe53be3d0fc2f59">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">INV (16), (cancer causing, related alteration)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses alterations in genes or chromosomes that have been identified as contributing to the development of cancer. These alterations may involve mutations, translocations, or other modifications that can lead to uncontrolled cell growth or malignancy. The focus is on acquired changes that are not inherited but rather occur during an individual's lifetime, often due to environmental factors or other influences. This classification serves to categorize various specific alterations recognized in the context of cancer research and diagnostics, facilitating a better understanding of their implications in oncology and personalized medicine.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU155#005"/>
          <hierarchical_position>42060211</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW946#015" guid="be43fc21fad14e36b4c9b1ccf707d150">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Telomerase (cancer causing, related alteration)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific type of biomarker associated with the identification of alterations that may contribute to cancer development. This category encompasses alterations in telomerase activity or expression that are linked to oncogenic processes. These alterations are pivotal in understanding the mechanisms of tumorigenesis and may play a role in tumor progression and resistance to treatment. This classification is distinct from other related alterations that involve different genes or chromosomal changes associated with malignancies. It serves as a critical component in the diagnosis and monitoring of cancer, providing insights into the genetic underpinnings of the disease.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU155#005"/>
          <hierarchical_position>42060212</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW947#015" guid="02f2f81926f24aa494d21b417f07a349">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HER-2/neu (cancer causing, related alteration)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses specific alterations in genes or chromosomes that are associated with the development of cancer. These alterations can lead to abnormal cellular behavior and contribute to the progression of malignancies. The focus is on identifying and analyzing genetic changes that may serve as biomarkers for diagnosis, prognosis, or therapeutic targets. Each entry within this classification represents a distinct genetic alteration that has been implicated in oncogenesis, providing a framework for understanding their roles in cancer biology. The classification facilitates research, clinical applications, and the development of targeted therapies, enhancing the ability to tailor treatment strategies based on individual genetic profiles.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU155#005"/>
          <hierarchical_position>42060213</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW948#015" guid="d563ec1d92c5418e86aefafbf1c1e914">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Acquired gene or Chromosome alteration test</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic procedure designed to identify alterations in genes or chromosomes that may influence the development of diseases, particularly those associated with cancer. This test evaluates specific genetic variations that are acquired rather than inherited, providing critical insights into the molecular mechanisms of disease. The results can assist healthcare professionals in determining the appropriate therapeutic strategies and personalized treatment plans for patients. This category encompasses various methodologies and technologies used to detect, analyze, and interpret genetic changes, reflecting the evolving landscape of molecular diagnostics in the context of oncology and related fields.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU155#005"/>
          <hierarchical_position>42060214</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW949#015" guid="1962f39a32454d82aa96ade7f40e4a78">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Acquired gene or chromosome alteration (IVD, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU155#005"/>
          <hierarchical_position>42060290</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU147#005" guid="be50519de6a14b2a87307dfb4bdf3dc2">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Parasitology (infectious immunology)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses the study and testing of parasitic infections and their corresponding immune responses. It specifically focuses on the detection and analysis of antibodies and antigens related to various parasitic organisms, which can cause significant health issues in humans and animals. The classification includes diagnostic products designed for in vitro use, aimed at identifying specific parasitic infections through serological and immunological methods. These products are essential for diagnosing infections caused by a range of parasites, facilitating timely and effective treatment. The offerings within this classification are critical for both clinical and research applications, enabling healthcare professionals to monitor and respond to parasitic diseases effectively.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS277#005"/>
          <hierarchical_position>42050500</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW799#015" guid="b970437f4496475cb94a29da98d56e65">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Toxoplasma antibody (total, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a test or assay designed to detect the presence of antibodies against a specific protozoan parasite, commonly associated with infection. This methodology is employed in the context of in vitro diagnostics to assist in the diagnosis and monitoring of infections caused by the mentioned organism. It is intended for use in clinical laboratories and healthcare settings, providing valuable information regarding an individual's immune response to the pathogen. The total antibody detection encompasses various immunoglobulin types that may indicate current or past exposure to the parasite, thereby aiding healthcare professionals in making informed decisions regarding treatment and management of the infection. The test is characterized by its specificity and sensitivity, ensuring reliable results for patient assessment.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU147#005"/>
          <hierarchical_position>42050501</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW800#015" guid="db2f05c5c7814a64b90904e5d0f59d0d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Toxoplasma antibody (IgG, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic test designed to detect the presence of antibodies, specifically Immunoglobulin G (IgG), against Toxoplasma gondii, which is a parasitic organism. This test is utilized in the field of infectious immunology and serves as an important tool for assessing past exposure to the parasite, aiding in the diagnosis of infections. By measuring the levels of IgG antibodies, healthcare professionals can evaluate immune response and determine whether an individual has been previously infected, which is especially relevant in pregnant women and immunocompromised patients. The test is typically performed in vitro, providing critical information for clinical decision-making.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU147#005"/>
          <hierarchical_position>42050502</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW801#015" guid="eef6853a47524dc2b2e150e2f1d4df1d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Toxoplasma antibody (IgG, avidity, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a specific type of immunological test designed to detect antibodies of a particular pathogen in a biological sample. It focuses on the detection of IgG antibodies, which indicate a past or ongoing immune response to a specific infection. The test may also assess avidity, which reflects the strength of the antibody binding to the antigen, providing additional insight into the timing and nature of the immune response. This classification is distinct from other related tests that may target different types of antibodies or other pathogens. It is used primarily in in vitro diagnostics to aid in the diagnosis and monitoring of infections, contributing valuable information for clinical decision-making.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU147#005"/>
          <hierarchical_position>42050503</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW802#015" guid="8bcfa6fbdb93426fa4cb70591935f3c2">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Toxoplasma antibody (IgM, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic test designed to detect specific antibodies of the IgM class against Toxoplasma gondii, utilized in the context of in vitro diagnostics. This test is significant for identifying recent or acute infections, as the presence of IgM antibodies typically indicates a primary immune response to the pathogen. It is particularly relevant in clinical settings for assessing the immune status of individuals, especially in pregnant women or immunocompromised patients. The assay contributes to the differential diagnosis of Toxoplasmosis and aids in the management of the disease by providing critical information regarding the timing of infection. This classification encompasses various related immunological tests that target different antibody types or other pathogens in the realm of parasitology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU147#005"/>
          <hierarchical_position>42050504</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW803#015" guid="630497f5aba84969aa8bf7bc2afee065">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Entamoeba histolytica (parasitology, antigen, antibody, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic tools and reagents related to the detection and analysis of a specific parasitic infection caused by a protozoan organism. It includes assays designed for identifying the presence of antigens or antibodies associated with this organism in biological samples. These diagnostic products are utilized in laboratory settings, particularly in the field of infectious disease immunology, to aid in the diagnosis and monitoring of infections. The focus is on products that facilitate the detection of immunological responses or direct identification of the pathogen, providing crucial information for clinical decision-making and patient management. This classification is distinct in its emphasis on a specific organism within the broader context of parasitology and infectious immunology, differing from other related diagnostic assays targeting various parasites.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU147#005"/>
          <hierarchical_position>42050505</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW804#015" guid="99b8d68be35045e88b3f33fc04bc979e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Chagas (parasitology, antigen, antibody, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a classification for diagnostic tests specifically related to the detection of Chagas disease, focusing on the identification of either antigens or antibodies associated with the disease. These tests are utilized in the field of parasitology and infectious immunology to aid in the diagnosis and monitoring of Chagas disease, which is caused by the Trypanosoma cruzi parasite. The classification encompasses various in vitro diagnostic methods that can determine the presence of specific immunological markers indicative of infection. This category is distinct from other related tests that target different pathogens or immunological responses, emphasizing its unique role in the diagnosis of Chagas disease.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU147#005"/>
          <hierarchical_position>42050506</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW805#015" guid="825bb49376b1433e8cbb9707e71264ff">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Distomatosis (parasitology, antigen, antibody, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic tests and reagents used for the detection and analysis of specific parasitic infections, focusing on the identification of antigens and antibodies related to distomatosis. These tests are essential for immunological assessments in clinical settings, facilitating the diagnosis of infections caused by trematodes. The classification includes various forms of in vitro diagnostics that utilize innovative methodologies to enhance the accuracy and reliability of results. It serves as a critical tool for healthcare professionals in the evaluation of parasitic diseases, allowing for targeted treatment and management of affected individuals. This category is distinct from other classifications that address different parasitic infections or antibody types, ensuring a precise focus on distomatosis-related diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU147#005"/>
          <hierarchical_position>42050507</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW806#015" guid="f00b9a394309416dbf70ac314981593c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Echinococcus (parasitology, antigen, antibody, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to diagnostic products used in the detection and identification of specific parasitic infections caused by Echinococcus species. These products are utilized in laboratory settings, particularly in immunodiagnostic applications, to measure the presence of antigens or antibodies related to Echinococcus. The focus is on the development and use of in vitro diagnostic tests that aid in the diagnosis of infections associated with this parasite. This category is distinct from other classifications that encompass various parasitic infections, reflecting unique characteristics specific to Echinococcus-related immunological responses. The products included in this classification are essential for accurate and timely diagnosis, contributing to effective patient management and treatment strategies in parasitology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU147#005"/>
          <hierarchical_position>42050508</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW807#015" guid="c6f3dc32bec7462bb1b872be3fc1a3a9">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Leishmania (parasitology, antigen, antibody, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic entities utilized in the identification and analysis of specific parasitic infections, focusing on the detection of antigens or antibodies related to Leishmania. It serves as a vital tool in infectious immunology, enabling healthcare professionals to assess immune responses and establish diagnoses for conditions associated with this parasite. The items classified within this category are distinct from other similar diagnostic products, which may target different parasites or utilize varying methodologies for antibody detection. This classification aids in the systematic organization and retrieval of related diagnostic tools, facilitating improved patient care and research in parasitology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU147#005"/>
          <hierarchical_position>42050509</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW808#015" guid="1a2f9fd2574443299439e9900bb2d979">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Schistosoma (parasitology, antigen, antibody, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic tests and reagents related to the detection and analysis of the Schistosoma parasite. It specifically focuses on the identification of antigens and antibodies associated with Schistosoma infections for use in in vitro diagnostics. The products categorized here are utilized in various laboratory settings to assist in the diagnosis of schistosomiasis, a disease caused by parasitic worms belonging to the Schistosoma genus. The classification is distinct from other classifications that pertain to different parasitic organisms and their corresponding diagnostic methods. It serves to facilitate the organization and retrieval of relevant diagnostic tools, ensuring accuracy and efficiency in the identification of schistosomiasis in clinical and research environments.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU147#005"/>
          <hierarchical_position>42050510</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW809#015" guid="0c6b43f26dfe4d4ea2e53a63c8f80554">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cryptosporidium (parasitology, antigen, antibody, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a classification representing biological entities that are implicated in parasitic infections, specifically targeting the detection and analysis of specific antigens or antibodies associated with the organism in question. This classification encompasses diagnostic tools used in vitro to identify the presence of such biological markers, which can indicate infection or exposure to the specified parasite. The defined category prioritizes accuracy and specificity in the context of immunological testing, facilitating clinical decision-making and improving patient outcomes. This classification is distinct from others that encompass different parasites or their associated immunological responses, ensuring clarity and precision in the diagnostic landscape.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU147#005"/>
          <hierarchical_position>42050511</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW810#015" guid="a6c865163aed4fd6878d9944c0c5dd88">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Giardia lamblia (parasitology, antigen, antibody, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to the detection and diagnosis of a specific protozoan parasite known for causing gastrointestinal infections in humans and animals. It encompasses various methods for identifying the presence of the organism or the immune response to it, specifically through the analysis of antigens or antibodies in biological specimens. The focus is on in vitro diagnostic applications that aid in confirming infections and guiding treatment decisions. This classification is distinct from other related entities that address different pathogens or immunological markers, reflecting the unique characteristics and clinical implications associated with this particular parasite.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU147#005"/>
          <hierarchical_position>42050512</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW811#015" guid="dfee12bd761d4d68bc6220e0b1f5193c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Plasmodium (malaria, parasitology, antigen, antibody, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic tools and reagents specifically related to the detection and analysis of Plasmodium species, which are protozoan parasites responsible for malaria. It includes various forms of assays and tests designed to identify specific antigens or antibodies associated with Plasmodium infections. The focus is on in vitro diagnostic applications, which may involve serological testing and other immunological methods. This classification aims to facilitate the understanding and differentiation of products used in the diagnosis of malaria, aligning with the broader field of parasitology and infectious immunology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU147#005"/>
          <hierarchical_position>42050513</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW812#015" guid="b3c87fb5e09d4591b403b954626c7a82">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Parasitology (infectious immunology, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU147#005"/>
          <hierarchical_position>42050590</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU106#005" guid="2209012d71024e498d3df4d23c314fdc">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Control, standard, calibrator (clinical chemistry)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a range of items utilized in clinical chemistry for the purpose of ensuring the accuracy and reliability of analytical measurements. It includes materials designed to assess the performance of testing procedures, ensuring that they yield valid results. This category covers both assayed and unassayed multi-component serum, as well as specific control serums tailored for various analytes such as lipids and bilirubin. Additionally, it features controls and calibrators that serve to standardize testing processes, promoting consistency across different laboratory settings. The classification also includes aqueous standards and controls derived from urine and cerebrospinal fluid, emphasizing the diverse applications of these materials in clinical diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS273#005"/>
          <hierarchical_position>42010600</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV752#015" guid="3b409b650c9c4669ba5422ca906df01d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Assayed multi-component serum (CC)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a type of serum that has been analyzed and verified to contain specific components at known concentrations, used primarily for calibration and quality control purposes in clinical chemistry laboratories. This serum serves as a reference material, helping to ensure the accuracy and reliability of analytical results during testing processes. It is characterized by its multi-component nature, which includes various substances that may be used to assess the performance of diagnostic assays. The use of this serum is essential for validating test procedures and maintaining the standardization of laboratory measurements, thereby contributing to the overall quality assurance in clinical diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU106#005"/>
          <hierarchical_position>42010601</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV753#015" guid="360b806b6b9a4e04a76a69dd531c2bf5">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Unassayed multi-component serum (CC)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a category that encompasses biological fluids composed of multiple components that have not undergone testing to determine their specific values or concentrations. This classification is utilized in clinical chemistry for the purpose of quality control, calibration, and standardization in laboratory settings. These substances are designed to provide a reference point for laboratory analyses and may contain a variety of analytes, serving as a benchmark for ensuring the accuracy and reliability of diagnostic tests. Their unassayed nature distinguishes them from other similar products that have known values, offering a unique utility in the validation of analytical methods and instrumentation without predetermined measurement standards.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU106#005"/>
          <hierarchical_position>42010602</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV754#015" guid="4715cc0225704a3091dcf5540e3ae7b8">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Enzyme control serum</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specialized liquid formulation containing enzymes designed for use in laboratory settings to ensure the accuracy and reliability of analytical procedures. This product is utilized primarily in clinical chemistry applications, serving as a reference material to validate and calibrate testing methods. It is characterized by its specific enzymatic content, which is critical for assessing the performance of analytical instruments and reagents. The formulation is meticulously prepared to maintain stability and consistency, allowing for precise comparisons in various diagnostic tests. This type of serum plays a vital role in quality control processes, helping to ensure that test results are accurate and trustworthy.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU106#005"/>
          <hierarchical_position>42010603</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV755#015" guid="616b5966f0a9452888dcf4f790ddc919">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Lipid control serum</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a preparation designed for use in clinical chemistry laboratories, specifically formulated to assess and validate the performance of analytical methods related to lipid measurement. This type of serum serves as a reference material that ensures accuracy and reliability in testing processes. It may contain a defined concentration of lipids and other related constituents, allowing for the calibration of instrumentation and the control of assay variances. Utilized in quality assurance protocols, this product plays a critical role in maintaining the integrity of laboratory results, facilitating the monitoring of lipid levels in various biological samples.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU106#005"/>
          <hierarchical_position>42010604</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV756#015" guid="2134a76846d84dbea45671f271216896">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Bilirubin control serum</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a preparation used for the calibration and quality control of analytical procedures in clinical chemistry, specifically designed to provide a known concentration of bilirubin for the assessment of test accuracy and performance. This material serves as a reference to ensure consistency and reliability in laboratory results, allowing for the comparison of measurements across different assays and instruments. It is formulated to mimic physiological conditions and is utilized in various testing environments to validate methods and maintain compliance with regulatory standards. The product is essential for laboratories aiming to achieve precise diagnostics in the evaluation of bilirubin levels, which are critical for various clinical assessments.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU106#005"/>
          <hierarchical_position>42010605</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV757#015" guid="0e0aa84dbe4545bea56d6e4c2fc02d1e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Electrolyte control</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses substances used to monitor and ensure the accuracy of analytical processes in clinical chemistry. These substances are characterized by their ability to maintain and regulate the electrolyte balance during testing procedures. They serve as essential tools for verifying the performance of diagnostic equipment and methods, ensuring reliable results in the evaluation of biological samples. The category includes various formulations that may be utilized in a laboratory setting to assess the precision and consistency of test outcomes related to electrolyte levels, thus contributing to effective patient care and diagnostic accuracy.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU106#005"/>
          <hierarchical_position>42010606</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV758#015" guid="1c14c21b1eef423c85fc2fb4dc72a8e2">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Diabetes control</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses products designed specifically for the management and monitoring of diabetes. These items are utilized in clinical settings to ensure accurate measurement and control of glucose levels and other related parameters in individuals with diabetes. The offerings in this category may include various types of control solutions, calibration materials, and reference standards that are essential for the validation and quality assurance of diabetes testing methods. They play a critical role in enabling healthcare professionals to achieve reliable results in the assessment of diabetic patients, contributing to effective treatment and management strategies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU106#005"/>
          <hierarchical_position>42010607</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV759#015" guid="b1d25e4dd888483196116ad3e6e58a59">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Calibrator multi-component (CC)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a calibrator designed to provide a reference point for multiple components in analytical procedures, facilitating the accurate measurement and evaluation of clinical chemistry parameters. This type of calibrator is used to ensure the reliability and consistency of test results across various assays. It is essential for establishing calibration curves and verifying the performance of analytical methods in clinical laboratories. By serving as a standard, it aids in the quality control processes, ensuring that diagnostic tests yield precise and reproducible results. Its application is crucial in enhancing the overall effectiveness of diagnostic testing in clinical chemistry.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU106#005"/>
          <hierarchical_position>42010608</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW415#015" guid="f3ac710ed5f7440bab945599140ea3ed">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Stem cell enumeration control (flow cytometry)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specialized reagent utilized in the quantitative analysis of stem cells through flow cytometry techniques. This product is designed to facilitate the enumeration of stem cells by providing necessary controls to ensure accuracy and reliability in the measurement process. It plays a crucial role in various research and clinical applications where precise cell counting and characterization are essential. The reagent aids in maintaining consistency across experiments, enabling researchers and clinicians to obtain reproducible results when assessing stem cell populations. Its application is particularly relevant in the fields of regenerative medicine, hematology, and oncology, where understanding stem cell dynamics is vital for advancing therapeutic strategies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU130#005"/>
          <hierarchical_position>42030515</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW416#015" guid="c4fc3c2c0457448483b4ad5c60bc6436">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cell staining reagent cell nuclear staining (auxiliary, supplem. flow cytometry)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specialized chemical formulation used in laboratory settings to facilitate the visualization of cellular components, particularly nuclei, during flow cytometric analysis. This reagent enhances the identification and differentiation of various cell types by selectively binding to nuclear structures, allowing for improved clarity and accuracy in the assessment of cell populations. It is commonly utilized as an auxiliary agent in conjunction with other staining protocols to provide supplementary insights into cellular characteristics and behaviors. This product is essential for researchers and clinicians who require precise and reliable methods for analyzing cellular morphology and functionality in various biological samples.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU130#005"/>
          <hierarchical_position>42030516</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW417#015" guid="84074d020dbb464184930224e4c96544">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cell staining reagent detect reticulocytes (auxiliary, supplem. flow cytometry)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses specialized substances used in biological research and diagnostic applications, specifically designed for the detection and visualization of reticulocytes within a cellular context. These reagents facilitate the identification of immature red blood cells, providing essential information for hematological analysis. The products in this category are typically utilized in conjunction with advanced techniques such as flow cytometry, enhancing the accuracy and reliability of cell population assessments. They play a crucial role in understanding various physiological and pathological conditions related to blood cell development and function, thus contributing to clinical diagnostics and research in hematology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU130#005"/>
          <hierarchical_position>42030517</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW418#015" guid="1842336332fb4826b147bd343f11432c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Monoclonal antibody (unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU130#005"/>
          <hierarchical_position>42030590</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU115#006" guid="430aa9c79fc2478887800f67b3d67bc6">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Anemia related (vitamin test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic tests and assays specifically designed to assess various parameters related to anemia, focusing on the measurement of vitamins and other critical components that influence red blood cell production and overall hematological health. It includes tests that evaluate the presence and levels of essential vitamins and proteins necessary for the synthesis of hemoglobin and the proper function of erythrocytes. These assessments are vital for diagnosing types of anemia linked to nutritional deficiencies or other underlying health issues. The classification distinctly excludes tests related to proteins indicative of allergies, tumors, thyroid function, fertility, therapeutic drug levels, toxicology, autoimmune diseases, inflammatory markers, liver and cardiac function, as well as rapid tests, ensuring a focused approach to anemia-related diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS274#006"/>
          <hierarchical_position>42020700</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW019#015" guid="d95c945775fd44e890a6a73f1f4f30d4">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Erythropoietin</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological agent that stimulates the production of red blood cells in the bone marrow, primarily used in the treatment of anemia, particularly in individuals with chronic kidney disease or undergoing chemotherapy. This substance acts by binding to specific receptors on erythroid progenitor cells, promoting their proliferation and differentiation. It is often administered through injection and is crucial for managing conditions that lead to reduced erythropoiesis. The therapeutic application of this agent helps improve hemoglobin levels and overall oxygen-carrying capacity of the blood, thereby alleviating symptoms associated with anemia and enhancing the quality of life for affected patients.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU115#006"/>
          <hierarchical_position>42020701</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW020#015" guid="2351697d68774532b11dd6d73348604f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Ferritin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a protein complex that serves as an important biomarker in the diagnosis and management of iron metabolism disorders, particularly related to anemia. This entity is typically measured in a laboratory setting and is used to assess iron stores in the body, aiding in the evaluation of various conditions associated with iron deficiency or overload. The measurement of this biomarker can provide critical insights into the underlying causes of anemia and guide appropriate therapeutic interventions. It plays a significant role in clinical diagnostics, contributing to the understanding of an individual’s iron status and related health issues.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU115#006"/>
          <hierarchical_position>42020702</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW021#015" guid="e20a3fea50c4434c97c87e5519069d8e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Folate (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a category designated for substances that are involved in the metabolic processes related to folate, specifically within the context of laboratory diagnostics for anemia. This category encompasses various forms and preparations of folate used in in vitro diagnostic applications. These substances play a critical role in the synthesis of nucleic acids and amino acids, which are essential for cell division and growth. Monitoring folate levels is vital for assessing and managing conditions related to deficiencies that may contribute to anemia. This classification distinguishes these substances from other related analytes that address different aspects of anemia diagnosis and treatment.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU115#006"/>
          <hierarchical_position>42020703</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW022#015" guid="07c064891f484e67b6403690bac8eb6a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Iron (IC, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">iron is a vital mineral that plays a crucial role in various physiological processes, particularly in the formation of hemoglobin, which is essential for transporting oxygen in the bloodstream. This element is commonly assessed in clinical settings to evaluate iron levels and diagnose conditions related to iron deficiency or overload. The measurement of iron levels can provide valuable insights into an individual's nutritional status and overall health, particularly in relation to anemia. It is distinct from other related tests that measure various vitamins and proteins involved in red blood cell production and metabolic functions, each serving specific diagnostic purposes in the assessment of anemia and related conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU115#006"/>
          <hierarchical_position>42020704</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW023#015" guid="ed7aa604d68c4356834e2195881cbcdd">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Iron binding capacity (total, IC)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to the measurement of the total binding capacity of iron in the presence of various proteins and compounds in the body. It is an important indicator for assessing iron metabolism and can provide insights into potential deficiencies or excesses related to iron in the biological system. The total iron binding capacity is often evaluated in the context of diagnosing conditions that affect red blood cell production and overall hematological health. This metric can assist healthcare professionals in understanding the underlying causes of anemia and guiding appropriate treatment strategies. It differs from tests that measure specific components or other vitamins related to blood health and metabolism.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU115#006"/>
          <hierarchical_position>42020705</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW024#015" guid="08b197d0a848408ab092feb97b0cf6c8">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Soluble transferrin receptor</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical marker utilized in the evaluation of iron deficiency and related disorders, this entity is indicative of the availability of iron in the body and assists in assessing the status of iron metabolism. It is particularly useful in diagnosing conditions associated with reduced iron levels, and its measurement can provide insights into the underlying mechanisms of anemia and other related hematological conditions. The determination of this marker can aid healthcare professionals in making informed decisions regarding diagnosis, treatment, and monitoring of patients with suspected deficiencies or disorders linked to iron utilization. It serves as a critical tool in laboratory diagnostics, contributing to a comprehensive understanding of an individual's nutritional and health status.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU115#006"/>
          <hierarchical_position>42020706</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW025#015" guid="6fa3829db4dd4938b11e6ace3ba685aa">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Reticulocyte haemoglobin content</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a specific biochemical measurement that indicates the amount of hemoglobin within reticulocytes, which are immature red blood cells. This measurement is utilized in the assessment of various types of anemia, providing insights into the body’s erythropoietic activity and iron availability. It serves as an important diagnostic tool in evaluating and monitoring conditions related to red blood cell production and function, particularly in cases where traditional markers of anemia may not provide a complete picture. By analyzing reticulocyte hemoglobin content, healthcare professionals can gain a deeper understanding of a patient's iron status and overall hematologic health, thereby facilitating more accurate diagnoses and effective treatment strategies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU115#006"/>
          <hierarchical_position>42020707</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW026#015" guid="24fef6a7d5194c6788fcde1c0251ded1">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Vitamin B1</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance essential for various metabolic processes, particularly in the conversion of carbohydrates into energy. This nutrient plays a crucial role in maintaining proper nerve function and supports the synthesis of neurotransmitters. It is commonly associated with the prevention and treatment of specific deficiencies, especially those related to certain health conditions. This classification encompasses products or services that include this nutrient in various forms, such as tablets, capsules, and injectable solutions, which are utilized in both clinical and supplemental contexts to promote overall health and well-being. The offerings in this category are distinguished by their specific applications and biochemical properties, setting them apart from other related nutritional substances.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU115#006"/>
          <hierarchical_position>42020708</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW027#015" guid="308dce4dac424ce3a1d9addc83afdc61">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Vitamin B2</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance that is a water-soluble vitamin, essential for various biological functions, including energy production and the metabolism of fats, carbohydrates, and proteins. It plays a crucial role in maintaining healthy skin, eyes, and nerve functions, as well as supporting the body's ability to produce red blood cells. This vitamin is commonly found in various food sources and can also be administered as a dietary supplement. Its deficiency may lead to specific health issues, particularly related to energy levels and overall metabolic function.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU115#006"/>
          <hierarchical_position>42020709</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW028#015" guid="3ee991422e35440289ee8c985055ebbf">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Vitamin B6</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a naturally occurring water-soluble vitamin that plays a crucial role in various physiological processes, including amino acid metabolism, neurotransmitter synthesis, and the formation of red blood cells. It is essential for maintaining proper brain function and is involved in the synthesis of important molecules within the body. Deficiency in this vitamin can lead to various health issues, particularly those related to anemia and neurological disorders. This vitamin is commonly found in various food sources and can also be supplemented as part of a nutritional regimen. It is typically assessed in clinical settings to evaluate vitamin status related to specific health conditions and to guide dietary recommendations.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU115#006"/>
          <hierarchical_position>42020710</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW029#015" guid="1b733187f16648e091eb0905391c96f6">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Vitamin B12</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance that is essential for various physiological functions in the body, particularly in the formation of red blood cells and the maintenance of the nervous system. It is a water-soluble vitamin primarily found in animal-derived foods and is crucial for DNA synthesis and neurological function. Deficiencies in this nutrient can lead to specific health issues, including certain types of anemia and neurological disorders. This classification encompasses various forms of the vitamin, including supplements and diagnostic tests that measure its levels in the human body, contributing to the assessment of nutritional status and the diagnosis of related health conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU115#006"/>
          <hierarchical_position>42020711</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW030#015" guid="f30b63ac12fa4429b45f9659fa50ca52">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Vitamin D (cholecalciferol)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a naturally occurring fat-soluble vitamin essential for maintaining healthy bones and supporting immune function. It plays a crucial role in calcium and phosphorus metabolism and is primarily synthesized in the skin upon exposure to sunlight. This vitamin can also be obtained through dietary sources, such as fatty fish, fortified foods, and supplements. Its deficiency may lead to various health issues, including bone disorders and weakened immune response. The substance is commonly measured in clinical laboratories to assess levels in the body, especially in relation to conditions that may affect absorption or synthesis.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU115#006"/>
          <hierarchical_position>42020712</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW031#015" guid="be170ad3e1e645fcb82717890d0441ca">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Intrinsic factor (blocking antibody)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance or factor that can interfere with the expected biological response of antibodies, specifically in the context of anemia testing related to vitamin levels. This factor may impede the accurate measurement or functionality of antibodies involved in the diagnosis and assessment of anemia, particularly when evaluating the role of vitamins in red blood cell production and overall hematological health. Understanding and identifying this factor is essential for ensuring the reliability of diagnostic tests and for optimizing patient management in cases of suspected vitamin deficiency anemia.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU115#006"/>
          <hierarchical_position>42020713</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW032#015" guid="9dbc3209ce1947d2b38e900b66f436c3">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Vitamin B 12, folate</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses substances that are essential for the production of red blood cells and the maintenance of normal metabolic functions related to blood health. The focus is on compounds that play a critical role in reducing the risk of anemia by supporting cellular processes and overall well-being. These elements are involved in various biochemical pathways and are crucial for the synthesis of nucleic acids and neurotransmitters. They are typically assessed through laboratory tests to evaluate their levels in biological samples, aiding in the diagnosis and management of conditions associated with nutrient deficiencies. This classification distinguishes itself from other related tests by concentrating specifically on those nutrients that are pivotal in combating specific types of anemia and promoting optimal physiological functioning.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU115#006"/>
          <hierarchical_position>42020714</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW033#015" guid="5128b9f31be34ec3b4f0f993ea654b35">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Anemia related (vitamin test, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU115#006"/>
          <hierarchical_position>42020790</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU155#005" guid="d808a0eab19a4643bf94b52d09711f99">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Acquired gene or chromosome alteration (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses alterations in genes or chromosomes that are acquired rather than inherited, specifically in the context of diagnostic testing for diseases. It includes various specific alterations that are known to be associated with the development of cancer. The focus is on identifying changes that occur due to environmental factors, lifestyle, or other external influences rather than those present from birth. This category is essential for understanding the progression of diseases and for tailoring treatment strategies based on the unique genetic profile of an individual. It includes tests that detect specific mutations linked to various types of cancers, aiding in both diagnosis and potential therapeutic interventions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS278#005"/>
          <hierarchical_position>42060200</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW935#015" guid="c5303b4ff54d42eea57cb1b7818385f4">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">P53 (cancer causing, related alteration)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of genetic alteration associated with cancer development, characterized by changes in the genetic material that contribute to tumorigenesis. These alterations may involve mutations, translocations, or other modifications that disrupt normal cellular functions, leading to uncontrolled cell growth and division. The classification highlights the relevance of these alterations in cancer pathology and their potential implications in diagnosis, treatment, and prognosis. This particular category focuses on a distinct subset of alterations that are recognized for their significant roles in oncogenesis, differentiating them from other genetic alterations and tests within the broader context of acquired genetic changes related to cancer.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU155#005"/>
          <hierarchical_position>42060201</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW936#015" guid="7a752b96373c4a14bcdf143a00674fa3">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">K-ras (cancer causing, related alteration)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to specific alterations in the K-ras gene that are associated with cancer development. These alterations may involve mutations or changes in the gene's sequence that contribute to tumorigenesis. K-ras is a vital component of cell signaling pathways that regulate cell growth and division</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU155#005"/>
          <hierarchical_position>42060202</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW937#015" guid="c474805fdc4c4a0eb64ca3ec5243e207">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">BRCA 1+2 (cancer causing, related alteration)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses hereditary factors associated with specific alterations linked to increased cancer risk. It includes genetic tests and analyses that identify variations in genes known for their roles in cancer development. These alterations can influence cellular behavior and contribute to malignancy. The focus is on inherited mutations that predispose individuals to various forms of cancer, enabling targeted screening and personalized treatment approaches. This category aims to facilitate the understanding of genetic contributions to cancer, allowing healthcare professionals to assess risks and implement preventive strategies based on genetic findings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU155#005"/>
          <hierarchical_position>42060203</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW938#015" guid="545dc7ef5790424f8ac195f55375bd60">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">RET (cancer causing, related alteration)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a specific type of genetic alteration associated with cancer development, characterized by changes in the structure or number of chromosomes or genes that can lead to malignancy. These alterations may arise from various factors, including environmental influences or inherent genetic predispositions. The focus is on changes that have a direct link to oncogenic processes, distinguishing them from other types of genetic alterations. This category encompasses a range of alterations that are recognized for their implications in cancer diagnosis, prognosis, and potential therapeutic targets. The classification facilitates the identification and study of specific alterations that contribute to cancer pathology, aiding in research and clinical applications.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU155#005"/>
          <hierarchical_position>42060204</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW939#015" guid="3b3d069d4e5d49d387984b0ea75daaec">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">C-MYC (cancer causing, related alteration)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses alterations in genetic material that are associated with cancer development and progression. These alterations can occur in various genes or chromosomes and may lead to disruptions in normal cellular functions, contributing to malignancy. The focus is on specific changes that have been identified as significant in cancer pathology, distinguishing them from other known alterations. This classification aims to facilitate the identification and study of such genetic modifications, aiding in research and diagnostics related to cancer. Each entry within this category reflects a unique pathway or mechanism through which genetic alterations can influence tumorigenesis, providing a comprehensive framework for understanding the complexities of cancer genetics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU155#005"/>
          <hierarchical_position>42060205</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW940#015" guid="90d6705d38b74a7cbf3ce67bdc5ad16b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HNPCC (cancer causing, related alteration)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses genetic alterations associated with cancer that arise after birth, distinguishing them from inherited mutations. It includes changes to the genetic material that can influence cellular behavior and contribute to the development or progression of cancer. These alterations may involve modifications to specific genes or chromosomes that impact cellular functions such as growth, division, and apoptosis. The classification aims to facilitate the identification, diagnosis, and understanding of specific cancer-related genetic changes, enabling targeted therapeutic strategies and personalized medicine approaches. By categorizing these alterations, it supports research and clinical applications focused on cancer biology and treatment.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU155#005"/>
          <hierarchical_position>42060206</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW941#015" guid="3e6a7e7aecdc4e4e97b23bff5d4da44a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">APC (cancer causing, related alteration)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to genetic alterations that are acquired and are associated with an increased risk of cancer. These alterations can occur in various genes or chromosomes and may play a significant role in tumorigenesis. The focus is on specific changes that can lead to uncontrolled cell growth and cancer development. This category encompasses a wide range of alterations, distinguishing itself from others that target different genes known for their involvement in cancer pathways. The classification aids in the identification and understanding of these alterations, which are crucial for diagnostic and therapeutic purposes in oncology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU155#005"/>
          <hierarchical_position>42060207</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW942#015" guid="18db50a02c4b4839b922f22b688b1f22">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">T(9,22), (cancer causing, related alteration)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification identifies specific genetic alterations associated with an increased risk of cancer. It encompasses chromosomal translocations or mutations that result in functional changes within cellular processes, potentially leading to malignant transformations. The alterations categorized here are distinguished by their unique genetic signatures and mechanisms of action, which contribute to tumorigenesis. This classification aims to facilitate the understanding of the underlying genetic factors involved in cancer development and progression, thereby aiding in diagnostics, research, and therapeutic strategies. It is vital for the identification of potential biomarkers and targets for personalized medicine in oncology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU155#005"/>
          <hierarchical_position>42060208</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW943#015" guid="abe3735069ea4aa5b47df390079b1836">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">T(8,14), (cancer causing, related alteration)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a classification for genetic changes associated with cancer, specifically focusing on the alteration identified as T(8,14). This alteration is characterized by its involvement in the development of malignancies through modifications in genetic material. Such alterations can influence cellular behavior, leading to uncontrolled growth and the potential for tumor formation. This category encompasses various genetic transformations that are recognized for their significance in oncogenesis and may serve as critical indicators for diagnosis, prognosis, or targeted therapy in clinical settings. The classification aids in the systematic organization of genetic alterations to enhance understanding and facilitate research into cancer mechanisms and treatment strategies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU155#005"/>
          <hierarchical_position>42060209</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW171#015" guid="0757c5b5e7ae477d957f8258742b7627">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">C-reactive protein</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biomarker associated with inflammation, specifically used to assess the presence and intensity of inflammatory processes in the body. This substance is produced by the liver in response to inflammation and can indicate various medical conditions. Its measurement is crucial for diagnosing and monitoring diseases characterized by inflammatory responses, particularly in the context of autoimmune disorders. The presence and levels of this biomarker can provide valuable insights into the severity of inflammation, aiding in clinical decision-making and treatment planning. This classification distinguishes it from other inflammatory markers based on its unique biochemical properties and clinical significance.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU119#006"/>
          <hierarchical_position>42021109</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW172#015" guid="b68c9c6495d44362b4ce2efcd64095ab">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Rheumatoid factor</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical marker that is indicative of the presence of rheumatoid arthritis and other autoimmune disorders. This marker is typically measured in blood tests and serves as a significant tool in the diagnosis and monitoring of inflammatory conditions. Elevated levels of this factor can suggest an ongoing immune response, assisting healthcare professionals in evaluating the severity of the disease and determining appropriate therapeutic interventions. In clinical practice, it is often analyzed alongside other specific markers to provide a comprehensive understanding of the patient's autoimmune status.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU119#006"/>
          <hierarchical_position>42021110</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW173#015" guid="025e91d1016e4291b5fd11aefe7cf1b7">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Anti-cyclic citrullinated peptide</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific type of biochemical marker associated with autoimmune conditions, particularly indicative of rheumatoid arthritis. This biomarker is formed from the modification of proteins in the body, leading to the production of antibodies that target citrullinated proteins. It serves as a crucial tool in the diagnosis and monitoring of inflammatory diseases, providing insights into the presence and severity of rheumatoid arthritis. The detection of this peptide is significant in clinical settings, allowing healthcare providers to differentiate between various forms of arthritis and guide treatment decisions. This marker is particularly noted for its high specificity and sensitivity in identifying rheumatoid arthritis compared to other inflammatory disorders.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU119#006"/>
          <hierarchical_position>42021111</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW174#015" guid="d64707633cb546f79fb60b68e8785c4b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Anti-streptococcal screening</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic procedure designed to detect the presence of antibodies associated with streptococcal infections, particularly focusing on those that may indicate an autoimmune response or inflammatory condition. This assessment is crucial for evaluating the immune system's reaction to streptococcal bacteria, which can play a role in various rheumatic diseases. The procedure aids healthcare professionals in distinguishing between different inflammatory markers, thereby facilitating accurate diagnosis and management of related conditions. It is distinct from other tests that target specific antibodies or reactions related to streptococcal infections and inflammatory markers.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU119#006"/>
          <hierarchical_position>42021112</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW175#015" guid="9b97ac757ec1454e8bf659db9a20d12c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Rheumatoid (inflammatory disease marker, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU119#006"/>
          <hierarchical_position>42021190</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU121#006" guid="47b582ceff52432ebb6b3e4eb5dd8d21">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cardiac marker</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a category of biological substances that are utilized in the assessment of cardiovascular health and related conditions. These entities are typically proteins or peptides that serve as biomarkers, aiding in the diagnosis and monitoring of heart diseases and other cardiac dysfunctions. The focus is on substances that reflect the physiological state of the heart, providing critical information regarding its function and any potential injuries or stress it may be experiencing. The classification is distinct from other diagnostic categories, emphasizing the specificity and relevance of these markers in clinical settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS274#006"/>
          <hierarchical_position>42021300</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW179#015" guid="38ff6940d137483c97e99b864f088b2c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">BNP, proBNP (including other natriuric peptides)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a category encompassing various biological markers related to cardiac function, specifically focusing on natriuretic peptides. These markers are crucial for assessing heart conditions and diagnosing heart failure. They are involved in fluid balance and blood pressure regulation, offering insights into the cardiac state of patients. This classification is distinct from other cardiac markers that serve different physiological roles or indicate alternative conditions. The entities within this category are utilized in clinical settings to provide valuable information about myocardial stress and overall cardiovascular health.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU121#006"/>
          <hierarchical_position>42021301</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW180#015" guid="94a6192bad7e4feebb055a390e6fbc22">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Creatine kinase (MB mass, IC)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical substance that serves as a critical biomarker for cardiac conditions. This substance is specifically measured to assess myocardial damage and is often utilized in clinical settings to evaluate the health of the heart. It is characterized by its ability to provide insights into the functioning of cardiac muscle, particularly during episodes of stress or injury. The measurement of this substance is instrumental in diagnosing and monitoring various cardiac-related diseases, contributing to effective patient management and treatment strategies. Its role in clinical diagnostics underscores its importance in the evaluation of cardiovascular health.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU121#006"/>
          <hierarchical_position>42021302</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW181#015" guid="8a081061c37e484081918ce50af9f6bf">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Fatty acid binding protein</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific type of protein that plays a crucial role in the transport and binding of fatty acids within the body. This category encompasses proteins that are involved in the regulation of lipid metabolism and may serve as biomarkers for various physiological and pathological conditions. Their measurement can provide valuable insights into metabolic processes and cardiovascular health, distinguishing them from other proteins that serve different functions or are associated with other markers of cardiac health. Understanding the levels and activities of these proteins can aid in the diagnosis and monitoring of certain medical conditions related to heart function and metabolic disorders.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU121#006"/>
          <hierarchical_position>42021303</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW182#015" guid="6730025ef4434bfe95dbded47f7db69f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Glycogen phosphorylase BB</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of enzyme that plays a crucial role in glycogen metabolism, particularly in the breakdown of glycogen to glucose. It is primarily found in various tissues, with a significant presence in the brain and heart, making it relevant as a biomarker for cardiac conditions. The enzyme is involved in the regulation of energy release during metabolic processes and is utilized in clinical settings to assess potential cardiac damage or stress. This category is distinct from other biochemical markers associated with cardiac health, highlighting its unique biochemical properties and applications in diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU121#006"/>
          <hierarchical_position>42021304</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW183#015" guid="cf20d2480f194d8e9de700c49f7b8547">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Myoglobin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of protein found in muscle tissue that plays a crucial role in oxygen binding and transport. It is relevant in the context of diagnostic applications, particularly within the healthcare sector, where it serves as a biomarker for various conditions. Differentiating this protein from others in related categories is essential for accurate identification and understanding of its clinical significance. This classification is particularly focused on its use in in vitro diagnostics, highlighting its importance in assessing cardiac health and related diseases. The classification ensures clarity in identifying and utilizing this biomarker in medical testing and research.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU121#006"/>
          <hierarchical_position>42021305</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW184#015" guid="9a53f92994dd45f6953bfb2c1087ee2f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Myosin light chain</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific protein that plays a crucial role in muscle contraction, particularly in cardiac muscle, which is involved in the regulation of cellular processes related to muscle function. It serves as a biomarker for diagnosing and monitoring cardiovascular conditions, reflecting changes in cardiac status. This protein is essential for understanding various heart diseases and conditions, providing valuable insights into the heart's mechanical properties and functional health. Its measurement can aid in the assessment of cardiac muscle integrity and response to injury or stress, contributing to comprehensive cardiovascular diagnostics and treatment strategies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU121#006"/>
          <hierarchical_position>42021306</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW185#015" guid="a12b22b0c68f42b6bd15495a1ecbb564">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Troponin I/T</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical substance utilized in clinical diagnostics, specifically in the evaluation of cardiac conditions. This marker is primarily associated with myocardial injury and is used to aid in the diagnosis of various cardiac diseases. Its measurement in blood samples can provide essential information regarding cardiac function and damage, facilitating timely medical interventions. This category encompasses various tests and methodologies that detect the presence and levels of the substance, which can be critical in emergency and routine cardiac care settings. The classification is distinct from other cardiac-related indicators that assess different aspects of heart health and function.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU121#006"/>
          <hierarchical_position>42021307</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW186#015" guid="2c8c8c29518342e89231d3b36cc38d2c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Homocysteine</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical compound found in the body, homocysteine is an amino acid that plays a crucial role in various metabolic processes. Elevated levels of this substance are associated with an increased risk of cardiovascular diseases and can serve as an important indicator in clinical assessments. Monitoring homocysteine levels can provide valuable insights into an individual's cardiovascular health, as it is involved in the metabolism of other essential nutrients and can influence various physiological functions. Its measurement is often utilized in conjunction with other biomarkers to assess heart condition and overall metabolic status, thereby aiding in the diagnosis and management of cardiovascular-related health issues.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU121#006"/>
          <hierarchical_position>42021308</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW187#015" guid="a0fe5a43f4e7437a81b11e5e9879473a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">High-sensitivity C-reactive protein</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical substance utilized in medical diagnostics, specifically as a marker for inflammation and cardiovascular disease. This compound is measured in blood tests to assess the presence and severity of inflammatory processes, particularly in relation to cardiovascular health. Its levels can indicate the risk of heart disease or other conditions associated with inflammation. The measurement of this protein is critical in clinical settings for evaluating patient health and guiding treatment decisions. It serves as an important tool for healthcare professionals in the diagnosis and monitoring of various health conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU121#006"/>
          <hierarchical_position>42021309</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW188#015" guid="35b641bd37384a6cb25e17270923ce1e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Ischemia modified albumin</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a type of biochemical marker used in the assessment of cardiac conditions, specifically indicating myocardial ischemia. This substance is modified by the presence of ischemia, which alters its structure and function, allowing for enhanced detection of cardiac injury. It plays a significant role in the diagnostic process for various cardiovascular diseases, contributing to the evaluation of patient risk and guiding therapeutic decisions. The analysis of this marker is essential in clinical settings, particularly in emergency medicine, to differentiate between various types of cardiac dysfunctions and to monitor the effectiveness of treatment interventions. Its specificity and sensitivity make it a valuable tool in contemporary cardiology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU121#006"/>
          <hierarchical_position>42021310</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW189#015" guid="136947753e584fab97f3b94bb3cce262">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Myeloperoxidase</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical enzyme primarily produced by certain white blood cells, playing a role in the immune response by catalyzing the production of reactive species that aid in the destruction of pathogens. It is particularly significant in the context of cardiovascular health, where elevated levels may indicate inflammation or tissue damage. This substance is utilized in various diagnostic applications to assess cardiac conditions, providing insights into myocardial injury or stress. Its measurement is essential for evaluating patients with suspected heart-related issues, contributing to the overall understanding of cardiac markers and their implications in clinical settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU121#006"/>
          <hierarchical_position>42021311</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW190#015" guid="97988daa2b12481bbae36c75cc68da95">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Lipoprotein-associated phospholipase A2</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical substance that plays a role in the metabolism of lipoproteins and is involved in various physiological and pathological processes. This entity is specifically associated with cardiovascular health and disease, serving as a potential biomarker for assessing cardiovascular risk and conditions. Its measurement can provide insights into inflammatory processes and cardiovascular events, differentiating it from other markers related to cardiac function and damage. This classification encompasses entities that are instrumental in understanding the complexities of heart disease and its underlying mechanisms.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU121#006"/>
          <hierarchical_position>42021312</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW191#015" guid="5ccc01f55d474671b798da97aa879653">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cardiac marker (unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU121#006"/>
          <hierarchical_position>42021390</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU137#005" guid="d2603918c7654170953f80f1617c3fd5">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Mycology (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specialized category focusing on the study and analysis of fungi and yeast within the context of in vitro diagnostics. It includes various tools and materials that facilitate the cultivation, identification, and susceptibility testing of fungal organisms. Products and systems in this classification are designed to support laboratory processes involving the detection and characterization of fungal pathogens, providing essential resources for clinical and research applications. Items classified here may include prepared media in various forms, identification systems, and testing kits tailored specifically for fungi and yeast, catering to both manual and automated methodologies. This category serves as a distinct grouping separate from other microbiological classifications, ensuring precise identification and application in laboratory settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS276#005"/>
          <hierarchical_position>42040300</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW518#015" guid="f5e2c2aba4fb4393b896e6ed3fc03176">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Dehydrated culture media for yeast and fungi (mycology)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a classification for dehydrated culture media specifically designed for the growth and maintenance of yeast and fungal organisms in laboratory settings. This category encompasses a variety of formulations that are provided in a dehydrated state, allowing for easy storage and transportation. Upon rehydration, these media serve as a nutrient-rich environment to support the cultivation of yeast and fungi for various applications, including research, diagnostics, and quality control. The products within this classification are distinct from other media types, such as those that are pre-prepared or provided in plate formats, as well as those intended for identification or susceptibility testing procedures.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU137#005"/>
          <hierarchical_position>42040301</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW519#015" guid="00c87f30af464ebd9cd396f7e19065a5">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">PPM for yeast and fungi (prepared media in plate, mycology)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses prepared media specifically designed for the cultivation and isolation of yeast and fungi in laboratory settings. These media are available in plate format, facilitating ease of use and application in mycological studies. The focus is on formulations that support the growth of various yeast and fungal species, enabling accurate identification and analysis. This category is distinct from other related classifications that include dehydrated media, chromogenic media, tube formats, dip slides, bottled media, and identification or susceptibility testing systems, whether manual or automated. The products in this classification are essential for microbiological research, diagnostics, and various applications in clinical and environmental microbiology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU137#005"/>
          <hierarchical_position>42040302</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW520#015" guid="54831ad81a4541c9919a62dbcdd43330">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Chromogenic media for yeast and fungi (prepared media in plate, mycology)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">prepared media specifically designed for the cultivation and identification of yeast and fungi, utilizing chromogenic substrates. These media facilitate the differentiation of various microorganisms based on their metabolic activities, enabling more precise identification and characterization. Typically presented in plate format, these media support a range of mycological applications, including clinical diagnostics, environmental sampling, and research purposes. They provide a visual indication of microbial growth through color changes, allowing for easier observation and analysis of results. This classification encompasses products that offer a reliable and efficient method for isolating and identifying specific yeast and fungal species, thus playing a crucial role in microbiological studies and diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU137#005"/>
          <hierarchical_position>42040303</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW521#015" guid="2b2024f8ab624108a60c3715cb9b145e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Tube for yeast and fungi (mycology)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses items designed specifically for the cultivation and study of yeast and fungi within the field of mycology. These items facilitate the growth and maintenance of these microorganisms, allowing for various applications in research, diagnostics, and industrial processes. They are utilized to provide a suitable environment for yeast and fungi to thrive, enabling the observation of their biological characteristics and the evaluation of their behaviors under different conditions. This category is distinct from other classifications that pertain to various forms of prepared media, identification systems, and susceptibility testing, each serving unique purposes and methodologies within the realm of mycology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU137#005"/>
          <hierarchical_position>42040304</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW522#015" guid="ee085fd5ca2d4d4aa18e027420980104">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Dip slides (mycology)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic tool utilized in the field of mycology, specifically designed for the isolation and identification of fungal microorganisms. This product typically consists of a sterile slide coated with a nutrient medium that supports the growth of fungi when exposed to environmental samples. It enables healthcare professionals and researchers to perform visual examinations and assessments of fungal presence, aiding in the diagnosis of fungal infections or related conditions. The functional application of this tool is crucial in both clinical and laboratory settings, providing valuable insights into the types of fungi present in a sample, thereby assisting in effective treatment decisions and further research in mycological studies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU137#005"/>
          <hierarchical_position>42040305</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW523#015" guid="6ed30d1de1ce4a0395667027ae9b6ea8">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Bottled media for yeast and fungi (mycology)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses liquid media specifically formulated for the cultivation and maintenance of yeast and fungi. These products are typically packaged in bottles and are utilized in various laboratory and research settings. They provide the necessary nutrients and environmental conditions required for the growth of these microorganisms, facilitating studies in microbiology, biotechnology, and related fields. The bottled media is distinct from other types of media, such as dehydrated or prepared media, and serves a unique purpose in fostering yeast and fungal cultures for diagnostic, research, or educational purposes. These formulations may vary in composition to support different species or strains, ensuring optimal growth and viability.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU137#005"/>
          <hierarchical_position>42040306</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW524#015" guid="f3275c902e534083a4eb6db704648e23">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Identification system for yeast and fungi (manual)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a system designed for the identification of yeast and fungi through manual processes, employing various methodologies to accurately recognize and categorize different species. This system may utilize biochemical tests, morphological assessments, and other traditional techniques to facilitate the differentiation of microorganisms. It is particularly valuable in laboratory settings where automated systems are not utilized or when specific manual approaches are preferred. This identification system aids in the analysis and understanding of yeast and fungi, contributing to various scientific, clinical, and industrial applications. The focus is on providing reliable results through hands-on examination and interpretation by trained personnel.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU137#005"/>
          <hierarchical_position>42040307</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW525#015" guid="2a7fbfe67c3a43b2819daa3034b1bd7f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Identification system for yeast and fungi (automated)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a system designed to automate the identification of yeast and fungi, utilizing advanced technologies and methodologies to facilitate accurate and efficient testing. This system is intended for use in laboratories and clinical settings, providing rapid results to support diagnostic processes. It encompasses various techniques that may include molecular biology, biochemical assays, and other innovative approaches to differentiate between species and strains of yeast and fungi. Such systems are crucial for ensuring the correct identification of microorganisms, which is essential for effective treatment and management of infections. The automated nature of this system enhances throughput, reduces manual intervention, and minimizes the potential for human error in the identification process, thereby improving overall laboratory efficiency and diagnostic accuracy.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU137#005"/>
          <hierarchical_position>42040308</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW526#015" guid="8a85be2b9cc64b139dd59b1676bc01d7">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Identification system for yeast and fungi, NA</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a collection of tools and methodologies designed to facilitate the identification and differentiation of yeast and fungal organisms. This system encompasses a range of techniques that may include biochemical assays, molecular methods, and other diagnostic approaches specifically tailored for the accurate recognition of various yeast and fungal species. It is utilized in laboratory settings to support clinical diagnostics, research, and quality control, providing essential information for the effective management of fungal infections and studies in mycology. The systems may vary in complexity and automation, catering to different laboratory requirements and workflows.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU137#005"/>
          <hierarchical_position>42040309</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW527#015" guid="c84c09d2ffdf44d390495453b324ce9a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Serological identification of yeast and fungi</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses products and systems specifically designed for the serological identification of yeast and fungi. These items are utilized in laboratory settings to detect and characterize various fungal and yeast species through serological methods, which typically involve the use of antibodies or antigens. The focus is on distinguishing these microorganisms based on their immunological responses, aiding in the diagnosis and study of fungal infections. This classification is distinct from other diagnostic tools and media types that are used for culturing, preparing, or testing yeast and fungi, ensuring a clear differentiation in the classification system.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU137#005"/>
          <hierarchical_position>42040310</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV760#015" guid="63c152221fc7479f8c1bf613023a633d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Calibrator single component (CC)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a calibrator designed for use in analytical processes, specifically tailored to provide a reference point for measurement accuracy in clinical chemistry applications. This type of calibrator consists of a single component, ensuring precise adjustments and enhancements in the calibration of analytical instruments. It is utilized to verify the accuracy and reliability of test results by establishing a known standard against which test responses can be compared. The single-component nature of this calibrator allows for straightforward application and interpretation in laboratory settings, distinguishing it from more complex calibrators that may include multiple components or serve broader calibration functions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU106#005"/>
          <hierarchical_position>42010609</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV761#015" guid="d61f34ab98da489eb88b28692fcd22f4">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Aqueous standard (CC)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">aqueous standards are reference materials specifically designed for use in analytical testing and calibration processes in clinical chemistry. These substances are prepared in a liquid form, typically composed of water-based solutions that ensure consistency and reliability in measurements. They serve as benchmarks for performance evaluation and quality assurance, enabling accurate calibration of instruments and validation of analytical methods. Aqueous standards are crucial for establishing traceability in laboratory results, ensuring that measurements are comparable across different systems and laboratories. Their formulation is standardized to provide known concentrations of analytes, facilitating the assessment of both precision and accuracy in laboratory analyses.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU106#005"/>
          <hierarchical_position>42010610</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV763#015" guid="750a7045752e49678387e67017268a40">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Urine control</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a category dedicated to products designed for the monitoring and management of urine samples, focusing on the assessment of various parameters relevant to clinical chemistry. These products are utilized in laboratory settings to ensure accurate testing and analysis of urine, facilitating the detection of abnormalities and aiding in the diagnosis of medical conditions. The offerings within this category may include quality control materials, reference standards, and calibration solutions specifically formulated for urine analysis. Their primary purpose is to support the reliability and precision of clinical tests, contributing to effective patient care and laboratory efficiency.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU106#005"/>
          <hierarchical_position>42010612</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV764#015" guid="9483c938549e4858afbd665c1d9d8044">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">CSF control</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a set of specialized solutions or materials designed to ensure the accuracy and reliability of analytical measurements in clinical chemistry. These controls are essential for validating the performance of laboratory tests, serving as benchmarks to assess the precision and accuracy of test results. They may contain known concentrations of various analytes and are used in routine quality control processes. The application of these controls helps to maintain consistency in laboratory operations and supports compliance with regulatory standards. The focus is on enhancing the overall quality of diagnostic testing through systematic verification and calibration procedures.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU106#005"/>
          <hierarchical_position>42010613</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV765#015" guid="64faf9b4f23647d497be584fa44b79e1">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Control, standard, calibrator (clinical chemistry, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU106#005"/>
          <hierarchical_position>42010690</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-AFU804#011" guid="8e52cfaa76564d64968fbbc4d1ae25ea">
          <date_of_original_definition>2014-11-30Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Control, standard, calibrator (clinical chemistry, accessories)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects with complemental characteristics, without which the basic function of the objects classified under the parent-class on the 3rd level is still guaranteed</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU106#005"/>
          <hierarchical_position>42010692</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU128#005" guid="e22250477b7a41b3b4511a28c371e7fd">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Immunohaematology (blood grouping)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses products and services specifically designed for the analysis, identification, and characterization of blood groups within the context of immunohaematology. It includes various reagents and materials utilized in the determination of blood group antigens and antibodies, facilitating compatibility testing and transfusion processes. The offerings consist of items essential for conducting blood typing, screening for antibodies, and verifying the presence of specific blood group factors. Additionally, this classification covers specialized controls and enhancement media that improve the accuracy and reliability of immunohaematological testing. The focus is on materials that support the understanding of blood group serology and the immune response related to blood transfusion and organ transplantation.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS275#005"/>
          <hierarchical_position>42030300</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW380#015" guid="2e6b72e9cbab467da3082aef65d5e8a9">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">ABO grouping cell</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a classification for a specific type of biological product used in the field of immunohaematology, which is essential for blood typing and compatibility testing. This product is utilized to identify and categorize blood groups based on the presence of specific antigens on the surface of red blood cells. It plays a crucial role in transfusion medicine and prenatal testing, enabling healthcare professionals to determine blood compatibility and assist in safe blood transfusions. This classification is distinct from other related products that focus on different aspects of blood group determination and antibody screening, ensuring clarity in the identification and usage of each specific product within the field.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU128#005"/>
          <hierarchical_position>42030301</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW381#015" guid="0197777ab67f4431b27fb29036316dea">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">ABO serum</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological product derived from human blood, specifically designed for use in immunohaematological testing and analysis. This product is utilized in various diagnostic procedures related to blood typing and compatibility testing, particularly in determining the ABO blood group of individuals. It contains antibodies that react specifically with A and B antigens present on red blood cells, facilitating the identification of blood groups. This type of serum is essential for ensuring safe blood transfusions and organ transplants, as it helps prevent adverse reactions by accurately matching donors and recipients based on their blood group compatibility.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU128#005"/>
          <hierarchical_position>42030302</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW382#015" guid="20cfbaa632114199b59ed2f398b01634">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Rhesus D</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specialized category of biological products utilized in immunohaematology for determining the presence of specific blood group antigens, particularly the Rhesus D antigen. These products are essential in blood typing and compatibility testing, playing a crucial role in transfusion medicine and prenatal testing. They assist in identifying individuals who are Rh-positive or Rh-negative, which is vital for ensuring safe blood transfusions and managing Rh incompatibility in pregnancy. The classification includes various forms of reagents, control cells, and testing kits designed for laboratory use in the analysis and screening of blood samples to facilitate accurate diagnosis and treatment in clinical settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU128#005"/>
          <hierarchical_position>42030303</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW383#015" guid="17b20c28ecd54cd78dd96f25d6f6d8cf">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Rhesus phenotype</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="DeepL">Specific combination of antigens on the surface of red blood cells that determines whether an individual has a positive or negative characteristic according to the Rhesus blood group system.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">Machine generated by Chat GPT4</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU128#005"/>
          <hierarchical_position>42030304</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW384#015" guid="67e0b51396eb41acb181f24cf56ba2fd">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Antibody 2 cell screening</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specialized biological reagent utilized in the process of identifying and analyzing specific antibodies present in a blood sample. This reagent is essential for conducting tests that facilitate the detection of antibodies that may react with red blood cells, aiding in compatibility assessments and transfusion medicine. It plays a critical role in immunohaematology by enhancing the accuracy of blood grouping and antibody screening procedures. The product is designed to optimize the evaluation of immune responses related to blood characteristics, ensuring precise diagnostics and patient safety in transfusion practices.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU128#005"/>
          <hierarchical_position>42030305</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW385#015" guid="78d5777658ea46a7ac4d6363bacc8545">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Antibody 3 cell screening</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic reagent utilized in immunohaematology, specifically designed for the identification and detection of antibodies in blood samples through a three-cell screening method. This tool is essential for evaluating the presence of unexpected antibodies, which may indicate potential incompatibility in blood transfusion scenarios. By utilizing a panel of three different red blood cell lines, it enhances the accuracy of antibody detection and ensures thorough compatibility testing. It plays a critical role in ensuring patient safety and effective blood management by supporting clinicians in the assessment of blood group antigens and the subsequent decision-making process in transfusion practices.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU128#005"/>
          <hierarchical_position>42030306</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW386#015" guid="213699b40bd54f97a6cb7923c41a88b9">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Antibody identification cell panel</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a testing tool designed for the identification of antibodies in blood samples, this item is essential in the field of immunohaematology. It consists of a panel of specific cells that interact with serum or plasma, aiding in the detection of unexpected antibodies that may affect blood transfusions or pregnancy. This tool is utilized in various diagnostic procedures to enhance blood typing accuracy and ensure compatibility between donors and recipients. It plays a crucial role in transfusion medicine, safeguarding patients from potential hemolytic reactions. The item is distinct from other testing tools that focus on different aspects of blood grouping and antibody detection.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU128#005"/>
          <hierarchical_position>42030307</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW387#015" guid="611f9b0d453d46b689c19ed33a19cf25">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Polyspecific antihuman serum</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a preparation designed to identify or detect a broad range of human antibodies, typically used in blood typing and immunohematology testing. This serum is derived from human sources and contains multiple antibody specificities, allowing for the detection of various blood group antigens. It plays a crucial role in compatibility testing prior to transfusions and in the diagnosis of certain blood disorders. The application of this serum aids in enhancing the accuracy of serological tests and contributes to the safety of blood transfusions by ensuring proper matching between donors and recipients. Its usage is vital in clinical laboratories for the evaluation of immune responses and for research purposes in immunology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU128#005"/>
          <hierarchical_position>42030308</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW388#015" guid="cf8283c1b3d34031bf97468ad463f735">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Monospecific antihuman serum</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a preparation specifically designed to react with human antibodies, providing a focused response to a single antigen or antigenic determinant. This product is utilized in various diagnostic and therapeutic applications within the field of immunohaematology, particularly for the identification and quantification of specific blood group antigens. Its use is essential for accurate blood typing, compatibility testing, and the investigation of transfusion reactions. The formulation is characterized by its specificity and effectiveness in immunological assays, distinguishing it from broader-spectrum alternatives. This type of serum plays a critical role in enhancing the reliability of blood grouping procedures and ensuring patient safety in transfusion medicine.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU128#005"/>
          <hierarchical_position>42030309</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW389#015" guid="a25a8dd80ad444d085d96bcf473b96b7">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Enhancement media (e.g. bovine albumin, LISS, PEG)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a category encompassing various substances utilized to enhance the effectiveness of immunohaematological procedures. These materials are specifically designed to improve the performance and reliability of tests related to blood grouping and compatibility. They play a crucial role in facilitating reactions between antibodies and antigens, thereby aiding in the identification and characterization of blood types and compatibility assessments. This classification includes a range of enhancement media that may vary in composition and application, ensuring optimal conditions for accurate immunological analysis in clinical and laboratory settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU128#005"/>
          <hierarchical_position>42030310</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW390#015" guid="8fd541623919463d97978cbcf42d1382">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Enzyme (e.g. bromelin, papain)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological catalyst that accelerates chemical reactions in living organisms, often used in various biochemical processes. This category includes naturally occurring and recombinant enzymes that facilitate specific reactions, enhancing the efficiency of assays and tests in the field of immunohaematology. These enzymes are critical in blood grouping and typing procedures, playing a significant role in the detection and identification of blood group antigens and antibodies, thereby contributing to accurate and reliable immunohaematological assessments. Their application extends to various diagnostic and therapeutic contexts, supporting advancements in medical research and clinical practice.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU128#005"/>
          <hierarchical_position>42030311</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW391#015" guid="8d26ea09201f4a03bf69b35ba6c70909">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Coombs control cell (immunohaematology)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specialized biological material used in immunohaematology for the purpose of validating and controlling testing procedures related to blood grouping. This item is utilized in laboratory settings to ensure the accuracy and reliability of blood typing results by serving as a reference standard during serological tests. It is designed to mimic specific blood group characteristics and is essential for quality assurance in immunological assays. The product is characterized by its ability to react predictably with corresponding antibodies, facilitating the identification of blood group antigens and ensuring compliance with testing protocols.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU128#005"/>
          <hierarchical_position>42030312</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW392#015" guid="448a95471d1c4838878a0a007514f4d0">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Control kit (immunohaematology)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a collection of items designed for use in immunohaematology procedures, particularly those related to the testing and analysis of blood group antigens and antibodies. This set typically includes various components that facilitate the accurate determination of blood types and compatibility for transfusions, as well as the detection of specific antibodies. These kits are essential for laboratories performing blood grouping, cross-matching, and other immunological assessments. The components may vary in formulation and function but are standardized to ensure reliability and effectiveness in clinical applications.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU128#005"/>
          <hierarchical_position>42030313</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW393#015" guid="fc208e0bbbc745379d02f6623fb42741">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Immunohaematology (blood grouping, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU128#005"/>
          <hierarchical_position>42030390</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU119#006" guid="c8ca2bba588e4620bdc6a204b72886f4">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Rheumatoid (inflammatory disease marker)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a category of biological markers specifically associated with rheumatoid inflammatory diseases, which are conditions characterized by an immune system response leading to inflammation. These markers are utilized in diagnostic procedures to aid in the identification and monitoring of rheumatoid diseases. The items classified within this category include various antibodies and proteins that provide valuable insights into the presence and severity of inflammation and immune responses. Such markers are crucial for clinicians in assessing disease activity, guiding treatment decisions, and evaluating therapeutic responses in patients with autoimmune conditions. The classification distinctly separates these markers from those related to other immunological tests or disease categories, ensuring clarity and precision in the diagnostics landscape.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS274#006"/>
          <hierarchical_position>42021100</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW163#015" guid="cbb6b9865c2848f9a5166df048d5595b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Anti-streptococcal deoxyribonuclease B (Anti-DNAase B)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of biological marker used in the diagnosis and monitoring of inflammatory diseases, particularly those associated with streptococcal infections. The focus is on a specific enzyme that targets and breaks down DNA produced by streptococci, which can be indicative of the body's immune response to such infections. It plays a crucial role in the evaluation of certain autoimmune conditions, helping to differentiate between various inflammatory responses. This category is distinct from other related markers that indicate immune reactions or the presence of antibodies against different streptococcal components, thus serving a unique purpose in the clinical assessment of inflammatory diseases linked to streptococcal pathogens.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU119#006"/>
          <hierarchical_position>42021101</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW164#015" guid="8510a1a05f264a26afa1026b35c29a11">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Anti-streptococcal hyaluronidase</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specialized enzyme that facilitates the breakdown of hyaluronic acid, primarily utilized in diagnostic testing for the presence of specific antibodies associated with streptococcal infections. This enzyme plays a significant role in the evaluation of inflammatory conditions, particularly those related to rheumatoid diseases. The presence of anti-streptococcal hyaluronidase in the serum can indicate an immune response to streptococcal antigens, contributing to the overall assessment of inflammatory markers in clinical practice. It is differentiated from other related tests and markers that evaluate immune responses to different streptococcal components, providing valuable insights into the pathophysiology of autoimmune and inflammatory disorders.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU119#006"/>
          <hierarchical_position>42021102</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW165#015" guid="5d4541bab916407490aadede11d68593">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Anti-streptokinase</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological substance that is utilized in diagnostic testing to identify the presence of antibodies specifically targeting streptokinase, an enzyme produced by certain bacteria. This marker is relevant in the context of inflammatory diseases, particularly in assessing immune responses associated with infections and autoimmune conditions. The detection of this substance aids in the evaluation of the body's reaction to streptococcal infections and contributes to the overall understanding of inflammatory processes. Its measurement can provide valuable insights into the severity and progression of related health conditions, thereby assisting healthcare professionals in making informed decisions regarding patient care and management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU119#006"/>
          <hierarchical_position>42021103</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW166#015" guid="3f317cf3005840f19f20b1294cef8705">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Anti-streptolysin O reaction time, titre (qualitative)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a test that measures the presence and concentration of antibodies against streptolysin O, a toxin produced by certain strains of streptococcus bacteria, to assess the immune response in an individual. This qualitative analysis focuses on determining whether antibodies are present, indicating prior exposure to the bacteria, which may be associated with specific inflammatory conditions. The result is expressed as a titre, reflecting the highest dilution of serum that still shows a reaction, providing insight into the immune status related to streptococcal infections. This test is part of a broader panel used for diagnosing and monitoring inflammatory diseases, particularly those related to autoimmune responses.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU119#006"/>
          <hierarchical_position>42021104</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW167#015" guid="b818d54cf0d948a5be824bf382a8aac3">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Anti-streptolysin O (quantitative)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a quantitative measurement that detects and assesses the presence of antibodies against streptolysin O, a hemolytic toxin produced by certain strains of Streptococcus bacteria. This test is utilized primarily in the diagnosis and monitoring of infections related to streptococcal bacteria, particularly in cases where rheumatic fever or post-streptococcal glomerulonephritis is suspected. The quantification provides valuable information regarding the immune response to the streptococcal infection, helping healthcare professionals evaluate the severity and progression of the disease. This assessment is crucial for differentiating between various inflammatory conditions and guiding appropriate treatment strategies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU119#006"/>
          <hierarchical_position>42021105</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW168#015" guid="f726b069662d488d85d5427f7d8a2cad">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Anti-staphylolysin reaction time, titre (qualitative)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a specific immunological test used to detect the presence and level of antibodies against staphylolysin, a toxin produced by certain staphylococci bacteria. The test measures the reaction time and titre qualitatively, indicating whether antibodies are present and their relative concentration. It serves as a marker in the diagnosis and monitoring of conditions related to staphylococcal infections and inflammatory responses. This classification is distinct from other tests for various inflammatory disease markers, which assess different antibodies or immune responses related to other pathogens or immune conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU119#006"/>
          <hierarchical_position>42021106</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW169#015" guid="d4886099cf804068920c2f008951afa6">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Anti-staphylolysin (quantitative)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance that is measured to assess the presence of antibodies against staphylococcal bacteria in the bloodstream, specifically in a quantitative manner. This measurement is utilized in the context of diagnosing and monitoring inflammatory diseases, particularly those associated with autoimmune responses. It serves as a biomarker to help evaluate the immune system's activity and its response to staphylococcal infections. The definition distinguishes it from similar antibodies that target different pathogens or utilize qualitative assessment methods. This measurement is critical in clinical settings for guiding treatment decisions and understanding disease progression.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU119#006"/>
          <hierarchical_position>42021107</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW170#015" guid="09249e7635f4471cb721c27c3f27dde6">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Circulating immune complexe</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a circulating immune complex is a formation that occurs when antibodies bind to soluble antigens, leading to the creation of aggregates that can circulate within the bloodstream. These complexes can play a significant role in various immune responses and are often associated with inflammatory conditions. Their presence can indicate an abnormal immune response, particularly in the context of autoimmune diseases. The analysis of circulating immune complexes is often utilized in diagnosing specific inflammatory markers, contributing to the understanding of disease mechanisms and aiding in the assessment of disease activity and progression. This classification encompasses a range of related markers that are essential in the evaluation of immune system function and the presence of inflammatory processes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU119#006"/>
          <hierarchical_position>42021108</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU103#005" guid="4e0afdfb036d485fb70a482f33596222">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Electrolyte reagent (excluding electrode)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a variety of substances utilized in clinical chemistry for the analysis and measurement of electrolytes in biological samples, excluding any electrodes. These reagents play a crucial role in diagnostic laboratories, facilitating the assessment of electrolyte balance and metabolic functions within the body. The focus is on specific chemical compounds that are integral to various analytical procedures, ensuring accurate and reliable results in clinical diagnostics. The range includes essential electrolytes necessary for physiological processes, each contributing to the understanding of patient health and aiding in the diagnosis of medical conditions. These substances are characterized by their distinct chemical properties and applications, tailored for use in in vitro diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS273#005"/>
          <hierarchical_position>42010300</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV713#015" guid="9fa43edcb7944ac480c535f46f9e2844">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Ammonia (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a nitrogen-based compound commonly used in various scientific and industrial applications, particularly in the context of laboratory diagnostics and medical testing. This substance plays a critical role in the formulation of electrolyte solutions, aiding in the assessment of physiological conditions and the maintenance of fluid and electrolyte balance in biological systems. Its unique chemical properties distinguish it from other related compounds that serve similar functions, allowing for precise measurements and analyses in clinical environments. The classification encompasses its specific use in in vitro diagnostics, emphasizing its importance in laboratory settings while excluding other similar reagents that may serve different roles or have distinct chemical compositions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU103#005"/>
          <hierarchical_position>42010301</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV714#015" guid="71dcf888d97945b8b8db3fd38163cdc9">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Bicarbonate (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a chemical compound typically used in analytical and diagnostic processes within clinical laboratories. This substance plays a crucial role in various biochemical reactions and is often utilized for its buffering properties. It is essential in maintaining pH balance in biological samples and is integral to electrolyte balance assessments. This category specifically encompasses formulations designed for in vitro diagnostic applications, distinguishing it from other similar electrolyte reagents. The focus is on its unique biochemical characteristics and applications, which set it apart from other compounds used in laboratory analyses.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU103#005"/>
          <hierarchical_position>42010302</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV715#015" guid="569df67cf3334e45b5b862f29053371c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Calcium (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance characterized as a crucial component in various in vitro diagnostic applications, specifically utilized for determining calcium levels in biological samples. This material plays a significant role in clinical assessments, aiding in the diagnosis and monitoring of conditions related to calcium metabolism, such as bone disorders and parathyroid function abnormalities. It is distinguished from other electrolyte reagents used in diagnostics by its unique chemical properties and specific applications in testing protocols. The classification encompasses various forms and formulations suitable for laboratory use, ensuring compliance with quality and safety standards necessary for medical testing.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU103#005"/>
          <hierarchical_position>42010303</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV716#015" guid="13194a2d6b98404986f3fd4ece5a9189">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Chloride (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a chemical compound that contains chlorine and is utilized in in vitro diagnostic processes. This substance plays a critical role in various analytical procedures, serving as an electrolyte reagent to aid in the assessment of physiological and biochemical parameters in biological samples. It is distinct from other related substances used in diagnostics, each of which possesses unique properties and applications. This classification encompasses various forms and derivatives of the compound, specifically tailored for laboratory and clinical use, ensuring accuracy in the measurement and analysis of chloride levels in specimens.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU103#005"/>
          <hierarchical_position>42010304</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV717#015" guid="59ecb38914324b209f9df9405b2b3c19">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Lithium (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a chemical substance characterized by its use in various applications, particularly in the field of diagnostics and analytical chemistry. This material plays a crucial role in electrolyte solutions, providing essential ions that facilitate biochemical processes. It is distinct from other related compounds in its specific properties and applications. This substance is often utilized in laboratory settings, particularly for its ability to maintain ionic balance and support various analytical methods. Its unique characteristics and functionality set it apart from other electrolyte reagents, highlighting its importance in the formulation of diagnostic solutions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU103#005"/>
          <hierarchical_position>42010305</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV718#015" guid="846c322e6b6e415e98a8ca675a4a8e33">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Magnesium (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a chemical element that serves as a crucial component in various analytical and diagnostic processes, particularly in the context of in vitro diagnostics (IVD). This substance is utilized in clinical laboratories for the assessment of electrolyte balance, aiding in the evaluation of metabolic and physiological conditions. Its unique properties differentiate it from similar substances used in diagnostic applications, making it essential for specific testing protocols. The classification encompasses all forms and preparations of this element that are intended for laboratory use, excluding other types of electrolyte reagents that may serve different purposes or exhibit distinct characteristics in diagnostic settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU103#005"/>
          <hierarchical_position>42010306</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV719#015" guid="8c9955b9826441478c6c5c463e92617e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Phosphate inorganic, phosphorus (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance characterized by the presence of phosphorus in an inorganic form, typically utilized for its roles in biochemical processes and as a critical component in various applications, including laboratory reagents and analytical chemistry. This material is distinct from other similar substances based on its unique chemical properties and specific applications, which may include its use in diagnostics, research, and other scientific contexts. The classification highlights its importance in the field of electrolytes, emphasizing its function and relevance in various analytical and experimental settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU103#005"/>
          <hierarchical_position>42010307</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV720#015" guid="845df35b7a6344dbabdd9393c591cfa1">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Potassium (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance that serves as an electrolyte reagent, specifically utilized for diagnostic purposes in vitro. This reagent plays a critical role in various biochemical assays and is essential for the accurate measurement of potassium levels in biological samples. It is distinct from other electrolyte reagents based on its unique chemical properties and applications in clinical settings, facilitating the assessment of metabolic functions and electrolyte balance. The reagent is typically supplied in a form that ensures stability and reliability during testing, contributing to the overall accuracy of diagnostic results in laboratory environments.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU103#005"/>
          <hierarchical_position>42010308</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV721#015" guid="04c466d0237c4c13968cae8d8f87b585">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Sodium (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a chemical substance used primarily in in vitro diagnostic applications, characterized by its essential role in electrolyte balance and fluid regulation within biological systems. This substance is typically utilized in laboratory settings to assist in various diagnostic tests, contributing to the assessment of electrolyte levels and overall metabolic function. It is distinct from other electrolyte reagents, which serve similar diagnostic purposes but are based on different chemical compositions and physiological roles. The classification highlights the unique properties and applications of this particular reagent within the broader context of electrolyte analysis in medical diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU103#005"/>
          <hierarchical_position>42010309</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV722#015" guid="abba8808441241988aeedfeaeea5cb83">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Electrolyte reagent (excluding electrode, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU103#005"/>
          <hierarchical_position>42010390</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU159#005" guid="8d381aa3f3ac4d37a1ba79e91420444e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Haematology, histology, cytology instrument (HHC)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses materials specifically designed to fill gaps, seal joints, and provide a barrier against various elements. These substances are utilized in a wide range of applications, enhancing durability and performance by preventing leakage, infiltration, or contamination. The materials classified herein are differentiated by their composition and intended use, including products derived from rubberlike substances, plastics, high polymers, and both artificial and natural fibers. Each type serves unique functions in construction, manufacturing, and repair processes, ensuring structural integrity and longevity of assemblies in diverse environments. The classification reflects the essential role these materials play in enhancing product functionality and safety across multiple industries.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS279#005"/>
          <hierarchical_position>42070200</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW967#015" guid="acf33959618d4f0f86b2677b22a5cc64">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Consumable for haematology, histology, cytology instrument</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses items specifically designed for use with instruments utilized in the fields of haematology, histology, and cytology. These consumables are essential for the proper functioning and maintenance of diagnostic and analytical equipment within these disciplines. They may include reagents, stains, slides, and other materials that facilitate sample processing, analysis, and interpretation. The items classified here are distinct in their application and purpose, focusing on supporting laboratory procedures rather than software solutions or specific types of analytical devices. Their role is critical in ensuring accuracy and reliability in testing and research related to cellular and tissue analysis.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU159#005"/>
          <hierarchical_position>42070201</hierarchical_position>
          <keywords>
            <label id="0173-1#Z5-ACK908#001" language_code="en" country_code="US">Consumable histology, cytology (HC) instrument</label>
            <label id="0173-1#Z5-ACK906#001" language_code="en" country_code="US">Consumable blood grouping (BG) instrument</label>
            <label id="0173-1#Z5-ACK905#001" language_code="en" country_code="US">Consumable haemostasis (HS) instrument</label>
            <label id="0173-1#Z5-ACK911#001" language_code="en" country_code="US">Consumable rapid test coagulation (RT_Coagulation ) instrument</label>
            <label id="0173-1#Z5-ACK912#001" language_code="en" country_code="US">Consumable haematology, histology, cytology (HHC) instrument</label>
            <label id="0173-1#Z5-ACK904#001" language_code="en" country_code="US">Consumable cell counting (CC) instrument</label>
            <label id="0173-1#Z5-ACK907#001" language_code="en" country_code="US">Consumable flow cytometry (FC) instrument</label>
            <label id="0173-1#Z5-ACK910#001" language_code="en" country_code="US">Consumable rapid test cell counting (RT_Cell Counting) instrument</label>
            <label id="0173-1#Z5-ACK909#001" language_code="en" country_code="US">Consumable haematology-, histology-, cytology rapid test (RT_HHC) instrument</label>
          </keywords>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW968#015" guid="d9aaac3aa5ba41c4a09caeb2d8906bb0">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Software for haematology, histology, cytology instrument</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses software specifically designed to operate and enhance the functionality of instruments utilized in the fields of haematology, histology, and cytology. Such software is integral for data analysis, instrument control, and workflow management in laboratories that focus on cellular and tissue examination. It supports various tasks including sample processing, result interpretation, and quality assurance, thereby facilitating accurate diagnostic outcomes. The software is distinct from consumables and other types of instruments that serve different purposes within the same medical and laboratory contexts. Its primary objective is to streamline operations, improve efficiency, and ensure compliance with regulatory standards in the analysis of biological samples.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU159#005"/>
          <hierarchical_position>42070202</hierarchical_position>
          <keywords>
            <label id="0173-1#Z5-ACK914#001" language_code="en" country_code="US">Software haemostasis (HS) instrument</label>
            <label id="0173-1#Z5-ACK913#001" language_code="en" country_code="US">Software cell counting (CC) instrument</label>
            <label id="0173-1#Z5-ACK918#001" language_code="en" country_code="US">Software haematology-, histology-, cytology rapid test (RT_HHC) instrument</label>
            <label id="0173-1#Z5-ACK915#001" language_code="en" country_code="US">Software blood grouping (BG) instrument</label>
            <label id="0173-1#Z5-ACK920#001" language_code="en" country_code="US">Software rapid test coagulation (RT_Coagulation ) instrument</label>
            <label id="0173-1#Z5-ACK917#001" language_code="en" country_code="US">Software histology, cytology (HC) instrument</label>
            <label id="0173-1#Z5-ACK916#001" language_code="en" country_code="US">Software flow cytometry (FC) instrument</label>
            <label id="0173-1#Z5-ACK919#001" language_code="en" country_code="US">Software rapid test cell counting (RT_ Cell Counting) instrument</label>
            <label id="0173-1#Z5-ACK921#001" language_code="en" country_code="US">Software haematology, histology, cytology (HHC) instrument</label>
          </keywords>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW969#015" guid="46be7557d1e04bc8950cc21ebaa35ea2">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cell counting (CC) instrument</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">an instrument designed specifically for the enumeration and analysis of cells within various biological samples. This device operates through techniques that may involve optics, fluidics, and advanced electronics to accurately measure cell quantities and characteristics. It is primarily utilized in medical and research laboratories to facilitate diagnostics, research studies, and quality control processes in cellular investigations. The functionality of this instrument is distinct from related technologies that focus on consumables or software solutions, as well as those that serve different applications in the fields of haematology, histology, cytology, and related disciplines.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU159#005"/>
          <hierarchical_position>42070203</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW970#015" guid="7746a630a43e4da785c11d2a198e9ec4">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Haemostasis (HS) instrument</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">an instrument specifically designed for the measurement and analysis of blood coagulation and related processes. This type of equipment is utilized in clinical settings to assess the body's ability to control bleeding and clotting, providing critical data for diagnosing and monitoring various medical conditions. The instruments may employ various methodologies to deliver accurate and reliable results, often integrating advanced technologies for enhanced performance and ease of use. They play a crucial role in ensuring patient safety and effective treatment in healthcare environments, particularly in laboratories specializing in blood-related diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU159#005"/>
          <hierarchical_position>42070204</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW971#015" guid="ec55c35ffae549d99905b1c3e2dee1eb">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Blood grouping (BG) instrument</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">an instrument designed specifically for the analysis and determination of blood groups through various methodologies. This device facilitates the identification of specific antigens and antibodies present in blood samples, thereby allowing for compatibility assessments in transfusions and other medical applications. The functionality of this instrument is distinct from other related devices that focus on consumables, software solutions, or devices intended for different aspects of blood analysis, such as cell counting or coagulation assessments. Its primary use is in laboratories and clinical settings where precise blood typing is essential for patient care and safety.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU159#005"/>
          <hierarchical_position>42070205</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW972#015" guid="0eb6f9e4c6974a27b481d6606232ac21">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Flow cytometry (FC) instrument</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">an analytical device specifically designed for the measurement and analysis of physical and chemical characteristics of cells or particles suspended in a fluid. This instrument utilizes laser technology to illuminate the sample, allowing for the detection of various parameters such as cell size, complexity, and fluorescence. It plays a critical role in various applications, including research, clinical diagnostics, and therapeutic monitoring, enabling the identification and quantification of specific cell populations. The device is integral to advanced studies in immunology, oncology, and other biomedical fields, providing vital insights into cellular processes and interactions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU159#005"/>
          <hierarchical_position>42070206</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW973#015" guid="e0b64cc54dcd4506887ff29fca503cd6">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Histology, cytology (HC) instrument</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses instruments specifically designed for histological and cytological analysis, facilitating the examination of tissue and cellular structures. These devices are utilized in laboratories to prepare, process, and analyze biological samples, enabling the identification and study of cellular morphology, composition, and pathology. The instruments are essential for both diagnostic and research purposes in medical and scientific settings, aiding in the understanding of disease processes, cellular behavior, and tissue characteristics. They operate through various methods, including staining, sectioning, and imaging, to provide critical insights into biological specimens.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU159#005"/>
          <hierarchical_position>42070207</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW974#015" guid="b873a4949dcb4fac84a3b1177b962cf1">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Haematology-, histology-, cytology rapid test (RT_HHC) instrument</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses instruments specifically designed for the rapid testing of biological samples in the fields of haematology, histology, and cytology. These instruments facilitate the quick assessment and analysis of cellular components, providing timely results that aid in diagnosis and treatment decisions. They are distinguished from other similar instruments by their focus on expedited testing processes, enhancing efficiency in clinical and laboratory environments. The instruments in this category are integral to workflows that require immediate insights into sample characteristics, thereby supporting healthcare professionals in delivering prompt patient care.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU159#005"/>
          <hierarchical_position>42070208</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW975#015" guid="aaec68f114ad4a7ea0a2c2872b2f7b6e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Haematology, histology, cytology instrument (HHC, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU159#005"/>
          <hierarchical_position>42070290</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-AFU672#011" guid="ae86dde790554e548988e58e1dec4fa8">
          <date_of_original_definition>2014-11-30Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Haematology, histology, cytology instrument (HHC, parts)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects with spare part characteristics that maintain or re-store the original condition of the objects classified under the parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU159#005"/>
          <hierarchical_position>42070291</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-AFU854#011" guid="e5aa408f80864b6690ff8f3b8f6cb83b">
          <date_of_original_definition>2014-11-30Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Haematology, histology, cytology instrument (HHC, accessories)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects with complemental characteristics, without which the basic function of the objects classified under the parent-class on the 3rd level is still guaranteed</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU159#005"/>
          <hierarchical_position>42070292</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU158#005" guid="31ca02a60c724e8bbbfbec63877df812">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Chemistry, immunochemistry instrument</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses instruments specifically designed for the field of chemistry and immunochemistry, focusing on the analysis and testing of biological samples. It includes a variety of devices that facilitate diagnostic processes, particularly in laboratory settings, where accuracy and efficiency are paramount. The instruments categorized here support a range of functions, from basic chemical analysis to complex immunological testing, ensuring compatibility with various consumables and software solutions tailored for enhanced performance. Additionally, this classification considers fast-testing methodologies, enabling point-of-care diagnostics, and integrates modular systems that combine multiple testing capabilities. This classification is distinct from other categories that specialize in different diagnostic fields, ensuring clarity and specificity for users seeking targeted solutions in chemistry and immunochemistry.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS279#005"/>
          <hierarchical_position>42070100</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW958#015" guid="ddc75db31a8c4695a32a4d8ef6084320">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Consumable for chemistry, immunochemistry instrument</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses items that are essential consumables used specifically in the operation and maintenance of instruments designed for chemistry and immunochemistry applications. These consumables support various laboratory processes, ensuring optimal performance and accuracy of the instruments. They are distinct from software solutions and other types of instruments within the broader chemistry and immunochemistry domain. The focus is on items that are utilized in conjunction with analytical devices, enhancing their functionality and reliability while facilitating experiments and analyses in related fields.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU158#005"/>
          <hierarchical_position>42070101</hierarchical_position>
          <keywords>
            <label id="0173-1#Z5-ACK874#001" language_code="en" country_code="US">Consumable electrophoresis (chromatography (EC) instrument</label>
            <label id="0173-1#Z5-ACK871#001" language_code="en" country_code="US">Consumable immunochemistry (IC) and infectious immunology (II) instrument</label>
            <label id="0173-1#Z5-ACK885#001" language_code="en" country_code="US">Consumable POC blood gas electrolyte</label>
            <label id="0173-1#Z5-ACK873#001" language_code="en" country_code="US">Consumable blood gas (electrolyte (GE), laboratory) instrument</label>
            <label id="0173-1#Z5-ACK879#001" language_code="en" country_code="US">Consumable rapid test blood gas point-of-care (RT_BG POC) instrument</label>
            <label id="0173-1#Z5-ACK884#001" language_code="en" country_code="US">Consumable POC electrolyte instrument</label>
            <label id="0173-1#Z5-ACK877#001" language_code="en" country_code="US">Consumable chemistry, immunochemistry rapid test and POC (RT_CI) instrument</label>
            <label id="0173-1#Z5-ACK876#001" language_code="en" country_code="US">Consumable high-pressure liquid chromatography (HPLC) instrument</label>
            <label id="0173-1#Z5-ACK882#001" language_code="en" country_code="US">Consumable rapid test clin. chem. -immunochem, combined (RT_CC/IC) instrument</label>
            <label id="0173-1#Z5-ACK878#001" language_code="en" country_code="US">Consumable rapid test blood glucose management (RT_BGM) instrument</label>
            <label id="0173-1#Z5-ACK883#001" language_code="en" country_code="US">Consumable POC blood gas instrument</label>
            <label id="0173-1#Z5-ACK872#001" language_code="en" country_code="US">Consumable integrated, modular chem., immunochem., infect. immunol., instrument</label>
            <label id="0173-1#Z5-ACK880#001" language_code="en" country_code="US">Consumable rapid test clinical chemistry (RT_CC) instrument</label>
            <label id="0173-1#Z5-ACK886#001" language_code="en" country_code="US">Consumable chemistry, immunochemistry (CI-, immunochemistry) instrument</label>
            <label id="0173-1#Z5-ACK875#001" language_code="en" country_code="US">Consumable electrophoresis (EP) instrument</label>
            <label id="0173-1#Z5-ACK870#001" language_code="en" country_code="US">Consumable chemistry (CH) instrument</label>
            <label id="0173-1#Z5-ACK881#001" language_code="en" country_code="US">Consumable rapid test immunochemistry (RT_IC) instrument</label>
          </keywords>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW959#015" guid="d939be45650f416d8811f42b2a2874d4">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Software for chemistry, immunochemistry instrument</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses software specifically designed to support and enhance the functionalities of instruments used in the fields of chemistry and immunochemistry. This software serves critical roles such as data analysis, instrument control, and process optimization, facilitating accurate and efficient laboratory operations. It is distinct from other classifications that include consumables or various types of instruments utilized in related scientific disciplines. The software may integrate with hardware systems, providing users with tools for managing complex data sets and improving overall workflow efficiency within laboratories focused on chemical and immunological testing.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU158#005"/>
          <hierarchical_position>42070102</hierarchical_position>
          <keywords>
            <label id="0173-1#Z5-ACK902#001" language_code="en" country_code="US">Software POC blood gas electrolyte instrument</label>
            <label id="0173-1#Z5-ACK900#001" language_code="en" country_code="US">Software POC blood gas instrument</label>
            <label id="0173-1#Z5-ACK893#001" language_code="en" country_code="US">Software high-pressure liquid chromatography (HPLC) instrument</label>
            <label id="0173-1#Z5-ACK896#001" language_code="en" country_code="US">Software rapid test blood gas point-of-care (RT_BG POC) instrument</label>
            <label id="0173-1#Z5-ACK901#001" language_code="en" country_code="US">Software POC electrolyte instrument</label>
            <label id="0173-1#Z5-ACK903#001" language_code="en" country_code="US">Software chemistry, immunochemistry (CI-, immunochemistry) instrument</label>
            <label id="0173-1#Z5-ACK891#001" language_code="en" country_code="US">Software electrophoresis (chromatography (EC) instrument</label>
            <label id="0173-1#Z5-ACK898#001" language_code="en" country_code="US">Software rapid test immunochemistry (RT_IC) instrument</label>
            <label id="0173-1#Z5-ACK897#001" language_code="en" country_code="US">Software rapid test clinical chemistry (RT_CC) instrument</label>
            <label id="0173-1#Z5-ACK892#001" language_code="en" country_code="US">Software electrophoresis (EP) instrument</label>
            <label id="0173-1#Z5-ACK888#001" language_code="en" country_code="US">Software immunochemistry (IC) and infectious immunology (II) instrument</label>
            <label id="0173-1#Z5-ACK889#001" language_code="en" country_code="US">Software integrated, modular chem., immunochem., infect. immunol., instrument</label>
            <label id="0173-1#Z5-ACK894#001" language_code="en" country_code="US">Software chemistry, immunochemistry rapid test and POC (RT_CI) instrument</label>
            <label id="0173-1#Z5-ACK899#001" language_code="en" country_code="US">Software rapid test clin. chem .-immunochem, combined (RT_CC/IC) instrument</label>
            <label id="0173-1#Z5-ACK890#001" language_code="en" country_code="US">Software blood gas (electrolyte (GE), laboratory) instrument</label>
            <label id="0173-1#Z5-ACK887#001" language_code="en" country_code="US">Software chemistry (CH) instrument</label>
            <label id="0173-1#Z5-ACK895#001" language_code="en" country_code="US">Software rapid test blood glucose management (RT_BGM) instrument</label>
          </keywords>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW960#015" guid="052e9cf3ef3e423788c23d9ec5a97f24">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Chemistry (CH) instrument</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses a range of specialized instruments utilized in the field of chemistry, specifically designed for immunochemical applications. These devices are essential for conducting various analytical procedures and experiments that involve the detection and quantification of substances through immunological methods. Instruments in this classification are characterized by their ability to facilitate complex processes in laboratory settings, enhancing the accuracy and efficiency of chemical analysis. They may support a variety of functions, including but not limited to sample preparation, reaction monitoring, and result interpretation, making them integral to both research and clinical environments.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU158#005"/>
          <hierarchical_position>42070103</hierarchical_position>
          <keywords>
            <label id="0173-1#Z5-ADW875#002" language_code="en" country_code="US">Clin. chem. analyzer (lab)</label>
          </keywords>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW961#015" guid="8d5b60cc4e6a43ba942ab6d8f08125a8">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Immunochemistry (IC) and infectious immunology instrument (II)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses instruments specifically designed for immunochemistry and infectious immunology applications. These devices are utilized in laboratory settings to conduct various tests and analyses related to immune responses and infectious diseases. They may include a range of functionalities that support the detection and quantification of biomarkers, antibodies, and other immunological parameters. The instruments in this category are distinct from consumables, software solutions, and other types of laboratory equipment, focusing instead on providing advanced capabilities for immunological research and diagnostics. Their design and operational features cater specifically to the needs of professionals in the fields of immunology and infectious disease management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU158#005"/>
          <hierarchical_position>42070104</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW962#015" guid="666134a32c6245b287a2a861e2fd697d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Integrated modular chemistry (IM), -immunochem., -infect. immunology instrument</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses instruments designed for integrated modular applications in the field of immunochemistry and infectious immunology. These devices are engineered to perform complex analyses and diagnostics by combining multiple functionalities into a single system. They support various laboratory workflows, enabling precise measurement and assessment of biological samples in the context of immune response and infectious disease detection. This category specifically excludes items that are consumables, software solutions, or instruments dedicated solely to general chemistry, distinct immunochemistry, or rapid testing methodologies. The focus is on comprehensive platforms that enhance laboratory efficiency and accuracy in the diagnosis and research of immunological reactions and infectious agents.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU158#005"/>
          <hierarchical_position>42070105</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW963#015" guid="1d225ec6b1b7499697d726f6fdaaa810">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Blood gas (electrolyte (GE), Laboratory) instrument</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses instruments specifically designed for the analysis and measurement of blood gas and electrolyte parameters in a laboratory setting. These devices facilitate the evaluation of critical physiological metrics, supporting diagnostic processes and patient monitoring. They are characterized by their ability to perform complex analyses typically involving various blood components, ensuring precise and reliable results. The instruments in this classification are distinct from those that serve consumable purposes, provide software solutions, or are dedicated to broader chemistry or immunochemistry applications. They play a vital role in clinical laboratories, enhancing the efficiency and accuracy of biochemical assessments in medical diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU158#005"/>
          <hierarchical_position>42070106</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW964#015" guid="bc058657df61406ca681085457f592ee">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Electrophoresis (chromatography (EC) instrument</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specialized apparatus designed for the separation and analysis of biomolecules or charged particles based on their size, charge, and other physical properties through the application of an electric field. This type of instrument is utilized in various scientific fields, including biochemistry and molecular biology, to facilitate the examination of complex samples. It enables researchers to obtain detailed insights into molecular characteristics, interactions, and functions, thereby supporting advancements in diagnostics, therapeutics, and fundamental research. The instrument typically operates in conjunction with specific protocols and may be complemented by additional tools or software for enhanced data analysis and interpretation.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU158#005"/>
          <hierarchical_position>42070107</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW528#015" guid="62323a998d1a4c1e8bbe9916a94f1197">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Susceptibility testing system for yeast and fungi (manual)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a testing system designed to evaluate the susceptibility of yeast and fungi to various antimicrobial agents. This system is primarily utilized in laboratory settings, enabling healthcare professionals to determine the effectiveness of specific treatments against fungal pathogens. It involves manual procedures that assess the response of microorganisms to different substances, allowing for tailored therapeutic decisions. The system is characterized by its capacity to provide reliable results that inform clinical practices, enhance patient care, and contribute to the understanding of antifungal resistance patterns. This classification encompasses the tools, methodologies, and processes associated with manual susceptibility testing specific to yeast and fungal species.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU137#005"/>
          <hierarchical_position>42040311</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW529#015" guid="29fdb5d8e2c14cf89785c96501265a82">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Susceptibility testing system for yeast and fungi (automated)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a system designed for the evaluation of the effectiveness of various antimicrobial agents against yeast and fungi, employing automated processes to streamline testing. This apparatus is utilized primarily in laboratories focusing on mycology, providing rapid and accurate results to inform treatment decisions. It encompasses mechanisms for preparing samples, administering tests, and interpreting outcomes, all while ensuring adherence to established protocols for clinical diagnostics. The automated nature enhances efficiency and reduces the potential for human error, making it an essential tool in the identification and management of fungal infections. This system stands apart from other related methodologies, which may involve manual processes or different forms of media preparation.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU137#005"/>
          <hierarchical_position>42040312</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW530#015" guid="b110c96da881499ebe66ae9932f58d8d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Mycology (IVD, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU137#005"/>
          <hierarchical_position>42040390</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU132#005" guid="f939ac1562714a319292be9b04fb3a14">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Histology, cytology (reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a range of substances and materials specifically designed for the examination and analysis of cells and tissues at the microscopic level. It includes agents used in various histological and cytological procedures, aimed at enhancing the visualization and identification of cellular components. The classification is distinct from related areas involving blood analysis and coagulation, focusing instead on reagents that facilitate staining, preservation, and preparation of biological specimens. It covers items such as kits for chromosome culture, staining solutions and powders, embedding and fixing media, as well as antisera used in immunohistological techniques. These products are essential for researchers and professionals engaged in cellular biology, pathology, and medical diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS275#005"/>
          <hierarchical_position>42030700</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW428#015" guid="1123a9dc762645768df9e852a0e29564">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Chromosome culture kit (reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a collection of specialized reagents designed for the cultivation and manipulation of chromosomes in laboratory settings. These kits typically include essential components that facilitate the growth, preservation, and analysis of chromosomal structures, enabling researchers to perform various cytogenetic studies. The reagents may support techniques such as chromosome isolation, visualization, and examination, contributing to advancements in genetic research, diagnostics, and related fields. This category is distinct from other reagent types used in histological and cytological applications, which focus on different aspects of biological tissue preparation and analysis.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU132#005"/>
          <hierarchical_position>42030701</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW429#015" guid="493827d4ffa54e7a89ea8181337655fd">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cytochemical staining (reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a chemical substance used in laboratory procedures to facilitate the visualization of specific cellular components or structures through the application of color reactions. This type of reagent is essential in histological and cytological analyses, enhancing the contrast of biological samples under microscopic examination. It is utilized in various techniques to identify, differentiate, or characterize tissues and cells, contributing to diagnostics, research, and educational purposes within medical and scientific fields. This classification encompasses a variety of formulations, including solutions and powders, tailored for specific staining applications in biological studies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU132#005"/>
          <hierarchical_position>42030702</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW430#015" guid="a75ce3d118214378aa27253982a76b44">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">DNA in situ hybridization (reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical substance specifically designed for the detection and localization of nucleic acids within fixed tissues or cells. This reagent facilitates the visualization of DNA sequences through hybridization techniques, allowing researchers and pathologists to analyze genetic material in its native context. It plays a crucial role in various applications, including genetic research, diagnostics, and the study of cellular processes. The reagent is characterized by its ability to form stable complexes with complementary DNA strands, enabling the identification of specific genetic markers. Its use contributes significantly to advancements in molecular biology, pathology, and genetics by providing insights into genetic expression and abnormalities within biological samples.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU132#005"/>
          <hierarchical_position>42030703</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW431#015" guid="670b82b3062e453dadcbb0b47a3c3bcf">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Embedding media (histology, cytology)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specialized substance utilized in histological and cytological procedures, primarily designed for the embedding of biological specimens. This material provides structural support during the sectioning process, ensuring that cellular details remain intact for microscopic examination. It is essential in the preparation of tissue samples, facilitating the preservation of cellular morphology and enhancing the clarity of subsequent staining techniques. The embedding media plays a crucial role in the overall histological workflow, contributing to accurate diagnosis and research by allowing for precise observation of tissue architecture and cellular characteristics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU132#005"/>
          <hierarchical_position>42030704</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW432#015" guid="32c152d662bd49bb891b5b082fe674dd">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Fixing reagent (histology, cytology)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a fixing reagent is a substance used in histological and cytological procedures to preserve and stabilize biological tissues or cells for examination and analysis. This reagent typically acts by cross-linking proteins and other cellular components, thereby maintaining the structural integrity of the specimen during processing. Fixing reagents are essential for preparing samples for microscopic evaluation, ensuring that cellular morphology and composition are accurately represented. They are characterized by their specific chemical properties, which allow them to effectively penetrate tissues and facilitate subsequent staining or imaging techniques that enhance visualization of cellular structures.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU132#005"/>
          <hierarchical_position>42030705</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW433#015" guid="4f319ca6bde64526af7a701ba087e83a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Mounting media (histology, cytology)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a category that encompasses various substances and materials specifically designed for supporting the preparation and analysis of biological samples in histological and cytological studies. These materials play a crucial role in the preservation and stabilization of specimens, ensuring that cellular structures and characteristics are adequately maintained during examination processes. Typically utilized in laboratory settings, these substances facilitate the embedding, sectioning, and mounting of tissue samples onto slides, enhancing the visibility and clarity of cellular components for microscopic evaluation. Their formulation is tailored to meet the precise needs of histological and cytological applications, providing essential support in research and diagnostic contexts.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU132#005"/>
          <hierarchical_position>42030706</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW434#015" guid="9d25910afd1b41479e41a6b1f9bb5ca3">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Stain powder (histology, cytology)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a powdered reagent specifically designed for staining purposes in histological and cytological applications. This product is utilized to enhance the visibility of cellular structures and tissues under a microscope, facilitating the analysis and identification of various biological specimens. The formulation may include specific dyes or staining agents that react with cellular components, allowing for differentiation and characterization of tissues. This type of reagent is essential in laboratory settings where precise visualization is critical for diagnostic, research, or educational purposes in the fields of pathology and cytology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU132#005"/>
          <hierarchical_position>42030707</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW435#015" guid="11609b32d660430fb4427d540702e826">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Stain solution (histology, cytology)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a solution specifically formulated for the staining of biological specimens in histological and cytological applications, aiding in the visualization of cellular structures and components. This product is utilized in laboratory procedures to enhance the contrast of tissue sections or cell preparations, allowing for more precise examination under a microscope. The formulation may vary to accommodate different staining techniques and protocols, and it is essential for researchers and laboratory professionals to select the appropriate solution based on the specific requirements of their analysis.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU132#005"/>
          <hierarchical_position>42030708</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW436#015" guid="df3b3d65eafc4ddc91d39bf0e6498e55">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Primary antiserum for immunohistology</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological reagent specifically designed for use in immunohistological techniques, utilized to identify and visualize specific antigens within tissue sections. This reagent is derived from the serum of immunized animals and contains antibodies that bind to target proteins, facilitating the study of cellular structures and functions. The application of this reagent enhances the detection of particular biological markers, aiding in diagnostic processes, research, and the understanding of various diseases. Its role is crucial in histopathology and related fields, helping to elucidate tissue characteristics at a microscopic level.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU132#005"/>
          <hierarchical_position>42030709</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW437#015" guid="0c8d661cfc2c449c98b411f804a1bbcb">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Secondary antiserum for immunohistology</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a tool characterized by a pointed end, primarily designed for making small holes or indentations in various materials. This instrument is often utilized in crafts, woodworking, or metalworking to facilitate precise tasks that require an entry point for other tools or for alignment purposes. The design typically features a sturdy shaft and a sharp tip, allowing for effective penetration into surfaces without causing significant damage. Its versatility makes it applicable in both professional and DIY projects, catering to a wide range of applications, including leatherworking, sewing, and construction.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU132#005"/>
          <hierarchical_position>42030710</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW438#015" guid="9f55e9d76a2c4d41b7078946b3d86a7d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Immunohistology kit</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a collection of diagnostic tools designed for the visualization of specific antigens in tissue sections, facilitating the study of cellular structures and functions. These kits typically contain reagents that enable the binding of antibodies to target proteins, allowing for the identification and localization of these proteins within biological samples. The application of such kits is critical in various fields, including pathology and research, where precise imaging of tissue morphology and protein expression is essential for diagnosis and analysis. The components often include primary and secondary antibodies, chromogenic substrates, and buffers, which work together to amplify and visualize the target proteins.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU132#005"/>
          <hierarchical_position>42030711</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW439#015" guid="c260ef0c033c445fabeef7ce2489d290">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Histology, cytology (reagent, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU132#005"/>
          <hierarchical_position>42030790</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU112#006" guid="57bb170732b247eb9b7ff27e218dd92b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Thyroid function hormone</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses substances and assays that specifically measure hormones related to thyroid function. These components are critical for evaluating the physiological state of the thyroid gland, which plays a vital role in regulating metabolism and overall health. The defined items within this category include various forms of thyroid hormones and related proteins, as well as specific tests designed to assess their levels in biological samples. Such evaluations are essential for diagnosing and monitoring thyroid-related disorders, ensuring accurate clinical decision-making. The focus is on distinct thyroid hormones and their metabolites, differentiating them from other categories related to immunological testing, therapeutic monitoring, or markers for various diseases.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS274#006"/>
          <hierarchical_position>42020400</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV911#015" guid="914de87274ff4826b23ff88dfe62057c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Free triiodothyronine</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biologically active hormone produced by the thyroid gland, free triiodothyronine plays a crucial role in regulating metabolism, growth, and development in the body. This hormone is a form of triiodothyronine that is not bound to proteins, allowing it to exert its effects on various tissues and organs. It is typically measured in clinical settings to assess thyroid function and diagnose related disorders. The measurement of free triiodothyronine provides valuable insights into the thyroid's activity and aids in the management of conditions associated with hormonal imbalances.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU112#006"/>
          <hierarchical_position>42020401</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV912#015" guid="6851eadea2194e628a9f55e29cbd84cb">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Free thyroxine</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance that is a form of the hormone thyroxine, which circulates in the bloodstream and is not bound to proteins. This unbound form of thyroxine is biologically active and plays a crucial role in regulating metabolism, growth, and development in organisms. The measurement of this hormone is significant in assessing thyroid function and diagnosing various thyroid disorders. It is distinct from other thyroid-related hormones and is utilized in laboratory diagnostics to provide insights into an individual's endocrine health, particularly in relation to thyroid activity and potential dysfunctions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU112#006"/>
          <hierarchical_position>42020402</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV913#015" guid="5b46af5108ec4fbeaffd41575129ba3f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Neonatal thyroid stimulating hormone</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biochemical substance that is specifically produced by the pituitary gland and plays a crucial role in stimulating the thyroid gland's production of thyroid hormones in newborns. This hormone is essential for regulating metabolism and growth in infants, particularly in the early stages of life. Its measurement is vital for assessing thyroid function and diagnosing potential thyroid disorders in neonates, ensuring appropriate medical intervention when necessary. The presence and levels of this hormone in the bloodstream can provide important insights into the overall health and development of a newborn, differentiating it from other thyroid-related hormones and ensuring targeted healthcare approaches.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU112#006"/>
          <hierarchical_position>42020403</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV914#015" guid="df4203abcb69435091d06e781b28b7a1">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Reverse triiodothyronine</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biologically active thyroid hormone that plays a crucial role in regulating metabolism and energy levels within the body. It is a derivative of thyroxine and is formed through the deiodination of triiodothyronine. This substance is important for various physiological processes, including growth, development, and the maintenance of metabolic homeostasis. It is particularly significant in the context of thyroid function assessment, where its levels can indicate thyroid gland activity and overall endocrine health. This classification encompasses substances that are utilized in laboratory diagnostics to evaluate thyroid hormone levels and their physiological impacts.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU112#006"/>
          <hierarchical_position>42020404</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV915#015" guid="f95514a43b544c00925407484f1ef788">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Triiodothyronine (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance that is a synthetic or natural form of the thyroid hormone triiodothyronine, primarily utilized in in vitro diagnostic applications. This compound plays a crucial role in evaluating thyroid function and metabolism, assisting in the diagnosis of various thyroid disorders. It is distinguished from related thyroid hormones and binding proteins based on its specific chemical structure and functional applications in diagnostics. The measurement of this hormone is essential for assessing thyroid health and guiding therapeutic interventions in clinical settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU112#006"/>
          <hierarchical_position>42020405</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV916#015" guid="56acdbf02ebb4338b549cf87842af40c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">T- uptake (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses substances and methods utilized for the assessment of thyroid hormone uptake specifically in the context of in vitro diagnostics. It includes a range of products and services designed to measure the absorption of thyroid hormones by tissues or serum, providing crucial information for diagnosing and managing thyroid-related disorders. The focus is on determining the efficiency and dynamics of hormone uptake, which can be indicative of various physiological or pathological conditions. This classification is distinct from other thyroid function assessments, as it specifically addresses the mechanisms and metrics related to the uptake process rather than the levels of individual hormones.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU112#006"/>
          <hierarchical_position>42020406</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV917#015" guid="d75292e8b47645e4bb15f8e5bc98b7cd">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Thyroxine (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance that is a synthetic or naturally occurring thyroid hormone used in diagnostic applications related to thyroid function. It plays a critical role in metabolism regulation and is essential for maintaining normal physiological processes. This compound is specifically utilized in laboratory testing to assess thyroid health and function, helping to diagnose conditions such as hypothyroidism or hyperthyroidism. The classification of this substance distinguishes it from other related thyroid hormones and markers, enabling precise identification and application within the field of medical diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU112#006"/>
          <hierarchical_position>42020407</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV918#015" guid="cf5b789f737c44b0849ecece2cbc7eb4">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Thyroglobulin (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">thyroglobulin is a glycoprotein produced by the thyroid gland, serving as a precursor for thyroid hormones. It plays a crucial role in the synthesis and storage of these hormones, which are essential for regulating metabolism, growth, and development. In vitro diagnostic (IVD) applications involving thyroglobulin are typically used to assess thyroid function, monitor thyroid disorders, and evaluate the effectiveness of treatment for thyroid conditions. The classification under this category is distinct from other related hormones and substances that influence or indicate thyroid activity, allowing for a more precise understanding and analysis of thyroid health in clinical settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU112#006"/>
          <hierarchical_position>42020408</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV919#015" guid="1f14506dac334f7ebf4ad91c5fe82ea2">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Thyroid binding globulin</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a protein that plays a crucial role in the transport and regulation of thyroid hormones in the bloodstream. It binds to thyroxine and triiodothyronine, ensuring their availability and stability for physiological processes. This protein is important for assessing thyroid function and can be measured in various clinical settings to evaluate thyroid health. Its levels can be influenced by various factors, including hormonal changes, medical conditions, and medications. The analysis of this protein provides valuable insights into thyroid-related disorders and helps guide treatment decisions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU112#006"/>
          <hierarchical_position>42020409</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV920#015" guid="236d560c2b804648aa946264d9f19e51">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Thyroid stimulating hormone</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological substance produced by the pituitary gland, responsible for regulating the function of the thyroid gland. It plays a crucial role in controlling the production of thyroid hormones, which are essential for maintaining metabolic processes in the body. This substance is specifically involved in stimulating the thyroid to produce hormones that affect growth, metabolism, and energy levels. Its measurement is significant in diagnosing and monitoring thyroid-related disorders, providing insights into thyroid gland functionality and overall endocrine health. The classification encompasses various forms and related substances, highlighting its specific role in thyroid function assessment.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU112#006"/>
          <hierarchical_position>42020410</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV921#015" guid="e5fbd31690b34cd6a2300253eb8f7634">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Neonatal thyroxine</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological substance specifically associated with the assessment of thyroid function in newborns, this entity is crucial for diagnosing and monitoring thyroid-related conditions at an early stage. It plays a significant role in evaluating the hormonal balance and metabolic processes in neonates, aiding in the identification of potential endocrine disorders. This substance is distinct from other related hormonal indicators, each serving unique diagnostic purposes within the spectrum of thyroid function assessment. The analysis of this substance is essential for ensuring optimal health outcomes in infants, contributing to the overall understanding of thyroid health and its impact on growth and development.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU112#006"/>
          <hierarchical_position>42020411</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV922#015" guid="7893ad7f90b84af196ac9f2983f15417">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Thyroid function hormone (unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU112#006"/>
          <hierarchical_position>42020490</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW423#015" guid="9ecc0178735e46dea422a034279905ef">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Colony stimulating factor (G-CSF,M-CSF,GM-CSF)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological substance that plays a crucial role in the stimulation and regulation of blood cell production and function. This category encompasses factors that specifically enhance the proliferation and differentiation of various types of blood cells, particularly those involved in the immune response. These agents are vital in therapeutic applications, especially in the treatment of conditions such as anemia, neutropenia, and other blood disorders. They function by interacting with specific receptors on target cells, initiating a cascade of biological responses that result in increased cell survival and enhanced immune system activity.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU131#006"/>
          <hierarchical_position>42030605</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW424#015" guid="1f4060a3169f4d00b467bcc368ee6f01">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Interleukin (IL-1,IL-1a,IL-1b,.. - IL-18)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific type of signaling molecule that plays a crucial role in the immune system, particularly in the modulation of inflammatory responses and the regulation of immune cell activity. This category encompasses various forms of interleukins, which are produced by a range of cells and act on other immune cells to promote communication and coordination in immune responses. These substances are key players in cell signaling pathways and are involved in numerous physiological processes, including cell proliferation, differentiation, and activation. The substances categorized here differ significantly from other signaling molecules that regulate immune functions, each having distinct mechanisms of action and roles within the immune system.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU131#006"/>
          <hierarchical_position>42030606</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW425#015" guid="1e771900ee384fcdadc3522344b84b17">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Interleukin receptor (IL-2R, IL6R)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological molecule that specifically interacts with interleukin proteins, acting as a receptor to mediate immune responses and cellular signaling. This receptor is vital for the functioning of interleukins in the immune system, influencing processes such as cell proliferation, differentiation, and apoptosis. It plays a crucial role in regulating immune responses and inflammation, contributing to various biological functions and therapeutic applications. The presence of this receptor is significant in understanding and manipulating immune-related diseases and conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU131#006"/>
          <hierarchical_position>42030607</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW426#015" guid="b66e287e77a847ac8a1de856b9396b10">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cytokine (calibrator, control)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance used for the calibration or control of assays that measure specific biological activity or concentrations of cytokines. This category encompasses agents that are utilized to ensure the accuracy and reliability of testing methods in immunological and biochemical analyses. These substances may serve as reference materials or standards to validate the performance of diagnostic tests, ensuring that results are consistent and comparable across different laboratories and testing conditions. The classification focuses on those agents that play a critical role in the quantification and validation of cytokine-related measurements, distinguishing them from other related immunomodulatory factors.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU131#006"/>
          <hierarchical_position>42030608</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW427#015" guid="c8e83cc016b84319ad0cbe0bcd7a7393">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cytokine (lymphokines), immunomodulator (unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU131#006"/>
          <hierarchical_position>42030690</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU150#005" guid="c2c5541f459044a38d78341606243d85">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Control, standard, calibrator (infectious immunology)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses items used for the verification and calibration of diagnostic processes related to infectious immunology. These items are essential for ensuring the accuracy and reliability of test results in the field of infectious disease detection and monitoring. They include materials that serve as benchmarks or standards to assess the performance of diagnostic assays and methodologies. The focus is specifically on controls that are designed for various aspects of infectious immunology, covering a range of infectious agents. This classification excludes items related to other areas of infectious immunology such as bacteriology, virology, and rapid testing approaches, and is dedicated to providing the necessary tools for quality assurance in laboratory settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS277#005"/>
          <hierarchical_position>42050800</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW820#015" guid="93c50575f8694418ad74996d8a3e202b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Bacteriology control (infectious immunology)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a category that encompasses products or services specifically designed for the monitoring and management of bacteriological assays within the field of infectious immunology. These offerings are utilized to ensure the accuracy and reliability of diagnostic tests related to bacterial infections, providing essential controls for laboratory analysis. This classification is distinct from other related categories focused on various infectious agents, emphasizing its unique role in the assessment and validation of bacteriological testing methodologies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU150#005"/>
          <hierarchical_position>42050801</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW821#015" guid="3f9c040211f6490eafa4e75c26576526">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Hepatitis virus control (infectious immunology)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to entities utilized in the detection, diagnosis, and management of infections caused by hepatitis viruses. These entities may include control materials, standards, and calibrators specifically designed for use in infectious immunology applications related to hepatitis. They ensure the accuracy and reliability of diagnostic tests by providing known reference points for comparison. This classification is distinct from other classifications focused on different infectious agents, emphasizing the unique requirements and characteristics associated with hepatitis virus testing and control.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU150#005"/>
          <hierarchical_position>42050802</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW822#015" guid="0d033e92320849429f86d0724374aadc">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Retrovirus control (infectious immunology)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses products or services specifically designed for the management and assessment of retroviruses within the field of infectious immunology. These items are utilized in various laboratory settings for the purpose of standardization, calibration, and control of procedures related to retroviral detection and analysis. The classification distinguishes these offerings from those designed for other infectious agents, ensuring clarity in their application and use. The focus is on ensuring accurate diagnostics and research outcomes through reliable control mechanisms tailored for retrovirus interactions and behavior in immunological contexts.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU150#005"/>
          <hierarchical_position>42050803</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW823#015" guid="fdeb1ff44b364b36ae7139a13266022e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Parasitology control (infectious immunology)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses products and services designed for the management and regulation of parasitic infections within the field of infectious immunology. It includes items that are utilized for the testing, evaluation, and validation of diagnostic procedures related to parasitology. These may consist of controls, standards, and calibrators specifically formulated to ensure the accuracy and reliability of assays and tests used to detect and quantify parasitic pathogens. The classification is distinct from other related areas within infectious immunology, focusing on unique characteristics and requirements pertinent to parasitology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU150#005"/>
          <hierarchical_position>42050804</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW824#015" guid="ca3918504be84347b67b9ad9737832e5">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Mycology control (infectious immunology)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a category dedicated to products specifically designed for the assessment and management of mycological infections within the field of infectious immunology. These products are essential for the detection, control, and quality assurance of mycological agents in various samples. They may include reference materials, calibrators, and controls that facilitate the accurate evaluation of laboratory tests related to fungal pathogens. This category is distinguished by its focus on mycology, setting it apart from other categories that address different infectious agents or broader immunological concerns. The offerings in this category contribute significantly to the reliability and effectiveness of diagnostic procedures in the realm of infectious diseases caused by fungi.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU150#005"/>
          <hierarchical_position>42050805</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW825#015" guid="f387b8eebe9f4f3d93b8e96db8ba410e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Multiconstituent control (infectious immunology)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses products or services designed for the assessment and validation of diagnostic tests related to infectious immunology, specifically those that involve multiple constituents. These items are utilized in laboratory settings to ensure the accuracy and reliability of testing methods, facilitating the detection and quantification of various infectious agents. They may include controls that consist of a combination of antigens, antibodies, or other relevant biological materials, which are essential for confirming the performance of immunological assays. The focus is on providing a comprehensive solution that addresses the complexities of testing across different infectious diseases, differentiating them from more specialized controls targeting specific pathogens or groups of pathogens.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU150#005"/>
          <hierarchical_position>42050806</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW826#015" guid="4e44af332d2b40beaf3f0dd825db0fbf">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Control, standard, calibrator (infectious immunology, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU150#005"/>
          <hierarchical_position>42050890</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU129#005" guid="639a23079f8b4a8784f7e6a5989bde38">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Tissue typing reagent</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a range of specialized substances utilized in the process of determining tissue compatibility, particularly for organ transplantation and related medical procedures. These reagents are essential for assessing human leukocyte antigen (HLA) profiles, which play a critical role in immune response and organ rejection. The items categorized here are specifically designed to facilitate various testing methodologies, including the screening and typing of HLA antibodies and antigens, as well as the stabilization and separation of lymphocytes for further analysis. This classification does not overlap with other related testing reagents, ensuring a clear distinction in the types of assays and procedures they support.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS275#005"/>
          <hierarchical_position>42030400</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW394#015" guid="0070062212ea46919f35072797666231">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Complement for HLA testing</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses products or services specifically designed to aid in human leukocyte antigen (HLA) testing processes. These items are used to enhance the accuracy and reliability of various immunological assays related to tissue compatibility. The offerings within this classification are distinct from other related testing reagents, focusing on supporting the detection and analysis of specific HLA markers. They may include components that facilitate the preparation, stabilization, or enhancement of testing procedures, ensuring optimal performance in laboratory settings. The primary purpose of these items is to provide essential tools necessary for effective tissue typing and transplantation compatibility assessments.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU129#005"/>
          <hierarchical_position>42030401</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW395#015" guid="d745ebb07f0948dca86784fdf2c8bfe7">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HLA antibody screening</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a category of diagnostic reagents specifically designed for the detection and analysis of human leukocyte antigens (HLA) through antibody screening methods. These reagents are essential for evaluating immune responses, particularly in the context of transplantation compatibility, autoimmune disorders, and disease susceptibility. The focus of this category is on products that facilitate the identification of antibodies against HLA molecules, which are crucial for ensuring successful organ transplants and understanding immune system interactions. This classification is distinct from other related categories that encompass different aspects of HLA testing and analysis, emphasizing the unique role of antibody screening in immunological assessments.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU129#005"/>
          <hierarchical_position>42030402</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW396#015" guid="07a8f35e9255423691a7b4f0ecd2804d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HLA antigen typing</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specialized process and associated reagents used for identifying and characterizing human leukocyte antigens (HLA) on the surface of cells. This process is essential for determining tissue compatibility in organ transplantation, understanding immune responses, and diagnosing certain diseases. It involves techniques that allow for the detection and analysis of specific HLA markers, which play a crucial role in the immune system's recognition of self versus non-self. This classification encompasses various methodologies and tools designed specifically for HLA antigen identification, distinguishing it from other related testing and reagents focused on different aspects of HLA analysis and immune response assessment.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU129#005"/>
          <hierarchical_position>42030403</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW397#015" guid="7a3f6c316b104ef2b18901e2ee254fdb">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HLA control cell</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specialized biological material utilized in the assessment and validation of human leukocyte antigen (HLA) compatibility for transplantation and immunological research. This type of control cell is specifically designed to ensure the accuracy and reliability of HLA typing tests by providing a known reference point. It is differentiated from other related materials by its unique properties and functions, which may include the ability to represent specific HLA types or subtypes. This classification encompasses a range of products that serve essential roles in laboratory settings, particularly in the context of tissue compatibility and transplantation science, where precision in HLA matching is critical.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU129#005"/>
          <hierarchical_position>42030404</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW398#015" guid="a7aa6ffbc4224a2d995b9cfe067378ea">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Lymphocyte separation media</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specialized solution designed to facilitate the isolation and separation of lymphocytes from blood or other biological samples. This media is formulated to maintain the viability and functionality of lymphocytes during the separation process, ensuring optimal conditions for subsequent analyses or applications in immunology and related fields. It plays a crucial role in various laboratory procedures, particularly those involving tissue typing and immune response studies. This category encompasses products specifically intended for use in the separation of lymphocytes, distinguishing them from other reagents used for complement testing or antibody screening.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU129#005"/>
          <hierarchical_position>42030405</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW399#015" guid="9fbf3299000642edae2a1044145eaa17">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Lymphocyte stabilizing media</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specialized solution designed to support the stabilization and maintenance of lymphocytes during laboratory procedures, particularly in tissue typing and related immunological assays. This type of media is formulated to enhance the viability and functionality of lymphocytes, ensuring accurate results in the evaluation of tissue compatibility and immune response. It is distinct from other reagents used in HLA testing and tissue typing, as it specifically focuses on preserving lymphocyte integrity without altering their biological characteristics. The media plays a critical role in facilitating reliable testing outcomes in transplantation and immunological studies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU129#005"/>
          <hierarchical_position>42030406</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW400#015" guid="1d3b26fd911d4f4cbf60328d8a1d11c0">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Tissue typing reagent (unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU129#005"/>
          <hierarchical_position>42030490</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW965#015" guid="66e94b3f50c54555a73294c19a19caac">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Chemistry, immunochemistry rapid test and POC (RT_CI) instrument</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses instruments specifically designed for rapid testing in the field of immunochemistry, including point-of-care applications. These devices facilitate the quick and efficient analysis of biological samples to detect and quantify specific substances, aiding in diagnostic decision-making. The instruments in this category are characterized by their ability to provide immediate results, enhancing the speed of clinical assessments. They are distinct from other types of equipment used in the broader field of chemistry and immunochemistry, which may focus on consumables, software applications, or different methodologies. This classification highlights the specialized nature of these rapid test instruments, underscoring their role in patient care and laboratory settings where timely results are critical.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU158#005"/>
          <hierarchical_position>42070108</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW966#015" guid="47c87d17d5f84804b940d9277ccce7a9">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Chemistry, immunochemistry instrument (unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU158#005"/>
          <hierarchical_position>42070190</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-AFU671#011" guid="f4fc0045ec2a418191ce6b9c644dbd9d">
          <date_of_original_definition>2014-11-30Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Chemistry, immunochemistry instrument (parts)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects with spare part characteristics that maintain or re-store the original condition of the objects classified under the parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU158#005"/>
          <hierarchical_position>42070191</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-AFU853#011" guid="fcdddc68d2934ff0bd0d1564ae825944">
          <date_of_original_definition>2014-11-30Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Chemistry, immunochemistry instrument (accessories)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects with complemental characteristics, without which the basic function of the objects classified under the parent-class on the 3rd level is still guaranteed</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU158#005"/>
          <hierarchical_position>42070192</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU105#005" guid="c8357c29816e438e85f6f813f5ec83db">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Multiple parameters (clinical chemistry laboratory)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a variety of laboratory reagents and devices utilized for the assessment of multiple parameters in clinical chemistry contexts. It includes items specifically designed to measure combinations of enzymes, substrates, and electrolytes, as well as those used in conjunction with electrode and biosensor technologies. The category is distinct from other classifications that focus on single components or specific types of tests. The offerings in this classification may include reagents that allow for the simultaneous analysis of various biochemical markers, enhancing the efficiency and accuracy of laboratory diagnostics. This classification aims to facilitate the identification and categorization of products that support comprehensive clinical evaluations through multi-parameter testing methodologies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS273#005"/>
          <hierarchical_position>42010500</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV742#015" guid="f648f9c3862b441880d94aa7fc8f7178">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Multiple enzyme only (clinical chemistry laboratory reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to laboratory reagents specifically designed for clinical chemistry applications that focus on the measurement of multiple enzymes. These reagents are utilized in various testing procedures to facilitate the analysis of biological samples, enabling healthcare professionals to assess enzyme levels for diagnostic purposes. The offerings in this category are distinguished by their exclusive use of enzymes, setting them apart from other reagent types that may involve substrates, electrolytes, or combinations thereof. The classification emphasizes quality and specificity in enzyme detection, ensuring accurate and reliable results in clinical laboratory settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU105#005"/>
          <hierarchical_position>42010501</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV743#015" guid="e253b45deac146538fc8ca19b900b1ee">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Multiple substrate (clinical chemistry laboratory reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a collection of laboratory reagents specifically designed for clinical chemistry applications that can interact with various substrates to facilitate the measurement of multiple parameters in biological samples. These reagents are formulated to provide accurate and reliable results in diagnostic testing, where the analysis of multiple chemical substances is essential. They may be utilized in conjunction with various analytical techniques and instruments to enhance the efficiency and effectiveness of clinical laboratory workflows. The focus is on reagents that enable the simultaneous assessment of diverse biochemical markers, contributing to comprehensive patient evaluations and informed clinical decision-making.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU105#005"/>
          <hierarchical_position>42010502</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV744#015" guid="a96bbea0da95454eb3fde7c374e74f71">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Multiple electrolyte (clinical chemistry laboratory reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a type of laboratory reagent specifically designed for clinical chemistry applications that measures various electrolytes simultaneously. This reagent is utilized in diagnostic procedures to assess and monitor the electrolyte balance within biological samples. It is characterized by its ability to provide multi-analyte results, offering insights into the physiological state of an individual. The reagent is distinct from other related categories, which may focus on enzymes, substrates, or specific testing methods such as electrochemical sensors. The versatility of this reagent enables healthcare professionals to conduct comprehensive analyses efficiently, aiding in clinical decision-making and patient management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU105#005"/>
          <hierarchical_position>42010503</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV745#015" guid="d5e7839d5acb4ff68b63a5c38da6a9ce">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Multiple parameters mix of all (clinical chemistry laboratory reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses a diverse array of reagents utilized in clinical chemistry laboratories that are designed to measure multiple parameters simultaneously. These reagents facilitate complex analyses by combining various components that can interact with multiple analytes, enhancing the efficiency and accuracy of laboratory testing. They are distinct from more specialized reagents that target individual parameters or specific types of analytes. This classification is essential for ensuring the appropriate selection and application of reagents in diagnostic processes, supporting a wide range of clinical assessments and providing critical information for patient care.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU105#005"/>
          <hierarchical_position>42010504</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV746#015" guid="50da2c1503094d3b8e1a554c9e3a44b6">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Multiple enzyme only (electrode, biosensor)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses measurement devices specifically designed to detect and quantify multiple enzyme activities within clinical chemistry applications using electrode or biosensor technology. These instruments are tailored for complex analytical environments, allowing for simultaneous analysis of various enzymatic reactions. They provide precise and reliable results, facilitating advanced diagnostics and monitoring of biochemical processes. Utilized primarily in clinical laboratories, these devices contribute to enhanced decision-making in patient care by offering comprehensive insights into metabolic functions through the assessment of enzyme levels. Their operation is based on the principles of electrochemical detection, making them essential tools in modern clinical analysis.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU105#005"/>
          <hierarchical_position>42010505</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV747#015" guid="f55055253a754a3db96ea6103cbb3d2e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Multiple substrate only (electrode, biosensor)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses devices and materials designed specifically for analytical procedures that utilize multiple substrates in conjunction with electrodes or biosensors. These products are primarily employed in clinical chemistry laboratories to facilitate the measurement of various biochemical parameters. The focus is on items that allow for the simultaneous detection or analysis of different substrates without the involvement of enzymes or other specific reactants. The unique functionality of these items supports a broad range of diagnostic applications, contributing to efficient and comprehensive testing in laboratory environments.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU105#005"/>
          <hierarchical_position>42010506</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV748#015" guid="ba0f8972f5f1477f803bdcd0f7834ef7">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Multiple electrolyte only (electrode, biosensor)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a category focused on devices and materials specifically designed for measuring multiple electrolytes using electrochemical methods. These products facilitate the analysis of various electrolyte concentrations in biological samples, typically utilized in clinical and laboratory settings. The offerings within this classification are distinguished by their capability to operate as electrodes or biosensors, ensuring accurate and reliable readings of electrolyte levels. This category emphasizes the importance of precise electrolyte measurement in clinical diagnostics, contributing to effective patient care and laboratory efficiency. Such products may include components that enhance sensitivity, specificity, and response time for electrolyte detection, differentiating them from other types of measurement devices and reagents used in clinical chemistry.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU105#005"/>
          <hierarchical_position>42010507</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV749#015" guid="fe75eecc57c94b9fa8034066bfffdd69">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Multiple blood gas only (electrode, biosensor)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a category encompassing devices or instruments specifically designed to measure multiple blood gas parameters utilizing electrode or biosensor technology. These tools are utilized in clinical settings to provide accurate and rapid assessments of blood gas levels, which are crucial for diagnosing and monitoring various medical conditions. The devices in this category are distinct in their focus on blood gas measurements, differentiating them from other laboratory reagents and instruments that analyze enzymes, substrates, or electrolytes. They are essential for healthcare professionals in evaluating respiratory and metabolic function, ensuring timely and effective patient care.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU105#005"/>
          <hierarchical_position>42010508</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV750#015" guid="8b27d1fbae7d45ffae82d84b4ecc6b15">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Multiple parameters mix of all (electrode, biosensor)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a variety of analytical tools designed for simultaneous measurement of multiple parameters within clinical chemistry laboratories. These tools utilize advanced technologies to provide comprehensive analysis, often integrating various sensing mechanisms to enhance detection and quantification. They are characterized by their ability to assess a broad spectrum of biochemical markers, facilitating a holistic view of patient health. This category is distinct from others that focus on single types of analytes or specific measurement techniques, thereby allowing for a more versatile application in laboratory settings. The versatility and comprehensive nature of these tools make them essential for complex diagnostic processes, enabling healthcare professionals to derive meaningful insights from diverse biochemical data.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU105#005"/>
          <hierarchical_position>42010509</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV751#015" guid="d9e3882a84b740b98e813f3993671481">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Multiple parameters (clinical chemistry laboratory, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU105#005"/>
          <hierarchical_position>42010590</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-AFU803#011" guid="13a3f4962d584cb2bf86ad054713a436">
          <date_of_original_definition>2014-11-30Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Multiple parameters (clinical chemistry laboratory, accessories)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects with complemental characteristics, without which the basic function of the objects classified under the parent-class on the 3rd level is still guaranteed</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU105#005"/>
          <hierarchical_position>42010592</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU110#006" guid="234ce18cf57749fc81f2b5ee08361ade">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Allergy testing (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses diagnostic tests specifically designed to identify and quantify allergic responses in individuals. These tests employ various methodologies to detect the presence of immunoglobulin E and other related antibodies in response to specific allergens. The focus is on assessing hypersensitivity reactions, which can be mediated by different immunological pathways. This classification includes tests that measure total and specific levels of immunoglobulin E, as well as other immunological markers associated with allergic conditions. The defined tests are essential for diagnosing allergies, guiding treatment options, and monitoring patient responses to allergen exposures through various testing formats, including single and multi-antigen assessments.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS274#006"/>
          <hierarchical_position>42020200</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV861#015" guid="473690b802b14fb3abf5aba9b8520974">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Immunoglobulin E (total, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic test designed to measure the total level of Immunoglobulin E (IgE) antibodies in a biological sample, typically used in the context of in vitro diagnostics. This test aids in the assessment of allergic conditions by quantifying the overall IgE response, which may indicate the presence of allergies or atopic diseases. The measurement is performed using specific methodologies that ensure the accuracy and reliability of results, contributing to the diagnosis and management of allergy-related health issues. This classification distinguishes it from other related tests that focus on specific IgE responses or utilize different testing formats and methodologies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU110#006"/>
          <hierarchical_position>42020201</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV862#015" guid="170f91c78d494dd18295d8e8507dcdba">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Immunoglobulin E (specific, monotest/monoresult, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic tool designed to detect the presence of specific Immunoglobulin E antibodies in biological samples, used primarily in the context of allergy testing. This testing method typically provides a singular result from a single examination, allowing for the identification of allergic sensitivities to particular antigens. It is utilized in clinical laboratories as part of in vitro diagnostics to assist healthcare professionals in diagnosing allergic conditions. This type of testing is distinct from other immunoglobulin E assessments that may measure total levels or involve multiple antigens, and it is specifically tailored to deliver precise results for individual allergens.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU110#006"/>
          <hierarchical_position>42020202</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV863#015" guid="87cf35e425dc49458b71e34cf73f8576">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Immunoglobulin E (monotest, monoresult, multi antigen, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a medical diagnostic product designed to measure the concentration of Immunoglobulin E (IgE) in a biological sample, specifically used for allergy testing. This product facilitates the identification of allergic reactions by providing results from a test that may analyze multiple antigens simultaneously. It is utilized in in vitro diagnostics (IVD) settings, offering precise and reliable assessments to aid in the diagnosis and management of allergies. Its capability to deliver either single or multiple results enhances its utility in clinical practice, distinguishing it from other related diagnostic tests that measure different forms or total levels of IgE or utilize alternative methodologies for assessing allergic responses.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU110#006"/>
          <hierarchical_position>42020203</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV864#015" guid="b5268c2cc6c642dcaee25d4a3669a38f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Immunoglobulin E (monotest, pluriresult, multi antigen, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic product designed for in vitro use, specifically focusing on the quantification of Immunoglobulin E levels. This product is characterized by its ability to perform multiple antigen tests simultaneously, providing comprehensive results in a single analysis. It is utilized in the assessment of allergic reactions and sensitivities, allowing healthcare professionals to evaluate the immune response to various allergens. The testing method employed is designed to be efficient and reliable, ensuring accurate identification of immunological responses. This diagnostic tool is crucial for developing personalized treatment plans for individuals with suspected allergic conditions. It is differentiated from other related assays based on its specific testing capabilities and results configuration.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU110#006"/>
          <hierarchical_position>42020204</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV865#015" guid="6a1eff9e31c8406cb7db764b7e2019a4">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Immunoglobulin E (screen, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic product designed for in vitro use that specifically measures the levels of Immunoglobulin E in biological samples, typically utilized in the context of allergy testing. This type of product plays a crucial role in identifying hypersensitivity reactions and determining individual allergic profiles. It is distinct from other related immunoglobulin tests that measure total or specific IgE levels or assess responses to multiple allergens simultaneously. The device or reagent is regulated under in vitro diagnostic standards, ensuring accuracy and reliability in clinical settings for the management of allergic conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU110#006"/>
          <hierarchical_position>42020205</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV866#015" guid="7f95f54d47fc44a39b0fbfaf00155d0b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Leukotriene stimulation test</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic procedure designed to evaluate the immune response by measuring the release of leukotrienes, which are inflammatory mediators produced by certain immune cells upon exposure to specific allergens. This test is utilized to assess allergic conditions and is particularly relevant in the context of respiratory disorders. It serves as a valuable tool for clinicians to better understand a patient's allergic profile, aiding in the diagnosis and management of allergic diseases. The procedure is distinct from other immunological tests that focus on different antibodies or immune responses, providing specific insights into leukotriene levels associated with allergic stimuli.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU110#006"/>
          <hierarchical_position>42020206</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV867#015" guid="13ecaa05670d464d87189d93251bde89">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Allergen specific (IgA)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to diagnostic tests that specifically measure the presence of Immunoglobulin A (IgA) antibodies in response to specific allergens. These tests are utilized in the context of allergy diagnostics, providing valuable insights into immunological reactions triggered by various allergens. By assessing IgA levels, healthcare professionals can gain a deeper understanding of an individual's allergic responses, distinguishing them from other immunological assays that focus on different immunoglobulin types or testing methodologies. The results from these tests can assist in diagnosing allergic conditions and guiding appropriate treatment strategies tailored to the individual's immune profile.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU110#006"/>
          <hierarchical_position>42020207</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV868#015" guid="17a966530a5e4427882682f51ebf2f58">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Allergen specific (IgG)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses diagnostic tests specifically designed to detect and quantify Immunoglobulin G (IgG) antibodies in response to allergens. These tests are utilized in the evaluation of hypersensitivity reactions and immune responses related to specific allergens. The focus is on identifying the presence and levels of IgG antibodies, which can provide insights into an individual's exposure to particular allergens and assist in the diagnosis and management of allergic conditions. This classification is distinct from others that target different immunoglobulin types or testing methodologies related to allergy diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU110#006"/>
          <hierarchical_position>42020208</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADV869#015" guid="06ee1200ed61461782e56731c1f44cdd">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Allergy testing (IVD, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU110#006"/>
          <hierarchical_position>42020290</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU131#006" guid="01fca82d5ac7439b804245922c68547c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cytokine (lymphokines), immunomodulator</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses biologically active proteins that play critical roles in cell signaling and the regulation of immune responses. These substances are involved in mediating and regulating immunity, inflammation, and hematopoiesis. The focus is on specific types of cytokines that serve as immunomodulatory agents, influencing the activity of immune cells and other biological processes. The entities within this category may include various forms of cytokines, their receptors, and related controls or calibrators used in laboratory settings. These items are essential for research and clinical applications in immunology and hematology, contributing to the understanding and manipulation of immune responses in various health conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS275#005"/>
          <hierarchical_position>42030600</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW419#015" guid="1fc9ee129aad4839b72c590de45c53ae">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Interferon (a,b,g)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological substance that serves as a signaling protein, produced by various cells, which modulates immune responses. This type is known for its ability to induce antiviral activity and regulate cell growth, differentiation, and immune system functions. It plays a crucial role in the immune system by facilitating communication between cells, influencing the activity of other immune cells, and contributing to the regulation of inflammation. This classification encompasses various forms of the substance, each with distinct properties and functions, which are utilized in therapeutic applications to treat a range of medical conditions, particularly those related to immune system disorders.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU131#006"/>
          <hierarchical_position>42030601</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW420#015" guid="285131bbc1124dfd9c88a817b5726cd6">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Soluble antigen, -receptor</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological substance that is capable of binding to a specific receptor, resulting in a measurable physiological response. These substances play a crucial role in the immune system by facilitating communication between cells and influencing various biological processes, such as cell growth, differentiation, and immune responses. They are typically derived from biological sources and are utilized in various applications, including research, diagnostics, and therapeutics. The classification of such substances is distinct from other immunomodulatory agents that serve different functions or have different mechanisms of action, emphasizing their unique role in modulating immune responses.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU131#006"/>
          <hierarchical_position>42030602</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW421#015" guid="7934a11c5dae42389d8601850ff4f6d8">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Tumor necrosis factor (TNFa,TNFb)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of biologically active protein that plays a crucial role in cell signaling and the immune response. It is characterized by its involvement in inflammation and apoptosis, modulating various cellular functions. This classification distinguishes itself from related categories based on the nature of the proteins and their specific roles in immune modulation. The focus is on proteins that interact with receptors to influence immune system activity, particularly in response to pathogens or stress. This classification is essential for understanding therapeutic applications and research in immunology and related fields.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU131#006"/>
          <hierarchical_position>42030603</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW422#015" guid="1223300fdbb94211ab75859f8856a115">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Tumor necrosis factor receptor (TNF-R I,TNF-R II)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a type of protein that plays a significant role in cell signaling, involved in the immune system's regulation and response. This protein interacts with specific receptors on the surface of cells, triggering various cellular processes that can influence inflammation, cell survival, and apoptosis. It is part of a broader category of signaling molecules that modulate the immune response and are critical in the pathophysiology of various diseases. This classification includes specific variations that may have distinct roles or mechanisms of action within the immune system, distinguishing it from other related signaling proteins that function differently in immune modulation or response.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU131#006"/>
          <hierarchical_position>42030604</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-AFU857#011" guid="b24ed776b7224587a940cf2585b6f8a6">
          <date_of_original_definition>2014-11-30Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Micro-array testing instrument (MA, accessories)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects with complemental characteristics, without which the basic function of the objects classified under the parent-class on the 3rd level is still guaranteed</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU162#005"/>
          <hierarchical_position>42070592</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU161#005" guid="1cf02756749a408d877192c82eac6c51">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Nucleic acid testing instrument (NA)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses devices and associated products specifically designed for the analysis and testing of nucleic acids. These instruments are utilized to detect, quantify, or analyze genetic material, playing a crucial role in various applications, including diagnostics, research, and biotechnology. The classification includes consumables and software that support the functionality of nucleic acid testing instruments, ensuring effective performance and reliable results. Notably, this category excludes instruments and products related to microarray technology, focusing instead on standalone systems and tools that facilitate the examination of nucleic acids in various samples. The aim is to provide a clear framework for identifying and organizing products related to nucleic acid testing, distinguishing them from other analytical instruments in the medical and scientific fields.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS279#005"/>
          <hierarchical_position>42070400</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW981#015" guid="2a2e5c3de84841f2941d5936c4839bd8">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Consumable for nucleic acid testing (NA) instrument excluding microarrays</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses items specifically designed for use in nucleic acid testing instruments, excluding any microarray technologies. These consumables are essential for the operation and effectiveness of nucleic acid testing processes, providing necessary components or materials that facilitate accurate and reliable testing outcomes. The classification distinctly separates these consumables from related software solutions and other types of nucleic acid testing instruments, ensuring clarity in their intended use and application within laboratory settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU161#005"/>
          <hierarchical_position>42070401</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW982#015" guid="50805317a5b84c2db3d1e77345c1a40d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Software for nucleic acid testing (NA) instrument excluding microarrays</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses software specifically designed for use with instruments that conduct nucleic acid testing, excluding microarray technologies. It includes applications and programs that facilitate the analysis, interpretation, and management of data generated by nucleic acid testing procedures. Such software may support various functionalities, including data acquisition, processing, and reporting, tailored to enhance the performance and usability of nucleic acid testing instruments. This classification is distinct from related categories that focus on consumables used alongside these instruments or the instruments themselves, highlighting its unique role in the testing process.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU161#005"/>
          <hierarchical_position>42070402</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW983#015" guid="520096c55ff8492bbab8d5301ad74dc6">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Nucleic acid testing instrument (excluding micro-arrays)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">an analytical device designed specifically for the detection, quantification, or analysis of nucleic acids, such as DNA and RNA, utilizing various methodologies and technologies. This instrument is distinct from consumables and software related to nucleic acid testing, focusing solely on the hardware aspect of the testing process. It operates through specific protocols and is essential for various applications in research, diagnostics, and biotechnology. The instrument is not intended for micro-array based techniques but is tailored for other nucleic acid testing methodologies, ensuring precision and reliability in the results obtained.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU161#005"/>
          <hierarchical_position>42070403</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW984#015" guid="9cdebd3dfd6d41988dbbf452f1e12b18">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Nucleic acid testing instrument (NA, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU161#005"/>
          <hierarchical_position>42070490</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-AFU674#011" guid="423638ae0783476cb420263a7a6c1f0b">
          <date_of_original_definition>2014-11-30Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Nucleic acid testing instrument (NA, parts)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects with spare part characteristics that maintain or re-store the original condition of the objects classified under the parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU161#005"/>
          <hierarchical_position>42070491</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-AFU856#011" guid="2127a0876b794c82a18c090548318f37">
          <date_of_original_definition>2014-11-30Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Nucleic acid testing instrument (NA, accessories)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects with complemental characteristics, without which the basic function of the objects classified under the parent-class on the 3rd level is still guaranteed</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU161#005"/>
          <hierarchical_position>42070492</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU163#005" guid="3064b9c4ca39450a86317dfbb09f3fba">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Sample processing system instrument (SP)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses instruments specifically designed for the processing of samples within laboratory settings. These instruments are utilized to prepare, manipulate, or analyze biological or chemical samples prior to further examination or testing. The focus is on systems that enhance the efficiency and accuracy of sample handling, including automated devices that can perform tasks such as sorting, aliquoting, and centrifugation. Additionally, this category includes associated consumables and software that support the operation and functionality of these instruments. This classification distinguishes itself from those related to chemistry, immunochemistry, hematology, histology, cytology, microbiology, and nucleic acid testing, emphasizing its unique role in sample processing workflows.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS279#005"/>
          <hierarchical_position>42070600</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW989#015" guid="7b6bb576eb1b44f8b7474c20e28e23d4">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Consumable for sample processing system instrument (SP)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses all items that are intended for use within sample processing systems. These items are essential for the efficient operation of instruments designed to handle, analyze, or manipulate samples. They may include various materials, tools, or supplies that support the functionality and maintenance of the sample processing systems. The focus is on consumables that are specifically designed to integrate seamlessly with these instruments, ensuring optimal performance and reliability during sample processing activities. This classification excludes software solutions and specialized equipment such as aliquoters, sorters, centrifuges, decappers, and recappers, which serve distinct operational roles within the broader context of sample processing.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU163#005"/>
          <hierarchical_position>42070601</hierarchical_position>
          <keywords>
            <label id="0173-1#Z5-ACK928#001" language_code="en" country_code="US">Consumable for aliquoter, sorter, centrifuge, decapper, recapper (SP)</label>
          </keywords>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW990#015" guid="62e1c87fff7f44629c19dd1b33f7998e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Software for sample processing system instrument (SP)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a category encompassing various software solutions specifically designed to facilitate the operation, management, and optimization of instruments used in sample processing systems. These software applications enhance the functionality of sample processing instruments by providing features such as data analysis, instrument control, operational monitoring, and workflow automation. They are integral to ensuring the efficient handling and processing of samples, thereby improving accuracy and productivity in laboratory environments. This classification distinguishes such software from other related categories focused on consumables or specific mechanical functions associated with sample processing instruments.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU163#005"/>
          <hierarchical_position>42070602</hierarchical_position>
          <keywords>
            <label id="0173-1#Z5-ACK929#001" language_code="en" country_code="US">Software for aliquoter, sorter, centrifuge, decapper, recapper (SP)</label>
          </keywords>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW991#015" guid="20609a595fa94217871b7ddf26a97334">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Aliquoter, sorter, centrifuge, decapper, recapper (SP)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses various instruments specifically designed for the processing of samples. These devices are engineered to perform tasks such as dividing samples into aliquots, sorting them based on predetermined criteria, and separating components through centrifugation. Additionally, the instruments may include functionalities for decapping and recapping sample containers. They are typically utilized in laboratory environments to enhance the efficiency and accuracy of sample handling and preparation, ensuring optimal conditions for subsequent analysis or experimentation. The products in this category are essential for laboratories that require precise manipulation of samples, distinguishing them from consumables and software associated with sample processing.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU163#005"/>
          <hierarchical_position>42070603</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW992#015" guid="3cf287f3a1284fd1876c60904e9233a2">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Sample processing system instrument (SP, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU163#005"/>
          <hierarchical_position>42070690</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-AFU676#011" guid="82b1491bd09a42c0bb4e053bfebb4181">
          <date_of_original_definition>2014-11-30Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Sample processing system instrument (SP, parts)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects with spare part characteristics that maintain or re-store the original condition of the objects classified under the parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU163#005"/>
          <hierarchical_position>42070691</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-AFU858#011" guid="f1091200fc5a47f793d41e76001001b9">
          <date_of_original_definition>2014-11-30Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Sample processing system instrument (SP, accessories)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects with complemental characteristics, without which the basic function of the objects classified under the parent-class on the 3rd level is still guaranteed</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU163#005"/>
          <hierarchical_position>42070692</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU164#007" guid="3775aac0afd54f4492856f0130c5753c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">IVD instrument (other)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Group (3rd level) for objects that cannot be classified into other specified groups in the existing structure, but that are classified to their parent-class on the 2nd level. A xx-xx-90-00-class cannot have any other sub-groups besides the generic xx-xx-90-90-class (…(Other, unspecified)) to be generally valid within the parent class on the 2nd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADS279#005"/>
          <hierarchical_position>42079000</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW998#015" guid="85e931f69ec54fad8f41b66b37346f28">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">IVD instrument (other, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU164#007"/>
          <hierarchical_position>42079090</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU152#005" guid="efe9c381b2ea4b5b97e08f98e4902392">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Infectious immunology (reagent, buffer, supplement)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses substances and materials specifically utilized in the field of infectious immunology that facilitate diagnostic and therapeutic processes. It includes reagents designed for the extraction and preparation of nucleic acids from bacterial and viral sources, as well as buffers and supplementary reagents that support various immunological applications. The focus is on items that enhance the efficacy and accuracy of tests related to infectious diseases, without overlapping with classifications that pertain to specific infectious agents or testing methodologies. This category is pivotal in advancing research and clinical practices within the realm of infectious immunology, ensuring that practitioners have access to essential tools for accurate diagnosis and treatment.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS277#005"/>
          <hierarchical_position>42051000</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW846#015" guid="fecc0cf860d44fd9acb7e47dd2876c48">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Reagent for bacterial DNA extraction and preparation</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a category that encompasses substances used in laboratory processes specifically aimed at isolating and preparing bacterial DNA. These substances facilitate the extraction and purification of genetic material from bacterial cells, allowing for subsequent analysis and experimentation. This classification is distinct from those intended for viral nucleic acids or other types of biochemical buffers and supplements. The purpose of these reagents is to support research, diagnostics, and other applications within the field of infectious immunology, providing essential tools for understanding bacterial genetics and disease mechanisms.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU152#005"/>
          <hierarchical_position>42051001</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW847#015" guid="d98fc013288b46eab873f83a1736770a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Reagent for viral DNA and/or RNA extraction and preparation</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance utilized in laboratory procedures specifically designed for the extraction and preparation of viral DNA and/or RNA from biological samples. This material is essential in various diagnostic and research applications, enabling the isolation and purification of nucleic acids for further analysis. It plays a critical role in studying viral pathogens, understanding viral biology, and developing molecular assays. The formulation often includes specialized chemicals that enhance the efficiency of nucleic acid extraction while minimizing the degradation of sensitive viral genetic material. This category is distinct from reagents aimed at bacterial DNA extraction, as well as other buffers and supplements that serve different purposes in immunological testing and analysis.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU152#005"/>
          <hierarchical_position>42051002</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW848#015" guid="115d394acf1a4677bea4d6e40396ee27">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Buffer (unassignable ), supplement reagent</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance that serves to enhance or stabilize the performance of a specific analytical or diagnostic process, particularly in the context of immunology. This type of material is typically unassignable due to its broad applicability and lack of direct association with a specific biological target or procedure. It is utilized to optimize the conditions under which tests are performed, ensuring reliable and accurate results. This category encompasses various formulations that support the overall functionality of laboratory assays without being linked to particular reagents designed for DNA or RNA extraction or preparation.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU152#005"/>
          <hierarchical_position>42051003</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW849#015" guid="ab3d05f4f45f48d595cc0584501086e6">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Supplement reagent (NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific type of chemical substance used in laboratory settings, designed to enhance or support the activity of other reagents in the context of infectious immunology. This material is not intended as a primary reagent for extraction or preparation processes but serves to optimize conditions or enhance the effectiveness of primary reagents. It plays a crucial role in various immunological assays and experiments, ensuring that reactions occur under optimal conditions. The supplement reagent is formulated to be compatible with a range of applications in infectious disease research, diagnostics, and therapeutic development, contributing to the overall reliability and accuracy of laboratory results.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU152#005"/>
          <hierarchical_position>42051004</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW850#015" guid="9194a6cbe1f84a2ab60147568634532b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Infectious immunology (reagent, buffer, supplement, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU152#005"/>
          <hierarchical_position>42051090</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU157#007" guid="406ba85d2e484b0e80a97b36fc199c52">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Genetic testing (IVD, other)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Group (3rd level) for objects that cannot be classified into other specified groups in the existing structure, but that are classified to their parent-class on the 2nd level. A xx-xx-90-00-class cannot have any other sub-groups besides the generic xx-xx-90-90-class (…(Other, unspecified)) to be generally valid within the parent class on the 2nd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADS278#005"/>
          <hierarchical_position>42069000</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADS280#006" guid="2e1eefcaeb77416496873203bd5756df">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Supporting software (bioinformatics)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">software tools designed to assist in the analysis, interpretation, and evaluation of biological data within the context of in-vitro diagnostics. These applications facilitate the processing and visualization of complex datasets generated from diagnostic tests, enhancing decision-making processes in healthcare. The focus is on providing support for various diagnostic procedures without directly engaging in the testing process itself. This category is distinct from software associated with specific diagnostic fields such as clinical chemistry, immunochemistry, haematology, microbiology, infectious immunology, genetic testing, IVD instruments, and dedicated sample containers. The applications may include algorithms, databases, and platforms that streamline data management and enhance the accuracy of diagnostic outcomes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADJ215#005"/>
          <hierarchical_position>42080000</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU167#006" guid="9f42df5a6bab4db4b6cddfb52a93b10b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Supporting software (interpretation, evaluation)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses software solutions designed to assist in the interpretation and evaluation of data within the bioinformatics field. These tools are specifically tailored to support diagnostics and clinical interpretation processes, enhancing the analysis and understanding of biological data. Additionally, the software in this category includes specialized applications focused on microbiology and epidemiology, designed to analyze and evaluate relevant information pertinent to these scientific disciplines. The solutions provided here aim to facilitate informed decision-making and improve the accuracy of assessments in various biological contexts.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS280#006"/>
          <hierarchical_position>42080100</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADX037#015" guid="caf497842050445fbaa6cadf3b6f93b6">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Diagnostics-, and clinical interpretation supporting software</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">software designed to assist in the analysis and interpretation of diagnostic data and clinical findings. This type of software facilitates the evaluation of patient information, laboratory results, and other health-related data to support healthcare professionals in making informed decisions. It typically includes tools for data visualization, statistical analysis, and integration with other medical systems, enabling users to derive insights that enhance the quality of care. Unlike specialized software focused solely on microbiological or epidemiological aspects, this software encompasses a broader range of applications that support various clinical interpretations across different medical disciplines.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU167#006"/>
          <hierarchical_position>42080101</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADX038#015" guid="cc47f8e96a4248be992e92887c233cc1">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Specific microbiology-, epidemiology software</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses software specifically designed for the analysis and interpretation of microbiological and epidemiological data. It facilitates the examination of microorganisms, their behavior, and their impact on public health. The software aids in the evaluation of epidemiological trends, patterns, and the spread of diseases, enabling professionals to make informed decisions based on scientific data. This classification is distinct from other types of software that focus on diagnostic and clinical interpretations, emphasizing its unique role in supporting research and public health initiatives.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU167#006"/>
          <hierarchical_position>42080102</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADX039#015" guid="42e736e3668141ab933fc9d2d21c2857">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Supporting software (interpretation, evaluation, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU167#006"/>
          <hierarchical_position>42080190</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-AFU859#011" guid="60440ed020a3461aabe5799de6f8d753">
          <date_of_original_definition>2014-11-30Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Supporting software (interpretation, evaluation, accessories)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects with complemental characteristics, without which the basic function of the objects classified under the parent-class on the 3rd level is still guaranteed</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU167#006"/>
          <hierarchical_position>42080192</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU168#008" guid="1ff7b21a41964954b52dd785ba8db1ad">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Supporting software (bioinformatics, other)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Group (3rd level) for objects that cannot be classified into other specified groups in the existing structure, but that are classified to their parent-class on the 2nd level. A xx-xx-90-00-class cannot have any other sub-groups besides the generic xx-xx-90-90-class (…(Other, unspecified)) to be generally valid within the parent class on the 2nd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADS280#006"/>
          <hierarchical_position>42089000</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADX040#015" guid="32a8ad6973d747a6ab5506d9560faf83">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Supporting software (bioinformatics, other, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU168#008"/>
          <hierarchical_position>42089090</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU139#005" guid="dbb2aed7071b4109b0d78a2a39227538">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Parasitology (microbiology)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specialized field within the broader domain of microbiology, focusing on the study and analysis of parasitic organisms. It includes methodologies and products specifically designed for the detection, identification, and examination of parasites that may affect human health. Distinct from other microbiological classifications, this category prioritizes the unique characteristics and requirements of parasitology, emphasizing the need for tailored reagents and detection methods. The offerings comprise various extraction reagents and staining solutions essential for the examination of parasitic samples, as well as serological tests that facilitate the identification of specific parasitic infections. This classification serves as a critical resource for laboratories engaged in diagnostic processes related to parasitic diseases.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS276#005"/>
          <hierarchical_position>42040500</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW535#015" guid="7082205a0a3b4235b4d61413d79f964d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Parasitology (extraction reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses specialized substances utilized for the extraction and analysis of parasitic organisms in microbiological studies. These reagents are essential for isolating and purifying parasites from various biological samples, facilitating further examination and identification. The focus is on tools specifically designed for the detection and study of parasitic infections, which differ from those used for staining or serological identification of specific parasites. The reagents in this classification are integral to research and diagnostic processes in parasitology, contributing to the understanding of parasitic diseases and their impact on health.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU139#005"/>
          <hierarchical_position>42040501</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW536#015" guid="3067fa6172da4de4ba834d78da9d8e4e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Parasitology stain (extraction reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance used in the examination and identification of parasites within biological samples. This type of reagent facilitates the visualization of specific cellular components or structures associated with parasitic organisms, aiding in diagnostic processes. It is commonly utilized in laboratories focused on microbiological analysis, particularly within the field of parasitology. The application of this agent is crucial for enhancing the accuracy and efficiency of detecting parasitic infections, thus contributing to effective patient management and treatment strategies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU139#005"/>
          <hierarchical_position>42040502</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW537#015" guid="e1c46e147cef443aa2c4a79076481d29">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Pneumocystis jirovecci, pneumocystis carinii (serological detection and ident.)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses the methodologies and tools utilized for the serological detection and identification of Pneumocystis jirovecii and Pneumocystis carinii, which are significant organisms within the field of microbiology. The focus is on diagnostic processes that enable the identification of these pathogens, which are crucial for understanding infections and their implications in various health conditions. This classification is distinct from other related categories that deal with different microorganisms or extraction techniques, emphasizing the unique approaches required for accurate detection and identification within parasitology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU139#005"/>
          <hierarchical_position>42040503</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW538#015" guid="9ddddc0f6b464c90ab41968c3408408d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Plasmodium falciparum (serological detection and ident.)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses products and services related to the detection and identification of the Plasmodium falciparum parasite through serological methods. These offerings are vital in the field of microbiology, particularly within parasitology, as they enable the diagnosis and study of malaria caused by this specific organism. The classification distinguishes these items from other related categories that focus on different parasites or methodological approaches, ensuring precise identification of the respective testing and identification tools. This classification is essential for laboratories and healthcare providers involved in infectious disease diagnostics, offering a clear framework for the categorization and utilization of these specialized products.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU139#005"/>
          <hierarchical_position>42040504</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW539#015" guid="ffbfbbd703a14dc4a5e9994946781cd4">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cryptosporidium (serological detection and ident.)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a category characterized by products or services specifically designed for the serological detection and identification of Cryptosporidium, a protozoan parasite known to cause gastrointestinal illness in humans and animals. This classification encompasses various testing kits, reagents, and methodologies employed in laboratory settings to accurately identify the presence of Cryptosporidium in biological samples. The focus is on diagnostic tools that utilize serological techniques, distinguishing them from other categories that address different parasites or detection methods, ensuring precise identification and differentiation in microbiological studies. The offerings within this category are essential for clinical diagnostics, environmental monitoring, and public health assessments related to parasitic infections.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU139#005"/>
          <hierarchical_position>42040505</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW540#015" guid="6ba82b77eb044e31a96c52608b6921ae">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Parasitology (microbiology, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU139#005"/>
          <hierarchical_position>42040590</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU160#005" guid="2ecc7ffa6c4443e4aeb1fb84a85cb225">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Microbiology instrument (MCB)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses devices specifically designed for microbiological analysis and testing applications. Instruments within this classification are utilized to identify, analyze, and quantify microorganisms, including bacteria, viruses, fungi, and parasites, in various sample types. The focus is on tools that support processes such as susceptibility testing, identification of microbial species, and blood culture procedures. Additionally, this category includes consumables essential for the operation of microbiological instruments, as well as software solutions that enhance functionality and data management. The classification distinctly excludes instruments used for other types of clinical analyses, ensuring a specialized focus on microbiological methodologies and technologies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS279#005"/>
          <hierarchical_position>42070300</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW976#015" guid="47f024515d994a9690cce1a9ab8c50f4">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Consumable for microbiology instrument</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses items that are specifically designed for use with microbiology instruments, intended for one-time or limited-use applications. These consumables are essential for performing various microbiological tests and procedures, facilitating accurate analysis and experimentation in laboratories. They include a range of materials and supplies that support the functionality of microbiology instruments, ensuring optimal performance and reliability during testing. These items may vary in form and function, serving diverse roles such as sample preparation, containment, or enhancement of instrument capabilities, while adhering to quality standards necessary for laboratory use.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU160#005"/>
          <hierarchical_position>42070301</hierarchical_position>
          <keywords>
            <label id="0173-1#Z5-ACK922#001" language_code="en" country_code="US">Consumable microbiology susceptibility, identification (SI) instrument</label>
            <label id="0173-1#Z5-ACK924#001" language_code="en" country_code="US">Consumable MCB instrument</label>
            <label id="0173-1#Z5-ACK923#001" language_code="en" country_code="US">Consumable blood culture (BC) and mycobacteria (MB) instrument</label>
          </keywords>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW977#015" guid="bfe5cc76997944b59d72eaec3a331c0b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Software for microbiology instrument</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a category encompassing software specifically designed for the operation, control, and analysis of microbiology instruments. This software facilitates various functions such as data collection, processing, and interpretation of microbiological data, supporting laboratory workflows and enhancing the accuracy of results. It may include applications for managing experimental protocols, automating processes, and providing user interfaces that interact with microbiological instruments. This classification is distinct from related categories that pertain to consumables or different types of instruments used in microbiology, focusing solely on the digital tools that enhance the functionality and efficiency of microbiological analysis.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU160#005"/>
          <hierarchical_position>42070302</hierarchical_position>
          <keywords>
            <label id="0173-1#Z5-ACK925#001" language_code="en" country_code="US">Software microbiology susceptibility, identification (SI) instrument</label>
            <label id="0173-1#Z5-ACK927#001" language_code="en" country_code="US">Software MCB instrument</label>
            <label id="0173-1#Z5-ACK926#001" language_code="en" country_code="US">Software blood culture (BC) and mycobacteria (MB) instrument</label>
          </keywords>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW978#015" guid="c21a4f51a01b4e9fa37f0e9a61071a95">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Microbiology susceptibility, identification (SI) instrument</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a category of specialized equipment designed for the detection and assessment of microbial susceptibility and identification. These instruments facilitate the analysis of microorganisms to determine their resistance or sensitivity to various antimicrobial agents. They are essential in clinical and research laboratories for diagnosing infections, guiding treatment decisions, and conducting microbiological studies. These devices are distinct from other categories that include consumable items, software applications, or specific instruments tailored for blood culture and mycobacteria testing. Their advanced features typically enable automated processes, data management, and integration with laboratory information systems to enhance workflow efficiency and accuracy in microbiological testing.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU160#005"/>
          <hierarchical_position>42070303</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW979#015" guid="5593c9a8ee794d7a9faef46dd6a6952c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Blood culture (BC) and mycobacteria (MB) instrument</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specialized device designed to detect and cultivate microorganisms, including bacteria and fungi, from biological samples. This instrument facilitates the growth and analysis of pathogens, allowing for the identification of infectious agents and the determination of their resistance to antibiotics. It is essential for clinical laboratories and healthcare settings, playing a critical role in diagnosing infections and guiding treatment decisions. This category encompasses tools specifically intended for blood cultures and mycobacterial detection, distinguishing them from other related laboratory equipment that serves different purposes, such as consumables, software, or instruments focused on susceptibility and identification testing.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU160#005"/>
          <hierarchical_position>42070304</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW980#015" guid="b3e6fe998b0e404487f69c52cfe72949">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Microbiology instrument (MCB, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU160#005"/>
          <hierarchical_position>42070390</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-AFU673#011" guid="39214dd9b96a40af9f66d87f86166277">
          <date_of_original_definition>2014-11-30Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Microbiology instrument (MCB, parts)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects with spare part characteristics that maintain or re-store the original condition of the objects classified under the parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU160#005"/>
          <hierarchical_position>42070391</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-AFU855#011" guid="a30cbe12976d4d47967f3e199d322244">
          <date_of_original_definition>2014-11-30Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Microbiology instrument (MCB, accessories)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects with complemental characteristics, without which the basic function of the objects classified under the parent-class on the 3rd level is still guaranteed</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU160#005"/>
          <hierarchical_position>42070392</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU162#005" guid="8465a0c230de4546aec3eff1eef72b45">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Micro-array testing instrument (MA)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses instruments specifically designed for micro-array testing, which involves the analysis of biological material by utilizing a grid of probes to detect and quantify multiple targets simultaneously. These instruments are distinguished by their capability to process and interpret data derived from micro-array technology, offering high-throughput screening and comprehensive analysis. In addition to the primary instruments, this category also includes associated consumables, such as reagents and substrates specifically tailored for micro-array applications, as well as software solutions designed to facilitate data management, analysis, and visualization related to micro-array tests. The focus is on the unique characteristics and functionalities that set these instruments apart from those used in other analytical techniques, ensuring precision and efficiency in molecular diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS279#005"/>
          <hierarchical_position>42070500</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW985#015" guid="249dc04f6474400b95ae8ee364ed331e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Consumables for micro-array (MA) instrument</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses items that are essential for the operation and maintenance of micro-array testing instruments. These items are typically used in conjunction with the instruments to enhance their functionality, ensure accurate results, or facilitate the testing process. Consumables may include various materials, reagents, or components that are required for conducting tests, ensuring the reliability and efficiency of the micro-array technology. Their usage is critical for achieving optimal performance of the testing equipment and for obtaining valid data during micro-array experiments.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU162#005"/>
          <hierarchical_position>42070501</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW986#015" guid="1686c0524b134ff898de50053f1da411">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Software for micro-array (MA) instrument</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses software specifically designed for the operation, management, and analysis of micro-array testing instruments. It includes applications that facilitate the control of instrument functions, data acquisition, and the interpretation of results generated during micro-array experiments. The software may also provide functionalities for data visualization, statistical analysis, and integration with other laboratory information systems. This classification is distinct from related categories that focus on physical components or consumables used in conjunction with micro-array instruments, highlighting the unique role of software in enhancing the performance and utility of micro-array technologies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU162#005"/>
          <hierarchical_position>42070502</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW987#015" guid="44b7152be99a481aaeea2479b3b02226">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Micro-array instrument (MA)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses instruments specifically designed for micro-array technology, which facilitate the analysis of multiple biological samples simultaneously. These devices enable the detection and quantification of nucleic acids, proteins, or other biomolecules, providing researchers with essential tools for genomics, transcriptomics, and proteomics studies. The instruments are characterized by their ability to process high-throughput data and generate detailed profiles of biological interactions and expressions. This category is distinct from related classifications that cover consumables, such as reagents or substrates used in conjunction with micro-array instruments, as well as software solutions that support data analysis and interpretation, ensuring a clear delineation of functional capabilities within the micro-array testing ecosystem.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU162#005"/>
          <hierarchical_position>42070503</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW988#015" guid="33458da942be4f1285bac1bc86013596">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Micro-array testing instrument (MA, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU162#005"/>
          <hierarchical_position>42070590</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-AFU675#011" guid="85f4e06368d44c23852b3affb957cafc">
          <date_of_original_definition>2014-11-30Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Micro-array testing instrument (MA, parts)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects with spare part characteristics that maintain or re-store the original condition of the objects classified under the parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU162#005"/>
          <hierarchical_position>42070591</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW542#015" guid="8fb7e8b2556249468ea8e6ef3e98fdfa">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Control, standard, calibrator (microbiology, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU140#005"/>
          <hierarchical_position>42040690</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU141#005" guid="c07c152e6c6e42069da359626cb300be">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Rapid test (microbiology)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic tests designed for the rapid identification and analysis of microorganisms. It includes various methodologies that facilitate quick results in laboratory settings, particularly for infectious diseases. These tests are utilized in clinical diagnostics to detect the presence of pathogens, enabling timely decision-making in patient management. The focus is on assays that provide immediate or expedited results, distinguishing them from traditional culture techniques and other forms of microbiological analysis. This category emphasizes efficiency and speed in the detection process, serving a critical role in the field of in vitro diagnostics related to microbiological testing.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS276#005"/>
          <hierarchical_position>42040700</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW543#015" guid="78887ac9f180412e83b99effc0513e45">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Rapid test (microbiology, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU141#005"/>
          <hierarchical_position>42040790</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU122#006" guid="57bedf84dd184c7a9489a87bde1210e2">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Multiple parameter (immunochemistry)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a variety of immunochemical products and services that involve the simultaneous measurement or evaluation of multiple parameters within the context of immunological analysis. It is designed for applications requiring comprehensive assessments, combining different analytes or biomarkers to provide a holistic view of a physiological condition or disease state. This category is distinct from other classifications focusing on single or specific parameters, ensuring that products or services classified here are tailored for complex diagnostics and therapeutic monitoring scenarios. The aim is to facilitate the development, standardization, and utilization of advanced testing methodologies that improve diagnostic accuracy and patient management in the field of immunology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS274#006"/>
          <hierarchical_position>42021400</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW192#015" guid="bb7d1c581cab47878449aff5980b2d72">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Multiple parameter (immunochemistry, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU122#006"/>
          <hierarchical_position>42021490</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU133#005" guid="2b0c8af1a0be4c0798ee77942c5abe0f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Haematology (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses diagnostic tools and materials specifically related to the study and analysis of blood components and cellular structures. It includes various devices, reagents, and technologies used to perform tests that aid in the diagnosis and monitoring of blood-related conditions. The focus is on products that enable healthcare professionals to evaluate hematological parameters, assess cellular morphology, and conduct specialized tests essential for accurate medical assessments. Items classified here may facilitate both qualitative and quantitative analyses, contributing to a comprehensive understanding of hematological health and disease.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS275#005"/>
          <hierarchical_position>42030800</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW440#015" guid="8814c7ccd0114abca4cbf6c7d536eb6a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Haematology (IVD, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU133#005"/>
          <hierarchical_position>42030890</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU118#006" guid="097a97c0d15742b9a1168dd317e803e4">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Auto-immune disease</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses a diverse range of diagnostic tests and assays specifically designed to detect and quantify antibodies associated with auto-immune diseases. These tests are critical for the identification and monitoring of conditions where the immune system mistakenly attacks the body's own tissues. The offerings within this classification include a variety of screening methods and specific antibody assays tailored to identify different auto-immune markers. The focus lies on the evaluation of immune responses that may indicate the presence of auto-immune disorders, including the detection of specific autoantibodies linked to various diseases. The tools and methodologies employed are essential for clinicians in diagnosing, managing, and monitoring treatment responses in patients affected by these complex conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS274#006"/>
          <hierarchical_position>42021000</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW110#015" guid="4cf6d627a9154020a61ac9e5db79a09e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">ANA screening</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific set of laboratory tests designed to detect the presence of antinuclear antibodies in the serum, which are often indicative of autoimmune disorders. These tests are utilized to evaluate immune system activity and assist in diagnosing various autoimmune conditions. The focus of this classification is on assays that target a broad range of nuclear antigens, helping to identify the underlying causes of autoimmune responses. The results from these tests can provide crucial insights into the patient's health status and guide further clinical decision-making.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021001</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW111#015" guid="2e87352749a548e3b9fffd770f6156e4">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">ENA screening</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a diagnostic procedure designed to identify the presence of specific antibodies associated with various autoimmune conditions. This testing method is utilized to aid in the diagnosis of underlying autoimmune disorders by evaluating the immune response to endogenous proteins. The assay is characterized by its focus on a distinct set of autoantibodies, which can provide critical information regarding the patient’s immune status and potential autoimmune activity. Results from this testing can help healthcare professionals make informed decisions regarding treatment options and disease management strategies for individuals presenting symptoms indicative of autoimmune pathology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021002</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW112#015" guid="dab9f300fd164c698ee391527a971a4c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Anti cytoplasmic (antibody)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a specific category of antibodies that target cytoplasmic components within cells, often associated with autoimmune responses. These antibodies are involved in the immune system's recognition of self versus non-self, playing a crucial role in the diagnosis and monitoring of various autoimmune conditions. The presence of such antibodies can indicate an underlying autoimmune disorder and is significant in clinical diagnostics. This category is distinguished from other related antibody tests by its specific focus on cytoplasmic targets, providing essential information for healthcare professionals in the assessment and management of autoimmune diseases.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021003</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW113#015" guid="969785aca9ec4024b628c2a4f3ebf866">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">DS DNA (antibody)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="DeepL">Immunoglobulins that are produced in the body against its own double-stranded DNA and serve as biomarkers for certain autoimmune diseases, in particular systemic lupus erythematosus.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">Machine generated by Chat GPT4</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021004</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW114#015" guid="1624354dd79c4581b806d4a826278d11">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">SS DNA (antibody)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a specific type of antibody associated with autoimmune diseases, particularly targeting double-stranded DNA. These antibodies are primarily involved in the immune response against the body’s own nucleic acids, which can lead to various autoimmune conditions. The presence of this antibody is often indicative of certain disorders, and its detection plays a crucial role in diagnostic processes. The classification distinguishes this type of antibody from other related antibodies that are involved in different autoimmune mechanisms. The specificity of this antibody type is essential for accurate diagnosis and understanding of the underlying autoimmune pathology, aiding in the management and treatment of affected individuals.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021005</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW115#015" guid="a3e14055a1d847e4ad5c45c56076bee5">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Histone (H1,H2a,H3,H4 to Hn)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to proteins known as histones, specifically variants including H1, H2a, H3, H4, and additional forms. Histones are essential components of chromatin in eukaryotic cells, playing a critical role in the packaging of DNA into structural units called nucleosomes, which facilitate the organization and regulation of genetic material. The presence and modifications of these histones are often studied in the context of various biological processes, including gene expression and cellular response to damage. Their significance extends to areas such as epigenetics and autoimmune responses, where altered histone patterns may be indicative of certain conditions or diseases. This classification distinguishes histones from other related proteins and antibodies typically involved in autoimmune disorders, focusing specifically on their unique characteristics and relevance.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021006</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW116#015" guid="82e3d1683e864392aa6aebbc1e009bc6">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Jo-1 (auto-immune disease)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic tools and reagents specifically designed for the identification and analysis of auto-antibodies associated with various autoimmune conditions. These items are intended for use in laboratory settings and may include assays, kits, and individual components that facilitate the detection of specific auto-antibodies linked to autoimmune diseases. The focus is on products that assist in diagnosing autoimmune disorders through the measurement of auto-antibody levels, providing essential information for patient management and treatment decisions. This classification does not include screening methods for general antibodies or other unrelated diagnostic categories, ensuring a clear distinction in the range of products covered.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021007</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW117#015" guid="33f2e2f4eaba4a429957aed9db448408">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">PM-Scl (antibody)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a category of specialized biological molecules that are produced by the immune system in response to specific antigens associated with autoimmune conditions. These molecules play a critical role in diagnosing and understanding autoimmune diseases by targeting proteins or structures within the body that may be mistakenly recognized as foreign. The focus of this classification is on antibodies that are linked to systemic and organ-specific autoimmune responses, aiding in the identification of underlying pathophysiological mechanisms. This classification encompasses a variety of antibodies that may vary in their specificity and reactivity, contributing to a comprehensive understanding of autoimmune disorders and facilitating targeted therapeutic approaches.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021008</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW118#015" guid="6a6c286caf48480197e811c78d28f0b4">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Scl-70 (auto-immune disease, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a category of diagnostic tests utilized for identifying specific autoantibodies associated with particular autoimmune conditions. These tests are essential in the diagnosis and management of autoimmune diseases, providing crucial information regarding the immune response and potential underlying pathologies. The focus is on detecting Scl-70 antibodies, which are primarily associated with systemic sclerosis, a condition characterized by skin thickening and internal organ involvement. The relevance of this classification lies in its distinctiveness from other antibody testing categories, emphasizing its unique role in autoimmune disease diagnostics. These tests support healthcare providers in formulating treatment plans and monitoring disease progression, thereby enhancing patient care in autoimmune disorders.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021009</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW119#015" guid="a4f704491e5841fda545aadd39f33c34">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Sm (auto-immune disease, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification category encompasses diagnostic tests and related products specifically designed to detect and analyze auto-immune diseases. These items are utilized in laboratories to identify auto-antibodies that may indicate the presence of various auto-immune conditions. The focus is on assays that target specific auto-antibodies, which play a critical role in the diagnosis and monitoring of auto-immune disorders. The classification is distinct from other categories that may include different types of auto-antibodies or testing methodologies, ensuring clarity in the types of tests and their intended use in clinical settings. Items within this category are essential for healthcare professionals in understanding and managing auto-immune diseases, facilitating accurate diagnosis and treatment planning.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021010</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW120#015" guid="179e7a1b674a4084aaa0700d6b451199">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">SS-A (auto-immune disease, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic tools and reagents specifically designed for the detection and analysis of auto-antibodies associated with autoimmune diseases. These products are utilized in in vitro diagnostic testing to identify specific auto-immune responses, aiding in the diagnosis and management of various conditions characterized by the presence of these antibodies. The focus is on identifying unique markers that are indicative of specific auto-immune disorders, facilitating targeted therapeutic interventions and monitoring disease progression. The classification distinctly separates this category from other related diagnostic tests that assess different auto-antibodies or immunological responses.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021011</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW121#015" guid="048cfed070154c76959fce64cde871d2">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">SS-B (auto-immune disease, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific category of diagnostic tools and reagents utilized in the detection and analysis of auto-immune diseases. These products facilitate the identification of various autoantibodies that are indicative of specific auto-immune disorders. The classification focuses on in vitro diagnostic (IVD) solutions that aid healthcare professionals in diagnosing and managing conditions characterized by the immune system's aberrant response. The items within this category are essential for laboratory testing and encompass a range of assays and kits tailored to detect the presence of particular autoantibodies associated with distinct auto-immune conditions, thereby supporting clinical decision-making and patient management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021012</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW122#015" guid="a5d5101e58c441089fa9201d543e5a63">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">U1-snRNP (antibody)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">an antibody that specifically targets U1 small nuclear ribonucleoprotein, which plays a critical role in the splicing of pre-mRNA. This type of antibody is often associated with certain autoimmune conditions and can be used in diagnostic procedures to detect the presence of specific autoantibodies in patient serum. The identification of this antibody can aid in the diagnosis and management of diseases characterized by immune system dysregulation, helping to differentiate them from other related conditions that involve different autoantibodies. The presence of U1-snRNP antibodies may indicate a specific autoimmune response and is an important marker in clinical immunology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021013</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW123#015" guid="2fb89317a4bf487f9c44b96e2fc084fa">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Anti-centromere (antibody)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific type of antibody that targets centromere proteins, commonly associated with certain autoimmune disorders. These antibodies can be detected in the serum of patients and may serve as important biomarkers in diagnosing and monitoring specific conditions related to autoimmune diseases. Their presence can indicate an immune response against the body's own cellular components, particularly in disorders characterized by the production of autoantibodies. Testing for this type of antibody can provide valuable insights into the underlying pathophysiology of autoimmune conditions and assist healthcare professionals in tailoring appropriate therapeutic strategies for affected individuals.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021014</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW124#015" guid="08ccde529e044d3382c4acf9d12ebf06">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Anti-ganglioside-antibody (total)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance that is produced by the immune system and targets gangliosides, which are complex molecules found in nerve tissues. This type of antibody may play a role in the diagnosis and monitoring of autoimmune conditions, where the body's immune system mistakenly attacks its own tissues. The presence of these antibodies can be indicative of various neurological disorders and may assist in understanding disease mechanisms, guiding treatment decisions, and evaluating patient responses. Detection methods may vary, and results should be interpreted in conjunction with clinical findings and other diagnostic tests to ensure an accurate assessment of the individual's health status.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021015</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW125#015" guid="e16995fd76e344ecbfa6952ea86afb76">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Anti-GM1 (auto-immune disease, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a specific category of immunological markers associated with the diagnosis and monitoring of auto-immune diseases. It encompasses antibodies that react against gangliosides, which are complex molecules present in the nervous system and other tissues. The presence of these antibodies can indicate an underlying autoimmune process, often linked to neurological disorders. Testing for this category is primarily conducted through in vitro diagnostics (IVD), allowing for the detection and quantification of the antibodies in patient samples. This category is distinct from other immunological tests that focus on different types of antibodies or target different auto-immune conditions, highlighting its unique role in the broader context of auto-immune disease diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021016</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW126#015" guid="596ef657dc374e08a8dc1d6124f52950">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Asialo-GM1 (auto-immune disease, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of diagnostic biomarker utilized in the evaluation of auto-immune disorders. It is characterized by the presence of antibodies that target particular neuronal components, playing a crucial role in the identification of various autoimmune conditions. The biomarkers in this category are relevant for in vitro diagnostic applications and assist healthcare professionals in understanding the underlying mechanisms of auto-immune responses. By detecting these specific antibodies, clinicians can obtain valuable insights into the patient's immune status and facilitate appropriate management strategies. This classification is distinct from other related diagnostic markers that target different auto-antigens or antibodies associated with various immune-mediated diseases.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021017</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW127#015" guid="95c57e506b584719aded37587dac8938">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Anti-GD1b (auto-immune disease, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic reagents specifically designed to detect antibodies associated with a particular auto-immune disease involving the presence of anti-GD1b antibodies. These reagents are utilized in the context of in-vitro diagnostics (IVD) to aid in the diagnosis and monitoring of conditions related to auto-immunity. The focus is on the unique properties and behaviors of these antibodies in the diagnostic process, distinguishing them from other antibody tests. The category is pivotal for healthcare professionals to identify specific auto-immune responses that may influence patient management and treatment strategies. It emphasizes the relevance of antibody detection in understanding the underlying mechanisms of auto-immune diseases and their clinical implications.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021018</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW957#015" guid="aa0accec124047c695dbcc7b1703d08b">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Genetic testing (IVD, other, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU157#007"/>
          <hierarchical_position>42069090</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU149#005" guid="173cd691c4684a2d99fffd5ea4f172de">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Multiple parameters (infectious immunology)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a diverse range of testing methodologies and analytical procedures that assess multiple parameters within the field of infectious immunology. It is characterized by the simultaneous evaluation of various infectious agents or biomarkers, enabling comprehensive diagnostic insights. The focus is on assays that utilize advanced techniques to detect and quantify multiple microorganisms or viral pathogens, enhancing the understanding of infectious diseases. This classification is distinct from other areas within infectious immunology by its emphasis on multi-target testing, which provides a broader spectrum of information on pathogen presence and activity. Included within this classification are specific testing panels designed to identify both gram-positive and gram-negative fungi, as well as combinations of viral targets, thereby supporting effective disease management and therapeutic decisions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS277#005"/>
          <hierarchical_position>42050700</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW816#015" guid="520a6f1ed85b442cac25afc166782654">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Gram positive-, gram negative fungi (multiple bacteria panel, NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a category that encompasses diagnostic tools and reagents specifically designed for the simultaneous detection and analysis of multiple types of microorganisms, including gram-positive and gram-negative fungi. These diagnostic solutions facilitate the identification of various bacterial species within a single testing framework, enhancing efficiency in clinical settings. The products in this category are instrumental in infectious immunology, allowing for comprehensive testing that supports the diagnosis and monitoring of infectious diseases. They are utilized in laboratories and healthcare environments to improve patient outcomes through rapid and accurate pathogen identification.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU149#005"/>
          <hierarchical_position>42050701</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW817#015" guid="7bc7eb28079d4bb7b6b0f75f3fa33301">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Gram positive-, gram negative fungi (multiple bacteria panel)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a category encompassing various diagnostic assays designed to detect and identify the presence of both gram-positive and gram-negative fungi, utilizing a comprehensive panel approach. This classification emphasizes the simultaneous analysis of multiple bacterial pathogens in a single testing procedure, facilitating efficient diagnosis and monitoring of infections. The assays included in this category are distinguished by their ability to provide insights into a wide range of infectious agents, enhancing clinical decision-making. The focus is on the detection capabilities that are crucial for understanding complex infections, thereby aiding in the development of targeted treatment strategies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU149#005"/>
          <hierarchical_position>42050702</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW818#015" guid="29ddddf15aa3490c8f4a563cd7a0299e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">HBV, HCV, HIV combination (multiple virus panel, NA reagent)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a collection of diagnostic reagents specifically designed for simultaneous detection and analysis of multiple viral targets, including hepatitis B virus, hepatitis C virus, and human immunodeficiency virus. These reagents are utilized in immunological testing to assess the presence of these viruses in biological samples. This category emphasizes the capability to evaluate multiple infectious agents in a single test, offering a comprehensive approach to diagnosing viral infections. It is distinct from other categories that focus on bacterial detection, highlighting its unique application in the field of infectious disease diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU149#005"/>
          <hierarchical_position>42050703</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW819#015" guid="9aefaed436b74554a3c35cf89d6ab262">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Multiple parameters (infectious immunology, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU149#005"/>
          <hierarchical_position>42050790</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU138#005" guid="7c2b8208c3bc41c6b54f5a4d6099a860">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Viral culture</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses products and materials specifically designed for the cultivation and maintenance of viral specimens in a laboratory setting. It includes a variety of items essential for the successful growth and study of viruses, facilitating research and diagnostic processes in microbiology. The offerings in this category are distinct from those related to bacterial cultures, fungal studies, parasitological examinations, and standard controls in microbiological testing. Key inclusions are specialized cells used for tissue culture, nutrient-rich media formulated for viral propagation, and serum products vital for supporting viral growth in controlled environments. These items play a crucial role in advancing virology research and improving diagnostic capabilities in the field of infectious diseases.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS276#005"/>
          <hierarchical_position>42040400</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW531#015" guid="9a3deb92629640338d84cc0c14fed033">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Cells for tissue culture</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specialized category encompassing biological entities specifically designed for the cultivation and maintenance of tissues in a laboratory setting. These entities are utilized in various applications, including research, drug development, and regenerative medicine. They provide a controlled environment that mimics in vivo conditions, allowing for the growth of cells derived from various sources. This classification focuses on the unique characteristics and functionalities that distinguish these biological entities from other related products, such as growth media and serum formulations. The products within this category facilitate the study of cellular behavior, interactions, and responses, contributing to advancements in biological and medical sciences.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU138#005"/>
          <hierarchical_position>42040401</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW532#015" guid="8220597bac6740c5a2056cef142eb3f8">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Media for tissue culture</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses a range of products specifically designed to support and facilitate the growth and maintenance of cells in controlled laboratory conditions. These materials are essential for researchers and scientists working with tissue cultures, particularly in the context of viral studies. They may include various media formulations that provide the necessary nutrients, growth factors, and environmental conditions to promote cell viability and proliferation. The offerings in this category are distinct from other related products aimed at different aspects of tissue culture, ensuring that users can select the most appropriate solutions for their specific experimental needs.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU138#005"/>
          <hierarchical_position>42040402</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW533#015" guid="1a4e8ced258944ba8120dfffefca347c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Serum for tissue culture</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specialized solution designed for use in the cultivation of cells, specifically tailored to support the growth and maintenance of tissues in laboratory settings. This formulation is essential for research and experimental applications, providing the necessary nutrients and growth factors to facilitate cellular development. It is distinct from other formulations used in laboratory environments, such as those intended for the propagation of specific cell types or general media that support a broader range of cellular activities. The product is typically employed in virology and related fields to ensure optimal conditions for viral propagation and study.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU138#005"/>
          <hierarchical_position>42040403</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW534#015" guid="8255ef0de7134de8ab5252f4521b00f4">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Viral culture (unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU138#005"/>
          <hierarchical_position>42040490</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU156#005" guid="97f73329d373413a97d33a9b69dfc538">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Multiple parameters (genetic testing)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a category that encompasses diagnostic procedures and tests designed to analyze various genetic parameters, typically utilized in the field of personalized medicine and pharmacogenomics. It includes methodologies that assess multiple genetic factors simultaneously, facilitating comprehensive evaluations that can inform treatment decisions. The focus is on tests that can identify variations in genes and chromosomes, which may influence an individual's response to medications or susceptibility to diseases. The procedures in this category are distinct from those targeting specific genetic alterations and are essential for understanding complex genetic interactions and their implications for health management.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS278#005"/>
          <hierarchical_position>42060300</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW950#015" guid="f6b0a22c62e74417a6464b4456c715ba">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">CYP 450 (individual test)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific analytical procedure designed to assess genetic variations related to the cytochrome P450 enzyme system, focusing on individual genetic markers. This testing method evaluates the impact of specific genetic mutations on drug metabolism, enabling healthcare professionals to tailor pharmacotherapy based on an individual's genetic profile. Unlike broader testing methods that analyze multiple genetic markers simultaneously through advanced technologies, this approach is concentrated on assessing a single parameter, providing detailed insights into individual genetic characteristics that affect therapeutic responses. It is widely utilized in personalized medicine to optimize treatment plans and enhance patient outcomes through informed decision-making based on genetic predispositions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU156#005"/>
          <hierarchical_position>42060301</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW951#015" guid="78dacc6499804d85b4a2e29cfcee3e62">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">CYP 450 (multiple test on micro-arrays)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a category designated for testing methodologies that assess multiple genetic variations simultaneously through micro-array technology, specifically related to cytochrome P450 enzymes. This classification encompasses comprehensive analyses that provide insights into the metabolic pathways of various substances, aiding in the evaluation of genetic predispositions and responses to medications. The focus is on the simultaneous interpretation of multiple genetic markers, distinguishing it from individual testing methods that examine a single genetic variant. This category is essential for advanced genetic testing applications in personalized medicine and pharmacogenomics, facilitating informed decision-making in therapeutic treatments based on genetic profiles.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU156#005"/>
          <hierarchical_position>42060302</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW952#015" guid="87152c4497994e1bb9e9f6514324f295">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Multiple parameters (genetic testing, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU156#005"/>
          <hierarchical_position>42060390</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU120#006" guid="f7c97be2039d4595b5ab69dee208b45d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Liver function (organ function assay, immunochemistry, immunology)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses assays and tests specifically designed to evaluate liver function through various immunochemical methods. It includes diagnostic procedures that assess the biochemical and immunological aspects of liver health, focusing on the detection and quantification of specific proteins and markers related to liver function. The classification differentiates itself from other immunochemical assessments by concentrating on the unique functional attributes of the liver, employing techniques that may involve the analysis of serum or plasma samples. The offerings in this category are vital for clinical evaluations, aiding in the diagnosis of liver-related conditions and monitoring the effectiveness of treatments.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS274#006"/>
          <hierarchical_position>42021200</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW176#015" guid="648fe35a16c34765bf0327c9bd5ef4fd">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">MEGX (liver function, immunochemistry)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses diagnostic assays and tests specifically designed to evaluate liver function through immunochemical methods. It includes various immunoassays that measure biomarkers related to liver health, enabling the assessment of hepatic activity and function. The focus is on identifying specific liver-related conditions and monitoring organ health through the analysis of immunological responses. This classification is distinct in its methodology and biomarkers from other liver function assays, emphasizing its unique role in immunochemistry and the broader field of immunology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU120#006"/>
          <hierarchical_position>42021201</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW177#015" guid="fc0ba7635d394f33a0458477b2fc6987">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Carbo hydrate deficient transferrin (liver function, immunochemistry)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a type of biochemical test that measures the levels of carbohydrate-deficient transferrin in biological samples, primarily to assess liver function and diagnose related disorders. This assay is utilized in immunochemistry and immunology to evaluate the metabolic activity of the liver and can aid in identifying conditions such as alcohol abuse or liver disease. Unlike other liver function tests, this analysis focuses specifically on the presence and concentration of transferrin variants that lack carbohydrate moieties, providing unique insights into liver health and function. The method typically involves sophisticated laboratory techniques to ensure accurate and reliable results.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU120#006"/>
          <hierarchical_position>42021202</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW178#015" guid="4a4c76dc0ab54b31b7c553b060701261">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Liver function (organ function assay, immunochemistry, immunology, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU120#006"/>
          <hierarchical_position>42021290</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU148#005" guid="59fd6eafb2384f5ba0a8f1ed823f3799">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Mycology (infectious immunology)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to the study and analysis of fungal infections and their implications within the context of infectious immunology. It encompasses a range of diagnostic methods and tools specifically designed for the identification and evaluation of pathogenic fungi, particularly in relation to their impact on the immune system. The focus is on understanding the interactions between fungal pathogens and host immune responses, facilitating the development of targeted diagnostic procedures and treatment strategies. The classification includes specific categories for various fungal species commonly associated with infections, providing a framework for the assessment of diagnostic reagents and methods used in laboratory settings. The aim is to enhance the understanding and management of mycological infections in clinical environments.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS277#005"/>
          <hierarchical_position>42050600</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW813#015" guid="17f587109aca4eb9bf7aebf3c999fb38">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Aspergillus (mycology, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">aspergillus refers to a genus of fungi that is significant in the field of mycology, particularly within the context of infectious immunology and in vitro diagnostics. These organisms play a crucial role in various ecological systems and can also be associated with human health, where they may lead to infections in immunocompromised individuals. In diagnostic applications, specific tests and methodologies are employed to identify and quantify Aspergillus species, aiding in the clinical management of related diseases. The classification distinguishes this genus from other fungal organisms, such as Candida albicans, by focusing on unique characteristics, pathogenic potential, and diagnostic approaches relevant to Aspergillus.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU148#005"/>
          <hierarchical_position>42050601</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW814#015" guid="6f545663095744a6bd6204cf91ced350">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Candida albicans (mycology, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific type of yeast that is commonly found in the human body and can be associated with various infections, particularly in immunocompromised individuals. This organism is of significant interest in the field of medical mycology and plays a crucial role in infectious immunology. It is primarily studied in relation to its pathogenic potential, diagnostic methodologies, and therapeutic approaches within in vitro diagnostics. Differentiated from similar organisms, this classification focuses on its unique characteristics, clinical implications, and the methodologies employed for its identification and management in a medical context.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU148#005"/>
          <hierarchical_position>42050602</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW815#015" guid="a23d584e6b2449daa1567c81f60fa82a">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Mycology (infectious immunology, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU148#005"/>
          <hierarchical_position>42050690</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU140#005" guid="3c9c7fabea824f6c9f1562f1b81b7298">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Control, standard, calibrator (microbiology)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses items used in the quality control and standardization processes within the field of microbiological testing. It includes substances and materials essential for calibrating instruments, validating methodologies, and ensuring the reliability of microbiological assays. The focus is on products that facilitate the accurate assessment of microbial organisms and their characteristics, providing a framework for consistent testing practices. This category is distinct from those related to specific areas such as bacterial culture, identification, susceptibility testing, fungal analysis, viral cultures, and parasitological studies, as well as rapid testing methods. Items classified here are pivotal for maintaining the integrity and precision of microbiological diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADS276#005"/>
          <hierarchical_position>42040600</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW541#015" guid="b6715a3681fb4623a4ac4e7bac5e3550">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">QC strain bacteriology</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a classification pertaining to a specific category of biological entities utilized in microbiological analysis, particularly focused on quality control strains. These entities are standardized microorganisms that are employed to validate, calibrate, or control analytical methods and procedures in the field of bacteriology. They serve as benchmarks for performance evaluation and are essential for ensuring the accuracy and reliability of microbiological testing. The designated strains can be used to assess the efficacy of various testing protocols, providing a reference point that facilitates consistent results across different laboratory environments.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU140#005"/>
          <hierarchical_position>42040601</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW160#015" guid="b0f6c9a519df4b90be574482270d0ce3">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Acetylcholin receptor antibody</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specialized immunological reagent designed to identify and bind to acetylcholine receptor proteins, which are critical in neuromuscular transmission and may play a role in various auto-immune conditions. This substance is utilized primarily in diagnostic applications to assist in the detection of auto-immune disorders that affect the neuromuscular junction. It serves as a valuable tool in clinical laboratories for the evaluation of patients exhibiting symptoms related to auto-immune diseases that involve disruptions in normal receptor function. This classification encompasses reagents that are specifically directed against acetylcholine receptors, differentiating them from other auto-antibodies that target different proteins or structures within the immune system.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021051</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW161#015" guid="8edbc7807dd54e42ad778a14b49ac850">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">LDL antibody</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of antibody that targets low-density lipoprotein (LDL) particles, which are often implicated in autoimmune responses. These antibodies are significant in the context of diagnosing and monitoring autoimmune diseases, as they can indicate abnormal immune system activity against LDL. This classification is distinct from other antibody tests that focus on various autoantigens associated with different autoimmune disorders. The identification of LDL antibodies can aid in understanding the underlying mechanisms of autoimmune conditions and may provide insights into therapeutic approaches. This category is essential for healthcare professionals in assessing patient profiles and determining appropriate treatment strategies in the realm of immunology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021052</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW162#015" guid="d85f329524b34322b6dce2f9a0a7f508">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Auto-immune disease (unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021090</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU125#008" guid="efe6a35975d74f8dabf0786d7ad02b69">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Immunochemistry (immunology, other)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Group (3rd level) for objects that cannot be classified into other specified groups in the existing structure, but that are classified to their parent-class on the 2nd level. A xx-xx-90-00-class cannot have any other sub-groups besides the generic xx-xx-90-90-class (…(Other, unspecified)) to be generally valid within the parent class on the 2nd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADS274#006"/>
          <hierarchical_position>42029000</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW128#015" guid="cb015b0a9be047c098a4a11c332826f1">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Gal(b1-3) (auto-immune disease, IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic tools and tests specifically designed to detect and quantify antibodies associated with autoimmune diseases, particularly focusing on those related to galactose-binding proteins. These diagnostic entities are utilized in the in vitro diagnostic (IVD) context to aid in the identification and monitoring of autoimmune conditions. The classification emphasizes the importance of distinguishing these specific antibodies from others in the broader context of autoimmune disease diagnostics, ensuring precise identification and management of related health conditions. The assays may involve various methodologies, including serological tests, to provide insights into the immune response and potential pathologies linked to galactose-binding proteins.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021019</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW129#015" guid="48b8419e7d574ef5bcc96edd43dd59e2">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">GalNAc (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific category of biochemical substances that are utilized primarily in the diagnosis and monitoring of autoimmune diseases. These substances are characterized by their ability to interact with specific antibodies related to autoimmune responses. They play a crucial role in laboratory diagnostics, enabling healthcare professionals to identify and evaluate various autoimmune disorders effectively. The classification distinguishes this category from other associated antibody screenings, focusing on unique markers and their implications in the context of autoimmune pathology. The substances within this category are essential for understanding the immune system's response and assisting in the development of targeted therapeutic strategies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021020</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW130#015" guid="7baade28a59f45c9b5e48a1d8e26bdca">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Anti-MAG (myelin associated glycoprotein)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses specific antibodies that target myelin-associated glycoproteins, which are significant in the context of autoimmune diseases. These antibodies are integral to diagnosing conditions where the immune system mistakenly attacks components of the nervous system, potentially leading to demyelination. The presence of such antibodies can indicate underlying autoimmune processes and assist healthcare professionals in identifying and managing related disorders. Differentiation from other antibody tests is essential, as this classification focuses specifically on the immune response against myelin-associated glycoproteins rather than other autoimmune markers. This classification is crucial for developing targeted therapeutic strategies and monitoring disease progression in affected individuals.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021021</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW131#015" guid="3a22831263ec40be842d65800b0e754d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Anti-CAR (cancer associated retinopathy)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of antibody associated with cancer-related vision impairment, characterized by the presence of autoantibodies that target retinal antigens. The assets in this category are primarily utilized in diagnostic processes to identify and monitor the progression of cancer-associated retinopathy. They play a crucial role in the assessment of autoimmune responses linked to ocular manifestations of malignancies. This classification distinctly identifies these assets from other serological tests that focus on different autoimmune diseases and their associated antibodies. The unique properties and clinical relevance of these antibodies facilitate targeted therapeutic approaches and contribute to personalized patient management strategies in oncology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021022</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW132#015" guid="da153dd827144b6aa782f4b3e6f54182">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Anti-Hu (antibody)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of protein produced by the immune system that targets and binds to particular proteins associated with autoimmune diseases. These proteins can indicate the presence of an autoimmune response, which occurs when the body's immune system mistakenly attacks its own tissues. The presence of such proteins can be used in diagnostics to support the identification of various autoimmune conditions. This category is distinct from other related protein classifications that target different specific proteins or combinations associated with autoimmune diseases. The classification is essential for understanding the underlying mechanisms of autoimmune responses and for guiding appropriate therapeutic interventions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021023</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW133#015" guid="3ab2370fab814e6ca9d507808ef75e0c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Anti-Yo (antibody)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses a specific type of immunological marker that plays a crucial role in diagnosing and monitoring autoimmune diseases. These markers are typically proteins produced by the immune system that mistakenly target the body's own cells. The presence of these antibodies can indicate an autoimmune response, aiding in the identification of various autoimmune conditions. This classification is distinct from other immunological tests that may assess different types of antibodies or related markers. The focus here is on antibodies that are specifically associated with particular autoimmune conditions, helping healthcare professionals to better understand and manage these complex diseases.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021024</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW134#015" guid="8b101cc398284b61b01a6db9c2d7fb72">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Anti-Ri (antibody)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a specific type of immunological diagnostic test designed to identify antibodies associated with autoimmune conditions. These antibodies are proteins produced by the immune system that mistakenly target the body's own tissues, indicating an autoimmune response. The focus is on a unique subset of antibodies that may play a crucial role in the diagnosis and monitoring of autoimmune diseases, which are disorders characterized by the immune system attacking healthy cells. The classification differentiates this specific type of antibody from others based on their reactivity and the diseases they are associated with, facilitating a clearer understanding for healthcare professionals in the diagnosis and treatment of autoimmune disorders.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021025</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW135#015" guid="321aed6bddc84e1a8f2cc587c0dcc207">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Anti-GQ1b (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific category of diagnostic tests and reagents that are utilized to identify antibodies associated with a particular autoimmune condition. The focus is on assays that detect the presence of anti-GQ1b antibodies, which are relevant in the context of autoimmune disorders. These tests play a crucial role in diagnosing and understanding the pathophysiology of conditions linked to these antibodies. The category is distinct from other autoimmune disease tests and is characterized by its specific target of anti-GQ1b, providing valuable insights for clinicians in managing and treating affected individuals. The products and services within this classification are essential for laboratory diagnostics, offering precise identification and monitoring of autoimmune responses.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021026</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW136#015" guid="e1409ca8ab3c43b0bdbc0e26ac9a0684">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Thyroid peroxidase (inclusive microsomal, antibody)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of antibody associated with the diagnosis and management of autoimmune conditions affecting the thyroid gland. It is characterized by the presence of antibodies that target thyroid peroxidase, an enzyme crucial for the synthesis of thyroid hormones. The detection of these antibodies can aid in identifying autoimmune thyroid disorders, providing important insights for clinical assessments and therapeutic decisions. This classification is distinct from other related antibody tests that focus on different autoimmune responses, ensuring a precise categorization within the broader context of autoimmune disease diagnostics.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021027</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW137#015" guid="7172b85b22ea4b6db1a7a1ce0b79e114">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">TSH receptor antibody</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specialized protein produced by the immune system that specifically binds to and interacts with the TSH (thyroid-stimulating hormone) receptor, which is crucial for regulating thyroid gland function. This antibody may play a role in the diagnosis and monitoring of autoimmune thyroid diseases, where the body's immune response mistakenly targets its own thyroid tissue. The presence of this antibody can indicate an abnormal immune response and is often used in clinical settings to evaluate conditions related to thyroid dysfunction, providing insights into the underlying pathophysiology of such disorders. It serves as an important biomarker in the context of immune-mediated thyroid diseases.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021028</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW138#015" guid="b3fb6ffb69d0418da7d9755864e9e110">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Thyroglobulin autoantibody</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a type of antibody associated with autoimmune responses, specifically targeting thyroglobulin, which is a protein produced by the thyroid gland. The presence of thyroglobulin autoantibodies may indicate an autoimmune thyroid disorder, where the immune system erroneously attacks the body's own thyroid tissue. This can lead to various thyroid dysfunctions, including hypothyroidism or hyperthyroidism. Testing for these antibodies is crucial in the diagnosis and management of thyroid-related autoimmune diseases, aiding healthcare professionals in determining the underlying causes of thyroid dysfunction and guiding appropriate treatment strategies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021029</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW139#015" guid="78a1aaff26db4f589ac74c7190ea6d71">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Anti-cardiolipin antibody</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a type of immunological marker that indicates the presence of antibodies directed against cardiolipin, a phospholipid component of cell membranes, which can be involved in various pathological conditions. The detection of these antibodies is significant in the diagnosis and management of autoimmune disorders, particularly those related to thrombosis and pregnancy complications. This marker is typically assessed through laboratory testing and plays a crucial role in the evaluation of patients with suspected autoimmune diseases. The presence of anti-cardiolipin antibodies can provide insights into the immune system's activity and its potential dysregulation in the context of autoimmune responses. This classification is distinct from other specific antibody tests related to various autoimmune conditions and provides targeted information relevant to clinical diagnosis and treatment planning.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021030</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW140#015" guid="7e1b051bbd914df1b84c1eaea437cca7">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Anti-mitochondrial antibody</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a substance produced by the immune system that targets components within mitochondria, which are essential organelles responsible for energy production in cells. The presence of these antibodies may indicate an autoimmune response, where the body's immune system mistakenly attacks its own tissues. This condition is often associated with various autoimmune diseases, leading to potential disruptions in normal cellular function and metabolism. Testing for these antibodies can assist in diagnosing specific autoimmune conditions and determining appropriate treatment strategies. The classification of this substance helps in understanding its role in autoimmune pathology and in identifying related clinical implications.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021031</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW141#015" guid="d7792b5a8c1545dd8a1a42f1ca8a67b8">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Anti-phosphatidylserin antibody</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific type of immunological marker that targets phosphatidylserine, a phospholipid component found in cell membranes, often associated with auto-immune responses. This antibody plays a crucial role in diagnosing and understanding various auto-immune disorders by indicating the presence of an abnormal immune response against the body's own tissues. The detection of this antibody is significant in the clinical evaluation of patients, aiding in the identification of specific auto-immune conditions. Its unique characteristics distinguish it from other antibodies related to auto-immune diseases, providing clinicians with valuable insights into the underlying pathophysiology.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021032</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW142#015" guid="dd18cc22c40e47a785d154db6131c22c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Anti-b2-glycoprotein I antibody</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a specific type of antibody that targets a particular protein involved in immune responses. It is utilized in diagnostic evaluations related to autoimmune conditions, helping to identify the presence of antibodies that may indicate an autoimmune disorder. The focus of this classification is on the recognition of the anti-b2-glycoprotein I antibody, which plays a significant role in the diagnosis and monitoring of certain autoimmune diseases. This antibody is distinct from others associated with different immune responses and serves as a crucial marker in clinical assessments. Its identification aids healthcare professionals in understanding the underlying autoimmune processes affecting patients and supports informed decision-making in treatment strategies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021033</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW143#015" guid="f41acd03b9004f2aa12fc4bf00e654bc">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Complement activation</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">complement activation refers to a biological process involving the activation of a group of proteins known as complement proteins, which play a crucial role in the immune response. This process enhances the ability of antibodies and phagocytic cells to clear pathogens and damaged cells, promote inflammation, and facilitate the removal of immune complexes. In the context of auto-immune diseases, complement activation may be dysregulated, leading to tissue damage and contributing to the pathophysiology of various conditions. Assessing complement activation can provide insights into the underlying mechanisms of auto-immune responses and aid in the diagnosis and management of related disorders.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021034</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW144#015" guid="08477f8a31034befa55f28a8721780e7">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Gliadin antibody</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of antibody that targets gliadin, a protein found in gluten. It is utilized primarily in the diagnosis and management of conditions related to gluten sensitivity and celiac disease, which are characterized by an inappropriate immune response to gluten. Testing for this antibody serves as an important tool in the assessment of individuals suspected of having autoimmune disorders associated with gluten ingestion. The presence of gliadin antibodies can indicate an adverse reaction to gluten and assist healthcare professionals in formulating appropriate management strategies for affected individuals. This classification is distinct from other autoimmune disease-related antibody tests, which may target various other proteins or antigens associated with different autoimmune conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021035</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW145#015" guid="0e6ce712bb434171a4d34b85633c541d">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Goodpasture antibody</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of antibody associated with a range of autoimmune conditions, characterized by its role in the immune system's response to self-antigens. These antibodies play a crucial role in the diagnosis and management of various autoimmune diseases, aiding in the identification of underlying immune dysregulation. Typically, they are detected through specialized immunological assays, allowing healthcare professionals to ascertain the presence of autoimmune activity. This category is distinct from other antibody types and serves as an important biomarker in clinical settings, contributing to the understanding of autoimmune mechanisms and informing treatment strategies. The classification is utilized for accurate categorization in medical diagnostics, ensuring clarity in the identification and study of these antibodies.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021036</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW146#015" guid="c8352feff1c14e1fa4bc0b7ec2fca95f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">LKM1 and related protein antibody</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of biological reagent used primarily in research and diagnostic applications related to auto-immune diseases. It is designed to detect and quantify proteins associated with the immune response, particularly those that may indicate the presence of specific auto-antibodies. These reagents are essential for understanding various pathological conditions and are utilized in laboratory settings to support clinical diagnosis and therapeutic monitoring. The focus is on those reagents that exhibit specificity to unique protein targets, aiding in the identification of immune responses that can lead to or indicate the presence of auto-immune disorders. This classification serves to differentiate these reagents from others used for broader screening or unrelated auto-immune markers, ensuring clarity in their application and relevance to specific diagnostic needs.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021037</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW147#015" guid="90810cb2f7bc4a8aa41f8d2d92556397">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">MPO ANCA (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification pertains to a specific category of diagnostic tools and reagents used in the detection and analysis of auto-immune diseases. Products within this classification are designed to identify particular auto-antibodies that may indicate the presence of autoimmune disorders. They are utilized in laboratory settings for in vitro diagnostics, providing essential information for healthcare providers to aid in the diagnosis and management of various conditions associated with abnormal immune responses. The classification emphasizes the uniqueness of the products, distinguishing them from other related diagnostic categories by their specific target auto-antibodies and their relevance to particular diseases.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021038</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW148#015" guid="cfa4c6f426bb490f9fef9609dbb872bf">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">PR3 ANCA (IVD)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic tools and materials specifically related to the detection and analysis of antibodies associated with auto-immune disorders. It includes assays and reagents designed to identify the presence of particular auto-antibodies that may indicate the existence of various auto-immune conditions. The focus is on products that facilitate the assessment of immune responses, aiding in the diagnosis of diseases characterized by the body’s immune system mistakenly targeting its own tissues. This category is distinct in its emphasis on a specific subset of auto-immune markers, providing essential resources for healthcare professionals in diagnosing and monitoring auto-immune diseases. The products within this classification are vital for ensuring accurate and reliable testing in clinical settings.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021039</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW149#015" guid="7ebd643346564e129a9f1fa704fccabf">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Parietal cell antibody</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses specific antibodies that target parietal cells within the stomach lining, playing a significant role in the immune response associated with certain autoimmune conditions. Detection of these antibodies is crucial for diagnosing and monitoring diseases where the immune system mistakenly attacks the body's own tissues, particularly in relation to gastric functions. The presence of parietal cell antibodies may indicate an underlying autoimmune disorder that affects the gastric mucosa, leading to conditions such as atrophic gastritis or pernicious anemia. This classification is distinct from other antibody screenings and tests related to autoimmune diseases, focusing specifically on the antibodies directed against parietal cells, which produce intrinsic factor vital for vitamin B12 absorption.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021040</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW150#015" guid="a2d4f8db946f414cb338f5b5b6cce75e">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Sp 100 antibody</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of antibody associated with autoimmune responses, particularly in the context of diagnosing or monitoring autoimmune diseases. It refers to antibodies that target specific proteins or structures within the body, contributing to the immune system's aberrant response. These antibodies can be indicative of various autoimmune disorders and play a crucial role in both clinical diagnostics and therapeutic monitoring. The presence of these antibodies may assist healthcare professionals in understanding the underlying pathophysiology of autoimmune conditions and guiding appropriate treatment strategies. This classification is distinct from other antibody types associated with different autoimmune conditions, each having unique diagnostic significance.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021041</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW151#015" guid="91242c0c449a4fbb9d78e66c0a545546">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Sperm antibody</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of antibody that is produced in response to sperm antigens, which may play a role in fertility and reproductive health. The presence of these antibodies can interfere with sperm function and may be associated with certain fertility issues. This category is distinct from other antibody classifications related to auto-immune diseases, which often target various cellular components or systemic functions. The focus here is on antibodies that specifically recognize and bind to sperm proteins, potentially impacting reproductive outcomes. Understanding the implications of sperm antibodies is crucial in the context of reproductive immunology and may guide therapeutic approaches in cases of infertility.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021042</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW152#015" guid="93097620921249fa8fa350bbc1bb6448">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Antibody to glomerular basal membrane</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification refers to a type of antibody that specifically targets components of the glomerular basement membrane, which is a critical structure in the kidney involved in filtration and barrier functions. The presence of such antibodies is associated with certain auto-immune conditions that can lead to kidney damage and dysfunction. This classification distinguishes these antibodies based on their unique role in the pathogenesis of diseases affecting renal function, particularly those related to auto-immunity. Understanding the presence and levels of this antibody is important for diagnosing and managing conditions related to auto-immune responses that impact the kidneys. It plays a significant role in the broader context of auto-immune disorders, aiding in the differentiation of various antibody-mediated conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021043</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW153#015" guid="8cb039b8bd4c4b1087f92a2ef685b379">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Antibody to endomysial autoantigenes</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses a specific type of immunological agent that targets endomysial autoantigens, which are proteins associated with the intestinal tissue. These antibodies play a critical role in the diagnosis and monitoring of certain autoimmune conditions, particularly those affecting the gastrointestinal system. Their presence can indicate an autoimmune response, often associated with conditions that lead to tissue damage and inflammation. This category is distinct from other immunological tests that assess a variety of autoantibodies related to different autoimmune diseases, each with its own unique antigenic targets. The detection of these antibodies can aid clinicians in understanding the underlying autoimmune processes and tailoring appropriate treatment strategies for affected individuals.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021044</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW154#015" guid="f4681215f0804e6f8e90da1c29c8071f">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Antibody to soluble liverantigenes</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific type of antibody that targets soluble liver antigens, playing a crucial role in the immune response related to liver conditions and autoimmune disorders. These antibodies are indicative of certain autoimmune processes and can be essential for diagnosing and monitoring specific liver-related diseases. The presence of this antibody can assist healthcare professionals in understanding the underlying mechanisms of liver dysfunction and guide appropriate therapeutic interventions. This classification encompasses a distinct category within the broader scope of autoimmune disease diagnostics, differentiating it from other antibody tests that assess various autoimmune conditions. The analysis of this antibody is vital for developing targeted treatment strategies and improving patient outcomes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021045</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW155#015" guid="44890240a2df425aaf0dcad6d66b41a0">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Nucleosome antibody</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific type of antibody that targets nucleosomes, which are the fundamental units of chromatin in eukaryotic cells, plays a crucial role in the immune response, particularly in the context of auto-immune diseases. This antibody is involved in the recognition of nucleosomal structures, potentially contributing to the pathogenesis of various conditions characterized by abnormal immune responses. Its detection can be significant for diagnosing and monitoring auto-immune disorders, providing insights into the underlying mechanisms of these diseases and aiding in the development of targeted therapeutic strategies. The presence of nucleosome antibodies may indicate immune dysregulation and is often assessed in conjunction with other auto-antibodies for a comprehensive evaluation of auto-immune conditions.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021046</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW156#015" guid="19e58c7ba5964697b9085cd307746218">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Saccharomyces cerevisiae antibody</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a biological molecule that specifically targets and binds to the Saccharomyces cerevisiae yeast, which is often utilized in various immunological assays and research applications. This type of antibody plays a crucial role in the detection and quantification of the yeast in clinical and laboratory settings, aiding in the understanding of immune responses and potential auto-immune conditions related to yeast exposure. Its specificity enhances diagnostics and therapeutic monitoring, providing valuable insights into the underlying mechanisms of immune system activity. The classification under the broader context of immune-related substances highlights its relevance in the study of auto-immune diseases and related disorders.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021047</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW157#015" guid="2ad8d11c112f49a69d9eb48f23b4c864">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Ribosomal phosphoprotein antibody</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this category encompasses antibodies that specifically target ribosomal phosphoproteins, which are integral components of the cellular machinery responsible for protein synthesis. These antibodies play a significant role in the immune response and are associated with various autoimmune conditions. The presence of ribosomal phosphoprotein antibodies can indicate the body's abnormal immune activity against its own proteins, which may contribute to the development or progression of autoimmune diseases. Testing for these antibodies is vital in the diagnostic process, providing insights into underlying autoimmune disorders and assisting in the management of patient care.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021048</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW158#015" guid="3c562c0d830d4e0f86aab18fc817730c">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Tissue transglutaminase antibody</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">a specific type of immunological marker utilized in the diagnosis and monitoring of certain autoimmune conditions. This antibody targets an enzyme involved in various cellular processes, including the cross-linking of proteins and the regulation of cellular functions. Its presence is indicative of an autoimmune response, particularly in relation to conditions affecting the gastrointestinal tract. Testing for this antibody is crucial for identifying and managing disorders characterized by gluten sensitivity and related pathologies. This immunological marker is part of a broader category of diagnostic tools aimed at detecting autoimmune diseases, which encompass various other antibodies linked to distinct pathophysiological processes.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021049</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW159#015" guid="586fb7bbb3a048fcafca009d7b45e688">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Tissue transglutaminase-, gliadin-antibody combitest</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Translator">this classification encompasses diagnostic tests designed to detect the presence of specific antibodies associated with auto-immune diseases. These tests are utilized to assess immune responses and facilitate the diagnosis of conditions characterized by abnormal immune activity. The focus is on identifying antibodies that target tissue transglutaminase and gliadin, which are relevant in the context of certain auto-immune disorders. This category serves to differentiate these specific antibody tests from others that screen for different auto-immune markers, enabling healthcare professionals to evaluate patient conditions more accurately and tailor treatment strategies accordingly. The tests within this classification are essential tools in the clinical setting for diagnosing and managing auto-immune diseases.</text>
          </definition>
          <source_doc_of_definition xsi:type="ontoml:IDENTIFIED_DOCUMENT_Type">
            <document_identifier>
              <label language_code="en" country_code="US">machine generated by GPT-4o mini</label>
            </document_identifier>
          </source_doc_of_definition>
          <its_superclass class_ref="0173-1#01-ADU118#006"/>
          <hierarchical_position>42021050</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADW293#015" guid="7b01c4e55f894d78b36a32d92f3e99e9">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Immunochemistry (immunology, other, unspecified)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Sub-group (4th level) for objects that cannot be classified into other specified sub-groups in the existing structure, but that are classified to their parent-class on the 3rd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADU125#008"/>
          <hierarchical_position>42029090</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-ADU153#007" guid="22e2858ea5564850858db40efadfa1f8">
          <date_of_original_definition>2011-02-11Z</date_of_original_definition>
          <date_of_current_version>2025-10-24Z</date_of_current_version>
          <date_of_current_revision>2025-10-24Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">Infectious immunology (other)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Non-Native">Group (3rd level) for objects that cannot be classified into other specified groups in the existing structure, but that are classified to their parent-class on the 2nd level. A xx-xx-90-00-class cannot have any other sub-groups besides the generic xx-xx-90-90-class (…(Other, unspecified)) to be generally valid within the parent class on the 2nd level</text>
          </definition>
          <its_superclass class_ref="0173-1#01-ADS277#005"/>
          <hierarchical_position>42059000</hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:ITEM_CLASS_CASE_OF_Type" id="0173-1---ASSET_1_1#01-AHY105#002" guid="ce4a2473022541c39a3aacbe4fe5ddcc">
          <date_of_original_definition>2023-10-08Z</date_of_original_definition>
          <date_of_current_version>2024-10-06Z</date_of_current_version>
          <date_of_current_revision>2024-10-06Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US">Asset (empty)</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US">Asset (empty)</text>
          </definition>
          <its_superclass class_ref="0173-1---BASIC_1_1#01-AAA001#001"/>
          <instance_sharable>true</instance_sharable>
          <is_case_of>
            <class class_ref="0173-1#01-ADV816#015"/>
            <class class_ref="0173-1#01-ADV817#015"/>
            <class class_ref="0173-1#01-ADV818#015"/>
            <class class_ref="0173-1#01-ADV819#015"/>
            <class class_ref="0173-1#01-ADV820#015"/>
            <class class_ref="0173-1#01-ADV821#015"/>
            <class class_ref="0173-1#01-ADV822#015"/>
            <class class_ref="0173-1#01-ADV823#015"/>
            <class class_ref="0173-1#01-ADV824#015"/>
            <class class_ref="0173-1#01-ADV825#015"/>
            <class class_ref="0173-1#01-ADV826#015"/>
            <class class_ref="0173-1#01-ADV827#015"/>
            <class class_ref="0173-1#01-ADV828#015"/>
            <class class_ref="0173-1#01-ADV829#015"/>
            <class class_ref="0173-1#01-ADV830#015"/>
            <class class_ref="0173-1#01-ADV831#015"/>
            <class class_ref="0173-1#01-ADV832#015"/>
            <class class_ref="0173-1#01-ADV833#015"/>
            <class class_ref="0173-1#01-ADV834#015"/>
            <class class_ref="0173-1#01-ADV835#015"/>
            <class class_ref="0173-1#01-ADV836#015"/>
            <class class_ref="0173-1#01-ADV837#015"/>
            <class class_ref="0173-1#01-ADV838#015"/>
            <class class_ref="0173-1#01-ADV839#015"/>
            <class class_ref="0173-1#01-ADV840#015"/>
            <class class_ref="0173-1#01-ADV841#015"/>
            <class class_ref="0173-1#01-ADV842#015"/>
            <class class_ref="0173-1#01-ADV843#015"/>
            <class class_ref="0173-1#01-ADV844#015"/>
            <class class_ref="0173-1#01-ADV845#015"/>
            <class class_ref="0173-1#01-ADV846#015"/>
            <class class_ref="0173-1#01-ADV847#015"/>
            <class class_ref="0173-1#01-ADV848#015"/>
            <class class_ref="0173-1#01-ADV849#015"/>
            <class class_ref="0173-1#01-ADV850#015"/>
            <class class_ref="0173-1#01-ADV851#015"/>
            <class class_ref="0173-1#01-ADV852#015"/>
            <class class_ref="0173-1#01-ADV853#015"/>
            <class class_ref="0173-1#01-ADV854#015"/>
            <class class_ref="0173-1#01-ADV855#015"/>
            <class class_ref="0173-1#01-ADV856#015"/>
            <class class_ref="0173-1#01-ADV857#015"/>
            <class class_ref="0173-1#01-ADV858#015"/>
            <class class_ref="0173-1#01-ADV859#015"/>
            <class class_ref="0173-1#01-ADV860#015"/>
            <class class_ref="0173-1#01-ADV870#015"/>
            <class class_ref="0173-1#01-ADV871#015"/>
            <class class_ref="0173-1#01-ADV872#015"/>
            <class class_ref="0173-1#01-ADV873#015"/>
            <class class_ref="0173-1#01-ADV874#015"/>
            <class class_ref="0173-1#01-ADV875#015"/>
            <class class_ref="0173-1#01-ADV876#015"/>
            <class class_ref="0173-1#01-ADV877#015"/>
            <class class_ref="0173-1#01-ADV878#015"/>
            <class class_ref="0173-1#01-ADV879#015"/>
            <class class_ref="0173-1#01-ADV880#015"/>
            <class class_ref="0173-1#01-ADV881#015"/>
            <class class_ref="0173-1#01-ADV882#015"/>
            <class class_ref="0173-1#01-ADV883#015"/>
            <class class_ref="0173-1#01-ADV884#015"/>
            <class class_ref="0173-1#01-ADV885#015"/>
            <class class_ref="0173-1#01-ADV886#015"/>
            <class class_ref="0173-1#01-ADV887#015"/>
            <class class_ref="0173-1#01-ADV888#015"/>
            <class class_ref="0173-1#01-ADV889#015"/>
            <class class_ref="0173-1#01-ADV890#015"/>
            <class class_ref="0173-1#01-ADV891#015"/>
            <class class_ref="0173-1#01-ADV892#015"/>
            <class class_ref="0173-1#01-ADV893#015"/>
            <class class_ref="0173-1#01-ADV894#015"/>
            <class class_ref="0173-1#01-ADV895#015"/>
            <class class_ref="0173-1#01-ADV896#015"/>
            <class class_ref="0173-1#01-ADV897#015"/>
            <class class_ref="0173-1#01-ADV898#015"/>
            <class class_ref="0173-1#01-ADV899#015"/>
            <class class_ref="0173-1#01-ADV900#015"/>
            <class class_ref="0173-1#01-ADV901#015"/>
            <class class_ref="0173-1#01-ADV902#015"/>
            <class class_ref="0173-1#01-ADV903#015"/>
            <class class_ref="0173-1#01-ADV904#015"/>
            <class class_ref="0173-1#01-ADV905#015"/>
            <class class_ref="0173-1#01-ADV906#015"/>
            <class class_ref="0173-1#01-ADV907#015"/>
            <class class_ref="0173-1#01-ADV908#015"/>
            <class class_ref="0173-1#01-ADV909#015"/>
            <class class_ref="0173-1#01-ADV910#015"/>
            <class class_ref="0173-1#01-ADW034#015"/>
            <class class_ref="0173-1#01-ADW035#015"/>
            <class class_ref="0173-1#01-ADW036#015"/>
            <class class_ref="0173-1#01-ADW037#015"/>
            <class class_ref="0173-1#01-ADW038#015"/>
            <class class_ref="0173-1#01-ADW039#015"/>
            <class class_ref="0173-1#01-ADW040#015"/>
            <class class_ref="0173-1#01-ADW041#015"/>
            <class class_ref="0173-1#01-ADW042#015"/>
            <class class_ref="0173-1#01-ADW043#015"/>
            <class class_ref="0173-1#01-ADW044#015"/>
            <class class_ref="0173-1#01-ADW045#015"/>
            <class class_ref="0173-1#01-ADW046#015"/>
            <class class_ref="0173-1#01-ADW047#015"/>
            <class class_ref="0173-1#01-ADW048#015"/>
            <class class_ref="0173-1#01-ADW049#015"/>
            <class class_ref="0173-1#01-ADW050#015"/>
            <class class_ref="0173-1#01-ADW051#015"/>
            <class class_ref="0173-1#01-ADW052#015"/>
            <class class_ref="0173-1#01-ADW053#015"/>
            <class class_ref="0173-1#01-ADW054#015"/>
            <class class_ref="0173-1#01-ADW055#015"/>
            <class class_ref="0173-1#01-ADW056#015"/>
            <class class_ref="0173-1#01-ADW057#015"/>
            <class class_ref="0173-1#01-ADW058#015"/>
            <class class_ref="0173-1#01-ADW059#015"/>
            <class class_ref="0173-1#01-ADW060#015"/>
            <class class_ref="0173-1#01-ADW061#015"/>
            <class class_ref="0173-1#01-ADW062#015"/>
            <class class_ref="0173-1#01-ADW063#015"/>
            <class class_ref="0173-1#01-ADW064#015"/>
            <class class_ref="0173-1#01-ADW065#015"/>
            <class class_ref="0173-1#01-ADW066#015"/>
            <class class_ref="0173-1#01-ADW067#015"/>
            <class class_ref="0173-1#01-ADW068#015"/>
            <class class_ref="0173-1#01-ADW069#015"/>
            <class class_ref="0173-1#01-ADW070#015"/>
            <class class_ref="0173-1#01-ADW071#015"/>
            <class class_ref="0173-1#01-ADW072#015"/>
            <class class_ref="0173-1#01-ADW073#015"/>
            <class class_ref="0173-1#01-ADW074#015"/>
            <class class_ref="0173-1#01-ADW075#015"/>
            <class class_ref="0173-1#01-ADW076#015"/>
            <class class_ref="0173-1#01-ADW077#015"/>
            <class class_ref="0173-1#01-ADW078#015"/>
            <class class_ref="0173-1#01-ADW079#015"/>
            <class class_ref="0173-1#01-ADW080#015"/>
            <class class_ref="0173-1#01-ADW081#015"/>
            <class class_ref="0173-1#01-ADW082#015"/>
            <class class_ref="0173-1#01-ADW083#015"/>
            <class class_ref="0173-1#01-ADW084#015"/>
            <class class_ref="0173-1#01-ADW085#015"/>
            <class class_ref="0173-1#01-ADW086#015"/>
            <class class_ref="0173-1#01-ADW087#015"/>
            <class class_ref="0173-1#01-ADW088#015"/>
            <class class_ref="0173-1#01-ADW089#015"/>
            <class class_ref="0173-1#01-ADW090#015"/>
            <class class_ref="0173-1#01-ADW091#015"/>
            <class class_ref="0173-1#01-ADW092#015"/>
            <class class_ref="0173-1#01-ADW093#015"/>
            <class class_ref="0173-1#01-ADW094#015"/>
            <class class_ref="0173-1#01-ADW095#015"/>
            <class class_ref="0173-1#01-ADW096#015"/>
            <class class_ref="0173-1#01-ADW097#015"/>
            <class class_ref="0173-1#01-ADW098#015"/>
            <class class_ref="0173-1#01-ADW099#015"/>
            <class class_ref="0173-1#01-ADW100#015"/>
            <class class_ref="0173-1#01-ADW101#015"/>
            <class class_ref="0173-1#01-ADW102#015"/>
            <class class_ref="0173-1#01-ADW103#015"/>
            <class class_ref="0173-1#01-ADW104#015"/>
            <class class_ref="0173-1#01-ADW105#015"/>
            <class class_ref="0173-1#01-ADW106#015"/>
            <class class_ref="0173-1#01-ADW107#015"/>
            <class class_ref="0173-1#01-ADW108#015"/>
            <class class_ref="0173-1#01-ADW109#015"/>
            <class class_ref="0173-1#01-ADV676#015"/>
            <class class_ref="0173-1#01-ADV677#015"/>
            <class class_ref="0173-1#01-ADV678#015"/>
            <class class_ref="0173-1#01-ADV679#015"/>
            <class class_ref="0173-1#01-ADV680#015"/>
            <class class_ref="0173-1#01-ADV681#015"/>
            <class class_ref="0173-1#01-ADV682#015"/>
            <class class_ref="0173-1#01-ADV683#015"/>
            <class class_ref="0173-1#01-ADV684#015"/>
            <class class_ref="0173-1#01-ADV685#015"/>
            <class class_ref="0173-1#01-ADV686#015"/>
            <class class_ref="0173-1#01-ADV687#015"/>
            <class class_ref="0173-1#01-ADV688#015"/>
            <class class_ref="0173-1#01-ADV689#015"/>
            <class class_ref="0173-1#01-ADV690#015"/>
            <class class_ref="0173-1#01-ADV691#015"/>
            <class class_ref="0173-1#01-ADV692#015"/>
            <class class_ref="0173-1#01-ADV693#015"/>
            <class class_ref="0173-1#01-ADV694#015"/>
            <class class_ref="0173-1#01-ADV695#015"/>
            <class class_ref="0173-1#01-ADV696#015"/>
            <class class_ref="0173-1#01-ADV697#015"/>
            <class class_ref="0173-1#01-ADV698#015"/>
            <class class_ref="0173-1#01-ADV699#015"/>
            <class class_ref="0173-1#01-ADV700#015"/>
            <class class_ref="0173-1#01-ADV701#015"/>
            <class class_ref="0173-1#01-ADV702#015"/>
            <class class_ref="0173-1#01-ADV703#015"/>
            <class class_ref="0173-1#01-ADV704#015"/>
            <class class_ref="0173-1#01-ADV705#015"/>
            <class class_ref="0173-1#01-ADV706#015"/>
            <class class_ref="0173-1#01-ADV707#015"/>
            <class class_ref="0173-1#01-ADV708#015"/>
            <class class_ref="0173-1#01-ADV709#015"/>
            <class class_ref="0173-1#01-ADV710#015"/>
            <class class_ref="0173-1#01-ADV711#015"/>
            <class class_ref="0173-1#01-ADV712#015"/>
            <class class_ref="0173-1#01-ADW473#015"/>
            <class class_ref="0173-1#01-ADW710#015"/>
            <class class_ref="0173-1#01-ADW711#015"/>
            <class class_ref="0173-1#01-ADW712#015"/>
            <class class_ref="0173-1#01-ADW713#015"/>
            <class class_ref="0173-1#01-ADW714#015"/>
            <class class_ref="0173-1#01-ADW715#015"/>
            <class class_ref="0173-1#01-ADW716#015"/>
            <class class_ref="0173-1#01-ADW717#015"/>
            <class class_ref="0173-1#01-ADW718#015"/>
            <class class_ref="0173-1#01-ADW719#015"/>
            <class class_ref="0173-1#01-ADW720#015"/>
            <class class_ref="0173-1#01-ADW721#015"/>
            <class class_ref="0173-1#01-ADW722#015"/>
            <class class_ref="0173-1#01-ADW723#015"/>
            <class class_ref="0173-1#01-ADW724#015"/>
            <class class_ref="0173-1#01-ADW725#015"/>
            <class class_ref="0173-1#01-ADW726#015"/>
            <class class_ref="0173-1#01-ADW727#015"/>
            <class class_ref="0173-1#01-ADW728#015"/>
            <class class_ref="0173-1#01-ADW729#015"/>
            <class class_ref="0173-1#01-ADW730#015"/>
            <class class_ref="0173-1#01-ADW731#015"/>
            <class class_ref="0173-1#01-ADW732#015"/>
            <class class_ref="0173-1#01-ADW733#015"/>
            <class class_ref="0173-1#01-ADW734#015"/>
            <class class_ref="0173-1#01-ADW735#015"/>
            <class class_ref="0173-1#01-ADW736#015"/>
            <class class_ref="0173-1#01-ADW737#015"/>
            <class class_ref="0173-1#01-ADW738#015"/>
            <class class_ref="0173-1#01-ADW739#015"/>
            <class class_ref="0173-1#01-ADW740#015"/>
            <class class_ref="0173-1#01-ADW741#015"/>
            <class class_ref="0173-1#01-ADW211#015"/>
            <class class_ref="0173-1#01-ADW212#015"/>
            <class class_ref="0173-1#01-ADW213#015"/>
            <class class_ref="0173-1#01-ADW214#015"/>
            <class class_ref="0173-1#01-ADW215#015"/>
            <class class_ref="0173-1#01-ADW216#015"/>
            <class class_ref="0173-1#01-ADW217#015"/>
            <class class_ref="0173-1#01-ADW218#015"/>
            <class class_ref="0173-1#01-ADW219#015"/>
            <class class_ref="0173-1#01-ADW220#015"/>
            <class class_ref="0173-1#01-ADW221#015"/>
            <class class_ref="0173-1#01-ADW222#015"/>
            <class class_ref="0173-1#01-ADW223#015"/>
            <class class_ref="0173-1#01-ADW224#015"/>
            <class class_ref="0173-1#01-ADW225#015"/>
            <class class_ref="0173-1#01-ADW226#015"/>
            <class class_ref="0173-1#01-ADW227#015"/>
            <class class_ref="0173-1#01-ADW228#015"/>
            <class class_ref="0173-1#01-ADW229#015"/>
            <class class_ref="0173-1#01-ADW230#015"/>
            <class class_ref="0173-1#01-ADW231#015"/>
            <class class_ref="0173-1#01-ADW232#015"/>
            <class class_ref="0173-1#01-ADW233#015"/>
            <class class_ref="0173-1#01-ADW234#015"/>
            <class class_ref="0173-1#01-ADW235#015"/>
            <class class_ref="0173-1#01-ADW236#015"/>
            <class class_ref="0173-1#01-ADW237#015"/>
            <class class_ref="0173-1#01-ADW238#015"/>
            <class class_ref="0173-1#01-ADW239#015"/>
            <class class_ref="0173-1#01-ADV646#015"/>
            <class class_ref="0173-1#01-ADV647#015"/>
            <class class_ref="0173-1#01-ADV648#015"/>
            <class class_ref="0173-1#01-ADV649#015"/>
            <class class_ref="0173-1#01-ADV650#015"/>
            <class class_ref="0173-1#01-ADV651#015"/>
            <class class_ref="0173-1#01-ADV652#015"/>
            <class class_ref="0173-1#01-ADV653#015"/>
            <class class_ref="0173-1#01-ADV654#015"/>
            <class class_ref="0173-1#01-ADV655#015"/>
            <class class_ref="0173-1#01-ADV656#015"/>
            <class class_ref="0173-1#01-ADV657#015"/>
            <class class_ref="0173-1#01-ADV658#015"/>
            <class class_ref="0173-1#01-ADV659#015"/>
            <class class_ref="0173-1#01-ADV660#015"/>
            <class class_ref="0173-1#01-ADV661#015"/>
            <class class_ref="0173-1#01-ADV662#015"/>
            <class class_ref="0173-1#01-ADV663#015"/>
            <class class_ref="0173-1#01-ADV664#015"/>
            <class class_ref="0173-1#01-ADV665#015"/>
            <class class_ref="0173-1#01-ADV666#015"/>
            <class class_ref="0173-1#01-ADV667#015"/>
            <class class_ref="0173-1#01-ADV668#015"/>
            <class class_ref="0173-1#01-ADV669#015"/>
            <class class_ref="0173-1#01-ADV670#015"/>
            <class class_ref="0173-1#01-ADV671#015"/>
            <class class_ref="0173-1#01-ADV672#015"/>
            <class class_ref="0173-1#01-ADV673#015"/>
            <class class_ref="0173-1#01-ADV674#015"/>
            <class class_ref="0173-1#01-ADV675#015"/>
            <class class_ref="0173-1#01-ADW907#015"/>
            <class class_ref="0173-1#01-ADW908#015"/>
            <class class_ref="0173-1#01-ADW909#015"/>
            <class class_ref="0173-1#01-ADW910#015"/>
            <class class_ref="0173-1#01-ADW911#015"/>
            <class class_ref="0173-1#01-ADW912#015"/>
            <class class_ref="0173-1#01-ADW913#015"/>
            <class class_ref="0173-1#01-ADW914#015"/>
            <class class_ref="0173-1#01-ADW915#015"/>
            <class class_ref="0173-1#01-ADW916#015"/>
            <class class_ref="0173-1#01-ADW917#015"/>
            <class class_ref="0173-1#01-ADW918#015"/>
            <class class_ref="0173-1#01-ADW919#015"/>
            <class class_ref="0173-1#01-ADW920#015"/>
            <class class_ref="0173-1#01-ADW921#015"/>
            <class class_ref="0173-1#01-ADW922#015"/>
            <class class_ref="0173-1#01-ADW923#015"/>
            <class class_ref="0173-1#01-ADW924#015"/>
            <class class_ref="0173-1#01-ADW925#015"/>
            <class class_ref="0173-1#01-ADW926#015"/>
            <class class_ref="0173-1#01-ADW927#015"/>
            <class class_ref="0173-1#01-ADW928#015"/>
            <class class_ref="0173-1#01-ADW929#015"/>
            <class class_ref="0173-1#01-ADW930#015"/>
            <class class_ref="0173-1#01-ADW931#015"/>
            <class class_ref="0173-1#01-ADW932#015"/>
            <class class_ref="0173-1#01-ADW933#015"/>
            <class class_ref="0173-1#01-ADW934#015"/>
            <class class_ref="0173-1#01-ADV766#015"/>
            <class class_ref="0173-1#01-ADV767#015"/>
            <class class_ref="0173-1#01-ADV768#015"/>
            <class class_ref="0173-1#01-ADV769#015"/>
            <class class_ref="0173-1#01-ADV770#015"/>
            <class class_ref="0173-1#01-ADV771#015"/>
            <class class_ref="0173-1#01-ADV772#015"/>
            <class class_ref="0173-1#01-ADV773#015"/>
            <class class_ref="0173-1#01-ADV774#015"/>
            <class class_ref="0173-1#01-ADV775#015"/>
            <class class_ref="0173-1#01-ADV776#015"/>
            <class class_ref="0173-1#01-ADV777#015"/>
            <class class_ref="0173-1#01-ADV778#015"/>
            <class class_ref="0173-1#01-ADV779#015"/>
            <class class_ref="0173-1#01-ADV780#015"/>
            <class class_ref="0173-1#01-ADV781#015"/>
            <class class_ref="0173-1#01-ADV782#015"/>
            <class class_ref="0173-1#01-ADV783#015"/>
            <class class_ref="0173-1#01-ADV784#015"/>
            <class class_ref="0173-1#01-ADV785#015"/>
            <class class_ref="0173-1#01-ADV786#015"/>
            <class class_ref="0173-1#01-ADV787#015"/>
            <class class_ref="0173-1#01-ADV788#015"/>
            <class class_ref="0173-1#01-ADV789#015"/>
            <class class_ref="0173-1#01-ADV790#015"/>
            <class class_ref="0173-1#01-ADV791#015"/>
            <class class_ref="0173-1#01-ADV792#015"/>
            <class class_ref="0173-1#01-ADV793#015"/>
            <class class_ref="0173-1#01-ADV923#015"/>
            <class class_ref="0173-1#01-ADV924#015"/>
            <class class_ref="0173-1#01-ADV925#015"/>
            <class class_ref="0173-1#01-ADV926#015"/>
            <class class_ref="0173-1#01-ADV927#015"/>
            <class class_ref="0173-1#01-ADV928#015"/>
            <class class_ref="0173-1#01-ADV929#015"/>
            <class class_ref="0173-1#01-ADV930#015"/>
            <class class_ref="0173-1#01-ADV931#015"/>
            <class class_ref="0173-1#01-ADV932#015"/>
            <class class_ref="0173-1#01-ADV933#015"/>
            <class class_ref="0173-1#01-ADV934#015"/>
            <class class_ref="0173-1#01-ADV936#015"/>
            <class class_ref="0173-1#01-ADV937#015"/>
            <class class_ref="0173-1#01-ADV938#015"/>
            <class class_ref="0173-1#01-ADV939#015"/>
            <class class_ref="0173-1#01-ADV940#015"/>
            <class class_ref="0173-1#01-ADV941#015"/>
            <class class_ref="0173-1#01-ADV942#015"/>
            <class class_ref="0173-1#01-ADV943#015"/>
            <class class_ref="0173-1#01-ADV944#015"/>
            <class class_ref="0173-1#01-ADV945#015"/>
            <class class_ref="0173-1#01-ADV946#015"/>
            <class class_ref="0173-1#01-ADV947#015"/>
            <class class_ref="0173-1#01-ADV948#015"/>
            <class class_ref="0173-1#01-ADV949#015"/>
            <class class_ref="0173-1#01-ADV950#015"/>
            <class class_ref="0173-1#01-AFU809#011"/>
            <class class_ref="0173-1#01-ADX041#015"/>
            <class class_ref="0173-1#01-ADX042#015"/>
            <class class_ref="0173-1#01-ADX043#015"/>
            <class class_ref="0173-1#01-ADX044#015"/>
            <class class_ref="0173-1#01-ADX045#015"/>
            <class class_ref="0173-1#01-ADX046#015"/>
            <class class_ref="0173-1#01-AFU678#011"/>
            <class class_ref="0173-1#01-AFU860#011"/>
            <class class_ref="0173-1#01-ADX047#015"/>
            <class class_ref="0173-1#01-ADX048#015"/>
            <class class_ref="0173-1#01-ADX049#015"/>
            <class class_ref="0173-1#01-AFU679#011"/>
            <class class_ref="0173-1#01-AFU861#011"/>
            <class class_ref="0173-1#01-ADX050#015"/>
            <class class_ref="0173-1#01-ADX051#015"/>
            <class class_ref="0173-1#01-AFU680#011"/>
            <class class_ref="0173-1#01-AFU862#011"/>
            <class class_ref="0173-1#01-ADX052#015"/>
            <class class_ref="0173-1#01-AFU681#011"/>
            <class class_ref="0173-1#01-AFU863#011"/>
            <class class_ref="0173-1#01-ADX054#015"/>
            <class class_ref="0173-1#01-ADW569#015"/>
            <class class_ref="0173-1#01-ADW496#015"/>
            <class class_ref="0173-1#01-ADW497#015"/>
            <class class_ref="0173-1#01-ADW498#015"/>
            <class class_ref="0173-1#01-ADW499#015"/>
            <class class_ref="0173-1#01-ADW500#015"/>
            <class class_ref="0173-1#01-ADW501#015"/>
            <class class_ref="0173-1#01-ADW502#015"/>
            <class class_ref="0173-1#01-ADW503#015"/>
            <class class_ref="0173-1#01-ADW504#015"/>
            <class class_ref="0173-1#01-ADW505#015"/>
            <class class_ref="0173-1#01-ADW506#015"/>
            <class class_ref="0173-1#01-ADW507#015"/>
            <class class_ref="0173-1#01-ADW508#015"/>
            <class class_ref="0173-1#01-ADW509#015"/>
            <class class_ref="0173-1#01-ADW510#015"/>
            <class class_ref="0173-1#01-ADW511#015"/>
            <class class_ref="0173-1#01-ADW512#015"/>
            <class class_ref="0173-1#01-ADW513#015"/>
            <class class_ref="0173-1#01-ADW514#015"/>
            <class class_ref="0173-1#01-ADW515#015"/>
            <class class_ref="0173-1#01-ADW516#015"/>
            <class class_ref="0173-1#01-ADW517#015"/>
            <class class_ref="0173-1#01-ADW474#015"/>
            <class class_ref="0173-1#01-ADW475#015"/>
            <class class_ref="0173-1#01-ADW476#015"/>
            <class class_ref="0173-1#01-ADW477#015"/>
            <class class_ref="0173-1#01-ADW478#015"/>
            <class class_ref="0173-1#01-ADW479#015"/>
            <class class_ref="0173-1#01-ADW480#015"/>
            <class class_ref="0173-1#01-ADW481#015"/>
            <class class_ref="0173-1#01-ADW482#015"/>
            <class class_ref="0173-1#01-ADW483#015"/>
            <class class_ref="0173-1#01-ADW484#015"/>
            <class class_ref="0173-1#01-ADW485#015"/>
            <class class_ref="0173-1#01-ADW486#015"/>
            <class class_ref="0173-1#01-ADW487#015"/>
            <class class_ref="0173-1#01-ADW488#015"/>
            <class class_ref="0173-1#01-ADW489#015"/>
            <class class_ref="0173-1#01-ADW490#015"/>
            <class class_ref="0173-1#01-ADW491#015"/>
            <class class_ref="0173-1#01-ADW492#015"/>
            <class class_ref="0173-1#01-ADW493#015"/>
            <class class_ref="0173-1#01-ADW494#015"/>
            <class class_ref="0173-1#01-ADW495#015"/>
            <class class_ref="0173-1#01-ADV815#015"/>
            <class class_ref="0173-1#01-ADV723#015"/>
            <class class_ref="0173-1#01-ADV724#015"/>
            <class class_ref="0173-1#01-ADV725#015"/>
            <class class_ref="0173-1#01-ADV726#015"/>
            <class class_ref="0173-1#01-ADV727#015"/>
            <class class_ref="0173-1#01-ADV728#015"/>
            <class class_ref="0173-1#01-ADV729#015"/>
            <class class_ref="0173-1#01-ADV730#015"/>
            <class class_ref="0173-1#01-ADV731#015"/>
            <class class_ref="0173-1#01-ADV732#015"/>
            <class class_ref="0173-1#01-ADV733#015"/>
            <class class_ref="0173-1#01-ADV734#015"/>
            <class class_ref="0173-1#01-ADV735#015"/>
            <class class_ref="0173-1#01-ADV736#015"/>
            <class class_ref="0173-1#01-ADV737#015"/>
            <class class_ref="0173-1#01-ADV738#015"/>
            <class class_ref="0173-1#01-ADV739#015"/>
            <class class_ref="0173-1#01-ADV740#015"/>
            <class class_ref="0173-1#01-ADV741#015"/>
            <class class_ref="0173-1#01-AFU664#011"/>
            <class class_ref="0173-1#01-AFU802#011"/>
            <class class_ref="0173-1#01-ADW827#015"/>
            <class class_ref="0173-1#01-ADW828#015"/>
            <class class_ref="0173-1#01-ADW829#015"/>
            <class class_ref="0173-1#01-ADW830#015"/>
            <class class_ref="0173-1#01-ADW831#015"/>
            <class class_ref="0173-1#01-ADW832#015"/>
            <class class_ref="0173-1#01-ADW833#015"/>
            <class class_ref="0173-1#01-ADW834#015"/>
            <class class_ref="0173-1#01-ADW835#015"/>
            <class class_ref="0173-1#01-ADW836#015"/>
            <class class_ref="0173-1#01-ADW837#015"/>
            <class class_ref="0173-1#01-ADW838#015"/>
            <class class_ref="0173-1#01-ADW839#015"/>
            <class class_ref="0173-1#01-ADW840#015"/>
            <class class_ref="0173-1#01-ADW841#015"/>
            <class class_ref="0173-1#01-ADW842#015"/>
            <class class_ref="0173-1#01-ADW843#015"/>
            <class class_ref="0173-1#01-ADW844#015"/>
            <class class_ref="0173-1#01-ADW845#015"/>
            <class class_ref="0173-1#01-AFU670#011"/>
            <class class_ref="0173-1#01-ADW193#015"/>
            <class class_ref="0173-1#01-ADW194#015"/>
            <class class_ref="0173-1#01-ADW195#015"/>
            <class class_ref="0173-1#01-ADW196#015"/>
            <class class_ref="0173-1#01-ADW197#015"/>
            <class class_ref="0173-1#01-ADW198#015"/>
            <class class_ref="0173-1#01-ADW199#015"/>
            <class class_ref="0173-1#01-ADW200#015"/>
            <class class_ref="0173-1#01-ADW201#015"/>
            <class class_ref="0173-1#01-ADW202#015"/>
            <class class_ref="0173-1#01-ADW203#015"/>
            <class class_ref="0173-1#01-ADW204#015"/>
            <class class_ref="0173-1#01-ADW205#015"/>
            <class class_ref="0173-1#01-ADW206#015"/>
            <class class_ref="0173-1#01-ADW207#015"/>
            <class class_ref="0173-1#01-ADW208#015"/>
            <class class_ref="0173-1#01-ADW209#015"/>
            <class class_ref="0173-1#01-ADW210#015"/>
            <class class_ref="0173-1#01-ADW294#015"/>
            <class class_ref="0173-1#01-ADW295#015"/>
            <class class_ref="0173-1#01-ADW296#015"/>
            <class class_ref="0173-1#01-ADW297#015"/>
            <class class_ref="0173-1#01-ADW298#015"/>
            <class class_ref="0173-1#01-ADW299#015"/>
            <class class_ref="0173-1#01-ADW300#015"/>
            <class class_ref="0173-1#01-ADW301#015"/>
            <class class_ref="0173-1#01-ADW302#015"/>
            <class class_ref="0173-1#01-ADW303#015"/>
            <class class_ref="0173-1#01-ADW304#015"/>
            <class class_ref="0173-1#01-ADW305#015"/>
            <class class_ref="0173-1#01-ADW306#015"/>
            <class class_ref="0173-1#01-ADW307#015"/>
            <class class_ref="0173-1#01-ADW308#015"/>
            <class class_ref="0173-1#01-ADW309#015"/>
            <class class_ref="0173-1#01-ADW310#015"/>
            <class class_ref="0173-1#01-ADW311#015"/>
            <class class_ref="0173-1#01-ADW312#015"/>
            <class class_ref="0173-1#01-ADW401#015"/>
            <class class_ref="0173-1#01-ADW402#015"/>
            <class class_ref="0173-1#01-ADW403#015"/>
            <class class_ref="0173-1#01-ADW404#015"/>
            <class class_ref="0173-1#01-ADW405#015"/>
            <class class_ref="0173-1#01-ADW406#015"/>
            <class class_ref="0173-1#01-ADW407#015"/>
            <class class_ref="0173-1#01-ADW408#015"/>
            <class class_ref="0173-1#01-ADW409#015"/>
            <class class_ref="0173-1#01-ADW410#015"/>
            <class class_ref="0173-1#01-ADW411#015"/>
            <class class_ref="0173-1#01-ADW412#015"/>
            <class class_ref="0173-1#01-ADW413#015"/>
            <class class_ref="0173-1#01-ADW414#015"/>
            <class class_ref="0173-1#01-ADW415#015"/>
            <class class_ref="0173-1#01-ADW416#015"/>
            <class class_ref="0173-1#01-ADW417#015"/>
            <class class_ref="0173-1#01-ADW418#015"/>
            <class class_ref="0173-1#01-ADW019#015"/>
            <class class_ref="0173-1#01-ADW020#015"/>
            <class class_ref="0173-1#01-ADW021#015"/>
            <class class_ref="0173-1#01-ADW022#015"/>
            <class class_ref="0173-1#01-ADW023#015"/>
            <class class_ref="0173-1#01-ADW024#015"/>
            <class class_ref="0173-1#01-ADW025#015"/>
            <class class_ref="0173-1#01-ADW026#015"/>
            <class class_ref="0173-1#01-ADW027#015"/>
            <class class_ref="0173-1#01-ADW028#015"/>
            <class class_ref="0173-1#01-ADW029#015"/>
            <class class_ref="0173-1#01-ADW030#015"/>
            <class class_ref="0173-1#01-ADW031#015"/>
            <class class_ref="0173-1#01-ADW032#015"/>
            <class class_ref="0173-1#01-ADW033#015"/>
            <class class_ref="0173-1#01-ADW935#015"/>
            <class class_ref="0173-1#01-ADW936#015"/>
            <class class_ref="0173-1#01-ADW937#015"/>
            <class class_ref="0173-1#01-ADW938#015"/>
            <class class_ref="0173-1#01-ADW939#015"/>
            <class class_ref="0173-1#01-ADW940#015"/>
            <class class_ref="0173-1#01-ADW941#015"/>
            <class class_ref="0173-1#01-ADW942#015"/>
            <class class_ref="0173-1#01-ADW943#015"/>
            <class class_ref="0173-1#01-ADW944#015"/>
            <class class_ref="0173-1#01-ADW945#015"/>
            <class class_ref="0173-1#01-ADW946#015"/>
            <class class_ref="0173-1#01-ADW947#015"/>
            <class class_ref="0173-1#01-ADW948#015"/>
            <class class_ref="0173-1#01-ADW949#015"/>
            <class class_ref="0173-1#01-ADW799#015"/>
            <class class_ref="0173-1#01-ADW800#015"/>
            <class class_ref="0173-1#01-ADW801#015"/>
            <class class_ref="0173-1#01-ADW802#015"/>
            <class class_ref="0173-1#01-ADW803#015"/>
            <class class_ref="0173-1#01-ADW804#015"/>
            <class class_ref="0173-1#01-ADW805#015"/>
            <class class_ref="0173-1#01-ADW806#015"/>
            <class class_ref="0173-1#01-ADW807#015"/>
            <class class_ref="0173-1#01-ADW808#015"/>
            <class class_ref="0173-1#01-ADW809#015"/>
            <class class_ref="0173-1#01-ADW810#015"/>
            <class class_ref="0173-1#01-ADW811#015"/>
            <class class_ref="0173-1#01-ADW812#015"/>
            <class class_ref="0173-1#01-ADV752#015"/>
            <class class_ref="0173-1#01-ADV753#015"/>
            <class class_ref="0173-1#01-ADV754#015"/>
            <class class_ref="0173-1#01-ADV755#015"/>
            <class class_ref="0173-1#01-ADV756#015"/>
            <class class_ref="0173-1#01-ADV757#015"/>
            <class class_ref="0173-1#01-ADV758#015"/>
            <class class_ref="0173-1#01-ADV759#015"/>
            <class class_ref="0173-1#01-ADV760#015"/>
            <class class_ref="0173-1#01-ADV761#015"/>
            <class class_ref="0173-1#01-ADV763#015"/>
            <class class_ref="0173-1#01-ADV764#015"/>
            <class class_ref="0173-1#01-ADV765#015"/>
            <class class_ref="0173-1#01-AFU804#011"/>
            <class class_ref="0173-1#01-ADW380#015"/>
            <class class_ref="0173-1#01-ADW381#015"/>
            <class class_ref="0173-1#01-ADW382#015"/>
            <class class_ref="0173-1#01-ADW383#015"/>
            <class class_ref="0173-1#01-ADW384#015"/>
            <class class_ref="0173-1#01-ADW385#015"/>
            <class class_ref="0173-1#01-ADW386#015"/>
            <class class_ref="0173-1#01-ADW387#015"/>
            <class class_ref="0173-1#01-ADW388#015"/>
            <class class_ref="0173-1#01-ADW389#015"/>
            <class class_ref="0173-1#01-ADW390#015"/>
            <class class_ref="0173-1#01-ADW391#015"/>
            <class class_ref="0173-1#01-ADW392#015"/>
            <class class_ref="0173-1#01-ADW393#015"/>
            <class class_ref="0173-1#01-ADW163#015"/>
            <class class_ref="0173-1#01-ADW164#015"/>
            <class class_ref="0173-1#01-ADW165#015"/>
            <class class_ref="0173-1#01-ADW166#015"/>
            <class class_ref="0173-1#01-ADW167#015"/>
            <class class_ref="0173-1#01-ADW168#015"/>
            <class class_ref="0173-1#01-ADW169#015"/>
            <class class_ref="0173-1#01-ADW170#015"/>
            <class class_ref="0173-1#01-ADW171#015"/>
            <class class_ref="0173-1#01-ADW172#015"/>
            <class class_ref="0173-1#01-ADW173#015"/>
            <class class_ref="0173-1#01-ADW174#015"/>
            <class class_ref="0173-1#01-ADW175#015"/>
            <class class_ref="0173-1#01-ADW179#015"/>
            <class class_ref="0173-1#01-ADW180#015"/>
            <class class_ref="0173-1#01-ADW181#015"/>
            <class class_ref="0173-1#01-ADW182#015"/>
            <class class_ref="0173-1#01-ADW183#015"/>
            <class class_ref="0173-1#01-ADW184#015"/>
            <class class_ref="0173-1#01-ADW185#015"/>
            <class class_ref="0173-1#01-ADW186#015"/>
            <class class_ref="0173-1#01-ADW187#015"/>
            <class class_ref="0173-1#01-ADW188#015"/>
            <class class_ref="0173-1#01-ADW189#015"/>
            <class class_ref="0173-1#01-ADW190#015"/>
            <class class_ref="0173-1#01-ADW191#015"/>
            <class class_ref="0173-1#01-ADW518#015"/>
            <class class_ref="0173-1#01-ADW519#015"/>
            <class class_ref="0173-1#01-ADW520#015"/>
            <class class_ref="0173-1#01-ADW521#015"/>
            <class class_ref="0173-1#01-ADW522#015"/>
            <class class_ref="0173-1#01-ADW523#015"/>
            <class class_ref="0173-1#01-ADW524#015"/>
            <class class_ref="0173-1#01-ADW525#015"/>
            <class class_ref="0173-1#01-ADW526#015"/>
            <class class_ref="0173-1#01-ADW527#015"/>
            <class class_ref="0173-1#01-ADW528#015"/>
            <class class_ref="0173-1#01-ADW529#015"/>
            <class class_ref="0173-1#01-ADW530#015"/>
            <class class_ref="0173-1#01-ADW428#015"/>
            <class class_ref="0173-1#01-ADW429#015"/>
            <class class_ref="0173-1#01-ADW430#015"/>
            <class class_ref="0173-1#01-ADW431#015"/>
            <class class_ref="0173-1#01-ADW432#015"/>
            <class class_ref="0173-1#01-ADW433#015"/>
            <class class_ref="0173-1#01-ADW434#015"/>
            <class class_ref="0173-1#01-ADW435#015"/>
            <class class_ref="0173-1#01-ADW436#015"/>
            <class class_ref="0173-1#01-ADW437#015"/>
            <class class_ref="0173-1#01-ADW438#015"/>
            <class class_ref="0173-1#01-ADW439#015"/>
            <class class_ref="0173-1#01-ADV911#015"/>
            <class class_ref="0173-1#01-ADV912#015"/>
            <class class_ref="0173-1#01-ADV913#015"/>
            <class class_ref="0173-1#01-ADV914#015"/>
            <class class_ref="0173-1#01-ADV915#015"/>
            <class class_ref="0173-1#01-ADV916#015"/>
            <class class_ref="0173-1#01-ADV917#015"/>
            <class class_ref="0173-1#01-ADV918#015"/>
            <class class_ref="0173-1#01-ADV919#015"/>
            <class class_ref="0173-1#01-ADV920#015"/>
            <class class_ref="0173-1#01-ADV921#015"/>
            <class class_ref="0173-1#01-ADV922#015"/>
            <class class_ref="0173-1#01-ADV713#015"/>
            <class class_ref="0173-1#01-ADV714#015"/>
            <class class_ref="0173-1#01-ADV715#015"/>
            <class class_ref="0173-1#01-ADV716#015"/>
            <class class_ref="0173-1#01-ADV717#015"/>
            <class class_ref="0173-1#01-ADV718#015"/>
            <class class_ref="0173-1#01-ADV719#015"/>
            <class class_ref="0173-1#01-ADV720#015"/>
            <class class_ref="0173-1#01-ADV721#015"/>
            <class class_ref="0173-1#01-ADV722#015"/>
            <class class_ref="0173-1#01-ADW967#015"/>
            <class class_ref="0173-1#01-ADW968#015"/>
            <class class_ref="0173-1#01-ADW969#015"/>
            <class class_ref="0173-1#01-ADW970#015"/>
            <class class_ref="0173-1#01-ADW971#015"/>
            <class class_ref="0173-1#01-ADW972#015"/>
            <class class_ref="0173-1#01-ADW973#015"/>
            <class class_ref="0173-1#01-ADW974#015"/>
            <class class_ref="0173-1#01-ADW975#015"/>
            <class class_ref="0173-1#01-AFU672#011"/>
            <class class_ref="0173-1#01-AFU854#011"/>
            <class class_ref="0173-1#01-ADW958#015"/>
            <class class_ref="0173-1#01-ADW959#015"/>
            <class class_ref="0173-1#01-ADW960#015"/>
            <class class_ref="0173-1#01-ADW961#015"/>
            <class class_ref="0173-1#01-ADW962#015"/>
            <class class_ref="0173-1#01-ADW963#015"/>
            <class class_ref="0173-1#01-ADW964#015"/>
            <class class_ref="0173-1#01-ADW965#015"/>
            <class class_ref="0173-1#01-ADW966#015"/>
            <class class_ref="0173-1#01-AFU671#011"/>
            <class class_ref="0173-1#01-AFU853#011"/>
            <class class_ref="0173-1#01-ADV742#015"/>
            <class class_ref="0173-1#01-ADV743#015"/>
            <class class_ref="0173-1#01-ADV744#015"/>
            <class class_ref="0173-1#01-ADV745#015"/>
            <class class_ref="0173-1#01-ADV746#015"/>
            <class class_ref="0173-1#01-ADV747#015"/>
            <class class_ref="0173-1#01-ADV748#015"/>
            <class class_ref="0173-1#01-ADV749#015"/>
            <class class_ref="0173-1#01-ADV750#015"/>
            <class class_ref="0173-1#01-ADV751#015"/>
            <class class_ref="0173-1#01-AFU803#011"/>
            <class class_ref="0173-1#01-ADV861#015"/>
            <class class_ref="0173-1#01-ADV862#015"/>
            <class class_ref="0173-1#01-ADV863#015"/>
            <class class_ref="0173-1#01-ADV864#015"/>
            <class class_ref="0173-1#01-ADV865#015"/>
            <class class_ref="0173-1#01-ADV866#015"/>
            <class class_ref="0173-1#01-ADV867#015"/>
            <class class_ref="0173-1#01-ADV868#015"/>
            <class class_ref="0173-1#01-ADV869#015"/>
            <class class_ref="0173-1#01-ADW419#015"/>
            <class class_ref="0173-1#01-ADW420#015"/>
            <class class_ref="0173-1#01-ADW421#015"/>
            <class class_ref="0173-1#01-ADW422#015"/>
            <class class_ref="0173-1#01-ADW423#015"/>
            <class class_ref="0173-1#01-ADW424#015"/>
            <class class_ref="0173-1#01-ADW425#015"/>
            <class class_ref="0173-1#01-ADW426#015"/>
            <class class_ref="0173-1#01-ADW427#015"/>
            <class class_ref="0173-1#01-ADW820#015"/>
            <class class_ref="0173-1#01-ADW821#015"/>
            <class class_ref="0173-1#01-ADW822#015"/>
            <class class_ref="0173-1#01-ADW823#015"/>
            <class class_ref="0173-1#01-ADW824#015"/>
            <class class_ref="0173-1#01-ADW825#015"/>
            <class class_ref="0173-1#01-ADW826#015"/>
            <class class_ref="0173-1#01-ADW394#015"/>
            <class class_ref="0173-1#01-ADW395#015"/>
            <class class_ref="0173-1#01-ADW396#015"/>
            <class class_ref="0173-1#01-ADW397#015"/>
            <class class_ref="0173-1#01-ADW398#015"/>
            <class class_ref="0173-1#01-ADW399#015"/>
            <class class_ref="0173-1#01-ADW400#015"/>
            <class class_ref="0173-1#01-ADX037#015"/>
            <class class_ref="0173-1#01-ADX038#015"/>
            <class class_ref="0173-1#01-ADX039#015"/>
            <class class_ref="0173-1#01-AFU859#011"/>
            <class class_ref="0173-1#01-ADX040#015"/>
            <class class_ref="0173-1#01-ADW535#015"/>
            <class class_ref="0173-1#01-ADW536#015"/>
            <class class_ref="0173-1#01-ADW537#015"/>
            <class class_ref="0173-1#01-ADW538#015"/>
            <class class_ref="0173-1#01-ADW539#015"/>
            <class class_ref="0173-1#01-ADW540#015"/>
            <class class_ref="0173-1#01-ADW976#015"/>
            <class class_ref="0173-1#01-ADW977#015"/>
            <class class_ref="0173-1#01-ADW978#015"/>
            <class class_ref="0173-1#01-ADW979#015"/>
            <class class_ref="0173-1#01-ADW980#015"/>
            <class class_ref="0173-1#01-AFU673#011"/>
            <class class_ref="0173-1#01-AFU855#011"/>
            <class class_ref="0173-1#01-ADW985#015"/>
            <class class_ref="0173-1#01-ADW986#015"/>
            <class class_ref="0173-1#01-ADW987#015"/>
            <class class_ref="0173-1#01-ADW988#015"/>
            <class class_ref="0173-1#01-AFU675#011"/>
            <class class_ref="0173-1#01-AFU857#011"/>
            <class class_ref="0173-1#01-ADW981#015"/>
            <class class_ref="0173-1#01-ADW982#015"/>
            <class class_ref="0173-1#01-ADW983#015"/>
            <class class_ref="0173-1#01-ADW984#015"/>
            <class class_ref="0173-1#01-AFU674#011"/>
            <class class_ref="0173-1#01-AFU856#011"/>
            <class class_ref="0173-1#01-ADW989#015"/>
            <class class_ref="0173-1#01-ADW990#015"/>
            <class class_ref="0173-1#01-ADW991#015"/>
            <class class_ref="0173-1#01-ADW992#015"/>
            <class class_ref="0173-1#01-AFU676#011"/>
            <class class_ref="0173-1#01-AFU858#011"/>
            <class class_ref="0173-1#01-ADW998#015"/>
            <class class_ref="0173-1#01-ADW846#015"/>
            <class class_ref="0173-1#01-ADW847#015"/>
            <class class_ref="0173-1#01-ADW848#015"/>
            <class class_ref="0173-1#01-ADW849#015"/>
            <class class_ref="0173-1#01-ADW850#015"/>
            <class class_ref="0173-1#01-ADW957#015"/>
            <class class_ref="0173-1#01-ADW816#015"/>
            <class class_ref="0173-1#01-ADW817#015"/>
            <class class_ref="0173-1#01-ADW818#015"/>
            <class class_ref="0173-1#01-ADW819#015"/>
            <class class_ref="0173-1#01-ADW531#015"/>
            <class class_ref="0173-1#01-ADW532#015"/>
            <class class_ref="0173-1#01-ADW533#015"/>
            <class class_ref="0173-1#01-ADW534#015"/>
            <class class_ref="0173-1#01-ADW950#015"/>
            <class class_ref="0173-1#01-ADW951#015"/>
            <class class_ref="0173-1#01-ADW952#015"/>
            <class class_ref="0173-1#01-ADW176#015"/>
            <class class_ref="0173-1#01-ADW177#015"/>
            <class class_ref="0173-1#01-ADW178#015"/>
            <class class_ref="0173-1#01-ADW813#015"/>
            <class class_ref="0173-1#01-ADW814#015"/>
            <class class_ref="0173-1#01-ADW815#015"/>
            <class class_ref="0173-1#01-ADW541#015"/>
            <class class_ref="0173-1#01-ADW542#015"/>
            <class class_ref="0173-1#01-ADW543#015"/>
            <class class_ref="0173-1#01-ADW192#015"/>
            <class class_ref="0173-1#01-ADW440#015"/>
            <class class_ref="0173-1#01-ADW110#015"/>
            <class class_ref="0173-1#01-ADW111#015"/>
            <class class_ref="0173-1#01-ADW112#015"/>
            <class class_ref="0173-1#01-ADW113#015"/>
            <class class_ref="0173-1#01-ADW114#015"/>
            <class class_ref="0173-1#01-ADW115#015"/>
            <class class_ref="0173-1#01-ADW116#015"/>
            <class class_ref="0173-1#01-ADW117#015"/>
            <class class_ref="0173-1#01-ADW118#015"/>
            <class class_ref="0173-1#01-ADW119#015"/>
            <class class_ref="0173-1#01-ADW120#015"/>
            <class class_ref="0173-1#01-ADW121#015"/>
            <class class_ref="0173-1#01-ADW122#015"/>
            <class class_ref="0173-1#01-ADW123#015"/>
            <class class_ref="0173-1#01-ADW124#015"/>
            <class class_ref="0173-1#01-ADW125#015"/>
            <class class_ref="0173-1#01-ADW126#015"/>
            <class class_ref="0173-1#01-ADW127#015"/>
            <class class_ref="0173-1#01-ADW128#015"/>
            <class class_ref="0173-1#01-ADW129#015"/>
            <class class_ref="0173-1#01-ADW130#015"/>
            <class class_ref="0173-1#01-ADW131#015"/>
            <class class_ref="0173-1#01-ADW132#015"/>
            <class class_ref="0173-1#01-ADW133#015"/>
            <class class_ref="0173-1#01-ADW134#015"/>
            <class class_ref="0173-1#01-ADW135#015"/>
            <class class_ref="0173-1#01-ADW136#015"/>
            <class class_ref="0173-1#01-ADW137#015"/>
            <class class_ref="0173-1#01-ADW138#015"/>
            <class class_ref="0173-1#01-ADW139#015"/>
            <class class_ref="0173-1#01-ADW140#015"/>
            <class class_ref="0173-1#01-ADW141#015"/>
            <class class_ref="0173-1#01-ADW142#015"/>
            <class class_ref="0173-1#01-ADW143#015"/>
            <class class_ref="0173-1#01-ADW144#015"/>
            <class class_ref="0173-1#01-ADW145#015"/>
            <class class_ref="0173-1#01-ADW146#015"/>
            <class class_ref="0173-1#01-ADW147#015"/>
            <class class_ref="0173-1#01-ADW148#015"/>
            <class class_ref="0173-1#01-ADW149#015"/>
            <class class_ref="0173-1#01-ADW150#015"/>
            <class class_ref="0173-1#01-ADW151#015"/>
            <class class_ref="0173-1#01-ADW152#015"/>
            <class class_ref="0173-1#01-ADW153#015"/>
            <class class_ref="0173-1#01-ADW154#015"/>
            <class class_ref="0173-1#01-ADW155#015"/>
            <class class_ref="0173-1#01-ADW156#015"/>
            <class class_ref="0173-1#01-ADW157#015"/>
            <class class_ref="0173-1#01-ADW158#015"/>
            <class class_ref="0173-1#01-ADW159#015"/>
            <class class_ref="0173-1#01-ADW160#015"/>
            <class class_ref="0173-1#01-ADW161#015"/>
            <class class_ref="0173-1#01-ADW162#015"/>
            <class class_ref="0173-1#01-ADW293#015"/>
            <class class_ref="0173-1#01-ADW906#015"/>
            <class class_ref="0173-1#01-ADW742#015"/>
            <class class_ref="0173-1#01-ADW743#015"/>
            <class class_ref="0173-1#01-ADW744#015"/>
            <class class_ref="0173-1#01-ADW745#015"/>
            <class class_ref="0173-1#01-ADW746#015"/>
            <class class_ref="0173-1#01-ADW747#015"/>
            <class class_ref="0173-1#01-ADW748#015"/>
            <class class_ref="0173-1#01-ADW749#015"/>
            <class class_ref="0173-1#01-ADW750#015"/>
            <class class_ref="0173-1#01-ADW751#015"/>
            <class class_ref="0173-1#01-ADW752#015"/>
            <class class_ref="0173-1#01-ADW753#015"/>
            <class class_ref="0173-1#01-ADW754#015"/>
            <class class_ref="0173-1#01-ADW755#015"/>
            <class class_ref="0173-1#01-ADW756#015"/>
            <class class_ref="0173-1#01-ADW757#015"/>
            <class class_ref="0173-1#01-ADW758#015"/>
            <class class_ref="0173-1#01-ADW759#015"/>
            <class class_ref="0173-1#01-ADW760#015"/>
            <class class_ref="0173-1#01-ADW761#015"/>
            <class class_ref="0173-1#01-ADW762#015"/>
            <class class_ref="0173-1#01-ADW763#015"/>
            <class class_ref="0173-1#01-ADW764#015"/>
            <class class_ref="0173-1#01-ADW765#015"/>
            <class class_ref="0173-1#01-ADW766#015"/>
            <class class_ref="0173-1#01-ADW767#015"/>
            <class class_ref="0173-1#01-ADW768#015"/>
            <class class_ref="0173-1#01-ADW769#015"/>
            <class class_ref="0173-1#01-ADW770#015"/>
            <class class_ref="0173-1#01-ADW771#015"/>
            <class class_ref="0173-1#01-ADW772#015"/>
            <class class_ref="0173-1#01-ADW773#015"/>
            <class class_ref="0173-1#01-ADW774#015"/>
            <class class_ref="0173-1#01-ADW775#015"/>
            <class class_ref="0173-1#01-ADW776#015"/>
            <class class_ref="0173-1#01-ADW777#015"/>
            <class class_ref="0173-1#01-ADW778#015"/>
            <class class_ref="0173-1#01-ADW779#015"/>
            <class class_ref="0173-1#01-ADW780#015"/>
            <class class_ref="0173-1#01-ADW781#015"/>
            <class class_ref="0173-1#01-ADW782#015"/>
            <class class_ref="0173-1#01-ADW783#015"/>
            <class class_ref="0173-1#01-ADW784#015"/>
            <class class_ref="0173-1#01-ADW785#015"/>
            <class class_ref="0173-1#01-ADW786#015"/>
            <class class_ref="0173-1#01-ADW787#015"/>
            <class class_ref="0173-1#01-ADW788#015"/>
            <class class_ref="0173-1#01-ADW789#015"/>
            <class class_ref="0173-1#01-ADW790#015"/>
            <class class_ref="0173-1#01-ADW791#015"/>
            <class class_ref="0173-1#01-ADW792#015"/>
            <class class_ref="0173-1#01-ADW793#015"/>
            <class class_ref="0173-1#01-ADW794#015"/>
            <class class_ref="0173-1#01-ADW795#015"/>
            <class class_ref="0173-1#01-ADW796#015"/>
            <class class_ref="0173-1#01-ADW797#015"/>
            <class class_ref="0173-1#01-ADW798#015"/>
            <class class_ref="0173-1#01-ADW652#015"/>
            <class class_ref="0173-1#01-ADW653#015"/>
            <class class_ref="0173-1#01-ADW654#015"/>
            <class class_ref="0173-1#01-ADW655#015"/>
            <class class_ref="0173-1#01-ADW656#015"/>
            <class class_ref="0173-1#01-ADW657#015"/>
            <class class_ref="0173-1#01-ADW658#015"/>
            <class class_ref="0173-1#01-ADW659#015"/>
            <class class_ref="0173-1#01-ADW660#015"/>
            <class class_ref="0173-1#01-ADW661#015"/>
            <class class_ref="0173-1#01-ADW662#015"/>
            <class class_ref="0173-1#01-ADW663#015"/>
            <class class_ref="0173-1#01-ADW664#015"/>
            <class class_ref="0173-1#01-ADW665#015"/>
            <class class_ref="0173-1#01-ADW666#015"/>
            <class class_ref="0173-1#01-ADW667#015"/>
            <class class_ref="0173-1#01-ADW668#015"/>
            <class class_ref="0173-1#01-ADW669#015"/>
            <class class_ref="0173-1#01-ADW670#015"/>
            <class class_ref="0173-1#01-ADW671#015"/>
            <class class_ref="0173-1#01-ADW672#015"/>
            <class class_ref="0173-1#01-ADW673#015"/>
            <class class_ref="0173-1#01-ADW674#015"/>
            <class class_ref="0173-1#01-ADW675#015"/>
            <class class_ref="0173-1#01-ADW676#015"/>
            <class class_ref="0173-1#01-ADW677#015"/>
            <class class_ref="0173-1#01-ADW678#015"/>
            <class class_ref="0173-1#01-ADW679#015"/>
            <class class_ref="0173-1#01-ADW680#015"/>
            <class class_ref="0173-1#01-ADW681#015"/>
            <class class_ref="0173-1#01-ADW682#015"/>
            <class class_ref="0173-1#01-ADW683#015"/>
            <class class_ref="0173-1#01-ADW684#015"/>
            <class class_ref="0173-1#01-ADW685#015"/>
            <class class_ref="0173-1#01-ADW686#015"/>
            <class class_ref="0173-1#01-ADW687#015"/>
            <class class_ref="0173-1#01-ADW688#015"/>
            <class class_ref="0173-1#01-ADW689#015"/>
            <class class_ref="0173-1#01-ADW690#015"/>
            <class class_ref="0173-1#01-ADW691#015"/>
            <class class_ref="0173-1#01-ADW692#015"/>
            <class class_ref="0173-1#01-ADW693#015"/>
            <class class_ref="0173-1#01-ADW694#015"/>
            <class class_ref="0173-1#01-ADW695#015"/>
            <class class_ref="0173-1#01-ADW696#015"/>
            <class class_ref="0173-1#01-ADW697#015"/>
            <class class_ref="0173-1#01-ADW698#015"/>
            <class class_ref="0173-1#01-ADW699#015"/>
            <class class_ref="0173-1#01-ADW700#015"/>
            <class class_ref="0173-1#01-ADW701#015"/>
            <class class_ref="0173-1#01-ADW702#015"/>
            <class class_ref="0173-1#01-ADW703#015"/>
            <class class_ref="0173-1#01-ADW704#015"/>
            <class class_ref="0173-1#01-ADW705#015"/>
            <class class_ref="0173-1#01-ADW706#015"/>
            <class class_ref="0173-1#01-ADW707#015"/>
            <class class_ref="0173-1#01-ADW708#015"/>
            <class class_ref="0173-1#01-ADW709#015"/>
            <class class_ref="0173-1#01-ADW313#015"/>
            <class class_ref="0173-1#01-ADW314#015"/>
            <class class_ref="0173-1#01-ADW315#015"/>
            <class class_ref="0173-1#01-ADW316#015"/>
            <class class_ref="0173-1#01-ADW317#015"/>
            <class class_ref="0173-1#01-ADW318#015"/>
            <class class_ref="0173-1#01-ADW319#015"/>
            <class class_ref="0173-1#01-ADW320#015"/>
            <class class_ref="0173-1#01-ADW321#015"/>
            <class class_ref="0173-1#01-ADW322#015"/>
            <class class_ref="0173-1#01-ADW323#015"/>
            <class class_ref="0173-1#01-ADW324#015"/>
            <class class_ref="0173-1#01-ADW325#015"/>
            <class class_ref="0173-1#01-ADW326#015"/>
            <class class_ref="0173-1#01-ADW327#015"/>
            <class class_ref="0173-1#01-ADW328#015"/>
            <class class_ref="0173-1#01-ADW329#015"/>
            <class class_ref="0173-1#01-ADW330#015"/>
            <class class_ref="0173-1#01-ADW331#015"/>
            <class class_ref="0173-1#01-ADW332#015"/>
            <class class_ref="0173-1#01-ADW333#015"/>
            <class class_ref="0173-1#01-ADW334#015"/>
            <class class_ref="0173-1#01-ADW335#015"/>
            <class class_ref="0173-1#01-ADW336#015"/>
            <class class_ref="0173-1#01-ADW337#015"/>
            <class class_ref="0173-1#01-ADW338#015"/>
            <class class_ref="0173-1#01-ADW339#015"/>
            <class class_ref="0173-1#01-ADW340#015"/>
            <class class_ref="0173-1#01-ADW341#015"/>
            <class class_ref="0173-1#01-ADW342#015"/>
            <class class_ref="0173-1#01-ADW343#015"/>
            <class class_ref="0173-1#01-ADW344#015"/>
            <class class_ref="0173-1#01-ADW345#015"/>
            <class class_ref="0173-1#01-ADW346#015"/>
            <class class_ref="0173-1#01-ADW347#015"/>
            <class class_ref="0173-1#01-ADW348#015"/>
            <class class_ref="0173-1#01-ADW349#015"/>
            <class class_ref="0173-1#01-ADW350#015"/>
            <class class_ref="0173-1#01-ADW351#015"/>
            <class class_ref="0173-1#01-ADW352#015"/>
            <class class_ref="0173-1#01-ADW353#015"/>
            <class class_ref="0173-1#01-ADW354#015"/>
            <class class_ref="0173-1#01-ADW355#015"/>
            <class class_ref="0173-1#01-ADW356#015"/>
            <class class_ref="0173-1#01-ADW357#015"/>
            <class class_ref="0173-1#01-ADW358#015"/>
            <class class_ref="0173-1#01-ADW359#015"/>
            <class class_ref="0173-1#01-ADW360#015"/>
            <class class_ref="0173-1#01-ADW361#015"/>
            <class class_ref="0173-1#01-ADW362#015"/>
            <class class_ref="0173-1#01-ADW363#015"/>
            <class class_ref="0173-1#01-ADW364#015"/>
            <class class_ref="0173-1#01-ADW365#015"/>
            <class class_ref="0173-1#01-ADW366#015"/>
            <class class_ref="0173-1#01-ADW367#015"/>
            <class class_ref="0173-1#01-ADW368#015"/>
            <class class_ref="0173-1#01-ADW369#015"/>
            <class class_ref="0173-1#01-ADW370#015"/>
            <class class_ref="0173-1#01-ADW371#015"/>
            <class class_ref="0173-1#01-ADW372#015"/>
            <class class_ref="0173-1#01-ADW373#015"/>
            <class class_ref="0173-1#01-ADW374#015"/>
            <class class_ref="0173-1#01-ADW375#015"/>
            <class class_ref="0173-1#01-ADW376#015"/>
            <class class_ref="0173-1#01-ADW377#015"/>
            <class class_ref="0173-1#01-ADW378#015"/>
            <class class_ref="0173-1#01-ADW379#015"/>
            <class class_ref="0173-1#01-ADV951#015"/>
            <class class_ref="0173-1#01-ADV952#015"/>
            <class class_ref="0173-1#01-ADV953#015"/>
            <class class_ref="0173-1#01-ADV954#015"/>
            <class class_ref="0173-1#01-ADV955#015"/>
            <class class_ref="0173-1#01-ADV956#015"/>
            <class class_ref="0173-1#01-ADV957#015"/>
            <class class_ref="0173-1#01-ADV958#015"/>
            <class class_ref="0173-1#01-ADV959#015"/>
            <class class_ref="0173-1#01-ADV960#015"/>
            <class class_ref="0173-1#01-ADV961#015"/>
            <class class_ref="0173-1#01-ADV962#015"/>
            <class class_ref="0173-1#01-ADV963#015"/>
            <class class_ref="0173-1#01-ADV964#015"/>
            <class class_ref="0173-1#01-ADV965#015"/>
            <class class_ref="0173-1#01-ADV966#015"/>
            <class class_ref="0173-1#01-ADV967#015"/>
            <class class_ref="0173-1#01-ADV968#015"/>
            <class class_ref="0173-1#01-ADV969#015"/>
            <class class_ref="0173-1#01-ADV970#015"/>
            <class class_ref="0173-1#01-ADV971#015"/>
            <class class_ref="0173-1#01-ADV972#015"/>
            <class class_ref="0173-1#01-ADV973#015"/>
            <class class_ref="0173-1#01-ADV974#015"/>
            <class class_ref="0173-1#01-ADV975#015"/>
            <class class_ref="0173-1#01-ADV976#015"/>
            <class class_ref="0173-1#01-ADV977#015"/>
            <class class_ref="0173-1#01-ADV978#015"/>
            <class class_ref="0173-1#01-ADV979#015"/>
            <class class_ref="0173-1#01-ADV980#015"/>
            <class class_ref="0173-1#01-ADV981#015"/>
            <class class_ref="0173-1#01-ADV982#015"/>
            <class class_ref="0173-1#01-ADV983#015"/>
            <class class_ref="0173-1#01-ADV984#015"/>
            <class class_ref="0173-1#01-ADV985#015"/>
            <class class_ref="0173-1#01-ADV986#015"/>
            <class class_ref="0173-1#01-ADV987#015"/>
            <class class_ref="0173-1#01-ADV988#015"/>
            <class class_ref="0173-1#01-ADV989#015"/>
            <class class_ref="0173-1#01-ADV990#015"/>
            <class class_ref="0173-1#01-ADV991#015"/>
            <class class_ref="0173-1#01-ADV992#015"/>
            <class class_ref="0173-1#01-ADV993#015"/>
            <class class_ref="0173-1#01-ADV994#015"/>
            <class class_ref="0173-1#01-ADV995#015"/>
            <class class_ref="0173-1#01-ADV996#015"/>
            <class class_ref="0173-1#01-ADV997#015"/>
            <class class_ref="0173-1#01-ADV998#015"/>
            <class class_ref="0173-1#01-ADV999#015"/>
            <class class_ref="0173-1#01-ADW000#015"/>
            <class class_ref="0173-1#01-ADW001#015"/>
            <class class_ref="0173-1#01-ADW002#015"/>
            <class class_ref="0173-1#01-ADW003#015"/>
            <class class_ref="0173-1#01-ADW004#015"/>
            <class class_ref="0173-1#01-ADW005#015"/>
            <class class_ref="0173-1#01-ADW006#015"/>
            <class class_ref="0173-1#01-ADW007#015"/>
            <class class_ref="0173-1#01-ADW008#015"/>
            <class class_ref="0173-1#01-ADW009#015"/>
            <class class_ref="0173-1#01-ADW010#015"/>
            <class class_ref="0173-1#01-ADW011#015"/>
            <class class_ref="0173-1#01-ADW012#015"/>
            <class class_ref="0173-1#01-ADW013#015"/>
            <class class_ref="0173-1#01-ADW014#015"/>
            <class class_ref="0173-1#01-ADW015#015"/>
            <class class_ref="0173-1#01-ADW016#015"/>
            <class class_ref="0173-1#01-ADW017#015"/>
            <class class_ref="0173-1#01-ADW018#015"/>
            <class class_ref="0173-1#01-ADW570#015"/>
            <class class_ref="0173-1#01-ADW571#015"/>
            <class class_ref="0173-1#01-ADW572#015"/>
            <class class_ref="0173-1#01-ADW573#015"/>
            <class class_ref="0173-1#01-ADW574#015"/>
            <class class_ref="0173-1#01-ADW575#015"/>
            <class class_ref="0173-1#01-ADW576#015"/>
            <class class_ref="0173-1#01-ADW577#015"/>
            <class class_ref="0173-1#01-ADW578#015"/>
            <class class_ref="0173-1#01-ADW579#015"/>
            <class class_ref="0173-1#01-ADW580#015"/>
            <class class_ref="0173-1#01-ADW581#015"/>
            <class class_ref="0173-1#01-ADW582#015"/>
            <class class_ref="0173-1#01-ADW583#015"/>
            <class class_ref="0173-1#01-ADW584#015"/>
            <class class_ref="0173-1#01-ADW585#015"/>
            <class class_ref="0173-1#01-ADW586#015"/>
            <class class_ref="0173-1#01-ADW587#015"/>
            <class class_ref="0173-1#01-ADW588#015"/>
            <class class_ref="0173-1#01-ADW589#015"/>
            <class class_ref="0173-1#01-ADW590#015"/>
            <class class_ref="0173-1#01-ADW591#015"/>
            <class class_ref="0173-1#01-ADW592#015"/>
            <class class_ref="0173-1#01-ADW593#015"/>
            <class class_ref="0173-1#01-ADW594#015"/>
            <class class_ref="0173-1#01-ADW595#015"/>
            <class class_ref="0173-1#01-ADW596#015"/>
            <class class_ref="0173-1#01-ADW597#015"/>
            <class class_ref="0173-1#01-ADW598#015"/>
            <class class_ref="0173-1#01-ADW599#015"/>
            <class class_ref="0173-1#01-ADW600#015"/>
            <class class_ref="0173-1#01-ADW601#015"/>
            <class class_ref="0173-1#01-ADW602#015"/>
            <class class_ref="0173-1#01-ADW603#015"/>
            <class class_ref="0173-1#01-ADW604#015"/>
            <class class_ref="0173-1#01-ADW605#015"/>
            <class class_ref="0173-1#01-ADW606#015"/>
            <class class_ref="0173-1#01-ADW607#015"/>
            <class class_ref="0173-1#01-ADW608#015"/>
            <class class_ref="0173-1#01-ADW609#015"/>
            <class class_ref="0173-1#01-ADW610#015"/>
            <class class_ref="0173-1#01-ADW611#015"/>
            <class class_ref="0173-1#01-ADW612#015"/>
            <class class_ref="0173-1#01-ADW613#015"/>
            <class class_ref="0173-1#01-ADW614#015"/>
            <class class_ref="0173-1#01-ADW615#015"/>
            <class class_ref="0173-1#01-ADW616#015"/>
            <class class_ref="0173-1#01-ADW617#015"/>
            <class class_ref="0173-1#01-ADW618#015"/>
            <class class_ref="0173-1#01-ADW619#015"/>
            <class class_ref="0173-1#01-ADW620#015"/>
            <class class_ref="0173-1#01-ADW621#015"/>
            <class class_ref="0173-1#01-ADW622#015"/>
            <class class_ref="0173-1#01-ADW623#015"/>
            <class class_ref="0173-1#01-ADW624#015"/>
            <class class_ref="0173-1#01-ADW625#015"/>
            <class class_ref="0173-1#01-ADW626#015"/>
            <class class_ref="0173-1#01-ADW627#015"/>
            <class class_ref="0173-1#01-ADW628#015"/>
            <class class_ref="0173-1#01-ADW629#015"/>
            <class class_ref="0173-1#01-ADW630#015"/>
            <class class_ref="0173-1#01-ADW631#015"/>
            <class class_ref="0173-1#01-ADW632#015"/>
            <class class_ref="0173-1#01-ADW633#015"/>
            <class class_ref="0173-1#01-ADW634#015"/>
            <class class_ref="0173-1#01-ADW635#015"/>
            <class class_ref="0173-1#01-ADW651#015"/>
          </is_case_of>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:CATEGORIZATION_CLASS_Type" id="0173-1#01-AAA002#001" guid="f708f5e2666157e628412aeb54dc547c">
          <date_of_original_definition>2006-12-19Z</date_of_original_definition>
          <date_of_current_version>2023-07-20Z</date_of_current_version>
          <date_of_current_revision>2006-12-19Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">ECLASS</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Native">hierarchical dictionary of products, systems and services according to a logical structure and levels of detail corresponding to the specific properties of these products</text>
          </definition>
          <hierarchical_position></hierarchical_position>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:ITEM_CLASS_Type" id="0173-1---BASIC_1_1#01-AAA001#001" guid="e779b15189f7446cb1e436c827eba37f">
          <date_of_original_definition>2024-04-18Z</date_of_original_definition>
          <date_of_current_version>2024-04-18Z</date_of_current_version>
          <date_of_current_revision>2024-04-18Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">ECLASS Application Classes</label>
          </preferred_name>
          <definition>
            <text language_code="en" country_code="US" translation_quality_level="Native">representation of a type or family of product (device, equipment, software or service) which can be described by a generic set of properties</text>
          </definition>
          <its_superclass class_ref="0173-1#01-RAA001#001"/>
          <instance_sharable>true</instance_sharable>
        </ontoml:class>
        <ontoml:class xsi:type="ontoml:ITEM_CLASS_Type" id="0173-1#01-RAA001#001" guid="fd29e8bb51a74c67919d512ea690c0d4">
          <date_of_original_definition>2000-01-01Z</date_of_original_definition>
          <date_of_current_version>2000-01-01Z</date_of_current_version>
          <date_of_current_revision>2000-01-01Z</date_of_current_revision>
          <revision>1</revision>
          <status>66</status>
          <source_language language_code="en" country_code="US"/>
          <preferred_name>
            <label language_code="en" country_code="US" translation_quality_level="Non-Native">ECLASS</label>
          </preferred_name>
          <definition>
            <text>-</text>
          </definition>
        </ontoml:class>
      </contained_classes>
      <contained_suppliers>
        <ontoml:supplier id="0173-1">
          <revision>1</revision>
          <org>
            <id>0173-1</id>
            <name>ECLASS</name>
          </org>
        </ontoml:supplier>
      </contained_suppliers>
    </dictionary>
  </ontoml:ontoml>
</dic:eclass_dictionary>